"dataset_name","analysis_key","analysis_number","subgroup_number","analysis_name","k","double_zero","sparse_events","orcc_ok","rd_ok","recommended_method","recommendation_reason"
"CD000028_pub4_data","1::overall","1","overall","All-cause mortality",13,0,0,TRUE,TRUE,"OR_cc","default_or"
"CD000028_pub4_data","2::1","2","1","Cause of cardiovascular mortality",22,0,2,TRUE,TRUE,"RD","sparse_events"
"CD000028_pub4_data","2::2","2","2","Cause of cardiovascular mortality",20,0,2,TRUE,TRUE,"RD","sparse_events"
"CD000028_pub4_data","3::overall","3","overall","Cardiovascular mortality and morbidity",15,0,0,TRUE,TRUE,"OR_cc","default_or"
"CD000028_pub4_data","4::overall","4","overall","Cerebrovascular mortality and morbidity",13,0,0,TRUE,TRUE,"OR_cc","default_or"
"CD000028_pub4_data","5::overall","5","overall","Coronary heart disease mortality and morbidity",13,0,0,TRUE,TRUE,"OR_cc","default_or"
"CD000028_pub4_data","6::overall","6","overall","Withdrawal due to adverse effects",4,0,0,TRUE,TRUE,"OR_cc","default_or"
"CD000028_pub4_data","1::1","1","1","All-cause mortality",12,0,0,TRUE,TRUE,"OR_cc","default_or"
"CD000028_pub4_data","1::2","1","2","All-cause mortality",11,1,1,TRUE,TRUE,"RD","double_zero"
"CD000028_pub4_data","3::1","3","1","Cerebrovascular mortality and morbidity",11,0,0,TRUE,TRUE,"OR_cc","default_or"
"CD000028_pub4_data","3::2","3","2","Cerebrovascular mortality and morbidity",10,0,1,TRUE,TRUE,"RD","sparse_events"
"CD000028_pub4_data","4::1","4","1","Coronary heart disease mortality and morbidity",10,0,0,TRUE,TRUE,"OR_cc","default_or"
"CD000028_pub4_data","4::2","4","2","Coronary heart disease mortality and morbidity",9,1,4,TRUE,TRUE,"RD","double_zero"
"CD000143_pub2_data","1::overall","1","overall","Extubation failure",47,0,3,TRUE,TRUE,"RD","sparse_events"
"CD000143_pub2_data","2::overall","2","overall","Endotracheal reintubation",23,0,3,TRUE,TRUE,"RD","sparse_events"
"CD000143_pub2_data","4::overall","4","overall","Oxygen dependency at 28 days",5,0,0,TRUE,TRUE,"OR_cc","default_or"
"CD000219_pub5_data","1::overall","1","overall","Pain",27,0,0,TRUE,TRUE,"OR_cc","default_or"
"CD000219_pub5_data","2::overall","2","overall","Vomiting, diarrhoea or rash",11,0,2,TRUE,TRUE,"RD","sparse_events"
"CD000219_pub5_data","3::overall","3","overall","Abnormal tympanometry",14,0,0,TRUE,TRUE,"OR_cc","default_or"
"CD000219_pub5_data","4::overall","4","overall","Tympanic membrane perforation",7,2,4,TRUE,TRUE,"RD","double_zero"
"CD000219_pub5_data","5::overall","5","overall","Contralateral otitis (in unilateral cases)",6,0,0,TRUE,TRUE,"OR_cc","default_or"
"CD000219_pub5_data","6::overall","6","overall","Late AOM recurrences",6,0,0,TRUE,TRUE,"OR_cc","default_or"
"CD000478_pub5_data","1::overall","1","overall","Failure to maintain remission",32,1,8,TRUE,TRUE,"RD","double_zero"
"CD000478_pub5_data","2::overall","2","overall","Withdrawal due to adverse event",6,2,5,TRUE,TRUE,"RD","double_zero"
"CD000478_pub5_data","3::overall","3","overall","Pancreatitis",2,0,2,TRUE,TRUE,"RD","sparse_events"
"CD000478_pub5_data","4::overall","4","overall","Bone marrow suppression",2,0,2,TRUE,TRUE,"RD","sparse_events"
"CD000547_pub3_data","5::overall","5","overall","Haemoglobin (preoperative)",25,14,18,TRUE,TRUE,"RD","double_zero"
"CD000547_pub3_data","7::overall","7","overall","Total frequency of adverse events",63,5,35,TRUE,TRUE,"RD","double_zero"
"CD000547_pub3_data","8::overall","8","overall","Individual adverse events",57,1,12,TRUE,TRUE,"RD","double_zero"
"CD000547_pub3_data","6::overall","6","overall","Postoperative morbidity (complications)",17,0,9,TRUE,TRUE,"RD","sparse_events"
"CD000547_pub3_data","9::overall","9","overall","Proportion undergoing vaginal rather than abdominal procedure",4,1,1,TRUE,TRUE,"RD","double_zero"
"CD000547_pub3_data","10::overall","10","overall","Proportion with vertical incision",43,0,10,TRUE,TRUE,"RD","sparse_events"
"CD000547_pub3_data","4::overall","4","overall","Frequency of blood transfusions",9,3,6,TRUE,TRUE,"RD","double_zero"
"CD001155_pub3_data","1::overall","1","overall","Clinical vertebral fractures",182,89,128,TRUE,TRUE,"RD","double_zero"
"CD001155_pub3_data","2::overall","2","overall","Non-vertebral fractures",494,195,284,TRUE,TRUE,"RD","double_zero"
"CD001155_pub3_data","3::overall","3","overall","Hip fractures",83,43,50,TRUE,TRUE,"RD","double_zero"
"CD001155_pub3_data","4::overall","4","overall","Wrist fractures",78,29,49,TRUE,TRUE,"RD","double_zero"
"CD001155_pub3_data","5::overall","5","overall","Radiographic vertebral fractures",47,7,14,TRUE,TRUE,"RD","double_zero"
"CD001155_pub3_data","6::overall","6","overall","Withdrawals due to adverse events",40,4,15,TRUE,TRUE,"RD","double_zero"
"CD001155_pub3_data","7::overall","7","overall","Serious adverse events",21,1,2,TRUE,TRUE,"RD","double_zero"
"CD001155_pub3_data","8::overall","8","overall","Gastrointestinal adverse events",21,2,3,TRUE,TRUE,"RD","double_zero"
"CD001321_pub7_data","1::overall","1","overall","Symptomatic UTI: culture-verified UTI",103,4,11,TRUE,TRUE,"RD","double_zero"
"CD001321_pub7_data","2::overall","2","overall","Clinical UTI: symptoms, no culture",30,1,4,TRUE,TRUE,"RD","double_zero"
"CD001321_pub7_data","3::overall","3","overall","Microbiological UTI: positive culture without known symptoms",8,0,1,TRUE,TRUE,"RD","sparse_events"
"CD001321_pub7_data","4::overall","4","overall","Death",4,1,1,TRUE,TRUE,"RD","double_zero"
"CD001321_pub7_data","5::overall","5","overall","Gastrointestinal adverse events",10,0,5,TRUE,TRUE,"RD","sparse_events"
"CD001396_pub4_data","1::overall","1","overall","Self-rated overall premenstrual symptoms",49,46,46,TRUE,TRUE,"RD","double_zero"
"CD001396_pub4_data","2::overall","2","overall","Nausea",56,0,4,TRUE,TRUE,"RD","sparse_events"
"CD001396_pub4_data","3::overall","3","overall","Insomnia or sleep disturbance",29,0,6,TRUE,TRUE,"RD","sparse_events"
"CD001396_pub4_data","4::overall","4","overall","Sexual dysfunction or decreased libido",23,0,6,TRUE,TRUE,"RD","sparse_events"
"CD001396_pub4_data","5::overall","5","overall","Fatigue or sedation",14,0,4,TRUE,TRUE,"RD","sparse_events"
"CD001396_pub4_data","6::overall","6","overall","Dizziness or vertigo",21,0,5,TRUE,TRUE,"RD","sparse_events"
"CD001396_pub4_data","7::overall","7","overall","Tremor",8,0,3,TRUE,TRUE,"RD","sparse_events"
"CD001396_pub4_data","8::overall","8","overall","Somnolence/decreased concentration",14,0,2,TRUE,TRUE,"RD","sparse_events"
"CD001396_pub4_data","9::overall","9","overall","Sweating",16,0,1,TRUE,TRUE,"RD","sparse_events"
"CD001396_pub4_data","10::overall","10","overall","Dry mouth",16,0,3,TRUE,TRUE,"RD","sparse_events"
"CD001396_pub4_data","11::overall","11","overall","Asthenia/decreased energy",13,0,3,TRUE,TRUE,"RD","sparse_events"
"CD001396_pub4_data","12::overall","12","overall","Diarrhoea",19,0,5,TRUE,TRUE,"RD","sparse_events"
"CD001396_pub4_data","13::overall","13","overall","Constipation",10,0,7,TRUE,TRUE,"RD","sparse_events"
"CD001396_pub4_data","14::overall","14","overall","Withdrawal due to adverse effects",26,0,7,TRUE,TRUE,"RD","sparse_events"
"CD001396_pub4_data","19::overall","19","overall","Response rates",30,0,0,TRUE,TRUE,"OR_cc","default_or"
"CD001396_pub4_data","20::overall","20","overall","Withdrawal for any reason",18,2,2,TRUE,TRUE,"RD","double_zero"
"CD001431_pub6_data","1::overall","1","overall","Informed values-choice congruence - all studies",437,249,256,TRUE,TRUE,"RD","double_zero"
"CD001431_pub6_data","2::overall","2","overall","Informed values-choice congruence - without studies of high risk of bias",377,200,207,TRUE,TRUE,"RD","double_zero"
"CD001431_pub6_data","3::overall","3","overall","Informed values-choice congruence - old vs new studies",353,237,243,TRUE,TRUE,"RD","double_zero"
"CD001431_pub6_data","4::overall","4","overall","Informed values-chose congruence - using MMIC",136,61,61,TRUE,TRUE,"RD","double_zero"
"CD001431_pub6_data","5::overall","5","overall","Informed values-chose congruence - using non-MMIC measures",116,49,50,TRUE,TRUE,"RD","double_zero"
"CD001431_pub6_data","6::overall","6","overall","Unclear values - old vs new studies",60,56,56,TRUE,TRUE,"RD","double_zero"
"CD001533_pub7_data","1::overall","1","overall","Number with frequent relapses by 12 to 24 months",43,5,6,TRUE,TRUE,"RD","double_zero"
"CD001533_pub7_data","2::overall","2","overall","Number relapsing by 12 to 24 months",47,6,11,TRUE,TRUE,"RD","double_zero"
"CD001533_pub7_data","3::overall","3","overall","Number with frequent relapses by 12 to 24 months: stratified by risk of selection bias",30,7,12,TRUE,TRUE,"RD","double_zero"
"CD001533_pub7_data","4::overall","4","overall","Number relapsing by 12 to 24 months: stratified by risk of selection bias",27,7,7,TRUE,TRUE,"RD","double_zero"
"CD001533_pub7_data","5::overall","5","overall","Adverse events",68,13,24,TRUE,TRUE,"RD","double_zero"
"CD001552_pub3_data","1::overall","1","overall","Clinical improvement at short-term follow-up: 3 months or less",10,3,3,TRUE,TRUE,"RD","double_zero"
"CD001552_pub3_data","2::overall","2","overall","Clinical improvement at long-term follow-up: over 3 months",13,6,6,TRUE,TRUE,"RD","double_zero"
"CD001552_pub3_data","3::overall","3","overall","Symptoms at short-term follow-up: 3 months or less",11,10,11,FALSE,TRUE,"RD","double_zero"
"CD001552_pub3_data","6::overall","6","overall","Function at long-term follow-up: over 3 months",8,7,7,FALSE,TRUE,"RD","double_zero"
"CD001552_pub3_data","7::overall","7","overall","Health-related quality of life at long-term follow-up: over 3 months",5,4,5,FALSE,TRUE,"RD","double_zero"
"CD001552_pub3_data","8::overall","8","overall","Adverse effects",4,2,3,TRUE,TRUE,"RD","double_zero"
"CD001552_pub3_data","9::overall","9","overall","Need for surgery or secondary surgery at short-term follow-up: 3 months or less",4,1,3,TRUE,TRUE,"RD","double_zero"
"CD001552_pub3_data","10::overall","10","overall","Need for surgery or secondary surgery at long-term follow-up: over 3 months",6,0,4,TRUE,TRUE,"RD","sparse_events"
"CD001703_pub4_data","25::overall","25","overall","Non-specific low back pain and spine-related leg pain: total adverse events",18,1,2,TRUE,TRUE,"RD","double_zero"
"CD001703_pub4_data","26::overall","26","overall","Non-specific low back pain and spine-related leg pain: serious adverse events",10,1,6,TRUE,TRUE,"RD","double_zero"
"CD001703_pub4_data","27::overall","27","overall","Non-specific low back pain and spine-related leg pain: withdrawals due to adverse events",22,1,7,TRUE,TRUE,"RD","double_zero"
"CD001797_pub4_data","1::overall","1","overall","Significant improvement in disability within 6 weeks",8,1,2,TRUE,TRUE,"RD","double_zero"
"CD001797_pub4_data","2::overall","2","overall","Significant improvement in disability within 6 weeks; generic inverse variance approach",4,2,2,TRUE,TRUE,"RD","double_zero"
"CD001797_pub4_data","3::overall","3","overall","Improvement ≥ 1 point on Rankin scale",5,2,3,TRUE,TRUE,"RD","double_zero"
"CD001797_pub4_data","6::overall","6","overall","Change in mean disability score on Rankin scale within 6 weeks",5,4,5,FALSE,TRUE,"RD","double_zero"
"CD001797_pub4_data","7::overall","7","overall","Change in muscle strength (mean Medical Research Council sum score) within 6 weeks",4,2,3,TRUE,TRUE,"RD","double_zero"
"CD001797_pub4_data","8::overall","8","overall","Change in mean disability score at 24 weeks or later",2,1,1,FALSE,TRUE,"RD","double_zero"
"CD001797_pub4_data","9::overall","9","overall","Frequency of serious side effects",3,0,1,TRUE,TRUE,"RD","sparse_events"
"CD001797_pub4_data","10::overall","10","overall","Frequency of any side effects",3,0,1,TRUE,TRUE,"RD","sparse_events"
"CD001837_pub4_data","1::overall","1","overall","Quit at longest follow-up (6 + months)",110,0,0,TRUE,TRUE,"OR_cc","default_or"
"CD001837_pub4_data","2::overall","2","overall","Combined (pharmacotherapy + behavioural) support versus no support post-discharge",20,0,0,TRUE,TRUE,"OR_cc","default_or"
"CD001837_pub4_data","3::overall","3","overall","Varenicline vs placebo or no varenicline",7,0,0,TRUE,TRUE,"OR_cc","default_or"
"CD001837_pub4_data","4::overall","4","overall","Combined (pharmacotherapy + behavioural) support vs neither",7,0,0,TRUE,TRUE,"OR_cc","default_or"
"CD001909_pub4_data","1::overall","1","overall","≥ 50% reduction in seizure frequency (intention-to-treat analysis)",51,4,17,TRUE,TRUE,"RD","double_zero"
"CD001909_pub4_data","2::overall","2","overall","≥ 50% reduction in seizure frequency (worst-case analysis)",25,2,6,TRUE,TRUE,"RD","double_zero"
"CD001909_pub4_data","3::overall","3","overall","≥ 50% reduction in seizure frequency (best-case analysis)",24,0,6,TRUE,TRUE,"RD","sparse_events"
"CD001909_pub4_data","4::overall","4","overall","Nausea",12,1,5,TRUE,TRUE,"RD","double_zero"
"CD001909_pub4_data","5::overall","5","overall","Somnolence",13,1,4,TRUE,TRUE,"RD","double_zero"
"CD001909_pub4_data","6::overall","6","overall","Diplopia",3,0,0,TRUE,TRUE,"OR_cc","default_or"
"CD001909_pub4_data","7::overall","7","overall","Headache",5,0,0,TRUE,TRUE,"OR_cc","default_or"
"CD001920_pub4_data","5::overall","5","overall","Length of stay",141,136,137,TRUE,TRUE,"RD","double_zero"
"CD001920_pub4_data","6::overall","6","overall","Adverse events",168,157,163,TRUE,TRUE,"RD","double_zero"
"CD002042_pub6_data","1::overall","1","overall","Participants exposed to blood transfusion (all trials)",57,0,0,TRUE,TRUE,"OR_cc","default_or"
"CD002042_pub6_data","2::1","2","1","Participants exposed to blood transfusion by clinical specialties",11,0,0,TRUE,TRUE,"OR_cc","default_or"
"CD002042_pub6_data","2::2","2","2","Participants exposed to blood transfusion by clinical specialties",5,0,0,TRUE,TRUE,"OR_cc","default_or"
"CD002042_pub6_data","2::3","2","3","Participants exposed to blood transfusion by clinical specialties",13,0,0,TRUE,TRUE,"OR_cc","default_or"
"CD002042_pub6_data","2::4","2","4","Participants exposed to blood transfusion by clinical specialties",9,0,0,TRUE,TRUE,"OR_cc","default_or"
"CD002042_pub6_data","2::5","2","5","Participants exposed to blood transfusion by clinical specialties",6,0,0,TRUE,TRUE,"OR_cc","default_or"
"CD002042_pub6_data","2::6","2","6","Participants exposed to blood transfusion by clinical specialties",5,0,0,TRUE,TRUE,"OR_cc","default_or"
"CD002042_pub6_data","2::8","2","8","Participants exposed to blood transfusion by clinical specialties",5,0,0,TRUE,TRUE,"OR_cc","default_or"
"CD002042_pub6_data","2::9","2","9","Participants exposed to blood transfusion by clinical specialties",2,0,0,TRUE,TRUE,"OR_cc","default_or"
"CD002042_pub6_data","2::10","2","10","Participants exposed to blood transfusion by clinical specialties",2,0,0,TRUE,TRUE,"OR_cc","default_or"
"CD002042_pub6_data","3::1","3","1","Participants exposed to blood transfusion by threshold difference",35,0,0,TRUE,TRUE,"OR_cc","default_or"
"CD002042_pub6_data","3::2","3","2","Participants exposed to blood transfusion by threshold difference",7,0,0,TRUE,TRUE,"OR_cc","default_or"
"CD002042_pub6_data","4::1","4","1","Participants exposed to blood transfusion by restrictive threshold",20,0,0,TRUE,TRUE,"OR_cc","default_or"
"CD002042_pub6_data","4::2","4","2","Participants exposed to blood transfusion by restrictive threshold",21,0,0,TRUE,TRUE,"OR_cc","default_or"
"CD002042_pub6_data","6::overall","6","overall","30-day mortality",44,7,20,TRUE,TRUE,"RD","double_zero"
"CD002042_pub6_data","7::1","7","1","30-day mortality: subgroup by restrictive haemoglobin level",24,4,8,TRUE,TRUE,"RD","double_zero"
"CD002042_pub6_data","7::2","7","2","30-day mortality: subgroup by restrictive haemoglobin level",19,3,10,TRUE,TRUE,"RD","double_zero"
"CD002042_pub6_data","8::1","8","1","30-day mortality: subgroup by clinical specialties (random-effects model)",5,1,2,TRUE,TRUE,"RD","double_zero"
"CD002042_pub6_data","8::2","8","2","30-day mortality: subgroup by clinical specialties (random-effects model)",4,0,1,TRUE,TRUE,"RD","sparse_events"
"CD002042_pub6_data","8::3","8","3","30-day mortality: subgroup by clinical specialties (random-effects model)",9,2,5,TRUE,TRUE,"RD","double_zero"
"CD002042_pub6_data","8::4","8","4","30-day mortality: subgroup by clinical specialties (random-effects model)",9,1,1,TRUE,TRUE,"RD","double_zero"
"CD002042_pub6_data","8::5","8","5","30-day mortality: subgroup by clinical specialties (random-effects model)",4,1,1,TRUE,TRUE,"RD","double_zero"
"CD002042_pub6_data","8::6","8","6","30-day mortality: subgroup by clinical specialties (random-effects model)",4,0,2,TRUE,TRUE,"RD","sparse_events"
"CD002042_pub6_data","8::8","8","8","30-day mortality: subgroup by clinical specialties (random-effects model)",5,1,5,TRUE,TRUE,"RD","double_zero"
"CD002042_pub6_data","8::10","8","10","30-day mortality: subgroup by clinical specialties (random-effects model)",3,0,2,TRUE,TRUE,"RD","sparse_events"
"CD002042_pub6_data","9::1","9","1","30-day mortality: subgroup by clinical specialties (fixed-effect model)",5,1,2,TRUE,TRUE,"RD","double_zero"
"CD002042_pub6_data","9::2","9","2","30-day mortality: subgroup by clinical specialties (fixed-effect model)",4,0,1,TRUE,TRUE,"RD","sparse_events"
"CD002042_pub6_data","9::3","9","3","30-day mortality: subgroup by clinical specialties (fixed-effect model)",9,2,5,TRUE,TRUE,"RD","double_zero"
"CD002042_pub6_data","9::4","9","4","30-day mortality: subgroup by clinical specialties (fixed-effect model)",9,1,1,TRUE,TRUE,"RD","double_zero"
"CD002042_pub6_data","9::5","9","5","30-day mortality: subgroup by clinical specialties (fixed-effect model)",4,1,1,TRUE,TRUE,"RD","double_zero"
"CD002042_pub6_data","9::6","9","6","30-day mortality: subgroup by clinical specialties (fixed-effect model)",4,0,2,TRUE,TRUE,"RD","sparse_events"
"CD002042_pub6_data","9::8","9","8","30-day mortality: subgroup by clinical specialties (fixed-effect model)",5,1,5,TRUE,TRUE,"RD","double_zero"
"CD002042_pub6_data","9::10","9","10","30-day mortality: subgroup by clinical specialties (fixed-effect model)",3,0,2,TRUE,TRUE,"RD","sparse_events"
"CD002042_pub6_data","10::1","10","1","30-day mortality: subgroup by prospective trial registration vs no prospective registration",27,4,11,TRUE,TRUE,"RD","double_zero"
"CD002042_pub6_data","10::2","10","2","30-day mortality: subgroup by prospective trial registration vs no prospective registration",17,3,9,TRUE,TRUE,"RD","double_zero"
"CD002042_pub6_data","11::1","11","1","30-day mortality: sensitivity analysis by allocation concealment",31,3,11,TRUE,TRUE,"RD","double_zero"
"CD002042_pub6_data","12::overall","12","overall","30-day mortality sensitivity analysis excluding trials at high risk of non-anaemic participants",31,4,11,TRUE,TRUE,"RD","double_zero"
"CD002042_pub6_data","13::overall","13","overall","In-hospital mortality (as defined by triallists)",19,3,6,TRUE,TRUE,"RD","double_zero"
"CD002042_pub6_data","14::overall","14","overall","90-day mortality",11,2,4,TRUE,TRUE,"RD","double_zero"
"CD002042_pub6_data","15::1","15","1","6-month, 12-month mortality",9,0,0,TRUE,TRUE,"OR_cc","default_or"
"CD002042_pub6_data","15::2","15","2","6-month, 12-month mortality",3,0,0,TRUE,TRUE,"OR_cc","default_or"
"CD002042_pub6_data","15::3","15","3","6-month, 12-month mortality",12,0,0,TRUE,TRUE,"OR_cc","default_or"
"CD002042_pub6_data","16::overall","16","overall","Neurocritically ill patients: unfavourable neurological outcome (dichotomised GOS-E or Rankin) at 6 to 12 months",7,0,0,TRUE,TRUE,"OR_cc","default_or"
"CD002042_pub6_data","17::overall","17","overall","Morbidity: myocardial infarction",36,7,23,TRUE,TRUE,"RD","double_zero"
"CD002042_pub6_data","18::overall","18","overall","Morbidity: congestive heart failure",22,4,10,TRUE,TRUE,"RD","double_zero"
"CD002042_pub6_data","19::overall","19","overall","Morbidity: cerebrovascular accident (CVA) – stroke",29,2,16,TRUE,TRUE,"RD","double_zero"
"CD002042_pub6_data","20::overall","20","overall","Morbidity: infection (composite)",39,2,7,TRUE,TRUE,"RD","double_zero"
"CD002042_pub6_data","21::overall","21","overall","Morbidity: pneumonia",21,0,7,TRUE,TRUE,"RD","sparse_events"
"CD002042_pub6_data","22::overall","22","overall","Morbidity: sepsis/bacteraemia",19,1,6,TRUE,TRUE,"RD","double_zero"
"CD002042_pub6_data","23::overall","23","overall","Morbidity: sepsis",13,0,4,TRUE,TRUE,"RD","sparse_events"
"CD002042_pub6_data","24::overall","24","overall","Morbidity: bacteraemia",12,1,3,TRUE,TRUE,"RD","double_zero"
"CD002042_pub6_data","25::overall","25","overall","Morbidity: meningitis, ventriculitis or brain abscess",3,0,1,TRUE,TRUE,"RD","sparse_events"
"CD002042_pub6_data","26::overall","26","overall","Morbidity: wound infection",15,0,5,TRUE,TRUE,"RD","sparse_events"
"CD002042_pub6_data","27::overall","27","overall","Morbidity: thromboembolism",21,2,16,TRUE,TRUE,"RD","double_zero"
"CD002042_pub6_data","28::overall","28","overall","Morbidity: rebleeding",12,1,4,TRUE,TRUE,"RD","double_zero"
"CD002042_pub6_data","29::overall","29","overall","Morbidity: clinically significant bleeding through thrombocytopaenia at longest follow-up",4,0,1,TRUE,TRUE,"RD","sparse_events"
"CD002042_pub6_data","30::overall","30","overall","Morbidity: acute kidney injury (AKI)",15,1,3,TRUE,TRUE,"RD","double_zero"
"CD002042_pub6_data","31::overall","31","overall","Morbidity: renal failure requiring dialysis/replacement therapy",9,3,4,TRUE,TRUE,"RD","double_zero"
"CD002042_pub6_data","32::overall","32","overall","Morbidity: delirium",10,0,1,TRUE,TRUE,"RD","sparse_events"
"CD002042_pub6_data","33::overall","33","overall","Adverse events (composite of all)",18,0,8,TRUE,TRUE,"RD","sparse_events"
"CD002042_pub6_data","34::overall","34","overall","Adverse events (serious only)",10,0,6,TRUE,TRUE,"RD","sparse_events"
"CD002042_pub6_data","4::overall","4","overall","30-day mortality",7,4,4,TRUE,TRUE,"RD","double_zero"
"CD002042_pub6_data","5::1","5","1","30-day mortality: subgroup by clinical specialties",4,2,3,TRUE,TRUE,"RD","double_zero"
"CD002042_pub6_data","6::1","6","1","30-day mortality: subgroup by prospective trial registration vs no prospective registration",4,2,2,TRUE,TRUE,"RD","double_zero"
"CD002042_pub6_data","6::2","6","2","30-day mortality: subgroup by prospective trial registration vs no prospective registration",3,2,2,FALSE,TRUE,"RD","double_zero"
"CD002042_pub6_data","8::overall","8","overall","30-day mortality (sensitivity analysis excluding Maitland study)",6,4,4,TRUE,TRUE,"RD","double_zero"
"CD002042_pub6_data","9::overall","9","overall","In-hospital mortality (as defined by triallists)",3,0,1,TRUE,TRUE,"RD","sparse_events"
"CD002042_pub6_data","10::overall","10","overall","90-day mortality",3,2,2,FALSE,TRUE,"RD","double_zero"
"CD002042_pub6_data","11::overall","11","overall","6-month mortality",2,0,1,TRUE,TRUE,"RD","sparse_events"
"CD002042_pub6_data","15::overall","15","overall","Morbidity: cerebrovascular accident (CVA)",2,0,2,TRUE,TRUE,"RD","sparse_events"
"CD002052_pub4_data","1::overall","1","overall","Hypotension",4,1,2,TRUE,TRUE,"RD","double_zero"
"CD002052_pub4_data","2::overall","2","overall","Apnoea",4,0,1,TRUE,TRUE,"RD","sparse_events"
"CD002052_pub4_data","3::overall","3","overall","All‐cause mortality until hospital discharge",6,0,2,TRUE,TRUE,"RD","sparse_events"
"CD002052_pub4_data","6::overall","6","overall","Intraventricular haemorrhage (any grade)",4,1,1,TRUE,TRUE,"RD","double_zero"
"CD002052_pub4_data","7::overall","7","overall","Pneumothorax",5,1,4,TRUE,TRUE,"RD","double_zero"
"CD002112_pub2_data","2::1","2","1","Number of children achieving 14 consecutive dry nights by the end of treatment",25,0,2,TRUE,TRUE,"RD","sparse_events"
"CD002112_pub2_data","2::2","2","2","Number of children achieving 14 consecutive dry nights by the end of treatment",21,0,5,TRUE,TRUE,"RD","sparse_events"
"CD002112_pub2_data","2::3","2","3","Number of children achieving 14 consecutive dry nights by the end of treatment",14,0,4,TRUE,TRUE,"RD","sparse_events"
"CD002112_pub2_data","2::4","2","4","Number of children achieving 14 consecutive dry nights by the end of treatment",8,0,2,TRUE,TRUE,"RD","sparse_events"
"CD002112_pub2_data","2::5","2","5","Number of children achieving 14 consecutive dry nights by the end of treatment",4,0,0,TRUE,TRUE,"OR_cc","default_or"
"CD002112_pub2_data","3::1","3","1","Mean number of wet nights at follow-up",11,9,10,TRUE,TRUE,"RD","double_zero"
"CD002112_pub2_data","3::2","3","2","Mean number of wet nights at follow-up",4,3,3,FALSE,TRUE,"RD","double_zero"
"CD002112_pub2_data","4::1","4","1","Number of children dry at follow-up (maintaining 14 consecutive dry nights after stopping treatment)",12,1,1,TRUE,TRUE,"RD","double_zero"
"CD002112_pub2_data","6::overall","6","overall","Adverse events",3,0,1,TRUE,TRUE,"RD","sparse_events"
"CD002112_pub2_data","2::6","2","6","Number of children achieving 14 consecutive dry nights by the end of treatment",4,0,1,TRUE,TRUE,"RD","sparse_events"
"CD002112_pub2_data","4::2","4","2","Number of children relapsing after cessation of treatment",5,0,0,TRUE,TRUE,"OR_cc","default_or"
"CD002112_pub2_data","4::3","4","3","Number of children relapsing after cessation of treatment",5,0,1,TRUE,TRUE,"RD","sparse_events"
"CD002112_pub2_data","4::4","4","4","Number of children relapsing after cessation of treatment",4,0,0,TRUE,TRUE,"OR_cc","default_or"
"CD002112_pub2_data","4::5","4","5","Number of children relapsing after cessation of treatment",4,0,0,TRUE,TRUE,"OR_cc","default_or"
"CD002112_pub2_data","4::6","4","6","Number of children relapsing after cessation of treatment",2,0,0,TRUE,TRUE,"OR_cc","default_or"
"CD002112_pub2_data","5::overall","5","overall","Adverse events",5,0,2,TRUE,TRUE,"RD","sparse_events"
"CD002112_pub2_data","2::overall","2","overall","Number of children achieving 14 consecutive dry nights by the end of treatment",15,0,0,TRUE,TRUE,"OR_cc","default_or"
"CD002112_pub2_data","3::overall","3","overall","Number of children dry at follow-up (maintaining 14 consecutive dry nights after stopping treatment)",6,0,0,TRUE,TRUE,"OR_cc","default_or"
"CD002112_pub2_data","4::overall","4","overall","Adverse events",8,0,4,TRUE,TRUE,"RD","sparse_events"
"CD002112_pub2_data","2::7","2","7","Number of children achieving 14 consecutive dry nights by the end of treatment",2,0,0,TRUE,TRUE,"OR_cc","default_or"
"CD002112_pub2_data","2::8","2","8","Number of children achieving 14 consecutive dry nights by the end of treatment",2,0,0,TRUE,TRUE,"OR_cc","default_or"
"CD002115_pub6_data","2::overall","2","overall","Number of participants with self-reported improvement in constipation (dichotomous)",13,8,8,TRUE,TRUE,"RD","double_zero"
"CD002115_pub6_data","9::overall","9","overall","Mean time spent per week on bowel care (dichotmous; participants spending < 10 minutes to pass stool)",4,2,2,TRUE,TRUE,"RD","double_zero"
"CD002115_pub6_data","11::overall","11","overall","Condition-specific quality of life measures (continuous)",7,5,6,TRUE,TRUE,"RD","double_zero"
"CD002115_pub6_data","13::overall","13","overall","Number of participants with adverse events (dichotomous)",4,0,3,TRUE,TRUE,"RD","sparse_events"
"CD002122_pub3_data","1::1","1","1","Pain (visual analogue scale)&nbsp;",5,0,1,TRUE,TRUE,"RD","sparse_events"
"CD002122_pub3_data","1::2","1","2","Pain (visual analogue scale)&nbsp;",4,0,0,TRUE,TRUE,"OR_cc","default_or"
"CD002122_pub3_data","1::3","1","3","Pain (visual analogue scale)&nbsp;",4,0,1,TRUE,TRUE,"RD","sparse_events"
"CD002122_pub3_data","1::4","1","4","Pain (visual analogue scale)&nbsp;",2,0,0,TRUE,TRUE,"OR_cc","default_or"
"CD002122_pub3_data","1::5","1","5","Pain (visual analogue scale)&nbsp;",3,0,0,TRUE,TRUE,"OR_cc","default_or"
"CD002122_pub3_data","2::1","2","1","Pain (4-point verbal rating scale)",8,0,1,TRUE,TRUE,"RD","sparse_events"
"CD002122_pub3_data","2::2","2","2","Pain (4-point verbal rating scale)",7,0,0,TRUE,TRUE,"OR_cc","default_or"
"CD002122_pub3_data","2::3","2","3","Pain (4-point verbal rating scale)",8,0,2,TRUE,TRUE,"RD","sparse_events"
"CD002122_pub3_data","2::4","2","4","Pain (4-point verbal rating scale)",8,1,2,TRUE,TRUE,"RD","double_zero"
"CD002122_pub3_data","2::5","2","5","Pain (4-point verbal rating scale)",6,0,1,TRUE,TRUE,"RD","sparse_events"
"CD002122_pub3_data","2::6","2","6","Pain (4-point verbal rating scale)",6,0,2,TRUE,TRUE,"RD","sparse_events"
"CD002122_pub3_data","3::1","3","1","Pain (dichotomous)",6,0,1,TRUE,TRUE,"RD","sparse_events"
"CD002122_pub3_data","3::2","3","2","Pain (dichotomous)",6,0,1,TRUE,TRUE,"RD","sparse_events"
"CD002122_pub3_data","3::3","3","3","Pain (dichotomous)",5,0,0,TRUE,TRUE,"OR_cc","default_or"
"CD002122_pub3_data","3::4","3","4","Pain (dichotomous)",5,0,0,TRUE,TRUE,"OR_cc","default_or"
"CD002122_pub3_data","3::5","3","5","Pain (dichotomous)",3,0,1,TRUE,TRUE,"RD","sparse_events"
"CD002122_pub3_data","3::6","3","6","Pain (dichotomous)",3,0,2,TRUE,TRUE,"RD","sparse_events"
"CD002122_pub3_data","3::7","3","7","Pain (dichotomous)",3,0,2,TRUE,TRUE,"RD","sparse_events"
"CD002122_pub3_data","4::1","4","1","Assessment of implant (continuous scale)",2,0,1,TRUE,TRUE,"RD","sparse_events"
"CD002122_pub3_data","6::1","6","1","Quality of life",3,0,0,TRUE,TRUE,"OR_cc","default_or"
"CD002122_pub3_data","6::2","6","2","Quality of life",3,0,0,TRUE,TRUE,"OR_cc","default_or"
"CD002122_pub3_data","6::3","6","3","Quality of life",3,0,0,TRUE,TRUE,"OR_cc","default_or"
"CD002122_pub3_data","7::1","7","1","Adverse effects",7,1,6,TRUE,TRUE,"RD","double_zero"
"CD002122_pub3_data","7::2","7","2","Adverse effects",6,0,1,TRUE,TRUE,"RD","sparse_events"
"CD002122_pub3_data","7::3","7","3","Adverse effects",7,0,2,TRUE,TRUE,"RD","sparse_events"
"CD002122_pub3_data","7::4","7","4","Adverse effects",3,0,0,TRUE,TRUE,"OR_cc","default_or"
"CD002122_pub3_data","7::5","7","5","Adverse effects",6,1,2,TRUE,TRUE,"RD","double_zero"
"CD002122_pub3_data","7::6","7","6","Adverse effects",7,0,0,TRUE,TRUE,"OR_cc","default_or"
"CD002122_pub3_data","7::7","7","7","Adverse effects",3,0,1,TRUE,TRUE,"RD","sparse_events"
"CD002122_pub3_data","7::8","7","8","Adverse effects",3,0,1,TRUE,TRUE,"RD","sparse_events"
"CD002122_pub3_data","7::9","7","9","Adverse effects",3,0,1,TRUE,TRUE,"RD","sparse_events"
"CD002122_pub3_data","7::10","7","10","Adverse effects",4,0,2,TRUE,TRUE,"RD","sparse_events"
"CD002122_pub3_data","7::11","7","11","Adverse effects",9,0,0,TRUE,TRUE,"OR_cc","default_or"
"CD002122_pub3_data","7::12","7","12","Adverse effects",8,0,1,TRUE,TRUE,"RD","sparse_events"
"CD002122_pub3_data","7::13","7","13","Adverse effects",4,0,1,TRUE,TRUE,"RD","sparse_events"
"CD002122_pub3_data","7::14","7","14","Adverse effects",4,0,0,TRUE,TRUE,"OR_cc","default_or"
"CD002122_pub3_data","7::15","7","15","Adverse effects",5,0,2,TRUE,TRUE,"RD","sparse_events"
"CD002122_pub3_data","7::16","7","16","Adverse effects",3,0,3,TRUE,TRUE,"RD","sparse_events"
"CD002122_pub3_data","7::17","7","17","Adverse effects",2,0,2,TRUE,TRUE,"RD","sparse_events"
"CD002122_pub3_data","7::18","7","18","Adverse effects",3,0,0,TRUE,TRUE,"OR_cc","default_or"
"CD002122_pub3_data","7::19","7","19","Adverse effects",2,0,1,TRUE,TRUE,"RD","sparse_events"
"CD002122_pub3_data","3::8","3","8","Adverse effects",2,0,1,TRUE,TRUE,"RD","sparse_events"
"CD002122_pub3_data","3::9","3","9","Adverse effects",2,0,1,TRUE,TRUE,"RD","sparse_events"
"CD002122_pub3_data","3::10","3","10","Adverse effects",2,0,1,TRUE,TRUE,"RD","sparse_events"
"CD002122_pub3_data","6::5","6","5","Adverse effects",2,0,1,TRUE,TRUE,"RD","sparse_events"
"CD002122_pub3_data","6::6","6","6","Adverse effects",3,0,1,TRUE,TRUE,"RD","sparse_events"
"CD002122_pub3_data","6::7","6","7","Adverse effects",3,0,0,TRUE,TRUE,"OR_cc","default_or"
"CD002122_pub3_data","6::10","6","10","Adverse effects",3,0,0,TRUE,TRUE,"OR_cc","default_or"
"CD002122_pub3_data","6::11","6","11","Adverse effects",3,0,2,TRUE,TRUE,"RD","sparse_events"
"CD002122_pub3_data","6::12","6","12","Adverse effects",2,0,0,TRUE,TRUE,"OR_cc","default_or"
"CD002122_pub3_data","6::16","6","16","Adverse effects",3,0,0,TRUE,TRUE,"OR_cc","default_or"
"CD002122_pub3_data","2::7","2","7","Adverse effects",4,0,2,TRUE,TRUE,"RD","sparse_events"
"CD002122_pub3_data","2::8","2","8","Adverse effects",4,0,1,TRUE,TRUE,"RD","sparse_events"
"CD002122_pub3_data","2::9","2","9","Adverse effects",4,0,1,TRUE,TRUE,"RD","sparse_events"
"CD002122_pub3_data","2::10","2","10","Adverse effects",3,0,1,TRUE,TRUE,"RD","sparse_events"
"CD002122_pub3_data","2::11","2","11","Adverse effects",3,1,1,TRUE,TRUE,"RD","double_zero"
"CD002122_pub3_data","2::12","2","12","Adverse effects",2,0,1,TRUE,TRUE,"RD","sparse_events"
"CD002203_pub5_data","3::overall","3","overall","Number free of pulmonary exacerbation",13,0,0,TRUE,TRUE,"OR_cc","default_or"
"CD002203_pub5_data","5::overall","5","overall","Adverse effects of antibiotic treatment",51,1,11,TRUE,TRUE,"RD","double_zero"
"CD002203_pub5_data","6::overall","6","overall","Serious adverse events",3,0,1,TRUE,TRUE,"RD","sparse_events"
"CD002203_pub5_data","7::overall","7","overall","Admission to hospital",7,3,3,TRUE,TRUE,"RD","double_zero"
"CD002203_pub5_data","9::overall","9","overall","Acquisition of Pseudomonas aeruginosa",4,1,1,TRUE,TRUE,"RD","double_zero"
"CD002203_pub5_data","10::overall","10","overall","Acquisition of Staphylococcal aureus",6,0,0,TRUE,TRUE,"OR_cc","default_or"
"CD002203_pub5_data","11::overall","11","overall","Eradication of Staphylococcal aureus present at baseline",2,0,1,TRUE,TRUE,"RD","sparse_events"
"CD002203_pub5_data","13::overall","13","overall","Acquisition of meticillin-resistant Staphylococcus aureus (MRSA)",5,0,1,TRUE,TRUE,"RD","sparse_events"
"CD002203_pub5_data","14::overall","14","overall","Acquisition of Haemophilus influenzae",4,0,0,TRUE,TRUE,"OR_cc","default_or"
"CD002203_pub5_data","16::overall","16","overall","Acquisition of non-tuberculous mycobacterium",2,0,1,TRUE,TRUE,"RD","sparse_events"
"CD002203_pub5_data","17::overall","17","overall","Need for additional oral antibiotics",5,0,0,TRUE,TRUE,"OR_cc","default_or"
"CD002203_pub5_data","20::overall","20","overall","Need for intravenous antibiotics",5,0,0,TRUE,TRUE,"OR_cc","default_or"
"CD002243_pub5_data","1::overall","1","overall","28-day all-cause mortality",75,1,5,TRUE,TRUE,"RD","double_zero"
"CD002243_pub5_data","2::1","2","1","28-day all-cause mortality - sensitivity analysis based on methodological quality",54,0,3,TRUE,TRUE,"RD","sparse_events"
"CD002243_pub5_data","2::2","2","2","28-day all-cause mortality - sensitivity analysis based on methodological quality",55,0,3,TRUE,TRUE,"RD","sparse_events"
"CD002243_pub5_data","2::3","2","3","28-day all-cause mortality - sensitivity analysis based on methodological quality",46,0,3,TRUE,TRUE,"RD","sparse_events"
"CD002243_pub5_data","2::4","2","4","28-day all-cause mortality - sensitivity analysis based on methodological quality",25,0,2,TRUE,TRUE,"RD","sparse_events"
"CD002243_pub5_data","3::1","3","1","28-day all-cause mortality by subgroups based on study drug",29,0,1,TRUE,TRUE,"RD","sparse_events"
"CD002243_pub5_data","3::2","3","2","28-day all-cause mortality by subgroups based on study drug",4,0,0,TRUE,TRUE,"OR_cc","default_or"
"CD002243_pub5_data","3::3","3","3","28-day all-cause mortality by subgroups based on study drug",6,0,0,TRUE,TRUE,"OR_cc","default_or"
"CD002243_pub5_data","3::4","3","4","28-day all-cause mortality by subgroups based on study drug",14,1,3,TRUE,TRUE,"RD","double_zero"
"CD002243_pub5_data","3::5","3","5","28-day all-cause mortality by subgroups based on study drug",8,0,1,TRUE,TRUE,"RD","sparse_events"
"CD002243_pub5_data","3::6","3","6","28-day all-cause mortality by subgroups based on study drug",8,0,0,TRUE,TRUE,"OR_cc","default_or"
"CD002243_pub5_data","4::1","4","1","28-day all-cause mortality by subgroups based on treatment dose/duration",61,0,3,TRUE,TRUE,"RD","sparse_events"
"CD002243_pub5_data","4::2","4","2","28-day all-cause mortality by subgroups based on treatment dose/duration",5,0,0,TRUE,TRUE,"OR_cc","default_or"
"CD002243_pub5_data","5::1","5","1","28-day all-cause mortality based on mode of drug administration",43,0,2,TRUE,TRUE,"RD","sparse_events"
"CD002243_pub5_data","5::2","5","2","28-day all-cause mortality based on mode of drug administration",23,1,3,TRUE,TRUE,"RD","double_zero"
"CD002243_pub5_data","6::1","6","1","28-day all-cause mortality based on mode of drug termination",43,1,3,TRUE,TRUE,"RD","double_zero"
"CD002243_pub5_data","6::2","6","2","28-day all-cause mortality based on mode of drug termination",25,0,2,TRUE,TRUE,"RD","sparse_events"
"CD002243_pub5_data","7::1","7","1","28-day all-cause mortality by subgroups based on age",62,0,2,TRUE,TRUE,"RD","sparse_events"
"CD002243_pub5_data","7::2","7","2","28-day all-cause mortality by subgroups based on age",5,1,3,TRUE,TRUE,"RD","double_zero"
"CD002243_pub5_data","8::1","8","1","28-day all-cause mortality by subgroups based on targeted population",14,0,0,TRUE,TRUE,"OR_cc","default_or"
"CD002243_pub5_data","8::2","8","2","28-day all-cause mortality by subgroups based on targeted population",29,0,1,TRUE,TRUE,"RD","sparse_events"
"CD002243_pub5_data","8::3","8","3","28-day all-cause mortality by subgroups based on targeted population",5,0,1,TRUE,TRUE,"RD","sparse_events"
"CD002243_pub5_data","8::4","8","4","28-day all-cause mortality by subgroups based on targeted population",16,1,3,TRUE,TRUE,"RD","double_zero"
"CD002243_pub5_data","8::5","8","5","28-day all-cause mortality by subgroups based on targeted population",7,0,0,TRUE,TRUE,"OR_cc","default_or"
"CD002243_pub5_data","9::1","9","1","28-day mortality in participants with versus without critical illness-related corticosteroid insufficiency",12,0,0,TRUE,TRUE,"OR_cc","default_or"
"CD002243_pub5_data","9::2","9","2","28-day mortality in participants with versus without critical illness-related corticosteroid insufficiency",9,0,0,TRUE,TRUE,"OR_cc","default_or"
"CD002243_pub5_data","10::overall","10","overall","Long-term mortality",15,3,3,TRUE,TRUE,"RD","double_zero"
"CD002243_pub5_data","11::overall","11","overall","Hospital mortality",40,0,1,TRUE,TRUE,"RD","sparse_events"
"CD002243_pub5_data","12::overall","12","overall","90-day all-cause mortality",13,0,0,TRUE,TRUE,"OR_cc","default_or"
"CD002243_pub5_data","13::overall","13","overall","Intensive care unit mortality",24,0,1,TRUE,TRUE,"RD","sparse_events"
"CD002243_pub5_data","18::overall","18","overall","Number of participants with shock reversal at day 7",18,0,0,TRUE,TRUE,"OR_cc","default_or"
"CD002243_pub5_data","19::overall","19","overall","Number of participants with shock reversal at 28 days",16,0,0,TRUE,TRUE,"OR_cc","default_or"
"CD002243_pub5_data","21::1","21","1","Number of participants with adverse events",32,7,18,TRUE,TRUE,"RD","double_zero"
"CD002243_pub5_data","21::2","21","2","Number of participants with adverse events",36,3,10,TRUE,TRUE,"RD","double_zero"
"CD002243_pub5_data","21::3","21","3","Number of participants with adverse events",29,2,5,TRUE,TRUE,"RD","double_zero"
"CD002243_pub5_data","21::4","21","4","Number of participants with adverse events",12,0,1,TRUE,TRUE,"RD","sparse_events"
"CD002243_pub5_data","21::5","21","5","Number of participants with adverse events",7,0,3,TRUE,TRUE,"RD","sparse_events"
"CD002243_pub5_data","21::6","21","6","Number of participants with adverse events",10,0,5,TRUE,TRUE,"RD","sparse_events"
"CD002243_pub5_data","21::7","21","7","Number of participants with adverse events",8,0,5,TRUE,TRUE,"RD","sparse_events"
"CD002243_pub5_data","21::8","21","8","Number of participants with adverse events",14,0,5,TRUE,TRUE,"RD","sparse_events"
"CD002243_pub5_data","3::overall","3","overall","Hospital mortality",3,0,0,TRUE,TRUE,"OR_cc","default_or"
"CD002243_pub5_data","5::overall","5","overall","Intensive care unit mortality",4,0,0,TRUE,TRUE,"OR_cc","default_or"
"CD002243_pub5_data","8::overall","8","overall","Number of participants with shock reversal at day 7",4,0,0,TRUE,TRUE,"OR_cc","default_or"
"CD002243_pub5_data","11::1","11","1","Number of participants with adverse events",2,0,0,TRUE,TRUE,"OR_cc","default_or"
"CD002243_pub5_data","11::2","11","2","Number of participants with adverse events",2,0,0,TRUE,TRUE,"OR_cc","default_or"
"CD002243_pub5_data","11::3","11","3","Number of participants with adverse events",3,0,0,TRUE,TRUE,"OR_cc","default_or"
"CD002243_pub5_data","11::4","11","4","Number of participants with adverse events",2,0,0,TRUE,TRUE,"OR_cc","default_or"
"CD002290_pub6_data","1::overall","1","overall","Relapse",88,0,3,TRUE,TRUE,"RD","sparse_events"
"CD002290_pub6_data","2::overall","2","overall","Adverse events",68,9,38,TRUE,TRUE,"RD","double_zero"
"CD002290_pub6_data","3::overall","3","overall","Relapse rate",46,4,21,TRUE,TRUE,"RD","double_zero"
"CD002290_pub6_data","4::overall","4","overall","Infection rate",22,3,7,TRUE,TRUE,"RD","double_zero"
"CD002290_pub6_data","5::overall","5","overall","Adverse events",5,1,1,TRUE,TRUE,"RD","double_zero"
"CD002303_pub4_data","1::overall","1","overall","Reulceration at 6 months",8,0,0,TRUE,TRUE,"OR_cc","default_or"
"CD002303_pub4_data","2::overall","2","overall","Noncompliance ",7,0,0,TRUE,TRUE,"OR_cc","default_or"
"CD002971_pub6_data","1::overall","1","overall","Necrotising enterocolitis",11,1,4,TRUE,TRUE,"RD","double_zero"
"CD002971_pub6_data","2::overall","2","overall","Late-onset invasive infection",7,0,0,TRUE,TRUE,"OR_cc","default_or"
"CD002971_pub6_data","3::overall","3","overall","All-cause mortality",9,0,3,TRUE,TRUE,"RD","sparse_events"
"CD002971_pub6_data","11::overall","11","overall","Cerebral palsy",4,0,0,TRUE,TRUE,"OR_cc","default_or"
"CD002971_pub6_data","14::overall","14","overall","Bayley-III score < 70",6,0,0,TRUE,TRUE,"OR_cc","default_or"
"CD002971_pub6_data","15::overall","15","overall","Neurodevelopmental disability at 18 months",2,0,0,TRUE,TRUE,"OR_cc","default_or"
"CD003129_pub2_data","1::overall","1","overall","Treatment response",4,0,0,TRUE,TRUE,"OR_cc","default_or"
"CD003129_pub2_data","5::overall","5","overall","Participant global assessment of well-being",2,1,1,FALSE,TRUE,"RD","double_zero"
"CD003129_pub2_data","6::overall","6","overall","Serious adverse events",5,2,5,TRUE,TRUE,"RD","double_zero"
"CD003129_pub2_data","7::overall","7","overall","Withdrawals due to adverse events",5,0,5,TRUE,TRUE,"RD","sparse_events"
"CD003216_pub3_data","1::overall","1","overall","Incidence of pressure ulcers",26,5,10,TRUE,TRUE,"RD","double_zero"
"CD003216_pub3_data","2::overall","2","overall","At least one adverse gastrointestinal effect",15,10,12,TRUE,TRUE,"RD","double_zero"
"CD003216_pub3_data","3::overall","3","overall","PUSH score",9,7,8,TRUE,TRUE,"RD","double_zero"
"CD003216_pub3_data","4::overall","4","overall","At least one adverse gastrointestinal effect",5,2,2,TRUE,TRUE,"RD","double_zero"
"CD003216_pub3_data","6::overall","6","overall","At least one adverse gastrointestinal effects",3,0,2,TRUE,TRUE,"RD","sparse_events"
"CD003331_pub6_data","1::overall","1","overall","All-cause mortality up to 12 months' follow-up",36,1,22,TRUE,TRUE,"RD","double_zero"
"CD003331_pub6_data","2::overall","2","overall","All-cause mortality more than 12 months' follow-up",8,0,2,TRUE,TRUE,"RD","sparse_events"
"CD003331_pub6_data","3::overall","3","overall","Hospital admissions (all-cause) up to 12 months' follow-up",24,0,10,TRUE,TRUE,"RD","sparse_events"
"CD003331_pub6_data","4::overall","4","overall","Hospital admissions (all-cause) more than 12 months' follow-up",8,0,0,TRUE,TRUE,"OR_cc","default_or"
"CD003331_pub6_data","5::overall","5","overall","Hospital admissions (heart failure only) up to 12 months' follow-up",10,0,6,TRUE,TRUE,"RD","sparse_events"
"CD003331_pub6_data","6::overall","6","overall","Hospital admissions (heart failure only) more than 12 months' follow-up",6,0,0,TRUE,TRUE,"OR_cc","default_or"
"CD003333_pub4_data","1::overall","1","overall","All-cause mortality",5,0,0,TRUE,TRUE,"OR_cc","default_or"
"CD003333_pub4_data","2::overall","2","overall","Non-fatal cardiovascular events (non-fatal stroke, myocardial infarction, pulmonary embolism, peripheral arterial embolism)",5,0,0,TRUE,TRUE,"OR_cc","default_or"
"CD003333_pub4_data","3::overall","3","overall","Major bleeding events",5,0,1,TRUE,TRUE,"RD","sparse_events"
"CD003357_pub5_data","1::overall","1","overall","Live birth rate per woman",10,0,0,TRUE,TRUE,"OR_cc","default_or"
"CD003357_pub5_data","2::overall","2","overall","Clinical pregnancy rate per woman",9,0,1,TRUE,TRUE,"RD","sparse_events"
"CD003357_pub5_data","3::overall","3","overall","Multiple pregnancy rate per woman",7,0,1,TRUE,TRUE,"RD","sparse_events"
"CD003357_pub5_data","4::overall","4","overall","Miscarriage rate",5,0,2,TRUE,TRUE,"RD","sparse_events"
"CD003357_pub5_data","5::overall","5","overall","Miscarriage rate per woman",3,0,1,TRUE,TRUE,"RD","sparse_events"
"CD003376_pub4_data","1::overall","1","overall","Clinical vertebral fractures",98,43,77,TRUE,TRUE,"RD","double_zero"
"CD003376_pub4_data","2::overall","2","overall","Non-vertebral fractures",70,18,33,TRUE,TRUE,"RD","double_zero"
"CD003376_pub4_data","3::overall","3","overall","Hip fractures",32,9,20,TRUE,TRUE,"RD","double_zero"
"CD003376_pub4_data","4::overall","4","overall","Wrist fractures",24,7,14,TRUE,TRUE,"RD","double_zero"
"CD003376_pub4_data","5::overall","5","overall","Radiographic vertebral fractures",26,6,9,TRUE,TRUE,"RD","double_zero"
"CD003376_pub4_data","6::overall","6","overall","Withdrawals due to adverse events",14,1,5,TRUE,TRUE,"RD","double_zero"
"CD003376_pub4_data","7::overall","7","overall","Serious adverse events",8,3,5,TRUE,TRUE,"RD","double_zero"
"CD003414_pub4_data","1::1","1","1","Live birth rate per woman",8,0,0,TRUE,TRUE,"OR_cc","default_or"
"CD003414_pub4_data","1::2","1","2","Live birth rate per woman",5,0,0,TRUE,TRUE,"OR_cc","default_or"
"CD003414_pub4_data","1::3","1","3","Live birth rate per woman",4,0,0,TRUE,TRUE,"OR_cc","default_or"
"CD003414_pub4_data","2::1","2","1","Miscarriage rate per woman",14,0,3,TRUE,TRUE,"RD","sparse_events"
"CD003414_pub4_data","2::2","2","2","Miscarriage rate per woman",5,0,2,TRUE,TRUE,"RD","sparse_events"
"CD003414_pub4_data","2::3","2","3","Miscarriage rate per woman",5,0,3,TRUE,TRUE,"RD","sparse_events"
"CD003414_pub4_data","3::1","3","1","Ongoing pregnancy rate per woman",8,0,0,TRUE,TRUE,"OR_cc","default_or"
"CD003414_pub4_data","3::2","3","2","Ongoing pregnancy rate per woman",4,0,0,TRUE,TRUE,"OR_cc","default_or"
"CD003414_pub4_data","3::3","3","3","Ongoing pregnancy rate per woman",5,0,0,TRUE,TRUE,"OR_cc","default_or"
"CD003414_pub4_data","4::1","4","1","Clinical pregnancy rate per woman",17,0,0,TRUE,TRUE,"OR_cc","default_or"
"CD003414_pub4_data","4::2","4","2","Clinical pregnancy rate per woman",6,0,0,TRUE,TRUE,"OR_cc","default_or"
"CD003414_pub4_data","4::3","4","3","Clinical pregnancy rate per woman",6,0,0,TRUE,TRUE,"OR_cc","default_or"
"CD003414_pub4_data","5::1","5","1","Ectopic pregnancy rate per woman",4,0,1,TRUE,TRUE,"RD","sparse_events"
"CD003414_pub4_data","6::1","6","1","Multiple pregnancy rate per woman",7,0,3,TRUE,TRUE,"RD","sparse_events"
"CD003414_pub4_data","6::2","6","2","Multiple pregnancy rate per woman",4,0,1,TRUE,TRUE,"RD","sparse_events"
"CD003414_pub4_data","6::3","6","3","Multiple pregnancy rate per woman",3,0,1,TRUE,TRUE,"RD","sparse_events"
"CD003414_pub4_data","4::4","4","4","Clinical pregnancy rate per woman",2,0,0,TRUE,TRUE,"OR_cc","default_or"
"CD003414_pub4_data","1::overall","1","overall","Live birth rate per woman",2,0,0,TRUE,TRUE,"OR_cc","default_or"
"CD003414_pub4_data","2::overall","2","overall","Miscarriage rate per woman",2,0,0,TRUE,TRUE,"OR_cc","default_or"
"CD003414_pub4_data","3::overall","3","overall","Endometrial thickness",2,1,1,FALSE,TRUE,"RD","double_zero"
"CD003429_pub5_data","2::overall","2","overall","Joint function protection (number of participants with no joint damage)",2,0,0,TRUE,TRUE,"OR_cc","default_or"
"CD003429_pub5_data","3::overall","3","overall","Sensitivity analysis (fixed-effect model): joint function protection (number of participants with no joint damage)",2,0,0,TRUE,TRUE,"OR_cc","default_or"
"CD003429_pub5_data","10::1","10","1","Adverse events",2,0,0,TRUE,TRUE,"OR_cc","default_or"
"CD003429_pub5_data","10::2","10","2","Adverse events",2,0,1,TRUE,TRUE,"RD","sparse_events"
"CD003429_pub5_data","10::3","10","3","Adverse events",2,0,2,TRUE,TRUE,"RD","sparse_events"
"CD003511_pub6_data","1::1","1","1","Miscarriage (all trials)",8,0,0,TRUE,TRUE,"OR_cc","default_or"
"CD003511_pub6_data","2::1","2","1","Miscarriage (placebo-controlled trials only)",6,0,0,TRUE,TRUE,"OR_cc","default_or"
"CD003511_pub6_data","2::2","2","2","Miscarriage (placebo-controlled trials only)",2,0,0,TRUE,TRUE,"OR_cc","default_or"
"CD003511_pub6_data","3::1","3","1","Miscarriage (women with previous recurrent miscarriage only)",3,0,0,TRUE,TRUE,"OR_cc","default_or"
"CD003511_pub6_data","3::2","3","2","Miscarriage (women with previous recurrent miscarriage only)",5,0,0,TRUE,TRUE,"OR_cc","default_or"
"CD003511_pub6_data","4::1","4","1","Miscarriage (by route of administration versus placebo)",4,0,0,TRUE,TRUE,"OR_cc","default_or"
"CD003511_pub6_data","4::2","4","2","Miscarriage (by route of administration versus placebo)",2,0,0,TRUE,TRUE,"OR_cc","default_or"
"CD003511_pub6_data","5::overall","5","overall","Live birth rate",5,0,0,TRUE,TRUE,"OR_cc","default_or"
"CD003511_pub6_data","6::overall","6","overall","Preterm birth",4,0,2,TRUE,TRUE,"RD","sparse_events"
"CD003511_pub6_data","7::overall","7","overall","Neonatal death",3,0,3,TRUE,TRUE,"RD","sparse_events"
"CD003511_pub6_data","8::overall","8","overall","Fetal genital abnormalities/virilization",3,2,3,FALSE,TRUE,"RD","double_zero"
"CD003511_pub6_data","9::overall","9","overall","Stillbirth",2,1,2,FALSE,TRUE,"RD","double_zero"
"CD003519_pub5_data","1::overall","1","overall","Exclusive breastfeeding at hospital discharge to 1 month post birth",22,0,0,TRUE,TRUE,"OR_cc","default_or"
"CD003519_pub5_data","2::overall","2","overall","Exclusive breastfeeding at hospital discharge to 1 month post birth - Marin 2010 sensitivity analysis",15,0,0,TRUE,TRUE,"OR_cc","default_or"
"CD003519_pub5_data","3::overall","3","overall","Exclusive breastfeeding at hospital discharge to 1 month post birth - Perez-Jimenez 2023 sensitivity analysis",15,0,1,TRUE,TRUE,"RD","sparse_events"
"CD003519_pub5_data","4::overall","4","overall","Exclusive breastfeeding 6 weeks to 6 months post birth",11,0,1,TRUE,TRUE,"RD","sparse_events"
"CD003519_pub5_data","5::overall","5","overall","Exclusive breastfeeding 6 weeks to 6 months post birth &nbsp;- Mulupuru 2019 sensitivity analysis",12,0,1,TRUE,TRUE,"RD","sparse_events"
"CD003519_pub5_data","12::overall","12","overall","Breastfeeding 1 month to 4 months post birth",14,0,1,TRUE,TRUE,"RD","sparse_events"
"CD003519_pub5_data","13::overall","13","overall","Breastfeeding 1 month to 4 months post birth - Sosa 1976a sensitivity analysis",13,0,1,TRUE,TRUE,"RD","sparse_events"
"CD003519_pub5_data","18::overall","18","overall","Successful first breastfeeding (IBFAT score 10-12 or BAT score 8-12 or not specified)",8,0,0,TRUE,TRUE,"OR_cc","default_or"
"CD003519_pub5_data","20::overall","20","overall","Infant transferred to the neonatal intensive care unit",4,0,1,TRUE,TRUE,"RD","sparse_events"
"CD003519_pub5_data","21::overall","21","overall","Infant transferred to the neonatal intensive care unit - Marin 2010 sensitivity analysis",3,0,1,TRUE,TRUE,"RD","sparse_events"
"CD003519_pub5_data","25::overall","25","overall","Mother's most certain preference for same postdelivery care in the future",3,0,0,TRUE,TRUE,"OR_cc","default_or"
"CD003519_pub5_data","1::1","1","1","Exclusive breastfeeding at hospital discharge to 1 month postbirth",14,0,0,TRUE,TRUE,"OR_cc","default_or"
"CD003519_pub5_data","1::2","1","2","Exclusive breastfeeding at hospital discharge to 1 month postbirth",22,0,0,TRUE,TRUE,"OR_cc","default_or"
"CD003519_pub5_data","2::1","2","1","Exclusive breastfeeding 6 weeks to 6 months post birth",14,0,1,TRUE,TRUE,"RD","sparse_events"
"CD003519_pub5_data","2::2","2","2","Exclusive breastfeeding 6 weeks to 6 months post birth",18,0,2,TRUE,TRUE,"RD","sparse_events"
"CD003519_pub5_data","3::1","3","1","Breastfeeding 1 month to 4 months post birth",16,0,0,TRUE,TRUE,"OR_cc","default_or"
"CD003519_pub5_data","3::2","3","2","Breastfeeding 1 month to 4 months post birth",14,0,2,TRUE,TRUE,"RD","sparse_events"
"CD003594_pub7_data","1::1","1","1","Complete remission",17,3,8,TRUE,TRUE,"RD","double_zero"
"CD003594_pub7_data","1::2","1","2","Complete remission",15,1,6,TRUE,TRUE,"RD","double_zero"
"CD003594_pub7_data","2::1","2","1","Complete or partial remission",15,3,3,TRUE,TRUE,"RD","double_zero"
"CD003594_pub7_data","2::2","2","2","Complete or partial remission",11,2,4,TRUE,TRUE,"RD","double_zero"
"CD003594_pub7_data","3::overall","3","overall","Kidney failure",9,3,3,TRUE,TRUE,"RD","double_zero"
"CD003594_pub7_data","4::1","4","1","Adverse events",3,0,2,TRUE,TRUE,"RD","sparse_events"
"CD003594_pub7_data","4::2","4","2","Adverse events",3,0,2,TRUE,TRUE,"RD","sparse_events"
"CD003594_pub7_data","1::3","1","3","Treatment response at 3 to 6 months",9,1,1,TRUE,TRUE,"RD","double_zero"
"CD003594_pub7_data","2::overall","2","overall","Death",6,0,4,TRUE,TRUE,"RD","sparse_events"
"CD003594_pub7_data","3::1","3","1","Adverse events",3,1,1,TRUE,TRUE,"RD","double_zero"
"CD003594_pub7_data","3::2","3","2","Adverse events",3,1,1,TRUE,TRUE,"RD","double_zero"
"CD003594_pub7_data","3::3","3","3","Adverse events",2,0,0,TRUE,TRUE,"OR_cc","default_or"
"CD003594_pub7_data","3::4","3","4","Adverse events",2,0,0,TRUE,TRUE,"OR_cc","default_or"
"CD003594_pub7_data","4::overall","4","overall","Mean time to remission",8,4,6,TRUE,TRUE,"RD","double_zero"
"CD003594_pub7_data","2::3","2","3","Treatment response at 12 months",6,0,0,TRUE,TRUE,"OR_cc","default_or"
"CD003594_pub7_data","5::1","5","1","Adverse events",5,0,3,TRUE,TRUE,"RD","sparse_events"
"CD003594_pub7_data","5::2","5","2","Adverse events",5,0,3,TRUE,TRUE,"RD","sparse_events"
"CD003594_pub7_data","5::3","5","3","Adverse events",5,1,2,TRUE,TRUE,"RD","double_zero"
"CD003594_pub7_data","5::4","5","4","Adverse events",2,0,1,TRUE,TRUE,"RD","sparse_events"
"CD003594_pub7_data","5::overall","5","overall","Kidney function: 50% decline in GFR by 78 weeks",3,2,2,FALSE,TRUE,"RD","double_zero"
"CD003594_pub7_data","6::1","6","1","Adverse events (weeks 0 to 26)",2,0,0,TRUE,TRUE,"OR_cc","default_or"
"CD003594_pub7_data","6::2","6","2","Adverse events (weeks 0 to 26)",2,0,0,TRUE,TRUE,"OR_cc","default_or"
"CD003594_pub7_data","6::3","6","3","Adverse events (weeks 0 to 26)",2,0,1,TRUE,TRUE,"RD","sparse_events"
"CD003594_pub7_data","1::overall","1","overall","Remission at 6 months",8,0,1,TRUE,TRUE,"RD","sparse_events"
"CD003594_pub7_data","4::3","4","3","Adverse events",2,0,1,TRUE,TRUE,"RD","sparse_events"
"CD003594_pub7_data","4::4","4","4","Adverse events",2,0,2,TRUE,TRUE,"RD","sparse_events"
"CD003594_pub7_data","4::5","4","5","Adverse events",2,0,2,TRUE,TRUE,"RD","sparse_events"
"CD003598_pub3_data","1::overall","1","overall","All-cause death",66,33,58,TRUE,TRUE,"RD","double_zero"
"CD003598_pub3_data","2::overall","2","overall","Graft loss",60,26,38,TRUE,TRUE,"RD","double_zero"
"CD003598_pub3_data","3::overall","3","overall","Creatinine clearance [mL/min]",56,48,51,TRUE,TRUE,"RD","double_zero"
"CD003598_pub3_data","5::overall","5","overall","Serum creatinine [µmol/L]",45,43,44,TRUE,TRUE,"RD","double_zero"
"CD003598_pub3_data","6::overall","6","overall","Cardiovascular death",39,32,37,TRUE,TRUE,"RD","double_zero"
"CD003598_pub3_data","7::overall","7","overall","Systolic blood pressure [mm Hg]",20,12,15,TRUE,TRUE,"RD","double_zero"
"CD003598_pub3_data","8::overall","8","overall","Diastolic blood pressure [mm Hg]",23,13,19,TRUE,TRUE,"RD","double_zero"
"CD003598_pub3_data","9::overall","9","overall","Mean arterial pressure [mm Hg]",24,20,21,TRUE,TRUE,"RD","double_zero"
"CD003598_pub3_data","10::overall","10","overall","Any rejection",36,20,23,TRUE,TRUE,"RD","double_zero"
"CD003598_pub3_data","11::overall","11","overall","Acute rejection",36,22,27,TRUE,TRUE,"RD","double_zero"
"CD003598_pub3_data","12::overall","12","overall","Rejection",10,6,7,TRUE,TRUE,"RD","double_zero"
"CD003598_pub3_data","13::overall","13","overall","Rejection rate",19,10,14,TRUE,TRUE,"RD","double_zero"
"CD003598_pub3_data","14::overall","14","overall","Proteinuria [g/24 hours]",16,7,11,TRUE,TRUE,"RD","double_zero"
"CD003598_pub3_data","15::overall","15","overall","Nonfatal myocardial infarction",11,2,8,TRUE,TRUE,"RD","double_zero"
"CD003598_pub3_data","16::overall","16","overall","Fatal myocardial infarction",12,5,9,TRUE,TRUE,"RD","double_zero"
"CD003598_pub3_data","17::overall","17","overall","Thrombosis of the graft arteria",12,5,10,TRUE,TRUE,"RD","double_zero"
"CD003598_pub3_data","18::overall","18","overall","Any adverse event",8,5,6,TRUE,TRUE,"RD","double_zero"
"CD003598_pub3_data","19::overall","19","overall","Hypotension",14,12,12,TRUE,TRUE,"RD","double_zero"
"CD003598_pub3_data","20::overall","20","overall","New onset hypertension",9,1,4,TRUE,TRUE,"RD","double_zero"
"CD003598_pub3_data","21::overall","21","overall","New onset diabetes",13,8,10,TRUE,TRUE,"RD","double_zero"
"CD003598_pub3_data","22::overall","22","overall","Hyperglycaemia",9,1,4,TRUE,TRUE,"RD","double_zero"
"CD003598_pub3_data","23::overall","23","overall","Oedema of legs",10,3,4,TRUE,TRUE,"RD","double_zero"
"CD003598_pub3_data","24::overall","24","overall","Withdrawal due to adverse events",15,4,12,TRUE,TRUE,"RD","double_zero"
"CD003598_pub3_data","25::overall","25","overall","Withdrawal due to rejection",14,9,12,TRUE,TRUE,"RD","double_zero"
"CD003598_pub3_data","26::overall","26","overall","Withdrawal due to congestive heart failure",6,2,6,TRUE,TRUE,"RD","double_zero"
"CD003598_pub3_data","27::overall","27","overall","Withdrawal due to heart block",6,2,6,TRUE,TRUE,"RD","double_zero"
"CD003598_pub3_data","28::overall","28","overall","Withdrawal due to hypotension",10,3,7,TRUE,TRUE,"RD","double_zero"
"CD003598_pub3_data","29::overall","29","overall","Withdrawal due to fatigue",3,0,2,TRUE,TRUE,"RD","sparse_events"
"CD003598_pub3_data","30::overall","30","overall","Cough",4,0,3,TRUE,TRUE,"RD","sparse_events"
"CD003598_pub3_data","31::overall","31","overall","Peripheral oedema",2,0,1,TRUE,TRUE,"RD","sparse_events"
"CD003598_pub3_data","33::overall","33","overall","Withdrawal due to adverse events",7,2,4,TRUE,TRUE,"RD","double_zero"
"CD003598_pub3_data","35::overall","35","overall","Withdrawal due to hyperkalaemia",2,0,2,TRUE,TRUE,"RD","sparse_events"
"CD003774_pub5_data","1::overall","1","overall","CMV disease",140,6,35,TRUE,TRUE,"RD","double_zero"
"CD003774_pub5_data","2::overall","2","overall","All symptomatic CMV disease stratified by antibody status",101,9,35,TRUE,TRUE,"RD","double_zero"
"CD003774_pub5_data","3::overall","3","overall","CMV disease in all patients by antiviral medication",76,5,15,TRUE,TRUE,"RD","double_zero"
"CD003774_pub5_data","4::overall","4","overall","CMV disease for different organ transplants",90,6,20,TRUE,TRUE,"RD","double_zero"
"CD003774_pub5_data","5::overall","5","overall","CMV disease and ganciclovir duration",66,10,19,TRUE,TRUE,"RD","double_zero"
"CD003774_pub5_data","6::overall","6","overall","CMV disease and ATG therapy and antiviral efficacy",27,2,9,TRUE,TRUE,"RD","double_zero"
"CD003774_pub5_data","7::overall","7","overall","CMV disease and immunosuppression without ATG induction and antiviral efficacy",16,0,0,TRUE,TRUE,"OR_cc","default_or"
"CD003774_pub5_data","8::overall","8","overall","All-cause death according to antiviral medication",25,5,11,TRUE,TRUE,"RD","double_zero"
"CD003774_pub5_data","9::overall","9","overall","All-cause death according to CMV status",26,3,9,TRUE,TRUE,"RD","double_zero"
"CD003774_pub5_data","10::overall","10","overall","All-cause death for different organ transplants",25,5,11,TRUE,TRUE,"RD","double_zero"
"CD003774_pub5_data","11::overall","11","overall","All-cause death and ganciclovir duration",41,5,18,TRUE,TRUE,"RD","double_zero"
"CD003774_pub5_data","12::overall","12","overall","All-cause death with or without ATG therapy and antiviral efficacy",15,4,10,TRUE,TRUE,"RD","double_zero"
"CD003774_pub5_data","13::overall","13","overall","CMV infection",17,0,0,TRUE,TRUE,"OR_cc","default_or"
"CD003774_pub5_data","14::overall","14","overall","Death due to CMV disease or other causes",14,1,9,TRUE,TRUE,"RD","double_zero"
"CD003774_pub5_data","15::overall","15","overall","Additional outcomes: all medications",42,2,10,TRUE,TRUE,"RD","double_zero"
"CD003774_pub5_data","16::overall","16","overall","Acute rejection according to method of diagnosis",13,0,0,TRUE,TRUE,"OR_cc","default_or"
"CD003774_pub5_data","17::overall","17","overall","Valaciclovir: additional outcomes",4,0,0,TRUE,TRUE,"OR_cc","default_or"
"CD003774_pub5_data","18::overall","18","overall","Adverse effects",23,6,8,TRUE,TRUE,"RD","double_zero"
"CD003833_pub5_data","6::overall","6","overall","Vascular events",4,0,3,TRUE,TRUE,"RD","sparse_events"
"CD003962_pub3_data","1::overall","1","overall","Kidney failure or doubling of serum creatinine",13,4,8,TRUE,TRUE,"RD","double_zero"
"CD003962_pub3_data","2::overall","2","overall","Complete remission of proteinuria",20,9,13,TRUE,TRUE,"RD","double_zero"
"CD003962_pub3_data","3::overall","3","overall","Partial remission of proteinuria",14,4,5,TRUE,TRUE,"RD","double_zero"
"CD003962_pub3_data","4::overall","4","overall","Proteinuria",36,32,32,TRUE,TRUE,"RD","double_zero"
"CD003962_pub3_data","6::overall","6","overall","Haematuria",12,11,11,FALSE,TRUE,"RD","double_zero"
"CD003962_pub3_data","8::overall","8","overall","Serum creatinine",34,33,33,FALSE,TRUE,"RD","double_zero"
"CD003962_pub3_data","9::overall","9","overall","Doubling of serum creatinine",11,7,9,TRUE,TRUE,"RD","double_zero"
"CD003962_pub3_data","10::overall","10","overall","> 50% increase in serum creatinine",11,8,9,TRUE,TRUE,"RD","double_zero"
"CD003962_pub3_data","13::overall","13","overall","Adverse events",18,7,11,TRUE,TRUE,"RD","double_zero"
"CD003962_pub3_data","15::overall","15","overall","Serious adverse events",6,1,3,TRUE,TRUE,"RD","double_zero"
"CD003962_pub3_data","5::overall","5","overall","Partial remission",8,6,6,TRUE,TRUE,"RD","double_zero"
"CD003962_pub3_data","7::overall","7","overall","Haematuria",7,6,6,FALSE,TRUE,"RD","double_zero"
"CD003962_pub3_data","14::overall","14","overall","Cardiovascular events",4,0,1,TRUE,TRUE,"RD","sparse_events"
"CD003962_pub3_data","16::overall","16","overall","Serious adverse events",2,0,2,TRUE,TRUE,"RD","sparse_events"
"CD003962_pub3_data","17::overall","17","overall","Gastrointestinal hemorrhage",2,0,1,TRUE,TRUE,"RD","sparse_events"
"CD003962_pub3_data","18::overall","18","overall","Leukopenia",3,0,1,TRUE,TRUE,"RD","sparse_events"
"CD003962_pub3_data","19::overall","19","overall","Hyperkalaemia",3,1,3,TRUE,TRUE,"RD","double_zero"
"CD003962_pub3_data","20::overall","20","overall","Nausea",2,1,1,FALSE,TRUE,"RD","double_zero"
"CD004184_pub3_data","1::overall","1","overall","All-cause mortality",2,0,2,TRUE,TRUE,"RD","sparse_events"
"CD004184_pub3_data","2::overall","2","overall","Serious adverse events",4,2,2,TRUE,TRUE,"RD","double_zero"
"CD004184_pub3_data","3::overall","3","overall","Overall adverse events",14,0,2,TRUE,TRUE,"RD","sparse_events"
"CD004184_pub3_data","4::overall","4","overall","Withdrawals from treatment due to adverse events",14,0,6,TRUE,TRUE,"RD","sparse_events"
"CD004307_pub7_data","1::1","1","1","Smoking cessation (subgrouped by when incentives were provided)",7,0,2,TRUE,TRUE,"RD","sparse_events"
"CD004307_pub7_data","1::2","1","2","Smoking cessation (subgrouped by when incentives were provided)",35,0,5,TRUE,TRUE,"RD","sparse_events"
"CD004307_pub7_data","2::1","2","1","Smoking cessation (grouped by substance misuse)",10,0,3,TRUE,TRUE,"RD","sparse_events"
"CD004307_pub7_data","2::2","2","2","Smoking cessation (grouped by substance misuse)",32,0,4,TRUE,TRUE,"RD","sparse_events"
"CD004307_pub7_data","3::overall","3","overall","Smoking cessation in mixed populations (generic inverse-variance analysis - including new cluster trials)",49,46,47,TRUE,TRUE,"RD","double_zero"
"CD004307_pub7_data","1::overall","1","overall","Smoking cessation at longest follow-up",13,0,2,TRUE,TRUE,"RD","sparse_events"
"CD004307_pub7_data","2::overall","2","overall","Abstinence at end of pregnancy",11,0,0,TRUE,TRUE,"OR_cc","default_or"
"CD004376_pub4_data","4::overall","4","overall","Participant-reported treatment success immediately post-intervention",11,0,0,TRUE,TRUE,"OR_cc","default_or"
"CD004376_pub4_data","5::overall","5","overall","Study withdrawals at final follow-up",123,19,43,TRUE,TRUE,"RD","double_zero"
"CD004376_pub4_data","6::overall","6","overall","Adverse events at final follow-up",48,27,36,TRUE,TRUE,"RD","double_zero"
"CD004406_pub6_data","1::overall","1","overall","Resolution of symptoms post-treatment (ITT analysis)",17,0,0,TRUE,TRUE,"OR_cc","default_or"
"CD004406_pub6_data","2::overall","2","overall","Resolution of symptoms post-treatment (evaluable participants)",15,0,1,TRUE,TRUE,"RD","sparse_events"
"CD004406_pub6_data","3::overall","3","overall","Resolution of symptoms within 24 hours of treatment (ITT analysis)",11,0,0,TRUE,TRUE,"OR_cc","default_or"
"CD004406_pub6_data","4::overall","4","overall","Resolution of symptoms ITT (subgroup sponsored versus no sponsor reported)",11,0,0,TRUE,TRUE,"OR_cc","default_or"
"CD004406_pub6_data","5::overall","5","overall","Sore throat (ITT analysis)",4,0,0,TRUE,TRUE,"OR_cc","default_or"
"CD004406_pub6_data","6::overall","6","overall","Fever (ITT analysis)",7,0,2,TRUE,TRUE,"RD","sparse_events"
"CD004406_pub6_data","7::overall","7","overall","Incidence of relapse (evaluable participants)",10,0,0,TRUE,TRUE,"OR_cc","default_or"
"CD004406_pub6_data","9::overall","9","overall","Adverse events (ITT analysis)",3,0,0,TRUE,TRUE,"OR_cc","default_or"
"CD004417_pub6_data","1::overall","1","overall","Number of participants with pain on days 3 to 6: delayed versus immediate antibiotics",55,0,0,TRUE,TRUE,"OR_cc","default_or"
"CD004417_pub6_data","2::overall","2","overall","Pain severity on day 3: delayed versus immediate antibiotics",35,9,9,TRUE,TRUE,"RD","double_zero"
"CD004417_pub6_data","3::overall","3","overall","Duration of pain: delayed versus immediate antibiotics (days)",18,10,10,TRUE,TRUE,"RD","double_zero"
"CD004417_pub6_data","4::overall","4","overall","Duration of pain: delayed versus no antibiotics (days) ",11,10,10,FALSE,TRUE,"RD","double_zero"
"CD004417_pub6_data","5::overall","5","overall","Rash: delayed (prescription collection) versus immediate antibiotics",2,0,0,TRUE,TRUE,"OR_cc","default_or"
"CD004508_pub5_data","1::overall","1","overall","Postoperative ileus",4,1,1,TRUE,TRUE,"RD","double_zero"
"CD004508_pub5_data","2::overall","2","overall","Nausea or vomiting, or both (random-effects model)",6,0,0,TRUE,TRUE,"OR_cc","default_or"
"CD004508_pub5_data","3::overall","3","overall","Nausea (random-effects model)",3,0,0,TRUE,TRUE,"OR_cc","default_or"
"CD004508_pub5_data","4::overall","4","overall","Vomiting",4,0,0,TRUE,TRUE,"OR_cc","default_or"
"CD004508_pub5_data","5::overall","5","overall","Abdominal distension",4,0,1,TRUE,TRUE,"RD","sparse_events"
"CD004508_pub5_data","6::overall","6","overall","Postoperative placement of nasogastric tube",3,1,2,TRUE,TRUE,"RD","double_zero"
"CD004508_pub5_data","12::overall","12","overall","Febrile morbidity",3,0,0,TRUE,TRUE,"OR_cc","default_or"
"CD004508_pub5_data","13::overall","13","overall","Infectious complications",2,0,1,TRUE,TRUE,"RD","sparse_events"
"CD004508_pub5_data","14::overall","14","overall","Wound complications",4,0,3,TRUE,TRUE,"RD","sparse_events"
"CD004508_pub5_data","15::overall","15","overall","Pneumonia",3,0,3,TRUE,TRUE,"RD","sparse_events"
"CD004661_pub4_data","1::overall","1","overall","Death (fetal, neonatal, or later (up to 2 years' corrected age))",50,7,16,TRUE,TRUE,"RD","double_zero"
"CD004661_pub4_data","2::overall","2","overall","Cerebral palsy (up to 2 years' corrected age)",64,5,15,TRUE,TRUE,"RD","double_zero"
"CD004661_pub4_data","3::overall","3","overall","Death or cerebral palsy (up to 2 years' corrected age)",49,10,10,TRUE,TRUE,"RD","double_zero"
"CD004661_pub4_data","4::overall","4","overall","Major neurodevelopmental disability (up to 2 years' corrected age)",24,2,2,TRUE,TRUE,"RD","double_zero"
"CD004661_pub4_data","5::overall","5","overall","Death or major neurodevelopmental disability (up to 2 years' corrected age)",29,8,15,TRUE,TRUE,"RD","double_zero"
"CD004661_pub4_data","6::overall","6","overall","Death (fetal, neonatal, or later (up to school age))",24,3,5,TRUE,TRUE,"RD","double_zero"
"CD004661_pub4_data","7::overall","7","overall","Cerebral palsy (school age)",23,0,0,TRUE,TRUE,"OR_cc","default_or"
"CD004661_pub4_data","8::overall","8","overall","Death or cerebral palsy (up to school age)",31,6,8,TRUE,TRUE,"RD","double_zero"
"CD004661_pub4_data","9::overall","9","overall","Major neurodevelopmental disability (school age)",22,0,0,TRUE,TRUE,"OR_cc","default_or"
"CD004661_pub4_data","10::overall","10","overall","Death or major neurodevelopmental disability (up to school age)",17,4,5,TRUE,TRUE,"RD","double_zero"
"CD004661_pub4_data","11::overall","11","overall","Severe maternal outcome potentially related to treatment (death, respiratory arrest, or cardiac arrest)",21,9,11,TRUE,TRUE,"RD","double_zero"
"CD004661_pub4_data","12::overall","12","overall","Adverse effects severe enough to stop treatment",14,0,0,TRUE,TRUE,"OR_cc","default_or"
"CD004661_pub4_data","13::overall","13","overall","Neonatal encephalopathy",18,11,12,TRUE,TRUE,"RD","double_zero"
"CD004661_pub4_data","14::overall","14","overall","Neonatal convulsions",17,4,4,TRUE,TRUE,"RD","double_zero"
"CD004661_pub4_data","15::overall","15","overall","Neonatal hypotonia",19,8,9,TRUE,TRUE,"RD","double_zero"
"CD004661_pub4_data","16::overall","16","overall","Necrotising enterocolitis",6,0,2,TRUE,TRUE,"RD","sparse_events"
"CD004661_pub4_data","17::overall","17","overall","Retinopathy of prematurity",4,0,1,TRUE,TRUE,"RD","sparse_events"
"CD004661_pub4_data","18::overall","18","overall","Patent ductus arteriosus",4,0,0,TRUE,TRUE,"OR_cc","default_or"
"CD004661_pub4_data","19::overall","19","overall","Respiratory distress syndrome",8,0,0,TRUE,TRUE,"OR_cc","default_or"
"CD004661_pub4_data","20::overall","20","overall","Chronic lung disease/bronchopulmonary dysplasia",6,0,0,TRUE,TRUE,"OR_cc","default_or"
"CD004661_pub4_data","21::overall","21","overall","Use of respiratory support (endotracheal intubation)",7,0,1,TRUE,TRUE,"RD","sparse_events"
"CD004661_pub4_data","22::overall","22","overall","Use of respiratory support (mechanical ventilation or continuous positive airway pressure) ",4,0,0,TRUE,TRUE,"OR_cc","default_or"
"CD004661_pub4_data","23::overall","23","overall","Use of inotropic support",2,0,0,TRUE,TRUE,"OR_cc","default_or"
"CD004661_pub4_data","25::overall","25","overall","Early- or late-onset sepsis",4,0,0,TRUE,TRUE,"OR_cc","default_or"
"CD004661_pub4_data","26::overall","26","overall","Severe adverse neonatal outcome composite",2,0,0,TRUE,TRUE,"OR_cc","default_or"
"CD004667_pub6_data","1::overall","1","overall","Spontaneous vaginal birth (as defined by trial authors)",60,0,0,TRUE,TRUE,"OR_cc","default_or"
"CD004667_pub6_data","2::overall","2","overall","Caesarean birth",64,0,0,TRUE,TRUE,"OR_cc","default_or"
"CD004667_pub6_data","3::overall","3","overall","Regional analgesia (epidural/spinal)",60,0,0,TRUE,TRUE,"OR_cc","default_or"
"CD004667_pub6_data","4::overall","4","overall","Intact perineum",48,0,0,TRUE,TRUE,"OR_cc","default_or"
"CD004667_pub6_data","5::overall","5","overall","Fetal loss at or after 24 weeks gestation",48,0,24,TRUE,TRUE,"RD","sparse_events"
"CD004667_pub6_data","6::overall","6","overall","Preterm birth (< 37 weeks)",40,0,0,TRUE,TRUE,"OR_cc","default_or"
"CD004667_pub6_data","7::overall","7","overall","Neonatal death (baby born alive at any gestation and dies within 28 days)",40,4,28,TRUE,TRUE,"RD","double_zero"
"CD004667_pub6_data","10::overall","10","overall","Induction of labour",14,0,0,TRUE,TRUE,"OR_cc","default_or"
"CD004667_pub6_data","11::overall","11","overall","Instrumental vaginal birth (forceps/vacuum)",14,0,0,TRUE,TRUE,"OR_cc","default_or"
"CD004667_pub6_data","12::overall","12","overall","Episiotomy",15,0,0,TRUE,TRUE,"OR_cc","default_or"
"CD004667_pub6_data","13::overall","13","overall","Third or fourth degree tear",7,0,2,TRUE,TRUE,"RD","sparse_events"
"CD004667_pub6_data","14::overall","14","overall","Postpartum haemorrhage (as defined by trial authors)",11,0,0,TRUE,TRUE,"OR_cc","default_or"
"CD004667_pub6_data","15::overall","15","overall","Breastfeeding initiation",8,0,0,TRUE,TRUE,"OR_cc","default_or"
"CD004667_pub6_data","18::overall","18","overall","Attendance at birth by known midwife",11,0,0,TRUE,TRUE,"OR_cc","default_or"
"CD004667_pub6_data","20::overall","20","overall","Birth weight less than 2500 g",8,0,0,TRUE,TRUE,"OR_cc","default_or"
"CD004667_pub6_data","22::overall","22","overall","Apgar score less than or equal to 7 at 5 minutes",13,0,1,TRUE,TRUE,"RD","sparse_events"
"CD004667_pub6_data","23::overall","23","overall","Admission to special care nursery/neonatal intensive care unit",13,0,0,TRUE,TRUE,"OR_cc","default_or"
"CD004667_pub6_data","24::overall","24","overall","Fetal loss before 24 weeks gestation",12,0,1,TRUE,TRUE,"RD","sparse_events"
"CD004703_pub3_data","1::overall","1","overall","Serious adverse events",40,31,38,TRUE,TRUE,"RD","double_zero"
"CD004703_pub3_data","2::overall","2","overall","Chronic pain (persisting for > 6 months after surgery)",26,16,24,TRUE,TRUE,"RD","double_zero"
"CD004703_pub3_data","3::overall","3","overall","Hernia recurrence",33,17,31,TRUE,TRUE,"RD","double_zero"
"CD004703_pub3_data","5::overall","5","overall","Haematoma or seroma",15,1,8,TRUE,TRUE,"RD","double_zero"
"CD004736_pub6_data","1::overall","1","overall","Maternal anaemia at term (Hb less than 110 g/L at 37 weeks' gestation or more) (ALL)",39,2,2,TRUE,TRUE,"RD","double_zero"
"CD004736_pub6_data","2::overall","2","overall","Maternal anaemia at term (Hb less than 110 g/L at 37 weeks' gestation or more): SUBGROUP ANALYSIS by gestational age at the start of supplementation",39,2,3,TRUE,TRUE,"RD","double_zero"
"CD004736_pub6_data","3::overall","3","overall","Maternal anaemia at term (Hb less than 110 g/L at 37 weeks' gestation or more): SUBGROUP ANALYSIS by anaemia status at the start of supplementation",39,5,5,TRUE,TRUE,"RD","double_zero"
"CD004736_pub6_data","4::overall","4","overall","Maternal anaemia at term (Hb less than 110 g/L at 37 weeks' gestation or more): SUBGROUP ANALYSIS by dose of iron",38,2,2,TRUE,TRUE,"RD","double_zero"
"CD004736_pub6_data","5::overall","5","overall","Maternal anaemia at term (Hb less than 110 g/L at 37 weeks' gestation or more): SUBGROUP ANALYSIS by malarial status of setting",38,3,3,TRUE,TRUE,"RD","double_zero"
"CD004736_pub6_data","6::overall","6","overall","Maternal iron deficiency at term (as defined by trialists, based on any indicator of iron status at 37 weeks' gestation or more) (ALL)",20,2,2,TRUE,TRUE,"RD","double_zero"
"CD004736_pub6_data","7::overall","7","overall","Maternal iron deficiency at term (as defined by trialists, based on any indicator of iron status at 37 weeks' gestation or more): SUBGROUP ANALYSIS by gestational age at the start of supplementation",19,1,1,TRUE,TRUE,"RD","double_zero"
"CD004736_pub6_data","8::overall","8","overall","Maternal iron deficiency at term (as defined by trialists, based on any indicator of iron status at 37 weeks' gestation or more): SUBGROUP ANALYSIS by anaemia status at the start of supplementation",20,3,3,TRUE,TRUE,"RD","double_zero"
"CD004736_pub6_data","9::overall","9","overall","Maternal iron deficiency at term (as defined by trialists, based on any indicator of iron status at 37 weeks' gestation or more): SUBGROUP ANALYSIS by dose of iron",21,0,0,TRUE,TRUE,"OR_cc","default_or"
"CD004736_pub6_data","10::overall","10","overall","Maternal iron deficiency at term (as defined by trialists, based on any indicator of iron status at 37 weeks' gestation or more): SUBGROUP ANALYSIS by malarial status of setting",27,4,6,TRUE,TRUE,"RD","double_zero"
"CD004736_pub6_data","11::overall","11","overall","Maternal iron-deficiency anaemia at term (Hb less than 110 g/L and at least one additional laboratory indicator at 37 weeks' gestation or more) (ALL)",22,4,6,TRUE,TRUE,"RD","double_zero"
"CD004736_pub6_data","12::overall","12","overall","Maternal iron-deficiency anaemia at term (Hb less than 110 g/L and at least one additional laboratory indicator at 37 weeks' gestation): SUBGROUP ANALYSIS by gestational age at the start of supplementation",22,4,6,TRUE,TRUE,"RD","double_zero"
"CD004736_pub6_data","13::overall","13","overall","Maternal iron-deficiency anaemia at term (Hb less than 110 g/L and at least one additional laboratory indicator at 37 weeks' gestation or more): SUBGROUP ANALYSIS by anaemia status at the start of supplementation",22,6,7,TRUE,TRUE,"RD","double_zero"
"CD004736_pub6_data","14::overall","14","overall","Maternal iron-deficiency anaemia at term (Hb less than 110 g/L and at least one additional laboratory indicator at 37 weeks' gestation or more): SUBGROUP ANALYSIS by dose of iron",23,8,10,TRUE,TRUE,"RD","double_zero"
"CD004736_pub6_data","15::overall","15","overall","Maternal iron-deficiency anaemia at term (Hb less than 110 g/L and at least one additional laboratory indicator at 37 weeks' gestation or more): SUBGROUP ANALYSIS by malarial status of setting",20,6,8,TRUE,TRUE,"RD","double_zero"
"CD004736_pub6_data","16::overall","16","overall","Maternal death (death while pregnant or within 42 days of termination of pregnancy) (ALL)",13,6,9,TRUE,TRUE,"RD","double_zero"
"CD004736_pub6_data","17::overall","17","overall","Adverse effects (any reported throughout the intervention period) (ALL)",28,8,11,TRUE,TRUE,"RD","double_zero"
"CD004736_pub6_data","18::overall","18","overall","Adverse effects (any reported throughout the intervention period): SUBGROUP ANALYSIS by gestational age at the start of supplementation",29,7,11,TRUE,TRUE,"RD","double_zero"
"CD004736_pub6_data","19::overall","19","overall","Adverse effects (any reported throughout the intervention period): SUBGROUP ANALYSIS by anaemia status at the start of supplementation",29,4,8,TRUE,TRUE,"RD","double_zero"
"CD004736_pub6_data","20::overall","20","overall","Adverse effects (any reported throughout the intervention period): SUBGROUP ANALYSIS by dose of iron",33,4,12,TRUE,TRUE,"RD","double_zero"
"CD004736_pub6_data","21::overall","21","overall","Adverse effects (any reported throughout the intervention period): SUBGROUP ANALYSIS by malarial status of setting",29,4,8,TRUE,TRUE,"RD","double_zero"
"CD004736_pub6_data","22::overall","22","overall","Maternal severe anaemia at any time during second and third trimester (Hb less than 70 g/L) (ALL)",24,12,17,TRUE,TRUE,"RD","double_zero"
"CD004736_pub6_data","23::overall","23","overall","Maternal severe anaemia at any time during second and third trimester (Hb less than 70 g/L): SUBGROUP ANALYSIS by gestational age at the start of supplementation",24,12,17,TRUE,TRUE,"RD","double_zero"
"CD004736_pub6_data","24::overall","24","overall","Maternal severe anaemia at any time during second and third trimester (Hb less than 70 g/L): SUBGROUP ANALYSIS by anaemia status at the start of supplementation",22,11,15,TRUE,TRUE,"RD","double_zero"
"CD004736_pub6_data","25::overall","25","overall","Maternal severe anaemia at any time during second and third trimester (Hb less than 70 g/L): SUBGROUP ANALYSIS by dose of iron",24,12,16,TRUE,TRUE,"RD","double_zero"
"CD004736_pub6_data","26::overall","26","overall","Maternal severe anaemia at any time during second and third trimester (Hb less than 70 g/L): SUBGROUP ANALYSIS by malarial status of setting",22,11,15,TRUE,TRUE,"RD","double_zero"
"CD004736_pub6_data","27::overall","27","overall","Maternal clinical malaria",9,1,2,TRUE,TRUE,"RD","double_zero"
"CD004736_pub6_data","28::overall","28","overall","Low birthweight (less than 2500 g) (ALL)",26,5,8,TRUE,TRUE,"RD","double_zero"
"CD004736_pub6_data","29::overall","29","overall","Low birthweight (less than 2500 g): SUBGROUP ANALYSIS by gestational age at the start of supplementation",26,5,8,TRUE,TRUE,"RD","double_zero"
"CD004736_pub6_data","30::overall","30","overall","Low birthweight (less than 2500 g): SUBGROUP ANALYSIS by anaemia status at the start of supplementation",24,2,5,TRUE,TRUE,"RD","double_zero"
"CD004736_pub6_data","31::overall","31","overall","Low birthweight (less than 2500 g): SUBGROUP ANALYSIS by dose of iron",23,3,7,TRUE,TRUE,"RD","double_zero"
"CD004736_pub6_data","32::overall","32","overall","Low birthweight (less than 2500 g): SUBGROUP ANALYSIS by malarial status of setting",25,7,10,TRUE,TRUE,"RD","double_zero"
"CD004736_pub6_data","33::overall","33","overall","Birthweight (g) (ALL)",32,30,31,TRUE,TRUE,"RD","double_zero"
"CD004736_pub6_data","34::overall","34","overall","Birthweight (g): SUBGROUP ANALYSIS by gestational age at the start of supplementation",32,28,29,TRUE,TRUE,"RD","double_zero"
"CD004736_pub6_data","35::overall","35","overall","Birthweight (g): SUBGROUP ANALYSIS by anaemia status at the start of supplementation",30,26,27,TRUE,TRUE,"RD","double_zero"
"CD004736_pub6_data","36::overall","36","overall","Birthweight (g): SUBGROUP ANALYSIS by dose of iron",34,31,32,TRUE,TRUE,"RD","double_zero"
"CD004736_pub6_data","37::overall","37","overall","Birthweight (g): SUBGROUP ANALYSIS by malarial status of setting",32,29,30,TRUE,TRUE,"RD","double_zero"
"CD004736_pub6_data","38::overall","38","overall","Preterm birth (less than 37 weeks of gestation) (ALL)",23,4,7,TRUE,TRUE,"RD","double_zero"
"CD004736_pub6_data","39::overall","39","overall","Preterm birth (less than 37 weeks of gestation): SUBGROUP ANALYSIS by gestational age at the start of supplementation",21,2,5,TRUE,TRUE,"RD","double_zero"
"CD004736_pub6_data","40::overall","40","overall","Preterm birth (less than 37 weeks of gestation): SUBGROUP ANALYSIS by anaemia status at the start of supplementation",23,5,8,TRUE,TRUE,"RD","double_zero"
"CD004736_pub6_data","41::overall","41","overall","Preterm birth (less than 37 weeks of gestation): SUBGROUP ANALYSIS by dose of iron",20,3,5,TRUE,TRUE,"RD","double_zero"
"CD004736_pub6_data","42::overall","42","overall","Preterm birth (less than 37 weeks of gestation): SUBGROUP ANALYSIS by malarial status of setting",19,2,5,TRUE,TRUE,"RD","double_zero"
"CD004736_pub6_data","43::overall","43","overall","Neonatal death (within 28 days after delivery) (ALL)",6,0,1,TRUE,TRUE,"RD","sparse_events"
"CD004736_pub6_data","44::overall","44","overall","Neonatal death (within 28 days after delivery): SUBGROUP ANALYSIS by gestational age at the start of supplementation",8,1,2,TRUE,TRUE,"RD","double_zero"
"CD004736_pub6_data","45::overall","45","overall","Neonatal death (within 28 days after delivery): SUBGROUP ANALYSIS by anaemia status at the start of supplementation",19,1,1,TRUE,TRUE,"RD","double_zero"
"CD004736_pub6_data","46::overall","46","overall","Neonatal death (within 28 days after delivery): SUBGROUP ANALYSIS by dose of iron",12,0,0,TRUE,TRUE,"OR_cc","default_or"
"CD004736_pub6_data","47::overall","47","overall","Neonatal death (within 28 days after delivery): SUBGROUP ANALYSIS by malarial status of setting",11,1,1,TRUE,TRUE,"RD","double_zero"
"CD004736_pub6_data","48::overall","48","overall","Congenital anomalies (ALL)",20,17,17,TRUE,TRUE,"RD","double_zero"
"CD004736_pub6_data","49::overall","49","overall","Congenital anomalies: SUBGROUP ANALYSIS by gestational age at the start of supplementation)",10,7,7,TRUE,TRUE,"RD","double_zero"
"CD004736_pub6_data","50::overall","50","overall","Congenital anomalies: SUBGROUP ANALYSIS by anaemia status at the start of supplementation",11,2,2,TRUE,TRUE,"RD","double_zero"
"CD004736_pub6_data","51::overall","51","overall","Congenital anomalies: SUBGROUP ANALYSIS by dose of iron",11,1,2,TRUE,TRUE,"RD","double_zero"
"CD004736_pub6_data","52::overall","52","overall","Congenital anomalies: SUBGROUP ANALYSIS by malarial status of setting",7,2,4,TRUE,TRUE,"RD","double_zero"
"CD004736_pub6_data","53::overall","53","overall","Maternal anaemia at or near term (Hb less than 110 g/L at 34 weeks' gestation or more) (ALL)",21,5,7,TRUE,TRUE,"RD","double_zero"
"CD004736_pub6_data","54::overall","54","overall","Maternal iron deficiency at or near term (as defined by as defined by trialists, based on any indicator of iron status at 34 weeks' gestation or more) (ALL)",14,6,6,TRUE,TRUE,"RD","double_zero"
"CD004736_pub6_data","55::overall","55","overall","Maternal iron-deficiency anaemia at or near term (Hb less than 110 g/L and at least one additional laboratory indicator at 34 weeks' gestation or more) (ALL)",9,1,1,TRUE,TRUE,"RD","double_zero"
"CD004736_pub6_data","56::overall","56","overall","Maternal Hb concentration at or near term (in g/L, at 34 weeks' gestation or more) (ALL)",19,18,19,FALSE,TRUE,"RD","double_zero"
"CD004736_pub6_data","57::overall","57","overall","Maternal Hb concentration within 6 weeks postpartum (in g/L) (ALL)",9,7,8,TRUE,TRUE,"RD","double_zero"
"CD004736_pub6_data","58::overall","58","overall","Maternal high haemoglobin concentrations during second or third trimester (Hb more than 130 g/L) (ALL)",9,1,2,TRUE,TRUE,"RD","double_zero"
"CD004736_pub6_data","59::overall","59","overall","Maternal high haemoglobin concentrations at or near term (Hb more than 130 g/L at 34 weeks' gestation or more) (ALL)",8,0,1,TRUE,TRUE,"RD","sparse_events"
"CD004736_pub6_data","60::overall","60","overall","Moderate anaemia at postpartum (Hb more than 80 g/L and less than 110 g/L) (ALL)",5,1,3,TRUE,TRUE,"RD","double_zero"
"CD004736_pub6_data","61::overall","61","overall","Maternal severe anaemia at or near term (Hb less than 70 g/L at 34 weeks' gestation or more) (ALL)",10,5,7,TRUE,TRUE,"RD","double_zero"
"CD004736_pub6_data","62::overall","62","overall","Severe anaemia postpartum (Hb less than 80 g/L) (ALL)",8,6,6,TRUE,TRUE,"RD","double_zero"
"CD004736_pub6_data","63::overall","63","overall","Puerperal infection (ALL)",5,0,1,TRUE,TRUE,"RD","sparse_events"
"CD004736_pub6_data","64::overall","64","overall","Antepartum haemorrhage (ALL)",2,0,1,TRUE,TRUE,"RD","sparse_events"
"CD004736_pub6_data","65::overall","65","overall","Postpartum haemorrhage (ALL)",3,0,2,TRUE,TRUE,"RD","sparse_events"
"CD004736_pub6_data","66::overall","66","overall","Transfusion provided (ALL)",2,0,2,TRUE,TRUE,"RD","sparse_events"
"CD004736_pub6_data","67::overall","67","overall","Diarrhoea (ALL)",5,1,4,TRUE,TRUE,"RD","double_zero"
"CD004736_pub6_data","68::overall","68","overall","Constipation (ALL)",7,0,2,TRUE,TRUE,"RD","sparse_events"
"CD004736_pub6_data","69::overall","69","overall","Nausea (ALL)",5,2,3,TRUE,TRUE,"RD","double_zero"
"CD004736_pub6_data","70::overall","70","overall","Heartburn (ALL)",3,1,1,TRUE,TRUE,"RD","double_zero"
"CD004736_pub6_data","71::overall","71","overall","Vomiting (ALL)",4,1,2,TRUE,TRUE,"RD","double_zero"
"CD004736_pub6_data","74::overall","74","overall","Pre-eclampsia (ALL)",2,0,2,TRUE,TRUE,"RD","sparse_events"
"CD004736_pub6_data","75::overall","75","overall","Very low birthweight (less than 1500 g) (ALL)",4,1,3,TRUE,TRUE,"RD","double_zero"
"CD004736_pub6_data","76::overall","76","overall","Very premature birth (less than 34 weeks' gestation) (ALL)",5,0,1,TRUE,TRUE,"RD","sparse_events"
"CD004871_pub5_data","2::overall","2","overall","Pain (dichotomous data; short-term)",9,1,1,TRUE,TRUE,"RD","double_zero"
"CD004871_pub5_data","3::overall","3","overall","Function-disability (short-term)",9,8,8,FALSE,TRUE,"RD","double_zero"
"CD004871_pub5_data","5::overall","5","overall","Participant-reported treatment success at short-term (dichotomous data)",2,1,1,FALSE,TRUE,"RD","double_zero"
"CD004871_pub5_data","7::overall","7","overall","Minor adverse events (dichotomous data; short-term)",4,2,2,TRUE,TRUE,"RD","double_zero"
"CD004904_pub4_data","1::overall","1","overall","Postpartum endometritis",4,0,1,TRUE,TRUE,"RD","sparse_events"
"CD004925_pub4_data","1::overall","1","overall","Urine leak and obstruction",32,1,20,TRUE,TRUE,"RD","double_zero"
"CD004925_pub4_data","2::overall","2","overall","Subgroup analysis for major urological complications: duration of stenting",11,0,6,TRUE,TRUE,"RD","sparse_events"
"CD004925_pub4_data","3::overall","3","overall","Subgroup analysis for major urological complications: surgeon's experience",10,0,6,TRUE,TRUE,"RD","sparse_events"
"CD004925_pub4_data","4::overall","4","overall","UTI",10,0,0,TRUE,TRUE,"OR_cc","default_or"
"CD004925_pub4_data","5::overall","5","overall","UTI: diagnostic criteria",8,0,0,TRUE,TRUE,"OR_cc","default_or"
"CD004925_pub4_data","6::overall","6","overall","UTI: antibiotic regimen",8,0,0,TRUE,TRUE,"OR_cc","default_or"
"CD004925_pub4_data","7::overall","7","overall","Haematuria",8,1,6,TRUE,TRUE,"RD","double_zero"
"CD004953_pub5_data","1::1","1","1","Death in the delivery room",7,4,6,TRUE,TRUE,"RD","double_zero"
"CD004953_pub5_data","2::overall","2","overall","Death during hospitalisation",13,3,5,TRUE,TRUE,"RD","double_zero"
"CD004953_pub5_data","3::1","3","1","Death",6,4,5,TRUE,TRUE,"RD","double_zero"
"CD004953_pub5_data","3::2","3","2","Death",12,3,5,TRUE,TRUE,"RD","double_zero"
"CD004953_pub5_data","4::overall","4","overall","Rate of mechanical ventilation",9,2,4,TRUE,TRUE,"RD","double_zero"
"CD004953_pub5_data","5::1","5","1","Chronic lung disease",6,0,2,TRUE,TRUE,"RD","sparse_events"
"CD004953_pub5_data","5::2","5","2","Chronic lung disease",7,1,2,TRUE,TRUE,"RD","double_zero"
"CD004953_pub5_data","6::overall","6","overall","Pneumothorax during hospitalisation",13,0,5,TRUE,TRUE,"RD","sparse_events"
"CD004953_pub5_data","7::1","7","1","Cranial ultrasound abnormalities",8,1,4,TRUE,TRUE,"RD","double_zero"
"CD004953_pub5_data","7::2","7","2","Cranial ultrasound abnormalities",4,0,2,TRUE,TRUE,"RD","sparse_events"
"CD004953_pub5_data","7::3","7","3","Cranial ultrasound abnormalities",6,0,4,TRUE,TRUE,"RD","sparse_events"
"CD004953_pub5_data","8::1","8","1","Endotracheal intubation",8,1,1,TRUE,TRUE,"RD","double_zero"
"CD004953_pub5_data","8::2","8","2","Endotracheal intubation",6,0,2,TRUE,TRUE,"RD","sparse_events"
"CD004953_pub5_data","9::1","9","1","Surfactant administration",4,1,1,TRUE,TRUE,"RD","double_zero"
"CD004953_pub5_data","9::2","9","2","Surfactant administration",12,1,1,TRUE,TRUE,"RD","double_zero"
"CD004953_pub5_data","12::overall","12","overall","Retinopathy of prematurity (ROP) stage ≥ 3",9,1,5,TRUE,TRUE,"RD","double_zero"
"CD004953_pub5_data","13::1","13","1","Patent ductus arteriosus (PDA)",7,0,1,TRUE,TRUE,"RD","sparse_events"
"CD004953_pub5_data","13::2","13","2","Patent ductus arteriosus (PDA)",4,2,3,TRUE,TRUE,"RD","double_zero"
"CD004953_pub5_data","1::2","1","2","Death",2,0,1,TRUE,TRUE,"RD","sparse_events"
"CD004953_pub5_data","3::overall","3","overall","Chronic lung disease, moderate to severe",2,1,1,FALSE,TRUE,"RD","double_zero"
"CD004953_pub5_data","8::overall","8","overall","Retinopathy of prematurity (ROP) stage ≥ 3",2,1,2,FALSE,TRUE,"RD","double_zero"
"CD004992_pub4_data","1::overall","1","overall","Recurrence of pelvic pain",4,0,0,TRUE,TRUE,"OR_cc","default_or"
"CD004992_pub4_data","2::overall","2","overall","Recurrence of endometrioma",4,0,1,TRUE,TRUE,"RD","sparse_events"
"CD004992_pub4_data","3::overall","3","overall","Requirement for further endometrioma surgery",2,0,0,TRUE,TRUE,"OR_cc","default_or"
"CD004992_pub4_data","4::overall","4","overall","Spontaneous pregnancy rate over the 12 months after surgery",3,0,1,TRUE,TRUE,"RD","sparse_events"
"CD005133_pub4_data","1::overall","1","overall","All symptomatic CMV disease",21,4,6,TRUE,TRUE,"RD","double_zero"
"CD005133_pub4_data","2::overall","2","overall","Death (any cause)",16,2,9,TRUE,TRUE,"RD","double_zero"
"CD005133_pub4_data","3::overall","3","overall","CMV organ involvement",28,1,17,TRUE,TRUE,"RD","double_zero"
"CD005133_pub4_data","4::overall","4","overall","CMV-associated symptoms",13,0,2,TRUE,TRUE,"RD","sparse_events"
"CD005133_pub4_data","5::overall","5","overall","Acute rejection",19,0,3,TRUE,TRUE,"RD","sparse_events"
"CD005133_pub4_data","6::overall","6","overall","Other infections",4,0,1,TRUE,TRUE,"RD","sparse_events"
"CD005133_pub4_data","7::overall","7","overall","Graft loss",9,0,7,TRUE,TRUE,"RD","sparse_events"
"CD005133_pub4_data","8::overall","8","overall","Adverse events",56,0,22,TRUE,TRUE,"RD","sparse_events"
"CD005133_pub4_data","9::overall","9","overall","High-risk recipients: D+/R- serostatus",4,0,2,TRUE,TRUE,"RD","sparse_events"
"CD005133_pub4_data","10::overall","10","overall","Low-risk recipients: D+ or D-/R+ serostatus",4,0,2,TRUE,TRUE,"RD","sparse_events"
"CD005187_pub6_data","1::overall","1","overall","Influenza",4,0,1,TRUE,TRUE,"RD","sparse_events"
"CD005187_pub6_data","2::overall","2","overall","Lower respiratory tract infection",4,0,0,TRUE,TRUE,"OR_cc","default_or"
"CD005187_pub6_data","3::overall","3","overall","Admission to hospital for respiratory illness",2,0,0,TRUE,TRUE,"OR_cc","default_or"
"CD005187_pub6_data","4::overall","4","overall","Deaths from lower respiratory tract infection ",6,0,0,TRUE,TRUE,"OR_cc","default_or"
"CD005187_pub6_data","5::overall","5","overall","Death from any cause",10,0,0,TRUE,TRUE,"OR_cc","default_or"
"CD005343_pub7_data","6::overall","6","overall","Postoperative mortality",4,0,2,TRUE,TRUE,"RD","sparse_events"
"CD005343_pub7_data","7::overall","7","overall","Surgically-related adverse effects (G3+)",32,1,12,TRUE,TRUE,"RD","double_zero"
"CD005343_pub7_data","8::overall","8","overall","Surgical resection",9,0,1,TRUE,TRUE,"RD","sparse_events"
"CD005343_pub7_data","15::overall","15","overall","Chemotherapy-related G3+AEs",2,0,0,TRUE,TRUE,"OR_cc","default_or"
"CD005495_pub5_data","2::overall","2","overall","Cognitive outcome at preschool age - Intelligence Quotient ",45,44,44,FALSE,TRUE,"RD","double_zero"
"CD005495_pub5_data","7::overall","7","overall","Motor outcome at school age ",12,0,0,TRUE,TRUE,"OR_cc","default_or"
"CD005495_pub5_data","8::overall","8","overall","Rate of cerebral palsy",36,0,5,TRUE,TRUE,"RD","sparse_events"
"CD005566_pub4_data","1::overall","1","overall","Mortality, including 'no major complications'",130,0,82,TRUE,TRUE,"RD","sparse_events"
"CD005566_pub4_data","2::overall","2","overall","Cardiac complications, including 'no major complications'",108,0,71,TRUE,TRUE,"RD","sparse_events"
"CD005566_pub4_data","3::overall","3","overall","Pulmonary complications, including 'no major complications'",102,0,44,TRUE,TRUE,"RD","sparse_events"
"CD005566_pub4_data","4::overall","4","overall","Re-thoracotomy",96,0,21,TRUE,TRUE,"RD","sparse_events"
"CD005566_pub4_data","5::overall","5","overall","Neurological complication (stroke)",86,0,23,TRUE,TRUE,"RD","sparse_events"
"CD005566_pub4_data","6::overall","6","overall","Renal failure",109,96,105,TRUE,TRUE,"RD","double_zero"
"CD005566_pub4_data","7::overall","7","overall","Inotropic support",108,85,89,TRUE,TRUE,"RD","double_zero"
"CD005582_pub5_data","1::overall","1","overall","The presence of PHN six months after the onset of acute herpetic rash",2,0,1,TRUE,TRUE,"RD","sparse_events"
"CD005582_pub5_data","3::overall","3","overall","Serious adverse events",6,2,5,TRUE,TRUE,"RD","double_zero"
"CD005582_pub5_data","4::overall","4","overall","Non-serious adverse events",6,1,3,TRUE,TRUE,"RD","double_zero"
"CD005595_pub4_data","2::overall","2","overall","Activity limitation (using OMAS; short-term follow-up,  ≤ 6 months)",27,25,27,TRUE,TRUE,"RD","double_zero"
"CD005595_pub4_data","4::overall","4","overall","HRQoL (using different measurement tools; at end of treatment)",11,10,11,FALSE,TRUE,"RD","double_zero"
"CD005595_pub4_data","8::overall","8","overall","Pain (VAS; end of treatment)",12,7,7,TRUE,TRUE,"RD","double_zero"
"CD005595_pub4_data","10::overall","10","overall","Adverse events",55,23,44,TRUE,TRUE,"RD","double_zero"
"CD005595_pub4_data","11::overall","11","overall","Adverse events (after surgical fracture management)",50,14,39,TRUE,TRUE,"RD","double_zero"
"CD005595_pub4_data","12::overall","12","overall","Adverse events (after non-surgical fracture management)",38,3,33,TRUE,TRUE,"RD","double_zero"
"CD005595_pub4_data","13::overall","13","overall","Adverse events (after initial fracture management period after either surgical or non-surgical treatment)",7,1,4,TRUE,TRUE,"RD","double_zero"
"CD005951_pub5_data","1::overall","1","overall","Death or dependence (mRS 4–6) at day 90",14,0,0,TRUE,TRUE,"OR_cc","default_or"
"CD005951_pub5_data","2::overall","2","overall","Intracerebral haemorrhage expansion by 24 hours",14,0,2,TRUE,TRUE,"RD","sparse_events"
"CD005951_pub5_data","3::overall","3","overall","All serious adverse events",8,1,3,TRUE,TRUE,"RD","double_zero"
"CD005951_pub5_data","4::overall","4","overall","Thromboembolic adverse events",15,1,8,TRUE,TRUE,"RD","double_zero"
"CD005951_pub5_data","5::overall","5","overall","Death from any cause by day 90",17,2,4,TRUE,TRUE,"RD","double_zero"
"CD005951_pub5_data","6::overall","6","overall","Death or dependence (Extended Glasgow Outcome Scale (GOS-E) 1–4) at day 90",4,0,0,TRUE,TRUE,"OR_cc","default_or"
"CD006023_pub4_data","1::overall","1","overall","Death (all causes)",81,24,63,TRUE,TRUE,"RD","double_zero"
"CD006023_pub4_data","2::overall","2","overall","Cardiovascular death",56,28,41,TRUE,TRUE,"RD","double_zero"
"CD006023_pub4_data","3::overall","3","overall","Hypercalcaemia",62,13,26,TRUE,TRUE,"RD","double_zero"
"CD006023_pub4_data","4::overall","4","overall","Nausea",53,14,28,TRUE,TRUE,"RD","double_zero"
"CD006023_pub4_data","5::overall","5","overall","Constipation",54,25,37,TRUE,TRUE,"RD","double_zero"
"CD006023_pub4_data","6::overall","6","overall","Serum phosphate [mg/dL]",68,54,62,TRUE,TRUE,"RD","double_zero"
"CD006023_pub4_data","7::overall","7","overall","Coronary artery calcium score",28,11,21,TRUE,TRUE,"RD","double_zero"
"CD006023_pub4_data","8::overall","8","overall","Myocardial infarction",30,10,23,TRUE,TRUE,"RD","double_zero"
"CD006023_pub4_data","9::overall","9","overall","Stroke",25,6,14,TRUE,TRUE,"RD","double_zero"
"CD006023_pub4_data","10::overall","10","overall","Hospitalisation",18,5,10,TRUE,TRUE,"RD","double_zero"
"CD006023_pub4_data","11::overall","11","overall","Fracture",18,8,14,TRUE,TRUE,"RD","double_zero"
"CD006023_pub4_data","12::overall","12","overall","Pruritus",14,4,13,TRUE,TRUE,"RD","double_zero"
"CD006023_pub4_data","13::overall","13","overall","Vomiting",22,11,16,TRUE,TRUE,"RD","double_zero"
"CD006023_pub4_data","14::overall","14","overall","Abdominal pain",21,10,16,TRUE,TRUE,"RD","double_zero"
"CD006023_pub4_data","15::overall","15","overall","Diarrhoea",17,7,11,TRUE,TRUE,"RD","double_zero"
"CD006023_pub4_data","16::overall","16","overall","Abdominal bloating",14,6,8,TRUE,TRUE,"RD","double_zero"
"CD006023_pub4_data","17::overall","17","overall","Kidney failure",20,15,18,TRUE,TRUE,"RD","double_zero"
"CD006023_pub4_data","18::overall","18","overall","Start dialysis",36,33,34,TRUE,TRUE,"RD","double_zero"
"CD006023_pub4_data","19::overall","19","overall","Serum calcium",31,29,30,TRUE,TRUE,"RD","double_zero"
"CD006023_pub4_data","20::overall","20","overall","Serum calcium-by-phosphate product",32,30,30,TRUE,TRUE,"RD","double_zero"
"CD006023_pub4_data","21::overall","21","overall","Serum iPTH",16,14,14,TRUE,TRUE,"RD","double_zero"
"CD006023_pub4_data","22::overall","22","overall","Serum alkaline phosphatase",18,17,17,FALSE,TRUE,"RD","double_zero"
"CD006023_pub4_data","23::overall","23","overall","Serum bicarbonate",14,13,13,FALSE,TRUE,"RD","double_zero"
"CD006023_pub4_data","24::overall","24","overall","eGFR",8,7,7,FALSE,TRUE,"RD","double_zero"
"CD006023_pub4_data","25::overall","25","overall","Bone mineral density: lumbar spine",6,5,5,FALSE,TRUE,"RD","double_zero"
"CD006023_pub4_data","26::overall","26","overall","Bone mineral density: hip",2,1,1,FALSE,TRUE,"RD","double_zero"
"CD006023_pub4_data","1::1","1","1","Death (all causes): age",12,2,6,TRUE,TRUE,"RD","double_zero"
"CD006023_pub4_data","1::2","1","2","Death (all causes): age",25,10,15,TRUE,TRUE,"RD","double_zero"
"CD006023_pub4_data","2::1","2","1","Death (all causes): CKD GFR category",8,4,5,TRUE,TRUE,"RD","double_zero"
"CD006023_pub4_data","2::2","2","2","Death (all causes): CKD GFR category",24,9,16,TRUE,TRUE,"RD","double_zero"
"CD006023_pub4_data","3::1","3","1","Death (all causes): study duration",8,4,8,TRUE,TRUE,"RD","double_zero"
"CD006023_pub4_data","3::2","3","2","Death (all causes): study duration",11,2,3,TRUE,TRUE,"RD","double_zero"
"CD006023_pub4_data","4::1","4","1","Cardiovascular death: age",3,1,2,TRUE,TRUE,"RD","double_zero"
"CD006023_pub4_data","4::2","4","2","Cardiovascular death: age",8,4,6,TRUE,TRUE,"RD","double_zero"
"CD006023_pub4_data","5::1","5","1","Cardiovascular death: CKD GFR category",2,1,2,FALSE,TRUE,"RD","double_zero"
"CD006023_pub4_data","5::2","5","2","Cardiovascular death: CKD GFR category",11,7,8,TRUE,TRUE,"RD","double_zero"
"CD006023_pub4_data","6::1","6","1","Cardiovascular death: study duration",7,5,7,TRUE,TRUE,"RD","double_zero"
"CD006023_pub4_data","6::2","6","2","Cardiovascular death: study duration",6,3,3,TRUE,TRUE,"RD","double_zero"
"CD006027_pub3_data","1::overall","1","overall","Pain (change from baseline in pain score (VAS-10 cm) at 30 minutes)",28,21,22,TRUE,TRUE,"RD","double_zero"
"CD006027_pub3_data","2::overall","2","overall","Need for rescue medication",33,0,2,TRUE,TRUE,"RD","sparse_events"
"CD006027_pub3_data","3::overall","3","overall","Pain recurrence within 24 hours",16,1,3,TRUE,TRUE,"RD","double_zero"
"CD006027_pub3_data","4::overall","4","overall","Minor adverse events",9,2,4,TRUE,TRUE,"RD","double_zero"
"CD006124_pub3_data","1::overall","1","overall","Analgesia requirements",14,9,13,TRUE,TRUE,"RD","double_zero"
"CD006124_pub3_data","2::overall","2","overall","Duration of procedure",16,11,14,TRUE,TRUE,"RD","double_zero"
"CD006124_pub3_data","3::overall","3","overall","Blood loss",15,9,10,TRUE,TRUE,"RD","double_zero"
"CD006124_pub3_data","4::overall","4","overall","Perioperative complications",15,0,5,TRUE,TRUE,"RD","sparse_events"
"CD006124_pub3_data","5::overall","5","overall","Reoperations",14,9,13,TRUE,TRUE,"RD","double_zero"
"CD006124_pub3_data","6::overall","6","overall","Warm ischaemia time",13,10,13,TRUE,TRUE,"RD","double_zero"
"CD006140_pub3_data","1::overall","1","overall","Any illicit opioid use (urine drug screen)",9,0,0,TRUE,TRUE,"OR_cc","default_or"
"CD006140_pub3_data","2::overall","2","overall","Days of illicit opioid use",5,0,1,TRUE,TRUE,"RD","sparse_events"
"CD006140_pub3_data","3::overall","3","overall","Opioid negative urine drug screens (proportion or count)",7,0,0,TRUE,TRUE,"OR_cc","default_or"
"CD006140_pub3_data","4::overall","4","overall","Retention",6,0,0,TRUE,TRUE,"OR_cc","default_or"
"CD006140_pub3_data","5::overall","5","overall","Acceptability",9,0,0,TRUE,TRUE,"OR_cc","default_or"
"CD006140_pub3_data","6::overall","6","overall","Any serious adverse event",15,2,3,TRUE,TRUE,"RD","double_zero"
"CD006140_pub3_data","7::overall","7","overall","Any non-serious adverse event",14,1,3,TRUE,TRUE,"RD","double_zero"
"CD006140_pub3_data","8::overall","8","overall","Death",11,5,5,TRUE,TRUE,"RD","double_zero"
"CD006140_pub3_data","9::overall","9","overall","Overdose",12,4,10,TRUE,TRUE,"RD","double_zero"
"CD006140_pub3_data","10::overall","10","overall","Study treatment terminated due to adverse event",11,1,5,TRUE,TRUE,"RD","double_zero"
"CD006140_pub3_data","17::overall","17","overall","Anxiety",3,0,0,TRUE,TRUE,"OR_cc","default_or"
"CD006182_pub3_data","1::1","1","1","Mortality or NDI at 18-24 months",20,7,8,TRUE,TRUE,"RD","double_zero"
"CD006182_pub3_data","2::1","2","1","NDI at 18-24 months among surivors",11,2,2,TRUE,TRUE,"RD","double_zero"
"CD006182_pub3_data","3::1","3","1","Moderate to severe CP among surviving infants",10,0,2,TRUE,TRUE,"RD","sparse_events"
"CD006182_pub3_data","4::1","4","1","Mortality before discharge from hospital",8,0,2,TRUE,TRUE,"RD","sparse_events"
"CD006182_pub3_data","5::1","5","1","Mortality before 18 to 24 months",3,0,0,TRUE,TRUE,"OR_cc","default_or"
"CD006182_pub3_data","6::1","6","1","Subsequent laparotomy during initial hospitalisation",5,0,0,TRUE,TRUE,"OR_cc","default_or"
"CD006182_pub3_data","1::2","1","2","Mortality within 28 days of the primary procedure",8,2,3,TRUE,TRUE,"RD","double_zero"
"CD006182_pub3_data","2::2","2","2","Mortality within 90 days of the primary procedure",4,0,1,TRUE,TRUE,"RD","sparse_events"
"CD006182_pub3_data","3::2","3","2","Intestinal fistula ",3,0,1,TRUE,TRUE,"RD","sparse_events"
"CD006182_pub3_data","7::1","7","1","Sepsis",2,0,1,TRUE,TRUE,"RD","sparse_events"
"CD006182_pub3_data","8::1","8","1","PN-Associated Cholestasis",2,0,0,TRUE,TRUE,"OR_cc","default_or"
"CD006185_pub6_data","1::overall","1","overall","Independent walking at end of intervention phase, all electromechanical devices used (critical outcome)",51,8,13,TRUE,TRUE,"RD","double_zero"
"CD006185_pub6_data","2::overall","2","overall","Independent walking at follow-up after study end (critical outcome)",8,0,0,TRUE,TRUE,"OR_cc","default_or"
"CD006185_pub6_data","7::1","7","1","Lost to study during intervention phase, dropouts",20,9,12,TRUE,TRUE,"RD","double_zero"
"CD006185_pub6_data","7::2","7","2","Lost to study during intervention phase, dropouts",54,20,41,TRUE,TRUE,"RD","double_zero"
"CD006185_pub6_data","7::3","7","3","Lost to study during intervention phase, dropouts",23,8,16,TRUE,TRUE,"RD","double_zero"
"CD006185_pub6_data","7::4","7","4","Lost to study during intervention phase, dropouts",4,2,3,TRUE,TRUE,"RD","double_zero"
"CD006185_pub6_data","8::overall","8","overall","Death from all causes until end of intervention phase",101,98,101,TRUE,TRUE,"RD","double_zero"
"CD006185_pub6_data","1::1","1","1","Regaining independent walking ability",135,17,32,TRUE,TRUE,"RD","double_zero"
"CD006185_pub6_data","1::2","1","2","Regaining independent walking ability",78,8,12,TRUE,TRUE,"RD","double_zero"
"CD006185_pub6_data","1::3","1","3","Regaining independent walking ability",60,11,20,TRUE,TRUE,"RD","double_zero"
"CD006185_pub6_data","1::4","1","4","Regaining independent walking ability",19,1,3,TRUE,TRUE,"RD","double_zero"
"CD006185_pub6_data","1::5","1","5","Regaining independent walking ability",42,6,9,TRUE,TRUE,"RD","double_zero"
"CD006257_pub2_data","1::overall","1","overall","Death: any cause",123,61,79,TRUE,TRUE,"RD","double_zero"
"CD006257_pub2_data","2::overall","2","overall","Withdrawn",80,18,37,TRUE,TRUE,"RD","double_zero"
"CD006257_pub2_data","3::overall","3","overall","Cardiovascular death",102,58,73,TRUE,TRUE,"RD","double_zero"
"CD006257_pub2_data","4::overall","4","overall","Kidney failure",25,5,8,TRUE,TRUE,"RD","double_zero"
"CD006257_pub2_data","5::overall","5","overall","Fatal or nonfatal myocardial infarction",23,4,11,TRUE,TRUE,"RD","double_zero"
"CD006257_pub2_data","6::overall","6","overall","Fatal or nonfatal stroke",17,2,8,TRUE,TRUE,"RD","double_zero"
"CD006257_pub2_data","7::overall","7","overall","Doubling of serum creatinine",21,2,3,TRUE,TRUE,"RD","double_zero"
"CD006257_pub2_data","8::overall","8","overall","Reduction in GFR",8,3,4,TRUE,TRUE,"RD","double_zero"
"CD006257_pub2_data","9::overall","9","overall","Change in GFR [mL/min/1.73 m²]",16,7,8,TRUE,TRUE,"RD","double_zero"
"CD006257_pub2_data","10::overall","10","overall","GFR (at end of treatment) [mL/min/1.73 m²]",24,7,9,TRUE,TRUE,"RD","double_zero"
"CD006257_pub2_data","11::overall","11","overall","Micro- to macroalbuminuria",38,2,8,TRUE,TRUE,"RD","double_zero"
"CD006257_pub2_data","12::overall","12","overall","Micro- to normoalbuminuria",29,6,12,TRUE,TRUE,"RD","double_zero"
"CD006257_pub2_data","13::overall","13","overall","Hyperkalaemia",10,1,4,TRUE,TRUE,"RD","double_zero"
"CD006257_pub2_data","14::overall","14","overall","Cough",14,3,9,TRUE,TRUE,"RD","double_zero"
"CD006257_pub2_data","15::overall","15","overall","Headache",8,1,6,TRUE,TRUE,"RD","double_zero"
"CD006257_pub2_data","16::overall","16","overall","Impotence",5,3,3,TRUE,TRUE,"RD","double_zero"
"CD006273_pub4_data","1::overall","1","overall","Adverse events",4,2,3,TRUE,TRUE,"RD","double_zero"
"CD006404_pub5_data","1::overall","1","overall","Total failure: day 28 (polymerase chain reaction-adjusted)",23,6,16,TRUE,TRUE,"RD","double_zero"
"CD006404_pub5_data","2::overall","2","overall","Total failure: day 42 (polymerase chain reaction-adjusted)",20,5,13,TRUE,TRUE,"RD","double_zero"
"CD006404_pub5_data","3::overall","3","overall","Total failure: day 28 (unadjusted)",32,7,16,TRUE,TRUE,"RD","double_zero"
"CD006404_pub5_data","4::overall","4","overall","Total failure: day 42 (unadjusted)",31,8,16,TRUE,TRUE,"RD","double_zero"
"CD006404_pub5_data","5::overall","5","overall","Early treatment failure",31,17,27,TRUE,TRUE,"RD","double_zero"
"CD006404_pub5_data","6::overall","6","overall","Serious adverse events",21,7,19,TRUE,TRUE,"RD","double_zero"
"CD006404_pub5_data","7::overall","7","overall","Adverse events leading to withdrawal",20,7,17,TRUE,TRUE,"RD","double_zero"
"CD006404_pub5_data","8::overall","8","overall","First treatment, alanine aminotransferase increase greater than five times the upper limit of normal",24,8,21,TRUE,TRUE,"RD","double_zero"
"CD006404_pub5_data","9::overall","9","overall","First treatment, aspartate aminotransferase increase greater than five times the upper limit of normal",27,8,21,TRUE,TRUE,"RD","double_zero"
"CD006404_pub5_data","10::overall","10","overall","First treatment, bilirubin increase greater than 2.5 times the upper limit of normal",12,4,10,TRUE,TRUE,"RD","double_zero"
"CD006404_pub5_data","11::overall","11","overall","Subsequent treatment(s), alanine aminotransferase increase greater than five times the upper limit of normal",5,1,4,TRUE,TRUE,"RD","double_zero"
"CD006404_pub5_data","12::overall","12","overall","Subsequent treatment(s), aspartate aminotransferase increase greater than five times the upper limit of normal",4,0,4,TRUE,TRUE,"RD","sparse_events"
"CD006404_pub5_data","13::overall","13","overall","Subsequent treatment(s), bilirubin increase greater than 2.5 times the upper limit of normal",4,1,4,TRUE,TRUE,"RD","double_zero"
"CD006404_pub5_data","14::overall","14","overall","Paediatric trials — total failure: day 28 (polymerase chain reaction-adjusted)",3,0,1,TRUE,TRUE,"RD","sparse_events"
"CD006404_pub5_data","15::overall","15","overall","Trials in children — total failure: day 42 (polymerase chain reaction-adjusted)",2,0,0,TRUE,TRUE,"OR_cc","default_or"
"CD006404_pub5_data","16::overall","16","overall","Trials in children — total failure: day 28 (unadjusted)",3,0,0,TRUE,TRUE,"OR_cc","default_or"
"CD006404_pub5_data","17::overall","17","overall","Trials in children — total failure: day 42 (unadjusted)",2,0,0,TRUE,TRUE,"OR_cc","default_or"
"CD006404_pub5_data","18::overall","18","overall","Trials in children — first treatment, alanine aminotransferase increase greater than five times the upper limit of normal",2,1,2,FALSE,TRUE,"RD","double_zero"
"CD006404_pub5_data","19::overall","19","overall","Trials in children — first treatment, aspartate aminotransferase increase greater than five times the upper limit of normal",2,1,2,FALSE,TRUE,"RD","double_zero"
"CD006404_pub5_data","10::1","10","1","Other adverse events",5,0,1,TRUE,TRUE,"RD","sparse_events"
"CD006404_pub5_data","10::2","10","2","Other adverse events",2,0,0,TRUE,TRUE,"OR_cc","default_or"
"CD006404_pub5_data","10::3","10","3","Other adverse events",2,0,0,TRUE,TRUE,"OR_cc","default_or"
"CD006404_pub5_data","10::4","10","4","Other adverse events",2,0,0,TRUE,TRUE,"OR_cc","default_or"
"CD006404_pub5_data","10::6","10","6","Other adverse events",5,0,3,TRUE,TRUE,"RD","sparse_events"
"CD006404_pub5_data","10::9","10","9","Other adverse events",4,0,1,TRUE,TRUE,"RD","sparse_events"
"CD006404_pub5_data","10::11","10","11","Other adverse events",8,0,2,TRUE,TRUE,"RD","sparse_events"
"CD006404_pub5_data","10::12","10","12","Other adverse events",10,0,1,TRUE,TRUE,"RD","sparse_events"
"CD006404_pub5_data","10::13","10","13","Other adverse events",2,0,0,TRUE,TRUE,"OR_cc","default_or"
"CD006404_pub5_data","10::16","10","16","Other adverse events",2,0,1,TRUE,TRUE,"RD","sparse_events"
"CD006404_pub5_data","10::19","10","19","Other adverse events",3,0,0,TRUE,TRUE,"OR_cc","default_or"
"CD006404_pub5_data","10::20","10","20","Other adverse events",8,0,2,TRUE,TRUE,"RD","sparse_events"
"CD006404_pub5_data","10::21","10","21","Other adverse events",5,0,2,TRUE,TRUE,"RD","sparse_events"
"CD006404_pub5_data","10::22","10","22","Other adverse events",2,0,1,TRUE,TRUE,"RD","sparse_events"
"CD006404_pub5_data","10::24","10","24","Other adverse events",2,0,1,TRUE,TRUE,"RD","sparse_events"
"CD006404_pub5_data","10::26","10","26","Other adverse events",3,0,1,TRUE,TRUE,"RD","sparse_events"
"CD006404_pub5_data","10::28","10","28","Other adverse events",2,0,1,TRUE,TRUE,"RD","sparse_events"
"CD006404_pub5_data","10::29","10","29","Other adverse events",3,0,1,TRUE,TRUE,"RD","sparse_events"
"CD006404_pub5_data","10::31","10","31","Other adverse events",10,0,2,TRUE,TRUE,"RD","sparse_events"
"CD006404_pub5_data","10::34","10","34","Other adverse events",7,0,0,TRUE,TRUE,"OR_cc","default_or"
"CD006404_pub5_data","10::35","10","35","Other adverse events",3,0,3,TRUE,TRUE,"RD","sparse_events"
"CD006404_pub5_data","10::37","10","37","Other adverse events",2,0,2,TRUE,TRUE,"RD","sparse_events"
"CD006404_pub5_data","10::38","10","38","Other adverse events",2,0,0,TRUE,TRUE,"OR_cc","default_or"
"CD006475_pub3_data","1::overall","1","overall","Asthma by 2 years of age",13,0,0,TRUE,TRUE,"OR_cc","default_or"
"CD006475_pub3_data","2::overall","2","overall","Eczema by 2 years of age",28,0,2,TRUE,TRUE,"RD","sparse_events"
"CD006475_pub3_data","3::overall","3","overall","Allergic rhinitis by 2 years ",12,0,2,TRUE,TRUE,"RD","sparse_events"
"CD006475_pub3_data","4::overall","4","overall","Food allergy by 2 years",3,0,0,TRUE,TRUE,"OR_cc","default_or"
"CD006475_pub3_data","5::overall","5","overall","Cow's milk protein allergy by 2 years",5,0,3,TRUE,TRUE,"RD","sparse_events"
"CD006475_pub3_data","6::1","6","1","Sensitivity analysis: eczema by 2 years by definition of allergic disease",19,0,2,TRUE,TRUE,"RD","sparse_events"
"CD006475_pub3_data","6::2","6","2","Sensitivity analysis: eczema by 2 years by definition of allergic disease",11,0,0,TRUE,TRUE,"OR_cc","default_or"
"CD006475_pub3_data","7::overall","7","overall","Sensitivity analysis: eczema by 2 years by risk of bias",4,0,1,TRUE,TRUE,"RD","sparse_events"
"CD006475_pub3_data","8::1","8","1","Subgroup analysis: eczema by 2 years by risk of allergy",16,0,0,TRUE,TRUE,"OR_cc","default_or"
"CD006475_pub3_data","8::2","8","2","Subgroup analysis: eczema by 2 years by risk of allergy",9,0,2,TRUE,TRUE,"RD","sparse_events"
"CD006475_pub3_data","9::1","9","1","Subgroup analysis: eczema by 2 years by method of feeding",17,0,1,TRUE,TRUE,"RD","sparse_events"
"CD006475_pub3_data","9::2","9","2","Subgroup analysis: eczema by 2 years by method of feeding",8,0,1,TRUE,TRUE,"RD","sparse_events"
"CD006475_pub3_data","10::1","10","1","Subgroup analysis: eczema by 2 years by probiotic type",10,0,0,TRUE,TRUE,"OR_cc","default_or"
"CD006475_pub3_data","10::2","10","2","Subgroup analysis: eczema by 2 years by probiotic type",16,0,2,TRUE,TRUE,"RD","sparse_events"
"CD006475_pub3_data","11::1","11","1","Subgroup analysis: eczema by 2 years by period of supplementation",7,0,0,TRUE,TRUE,"OR_cc","default_or"
"CD006475_pub3_data","11::2","11","2","Subgroup analysis: eczema by 2 years by period of supplementation",12,0,2,TRUE,TRUE,"RD","sparse_events"
"CD006475_pub3_data","3::1","3","1","Sensitivity analysis: eczema by 2 years of age by definition of allergic disease",3,0,0,TRUE,TRUE,"OR_cc","default_or"
"CD006475_pub3_data","4::1","4","1","Subgroup analysis: eczema by 2 years of age by risk of allergy",10,0,0,TRUE,TRUE,"OR_cc","default_or"
"CD006475_pub3_data","4::2","4","2","Subgroup analysis: eczema by 2 years of age by risk of allergy",5,0,0,TRUE,TRUE,"OR_cc","default_or"
"CD006475_pub3_data","5::1","5","1","Subgroup analysis: eczema by 2 years of age by synbiotic type",2,0,0,TRUE,TRUE,"OR_cc","default_or"
"CD006475_pub3_data","6::overall","6","overall","Sensitivity analysis: eczema by 10 years of age by risk of bias",2,0,0,TRUE,TRUE,"OR_cc","default_or"
"CD006475_pub3_data","7::1","7","1","Subgroup analysis: eczema by 10 years of age by risk of allergy",7,0,0,TRUE,TRUE,"OR_cc","default_or"
"CD006515_pub2_data","1::overall","1","overall","Death",2,1,1,FALSE,TRUE,"RD","double_zero"
"CD006515_pub2_data","2::overall","2","overall","Hospital admissions",2,0,0,TRUE,TRUE,"OR_cc","default_or"
"CD006515_pub2_data","3::overall","3","overall","Peritonitis",2,0,1,TRUE,TRUE,"RD","sparse_events"
"CD006515_pub2_data","4::overall","4","overall","Change of dialysis modality",4,0,2,TRUE,TRUE,"RD","sparse_events"
"CD006515_pub2_data","9::overall","9","overall","Other infectious complications",4,0,3,TRUE,TRUE,"RD","sparse_events"
"CD006515_pub2_data","10::overall","10","overall","Mechanical complications",5,0,4,TRUE,TRUE,"RD","sparse_events"
"CD006515_pub2_data","11::overall","11","overall","PD catheter removal",2,0,0,TRUE,TRUE,"OR_cc","default_or"
"CD006536_pub5_data","1::overall","1","overall","All-cause mortality",256,5,232,TRUE,TRUE,"RD","double_zero"
"CD006536_pub5_data","2::overall","2","overall","Cardiovascular mortality",152,9,120,TRUE,TRUE,"RD","double_zero"
"CD006536_pub5_data","3::overall","3","overall","Composite measure of death, reinfarction, re-hospitalisation for heart failure",80,71,74,TRUE,TRUE,"RD","double_zero"
"CD006536_pub5_data","4::overall","4","overall","Incidence of reinfarction",92,52,83,TRUE,TRUE,"RD","double_zero"
"CD006536_pub5_data","5::overall","5","overall","Incidence of re-hospitalisation for heart failure",57,29,47,TRUE,TRUE,"RD","double_zero"
"CD006536_pub5_data","6::overall","6","overall","Incidence of arrhythmias",16,0,8,TRUE,TRUE,"RD","sparse_events"
"CD006536_pub5_data","7::overall","7","overall","Incidence of restenosis",14,0,6,TRUE,TRUE,"RD","sparse_events"
"CD006536_pub5_data","8::overall","8","overall","Incidence of target vessel revascularisation",15,0,4,TRUE,TRUE,"RD","sparse_events"
"CD006606_pub5_data","1::overall","1","overall","Live birth – low risk of bias (odds ratio, random-effect)",2,0,0,TRUE,TRUE,"OR_cc","default_or"
"CD006606_pub5_data","2::overall","2","overall","Live birth – low risk of bias (risk ratio, random-effects)",2,0,0,TRUE,TRUE,"OR_cc","default_or"
"CD006606_pub5_data","3::overall","3","overall","Miscarriage – low risk of bias (odds ratio, random-effects)",2,0,0,TRUE,TRUE,"OR_cc","default_or"
"CD006606_pub5_data","4::overall","4","overall","Miscarriage – low risk of bias (risk ratio, random-effects)",2,0,0,TRUE,TRUE,"OR_cc","default_or"
"CD006606_pub5_data","5::overall","5","overall","Clinical pregnancy – low risk of bias (odds ratio, random-effects)",2,0,0,TRUE,TRUE,"OR_cc","default_or"
"CD006606_pub5_data","6::overall","6","overall","Clinical pregnancy – low risk of bias (risk ratio, random-effects)",2,0,0,TRUE,TRUE,"OR_cc","default_or"
"CD006606_pub5_data","7::overall","7","overall","Clinical pregnancy – all studies (odds ratio, random-effects)",4,0,0,TRUE,TRUE,"OR_cc","default_or"
"CD006606_pub5_data","8::overall","8","overall","Clinical pregnancy – all studies (risk ratio, random-effects)",4,0,0,TRUE,TRUE,"OR_cc","default_or"
"CD006606_pub5_data","9::overall","9","overall","Ovarian hyperstimulation syndrome – low risk of bias (odds ratio, random-effects)",2,0,1,TRUE,TRUE,"RD","sparse_events"
"CD006606_pub5_data","10::overall","10","overall","Ovarian hyperstimulation syndrome – low risk of bias (risk ratio, random-effects)",2,0,1,TRUE,TRUE,"RD","sparse_events"
"CD006606_pub5_data","11::overall","11","overall","Preterm birth – low risk of bias (odds ratio, random-effects)",2,0,0,TRUE,TRUE,"OR_cc","default_or"
"CD006606_pub5_data","12::overall","12","overall","Preterm birth – low risk of bias (risk ratio, random-effects)",2,0,0,TRUE,TRUE,"OR_cc","default_or"
"CD006689_pub3_data","1::overall","1","overall","Maternal peripheral parasitaemia at delivery (amplification techniques)",17,0,0,TRUE,TRUE,"OR_cc","default_or"
"CD006689_pub3_data","2::overall","2","overall","Maternal peripheral parasitaemia at delivery (microscopy)",16,0,4,TRUE,TRUE,"RD","sparse_events"
"CD006689_pub3_data","3::overall","3","overall","Maternal anaemia at delivery (< 11 g/dL)",14,0,2,TRUE,TRUE,"RD","sparse_events"
"CD006689_pub3_data","4::overall","4","overall","Placental malaria (any test)",16,0,1,TRUE,TRUE,"RD","sparse_events"
"CD006689_pub3_data","5::overall","5","overall","Placental malaria (blood smear)",14,3,6,TRUE,TRUE,"RD","double_zero"
"CD006689_pub3_data","6::overall","6","overall","Placental malaria (amplification techniques)",13,5,6,TRUE,TRUE,"RD","double_zero"
"CD006689_pub3_data","7::overall","7","overall","Placental malaria (histopathologic analysis)",14,4,6,TRUE,TRUE,"RD","double_zero"
"CD006689_pub3_data","8::overall","8","overall","Maternal peripheral parasitaemia during pregnancy (any test)",12,7,7,TRUE,TRUE,"RD","double_zero"
"CD006689_pub3_data","9::overall","9","overall","Clinical malaria episodes during pregnancy",10,4,5,TRUE,TRUE,"RD","double_zero"
"CD006689_pub3_data","10::overall","10","overall","Mean haemoglobin at delivery (in g/dL)",14,6,7,TRUE,TRUE,"RD","double_zero"
"CD006689_pub3_data","11::overall","11","overall","Maternal severe anaemia at delivery (< 7 g/dL)",15,6,7,TRUE,TRUE,"RD","double_zero"
"CD006689_pub3_data","12::overall","12","overall","Low birth weight (less than 2500 g)",16,4,5,TRUE,TRUE,"RD","double_zero"
"CD006689_pub3_data","13::overall","13","overall","Mean birth weight (g)",13,7,11,TRUE,TRUE,"RD","double_zero"
"CD006689_pub3_data","14::overall","14","overall","Cord blood parasitaemia (blood smear)",17,4,9,TRUE,TRUE,"RD","double_zero"
"CD006689_pub3_data","15::overall","15","overall","Cord blood parasitaemia (loop-mediated isothermal amplification)",9,2,5,TRUE,TRUE,"RD","double_zero"
"CD006689_pub3_data","16::overall","16","overall","Prematurity",14,1,5,TRUE,TRUE,"RD","double_zero"
"CD006689_pub3_data","17::overall","17","overall","Severe adverse events during pregnancy",14,1,4,TRUE,TRUE,"RD","double_zero"
"CD006689_pub3_data","18::overall","18","overall","Foetal loss",12,1,5,TRUE,TRUE,"RD","double_zero"
"CD006689_pub3_data","19::overall","19","overall","Congenital malformations",11,0,3,TRUE,TRUE,"RD","sparse_events"
"CD006689_pub3_data","20::overall","20","overall","Maternal mortality",11,2,5,TRUE,TRUE,"RD","double_zero"
"CD006689_pub3_data","21::overall","21","overall","Neonatal mortality",8,0,2,TRUE,TRUE,"RD","sparse_events"
"CD006689_pub3_data","22::overall","22","overall","Undetectable viral load",4,0,0,TRUE,TRUE,"OR_cc","default_or"
"CD006689_pub3_data","23::overall","23","overall","Mother-to-child transmission of HIV",2,0,2,TRUE,TRUE,"RD","sparse_events"
"CD006714_pub3_data","1::overall","1","overall","Abortion completed with intended method (defined as fetal expulsion)",3,0,0,TRUE,TRUE,"OR_cc","default_or"
"CD006714_pub3_data","2::overall","2","overall","Incomplete abortion requiring an additional procedure or intervention (immediate or delayed)",3,0,0,TRUE,TRUE,"OR_cc","default_or"
"CD006714_pub3_data","3::overall","3","overall","Bleeding: hemorrhage requiring transfusion",3,1,2,TRUE,TRUE,"RD","double_zero"
"CD006714_pub3_data","6::overall","6","overall","Injury: cervix, vagina, uterus ",2,1,2,FALSE,TRUE,"RD","double_zero"
"CD006714_pub3_data","7::overall","7","overall","Requirement for overnight hospitalization",3,0,0,TRUE,TRUE,"OR_cc","default_or"
"CD006742_pub3_data","1::overall","1","overall","All-Cause Mortality",5,1,2,TRUE,TRUE,"RD","double_zero"
"CD006742_pub3_data","2::overall","2","overall","Total cardiovascular events",4,1,1,TRUE,TRUE,"RD","double_zero"
"CD006742_pub3_data","3::overall","3","overall","Stroke",4,2,2,TRUE,TRUE,"RD","double_zero"
"CD006742_pub3_data","4::overall","4","overall","Coronary Heart Disease",3,1,1,TRUE,TRUE,"RD","double_zero"
"CD006839_pub5_data","1::1","1","1","Proportion of participants with clinical improvement in function compared to baseline",3,0,0,TRUE,TRUE,"OR_cc","default_or"
"CD006839_pub5_data","1::2","1","2","Proportion of participants with clinical improvement in function compared to baseline",2,0,0,TRUE,TRUE,"OR_cc","default_or"
"CD006839_pub5_data","3::2","3","2","Proportion of participants with deep/superficial wound infections",2,0,1,TRUE,TRUE,"RD","sparse_events"
"CD006839_pub5_data","2::overall","2","overall","Proportion of participants with hematoma/pain from scarring",4,0,0,TRUE,TRUE,"OR_cc","default_or"
"CD006839_pub5_data","1::overall","1","overall","Proportion of participants with clinical improvement in function at 3 months compared to baseline. Corticosteroid injection versus placebo",2,0,0,TRUE,TRUE,"OR_cc","default_or"
"CD006913_pub3_data","5::1","5","1","IBDQ (long-term) - psychotherapy vs care-as-usual ",10,7,7,TRUE,TRUE,"RD","double_zero"
"CD006913_pub3_data","5::2","5","2","IBDQ (long-term) - psychotherapy vs care-as-usual ",16,8,8,TRUE,TRUE,"RD","double_zero"
"CD006913_pub3_data","6::1","6","1","Quality of life (short-term), by disease activity - psychotherapy vs care-as-usual",15,12,12,TRUE,TRUE,"RD","double_zero"
"CD006913_pub3_data","6::2","6","2","Quality of life (short-term), by disease activity - psychotherapy vs care-as-usual",29,21,21,TRUE,TRUE,"RD","double_zero"
"CD006913_pub3_data","7::1","7","1","Quality of life (long-term), by disease activity - psychotherapy vs care-as-usual",10,6,6,TRUE,TRUE,"RD","double_zero"
"CD006913_pub3_data","7::2","7","2","Quality of life (long-term), by disease activity - psychotherapy vs care-as-usual",12,8,8,TRUE,TRUE,"RD","double_zero"
"CD006913_pub3_data","8::1","8","1","Quality of life (short-term), by comorbidity - psychotherapy vs care-as-usual",23,19,19,TRUE,TRUE,"RD","double_zero"
"CD006913_pub3_data","8::2","8","2","Quality of life (short-term), by comorbidity - psychotherapy vs care-as-usual",33,29,29,TRUE,TRUE,"RD","double_zero"
"CD006913_pub3_data","11::1","11","1","Quality of life (long-term), by type of therapy - psychotherapy vs care-as-usual",40,16,16,TRUE,TRUE,"RD","double_zero"
"CD006913_pub3_data","11::2","11","2","Quality of life (long-term), by type of therapy - psychotherapy vs care-as-usual",12,7,7,TRUE,TRUE,"RD","double_zero"
"CD006913_pub3_data","12::1","12","1","Quality of life (short-term), by therapy intensity - psychotherapy vs care-as-usual",53,38,38,TRUE,TRUE,"RD","double_zero"
"CD006913_pub3_data","12::2","12","2","Quality of life (short-term), by therapy intensity - psychotherapy vs care-as-usual",8,4,4,TRUE,TRUE,"RD","double_zero"
"CD006913_pub3_data","13::1","13","1","Quality of life (long-term), by therapy intensity - psychotherapy vs care-as-usual",44,20,20,TRUE,TRUE,"RD","double_zero"
"CD006913_pub3_data","13::2","13","2","Quality of life (long-term), by therapy intensity - psychotherapy vs care-as-usual",10,7,7,TRUE,TRUE,"RD","double_zero"
"CD006913_pub3_data","14::1","14","1","Quality of life (short-term), by mode of application - psychotherapy vs care-as-usual",34,33,33,FALSE,TRUE,"RD","double_zero"
"CD006913_pub3_data","15::1","15","1","Quality of life (short-term), by training of provider - psychotherapy vs care-as-usual",25,23,23,TRUE,TRUE,"RD","double_zero"
"CD006913_pub3_data","7::3","7","3","Failure to induce or maintain remission (long-term) - psychotherapy vs care-asusual  (ITT)",10,3,3,TRUE,TRUE,"RD","double_zero"
"CD006913_pub3_data","8::3","8","3","Failure to induce or maintain remission (long-term) - psychotherapy vs care-as-usual (PP, sensitivity analysis)",7,0,0,TRUE,TRUE,"OR_cc","default_or"
"CD006913_pub3_data","16::1","16","1","Failure to induce or maintain remission (long-term) (PP, sensitivity analysis) - educational intervention vs active control",2,0,0,TRUE,TRUE,"OR_cc","default_or"
"CD006913_pub3_data","28::1","28","1","Failure to induce or maintain remission (long-term) (ITT) - relaxation techniques vs active control",2,0,0,TRUE,TRUE,"OR_cc","default_or"
"CD006919_pub5_data","1::overall","1","overall","Live birth/ongoing pregnancies primary analysis",14,0,0,TRUE,TRUE,"OR_cc","default_or"
"CD006919_pub5_data","2::overall","2","overall","Live birth/ongoing pregnancies all studies",27,2,5,TRUE,TRUE,"RD","double_zero"
"CD006919_pub5_data","3::overall","3","overall","Clinical pregnancies primary analysis",26,10,11,TRUE,TRUE,"RD","double_zero"
"CD006919_pub5_data","4::overall","4","overall","Clinical pregnancies all studies",36,13,16,TRUE,TRUE,"RD","double_zero"
"CD006919_pub5_data","5::overall","5","overall","Number of oocytes",22,15,17,TRUE,TRUE,"RD","double_zero"
"CD006919_pub5_data","6::overall","6","overall","Amount of gonadotropins administered",14,10,12,TRUE,TRUE,"RD","double_zero"
"CD006919_pub5_data","7::overall","7","overall","Cycle cancellation",16,2,6,TRUE,TRUE,"RD","double_zero"
"CD006919_pub5_data","11::overall","11","overall","Cycle cancellation",2,0,0,TRUE,TRUE,"OR_cc","default_or"
"CD006942_pub4_data","1::1","1","1","Live birth or ongoing pregnancy rate per couple",8,0,3,TRUE,TRUE,"RD","sparse_events"
"CD006942_pub4_data","1::2","1","2","Live birth or ongoing pregnancy rate per couple",5,0,0,TRUE,TRUE,"OR_cc","default_or"
"CD006942_pub4_data","1::3","1","3","Live birth or ongoing pregnancy rate per couple",3,0,1,TRUE,TRUE,"RD","sparse_events"
"CD006942_pub4_data","2::1","2","1","Clinical pregnancy per couple",2,0,0,TRUE,TRUE,"OR_cc","default_or"
"CD006942_pub4_data","2::overall","2","overall","Clinical pregnancy per couple",3,0,0,TRUE,TRUE,"OR_cc","default_or"
"CD006942_pub4_data","3::overall","3","overall","Tubal pregnancy per couple",3,0,3,TRUE,TRUE,"RD","sparse_events"
"CD006942_pub4_data","1::overall","1","overall","Live birth or ongoing pregnancy rate per couple",2,0,0,TRUE,TRUE,"OR_cc","default_or"
"CD006982_pub5_data","3::overall","3","overall","Retinopathy of prematurity (any stage)",3,0,0,TRUE,TRUE,"OR_cc","default_or"
"CD006982_pub5_data","4::overall","4","overall","Retinopathy of prematurity (stage ≥ 3)",4,0,1,TRUE,TRUE,"RD","sparse_events"
"CD007024_pub3_data","3::overall","3","overall","Continuous abstinence",22,0,0,TRUE,TRUE,"OR_cc","default_or"
"CD007024_pub3_data","4::overall","4","overall","Point abstinence",16,0,1,TRUE,TRUE,"RD","sparse_events"
"CD007024_pub3_data","5::overall","5","overall","Dropout for any reason",26,0,0,TRUE,TRUE,"OR_cc","default_or"
"CD007024_pub3_data","6::overall","6","overall","Dropout due to adverse events",2,1,1,FALSE,TRUE,"RD","double_zero"
"CD007024_pub3_data","7::overall","7","overall","Any adverse events",2,1,2,FALSE,TRUE,"RD","double_zero"
"CD007024_pub3_data","8::overall","8","overall","Individual adverse events",19,1,4,TRUE,TRUE,"RD","double_zero"
"CD007026_pub7_data","1::overall","1","overall","All-cause death",14,0,6,TRUE,TRUE,"RD","sparse_events"
"CD007026_pub7_data","2::overall","2","overall","Non-death attrition",14,4,7,TRUE,TRUE,"RD","double_zero"
"CD007026_pub7_data","3::overall","3","overall","Total number of people with SAEs",10,0,3,TRUE,TRUE,"RD","sparse_events"
"CD007026_pub7_data","4::overall","4","overall","Total number of people with fatal SAEs",10,0,3,TRUE,TRUE,"RD","sparse_events"
"CD007026_pub7_data","5::overall","5","overall","Total number of people with non-fatal SAEs",3,0,1,TRUE,TRUE,"RD","sparse_events"
"CD007026_pub7_data","6::overall","6","overall","Total number of people with adverse events",5,0,0,TRUE,TRUE,"OR_cc","default_or"
"CD007079_pub4_data","1::overall","1","overall","Preterm birth < 37 weeks' gestation",20,2,3,TRUE,TRUE,"RD","double_zero"
"CD007079_pub4_data","2::overall","2","overall","Preterm birth < 37 weeks' gestation by dose of calcium",20,2,5,TRUE,TRUE,"RD","double_zero"
"CD007079_pub4_data","3::overall","3","overall","Preterm birth < 37 weeks' gestation by started to take calcium",20,3,4,TRUE,TRUE,"RD","double_zero"
"CD007079_pub4_data","4::overall","4","overall","Preterm birth < 37 weeks' gestation by type of calcium",17,1,3,TRUE,TRUE,"RD","double_zero"
"CD007079_pub4_data","5::overall","5","overall","Preterm birth < 34 weeks' gestation",11,1,3,TRUE,TRUE,"RD","double_zero"
"CD007079_pub4_data","6::overall","6","overall","Maternal weight gain (g/week)",8,3,3,TRUE,TRUE,"RD","double_zero"
"CD007079_pub4_data","10::overall","10","overall","Maternal bone mineral density (g/cm2) – first phalanx (calcium 600 mg)",6,1,1,TRUE,TRUE,"RD","double_zero"
"CD007079_pub4_data","14::overall","14","overall","Maternal death",2,0,1,TRUE,TRUE,"RD","sparse_events"
"CD007079_pub4_data","15::overall","15","overall","Mode of birth: vaginal birth",7,0,0,TRUE,TRUE,"OR_cc","default_or"
"CD007079_pub4_data","16::overall","16","overall","Mode of birth: instrumental vaginal birth",2,0,0,TRUE,TRUE,"OR_cc","default_or"
"CD007079_pub4_data","17::overall","17","overall","Mode of birth: caesarean section",8,0,0,TRUE,TRUE,"OR_cc","default_or"
"CD007110_pub4_data","1::overall","1","overall","All trials",24,17,24,TRUE,TRUE,"RD","double_zero"
"CD007110_pub4_data","2::overall","2","overall","Subgroup analysis – no interim PET vs interim PET-negative individuals only",20,15,19,TRUE,TRUE,"RD","double_zero"
"CD007110_pub4_data","3::overall","3","overall","Subgroup analysis – ABVD chemotherapy vs EBVP chemotherapy",17,14,17,TRUE,TRUE,"RD","double_zero"
"CD007130_pub5_data","1::overall","1","overall","Total mortality",14,7,10,TRUE,TRUE,"RD","double_zero"
"CD007130_pub5_data","4::overall","4","overall","Completers",26,0,0,TRUE,TRUE,"OR_cc","default_or"
"CD007130_pub5_data","11::overall","11","overall","Smoking 3 to 12 months",6,0,0,TRUE,TRUE,"OR_cc","default_or"
"CD007156_pub3_data","3::overall","3","overall","Difficulty in speech",3,0,0,TRUE,TRUE,"OR_cc","default_or"
"CD007156_pub3_data","4::overall","4","overall","Difficulty in swallowing",4,0,1,TRUE,TRUE,"RD","sparse_events"
"CD007310_pub3_data","3::overall","3","overall","Need for additional dilation",18,5,6,TRUE,TRUE,"RD","double_zero"
"CD007310_pub3_data","4::overall","4","overall","Ability to complete procedure (number completed on first attempt)",14,0,3,TRUE,TRUE,"RD","sparse_events"
"CD007310_pub3_data","5::overall","5","overall","Adverse events (pre-procedure expulsion)",22,0,12,TRUE,TRUE,"RD","sparse_events"
"CD007310_pub3_data","6::overall","6","overall","Side effects: nausea",17,0,3,TRUE,TRUE,"RD","sparse_events"
"CD007310_pub3_data","7::overall","7","overall","Side effects: vomiting",20,0,6,TRUE,TRUE,"RD","sparse_events"
"CD007310_pub3_data","8::overall","8","overall","Side effects: diarrhea",16,0,3,TRUE,TRUE,"RD","sparse_events"
"CD007310_pub3_data","9::overall","9","overall","Side effects: fever/chills",21,0,6,TRUE,TRUE,"RD","sparse_events"
"CD007310_pub3_data","10::overall","10","overall","Complications",19,0,7,TRUE,TRUE,"RD","sparse_events"
"CD007310_pub3_data","11::overall","11","overall","Patient acceptability and/or satisfaction",12,0,7,TRUE,TRUE,"RD","sparse_events"
"CD007310_pub3_data","12::overall","12","overall","Pain experienced by participants between initiation of cervical preparation method and abortion procedure",7,0,0,TRUE,TRUE,"OR_cc","default_or"
"CD007310_pub3_data","14::overall","14","overall","Provider acceptability and/or satisfaction",5,0,0,TRUE,TRUE,"OR_cc","default_or"
"CD007310_pub3_data","15::overall","15","overall","Provider assessment of difficulty of procedure",3,0,1,TRUE,TRUE,"RD","sparse_events"
"CD007310_pub3_data","16::overall","16","overall","Provider assessment of the procedure as very difficult",3,0,0,TRUE,TRUE,"OR_cc","default_or"
"CD007374_pub3_data","1::overall","1","overall","Death",8,2,6,TRUE,TRUE,"RD","double_zero"
"CD007374_pub3_data","2::overall","2","overall","HbA1c [%]",4,3,3,FALSE,TRUE,"RD","double_zero"
"CD007374_pub3_data","3::overall","3","overall","Attaining HbA1c < 6.5%",2,1,1,FALSE,TRUE,"RD","double_zero"
"CD007374_pub3_data","4::overall","4","overall","Kidney failure",3,2,3,FALSE,TRUE,"RD","double_zero"
"CD007374_pub3_data","5::overall","5","overall","Patient-oriented measures: beliefs at the end of treatment (attitude scales)",6,3,3,TRUE,TRUE,"RD","double_zero"
"CD007374_pub3_data","11::overall","11","overall","Patient-oriented measures: self-management behaviour changes at the end of treatment",7,0,1,TRUE,TRUE,"RD","sparse_events"
"CD007374_pub3_data","17::overall","17","overall","Glycaemic events",2,0,0,TRUE,TRUE,"OR_cc","default_or"
"CD007374_pub3_data","18::overall","18","overall","Non-fatal cardiovascular events",6,0,4,TRUE,TRUE,"RD","sparse_events"
"CD007374_pub3_data","22::overall","22","overall","Serious adverse events: emergency hospitalisation or death (including serious hypoglycaemic and CVD events)",2,0,0,TRUE,TRUE,"OR_cc","default_or"
"CD007388_pub3_data","1::overall","1","overall","Recurrence of convulsion",14,8,12,TRUE,TRUE,"RD","double_zero"
"CD007388_pub3_data","2::overall","2","overall","Maternal death",11,2,5,TRUE,TRUE,"RD","double_zero"
"CD007388_pub3_data","3::overall","3","overall","Maternal admission to intensive care unit",10,2,4,TRUE,TRUE,"RD","double_zero"
"CD007388_pub3_data","4::overall","4","overall","Caesarean section",11,1,6,TRUE,TRUE,"RD","double_zero"
"CD007388_pub3_data","5::overall","5","overall","Vaginal birth",13,6,8,TRUE,TRUE,"RD","double_zero"
"CD007388_pub3_data","6::overall","6","overall","Placental abruption",8,0,4,TRUE,TRUE,"RD","sparse_events"
"CD007388_pub3_data","7::overall","7","overall","Poor blood pressure control: non-use of antihypertensive drugs",4,0,2,TRUE,TRUE,"RD","sparse_events"
"CD007388_pub3_data","8::overall","8","overall","Severe maternal morbidity: HELLP syndrome",4,2,4,TRUE,TRUE,"RD","double_zero"
"CD007388_pub3_data","9::overall","9","overall","Severe morbidity: renal failure",5,1,3,TRUE,TRUE,"RD","double_zero"
"CD007388_pub3_data","10::overall","10","overall","Severe morbidity: liver failure",4,1,2,TRUE,TRUE,"RD","double_zero"
"CD007388_pub3_data","11::overall","11","overall","Severe morbidity: coagulopathy",3,1,1,TRUE,TRUE,"RD","double_zero"
"CD007388_pub3_data","12::overall","12","overall","Caesarean section",5,1,1,TRUE,TRUE,"RD","double_zero"
"CD007388_pub3_data","13::overall","13","overall","Vaginal birth",4,1,1,TRUE,TRUE,"RD","double_zero"
"CD007388_pub3_data","14::overall","14","overall","Placental abruption",6,0,2,TRUE,TRUE,"RD","sparse_events"
"CD007388_pub3_data","15::overall","15","overall","Postpartum haemorrhage",4,0,2,TRUE,TRUE,"RD","sparse_events"
"CD007388_pub3_data","16::overall","16","overall","Admission to neonatal intensive care unit",6,0,2,TRUE,TRUE,"RD","sparse_events"
"CD007388_pub3_data","17::overall","17","overall","Neonatal respiratory morbidity: respiratory depression requiring intubation",2,0,1,TRUE,TRUE,"RD","sparse_events"
"CD007569_pub4_data","1::overall","1","overall","Return to work",19,12,12,TRUE,TRUE,"RD","double_zero"
"CD007572_pub4_data","1::1","1","1","Failure to induce clinical remission (6 to 12 weeks)",2,0,0,TRUE,TRUE,"OR_cc","default_or"
"CD007572_pub4_data","1::2","1","2","Failure to induce clinical remission (6 to 12 weeks)",2,0,0,TRUE,TRUE,"OR_cc","default_or"
"CD007572_pub4_data","1::4","1","4","Failure to induce clinical remission (6 to 12 weeks)",5,0,0,TRUE,TRUE,"OR_cc","default_or"
"CD007572_pub4_data","1::5","1","5","Failure to induce clinical remission (6 to 12 weeks)",2,0,0,TRUE,TRUE,"OR_cc","default_or"
"CD007572_pub4_data","2::1","2","1","Failure to induce clinical remission (subgroup analyses anti-TNF pre-treated vs anti-TNF naive participants)",3,0,0,TRUE,TRUE,"OR_cc","default_or"
"CD007572_pub4_data","2::2","2","2","Failure to induce clinical remission (subgroup analyses anti-TNF pre-treated vs anti-TNF naive participants)",6,0,0,TRUE,TRUE,"OR_cc","default_or"
"CD007572_pub4_data","3::1","3","1","Failure to induce clinical remission (8 weeks, sensitivity analysis)",2,0,0,TRUE,TRUE,"OR_cc","default_or"
"CD007572_pub4_data","3::2","3","2","Failure to induce clinical remission (8 weeks, sensitivity analysis)",3,0,0,TRUE,TRUE,"OR_cc","default_or"
"CD007572_pub4_data","3::3","3","3","Failure to induce clinical remission (8 weeks, sensitivity analysis)",2,0,0,TRUE,TRUE,"OR_cc","default_or"
"CD007572_pub4_data","4::1","4","1","Failure to induce clinical response (≥ 100 points)",2,0,0,TRUE,TRUE,"OR_cc","default_or"
"CD007572_pub4_data","4::2","4","2","Failure to induce clinical response (≥ 100 points)",2,0,1,TRUE,TRUE,"RD","sparse_events"
"CD007572_pub4_data","4::4","4","4","Failure to induce clinical response (≥ 100 points)",5,0,0,TRUE,TRUE,"OR_cc","default_or"
"CD007572_pub4_data","4::5","4","5","Failure to induce clinical response (≥ 100 points)",2,0,0,TRUE,TRUE,"OR_cc","default_or"
"CD007572_pub4_data","6::overall","6","overall","Failure to induce endoscopic remission",2,0,0,TRUE,TRUE,"OR_cc","default_or"
"CD007572_pub4_data","7::overall","7","overall","Failure to induce endoscopic response",4,0,0,TRUE,TRUE,"OR_cc","default_or"
"CD007572_pub4_data","9::overall","9","overall","Serious adverse events",6,0,0,TRUE,TRUE,"OR_cc","default_or"
"CD007572_pub4_data","10::overall","10","overall","Serious adverse events (8 weeks, sensitivity analysis)",3,0,0,TRUE,TRUE,"OR_cc","default_or"
"CD007572_pub4_data","11::overall","11","overall","Withdrawals due to adverse events",4,0,1,TRUE,TRUE,"RD","sparse_events"
"CD007639_pub3_data","1::overall","1","overall","Bronchoconstriction (sidestream versus Pari LC plus)",23,22,23,FALSE,TRUE,"RD","double_zero"
"CD007639_pub3_data","2::overall","2","overall","Increased cough (Sidestream versus Pari LC plus)",22,20,21,TRUE,TRUE,"RD","double_zero"
"CD007639_pub3_data","3::overall","3","overall","Chest pain (Sidestream versus Pari LC plus)",17,15,16,TRUE,TRUE,"RD","double_zero"
"CD007639_pub3_data","4::overall","4","overall","Bronchoconstriction (CR60 versus Portaneb)",17,12,13,TRUE,TRUE,"RD","double_zero"
"CD007639_pub3_data","5::overall","5","overall","FEV1 (% predicted)",10,7,7,TRUE,TRUE,"RD","double_zero"
"CD007639_pub3_data","6::overall","6","overall","Satisfaction with device",9,7,7,TRUE,TRUE,"RD","double_zero"
"CD007639_pub3_data","11::overall","11","overall","Adverse events",5,0,0,TRUE,TRUE,"OR_cc","default_or"
"CD007639_pub3_data","12::overall","12","overall","FEV1: reduction over 10%",2,0,1,TRUE,TRUE,"RD","sparse_events"
"CD007639_pub3_data","15::overall","15","overall","Device malfunctions",4,3,3,FALSE,TRUE,"RD","double_zero"
"CD007674_pub3_data","2::overall","2","overall","Clinical recovery or improvement",54,21,21,TRUE,TRUE,"RD","double_zero"
"CD007674_pub3_data","3::overall","3","overall","Symptoms of worry",42,34,34,TRUE,TRUE,"RD","double_zero"
"CD007674_pub3_data","4::overall","4","overall","Symptoms of depression",73,24,24,TRUE,TRUE,"RD","double_zero"
"CD007674_pub3_data","5::overall","5","overall","Dropout rates",41,18,20,TRUE,TRUE,"RD","double_zero"
"CD007674_pub3_data","8::overall","8","overall","Overall quality of life (post-treatment)",16,1,1,TRUE,TRUE,"RD","double_zero"
"CD007674_pub3_data","6::overall","6","overall","Clinical recovery or improvement - GAD versus mixed anxiety disorders",14,0,0,TRUE,TRUE,"OR_cc","default_or"
"CD007784_pub3_data","1::overall","1","overall","Major cardiovascular events",16,1,1,TRUE,TRUE,"RD","double_zero"
"CD007784_pub3_data","2::overall","2","overall","Death",16,0,3,TRUE,TRUE,"RD","sparse_events"
"CD007784_pub3_data","3::overall","3","overall","Rhabdomyolysis",3,1,2,TRUE,TRUE,"RD","double_zero"
"CD007784_pub3_data","4::overall","4","overall","Cardiovascular death",9,1,4,TRUE,TRUE,"RD","double_zero"
"CD007784_pub3_data","5::overall","5","overall","Myocardial infarction",12,1,4,TRUE,TRUE,"RD","double_zero"
"CD007784_pub3_data","6::overall","6","overall","Stroke",8,0,2,TRUE,TRUE,"RD","sparse_events"
"CD007784_pub3_data","7::overall","7","overall","Revascularisation procedure",4,1,1,TRUE,TRUE,"RD","double_zero"
"CD007784_pub3_data","9::overall","9","overall","Kidney failure",3,0,1,TRUE,TRUE,"RD","sparse_events"
"CD007784_pub3_data","13::overall","13","overall","Elevated liver enzymes",7,3,4,TRUE,TRUE,"RD","double_zero"
"CD007784_pub3_data","14::overall","14","overall","Withdrawal due to adverse events",13,1,8,TRUE,TRUE,"RD","double_zero"
"CD007784_pub3_data","15::overall","15","overall","Cancer",2,0,0,TRUE,TRUE,"OR_cc","default_or"
"CD007784_pub3_data","17::overall","17","overall","Elevated creatine kinase",7,3,7,TRUE,TRUE,"RD","double_zero"
"CD007784_pub3_data","22::overall","22","overall","Subgroup analysis (cardiovascular disease): death",12,0,3,TRUE,TRUE,"RD","sparse_events"
"CD007784_pub3_data","23::overall","23","overall","Subgroup analysis (cardiovascular disease): major cardiovascular events",14,1,1,TRUE,TRUE,"RD","double_zero"
"CD007784_pub3_data","24::overall","24","overall","Subgroup analysis (statin dose): major cardiovascular death",14,1,1,TRUE,TRUE,"RD","double_zero"
"CD007784_pub3_data","25::overall","25","overall","Subgroup analysis (statin dose): death",12,0,3,TRUE,TRUE,"RD","sparse_events"
"CD007784_pub3_data","26::overall","26","overall","Subgroup analysis (statin dose): withdrawal due to adverse events",12,1,7,TRUE,TRUE,"RD","double_zero"
"CD007784_pub3_data","32::overall","32","overall","Subgroup analysis (age): withdrawal due to adverse events",12,1,7,TRUE,TRUE,"RD","double_zero"
"CD007784_pub3_data","36::overall","36","overall","Subgroup analysis (diabetes mellitus): withdrawal due to adverse events",13,1,7,TRUE,TRUE,"RD","double_zero"
"CD007784_pub3_data","37::overall","37","overall","Subgroup analysis (diabetes mellitus): death",13,0,3,TRUE,TRUE,"RD","sparse_events"
"CD007784_pub3_data","38::overall","38","overall","Subgroup analysis (diabetes mellitus): major cardiovascular death",14,1,1,TRUE,TRUE,"RD","double_zero"
"CD007784_pub3_data","45::overall","45","overall","Subgroup analysis (baseline cholesterol): withdrawal due to adverse events",13,1,7,TRUE,TRUE,"RD","double_zero"
"CD007784_pub3_data","48::overall","48","overall","Subgroup analysis (allocation concealment): death",13,0,3,TRUE,TRUE,"RD","sparse_events"
"CD007784_pub3_data","50::overall","50","overall","Subgroup analysis (allocation concealment): major cardiovascular events",14,1,1,TRUE,TRUE,"RD","double_zero"
"CD007784_pub3_data","53::overall","53","overall","Sensitivity analysis (excluding SHARP): major cardiovascular events",13,1,1,TRUE,TRUE,"RD","double_zero"
"CD007784_pub3_data","54::overall","54","overall","Sensitivity analysis (excluding SHARP): death",12,0,3,TRUE,TRUE,"RD","sparse_events"
"CD007784_pub3_data","55::overall","55","overall","Sensitivity analysis (funding): major cardiovascular events",5,1,1,TRUE,TRUE,"RD","double_zero"
"CD007784_pub3_data","56::overall","56","overall","Sensitivity analysis (funding): death",5,0,2,TRUE,TRUE,"RD","sparse_events"
"CD007784_pub3_data","57::overall","57","overall","Sensitivity analysis (funding): withdrawal due to adverse events",9,1,5,TRUE,TRUE,"RD","double_zero"
"CD007809_pub3_data","4::overall","4","overall","Number of participants reporting an adverse event at 12 weeks",10,9,9,FALSE,TRUE,"RD","double_zero"
"CD007809_pub3_data","5::overall","5","overall","Number of participants withdrawing due to an adverse event at 12 weeks",9,4,5,TRUE,TRUE,"RD","double_zero"
"CD007809_pub3_data","6::overall","6","overall","Number of participants withdrawing due to an adverse event",9,4,8,TRUE,TRUE,"RD","double_zero"
"CD007809_pub3_data","11::overall","11","overall","Number of participants reporting an adverse event",2,1,1,FALSE,TRUE,"RD","double_zero"
"CD007837_pub3_data","3::overall","3","overall","Objective surface measurements (waist asymmetry) (cm)",4,3,3,FALSE,TRUE,"RD","double_zero"
"CD007859_pub5_data","4::overall","4","overall","Pain (100-mm VAS): multistrand StSt versus superelastic nickel-titanium (NiTi)",23,22,22,FALSE,TRUE,"RD","double_zero"
"CD007859_pub5_data","7::overall","7","overall","Pain (analgesic consumption)",3,0,0,TRUE,TRUE,"OR_cc","default_or"
"CD007872_pub4_data","1::overall","1","overall","Estimated blood loss ≥ 500 mL",3,0,0,TRUE,TRUE,"OR_cc","default_or"
"CD007872_pub4_data","3::overall","3","overall","Estimated blood loss ≥ 1000 mL",2,0,0,TRUE,TRUE,"OR_cc","default_or"
"CD007872_pub4_data","5::overall","5","overall","Maternal death",2,1,1,FALSE,TRUE,"RD","double_zero"
"CD007872_pub4_data","7::overall","7","overall","Receipt of blood transfusion",3,1,1,TRUE,TRUE,"RD","double_zero"
"CD007872_pub4_data","8::overall","8","overall","Receipt of additional surgical interventions to control postpartum haemorrhage",3,1,1,TRUE,TRUE,"RD","double_zero"
"CD007872_pub4_data","9::overall","9","overall","Thromboembolic events",3,2,2,FALSE,TRUE,"RD","double_zero"
"CD007872_pub4_data","10::overall","10","overall","Receipt of additional uterotonics",2,0,0,TRUE,TRUE,"OR_cc","default_or"
"CD007872_pub4_data","14::overall","14","overall","Clinical diagnosis of postpartum haemorrhage",3,1,1,TRUE,TRUE,"RD","double_zero"
"CD007872_pub4_data","19::overall","19","overall","Seizures",3,1,2,TRUE,TRUE,"RD","double_zero"
"CD007872_pub4_data","22::overall","22","overall","Nausea",2,0,0,TRUE,TRUE,"OR_cc","default_or"
"CD007872_pub4_data","23::overall","23","overall","Vomiting",2,0,0,TRUE,TRUE,"OR_cc","default_or"
"CD007895_pub3_data","4::overall","4","overall","Withdrawals due to adverse effects",4,1,3,TRUE,TRUE,"RD","double_zero"
"CD007896_pub4_data","4::overall","4","overall","Withdrawals due to adverse effects",318,56,129,TRUE,TRUE,"RD","double_zero"
"CD008165_pub5_data","4::overall","4","overall","Proportion of patients with one or more potentially inappropriate medication",13,0,0,TRUE,TRUE,"OR_cc","default_or"
"CD008165_pub5_data","6::overall","6","overall","Proportion of patients with one or more potential prescribing omission",7,0,0,TRUE,TRUE,"OR_cc","default_or"
"CD008176_pub3_data","1::overall","1","overall","Cardiovascular death",26,1,7,TRUE,TRUE,"RD","double_zero"
"CD008176_pub3_data","2::overall","2","overall","Death (any cause)",129,18,79,TRUE,TRUE,"RD","double_zero"
"CD008176_pub3_data","3::overall","3","overall","Cardiovascular disease",50,3,14,TRUE,TRUE,"RD","double_zero"
"CD008176_pub3_data","4::overall","4","overall","Coronary heart disease",42,6,14,TRUE,TRUE,"RD","double_zero"
"CD008176_pub3_data","5::overall","5","overall","Heart failure",20,2,6,TRUE,TRUE,"RD","double_zero"
"CD008176_pub3_data","6::overall","6","overall","Cerebrovascular disease",24,0,14,TRUE,TRUE,"RD","sparse_events"
"CD008176_pub3_data","7::overall","7","overall","Peripheral vascular disease",14,0,4,TRUE,TRUE,"RD","sparse_events"
"CD008176_pub3_data","8::overall","8","overall","Kidney failure",33,0,11,TRUE,TRUE,"RD","sparse_events"
"CD008176_pub3_data","17::overall","17","overall","Albuminuria at end of study",15,12,13,TRUE,TRUE,"RD","double_zero"
"CD008176_pub3_data","18::overall","18","overall","Change in albuminuria",13,12,12,FALSE,TRUE,"RD","double_zero"
"CD008176_pub3_data","19::overall","19","overall","Vascular access thrombosis",19,0,6,TRUE,TRUE,"RD","sparse_events"
"CD008176_pub3_data","20::overall","20","overall","Graft loss",23,0,8,TRUE,TRUE,"RD","sparse_events"
"CD008176_pub3_data","21::overall","21","overall","Graft failure",16,0,5,TRUE,TRUE,"RD","sparse_events"
"CD008176_pub3_data","22::overall","22","overall","Delayed graft function",25,0,9,TRUE,TRUE,"RD","sparse_events"
"CD008176_pub3_data","23::overall","23","overall","Malignancy",12,0,12,TRUE,TRUE,"RD","sparse_events"
"CD008176_pub3_data","24::overall","24","overall","Major bleeding",25,0,16,TRUE,TRUE,"RD","sparse_events"
"CD008176_pub3_data","25::overall","25","overall","Infection",23,0,11,TRUE,TRUE,"RD","sparse_events"
"CD008237_pub4_data","2::1","2","1","Independent procedure completion: type of endoscopic procedure under study",6,1,2,TRUE,TRUE,"RD","double_zero"
"CD008237_pub4_data","2::2","2","2","Independent procedure completion: type of endoscopic procedure under study",2,1,1,FALSE,TRUE,"RD","double_zero"
"CD008237_pub4_data","3::1","3","1","Independent procedure completion: level of participant endoscopy experience",3,0,0,TRUE,TRUE,"OR_cc","default_or"
"CD008237_pub4_data","3::2","3","2","Independent procedure completion: level of participant endoscopy experience",3,0,1,TRUE,TRUE,"RD","sparse_events"
"CD008309_pub3_data","1::overall","1","overall","Composite outcome of death or bronchopulmonary dysplasia (BPD) at 36 weeks' postmenstrual age (PMA)",12,3,4,TRUE,TRUE,"RD","double_zero"
"CD008309_pub3_data","2::overall","2","overall","Failure to place LMA or ETT at first attempt",18,3,5,TRUE,TRUE,"RD","double_zero"
"CD008309_pub3_data","3::overall","3","overall","Bradycardia (heart rate < 100 beats per minute) during the intervention",20,6,12,TRUE,TRUE,"RD","double_zero"
"CD008309_pub3_data","4::overall","4","overall","Hypoxaemia (oxygen saturation < 80%) during the intervention",20,4,9,TRUE,TRUE,"RD","double_zero"
"CD008309_pub3_data","5::overall","5","overall","Apnoea (cessation of spontaneous breathing > 20 seconds) during the intervention",11,6,9,TRUE,TRUE,"RD","double_zero"
"CD008309_pub3_data","6::overall","6","overall","Surfactant reflux during the intervention",13,7,9,TRUE,TRUE,"RD","double_zero"
"CD008309_pub3_data","7::overall","7","overall","Postintervention intratracheal surfactant received",11,3,5,TRUE,TRUE,"RD","double_zero"
"CD008309_pub3_data","8::overall","8","overall","Number of doses of intratracheal surfactant received postintervention",4,2,3,TRUE,TRUE,"RD","double_zero"
"CD008309_pub3_data","9::overall","9","overall","Mechanical ventilation within first 72 hours",3,2,2,FALSE,TRUE,"RD","double_zero"
"CD008309_pub3_data","10::overall","10","overall","Mechanical ventilation within first 72 hours or not ventilated but reached failure criteria as defined by the study authors",3,2,2,FALSE,TRUE,"RD","double_zero"
"CD008309_pub3_data","11::overall","11","overall","Mechanical ventilation at any time",6,2,2,TRUE,TRUE,"RD","double_zero"
"CD008309_pub3_data","12::overall","12","overall","Pulmonary air leak, any (during first hospitalisation)",7,2,3,TRUE,TRUE,"RD","double_zero"
"CD008309_pub3_data","15::overall","15","overall","BPD (clinical definition) among survivors to 36 weeks' PMA",5,2,3,TRUE,TRUE,"RD","double_zero"
"CD008309_pub3_data","16::overall","16","overall","Any intraventricular haemorrhage",3,2,2,FALSE,TRUE,"RD","double_zero"
"CD008309_pub3_data","26::overall","26","overall","Death (all causes) during the first hospitalisation",3,2,3,FALSE,TRUE,"RD","double_zero"
"CD008469_pub3_data","1::overall","1","overall","Exacerbations leading to emergency department (ED) visits: subgrouped by time frame of follow-up",16,6,7,TRUE,TRUE,"RD","double_zero"
"CD008469_pub3_data","4::overall","4","overall","Day symptoms (change in mean symptom-free days in 2 weeks)",6,4,4,TRUE,TRUE,"RD","double_zero"
"CD008469_pub3_data","6::overall","6","overall","Exacerbations leading to hospitalisations: subgrouped by time frame of follow-up",11,1,2,TRUE,TRUE,"RD","double_zero"
"CD008493_pub5_data","1::overall","1","overall","Short-term mortality",20,6,14,TRUE,TRUE,"RD","double_zero"
"CD008493_pub5_data","2::overall","2","overall","Major adverse cardiac events",11,0,6,TRUE,TRUE,"RD","sparse_events"
"CD008493_pub5_data","3::overall","3","overall","Myocardial infarction",25,0,4,TRUE,TRUE,"RD","sparse_events"
"CD008493_pub5_data","4::overall","4","overall","Atrial fibrillation",17,0,1,TRUE,TRUE,"RD","sparse_events"
"CD008493_pub5_data","5::overall","5","overall","Stroke",15,0,2,TRUE,TRUE,"RD","sparse_events"
"CD008493_pub5_data","6::overall","6","overall","Renal failure",11,7,8,TRUE,TRUE,"RD","double_zero"
"CD008564_pub3_data","1::overall","1","overall","Total mortality",56,0,0,TRUE,TRUE,"OR_cc","default_or"
"CD008564_pub3_data","2::overall","2","overall","Total serious adverse events",57,0,0,TRUE,TRUE,"OR_cc","default_or"
"CD008564_pub3_data","3::overall","3","overall","Total cardiovascular events",46,0,0,TRUE,TRUE,"OR_cc","default_or"
"CD008564_pub3_data","4::overall","4","overall","Cardiovascular mortality",56,0,1,TRUE,TRUE,"RD","sparse_events"
"CD008564_pub3_data","5::overall","5","overall","Progression to end-stage renal disease ",38,0,1,TRUE,TRUE,"RD","sparse_events"
"CD008564_pub3_data","7::overall","7","overall","Doubling of serum creatinine level or 50% reduction in GFR at the end of study",5,0,0,TRUE,TRUE,"OR_cc","default_or"
"CD008564_pub3_data","10::overall","10","overall","Proportion of participants reaching target blood pressure levels at end of study",6,0,0,TRUE,TRUE,"OR_cc","default_or"
"CD008628_pub3_data","3::overall","3","overall","Function in the long term; number of people with scores of excellent, good, or satisfactory/fair",12,3,5,TRUE,TRUE,"RD","double_zero"
"CD008628_pub3_data","4::overall","4","overall","Chronic pain; number of people with pain",8,0,0,TRUE,TRUE,"OR_cc","default_or"
"CD008628_pub3_data","7::overall","7","overall","Return to normal activity (work) ",5,0,0,TRUE,TRUE,"OR_cc","default_or"
"CD008628_pub3_data","8::overall","8","overall","Postoperative complications requiring unplanned return to theatre",9,0,5,TRUE,TRUE,"RD","sparse_events"
"CD008628_pub3_data","9::overall","9","overall","Postoperative complications not requiring return to theatre",9,1,6,TRUE,TRUE,"RD","double_zero"
"CD008628_pub3_data","10::overall","10","overall","Ability to wear usual footwear",4,0,0,TRUE,TRUE,"OR_cc","default_or"
"CD008688_pub3_data","1::overall","1","overall","Pancreatic fistula (free definition)",3,0,0,TRUE,TRUE,"OR_cc","default_or"
"CD008688_pub3_data","2::overall","2","overall","Postoperative pancreatic fistula (ISGPS)",2,0,0,TRUE,TRUE,"OR_cc","default_or"
"CD008688_pub3_data","3::overall","3","overall","Postoperative mortality",3,2,3,FALSE,TRUE,"RD","double_zero"
"CD008688_pub3_data","4::overall","4","overall","Overall postoperative morbidity",2,0,0,TRUE,TRUE,"OR_cc","default_or"
"CD008688_pub3_data","5::overall","5","overall","Delayed gastric emptying",2,0,2,TRUE,TRUE,"RD","sparse_events"
"CD008688_pub3_data","6::overall","6","overall","Postoperative haemorrhage",2,1,1,FALSE,TRUE,"RD","double_zero"
"CD008688_pub3_data","7::overall","7","overall","Intra-abdominal fluid collection",2,0,0,TRUE,TRUE,"OR_cc","default_or"
"CD008709_pub4_data","1::overall","1","overall","Objective cure or improvement of urinary incontinence: between 12 and 24 months",27,0,0,TRUE,TRUE,"OR_cc","default_or"
"CD008709_pub4_data","2::overall","2","overall","Dyspareunia",6,0,0,TRUE,TRUE,"OR_cc","default_or"
"CD008709_pub4_data","3::overall","3","overall","Number of women affected by mesh exposure, extrusion or erosion in any area",11,0,1,TRUE,TRUE,"RD","sparse_events"
"CD008709_pub4_data","4::overall","4","overall","Bladder or urethral injuries: less than 30 days after surgery",10,0,1,TRUE,TRUE,"RD","sparse_events"
"CD008709_pub4_data","5::overall","5","overall","Infections (e.g. UTI, mesh infection)",30,0,2,TRUE,TRUE,"RD","sparse_events"
"CD008709_pub4_data","6::overall","6","overall","Patient-reported pain: 12 to 24 months",6,1,2,TRUE,TRUE,"RD","double_zero"
"CD008709_pub4_data","7::overall","7","overall","Dyspareunia",10,0,2,TRUE,TRUE,"RD","sparse_events"
"CD008709_pub4_data","8::overall","8","overall","Number of women affected by mesh exposure, extrusion or erosion in any area",13,1,5,TRUE,TRUE,"RD","double_zero"
"CD008709_pub4_data","9::overall","9","overall","Urinary retention",14,1,6,TRUE,TRUE,"RD","double_zero"
"CD008709_pub4_data","10::overall","10","overall","Bladder or urethral injuries: less than 30 days after surgery",17,2,11,TRUE,TRUE,"RD","double_zero"
"CD008709_pub4_data","11::overall","11","overall","Other injuries: less than 30 days after surgery",8,0,6,TRUE,TRUE,"RD","sparse_events"
"CD008709_pub4_data","12::overall","12","overall","Infections (e.g. UTI, mesh infection)",16,0,6,TRUE,TRUE,"RD","sparse_events"
"CD008709_pub4_data","13::overall","13","overall","De novo urgency",29,3,13,TRUE,TRUE,"RD","double_zero"
"CD008709_pub4_data","14::overall","14","overall","Requiring repeat continence surgery or mesh revision",37,1,25,TRUE,TRUE,"RD","double_zero"
"CD008709_pub4_data","15::overall","15","overall","Bladder or urethral injuries: less than 30 days after surgery",26,14,24,TRUE,TRUE,"RD","double_zero"
"CD008709_pub4_data","16::overall","16","overall","Other injuries: less than 30 days after surgery",18,7,15,TRUE,TRUE,"RD","double_zero"
"CD008709_pub4_data","17::overall","17","overall","Infections (e.g. UTI, mesh infections)",20,1,11,TRUE,TRUE,"RD","double_zero"
"CD008709_pub4_data","18::overall","18","overall","De novo urgency",22,1,5,TRUE,TRUE,"RD","double_zero"
"CD008709_pub4_data","20::overall","20","overall","Requiring repeat continence surgery or mesh revision",21,0,10,TRUE,TRUE,"RD","sparse_events"
"CD008858_pub5_data","1::overall","1","overall","Cumulative incidence of herpes zoster",7,0,0,TRUE,TRUE,"OR_cc","default_or"
"CD008858_pub5_data","2::overall","2","overall","Participants with adverse events",72,8,26,TRUE,TRUE,"RD","double_zero"
"CD008858_pub5_data","3::overall","3","overall","Duration in days of adverse events",48,6,7,TRUE,TRUE,"RD","double_zero"
"CD008858_pub5_data","4::overall","4","overall","Dropouts",27,1,11,TRUE,TRUE,"RD","double_zero"
"CD008858_pub5_data","5::overall","5","overall","Participants with no follow-up",3,0,0,TRUE,TRUE,"OR_cc","default_or"
"CD008873_pub5_data","1::overall","1","overall","Pre-eclampsia (ALL)",3,0,1,TRUE,TRUE,"RD","sparse_events"
"CD008873_pub5_data","2::overall","2","overall","Gestational diabetes (ALL)",4,2,4,TRUE,TRUE,"RD","double_zero"
"CD008873_pub5_data","3::overall","3","overall","Maternal adverse events",5,2,3,TRUE,TRUE,"RD","double_zero"
"CD008873_pub5_data","4::overall","4","overall","Preterm birth (less than 37 weeks' gestation) (ALL)",5,1,2,TRUE,TRUE,"RD","double_zero"
"CD008873_pub5_data","5::overall","5","overall","Low birthweight (less than 2500 g) (ALL)",4,0,0,TRUE,TRUE,"OR_cc","default_or"
"CD008873_pub5_data","6::overall","6","overall","Caesarean section",4,0,0,TRUE,TRUE,"OR_cc","default_or"
"CD008873_pub5_data","7::overall","7","overall","Gestational hypertension",3,0,1,TRUE,TRUE,"RD","sparse_events"
"CD008873_pub5_data","12::overall","12","overall","Birthweight (g)",7,6,6,FALSE,TRUE,"RD","double_zero"
"CD008873_pub5_data","13::overall","13","overall","Stillbirth",4,0,3,TRUE,TRUE,"RD","sparse_events"
"CD008873_pub5_data","14::overall","14","overall","Neonatal death",2,0,2,TRUE,TRUE,"RD","sparse_events"
"CD008879_pub3_data","1::overall","1","overall","Non-infectious complications",20,0,1,TRUE,TRUE,"RD","sparse_events"
"CD008879_pub3_data","2::overall","2","overall","Infectious complications",17,2,2,TRUE,TRUE,"RD","double_zero"
"CD008940_pub4_data","1::overall","1","overall","Participants abstinent at end of treatment",30,4,7,TRUE,TRUE,"RD","double_zero"
"CD008940_pub4_data","2::overall","2","overall","Participants experiencing adverse events",30,3,6,TRUE,TRUE,"RD","double_zero"
"CD008940_pub4_data","3::overall","3","overall","Participants experiencing severe adverse events",33,15,28,TRUE,TRUE,"RD","double_zero"
"CD008940_pub4_data","4::overall","4","overall","Participants withdrawn due to adverse effects",29,7,20,TRUE,TRUE,"RD","double_zero"
"CD008940_pub4_data","5::overall","5","overall","Completion of scheduled treatment",29,0,0,TRUE,TRUE,"OR_cc","default_or"
"CD008973_pub3_data","1::overall","1","overall","Complete resolution of phimosis",10,0,0,TRUE,TRUE,"OR_cc","default_or"
"CD008973_pub3_data","2::overall","2","overall","Partial resolution of phimosis",7,0,0,TRUE,TRUE,"OR_cc","default_or"
"CD008973_pub3_data","4::overall","4","overall","Long-term complete resolution of phimosis",2,0,0,TRUE,TRUE,"OR_cc","default_or"
"CD008973_pub3_data","5::overall","5","overall","Adverse effects (any)",11,9,10,TRUE,TRUE,"RD","double_zero"
"CD008973_pub3_data","6::overall","6","overall","Complete resolution of phimosis (subgroup analysis based on age)",10,0,0,TRUE,TRUE,"OR_cc","default_or"
"CD008973_pub3_data","7::overall","7","overall","Complete resolution of phimosis (subgroup analysis based on duration of treatment)",10,0,0,TRUE,TRUE,"OR_cc","default_or"
"CD008973_pub3_data","8::overall","8","overall","Complete resolution of phimosis (subgroup analysis based on potency of corticosteroid)",10,0,0,TRUE,TRUE,"OR_cc","default_or"
"CD008995_pub3_data","2::overall","2","overall","Clinical pregnancy",2,0,0,TRUE,TRUE,"OR_cc","default_or"
"CD009022_pub4_data","6::overall","6","overall","Visceral or vascular injury (rate)",3,1,3,TRUE,TRUE,"RD","double_zero"
"CD009022_pub4_data","7::overall","7","overall","Conversion to laparoscopic (use of more than one additional port)/open surgery (rate)",9,0,6,TRUE,TRUE,"RD","sparse_events"
"CD009022_pub4_data","8::overall","8","overall","Use of additional port site (rate)",5,0,2,TRUE,TRUE,"RD","sparse_events"
"CD009022_pub4_data","9::overall","9","overall","Wound infection (rate)",5,1,3,TRUE,TRUE,"RD","double_zero"
"CD009022_pub4_data","10::overall","10","overall","Intra-abdominal collection (rate)",5,0,3,TRUE,TRUE,"RD","sparse_events"
"CD009022_pub4_data","11::overall","11","overall","Postoperative ileus (rate)",3,0,2,TRUE,TRUE,"RD","sparse_events"
"CD009102_pub2_data","1::overall","1","overall","Death before discharge",3,0,0,TRUE,TRUE,"OR_cc","default_or"
"CD009102_pub2_data","2::overall","2","overall","Intubation and mechanical ventilation in DR",5,0,1,TRUE,TRUE,"RD","sparse_events"
"CD009102_pub2_data","3::overall","3","overall","Chest compressions in DR",3,0,0,TRUE,TRUE,"OR_cc","default_or"
"CD009102_pub2_data","6::overall","6","overall","Intubation and mechanical ventilation within 24 hours of birth",3,0,0,TRUE,TRUE,"OR_cc","default_or"
"CD009102_pub2_data","8::overall","8","overall","Air leak (pneumothorax, pneumomediastinum, pneumopericardium, pulmonary interstitial emphysema) reported either individually or as a composite outcome",2,0,0,TRUE,TRUE,"OR_cc","default_or"
"CD009102_pub2_data","11::overall","11","overall","Need for supplemental oxygen at 36 weeks' corrected gestational age",2,0,0,TRUE,TRUE,"OR_cc","default_or"
"CD009102_pub2_data","12::overall","12","overall","Cranial ultrasound abnormalities (IVH grade ≥ 3 or periventricular leukomalacia)",3,0,0,TRUE,TRUE,"OR_cc","default_or"
"CD009235_pub4_data","2::1","2","1","Mortality",25,5,10,TRUE,TRUE,"RD","double_zero"
"CD009235_pub4_data","2::2","2","2","Mortality",9,2,3,TRUE,TRUE,"RD","double_zero"
"CD009235_pub4_data","2::3","2","3","Mortality",4,0,1,TRUE,TRUE,"RD","sparse_events"
"CD009235_pub4_data","9::overall","9","overall","Reintubation",28,6,15,TRUE,TRUE,"RD","double_zero"
"CD009235_pub4_data","10::overall","10","overall","Self-extubation",12,3,8,TRUE,TRUE,"RD","double_zero"
"CD009235_pub4_data","11::overall","11","overall","Non invasive ventilation following extubation",23,3,9,TRUE,TRUE,"RD","double_zero"
"CD009235_pub4_data","12::overall","12","overall","Prolonged mechanical ventilation",11,2,5,TRUE,TRUE,"RD","double_zero"
"CD009235_pub4_data","13::overall","13","overall","Tracheostomy",17,3,4,TRUE,TRUE,"RD","double_zero"
"CD009235_pub4_data","16::1","16","1","Reintubation by study population",3,0,1,TRUE,TRUE,"RD","sparse_events"
"CD009235_pub4_data","16::2","16","2","Reintubation by study population",14,1,5,TRUE,TRUE,"RD","double_zero"
"CD009235_pub4_data","16::3","16","3","Reintubation by study population",11,5,9,TRUE,TRUE,"RD","double_zero"
"CD009235_pub4_data","19::1","19","1","Reintubation by automated system",8,4,7,TRUE,TRUE,"RD","double_zero"
"CD009235_pub4_data","19::2","19","2","Reintubation by automated system",9,0,3,TRUE,TRUE,"RD","sparse_events"
"CD009235_pub4_data","19::3","19","3","Reintubation by automated system",2,1,2,FALSE,TRUE,"RD","double_zero"
"CD009235_pub4_data","19::4","19","4","Reintubation by automated system",4,0,1,TRUE,TRUE,"RD","sparse_events"
"CD009235_pub4_data","19::5","19","5","Reintubation by automated system",3,0,0,TRUE,TRUE,"OR_cc","default_or"
"CD009235_pub4_data","19::6","19","6","Reintubation by automated system",2,1,2,FALSE,TRUE,"RD","double_zero"
"CD009235_pub4_data","22::1","22","1","Reintubation by non-automated strategy (control arm)",10,2,6,TRUE,TRUE,"RD","double_zero"
"CD009235_pub4_data","22::2","22","2","Reintubation by non-automated strategy (control arm)",18,4,9,TRUE,TRUE,"RD","double_zero"
"CD009244_pub3_data","1::overall","1","overall","Development of anal cancer",9,0,0,TRUE,TRUE,"OR_cc","default_or"
"CD009244_pub3_data","2::overall","2","overall","Development of anal cancer",8,3,4,TRUE,TRUE,"RD","double_zero"
"CD009244_pub3_data","3::overall","3","overall","Downgrading from AIN-III or II to AIN-I, or from HSIL to LSIL",7,0,0,TRUE,TRUE,"OR_cc","default_or"
"CD009244_pub3_data","4::overall","4","overall","Recurrence",3,0,0,TRUE,TRUE,"OR_cc","default_or"
"CD009252_pub2_data","2::overall","2","overall","Number or change in number of leakage episodes in 24 hours",27,25,25,TRUE,TRUE,"RD","double_zero"
"CD009252_pub2_data","3::overall","3","overall","Subjective symptom of cure or improvement",26,11,11,TRUE,TRUE,"RD","double_zero"
"CD009252_pub2_data","4::overall","4","overall","Satisfaction with treatment outcome",17,11,11,TRUE,TRUE,"RD","double_zero"
"CD009298_pub3_data","1::overall","1","overall","Operative delivery",6,0,0,TRUE,TRUE,"OR_cc","default_or"
"CD009298_pub3_data","2::1","2","1","Operative delivery (Subgroup analysis: occiput posterior versus occiput transverse)",5,0,0,TRUE,TRUE,"OR_cc","default_or"
"CD009298_pub3_data","2::2","2","2","Operative delivery (Subgroup analysis: occiput posterior versus occiput transverse)",2,0,1,TRUE,TRUE,"RD","sparse_events"
"CD009298_pub3_data","3::1","3","1","Operative delivery (Subgroup analysis: nulliparous versus multiparous)",6,0,0,TRUE,TRUE,"OR_cc","default_or"
"CD009298_pub3_data","3::2","3","2","Operative delivery (Subgroup analysis: nulliparous versus multiparous)",5,0,1,TRUE,TRUE,"RD","sparse_events"
"CD009298_pub3_data","4::1","4","1","Operative delivery (Subgroup analysis: digital (fingers) versus whole-hand rotation)",3,0,0,TRUE,TRUE,"OR_cc","default_or"
"CD009298_pub3_data","4::2","4","2","Operative delivery (Subgroup analysis: digital (fingers) versus whole-hand rotation)",5,0,0,TRUE,TRUE,"OR_cc","default_or"
"CD009298_pub3_data","4::3","4","3","Operative delivery (Subgroup analysis: digital (fingers) versus whole-hand rotation)",2,0,0,TRUE,TRUE,"OR_cc","default_or"
"CD009298_pub3_data","13::overall","13","overall","Caesarean section",6,0,1,TRUE,TRUE,"RD","sparse_events"
"CD009298_pub3_data","14::1","14","1","Caesarean section (Subgroup analysis: occiput posterior versus occiput transverse position)",5,0,1,TRUE,TRUE,"RD","sparse_events"
"CD009298_pub3_data","14::2","14","2","Caesarean section (Subgroup analysis: occiput posterior versus occiput transverse position)",2,1,1,FALSE,TRUE,"RD","double_zero"
"CD009298_pub3_data","15::1","15","1","Caesarean section (Subgroup analysis: nulliparous versus multiparous)",6,0,1,TRUE,TRUE,"RD","sparse_events"
"CD009298_pub3_data","15::2","15","2","Caesarean section (Subgroup analysis: nulliparous versus multiparous)",5,2,5,TRUE,TRUE,"RD","double_zero"
"CD009298_pub3_data","16::1","16","1","Caesarean section (Subgroup analysis: digital (fingers) versus whole-hand rotation)",3,0,0,TRUE,TRUE,"OR_cc","default_or"
"CD009298_pub3_data","16::2","16","2","Caesarean section (Subgroup analysis: digital (fingers) versus whole-hand rotation)",5,1,2,TRUE,TRUE,"RD","double_zero"
"CD009298_pub3_data","16::3","16","3","Caesarean section (Subgroup analysis: digital (fingers) versus whole-hand rotation)",2,0,2,TRUE,TRUE,"RD","sparse_events"
"CD009298_pub3_data","17::overall","17","overall","Instrumental delivery",6,0,0,TRUE,TRUE,"OR_cc","default_or"
"CD009298_pub3_data","18::1","18","1","Instrumental delivery (Subgroup analysis: occiput posterior versus occiput transverse position)",5,0,0,TRUE,TRUE,"OR_cc","default_or"
"CD009298_pub3_data","18::2","18","2","Instrumental delivery (Subgroup analysis: occiput posterior versus occiput transverse position)",2,0,1,TRUE,TRUE,"RD","sparse_events"
"CD009298_pub3_data","19::1","19","1","Instrumental delivery (Subgroup analysis: nulliparous versus multiparous)",6,0,0,TRUE,TRUE,"OR_cc","default_or"
"CD009298_pub3_data","19::2","19","2","Instrumental delivery (Subgroup analysis: nulliparous versus multiparous)",5,0,1,TRUE,TRUE,"RD","sparse_events"
"CD009298_pub3_data","20::1","20","1","Instrumental delivery (Subgroup analysis: digital (fingers) versus whole-hand rotation)",3,0,0,TRUE,TRUE,"OR_cc","default_or"
"CD009298_pub3_data","20::2","20","2","Instrumental delivery (Subgroup analysis: digital (fingers) versus whole-hand rotation)",5,0,0,TRUE,TRUE,"OR_cc","default_or"
"CD009298_pub3_data","20::3","20","3","Instrumental delivery (Subgroup analysis: digital (fingers) versus whole-hand rotation)",2,0,1,TRUE,TRUE,"RD","sparse_events"
"CD009298_pub3_data","21::overall","21","overall","Third- or fourth-degree perineal trauma",6,0,1,TRUE,TRUE,"RD","sparse_events"
"CD009298_pub3_data","22::1","22","1","Third- or fourth-degree perineal trauma (Subgroup analysis: occiput posterior versus occiput transverse position)",5,0,1,TRUE,TRUE,"RD","sparse_events"
"CD009298_pub3_data","22::2","22","2","Third- or fourth-degree perineal trauma (Subgroup analysis: occiput posterior versus occiput transverse position)",2,1,1,FALSE,TRUE,"RD","double_zero"
"CD009298_pub3_data","23::1","23","1","Third- or fourth-degree perineal trauma (Subgroup analysis: nulliparous versus multiparous)",6,0,1,TRUE,TRUE,"RD","sparse_events"
"CD009298_pub3_data","23::2","23","2","Third- or fourth-degree perineal trauma (Subgroup analysis: nulliparous versus multiparous)",5,2,5,TRUE,TRUE,"RD","double_zero"
"CD009298_pub3_data","24::1","24","1","Third- or fourth-degree perineal trauma (Subgroup analysis: digital (fingers) versus whole-hand rotation)",3,0,1,TRUE,TRUE,"RD","sparse_events"
"CD009298_pub3_data","24::2","24","2","Third- or fourth-degree perineal trauma (Subgroup analysis: digital (fingers) versus whole-hand rotation)",5,0,1,TRUE,TRUE,"RD","sparse_events"
"CD009298_pub3_data","24::3","24","3","Third- or fourth-degree perineal trauma (Subgroup analysis: digital (fingers) versus whole-hand rotation)",2,1,2,FALSE,TRUE,"RD","double_zero"
"CD009298_pub3_data","25::overall","25","overall","Postpartum haemorrhage ≥ 500 mL",6,0,0,TRUE,TRUE,"OR_cc","default_or"
"CD009298_pub3_data","26::1","26","1","Postpartum haemorrhage ≥ 500 mL (Subgroup analysis: occiput posterior versus occiput transverse position)",5,0,0,TRUE,TRUE,"OR_cc","default_or"
"CD009298_pub3_data","26::2","26","2","Postpartum haemorrhage ≥ 500 mL (Subgroup analysis: occiput posterior versus occiput transverse position)",2,0,1,TRUE,TRUE,"RD","sparse_events"
"CD009298_pub3_data","27::1","27","1","Postpartum haemorrhage ≥ 500 mL &nbsp;(Subgroup analysis: nulliparous versus multiparous)",6,0,0,TRUE,TRUE,"OR_cc","default_or"
"CD009298_pub3_data","27::2","27","2","Postpartum haemorrhage ≥ 500 mL &nbsp;(Subgroup analysis: nulliparous versus multiparous)",5,1,2,TRUE,TRUE,"RD","double_zero"
"CD009298_pub3_data","28::1","28","1","Postpartum haemorrhage ≥ 500 mL (Subgroup analysis: digital (fingers) versus whole-hand rotation)",3,0,0,TRUE,TRUE,"OR_cc","default_or"
"CD009298_pub3_data","28::2","28","2","Postpartum haemorrhage ≥ 500 mL (Subgroup analysis: digital (fingers) versus whole-hand rotation)",5,0,0,TRUE,TRUE,"OR_cc","default_or"
"CD009298_pub3_data","28::3","28","3","Postpartum haemorrhage ≥ 500 mL (Subgroup analysis: digital (fingers) versus whole-hand rotation)",2,0,1,TRUE,TRUE,"RD","sparse_events"
"CD009298_pub3_data","29::overall","29","overall","Forceps delivery",4,0,0,TRUE,TRUE,"OR_cc","default_or"
"CD009298_pub3_data","30::overall","30","overall","Vacuum-assisted delivery",4,0,0,TRUE,TRUE,"OR_cc","default_or"
"CD009298_pub3_data","31::overall","31","overall","Episiotomy",4,0,0,TRUE,TRUE,"OR_cc","default_or"
"CD009298_pub3_data","34::overall","34","overall","Maternal postnatal infection",4,2,4,TRUE,TRUE,"RD","double_zero"
"CD009298_pub3_data","36::overall","36","overall","Negative experience of childbirth at 6 weeks post delivery (as defined by trial authors)",2,0,0,TRUE,TRUE,"OR_cc","default_or"
"CD009298_pub3_data","37::overall","37","overall","Postnatal depression at &lt; 6 months' follow up",2,0,2,TRUE,TRUE,"RD","sparse_events"
"CD009298_pub3_data","38::overall","38","overall","Postnatal depression at ≥ 6 months' follow up",2,0,2,TRUE,TRUE,"RD","sparse_events"
"CD009298_pub3_data","39::overall","39","overall","Breastfeeding not successful &lt; 6 months' follow up",2,0,0,TRUE,TRUE,"OR_cc","default_or"
"CD009298_pub3_data","40::overall","40","overall","Breastfeeding not successful at ≥ 6 months' follow up",2,0,0,TRUE,TRUE,"OR_cc","default_or"
"CD009298_pub3_data","43::overall","43","overall","Cord blood gas acidosis",5,0,3,TRUE,TRUE,"RD","sparse_events"
"CD009298_pub3_data","44::overall","44","overall","Admission to neonatal intensive care unit",5,2,3,TRUE,TRUE,"RD","double_zero"
"CD009298_pub3_data","47::overall","47","overall","Neonatal jaundice treated with phototherapy",4,0,1,TRUE,TRUE,"RD","sparse_events"
"CD009298_pub3_data","51::overall","51","overall","Neonatal intracranial bleed",4,3,4,FALSE,TRUE,"RD","double_zero"
"CD009298_pub3_data","52::overall","52","overall","Neonatal fracture",4,3,4,FALSE,TRUE,"RD","double_zero"
"CD009298_pub3_data","53::overall","53","overall","Scalp haematoma (e.g. cephalohaematoma or subgaleal haemorrhage)",5,1,3,TRUE,TRUE,"RD","double_zero"
"CD009298_pub3_data","55::overall","55","overall","Neonatal neuropraxia",4,2,4,TRUE,TRUE,"RD","double_zero"
"CD009362_pub4_data","1::overall","1","overall","Pressure ulcer",56,2,6,TRUE,TRUE,"RD","double_zero"
"CD009362_pub4_data","2::overall","2","overall","Pressure ulcer stage",47,0,19,TRUE,TRUE,"RD","sparse_events"
"CD009362_pub4_data","3::overall","3","overall","Time to pressure ulcer development",9,4,6,TRUE,TRUE,"RD","double_zero"
"CD009362_pub4_data","4::overall","4","overall","Anatomical location of pressure ulcer development",20,0,8,TRUE,TRUE,"RD","sparse_events"
"CD009417_pub3_data","1::overall","1","overall","Mortality (any cause during hospitalisation or follow-up)",4,1,4,TRUE,TRUE,"RD","double_zero"
"CD009417_pub3_data","3::overall","3","overall","Adverse events of any severity or seriousness",5,0,0,TRUE,TRUE,"OR_cc","default_or"
"CD009417_pub3_data","4::overall","4","overall","Serious adverse events",4,0,1,TRUE,TRUE,"RD","sparse_events"
"CD009417_pub3_data","5::overall","5","overall","Need for mechanical ventilation",4,0,2,TRUE,TRUE,"RD","sparse_events"
"CD009417_pub3_data","7::overall","7","overall","Need for supplemental oxygen",2,0,0,TRUE,TRUE,"OR_cc","default_or"
"CD009417_pub3_data","9::overall","9","overall","Need for ICU admission",5,0,1,TRUE,TRUE,"RD","sparse_events"
"CD009508_pub2_data","3::overall","3","overall","Subjective cure/improvement",16,0,0,TRUE,TRUE,"OR_cc","default_or"
"CD009508_pub2_data","4::overall","4","overall","Satisfaction",6,0,0,TRUE,TRUE,"OR_cc","default_or"
"CD009531_pub3_data","1::overall","1","overall","Quality of life: average change in mental health component - 12 months",28,27,27,FALSE,TRUE,"RD","double_zero"
"CD009531_pub3_data","2::overall","2","overall","Mental state: clinically important change (binary) - 12 months ",31,27,27,TRUE,TRUE,"RD","double_zero"
"CD009531_pub3_data","3::overall","3","overall","Psychiatric hospital admissions - 12 months",8,5,5,TRUE,TRUE,"RD","double_zero"
"CD009531_pub3_data","4::overall","4","overall","Other hospital admissions",8,5,5,TRUE,TRUE,"RD","double_zero"
"CD009531_pub3_data","8::overall","8","overall","Medication adherence (patient-reported) (DAI-10)",2,0,0,TRUE,TRUE,"OR_cc","default_or"
"CD009531_pub3_data","14::overall","14","overall","Death",5,0,4,TRUE,TRUE,"RD","sparse_events"
"CD009531_pub3_data","19::overall","19","overall","Attrition/leaving the study early",8,0,0,TRUE,TRUE,"OR_cc","default_or"
"CD009535_pub3_data","1::overall","1","overall","Cardiovascular death",2,0,0,TRUE,TRUE,"OR_cc","default_or"
"CD009535_pub3_data","2::overall","2","overall","All-cause death",9,0,1,TRUE,TRUE,"RD","sparse_events"
"CD009535_pub3_data","5::overall","5","overall","Kidney transplantation during study period",6,0,1,TRUE,TRUE,"RD","sparse_events"
"CD009609_pub3_data","2::overall","2","overall","Adverse events",4,0,2,TRUE,TRUE,"RD","sparse_events"
"CD009609_pub3_data","9::overall","9","overall","Need for treatment escalation",8,0,0,TRUE,TRUE,"OR_cc","default_or"
"CD009679_pub3_data","2::overall","2","overall","Patient-reported lower limb function (Hospital for Special Surgery (HSS) score)",54,8,32,TRUE,TRUE,"RD","double_zero"
"CD009679_pub3_data","3::overall","3","overall","WOMAC Pain score",9,6,8,TRUE,TRUE,"RD","double_zero"
"CD009679_pub3_data","4::overall","4","overall","WOMAC Stiffness score",34,9,30,TRUE,TRUE,"RD","double_zero"
"CD009679_pub3_data","6::overall","6","overall","Reoperation (24 months)",18,4,8,TRUE,TRUE,"RD","double_zero"
"CD009679_pub3_data","7::overall","7","overall","Radiological outcomes (postoperatively)",11,5,10,TRUE,TRUE,"RD","double_zero"
"CD009679_pub3_data","8::overall","8","overall","Radiological evidence of tibiofemoral joint osteoarthritis",8,6,6,TRUE,TRUE,"RD","double_zero"
"CD009679_pub3_data","11::overall","11","overall","Return to pre-injury activity level",3,0,0,TRUE,TRUE,"OR_cc","default_or"
"CD009730_pub3_data","1::overall","1","overall","FVC % predicted (relative change)",32,31,31,FALSE,TRUE,"RD","double_zero"
"CD009730_pub3_data","2::overall","2","overall","Weight (relative change)",28,24,24,TRUE,TRUE,"RD","double_zero"
"CD009730_pub3_data","3::overall","3","overall","Time to next pulmonary exacerbation (days) – colistin versus tobramycin (varying doses)",20,11,16,TRUE,TRUE,"RD","double_zero"
"CD009730_pub3_data","4::overall","4","overall","FVC % predicted (relative change)",13,12,13,FALSE,TRUE,"RD","double_zero"
"CD009730_pub3_data","5::overall","5","overall","Time to next exacerbation (weeks)",8,4,4,TRUE,TRUE,"RD","double_zero"
"CD009730_pub3_data","7::overall","7","overall","Adverse effects – sensitivity reaction",7,6,7,FALSE,TRUE,"RD","double_zero"
"CD009730_pub3_data","8::overall","8","overall","Adverse effects",14,8,11,TRUE,TRUE,"RD","double_zero"
"CD009730_pub3_data","10::overall","10","overall","Proportion readmitted, requiring IV antibiotics or death in subsequent 3 months",2,0,0,TRUE,TRUE,"OR_cc","default_or"
"CD009730_pub3_data","12::overall","12","overall","Mortality",3,1,3,TRUE,TRUE,"RD","double_zero"
"CD009730_pub3_data","13::overall","13","overall","Adverse effects",11,1,7,TRUE,TRUE,"RD","double_zero"
"CD009730_pub3_data","15::overall","15","overall","Antibiotic resistance – number of participants isolating resistant strains",5,1,1,TRUE,TRUE,"RD","double_zero"
"CD009749_pub3_data","1::overall","1","overall","Live birth/ongoing pregnancy rate - DHEA",11,0,3,TRUE,TRUE,"RD","sparse_events"
"CD009749_pub3_data","2::overall","2","overall","Live birth/ongoing pregnancy rate - T",12,0,2,TRUE,TRUE,"RD","sparse_events"
"CD009749_pub3_data","3::overall","3","overall","Miscarriage rate - DHEA",10,0,5,TRUE,TRUE,"RD","sparse_events"
"CD009749_pub3_data","4::overall","4","overall","Miscarriage rate - T",12,2,11,TRUE,TRUE,"RD","double_zero"
"CD009749_pub3_data","5::overall","5","overall","Clinical pregnancy rate - DHEA",13,0,1,TRUE,TRUE,"RD","sparse_events"
"CD009749_pub3_data","6::overall","6","overall","Clinical pregnancy rate - T",16,0,4,TRUE,TRUE,"RD","sparse_events"
"CD009749_pub3_data","7::overall","7","overall","Multiple pregnancy",11,6,11,TRUE,TRUE,"RD","double_zero"
"CD009749_pub3_data","8::overall","8","overall","Adverse effects to the woman",10,0,10,TRUE,TRUE,"RD","sparse_events"
"CD009749_pub3_data","9::overall","9","overall","Pregnancy complications",4,0,4,TRUE,TRUE,"RD","sparse_events"
"CD009749_pub3_data","10::overall","10","overall","Sensitivity analyses ",25,0,8,TRUE,TRUE,"RD","sparse_events"
"CD009752_pub3_data","1::overall","1","overall","All-cause mortality: short term (0 to 30 days post surgery)",10,6,8,TRUE,TRUE,"RD","double_zero"
"CD009752_pub3_data","2::overall","2","overall","All-cause mortality: long term (31 days to two years post-surgery)",7,4,6,TRUE,TRUE,"RD","double_zero"
"CD009752_pub3_data","3::overall","3","overall","Severe adverse events: cardiac events",6,2,3,TRUE,TRUE,"RD","double_zero"
"CD009752_pub3_data","4::overall","4","overall","Severe adverse events: acute lung injury",4,1,1,TRUE,TRUE,"RD","double_zero"
"CD009752_pub3_data","5::overall","5","overall","Severe adverse events: stroke",3,1,2,TRUE,TRUE,"RD","double_zero"
"CD009752_pub3_data","6::overall","6","overall","Severe adverse events: thromboembolism",2,0,1,TRUE,TRUE,"RD","sparse_events"
"CD009752_pub3_data","7::overall","7","overall","Severe adverse events: renal failure (needing renal replacement therapy) ",3,2,3,FALSE,TRUE,"RD","double_zero"
"CD009752_pub3_data","8::overall","8","overall","Severe adverse events: infection",3,1,1,TRUE,TRUE,"RD","double_zero"
"CD009752_pub3_data","9::overall","9","overall","Severe adverse events: haemorrhage (return to theatre for bleeding)",5,3,5,TRUE,TRUE,"RD","double_zero"
"CD009752_pub3_data","11::overall","11","overall","Number of participants receiving any red cell transfusion",3,1,1,TRUE,TRUE,"RD","double_zero"
"CD009752_pub3_data","12::overall","12","overall","Number of participants receiving any fresh frozen plasma ",3,1,2,TRUE,TRUE,"RD","double_zero"
"CD009752_pub3_data","13::overall","13","overall","Number of participants receiving any platelet transfusion",2,1,1,FALSE,TRUE,"RD","double_zero"
"CD009788_pub3_data","1::overall","1","overall","Service use: hospitalization",4,0,0,TRUE,TRUE,"OR_cc","default_or"
"CD009788_pub3_data","7::overall","7","overall","Service use: emergency care visits",2,0,1,TRUE,TRUE,"RD","sparse_events"
"CD009788_pub3_data","11::overall","11","overall","Leaving the study early",5,0,0,TRUE,TRUE,"OR_cc","default_or"
"CD009945_pub3_data","1::overall","1","overall","50% responder",3,0,0,TRUE,TRUE,"OR_cc","default_or"
"CD009945_pub3_data","2::overall","2","overall","Treatment withdrawal",3,0,2,TRUE,TRUE,"RD","sparse_events"
"CD010001_pub4_data","1::overall","1","overall","Live birth or ongoing pregnancy",38,0,0,TRUE,TRUE,"OR_cc","default_or"
"CD010001_pub4_data","2::overall","2","overall","Vasodilator side effects",43,25,27,TRUE,TRUE,"RD","double_zero"
"CD010001_pub4_data","3::overall","3","overall","Specific vasodilator side effects",53,1,7,TRUE,TRUE,"RD","double_zero"
"CD010001_pub4_data","4::overall","4","overall","Clinical pregnancy",53,25,25,TRUE,TRUE,"RD","double_zero"
"CD010001_pub4_data","5::overall","5","overall","Endometrial thickness",33,28,28,TRUE,TRUE,"RD","double_zero"
"CD010001_pub4_data","6::overall","6","overall","Other adverse effects",23,3,16,TRUE,TRUE,"RD","double_zero"
"CD010136_pub4_data","1::overall","1","overall","Swelling at 7 days",3,2,2,FALSE,TRUE,"RD","double_zero"
"CD010136_pub4_data","2::overall","2","overall","Number of participants who required ibuprofen",3,2,2,FALSE,TRUE,"RD","double_zero"
"CD010145_pub2_data","1::1","1","1","Quality of life via FACT (short term)",2,1,1,FALSE,TRUE,"RD","double_zero"
"CD010145_pub2_data","2::1","2","1","Change in quality of life after treatment via QLQ-C30 (short term)",9,1,2,TRUE,TRUE,"RD","double_zero"
"CD010145_pub2_data","3::1","3","1","Change in quality of life after treatment via QLI (short term)",6,1,1,TRUE,TRUE,"RD","double_zero"
"CD010145_pub2_data","4::1","4","1","Quality of life via FACT (intermediate term)",4,1,1,TRUE,TRUE,"RD","double_zero"
"CD010145_pub2_data","5::1","5","1","Change in sleep after treatment via PSQI (short term)",2,1,1,FALSE,TRUE,"RD","double_zero"
"CD010145_pub2_data","6::1","6","1","Adverse event (headache)",2,1,2,FALSE,TRUE,"RD","double_zero"
"CD010145_pub2_data","7::1","7","1","Adverse event (fatigue)",3,0,1,TRUE,TRUE,"RD","sparse_events"
"CD010145_pub2_data","8::1","8","1","Adverse event (nausea)",2,1,1,FALSE,TRUE,"RD","double_zero"
"CD010145_pub2_data","9::1","9","1","One-year survival rate",3,0,0,TRUE,TRUE,"OR_cc","default_or"
"CD010145_pub2_data","10::1","10","1","Two-year survival rate",3,1,1,TRUE,TRUE,"RD","double_zero"
"CD010145_pub2_data","11::1","11","1","Three-year survival rate",3,1,1,TRUE,TRUE,"RD","double_zero"
"CD010145_pub2_data","12::1","12","1","Two-year disease-free survival (DFS) rate",2,0,0,TRUE,TRUE,"OR_cc","default_or"
"CD010145_pub2_data","13::1","13","1","Five-year disease-free survival (DFS) rate",2,1,1,FALSE,TRUE,"RD","double_zero"
"CD010145_pub2_data","14::1","14","1","Tumour complete response rate (CR) (short term)",2,1,2,FALSE,TRUE,"RD","double_zero"
"CD010145_pub2_data","15::1","15","1","Tumour partial response rate (PR) (short term)",2,0,1,TRUE,TRUE,"RD","sparse_events"
"CD010145_pub2_data","16::1","16","1","Tumour stable disease rate (SD) (short term)",2,0,0,TRUE,TRUE,"OR_cc","default_or"
"CD010145_pub2_data","17::1","17","1","Tumour progressive disease rate (PD) (short term)",2,0,0,TRUE,TRUE,"OR_cc","default_or"
"CD010145_pub2_data","2::2","2","2","Adverse event (fatigue)",2,0,1,TRUE,TRUE,"RD","sparse_events"
"CD010145_pub2_data","6::2","6","2","Three-year survival rate",2,0,2,TRUE,TRUE,"RD","sparse_events"
"CD010145_pub2_data","18::overall","18","overall","(Additional table) CR until progression of the disease",14,5,12,TRUE,TRUE,"RD","double_zero"
"CD010145_pub2_data","19::overall","19","overall","(Additional table) PR until progression of the disease",14,1,1,TRUE,TRUE,"RD","double_zero"
"CD010145_pub2_data","20::overall","20","overall","(Additional table) SD until progression of the disease",12,0,0,TRUE,TRUE,"OR_cc","default_or"
"CD010145_pub2_data","21::overall","21","overall","(Additional table) PD until progression of the disease",12,0,0,TRUE,TRUE,"OR_cc","default_or"
"CD010145_pub2_data","22::1","22","1","One-year survival rate without Novik 2021",2,0,0,TRUE,TRUE,"OR_cc","default_or"
"CD010145_pub2_data","1::overall","1","overall","Adverse events (related to the study treatment)",3,0,1,TRUE,TRUE,"RD","sparse_events"
"CD010145_pub2_data","11::overall","11","overall","Incidence of dermatitis at least grade 3",2,1,1,FALSE,TRUE,"RD","double_zero"
"CD010163_pub3_data","1::overall","1","overall","Tumour response",2,0,0,TRUE,TRUE,"OR_cc","default_or"
"CD010163_pub3_data","3::overall","3","overall","Recurrence of liver metastases ",2,0,1,TRUE,TRUE,"RD","sparse_events"
"CD010216_pub9_data","1::overall","1","overall","Smoking cessation",45,2,6,TRUE,TRUE,"RD","double_zero"
"CD010216_pub9_data","2::overall","2","overall","Adverse events",32,5,5,TRUE,TRUE,"RD","double_zero"
"CD010216_pub9_data","3::overall","3","overall","Serious adverse events",43,20,23,TRUE,TRUE,"RD","double_zero"
"CD010216_pub9_data","4::overall","4","overall","Carbon monoxide (ppm)",30,29,29,FALSE,TRUE,"RD","double_zero"
"CD010216_pub9_data","8::overall","8","overall","3-HPMA (pmol/mg creatinine)",6,5,6,FALSE,TRUE,"RD","double_zero"
"CD010216_pub9_data","11::overall","11","overall","HMPMA (pmol/mg creatinine)",7,3,3,TRUE,TRUE,"RD","double_zero"
"CD010216_pub9_data","12::overall","12","overall","PheT (pmol/mg creatinine)",3,2,2,FALSE,TRUE,"RD","double_zero"
"CD010216_pub9_data","18::overall","18","overall","Product use at 6+ months",7,1,1,TRUE,TRUE,"RD","double_zero"
"CD010290_pub4_data","1::overall","1","overall","Live birth rate per woman by urinary gonadotropins",9,0,2,TRUE,TRUE,"RD","sparse_events"
"CD010290_pub4_data","2::overall","2","overall","Live birth rate per woman by sponsor",10,2,4,TRUE,TRUE,"RD","double_zero"
"CD010290_pub4_data","3::overall","3","overall","Multiple pregnancy per woman by urinary gonadotropins",13,1,6,TRUE,TRUE,"RD","double_zero"
"CD010290_pub4_data","4::overall","4","overall","Multiple pregnancy per woman by sponsor",13,3,7,TRUE,TRUE,"RD","double_zero"
"CD010290_pub4_data","5::overall","5","overall","Clinical pregnancy rate per woman by urinary gonadotropins",11,0,2,TRUE,TRUE,"RD","sparse_events"
"CD010290_pub4_data","6::overall","6","overall","Multiple pregnancy per clinical pregnancy by urinary gonadotropins",11,2,6,TRUE,TRUE,"RD","double_zero"
"CD010290_pub4_data","7::overall","7","overall","Miscarriage rate per woman by urinary gonadotropins",10,0,4,TRUE,TRUE,"RD","sparse_events"
"CD010290_pub4_data","8::overall","8","overall","Ectopic pregnancy ",4,1,2,TRUE,TRUE,"RD","double_zero"
"CD010290_pub4_data","9::overall","9","overall","Incidence of OHSS per woman by urinary gonadotropins",14,6,11,TRUE,TRUE,"RD","double_zero"
"CD010290_pub4_data","10::overall","10","overall","Total gonadotrophin dose per woman (IU) by urinary gonadotropins",10,8,9,TRUE,TRUE,"RD","double_zero"
"CD010290_pub4_data","11::overall","11","overall","Total duration of stimulation per woman (days) by urinary gonadotropins",7,6,6,FALSE,TRUE,"RD","double_zero"
"CD010290_pub4_data","12::overall","12","overall","Sensitivity analysis: live birth rate per woman - low risk studies",3,0,0,TRUE,TRUE,"OR_cc","default_or"
"CD010290_pub4_data","13::overall","13","overall","Sensitivity analysis: live birth rate per woman - random effects model",6,0,1,TRUE,TRUE,"RD","sparse_events"
"CD010290_pub4_data","14::overall","14","overall","Sensitivity analysis: live birth rate per woman - odds ratio",5,0,1,TRUE,TRUE,"RD","sparse_events"
"CD010290_pub4_data","15::overall","15","overall","Sensitivity analysis: multiple pregnancy per woman - low risk studies",4,0,2,TRUE,TRUE,"RD","sparse_events"
"CD010290_pub4_data","16::overall","16","overall","Sensitivity analysis: multiple pregnancy per woman - random effects model",8,1,4,TRUE,TRUE,"RD","double_zero"
"CD010290_pub4_data","17::overall","17","overall","Sensitivity analysis: multiple pregnancy per woman - odds ratio",8,1,4,TRUE,TRUE,"RD","double_zero"
"CD010441_pub3_data","1::overall","1","overall","Incidence of perineal trauma (tears or episiotomy or both)",6,0,0,TRUE,TRUE,"OR_cc","default_or"
"CD010441_pub3_data","2::overall","2","overall","Incidence of episiotomy",6,0,0,TRUE,TRUE,"OR_cc","default_or"
"CD010441_pub3_data","3::overall","3","overall","Incidence of first and second degree perineal lacerations",6,0,0,TRUE,TRUE,"OR_cc","default_or"
"CD010441_pub3_data","4::overall","4","overall","Incidence of third and fourth degree perineal trauma",6,4,5,TRUE,TRUE,"RD","double_zero"
"CD010441_pub3_data","5::overall","5","overall","Incidence of perineal oedema 1 hour after vaginal delivery",3,0,1,TRUE,TRUE,"RD","sparse_events"
"CD010441_pub3_data","6::overall","6","overall","Incidence of perineal oedema 24 hours after vaginal delivery",3,1,1,TRUE,TRUE,"RD","double_zero"
"CD010441_pub3_data","7::overall","7","overall","Incidence of neonatal Apgar scores less than 7 at five minutes",2,1,2,FALSE,TRUE,"RD","double_zero"
"CD010533_pub3_data","1::overall","1","overall","Overall survival (OS)",22,20,21,TRUE,TRUE,"RD","double_zero"
"CD010533_pub3_data","3::overall","3","overall","Treatment-related mortality",17,1,9,TRUE,TRUE,"RD","double_zero"
"CD010533_pub3_data","4::overall","4","overall","Incidence of second primary malignancy",10,0,0,TRUE,TRUE,"OR_cc","default_or"
"CD010533_pub3_data","5::overall","5","overall","Incidence of second primary malignancy",10,0,0,TRUE,TRUE,"OR_cc","default_or"
"CD010533_pub3_data","7::overall","7","overall","Incidence of secondary malignancy",2,1,1,FALSE,TRUE,"RD","double_zero"
"CD010583_pub6_data","1::1","1","1","Mortality (30 days)",6,1,4,TRUE,TRUE,"RD","double_zero"
"CD010583_pub6_data","1::2","1","2","Mortality (30 days)",3,1,3,TRUE,TRUE,"RD","double_zero"
"CD010583_pub6_data","2::1","2","1","Mortality (90 days)",6,0,1,TRUE,TRUE,"RD","sparse_events"
"CD010583_pub6_data","3::1","3","1","Intra-abdominal infection",6,0,1,TRUE,TRUE,"RD","sparse_events"
"CD010583_pub6_data","3::2","3","2","Intra-abdominal infection",3,0,0,TRUE,TRUE,"OR_cc","default_or"
"CD010583_pub6_data","5::overall","5","overall","Morbidity",10,8,8,TRUE,TRUE,"RD","double_zero"
"CD010583_pub6_data","6::overall","6","overall","Length of hospital stay (days)",9,4,5,TRUE,TRUE,"RD","double_zero"
"CD010583_pub6_data","7::overall","7","overall","Additional open procedures for postoperative complications",8,0,2,TRUE,TRUE,"RD","sparse_events"
"CD010583_pub6_data","8::overall","8","overall","Additional radiological interventions for postoperative complications",4,0,0,TRUE,TRUE,"OR_cc","default_or"
"CD010583_pub6_data","4::overall","4","overall","Morbidity",6,0,0,TRUE,TRUE,"OR_cc","default_or"
"CD010583_pub6_data","2::2","2","2","Intra-abdominal infection",2,0,0,TRUE,TRUE,"OR_cc","default_or"
"CD010861_pub3_data","1::overall","1","overall","Maternal mortality",18,15,17,TRUE,TRUE,"RD","double_zero"
"CD010861_pub3_data","2::overall","2","overall","Fatigue 0-7 days",12,10,10,TRUE,TRUE,"RD","double_zero"
"CD010861_pub3_data","3::overall","3","overall","Fatigue 8-28 days",17,15,15,TRUE,TRUE,"RD","double_zero"
"CD010861_pub3_data","4::overall","4","overall","Fatigue > 28 days",5,4,4,FALSE,TRUE,"RD","double_zero"
"CD010861_pub3_data","5::overall","5","overall","Psychological wellbeing",6,3,3,TRUE,TRUE,"RD","double_zero"
"CD010861_pub3_data","6::overall","6","overall","Infection",9,2,4,TRUE,TRUE,"RD","double_zero"
"CD010861_pub3_data","7::overall","7","overall","Compliance to treatment",14,4,7,TRUE,TRUE,"RD","double_zero"
"CD010861_pub3_data","8::overall","8","overall","Serious adverse events",4,2,2,TRUE,TRUE,"RD","double_zero"
"CD010861_pub3_data","9::overall","9","overall","Anaphylaxis or evidence of hypersensitivity",12,10,12,TRUE,TRUE,"RD","double_zero"
"CD010861_pub3_data","10::overall","10","overall","Flushing/Fishbane reaction",5,1,5,TRUE,TRUE,"RD","double_zero"
"CD010861_pub3_data","11::overall","11","overall","Injection site discomfort / reaction",6,1,3,TRUE,TRUE,"RD","double_zero"
"CD010861_pub3_data","12::overall","12","overall","Constipation",10,1,3,TRUE,TRUE,"RD","double_zero"
"CD010861_pub3_data","13::overall","13","overall","Nausea",8,1,3,TRUE,TRUE,"RD","double_zero"
"CD010861_pub3_data","14::overall","14","overall","Gastrointestinal pain",5,1,4,TRUE,TRUE,"RD","double_zero"
"CD010861_pub3_data","15::overall","15","overall","Number of RBC transfused women",5,0,5,TRUE,TRUE,"RD","sparse_events"
"CD010966_pub4_data","1::overall","1","overall","FEV1 % predicted (absolute change from baseline)",65,55,65,TRUE,TRUE,"RD","double_zero"
"CD010966_pub4_data","2::overall","2","overall","Adverse effects: 100 mg and 200 mg lumacaftor groups (combined data) versus placebo at up to 1 month",141,44,107,TRUE,TRUE,"RD","double_zero"
"CD010966_pub4_data","3::overall","3","overall","Adverse effects: 200 mg lumacaftor group versus placebo at up to 1 month",121,50,103,TRUE,TRUE,"RD","double_zero"
"CD010966_pub4_data","4::overall","4","overall","Adverse effects requiring study drug discontinuation at up to 1 month",451,72,379,TRUE,TRUE,"RD","double_zero"
"CD010966_pub4_data","5::overall","5","overall","Sweat chloride concentration (change from baseline at up to 1 month) [mmol/L]",112,45,91,TRUE,TRUE,"RD","double_zero"
"CD010966_pub4_data","6::overall","6","overall","Sweat chloride concentration (change from baseline)",191,5,19,TRUE,TRUE,"RD","double_zero"
"CD010966_pub4_data","7::overall","7","overall","Absolute change from baseline in stature-for-age z score ",14,13,13,FALSE,TRUE,"RD","double_zero"
"CD010966_pub4_data","8::overall","8","overall","Rate of exacerbations",15,14,14,FALSE,TRUE,"RD","double_zero"
"CD010966_pub4_data","16::overall","16","overall","Most common adverse events (occurring in at least 10% of participants in either group)",69,1,23,TRUE,TRUE,"RD","double_zero"
"CD011039_pub2_data","1::overall","1","overall","All-cause mortality",2,0,0,TRUE,TRUE,"OR_cc","default_or"
"CD011039_pub2_data","2::overall","2","overall","Morbidity due to any cause",2,0,0,TRUE,TRUE,"OR_cc","default_or"
"CD011039_pub2_data","3::overall","3","overall","Morbidity (by type)",5,0,0,TRUE,TRUE,"OR_cc","default_or"
"CD011039_pub2_data","4::overall","4","overall","Serious adverse events",2,0,0,TRUE,TRUE,"OR_cc","default_or"
"CD011039_pub2_data","5::overall","5","overall","Serious adverse events (by type)",5,0,2,TRUE,TRUE,"RD","sparse_events"
"CD011039_pub2_data","6::overall","6","overall","Participants who did not receive a liver transplant",2,0,0,TRUE,TRUE,"OR_cc","default_or"
"CD011044_pub3_data","3::overall","3","overall","Degradation of QoL at 6 months",38,0,4,TRUE,TRUE,"RD","sparse_events"
"CD011044_pub3_data","4::overall","4","overall","Response rates",41,0,7,TRUE,TRUE,"RD","sparse_events"
"CD011044_pub3_data","5::overall","5","overall","Grade 3/4 anaemia",41,0,5,TRUE,TRUE,"RD","sparse_events"
"CD011044_pub3_data","6::overall","6","overall","Grade 3/4 neutropenia",39,1,7,TRUE,TRUE,"RD","double_zero"
"CD011044_pub3_data","7::overall","7","overall","Grade 3/4 thrombocytopaenia",36,1,11,TRUE,TRUE,"RD","double_zero"
"CD011044_pub3_data","8::overall","8","overall","Grade 3/4 nausea",33,0,12,TRUE,TRUE,"RD","sparse_events"
"CD011044_pub3_data","9::overall","9","overall","Grade 3/4 diarrhoea",15,2,5,TRUE,TRUE,"RD","double_zero"
"CD011044_pub3_data","10::overall","10","overall","Grade 3/4 neuropathy",9,1,1,TRUE,TRUE,"RD","double_zero"
"CD011120_pub3_data","1::overall","1","overall","Tobacco use cessation",19,0,3,TRUE,TRUE,"RD","sparse_events"
"CD011120_pub3_data","2::overall","2","overall","Quit attempts",5,0,0,TRUE,TRUE,"OR_cc","default_or"
"CD011120_pub3_data","3::overall","3","overall","All-cause mortality",3,0,0,TRUE,TRUE,"OR_cc","default_or"
"CD011197_pub3_data","1::overall","1","overall","Mortality",9,6,8,TRUE,TRUE,"RD","double_zero"
"CD011197_pub3_data","2::overall","2","overall","Serious adverse events",10,4,9,TRUE,TRUE,"RD","double_zero"
"CD011197_pub3_data","3::overall","3","overall","AF recurrence",4,0,0,TRUE,TRUE,"OR_cc","default_or"
"CD011204_pub3_data","1::overall","1","overall","Cognitive function, assessed with ADAS-cog: change from baseline at 3 months",84,32,36,TRUE,TRUE,"RD","double_zero"
"CD011204_pub3_data","2::overall","2","overall","Cognitive function, assessed with ADAS-cog, change from baseline at 6 months",132,42,50,TRUE,TRUE,"RD","double_zero"
"CD011204_pub3_data","3::overall","3","overall","Global rating, no change or improvement, galantamine 24 to 32 mg/day",30,1,2,TRUE,TRUE,"RD","double_zero"
"CD011204_pub3_data","4::overall","4","overall","Global rating, no change or improvement, galantamine 32 to 36 mg/day",22,1,5,TRUE,TRUE,"RD","double_zero"
"CD011204_pub3_data","5::overall","5","overall","Global rating, no change or improvement, galantamine 32 to 36 mg/day",18,0,1,TRUE,TRUE,"RD","sparse_events"
"CD011204_pub3_data","6::overall","6","overall","Proportion of participants experiencing somnolence",8,0,0,TRUE,TRUE,"OR_cc","default_or"
"CD011204_pub3_data","7::overall","7","overall","Proportion of participants experiencing abdominal pain",4,0,0,TRUE,TRUE,"OR_cc","default_or"
"CD011204_pub3_data","8::overall","8","overall","Proportion of participants experiencing decreased appetite",5,0,1,TRUE,TRUE,"RD","sparse_events"
"CD011204_pub3_data","9::overall","9","overall","Proportion of participants experiencing agitation",7,0,0,TRUE,TRUE,"OR_cc","default_or"
"CD011204_pub3_data","10::overall","10","overall","Proportion of participants experiencing headache",10,0,0,TRUE,TRUE,"OR_cc","default_or"
"CD011218_pub2_data","1::overall","1","overall","Frequency of wearing a seat belt (Fernandez 2008)",9,6,6,TRUE,TRUE,"RD","double_zero"
"CD011218_pub2_data","3::overall","3","overall","Frequency of wearing a seat belt (Johnston 2002)",2,0,0,TRUE,TRUE,"OR_cc","default_or"
"CD011305_pub3_data","2::overall","2","overall","All-cause mortality at 8 to 30 days",4,1,4,TRUE,TRUE,"RD","double_zero"
"CD011305_pub3_data","3::overall","3","overall","All-cause mortality at 31 to 100 days",5,2,4,TRUE,TRUE,"RD","double_zero"
"CD011305_pub3_data","4::overall","4","overall","Death due to infection (0 to 3 months)",3,1,3,TRUE,TRUE,"RD","double_zero"
"CD011305_pub3_data","6::overall","6","overall","Chemotherapy-related mortality (0 to 30 days)",3,0,3,TRUE,TRUE,"RD","sparse_events"
"CD011305_pub3_data","7::overall","7","overall","Transplant-related mortality (0 to 30 days)",2,1,2,FALSE,TRUE,"RD","double_zero"
"CD011305_pub3_data","8::overall","8","overall","Any bleeding - WHO/CTCAE grade ≥ 1 or equivalent (0 to 3 months)",3,0,0,TRUE,TRUE,"OR_cc","default_or"
"CD011305_pub3_data","9::overall","9","overall","Clinically significant bleeding - WHO/CTCAE grade ≥ 2 or equivalent (0 to 3 months)",5,0,2,TRUE,TRUE,"RD","sparse_events"
"CD011305_pub3_data","10::overall","10","overall","Severe bleeding - WHO/CTCAE grade ≥ 3 or equivalent (0 to 3 months)",5,0,3,TRUE,TRUE,"RD","sparse_events"
"CD011305_pub3_data","11::overall","11","overall","Adverse transfusion reactions (0 to 3 months)",3,0,0,TRUE,TRUE,"OR_cc","default_or"
"CD011305_pub3_data","12::overall","12","overall","Serious infectious episodes (0 to 3 months)",4,0,0,TRUE,TRUE,"OR_cc","default_or"
"CD011305_pub3_data","14::overall","14","overall","Number of participants with VOD (0 to 3 months)",2,0,1,TRUE,TRUE,"RD","sparse_events"
"CD011305_pub3_data","17::overall","17","overall","Number of participants with PLT transfusions from study entry (0 to 3 months)",4,0,0,TRUE,TRUE,"OR_cc","default_or"
"CD011330_pub2_data","2::1","2","1","Menopausal side effects",2,1,1,FALSE,TRUE,"RD","double_zero"
"CD011330_pub2_data","2::2","2","2","Menopausal side effects",2,0,2,TRUE,TRUE,"RD","sparse_events"
"CD011330_pub2_data","3::1","3","1","Withdrawal due to adverse events",3,2,3,FALSE,TRUE,"RD","double_zero"
"CD011330_pub2_data","3::3","3","3","Withdrawal due to adverse events",2,0,2,TRUE,TRUE,"RD","sparse_events"
"CD011381_pub3_data","1::overall","1","overall","Comparisons for relapse (12 months) ",70,0,6,TRUE,TRUE,"RD","sparse_events"
"CD011381_pub3_data","2::overall","2","overall","Comparisons for relapse (24 months)",83,0,2,TRUE,TRUE,"RD","sparse_events"
"CD011381_pub3_data","3::overall","3","overall","Comparisons for relapse (36 months)",12,0,0,TRUE,TRUE,"OR_cc","default_or"
"CD011381_pub3_data","4::overall","4","overall","Comparisons for disability worsening (24 months)",45,0,0,TRUE,TRUE,"OR_cc","default_or"
"CD011381_pub3_data","5::overall","5","overall","Comparisons for disability worsening (36 months)",4,1,1,TRUE,TRUE,"RD","double_zero"
"CD011381_pub3_data","11::overall","11","overall","Mortality",32,0,30,TRUE,TRUE,"RD","sparse_events"
"CD011468_pub2_data","1::overall","1","overall","Secondary patency",5,2,3,TRUE,TRUE,"RD","double_zero"
"CD011468_pub2_data","2::overall","2","overall","Secondary patency",2,0,0,TRUE,TRUE,"OR_cc","default_or"
"CD011535_pub7_data","1::3","1","3","Non-targeted treatments versus placebo",14,0,0,TRUE,TRUE,"OR_cc","default_or"
"CD011535_pub7_data","1::4","1","4","Non-targeted treatments versus placebo",16,2,4,TRUE,TRUE,"RD","double_zero"
"CD011535_pub7_data","2::overall","2","overall","Ciclosporin versus methotrexate",15,3,3,TRUE,TRUE,"RD","double_zero"
"CD011535_pub7_data","3::overall","3","overall","Fumaric acid esters versus methotrexate",9,1,3,TRUE,TRUE,"RD","double_zero"
"CD011535_pub7_data","4::1","4","1","Anti-TNF alpha versus placebo",48,0,3,TRUE,TRUE,"RD","sparse_events"
"CD011535_pub7_data","4::2","4","2","Anti-TNF alpha versus placebo",25,0,1,TRUE,TRUE,"RD","sparse_events"
"CD011535_pub7_data","4::3","4","3","Anti-TNF alpha versus placebo",67,1,6,TRUE,TRUE,"RD","double_zero"
"CD011535_pub7_data","4::4","4","4","Anti-TNF alpha versus placebo",24,1,3,TRUE,TRUE,"RD","double_zero"
"CD011535_pub7_data","4::overall","4","overall","Anti-TNF alpha versus placebo",5,0,0,TRUE,TRUE,"OR_cc","default_or"
"CD011535_pub7_data","5::overall","5","overall","Anti-IL12/23 versus placebo",59,1,4,TRUE,TRUE,"RD","double_zero"
"CD011535_pub7_data","6::1","6","1","Anti-IL17 versus placebo",16,0,1,TRUE,TRUE,"RD","sparse_events"
"CD011535_pub7_data","6::2","6","2","Anti-IL17 versus placebo",29,0,2,TRUE,TRUE,"RD","sparse_events"
"CD011535_pub7_data","6::3","6","3","Anti-IL17 versus placebo",25,0,1,TRUE,TRUE,"RD","sparse_events"
"CD011535_pub7_data","6::4","6","4","Anti-IL17 versus placebo",5,0,1,TRUE,TRUE,"RD","sparse_events"
"CD011535_pub7_data","6::5","6","5","Anti-IL17 versus placebo",10,1,2,TRUE,TRUE,"RD","double_zero"
"CD011535_pub7_data","6::6","6","6","Anti-IL17 versus placebo",82,0,8,TRUE,TRUE,"RD","sparse_events"
"CD011535_pub7_data","6::7","6","7","Anti-IL17 versus placebo",5,0,0,TRUE,TRUE,"OR_cc","default_or"
"CD011535_pub7_data","6::8","6","8","Anti-IL17 versus placebo",5,0,1,TRUE,TRUE,"RD","sparse_events"
"CD011535_pub7_data","6::overall","6","overall","Anti-IL17 versus placebo",5,0,0,TRUE,TRUE,"OR_cc","default_or"
"CD011535_pub7_data","7::1","7","1","Anti-IL23 versus placebo",25,0,3,TRUE,TRUE,"RD","sparse_events"
"CD011535_pub7_data","7::2","7","2","Anti-IL23 versus placebo",10,0,2,TRUE,TRUE,"RD","sparse_events"
"CD011535_pub7_data","7::3","7","3","Anti-IL23 versus placebo",32,0,2,TRUE,TRUE,"RD","sparse_events"
"CD011535_pub7_data","7::4","7","4","Anti-IL23 versus placebo",25,0,3,TRUE,TRUE,"RD","sparse_events"
"CD011535_pub7_data","8::3","8","3","Biologics versus non-targeted treatements",5,0,1,TRUE,TRUE,"RD","sparse_events"
"CD011535_pub7_data","8::5","8","5","Biologics versus non-targeted treatements",5,0,1,TRUE,TRUE,"RD","sparse_events"
"CD011535_pub7_data","8::7","8","7","Biologics versus non-targeted treatements",12,2,5,TRUE,TRUE,"RD","double_zero"
"CD011535_pub7_data","8::11","8","11","Biologics versus non-targeted treatements",4,0,0,TRUE,TRUE,"OR_cc","default_or"
"CD011535_pub7_data","8::15","8","15","Biologics versus non-targeted treatements",5,0,0,TRUE,TRUE,"OR_cc","default_or"
"CD011535_pub7_data","8::17","8","17","Biologics versus non-targeted treatements",5,0,1,TRUE,TRUE,"RD","sparse_events"
"CD011535_pub7_data","8::18","8","18","Biologics versus non-targeted treatements",5,0,1,TRUE,TRUE,"RD","sparse_events"
"CD011535_pub7_data","8::20","8","20","Biologics versus non-targeted treatements",5,0,1,TRUE,TRUE,"RD","sparse_events"
"CD011535_pub7_data","8::21","8","21","Biologics versus non-targeted treatements",5,0,0,TRUE,TRUE,"OR_cc","default_or"
"CD011535_pub7_data","8::23","8","23","Biologics versus non-targeted treatements",5,0,0,TRUE,TRUE,"OR_cc","default_or"
"CD011535_pub7_data","8::overall","8","overall","Biologics versus non-targeted treatements",5,0,0,TRUE,TRUE,"OR_cc","default_or"
"CD011535_pub7_data","9::2","9","2","Etanercept versus other anti-TNF alpha",5,0,0,TRUE,TRUE,"OR_cc","default_or"
"CD011535_pub7_data","9::3","9","3","Etanercept versus other anti-TNF alpha",5,0,1,TRUE,TRUE,"RD","sparse_events"
"CD011535_pub7_data","10::1","10","1","Anti-TNF alpha versus other biologics",5,0,0,TRUE,TRUE,"OR_cc","default_or"
"CD011535_pub7_data","10::2","10","2","Anti-TNF alpha versus other biologics",15,0,1,TRUE,TRUE,"RD","sparse_events"
"CD011535_pub7_data","10::3","10","3","Anti-TNF alpha versus other biologics",2,0,0,TRUE,TRUE,"OR_cc","default_or"
"CD011535_pub7_data","10::4","10","4","Anti-TNF alpha versus other biologics",5,0,0,TRUE,TRUE,"OR_cc","default_or"
"CD011535_pub7_data","10::15","10","15","Anti-TNF alpha versus other biologics",10,0,0,TRUE,TRUE,"OR_cc","default_or"
"CD011535_pub7_data","10::17","10","17","Anti-TNF alpha versus other biologics",5,0,0,TRUE,TRUE,"OR_cc","default_or"
"CD011535_pub7_data","10::18","10","18","Anti-TNF alpha versus other biologics",5,0,0,TRUE,TRUE,"OR_cc","default_or"
"CD011535_pub7_data","11::1","11","1","Anti-IL12/23 versus other biologics",5,0,0,TRUE,TRUE,"OR_cc","default_or"
"CD011535_pub7_data","11::2","11","2","Anti-IL12/23 versus other biologics",10,0,0,TRUE,TRUE,"OR_cc","default_or"
"CD011535_pub7_data","11::3","11","3","Anti-IL12/23 versus other biologics",5,0,0,TRUE,TRUE,"OR_cc","default_or"
"CD011535_pub7_data","11::4","11","4","Anti-IL12/23 versus other biologics",5,0,0,TRUE,TRUE,"OR_cc","default_or"
"CD011535_pub7_data","11::5","11","5","Anti-IL12/23 versus other biologics",15,0,0,TRUE,TRUE,"OR_cc","default_or"
"CD011535_pub7_data","11::6","11","6","Anti-IL12/23 versus other biologics",10,0,0,TRUE,TRUE,"OR_cc","default_or"
"CD011535_pub7_data","12::6","12","6","Anti-IL17 versus other biologics",4,0,0,TRUE,TRUE,"OR_cc","default_or"
"CD011535_pub7_data","12::9","12","9","Anti-IL17 versus other biologics",3,0,0,TRUE,TRUE,"OR_cc","default_or"
"CD011535_pub7_data","12::10","12","10","Anti-IL17 versus other biologics",3,0,0,TRUE,TRUE,"OR_cc","default_or"
"CD011535_pub7_data","12::11","12","11","Anti-IL17 versus other biologics",5,0,0,TRUE,TRUE,"OR_cc","default_or"
"CD011535_pub7_data","12::12","12","12","Anti-IL17 versus other biologics",5,0,0,TRUE,TRUE,"OR_cc","default_or"
"CD011535_pub7_data","13::1","13","1","Phosphodiesterase-4 inhibitors versus placebo",15,0,0,TRUE,TRUE,"OR_cc","default_or"
"CD011535_pub7_data","13::2","13","2","Phosphodiesterase-4 inhibitors versus placebo",3,0,0,TRUE,TRUE,"OR_cc","default_or"
"CD011535_pub7_data","13::3","13","3","Phosphodiesterase-4 inhibitors versus placebo",2,0,1,TRUE,TRUE,"RD","sparse_events"
"CD011535_pub7_data","14::1","14","1","TYK-2 inhibitors versus placebo",34,0,4,TRUE,TRUE,"RD","sparse_events"
"CD011535_pub7_data","14::2","14","2","TYK-2 inhibitors versus placebo",8,0,2,TRUE,TRUE,"RD","sparse_events"
"CD011535_pub7_data","15::1","15","1","Apremilast versus other systemic treatements",16,0,1,TRUE,TRUE,"RD","sparse_events"
"CD011535_pub7_data","15::2","15","2","Apremilast versus other systemic treatements",5,0,1,TRUE,TRUE,"RD","sparse_events"
"CD011535_pub7_data","15::4","15","4","Apremilast versus other systemic treatements",2,0,0,TRUE,TRUE,"OR_cc","default_or"
"CD011535_pub7_data","1::2","1","2","Non-targeted treatments versus placebo",8,0,0,TRUE,TRUE,"OR_cc","default_or"
"CD011535_pub7_data","12::2","12","2","Anti-IL17 versus other biologics",2,0,0,TRUE,TRUE,"OR_cc","default_or"
"CD011535_pub7_data","13::overall","13","overall","Ixekizumab versus secukinumab",3,1,1,TRUE,TRUE,"RD","double_zero"
"CD011535_pub7_data","14::3","14","3","Phosphodiesterase-4 inhibitors versus placebo",3,1,1,TRUE,TRUE,"RD","double_zero"
"CD011535_pub7_data","16::1","16","1","Apremilast versus other systemic treatements",6,0,0,TRUE,TRUE,"OR_cc","default_or"
"CD011535_pub7_data","16::2","16","2","Apremilast versus other systemic treatements",3,0,0,TRUE,TRUE,"OR_cc","default_or"
"CD011535_pub7_data","16::3","16","3","Apremilast versus other systemic treatements",2,1,2,FALSE,TRUE,"RD","double_zero"
"CD011535_pub7_data","16::4","16","4","Apremilast versus other systemic treatements",3,0,0,TRUE,TRUE,"OR_cc","default_or"
"CD011535_pub7_data","1::1","1","1","Non-targeted treatments versus placebo",5,0,0,TRUE,TRUE,"OR_cc","default_or"
"CD011535_pub7_data","15::3","15","3","Apremilast versus other systemic treatements",3,0,0,TRUE,TRUE,"OR_cc","default_or"
"CD011535_pub7_data","1::5","1","5","Biologic 1 versus biologic 2",2,0,0,TRUE,TRUE,"OR_cc","default_or"
"CD011535_pub7_data","1::6","1","6","Biologic 1 versus biologic 2",2,0,0,TRUE,TRUE,"OR_cc","default_or"
"CD011535_pub7_data","1::7","1","7","Biologic 1 versus biologic 2",2,0,0,TRUE,TRUE,"OR_cc","default_or"
"CD011535_pub7_data","1::8","1","8","Biologic 1 versus biologic 2",2,0,0,TRUE,TRUE,"OR_cc","default_or"
"CD011535_pub7_data","1::9","1","9","Biologic 1 versus biologic 2",4,0,0,TRUE,TRUE,"OR_cc","default_or"
"CD011535_pub7_data","1::10","1","10","Biologic 1 versus biologic 2",4,0,0,TRUE,TRUE,"OR_cc","default_or"
"CD011535_pub7_data","1::11","1","11","Biologic 1 versus biologic 2",2,0,0,TRUE,TRUE,"OR_cc","default_or"
"CD011535_pub7_data","1::12","1","12","Biologic 1 versus biologic 2",2,0,0,TRUE,TRUE,"OR_cc","default_or"
"CD011535_pub7_data","2::1","2","1","Small molecule 1 versus small molecule 2",2,0,0,TRUE,TRUE,"OR_cc","default_or"
"CD011575_pub3_data","1::overall","1","overall","All-cause mortality",4,0,0,TRUE,TRUE,"OR_cc","default_or"
"CD011575_pub3_data","2::overall","2","overall","Stroke",4,0,0,TRUE,TRUE,"OR_cc","default_or"
"CD011575_pub3_data","3::overall","3","overall","Serious cardiovascular adverse events",4,0,0,TRUE,TRUE,"OR_cc","default_or"
"CD011575_pub3_data","4::overall","4","overall","Cardiovascular mortality",4,0,0,TRUE,TRUE,"OR_cc","default_or"
"CD011575_pub3_data","5::overall","5","overall","Non-cardiovascular mortality",4,0,0,TRUE,TRUE,"OR_cc","default_or"
"CD011575_pub3_data","6::overall","6","overall","Myocardial infarction/acute coronary syndrome",4,0,0,TRUE,TRUE,"OR_cc","default_or"
"CD011575_pub3_data","7::overall","7","overall","Heart failure (decompensation/hospitalisation/death)",3,0,0,TRUE,TRUE,"OR_cc","default_or"
"CD011575_pub3_data","8::overall","8","overall","Renal failure",3,0,0,TRUE,TRUE,"OR_cc","default_or"
"CD011575_pub3_data","10::overall","10","overall","Total minor adverse events",2,0,0,TRUE,TRUE,"OR_cc","default_or"
"CD011575_pub3_data","11::overall","11","overall","Withdrawals due to adverse effects",3,0,0,TRUE,TRUE,"OR_cc","default_or"
"CD011575_pub3_data","14::overall","14","overall","All-cause mortality (excluding Wei)",3,0,0,TRUE,TRUE,"OR_cc","default_or"
"CD011575_pub3_data","15::overall","15","overall","Stroke (excluding Wei)",3,0,0,TRUE,TRUE,"OR_cc","default_or"
"CD011575_pub3_data","16::overall","16","overall","Serious cardiovascular adverse events (excluding Wei)",3,0,0,TRUE,TRUE,"OR_cc","default_or"
"CD011575_pub3_data","17::overall","17","overall","Cardiovascular mortality (excluding Wei)",3,0,0,TRUE,TRUE,"OR_cc","default_or"
"CD011575_pub3_data","18::overall","18","overall","All-cause mortality (excluding JATOS)",3,0,0,TRUE,TRUE,"OR_cc","default_or"
"CD011575_pub3_data","19::overall","19","overall","Serious cardioavascular adverse events (excluding JATOS)",3,0,0,TRUE,TRUE,"OR_cc","default_or"
"CD011575_pub3_data","20::overall","20","overall","Stroke (excluding JATOS)",3,0,0,TRUE,TRUE,"OR_cc","default_or"
"CD011575_pub3_data","21::overall","21","overall","Cardiovascular mortality (excluding JATOS)",3,0,0,TRUE,TRUE,"OR_cc","default_or"
"CD011600_pub3_data","3::overall","3","overall","Moderate-to-severe exacerbations (≥ 1 exacerbation)",5,0,0,TRUE,TRUE,"OR_cc","default_or"
"CD011600_pub3_data","10::overall","10","overall","SGRQ, ≥ 4 decrease from baseline",7,0,0,TRUE,TRUE,"OR_cc","default_or"
"CD011600_pub3_data","12::overall","12","overall","Pneumonia",9,0,0,TRUE,TRUE,"OR_cc","default_or"
"CD011600_pub3_data","14::overall","14","overall","Serious adverse events, pneumonia",9,0,0,TRUE,TRUE,"OR_cc","default_or"
"CD011600_pub3_data","15::overall","15","overall","Serious adverse event, all-cause",9,0,0,TRUE,TRUE,"OR_cc","default_or"
"CD011600_pub3_data","23::overall","23","overall","Death, all causes",9,0,0,TRUE,TRUE,"OR_cc","default_or"
"CD011600_pub3_data","25::overall","25","overall","Death, cardiovascular causes",8,0,2,TRUE,TRUE,"RD","sparse_events"
"CD011600_pub3_data","26::overall","26","overall","Death, respiratory causes",6,0,0,TRUE,TRUE,"OR_cc","default_or"
"CD011600_pub3_data","27::overall","27","overall","Death, COPD-related",2,0,0,TRUE,TRUE,"OR_cc","default_or"
"CD011624_pub3_data","21::overall","21","overall","Stillbirth",2,1,2,FALSE,TRUE,"RD","double_zero"
"CD011626_pub3_data","7::overall","7","overall","Adverse events",11,0,8,TRUE,TRUE,"RD","sparse_events"
"CD011627_pub3_data","1::1","1","1","Number of participants with incontinence-associated dermatitis",4,1,1,TRUE,TRUE,"RD","double_zero"
"CD011627_pub3_data","1::2","1","2","Number of participants with incontinence-associated dermatitis",3,0,0,TRUE,TRUE,"OR_cc","default_or"
"CD011627_pub3_data","1::3","1","3","Number of participants with incontinence-associated dermatitis",4,0,1,TRUE,TRUE,"RD","sparse_events"
"CD011627_pub3_data","1::4","1","4","Number of participants with incontinence-associated dermatitis",2,0,0,TRUE,TRUE,"OR_cc","default_or"
"CD011627_pub3_data","1::5","1","5","Number of participants with incontinence-associated dermatitis",2,1,1,FALSE,TRUE,"RD","double_zero"
"CD011627_pub3_data","1::6","1","6","Number of participants with incontinence-associated dermatitis",2,0,0,TRUE,TRUE,"OR_cc","default_or"
"CD011627_pub3_data","1::7","1","7","Number of participants with incontinence-associated dermatitis",2,0,0,TRUE,TRUE,"OR_cc","default_or"
"CD011670_pub3_data","1::overall","1","overall","Overall morbidity",4,0,1,TRUE,TRUE,"RD","sparse_events"
"CD011670_pub3_data","2::overall","2","overall","Wound infection",8,1,3,TRUE,TRUE,"RD","double_zero"
"CD011670_pub3_data","3::overall","3","overall","Abdominal abscess",5,1,3,TRUE,TRUE,"RD","double_zero"
"CD011670_pub3_data","4::overall","4","overall","Bowel obstruction",2,0,1,TRUE,TRUE,"RD","sparse_events"
"CD011670_pub3_data","5::overall","5","overall","Faecal fistula",5,1,5,TRUE,TRUE,"RD","double_zero"
"CD011671_pub3_data","1::overall","1","overall","Delayed graft function",16,0,0,TRUE,TRUE,"OR_cc","default_or"
"CD011671_pub3_data","2::overall","2","overall","Delayed graft function: type of donor",17,0,0,TRUE,TRUE,"OR_cc","default_or"
"CD011671_pub3_data","3::overall","3","overall","Delayed graft function: era of study",16,0,0,TRUE,TRUE,"OR_cc","default_or"
"CD011671_pub3_data","4::overall","4","overall","Delayed graft function: preservation times",16,0,0,TRUE,TRUE,"OR_cc","default_or"
"CD011671_pub3_data","7::overall","7","overall","Primary non-function",8,0,3,TRUE,TRUE,"RD","sparse_events"
"CD011671_pub3_data","10::overall","10","overall","Patient survival (12-month follow up, dichotomous)",5,0,0,TRUE,TRUE,"OR_cc","default_or"
"CD011671_pub3_data","11::overall","11","overall","Acute rejection in the first year",3,0,0,TRUE,TRUE,"OR_cc","default_or"
"CD011689_pub4_data","1::overall","1","overall","Death",51,46,50,TRUE,TRUE,"RD","double_zero"
"CD011689_pub4_data","2::overall","2","overall","PPH >= 1000 mL",107,16,36,TRUE,TRUE,"RD","double_zero"
"CD011689_pub4_data","3::overall","3","overall","Blood transfusion",103,21,52,TRUE,TRUE,"RD","double_zero"
"CD011689_pub4_data","4::overall","4","overall","Severe maternal morbidity: intensive care admissions",12,5,9,TRUE,TRUE,"RD","double_zero"
"CD011689_pub4_data","6::overall","6","overall","PPH >= 500 mL",107,3,12,TRUE,TRUE,"RD","double_zero"
"CD011689_pub4_data","7::overall","7","overall","Additional uterotonics",127,3,13,TRUE,TRUE,"RD","double_zero"
"CD011689_pub4_data","10::overall","10","overall","Breastfeeding",6,0,0,TRUE,TRUE,"OR_cc","default_or"
"CD011689_pub4_data","11::overall","11","overall","Nausea",81,1,16,TRUE,TRUE,"RD","double_zero"
"CD011689_pub4_data","12::overall","12","overall","Vomiting",101,4,24,TRUE,TRUE,"RD","double_zero"
"CD011689_pub4_data","13::overall","13","overall","Headache",48,0,18,TRUE,TRUE,"RD","sparse_events"
"CD011689_pub4_data","14::overall","14","overall","Abdominal pain",28,1,11,TRUE,TRUE,"RD","double_zero"
"CD011689_pub4_data","16::overall","16","overall","Shivering",91,4,13,TRUE,TRUE,"RD","double_zero"
"CD011689_pub4_data","17::overall","17","overall","Fever",73,5,14,TRUE,TRUE,"RD","double_zero"
"CD011689_pub4_data","19::1","19","1","Maternal sense of well-being",5,0,0,TRUE,TRUE,"OR_cc","default_or"
"CD011689_pub4_data","19::2","19","2","Maternal sense of well-being",6,0,0,TRUE,TRUE,"OR_cc","default_or"
"CD011689_pub4_data","20::1","20","1","Maternal satisfaction",11,3,3,TRUE,TRUE,"RD","double_zero"
"CD011689_pub4_data","20::2","20","2","Maternal satisfaction",9,0,0,TRUE,TRUE,"OR_cc","default_or"
"CD011689_pub4_data","20::3","20","3","Maternal satisfaction",6,0,0,TRUE,TRUE,"OR_cc","default_or"
"CD011689_pub4_data","18::overall","18","overall","Diarrhoea",56,7,25,TRUE,TRUE,"RD","double_zero"
"CD011689_pub4_data","15::overall","15","overall","Hypertension",19,0,2,TRUE,TRUE,"RD","sparse_events"
"CD011689_pub4_data","19::3","19","3","Maternal well-being",4,0,0,TRUE,TRUE,"OR_cc","default_or"
"CD011689_pub4_data","19::4","19","4","Maternal well-being",3,0,0,TRUE,TRUE,"OR_cc","default_or"
"CD011689_pub4_data","19::5","19","5","Maternal well-being",3,0,0,TRUE,TRUE,"OR_cc","default_or"
"CD011689_pub4_data","19::6","19","6","Maternal well-being",3,0,0,TRUE,TRUE,"OR_cc","default_or"
"CD011689_pub4_data","19::7","19","7","Maternal well-being",3,0,3,TRUE,TRUE,"RD","sparse_events"
"CD011689_pub4_data","19::8","19","8","Maternal well-being",3,0,0,TRUE,TRUE,"OR_cc","default_or"
"CD011689_pub4_data","20::4","20","4","Maternal satisfaction",3,0,0,TRUE,TRUE,"OR_cc","default_or"
"CD011689_pub4_data","1::1","1","1","Death",90,82,88,TRUE,TRUE,"RD","double_zero"
"CD011689_pub4_data","2::1","2","1","PPH >= 1000 mL",188,28,65,TRUE,TRUE,"RD","double_zero"
"CD011689_pub4_data","2::2","2","2","PPH >= 1000 mL",26,4,7,TRUE,TRUE,"RD","double_zero"
"CD011689_pub4_data","3::1","3","1","Blood transfusion",183,38,91,TRUE,TRUE,"RD","double_zero"
"CD011689_pub4_data","3::2","3","2","Blood transfusion",21,4,12,TRUE,TRUE,"RD","double_zero"
"CD011689_pub4_data","4::1","4","1","Severe maternal morbidity: intensive care admissions",21,9,15,TRUE,TRUE,"RD","double_zero"
"CD011689_pub4_data","6::1","6","1","PPH >= 500 mL",193,5,23,TRUE,TRUE,"RD","double_zero"
"CD011689_pub4_data","6::2","6","2","PPH >= 500 mL",17,1,1,TRUE,TRUE,"RD","double_zero"
"CD011689_pub4_data","7::1","7","1","Additional uterotonics",218,4,21,TRUE,TRUE,"RD","double_zero"
"CD011689_pub4_data","7::2","7","2","Additional uterotonics",34,2,4,TRUE,TRUE,"RD","double_zero"
"CD011689_pub4_data","10::1","10","1","Breastfeeding",10,0,0,TRUE,TRUE,"OR_cc","default_or"
"CD011689_pub4_data","11::1","11","1","Nausea",136,2,27,TRUE,TRUE,"RD","double_zero"
"CD011689_pub4_data","11::2","11","2","Nausea",23,0,3,TRUE,TRUE,"RD","sparse_events"
"CD011689_pub4_data","12::1","12","1","Vomiting",176,7,42,TRUE,TRUE,"RD","double_zero"
"CD011689_pub4_data","12::2","12","2","Vomiting",24,1,5,TRUE,TRUE,"RD","double_zero"
"CD011689_pub4_data","13::1","13","1","Headache",77,0,27,TRUE,TRUE,"RD","sparse_events"
"CD011689_pub4_data","13::2","13","2","Headache",18,0,8,TRUE,TRUE,"RD","sparse_events"
"CD011689_pub4_data","14::1","14","1","Abdominal pain",52,2,20,TRUE,TRUE,"RD","double_zero"
"CD011689_pub4_data","16::1","16","1","Shivering",160,7,20,TRUE,TRUE,"RD","double_zero"
"CD011689_pub4_data","17::1","17","1","Fever",129,8,22,TRUE,TRUE,"RD","double_zero"
"CD011689_pub4_data","18::1","18","1","Diarrhoea",106,14,47,TRUE,TRUE,"RD","double_zero"
"CD011689_pub4_data","15::1","15","1","Hypertension",35,0,4,TRUE,TRUE,"RD","sparse_events"
"CD011689_pub4_data","1::2","1","2","Death",11,9,11,TRUE,TRUE,"RD","double_zero"
"CD011689_pub4_data","4::2","4","2","Severe maternal morbidity: intensive care admissions",3,1,3,TRUE,TRUE,"RD","double_zero"
"CD011689_pub4_data","16::2","16","2","Shivering",22,1,5,TRUE,TRUE,"RD","double_zero"
"CD011689_pub4_data","17::2","17","2","Fever",16,2,5,TRUE,TRUE,"RD","double_zero"
"CD011689_pub4_data","3::3","3","3","Blood transfusion",2,0,1,TRUE,TRUE,"RD","sparse_events"
"CD011689_pub4_data","7::3","7","3","Additional uterotonics",2,0,1,TRUE,TRUE,"RD","sparse_events"
"CD011689_pub4_data","12::3","12","3","Vomiting",2,0,1,TRUE,TRUE,"RD","sparse_events"
"CD011689_pub4_data","14::2","14","2","Abdominal pain",4,0,2,TRUE,TRUE,"RD","sparse_events"
"CD011689_pub4_data","15::2","15","2","Hypertension",3,0,0,TRUE,TRUE,"OR_cc","default_or"
"CD011689_pub4_data","18::2","18","2","Diarrhoea",5,0,3,TRUE,TRUE,"RD","sparse_events"
"CD011689_pub4_data","2::3","2","3","PPH >= 1000 mL",2,0,0,TRUE,TRUE,"OR_cc","default_or"
"CD011689_pub4_data","6::3","6","3","PPH >= 500 mL",2,0,0,TRUE,TRUE,"OR_cc","default_or"
"CD011762_pub2_data","1::overall","1","overall","All-cause mortality",206,12,123,TRUE,TRUE,"RD","double_zero"
"CD011762_pub2_data","2::overall","2","overall","Major VTE",237,4,51,TRUE,TRUE,"RD","double_zero"
"CD011762_pub2_data","3::overall","3","overall","Symptomatic VTE",245,8,129,TRUE,TRUE,"RD","double_zero"
"CD011762_pub2_data","4::overall","4","overall","Major bleeding",291,7,106,TRUE,TRUE,"RD","double_zero"
"CD011762_pub2_data","5::overall","5","overall","Major bleeding: rivaroxaban versus LMWH",131,4,49,TRUE,TRUE,"RD","double_zero"
"CD011762_pub2_data","6::overall","6","overall","Major bleeding: other direct factor Xa inhibitors (excluding rivaroxaban) versus LMWH",163,3,60,TRUE,TRUE,"RD","double_zero"
"CD011762_pub2_data","7::overall","7","overall","Serious hepatic adverse events",93,1,12,TRUE,TRUE,"RD","double_zero"
"CD011762_pub2_data","8::overall","8","overall","Serious non-hepatic adverse events",131,0,50,TRUE,TRUE,"RD","sparse_events"
"CD011762_pub2_data","9::overall","9","overall","Fatal VTE",140,37,83,TRUE,TRUE,"RD","double_zero"
"CD011762_pub2_data","10::overall","10","overall","Asymptomatic distal DVT",145,13,29,TRUE,TRUE,"RD","double_zero"
"CD011762_pub2_data","11::overall","11","overall","Fatal bleeding",90,76,90,TRUE,TRUE,"RD","double_zero"
"CD011762_pub2_data","12::overall","12","overall","Liver enzymes elevation",80,0,7,TRUE,TRUE,"RD","sparse_events"
"CD011762_pub2_data","13::overall","13","overall","Minor adverse events",16,0,0,TRUE,TRUE,"OR_cc","default_or"
"CD011793_pub3_data","1::overall","1","overall","Mortality",10,0,10,TRUE,TRUE,"RD","sparse_events"
"CD011793_pub3_data","6::overall","6","overall","Deep sternal wound infection",8,0,7,TRUE,TRUE,"RD","sparse_events"
"CD011793_pub3_data","12::overall","12","overall","Re-exploration",13,0,7,TRUE,TRUE,"RD","sparse_events"
"CD011793_pub3_data","13::overall","13","overall","Postoperative atrial fibrillation",9,0,0,TRUE,TRUE,"OR_cc","default_or"
"CD011800_pub2_data","1::overall","1","overall","Vitamin D status (achieved 25-hydroxyvitamin D level)",3,2,3,FALSE,TRUE,"RD","double_zero"
"CD011806_pub2_data","1::overall","1","overall","Clinical response",7,4,5,TRUE,TRUE,"RD","double_zero"
"CD011806_pub2_data","2::overall","2","overall","Clinical relapse (mixed IBD)",7,2,3,TRUE,TRUE,"RD","double_zero"
"CD011806_pub2_data","3::overall","3","overall","Clinical relapse (mixed IBD) – sensitivity analysis (fixed-effect)",7,4,4,TRUE,TRUE,"RD","double_zero"
"CD011806_pub2_data","6::overall","6","overall","Withdrawals due to adverse events",12,11,12,FALSE,TRUE,"RD","double_zero"
"CD011806_pub2_data","7::overall","7","overall","Withdrawals due to adverse events – sensitivity analysis (fixed-effect)",12,11,12,FALSE,TRUE,"RD","double_zero"
"CD011806_pub2_data","17::overall","17","overall","Total serious adverse events – mixed dose (mixed population)",11,9,11,TRUE,TRUE,"RD","double_zero"
"CD011806_pub2_data","18::overall","18","overall","Total serious adverse events – mixed dose (mixed population) – sensitivity analysis (fixed-effect)",11,9,11,TRUE,TRUE,"RD","double_zero"
"CD011806_pub2_data","19::overall","19","overall","Total serious adverse events – mixed dose (mixed population) – sensitivity analysis (removal of studies at risk of bias)",4,3,4,FALSE,TRUE,"RD","double_zero"
"CD011841_pub3_data","1::overall","1","overall","Mean change in BCVA between baseline and 12 months (± 6)",32,29,30,TRUE,TRUE,"RD","double_zero"
"CD011841_pub3_data","2::overall","2","overall","Recurrence of central serous chorioretinopathy at 12 months (± 6)",25,5,8,TRUE,TRUE,"RD","double_zero"
"CD011841_pub3_data","3::overall","3","overall","Persistent central serous chorioretinopathy at 12 months (± 6)",16,7,7,TRUE,TRUE,"RD","double_zero"
"CD011841_pub3_data","4::overall","4","overall","Mean change in central retinal thickness between baseline and 12 months (± 6)",13,12,12,FALSE,TRUE,"RD","double_zero"
"CD011841_pub3_data","1::1","1","1","Recurrent/persistent central serous chorioretinopathy at 12 months (± 6)",2,1,1,FALSE,TRUE,"RD","double_zero"
"CD011841_pub3_data","1::2","1","2","Recurrent/persistent central serous chorioretinopathy at 12 months (± 6)",3,2,3,FALSE,TRUE,"RD","double_zero"
"CD011841_pub3_data","5::overall","5","overall","Adverse events",2,0,0,TRUE,TRUE,"OR_cc","default_or"
"CD011841_pub3_data","2::1","2","1","Recurrent/persistent central serous chorioretinopathy at 12 months (± 6)",3,0,0,TRUE,TRUE,"OR_cc","default_or"
"CD011841_pub3_data","2::2","2","2","Recurrent/persistent central serous chorioretinopathy at 12 months (± 6)",3,0,0,TRUE,TRUE,"OR_cc","default_or"
"CD011841_pub3_data","6::overall","6","overall","Adverse events (e.g. conjunctival hyperemia)",4,3,4,FALSE,TRUE,"RD","double_zero"
"CD011851_pub3_data","1::overall","1","overall","Fatal cardiovascular events",4,0,2,TRUE,TRUE,"RD","sparse_events"
"CD011851_pub3_data","2::overall","2","overall","Fatal cardiovascular events: sensitivity analysis using fixed-effect model",4,0,2,TRUE,TRUE,"RD","sparse_events"
"CD011858_pub2_data","1::overall","1","overall","Extracorporeal circuit thrombosis",20,4,12,TRUE,TRUE,"RD","double_zero"
"CD011858_pub2_data","2::overall","2","overall","Activated partial thromboplastin time",14,4,11,TRUE,TRUE,"RD","double_zero"
"CD011858_pub2_data","3::overall","3","overall","Platelet count",9,3,4,TRUE,TRUE,"RD","double_zero"
"CD011858_pub2_data","4::overall","4","overall","Death (any cause)",5,0,4,TRUE,TRUE,"RD","sparse_events"
"CD011858_pub2_data","5::overall","5","overall","Plasma anti-Xa level",4,1,4,TRUE,TRUE,"RD","double_zero"
"CD011858_pub2_data","6::overall","6","overall","Activated partial thromboplastin time",4,1,4,TRUE,TRUE,"RD","double_zero"
"CD011858_pub2_data","7::overall","7","overall","Platelet count",3,1,3,TRUE,TRUE,"RD","double_zero"
"CD011858_pub2_data","8::overall","8","overall","Potassium",3,1,3,TRUE,TRUE,"RD","double_zero"
"CD011858_pub2_data","9::overall","9","overall","Plasma anti-Xa level",4,3,4,FALSE,TRUE,"RD","double_zero"
"CD011858_pub2_data","10::overall","10","overall","Activated clotting time",2,1,2,FALSE,TRUE,"RD","double_zero"
"CD011858_pub2_data","11::overall","11","overall","Thrombin antithrombin complex ",2,1,2,FALSE,TRUE,"RD","double_zero"
"CD011866_pub3_data","1::overall","1","overall","Dropouts",48,2,4,TRUE,TRUE,"RD","double_zero"
"CD011866_pub3_data","2::overall","2","overall","Point abstinence, end of treatment",19,0,0,TRUE,TRUE,"OR_cc","default_or"
"CD011866_pub3_data","3::overall","3","overall","Point abstinence, longest follow-up",16,0,0,TRUE,TRUE,"OR_cc","default_or"
"CD011866_pub3_data","4::overall","4","overall","Continuous abstinence, end of treatment",17,1,1,TRUE,TRUE,"RD","double_zero"
"CD011866_pub3_data","5::overall","5","overall","Continuous abstinence, longest follow-up",9,5,5,TRUE,TRUE,"RD","double_zero"
"CD011885_pub2_data","1::overall","1","overall","Clinically relevant response, as defined by study authors",12,0,5,TRUE,TRUE,"RD","sparse_events"
"CD011885_pub2_data","2::overall","2","overall","Tolerability: leaving study early due to adverse effects",11,5,7,TRUE,TRUE,"RD","double_zero"
"CD011885_pub2_data","3::overall","3","overall","Quality of life: SF-36 score change (higher is better)",6,1,2,TRUE,TRUE,"RD","double_zero"
"CD011885_pub2_data","4::overall","4","overall","Exacerbations of psychosis, as defined by study authors",8,1,6,TRUE,TRUE,"RD","double_zero"
"CD011885_pub2_data","5::overall","5","overall","Acceptability: leaving study early for any reason",8,0,2,TRUE,TRUE,"RD","sparse_events"
"CD011885_pub2_data","6::overall","6","overall","Efficacy: leaving study early due to inefficacy of treatment",8,0,5,TRUE,TRUE,"RD","sparse_events"
"CD011885_pub2_data","7::overall","7","overall","General mental state: clinically important change in PANSS total score",10,0,3,TRUE,TRUE,"RD","sparse_events"
"CD011885_pub2_data","8::overall","8","overall","General mental state: average endpoint or change PANSS total score (lower is better)",12,9,10,TRUE,TRUE,"RD","double_zero"
"CD011885_pub2_data","10::overall","10","overall","Remission as defined by Andreasen (2005)",4,0,2,TRUE,TRUE,"RD","sparse_events"
"CD011885_pub2_data","13::overall","13","overall","Positive symptoms: clinically important change in PANSS positive subscore",2,0,0,TRUE,TRUE,"OR_cc","default_or"
"CD011885_pub2_data","15::overall","15","overall","Negative symptoms: clinically important change in PANSS negative subscore",2,0,0,TRUE,TRUE,"OR_cc","default_or"
"CD011885_pub2_data","18::overall","18","overall","Depressive symptoms: clinically relevant response, as defined by study authors",3,0,0,TRUE,TRUE,"OR_cc","default_or"
"CD011885_pub2_data","22::overall","22","overall","Aggressive behaviour: clinically important change in PANSS-Excited Component subscore",2,0,0,TRUE,TRUE,"OR_cc","default_or"
"CD011885_pub2_data","25::overall","25","overall","Adverse effects: number of participants experiencing at least one adverse effect",3,0,1,TRUE,TRUE,"RD","sparse_events"
"CD011885_pub2_data","26::overall","26","overall","Adverse effects: extrapyramidal – akathisia as a dichotomous outcome",3,0,1,TRUE,TRUE,"RD","sparse_events"
"CD011885_pub2_data","33::overall","33","overall","Adverse effects: extrapyramidal – extrapyramidal disorder as a dichotomous outcome",2,0,1,TRUE,TRUE,"RD","sparse_events"
"CD011885_pub2_data","37::overall","37","overall","Adverse effects: agitation",2,0,1,TRUE,TRUE,"RD","sparse_events"
"CD011885_pub2_data","38::overall","38","overall","Adverse effects: anxiety",2,0,1,TRUE,TRUE,"RD","sparse_events"
"CD011885_pub2_data","39::overall","39","overall","Adverse effects: diarrhoea",2,0,0,TRUE,TRUE,"OR_cc","default_or"
"CD011885_pub2_data","40::overall","40","overall","Adverse effects: dry mouth",2,0,1,TRUE,TRUE,"RD","sparse_events"
"CD011885_pub2_data","41::overall","41","overall","Adverse effects: fatigue",2,0,0,TRUE,TRUE,"OR_cc","default_or"
"CD011885_pub2_data","42::overall","42","overall","Adverse effects: headache",3,0,1,TRUE,TRUE,"RD","sparse_events"
"CD011885_pub2_data","44::overall","44","overall","Adverse effects: insomnia",3,0,1,TRUE,TRUE,"RD","sparse_events"
"CD011885_pub2_data","45::overall","45","overall","Adverse effects: lethargy",2,0,0,TRUE,TRUE,"OR_cc","default_or"
"CD011885_pub2_data","46::overall","46","overall","Adverse effects: prolactin – high levels",2,0,1,TRUE,TRUE,"RD","sparse_events"
"CD011885_pub2_data","48::overall","48","overall","Adverse effects: restlessness",2,0,1,TRUE,TRUE,"RD","sparse_events"
"CD011885_pub2_data","49::overall","49","overall","Adverse effects: sedation",3,0,0,TRUE,TRUE,"OR_cc","default_or"
"CD011885_pub2_data","50::overall","50","overall","Adverse effects: somnolence",2,0,1,TRUE,TRUE,"RD","sparse_events"
"CD011885_pub2_data","53::overall","53","overall","Adverse effects: weight – clinically important increase in weight (≥ 7%)",3,0,1,TRUE,TRUE,"RD","sparse_events"
"CD012067_pub3_data","1::overall","1","overall","Serum creatinine [mg/dL]",32,31,32,FALSE,TRUE,"RD","double_zero"
"CD012067_pub3_data","2::overall","2","overall","Doubling of serum creatinine",37,30,30,TRUE,TRUE,"RD","double_zero"
"CD012067_pub3_data","3::overall","3","overall","Mean change in eGFR [mL/min/1.73 m2]",29,21,25,TRUE,TRUE,"RD","double_zero"
"CD012067_pub3_data","5::overall","5","overall","Death",29,18,22,TRUE,TRUE,"RD","double_zero"
"CD012067_pub3_data","6::overall","6","overall","Pain",24,8,11,TRUE,TRUE,"RD","double_zero"
"CD012067_pub3_data","7::overall","7","overall","Systolic blood pressure [mm Hg]",14,13,13,FALSE,TRUE,"RD","double_zero"
"CD012067_pub3_data","8::overall","8","overall","Diastolic blood pressure [mm Hg]",17,7,9,TRUE,TRUE,"RD","double_zero"
"CD012067_pub3_data","9::overall","9","overall","Total kidney volume [mL/cm]",11,9,11,TRUE,TRUE,"RD","double_zero"
"CD012067_pub3_data","10::overall","10","overall","Height-adjusted total kidney volume [mL/cm]",17,7,8,TRUE,TRUE,"RD","double_zero"
"CD012067_pub3_data","12::overall","12","overall","Albuminuria [mg/mmol]",6,3,5,TRUE,TRUE,"RD","double_zero"
"CD012067_pub3_data","13::overall","13","overall","Spot urine osmolality [mOsm/kg]",16,5,9,TRUE,TRUE,"RD","double_zero"
"CD012067_pub3_data","14::overall","14","overall","Urine specific gravity [mOsm/kg]",9,6,6,TRUE,TRUE,"RD","double_zero"
"CD012067_pub3_data","15::overall","15","overall","Serious adverse events",7,3,3,TRUE,TRUE,"RD","double_zero"
"CD012067_pub3_data","16::overall","16","overall","Adverse events",47,9,11,TRUE,TRUE,"RD","double_zero"
"CD012067_pub3_data","17::overall","17","overall","Withdrawal due to adverse events",10,6,7,TRUE,TRUE,"RD","double_zero"
"CD012067_pub3_data","4::overall","4","overall","Quality of life scores",31,18,30,TRUE,TRUE,"RD","double_zero"
"CD012067_pub3_data","18::overall","18","overall","Cyst volume [L]",12,2,6,TRUE,TRUE,"RD","double_zero"
"CD012067_pub3_data","19::overall","19","overall","Parenchymal volume [mL]",6,5,5,FALSE,TRUE,"RD","double_zero"
"CD012067_pub3_data","20::overall","20","overall","Proteinuria [g/24 hours]",3,1,2,TRUE,TRUE,"RD","double_zero"
"CD012067_pub3_data","21::overall","21","overall","Albuminuria [g/24 hours]",29,2,9,TRUE,TRUE,"RD","double_zero"
"CD012067_pub3_data","22::overall","22","overall","Serious adverse events",2,0,0,TRUE,TRUE,"OR_cc","default_or"
"CD012067_pub3_data","23::overall","23","overall","Adverse events",25,0,8,TRUE,TRUE,"RD","sparse_events"
"CD012079_pub2_data","1::overall","1","overall","Awareness of prolapse (0.5 to 7 years)",27,0,2,TRUE,TRUE,"RD","sparse_events"
"CD012079_pub2_data","2::overall","2","overall","Repeat surgery (0.5 to 7 years)",70,9,38,TRUE,TRUE,"RD","double_zero"
"CD012079_pub2_data","3::overall","3","overall","Recurrent prolapse on examination (any compartment) ",39,0,2,TRUE,TRUE,"RD","sparse_events"
"CD012079_pub2_data","4::overall","4","overall","Recurrent prolapse on examination (anterior compartment) ",22,0,1,TRUE,TRUE,"RD","sparse_events"
"CD012079_pub2_data","5::overall","5","overall","Recurrent prolapse on examination (posterior compartment) ",7,0,1,TRUE,TRUE,"RD","sparse_events"
"CD012079_pub2_data","6::overall","6","overall","Visceral injury ",21,5,20,TRUE,TRUE,"RD","double_zero"
"CD012079_pub2_data","7::overall","7","overall","Mesh exposure",33,3,19,TRUE,TRUE,"RD","double_zero"
"CD012079_pub2_data","10::overall","10","overall","Bladder function: de novo stress urinary incontinence (0.5 to 7 years)",23,1,8,TRUE,TRUE,"RD","double_zero"
"CD012079_pub2_data","11::overall","11","overall","Bladder function: de novo urge incontinence or voiding dysfunction ",14,1,6,TRUE,TRUE,"RD","double_zero"
"CD012079_pub2_data","12::overall","12","overall","Painful intercourse - de novo dyspareunia ",19,0,8,TRUE,TRUE,"RD","sparse_events"
"CD012079_pub2_data","16::overall","16","overall","Patient Global Impression of Improvement (PGI-I) (better or very much better)",13,9,9,TRUE,TRUE,"RD","double_zero"
"CD012079_pub2_data","18::overall","18","overall","Length of stay in hospital (days)",11,8,11,TRUE,TRUE,"RD","double_zero"
"CD012079_pub2_data","19::overall","19","overall","Blood transfusion",10,2,9,TRUE,TRUE,"RD","double_zero"
"CD012079_pub2_data","20::overall","20","overall","Any repeat surgery (0.5 to 7 years)",27,1,9,TRUE,TRUE,"RD","double_zero"
"CD012079_pub2_data","21::overall","21","overall","Awareness of prolapse (0.5 to 7 years) including trials at high risk of bias ",19,0,1,TRUE,TRUE,"RD","sparse_events"
"CD012079_pub2_data","22::overall","22","overall","Repeat surgery (0.5 to 7 years) including trials at high risk of bias",59,7,33,TRUE,TRUE,"RD","double_zero"
"CD012079_pub2_data","23::overall","23","overall","Recurrent prolapse on examination (any compartment) including trials at high risk of bias",26,0,1,TRUE,TRUE,"RD","sparse_events"
"CD012079_pub2_data","24::overall","24","overall","Any repeat surgery (0.5 to 7 years) including trials at high risk of bias",28,1,9,TRUE,TRUE,"RD","double_zero"
"CD012152_pub4_data","1::overall","1","overall","Hypoglycaemia",2,0,0,TRUE,TRUE,"OR_cc","default_or"
"CD012152_pub4_data","2::overall","2","overall","Major neurological disability at two years of age ",2,0,0,TRUE,TRUE,"OR_cc","default_or"
"CD012152_pub4_data","4::overall","4","overall","Major neurological disability at two years of age - by risk factor",2,0,0,TRUE,TRUE,"OR_cc","default_or"
"CD012152_pub4_data","5::overall","5","overall","Receipt of treatment for hypoglycaemia during initial hospital stay",2,0,0,TRUE,TRUE,"OR_cc","default_or"
"CD012152_pub4_data","6::overall","6","overall","Separation from mother for treatment of hypoglycaemia (admission to NICU for hypoglycaemia)",2,0,0,TRUE,TRUE,"OR_cc","default_or"
"CD012152_pub4_data","7::overall","7","overall","Receipt of intravenous treatment for hypoglycaemia",2,0,0,TRUE,TRUE,"OR_cc","default_or"
"CD012152_pub4_data","8::overall","8","overall","Adverse effects (e.g. choking or vomiting at time of administration)",2,0,1,TRUE,TRUE,"RD","sparse_events"
"CD012152_pub4_data","9::overall","9","overall","Developmental disability at two years of age",2,0,0,TRUE,TRUE,"OR_cc","default_or"
"CD012152_pub4_data","11::overall","11","overall","Any neurological disability at two years of age - by risk factor",2,0,0,TRUE,TRUE,"OR_cc","default_or"
"CD012152_pub4_data","12::overall","12","overall","Any neurological disability at six to seven years of age - by risk factor",2,0,0,TRUE,TRUE,"OR_cc","default_or"
"CD012152_pub4_data","13::overall","13","overall","Any neurological disability at six to seven years of age - by single or multiple gel dose ",2,0,0,TRUE,TRUE,"OR_cc","default_or"
"CD012152_pub4_data","14::overall","14","overall","Receipt of oral dextrose gel treatment for hypoglycaemia",2,0,0,TRUE,TRUE,"OR_cc","default_or"
"CD012152_pub4_data","17::overall","17","overall","Neonatal seizures",2,0,2,TRUE,TRUE,"RD","sparse_events"
"CD012152_pub4_data","19::overall","19","overall","Breastfeeding (any) after discharge ",2,0,0,TRUE,TRUE,"OR_cc","default_or"
"CD012152_pub4_data","20::overall","20","overall","Visual impairment at two years of age",2,1,2,FALSE,TRUE,"RD","double_zero"
"CD012152_pub4_data","21::overall","21","overall","Hearing impairment at two years of age",2,0,2,TRUE,TRUE,"RD","sparse_events"
"CD012152_pub4_data","22::overall","22","overall","Cerebral palsy at two years of age",2,1,2,FALSE,TRUE,"RD","double_zero"
"CD012152_pub4_data","23::overall","23","overall","Developmental delay/intellectual impairment at two years of age",2,0,0,TRUE,TRUE,"OR_cc","default_or"
"CD012152_pub4_data","26::overall","26","overall","Developmental delay/intellectual impairment at six to seven years of age",2,0,0,TRUE,TRUE,"OR_cc","default_or"
"CD012152_pub4_data","27::overall","27","overall","Developmental delay/intellectual impairment at two years of age - by risk factor",2,0,0,TRUE,TRUE,"OR_cc","default_or"
"CD012152_pub4_data","28::overall","28","overall","Executive dysfunction at two years of age",2,0,0,TRUE,TRUE,"OR_cc","default_or"
"CD012152_pub4_data","30::overall","30","overall","Executive dysfunction at six to seven years of age - by single or multiple gel dose ",2,0,0,TRUE,TRUE,"OR_cc","default_or"
"CD012152_pub4_data","31::overall","31","overall","Executive dysfunction at two years of age - by risk factor",2,0,0,TRUE,TRUE,"OR_cc","default_or"
"CD012152_pub4_data","32::overall","32","overall","Executive dysfunction at six to seven years of age - by risk factor",2,0,0,TRUE,TRUE,"OR_cc","default_or"
"CD012152_pub4_data","34::overall","34","overall","Emotional-behavioural difficulty at six to seven years of age - by risk factor",2,0,0,TRUE,TRUE,"OR_cc","default_or"
"CD012152_pub4_data","35::overall","35","overall","Emotional-behavioural difficulty at six to seven years of age - by single or multiple gel dose",2,0,0,TRUE,TRUE,"OR_cc","default_or"
"CD012178_pub2_data","1::overall","1","overall","Incidence of ROP at any stage",4,0,0,TRUE,TRUE,"OR_cc","default_or"
"CD012178_pub2_data","2::overall","2","overall","Incidence of ROP stage 3 and above",4,0,0,TRUE,TRUE,"OR_cc","default_or"
"CD012178_pub2_data","3::overall","3","overall","Mortality assessed throughout NICU stay",4,0,2,TRUE,TRUE,"RD","sparse_events"
"CD012178_pub2_data","4::overall","4","overall","Incidence of IVH (all grades of IVH and severe IVH grades III and IV)",4,0,2,TRUE,TRUE,"RD","sparse_events"
"CD012178_pub2_data","5::overall","5","overall","Incidence of NEC",5,0,2,TRUE,TRUE,"RD","sparse_events"
"CD012186_pub2_data","1::overall","1","overall","SAEs",91,2,13,TRUE,TRUE,"RD","double_zero"
"CD012186_pub2_data","2::overall","2","overall","Withdrawals due to AEs",111,6,24,TRUE,TRUE,"RD","double_zero"
"CD012214_pub3_data","1::overall","1","overall","Regression of endometrial hyperplasia (with or without atypia) to proliferative, secretory, or atrophic endometrium",7,0,0,TRUE,TRUE,"OR_cc","default_or"
"CD012214_pub3_data","3::overall","3","overall","Hysterectomy rate",6,3,6,TRUE,TRUE,"RD","double_zero"
"CD012214_pub3_data","4::overall","4","overall","Abnormal uterine bleeding",4,1,3,TRUE,TRUE,"RD","double_zero"
"CD012214_pub3_data","5::overall","5","overall","Adverse effects during treatment",4,0,0,TRUE,TRUE,"OR_cc","default_or"
"CD012335_pub2_data","1::overall","1","overall","All‐cause mortality",2,0,1,TRUE,TRUE,"RD","sparse_events"
"CD012335_pub2_data","3::overall","3","overall","Cancer-related mortality",2,0,1,TRUE,TRUE,"RD","sparse_events"
"CD012335_pub2_data","5::overall","5","overall","Rate of cancer recurrence: overall",2,0,1,TRUE,TRUE,"RD","sparse_events"
"CD012335_pub2_data","6::overall","6","overall","Rate of cancer recurrence: pelvic recurrence",2,0,1,TRUE,TRUE,"RD","sparse_events"
"CD012335_pub2_data","7::overall","7","overall","Rate of cancer recurrence: extrapelvic recurrence",2,1,1,FALSE,TRUE,"RD","double_zero"
"CD012335_pub2_data","8::overall","8","overall","Overall perioperative adverse event",2,0,0,TRUE,TRUE,"OR_cc","default_or"
"CD012335_pub2_data","12::overall","12","overall","Severe perioperative adverse events (grade 3 or higher)",2,0,1,TRUE,TRUE,"RD","sparse_events"
"CD012397_pub2_data","3::overall","3","overall","Use of coercive measures: use of seclusion room (time, days)",2,0,0,TRUE,TRUE,"OR_cc","default_or"
"CD012397_pub2_data","4::overall","4","overall","Use of coercive measures: use of seclusion room (participants)",2,0,0,TRUE,TRUE,"OR_cc","default_or"
"CD012397_pub2_data","5::overall","5","overall","Use of coercive measures: use of seclusion room (incidents)",2,0,0,TRUE,TRUE,"OR_cc","default_or"
"CD012397_pub2_data","7::overall","7","overall","Specific behaviours: aggression, other episode of aggression (incidents per treatment days)",6,3,3,TRUE,TRUE,"RD","double_zero"
"CD012397_pub2_data","8::overall","8","overall","Specific behaviours: aggression, other episode of aggression (participants)",4,0,1,TRUE,TRUE,"RD","sparse_events"
"CD012426_pub2_data","1::overall","1","overall","Unfavourable functional outcome at 90 days",5,0,0,TRUE,TRUE,"OR_cc","default_or"
"CD012426_pub2_data","2::overall","2","overall","All-cause mortality at 90 days",4,0,1,TRUE,TRUE,"RD","sparse_events"
"CD012426_pub2_data","3::overall","3","overall","Improvement of stroke severity at 90 days",4,0,0,TRUE,TRUE,"OR_cc","default_or"
"CD012426_pub2_data","4::overall","4","overall","Serious adverse events at 90 days",7,0,0,TRUE,TRUE,"OR_cc","default_or"
"CD012426_pub2_data","5::overall","5","overall","Adverse events at 90 days",3,0,0,TRUE,TRUE,"OR_cc","default_or"
"CD012429_pub2_data","1::overall","1","overall","Change in mental state (BPRS)",16,9,10,TRUE,TRUE,"RD","double_zero"
"CD012429_pub2_data","2::overall","2","overall","Change in mental state (PANNS)",12,3,3,TRUE,TRUE,"RD","double_zero"
"CD012429_pub2_data","3::overall","3","overall","Sedation",8,0,4,TRUE,TRUE,"RD","sparse_events"
"CD012429_pub2_data","4::overall","4","overall","Constipation",6,0,2,TRUE,TRUE,"RD","sparse_events"
"CD012429_pub2_data","5::overall","5","overall","Headache",3,0,0,TRUE,TRUE,"OR_cc","default_or"
"CD012429_pub2_data","6::overall","6","overall","Somnolence",3,0,0,TRUE,TRUE,"OR_cc","default_or"
"CD012429_pub2_data","7::overall","7","overall","Fatigue",3,0,1,TRUE,TRUE,"RD","sparse_events"
"CD012429_pub2_data","8::overall","8","overall","Agitation",3,0,1,TRUE,TRUE,"RD","sparse_events"
"CD012429_pub2_data","9::overall","9","overall","Insomnia",4,0,1,TRUE,TRUE,"RD","sparse_events"
"CD012429_pub2_data","10::overall","10","overall","Akathisia",4,0,1,TRUE,TRUE,"RD","sparse_events"
"CD012429_pub2_data","11::overall","11","overall","Extrapyramidal disorder",3,0,0,TRUE,TRUE,"OR_cc","default_or"
"CD012429_pub2_data","12::overall","12","overall","Dystonia",3,0,1,TRUE,TRUE,"RD","sparse_events"
"CD012429_pub2_data","13::overall","13","overall","Dizziness",3,0,1,TRUE,TRUE,"RD","sparse_events"
"CD012429_pub2_data","14::overall","14","overall","Tremor",3,0,3,TRUE,TRUE,"RD","sparse_events"
"CD012429_pub2_data","18::overall","18","overall","Abdominal discomfort",3,0,3,TRUE,TRUE,"RD","sparse_events"
"CD012429_pub2_data","19::overall","19","overall","Diarrhea",3,0,3,TRUE,TRUE,"RD","sparse_events"
"CD012429_pub2_data","20::overall","20","overall","Dyspepsia",3,0,0,TRUE,TRUE,"OR_cc","default_or"
"CD012429_pub2_data","21::overall","21","overall","Nausea",4,0,1,TRUE,TRUE,"RD","sparse_events"
"CD012429_pub2_data","22::overall","22","overall","Toothache",3,0,3,TRUE,TRUE,"RD","sparse_events"
"CD012429_pub2_data","23::overall","23","overall","Vomiting",3,0,0,TRUE,TRUE,"OR_cc","default_or"
"CD012503_pub3_data","1::overall","1","overall","Mortality during follow-up (for all studies)",102,22,47,TRUE,TRUE,"RD","double_zero"
"CD012503_pub3_data","2::1","2","1","Subgroup analysis, recurrence of ischemic stroke at the endpoint (based on unilateral or bilateral limb RIC intervention)",36,10,17,TRUE,TRUE,"RD","double_zero"
"CD012503_pub3_data","2::2","2","2","Subgroup analysis, recurrence of ischemic stroke at the endpoint (based on unilateral or bilateral limb RIC intervention)",21,3,5,TRUE,TRUE,"RD","double_zero"
"CD012503_pub3_data","3::1","3","1","Subgroup analysis, recurrence of ischemic stroke at the endpoint (based on RIC intervention with reperfusion therapy)",17,4,8,TRUE,TRUE,"RD","double_zero"
"CD012503_pub3_data","3::2","3","2","Subgroup analysis, recurrence of ischemic stroke at the endpoint (based on RIC intervention with reperfusion therapy)",25,5,11,TRUE,TRUE,"RD","double_zero"
"CD012503_pub3_data","4::1","4","1","Subgroup analysis, recurrence of ischemic stroke at the endpoint (based on RIC intervention timing)",39,10,16,TRUE,TRUE,"RD","double_zero"
"CD012503_pub3_data","4::2","4","2","Subgroup analysis, recurrence of ischemic stroke at the endpoint (based on RIC intervention timing)",11,2,5,TRUE,TRUE,"RD","double_zero"
"CD012503_pub3_data","4::3","4","3","Subgroup analysis, recurrence of ischemic stroke at the endpoint (based on RIC intervention timing)",7,1,1,TRUE,TRUE,"RD","double_zero"
"CD012503_pub3_data","5::1","5","1","Subgroup analysis, recurrence of ischemic stroke at the endpoint (based on the duration of RIC intervention)",39,10,19,TRUE,TRUE,"RD","double_zero"
"CD012503_pub3_data","5::2","5","2","Subgroup analysis, recurrence of ischemic stroke at the endpoint (based on the duration of RIC intervention)",12,2,3,TRUE,TRUE,"RD","double_zero"
"CD012503_pub3_data","5::3","5","3","Subgroup analysis, recurrence of ischemic stroke at the endpoint (based on the duration of RIC intervention)",7,1,1,TRUE,TRUE,"RD","double_zero"
"CD012570_pub2_data","1::overall","1","overall","All-cause mortality",3,0,3,TRUE,TRUE,"RD","sparse_events"
"CD012570_pub2_data","2::overall","2","overall","Withdrawal due to adverse effects (WDAE)",9,0,0,TRUE,TRUE,"OR_cc","default_or"
"CD012570_pub2_data","3::overall","3","overall","Serious adverse events",6,0,2,TRUE,TRUE,"RD","sparse_events"
"CD012570_pub2_data","4::overall","4","overall","Adverse events",10,0,0,TRUE,TRUE,"OR_cc","default_or"
"CD012572_pub3_data","1::overall","1","overall","All-cause mortality",4,0,3,TRUE,TRUE,"RD","sparse_events"
"CD012572_pub3_data","3::overall","3","overall","Myocardial infarction (fatal and non-fatal)",2,0,2,TRUE,TRUE,"RD","sparse_events"
"CD012572_pub3_data","5::overall","5","overall","Stroke (fatal + non-fatal + transient ischaemic attack)",3,0,3,TRUE,TRUE,"RD","sparse_events"
"CD012572_pub3_data","13::overall","13","overall","Success rate – withdrawal/resumption due to hypertension or other clinical reason",3,0,0,TRUE,TRUE,"OR_cc","default_or"
"CD012586_pub2_data","1::1","1","1","Live birth or ongoing pregnancy",153,0,2,TRUE,TRUE,"RD","sparse_events"
"CD012586_pub2_data","1::2","1","2","Live birth or ongoing pregnancy",30,0,1,TRUE,TRUE,"RD","sparse_events"
"CD012586_pub2_data","1::3","1","3","Live birth or ongoing pregnancy",13,0,1,TRUE,TRUE,"RD","sparse_events"
"CD012586_pub2_data","2::1","2","1","OHSS",78,10,22,TRUE,TRUE,"RD","double_zero"
"CD012586_pub2_data","2::2","2","2","OHSS",17,0,3,TRUE,TRUE,"RD","sparse_events"
"CD012586_pub2_data","3::1","3","1","Clinical pregnancy",53,6,10,TRUE,TRUE,"RD","double_zero"
"CD012586_pub2_data","3::2","3","2","Clinical pregnancy",9,0,0,TRUE,TRUE,"OR_cc","default_or"
"CD012586_pub2_data","3::3","3","3","Clinical pregnancy",3,0,0,TRUE,TRUE,"OR_cc","default_or"
"CD012586_pub2_data","4::1","4","1","Multiple pregnancy",31,8,13,TRUE,TRUE,"RD","double_zero"
"CD012586_pub2_data","4::2","4","2","Multiple pregnancy",5,1,1,TRUE,TRUE,"RD","double_zero"
"CD012586_pub2_data","5::1","5","1","Miscarriage",38,7,12,TRUE,TRUE,"RD","double_zero"
"CD012586_pub2_data","5::2","5","2","Miscarriage",9,1,3,TRUE,TRUE,"RD","double_zero"
"CD012586_pub2_data","5::3","5","3","Miscarriage",3,0,1,TRUE,TRUE,"RD","sparse_events"
"CD012586_pub2_data","6::1","6","1","Ectopic",20,8,14,TRUE,TRUE,"RD","double_zero"
"CD012586_pub2_data","6::2","6","2","Ectopic",3,1,2,TRUE,TRUE,"RD","double_zero"
"CD012586_pub2_data","7::1","7","1","Cancellation",30,9,15,TRUE,TRUE,"RD","double_zero"
"CD012586_pub2_data","7::2","7","2","Cancellation",9,1,3,TRUE,TRUE,"RD","double_zero"
"CD012586_pub2_data","7::3","7","3","Cancellation",5,0,0,TRUE,TRUE,"OR_cc","default_or"
"CD012594_pub2_data","1::overall","1","overall","Number of unexpected (previously unknown) adverse drug reaction reports",2,0,0,TRUE,TRUE,"OR_cc","default_or"
"CD012609_pub2_data","1::overall","1","overall","Clinical relapse",7,0,0,TRUE,TRUE,"OR_cc","default_or"
"CD012609_pub2_data","2::overall","2","overall","Loss of clinical response",5,0,0,TRUE,TRUE,"OR_cc","default_or"
"CD012609_pub2_data","3::overall","3","overall","Loss of clinical response in patients with exclusively fistulating disease",5,0,0,TRUE,TRUE,"OR_cc","default_or"
"CD012609_pub2_data","4::overall","4","overall","Withdrawal due to adverse events ",7,0,1,TRUE,TRUE,"RD","sparse_events"
"CD012609_pub2_data","5::overall","5","overall","Serious adverse events ",2,0,0,TRUE,TRUE,"OR_cc","default_or"
"CD012609_pub2_data","6::overall","6","overall","Total adverse events ",2,0,0,TRUE,TRUE,"OR_cc","default_or"
"CD012623_pub2_data","1::overall","1","overall","Macular hole closure",25,0,0,TRUE,TRUE,"OR_cc","default_or"
"CD012635_pub2_data","1::overall","1","overall","All-cause mortality at 24 hours",4,0,0,TRUE,TRUE,"OR_cc","default_or"
"CD012635_pub2_data","2::overall","2","overall","All-cause mortality at 30 days",5,0,0,TRUE,TRUE,"OR_cc","default_or"
"CD012635_pub2_data","3::overall","3","overall","All-cause mortality at 30 days",2,0,0,TRUE,TRUE,"OR_cc","default_or"
"CD012635_pub2_data","4::overall","4","overall","Total thromboembolic events in the first 30 days after injury",5,0,2,TRUE,TRUE,"RD","sparse_events"
"CD012635_pub2_data","5::overall","5","overall","Arterial thromboembolic events in the first 30 days after injury",3,1,3,TRUE,TRUE,"RD","double_zero"
"CD012635_pub2_data","6::overall","6","overall","Venous thromboembolic events in the first 30 days after injury",3,0,1,TRUE,TRUE,"RD","sparse_events"
"CD012635_pub2_data","7::overall","7","overall","Requirement for surgery or interventional procedure within first 24 hours ",2,0,1,TRUE,TRUE,"RD","sparse_events"
"CD012635_pub2_data","1::1","1","1","All cause mortality at 24 hours ",2,0,0,TRUE,TRUE,"OR_cc","default_or"
"CD012635_pub2_data","2::1","2","1","All-cause mortality at 24 hours ",2,0,0,TRUE,TRUE,"OR_cc","default_or"
"CD012635_pub2_data","3::1","3","1","All-cause mortality at 30 days",3,0,0,TRUE,TRUE,"OR_cc","default_or"
"CD012635_pub2_data","6::1","6","1","Total thromboembolic events in the first 30 days after injury",2,0,1,TRUE,TRUE,"RD","sparse_events"
"CD012635_pub2_data","8::1","8","1","Arterial thromboembolic events in the first 30 days after injury",2,0,1,TRUE,TRUE,"RD","sparse_events"
"CD012635_pub2_data","9::1","9","1","Venous thromboembolic events in the first 30 days after injury",2,0,1,TRUE,TRUE,"RD","sparse_events"
"CD012642_pub2_data","1::overall","1","overall","Mortality (latest time reported up to hospital discharge)",21,5,8,TRUE,TRUE,"RD","double_zero"
"CD012642_pub2_data","2::overall","2","overall","Hyponatraemia (< 130 mmol/L)",24,1,12,TRUE,TRUE,"RD","double_zero"
"CD012642_pub2_data","3::overall","3","overall","Hypernatraemia (≥ 150 mmol/L)",28,3,17,TRUE,TRUE,"RD","double_zero"
"CD012642_pub2_data","4::overall","4","overall","Necrotising enterocolitis",9,0,6,TRUE,TRUE,"RD","sparse_events"
"CD012642_pub2_data","5::overall","5","overall","Patent ductus arteriosus",11,0,0,TRUE,TRUE,"OR_cc","default_or"
"CD012642_pub2_data","6::overall","6","overall","Bronchopulmonary dysplasia (≥ 28 days age)",4,0,0,TRUE,TRUE,"OR_cc","default_or"
"CD012642_pub2_data","7::overall","7","overall","Intraventricular haemorrhage (any)",4,0,1,TRUE,TRUE,"RD","sparse_events"
"CD012693_pub3_data","1::overall","1","overall","Live birth or ongoing pregnancy",21,0,1,TRUE,TRUE,"RD","sparse_events"
"CD012693_pub3_data","2::overall","2","overall","Severe OHSS",20,10,15,TRUE,TRUE,"RD","double_zero"
"CD012693_pub3_data","3::overall","3","overall","Clinical pregnancy",26,0,2,TRUE,TRUE,"RD","sparse_events"
"CD012693_pub3_data","5::overall","5","overall","Moderate or severe OHSS",22,6,10,TRUE,TRUE,"RD","double_zero"
"CD012693_pub3_data","6::overall","6","overall","Multiple pregnancy in randomised women",17,3,7,TRUE,TRUE,"RD","double_zero"
"CD012693_pub3_data","8::overall","8","overall","Poor response to stimulation",10,0,0,TRUE,TRUE,"OR_cc","default_or"
"CD012693_pub3_data","9::overall","9","overall","Normal response to stimulation",11,0,0,TRUE,TRUE,"OR_cc","default_or"
"CD012693_pub3_data","10::overall","10","overall","Hyper-response to stimulation",9,0,0,TRUE,TRUE,"OR_cc","default_or"
"CD012693_pub3_data","11::overall","11","overall","Cycle cancellations for poor response",26,2,11,TRUE,TRUE,"RD","double_zero"
"CD012693_pub3_data","12::overall","12","overall","Cycle cancellations for hyper-response",22,5,14,TRUE,TRUE,"RD","double_zero"
"CD012693_pub3_data","13::overall","13","overall","Cycle cancellations for poor or hyper-response",21,0,2,TRUE,TRUE,"RD","sparse_events"
"CD012693_pub3_data","14::overall","14","overall","Women with at least one transferable embryo",26,0,0,TRUE,TRUE,"OR_cc","default_or"
"CD012693_pub3_data","18::overall","18","overall","Cumulative live birth: 1 cycle (fresh + frozen)",9,0,0,TRUE,TRUE,"OR_cc","default_or"
"CD012693_pub3_data","19::overall","19","overall","Cumulative live birth: 18 months",6,1,1,TRUE,TRUE,"RD","double_zero"
"CD012693_pub3_data","20::overall","20","overall","Multiple pregnancy in women with clinical pregnancy",14,2,6,TRUE,TRUE,"RD","double_zero"
"CD012693_pub3_data","21::overall","21","overall","Dose-response: live birth or ongoing pregnancy",12,0,2,TRUE,TRUE,"RD","sparse_events"
"CD012693_pub3_data","22::overall","22","overall","Dose-response: cumulative live birth: 1 cycle (fresh + frozen)",10,0,0,TRUE,TRUE,"OR_cc","default_or"
"CD012693_pub3_data","23::overall","23","overall","Dose-response: clinical pregnancy",10,0,1,TRUE,TRUE,"RD","sparse_events"
"CD012693_pub3_data","24::overall","24","overall","Dose-response: log(N oocytes retrieved); data presented on the log scale - cannot interpret pooled estimates as N of oocytes",4,1,4,TRUE,TRUE,"RD","double_zero"
"CD012693_pub3_data","25::overall","25","overall","Dose-response: poor response to stimulation",10,1,5,TRUE,TRUE,"RD","double_zero"
"CD012693_pub3_data","26::overall","26","overall","Dose-response: normal response to stimulation",6,0,0,TRUE,TRUE,"OR_cc","default_or"
"CD012693_pub3_data","27::overall","27","overall","Dose-response: hyper-response to stimulation",12,1,10,TRUE,TRUE,"RD","double_zero"
"CD012693_pub3_data","28::overall","28","overall","Dose-response: cycle cancellations for poor response",12,0,6,TRUE,TRUE,"RD","sparse_events"
"CD012693_pub3_data","29::overall","29","overall","Dose-response: women with at least one transferable embryo",10,0,0,TRUE,TRUE,"OR_cc","default_or"
"CD012693_pub3_data","30::overall","30","overall","Dose-response: total dose of FSH",10,6,10,TRUE,TRUE,"RD","double_zero"
"CD012693_pub3_data","31::overall","31","overall","Dose-response: duration of FSH administration",12,8,12,TRUE,TRUE,"RD","double_zero"
"CD012693_pub3_data","32::overall","32","overall","Dose-response: cycle cancellations for poor or hyper-response",6,0,6,TRUE,TRUE,"RD","sparse_events"
"CD012693_pub3_data","33::overall","33","overall","Dose-response: women with at least one transferable embryo",4,0,0,TRUE,TRUE,"OR_cc","default_or"
"CD012712_pub2_data","1::overall","1","overall","Mortality before hospital discharge",59,15,23,TRUE,TRUE,"RD","double_zero"
"CD012712_pub2_data","2::overall","2","overall","Duration of respiratory support, days",97,8,18,TRUE,TRUE,"RD","double_zero"
"CD012712_pub2_data","3::overall","3","overall","Chronic lung disease at 36 weeks",40,0,8,TRUE,TRUE,"RD","sparse_events"
"CD012712_pub2_data","4::overall","4","overall","Pulmonary air leak syndromes",62,1,13,TRUE,TRUE,"RD","double_zero"
"CD012712_pub2_data","5::overall","5","overall","Length of hospital stay, days",49,25,35,TRUE,TRUE,"RD","double_zero"
"CD012712_pub2_data","6::overall","6","overall","Duration of oxygen therapy, days",40,21,27,TRUE,TRUE,"RD","double_zero"
"CD012712_pub2_data","7::overall","7","overall","Chronic lung disease at 36 weeks",27,0,6,TRUE,TRUE,"RD","sparse_events"
"CD012712_pub2_data","8::overall","8","overall","Death or chronic lung disease at 36 weeks",7,1,2,TRUE,TRUE,"RD","double_zero"
"CD012712_pub2_data","9::overall","9","overall","Patent ductus arteriosus",12,1,2,TRUE,TRUE,"RD","double_zero"
"CD012712_pub2_data","10::overall","10","overall","Pulmonary air leak syndromes",26,7,19,TRUE,TRUE,"RD","double_zero"
"CD012712_pub2_data","11::overall","11","overall","Proven sepsis",8,1,2,TRUE,TRUE,"RD","double_zero"
"CD012712_pub2_data","12::overall","12","overall","Necrotising enterocolitis",14,2,8,TRUE,TRUE,"RD","double_zero"
"CD012712_pub2_data","13::overall","13","overall","Necrotising enterocolitis (NEC) (Bell stage ≥ 2)",6,2,3,TRUE,TRUE,"RD","double_zero"
"CD012712_pub2_data","14::overall","14","overall","Spontaneous intestinal perforation",12,1,3,TRUE,TRUE,"RD","double_zero"
"CD012712_pub2_data","15::overall","15","overall","Intraventricular haemorrhage, any",16,2,9,TRUE,TRUE,"RD","double_zero"
"CD012712_pub2_data","16::overall","16","overall","Intraventricular haemorrhage, Papile grade 3/4",7,4,5,TRUE,TRUE,"RD","double_zero"
"CD012712_pub2_data","17::overall","17","overall","Periventricular leukomalacia",9,0,1,TRUE,TRUE,"RD","sparse_events"
"CD012712_pub2_data","18::overall","18","overall","Retinopathy of prematurity, any",7,0,1,TRUE,TRUE,"RD","sparse_events"
"CD012712_pub2_data","19::overall","19","overall","Retinopathy of prematurity, stage ≥ 3",9,8,8,FALSE,TRUE,"RD","double_zero"
"CD012712_pub2_data","20::overall","20","overall","Length of hospital stay, days",8,6,6,TRUE,TRUE,"RD","double_zero"
"CD012718_pub2_data","1::overall","1","overall","Primary caries prevention (at end of study follow-up)",20,17,17,TRUE,TRUE,"RD","double_zero"
"CD012718_pub2_data","2::overall","2","overall","Primary caries prevention (at end of study follow-up)",12,0,0,TRUE,TRUE,"OR_cc","default_or"
"CD012718_pub2_data","3::overall","3","overall","Caries arrest (at end of study follow-up)",9,8,8,FALSE,TRUE,"RD","double_zero"
"CD012718_pub2_data","4::overall","4","overall","Caries arrest (at end of study follow-up)",2,0,0,TRUE,TRUE,"OR_cc","default_or"
"CD012718_pub2_data","5::overall","5","overall","Secondary prevention of caries (at end of study follow-up; analysed with OR)",3,2,2,FALSE,TRUE,"RD","double_zero"
"CD012718_pub2_data","6::overall","6","overall","Secondary prevention of caries (at end of study follow-up; analysed using Peto OR)",2,0,0,TRUE,TRUE,"OR_cc","default_or"
"CD012718_pub2_data","7::overall","7","overall","Secondary prevention of caries (at end of study follow-up; analysed with OR)",2,0,0,TRUE,TRUE,"OR_cc","default_or"
"CD012718_pub2_data","8::overall","8","overall","Adverse effects",2,0,0,TRUE,TRUE,"OR_cc","default_or"
"CD012757_pub2_data","1::overall","1","overall","Mortality at longest follow-up",3,0,0,TRUE,TRUE,"OR_cc","default_or"
"CD012757_pub2_data","2::overall","2","overall","Mortality at 12 months' follow-up",2,0,0,TRUE,TRUE,"OR_cc","default_or"
"CD012757_pub2_data","3::overall","3","overall","Mortality at 24 months' follow-up",3,0,0,TRUE,TRUE,"OR_cc","default_or"
"CD012757_pub2_data","4::overall","4","overall","Mortality at 36 months' follow-up",2,0,0,TRUE,TRUE,"OR_cc","default_or"
"CD012757_pub2_data","6::overall","6","overall","Tumour response measures after treatment (overall response rate = complete response + partial response)",3,0,0,TRUE,TRUE,"OR_cc","default_or"
"CD012757_pub2_data","7::overall","7","overall","Tumour response measures after treatment (complete response)",2,0,0,TRUE,TRUE,"OR_cc","default_or"
"CD012757_pub2_data","8::overall","8","overall","Tumour response measures after treatment (partial response)",2,0,0,TRUE,TRUE,"OR_cc","default_or"
"CD012757_pub2_data","9::overall","9","overall","Tumour response measures after treatment (stable disease)",3,0,0,TRUE,TRUE,"OR_cc","default_or"
"CD012757_pub2_data","10::overall","10","overall","Tumour response measures after treatment (progressive disease)",3,0,0,TRUE,TRUE,"OR_cc","default_or"
"CD012850_pub2_data","1::overall","1","overall","Self-reported joint pain at rest (dichotomous data)",6,2,3,TRUE,TRUE,"RD","double_zero"
"CD012850_pub2_data","2::overall","2","overall","Self-reported joint pain at rest (continuous data)",8,6,8,TRUE,TRUE,"RD","double_zero"
"CD012850_pub2_data","3::overall","3","overall","Clinically assessed joint pain at rest",8,5,6,TRUE,TRUE,"RD","double_zero"
"CD012850_pub2_data","4::overall","4","overall","Clinically assessed joint pain at rest",6,3,3,TRUE,TRUE,"RD","double_zero"
"CD012850_pub2_data","5::overall","5","overall","Self-reported joint pain at mastication (dichotomous data)",4,1,1,TRUE,TRUE,"RD","double_zero"
"CD012850_pub2_data","6::overall","6","overall","Muscle pain at rest (dichotomous data)",5,2,3,TRUE,TRUE,"RD","double_zero"
"CD012850_pub2_data","7::overall","7","overall","Muscle pain at rest (continuous data)",3,1,2,TRUE,TRUE,"RD","double_zero"
"CD012850_pub2_data","8::overall","8","overall","Muscle pain at rest (continuous data)",3,2,2,FALSE,TRUE,"RD","double_zero"
"CD012850_pub2_data","11::overall","11","overall","Muscle pain at rest (continuous data)",3,2,2,FALSE,TRUE,"RD","double_zero"
"CD012850_pub2_data","12::overall","12","overall","Muscle pain at rest (continuous data)",2,1,1,FALSE,TRUE,"RD","double_zero"
"CD012850_pub2_data","13::overall","13","overall","Muscle pain at mastication (dichotomous data)",3,2,2,FALSE,TRUE,"RD","double_zero"
"CD012850_pub2_data","14::overall","14","overall","Muscle pain at mastication (dichotomous data)",2,1,1,FALSE,TRUE,"RD","double_zero"
"CD012850_pub2_data","15::overall","15","overall","Muscle pain at mastication (continuous data)",2,1,1,FALSE,TRUE,"RD","double_zero"
"CD012850_pub2_data","16::overall","16","overall","Severity of joint noise",3,1,2,TRUE,TRUE,"RD","double_zero"
"CD012850_pub2_data","17::overall","17","overall","Frequency of joint noise",6,0,0,TRUE,TRUE,"OR_cc","default_or"
"CD012850_pub2_data","18::overall","18","overall","Frequency of joint noise",4,2,2,TRUE,TRUE,"RD","double_zero"
"CD012850_pub2_data","19::overall","19","overall","Frequency of joint noise",3,2,2,FALSE,TRUE,"RD","double_zero"
"CD012850_pub2_data","20::overall","20","overall","Frequency of joint noise",4,2,2,TRUE,TRUE,"RD","double_zero"
"CD012891_pub2_data","3::overall","3","overall","Standard controlled ovarian hyperstimulation with gonadotropins + letrozole versus standard controlled ovarian hyperstimulation with gonadotropins + tamoxifen: number of oocytes retrieved after ovarian stimulation",6,2,4,TRUE,TRUE,"RD","double_zero"
"CD012891_pub2_data","1::1","1","1","Ovarian insufficiency grouped by strict or broad definition",6,0,1,TRUE,TRUE,"RD","sparse_events"
"CD012891_pub2_data","1::2","1","2","Ovarian insufficiency grouped by strict or broad definition",13,0,1,TRUE,TRUE,"RD","sparse_events"
"CD012891_pub2_data","4::overall","4","overall","Overall survival at 5 years",3,0,2,TRUE,TRUE,"RD","sparse_events"
"CD012891_pub2_data","7::overall","7","overall","Clinical pregnancy",7,0,4,TRUE,TRUE,"RD","sparse_events"
"CD012891_pub2_data","8::2","8","2","Clinical pregnancy grouped by receptor status",5,0,3,TRUE,TRUE,"RD","sparse_events"
"CD012905_pub2_data","1::overall","1","overall","Development of AKI",24,0,2,TRUE,TRUE,"RD","sparse_events"
"CD012905_pub2_data","2::overall","2","overall","Need for kidney replacement therapy",20,2,11,TRUE,TRUE,"RD","double_zero"
"CD012905_pub2_data","3::overall","3","overall","Death",16,4,9,TRUE,TRUE,"RD","double_zero"
"CD012905_pub2_data","6::overall","6","overall","Duration of ICU stay [days]",7,5,6,TRUE,TRUE,"RD","double_zero"
"CD012905_pub2_data","7::overall","7","overall","Adverse events",4,0,1,TRUE,TRUE,"RD","sparse_events"
"CD012905_pub2_data","8::overall","8","overall","Sensitivity analysis: development of AKI based on risk of attrition bias",8,0,1,TRUE,TRUE,"RD","sparse_events"
"CD012925_pub2_data","2::overall","2","overall","Provider adherence to recommended practice (continuous outcomes)",7,1,1,TRUE,TRUE,"RD","double_zero"
"CD012925_pub2_data","4::overall","4","overall","Patient/client health status and well-being (desirable outcomes)",13,12,12,FALSE,TRUE,"RD","double_zero"
"CD012925_pub2_data","5::overall","5","overall","Patient/client health status and well-being (undesirable outcomes)",20,14,14,TRUE,TRUE,"RD","double_zero"
"CD012925_pub2_data","6::overall","6","overall","Client utilisation of primary healthcare and/or services (risk ratio)",9,4,5,TRUE,TRUE,"RD","double_zero"
"CD012925_pub2_data","8::overall","8","overall","Client utilisation of primary health care and/or services (odds ratio)",7,5,5,TRUE,TRUE,"RD","double_zero"
"CD012942_pub2_data","1::overall","1","overall","Comparison 1 All antidepressants versus placebo, Outcome 1 Rate of treatment response measured as a reduction of at least 50% on the HAM-A",266,41,51,TRUE,TRUE,"RD","double_zero"
"CD012942_pub2_data","2::overall","2","overall","Comparison 2 Each class of antidepressant versus placebo, Outcome 1 Rate of treatment response measured as a reduction of at least 50% on the HAM-A",266,41,49,TRUE,TRUE,"RD","double_zero"
"CD012942_pub2_data","3::overall","3","overall","Comparison 3 Agomelatine versus placebo, Outcome 1 Rate of treatment response measured as a reduction of at least 50% on the HAM-A",28,4,5,TRUE,TRUE,"RD","double_zero"
"CD012942_pub2_data","4::overall","4","overall","Comparison 4 Duloxetine versus placebo, Outcome 1 Rate of treatment response measured as a reduction of at least 50% on the HAM-A",52,7,8,TRUE,TRUE,"RD","double_zero"
"CD012942_pub2_data","5::overall","5","overall","Comparison 5 Escitalopram versus placebo, Outcome 1 Rate of treatment response measured as a reduction of at least 50% on the HAM-A",57,7,9,TRUE,TRUE,"RD","double_zero"
"CD012942_pub2_data","6::overall","6","overall","Comparison 6 Sertraline versus placebo, Outcome 1 Rate of treatment response measured as a reduction of at least 50% on the HAM-A",44,2,3,TRUE,TRUE,"RD","double_zero"
"CD012942_pub2_data","7::overall","7","overall","Comparison 7 Venlafaxine versus placebo, Outcome 1 Rate of treatment response measured as a reduction of at least 50% on the HAM-A",35,7,8,TRUE,TRUE,"RD","double_zero"
"CD012942_pub2_data","8::overall","8","overall","Comparison 8 Vilazodone versus placebo, Outcome 1 Rate of treatment response measured as a reduction of at least 50% on the HAM-A",51,3,4,TRUE,TRUE,"RD","double_zero"
"CD012942_pub2_data","9::overall","9","overall","Comparison 9 Vortioxetine versus placebo, Outcome 1 Rate of treatment response measured as a reduction of at least 50% on the HAM-A",19,12,13,TRUE,TRUE,"RD","double_zero"
"CD012942_pub2_data","10::overall","10","overall","Comparison 10 Vortioxetine versus placebo, Outcome 2 Acceptability",6,1,1,TRUE,TRUE,"RD","double_zero"
"CD012967_pub2_data","5::overall","5","overall","Adverse events leading to cessation of treatment",3,0,2,TRUE,TRUE,"RD","sparse_events"
"CD012993_pub2_data","1::overall","1","overall","Change in 6MWT from baseline",9,8,9,FALSE,TRUE,"RD","double_zero"
"CD012993_pub2_data","3::overall","3","overall","Infusion reactions",4,2,2,TRUE,TRUE,"RD","double_zero"
"CD012993_pub2_data","4::overall","4","overall","Quality of life (measured by PCS in SF-36)",3,1,1,TRUE,TRUE,"RD","double_zero"
"CD012993_pub2_data","5::overall","5","overall","Treatment-related adverse events",8,7,7,FALSE,TRUE,"RD","double_zero"
"CD012993_pub2_data","7::overall","7","overall","Treatment-emergent adverse events - total",2,0,0,TRUE,TRUE,"OR_cc","default_or"
"CD012993_pub2_data","8::overall","8","overall","Treatment-emergent adverse events (breakdown 1)",6,0,2,TRUE,TRUE,"RD","sparse_events"
"CD012993_pub2_data","9::overall","9","overall","Treatment-emergent adverse events (breakdown 2)",13,0,0,TRUE,TRUE,"OR_cc","default_or"
"CD012997_pub3_data","1::overall","1","overall","Incidence of HUS",3,1,1,TRUE,TRUE,"RD","double_zero"
"CD013023_pub2_data","1::overall","1","overall","Arterial catheter failure",14,0,0,TRUE,TRUE,"OR_cc","default_or"
"CD013023_pub2_data","2::overall","2","overall","Dislodgement",15,3,12,TRUE,TRUE,"RD","double_zero"
"CD013023_pub2_data","3::overall","3","overall","Occlusion",13,0,4,TRUE,TRUE,"RD","sparse_events"
"CD013023_pub2_data","4::overall","4","overall","Adverse events",10,1,9,TRUE,TRUE,"RD","double_zero"
"CD013038_pub3_data","6::overall","6","overall","Necrotising enterocolitis during hospitalisation",2,0,0,TRUE,TRUE,"OR_cc","default_or"
"CD013038_pub3_data","7::overall","7","overall","Late infection during hospitalisation",2,0,1,TRUE,TRUE,"RD","sparse_events"
"CD013042_pub2_data","3::overall","3","overall","Mean grip strength (lb/in2)",22,17,17,TRUE,TRUE,"RD","double_zero"
"CD013042_pub2_data","4::overall","4","overall","Participant reported treatment success",40,1,2,TRUE,TRUE,"RD","double_zero"
"CD013042_pub2_data","5::overall","5","overall","Proportion of overall withdrawals",39,16,22,TRUE,TRUE,"RD","double_zero"
"CD013042_pub2_data","6::overall","6","overall","Proportion with any adverse event",17,5,8,TRUE,TRUE,"RD","double_zero"
"CD013042_pub2_data","8::overall","8","overall","Proportion on sick leave",2,0,0,TRUE,TRUE,"OR_cc","default_or"
"CD013051_pub3_data","1::1","1","1","Resolution of ear discharge",9,0,0,TRUE,TRUE,"OR_cc","default_or"
"CD013051_pub3_data","1::2","1","2","Resolution of ear discharge",2,0,0,TRUE,TRUE,"OR_cc","default_or"
"CD013051_pub3_data","2::1","2","1","Subgroup analysis: CSOM diagnosis",4,0,0,TRUE,TRUE,"OR_cc","default_or"
"CD013051_pub3_data","2::2","2","2","Subgroup analysis: CSOM diagnosis",2,0,0,TRUE,TRUE,"OR_cc","default_or"
"CD013052_pub3_data","1::1","1","1","Resolution of ear discharge at 1 to 2 weeks ",7,0,0,TRUE,TRUE,"OR_cc","default_or"
"CD013052_pub3_data","1::2","1","2","Resolution of ear discharge at 1 to 2 weeks ",3,0,0,TRUE,TRUE,"OR_cc","default_or"
"CD013052_pub3_data","1::3","1","3","Resolution of ear discharge at 1 to 2 weeks ",2,0,0,TRUE,TRUE,"OR_cc","default_or"
"CD013052_pub3_data","1::overall","1","overall","Resolution of ear discharge (1 to 2 weeks)",5,0,0,TRUE,TRUE,"OR_cc","default_or"
"CD013052_pub3_data","2::overall","2","overall","Resolution of ear discharge (2 to 4 weeks)",3,0,0,TRUE,TRUE,"OR_cc","default_or"
"CD013052_pub3_data","3::1","3","1","Subgroup analysis: CSOM diagnosis",6,0,2,TRUE,TRUE,"RD","sparse_events"
"CD013052_pub3_data","3::2","3","2","Subgroup analysis: CSOM diagnosis",6,1,1,TRUE,TRUE,"RD","double_zero"
"CD013052_pub3_data","5::1","5","1","Ototoxicity",2,1,2,FALSE,TRUE,"RD","double_zero"
"CD013052_pub3_data","2::1","2","1","Resolution of ear discharge (after 4 weeks)",4,0,0,TRUE,TRUE,"OR_cc","default_or"
"CD013053_pub3_data","1::1","1","1","Resolution of ear discharge",4,0,0,TRUE,TRUE,"OR_cc","default_or"
"CD013053_pub3_data","1::2","1","2","Resolution of ear discharge",2,0,0,TRUE,TRUE,"OR_cc","default_or"
"CD013053_pub3_data","2::1","2","1","Subgroup analyses: diagnosis of chronic suppurative otitis media (CSOM)",4,0,0,TRUE,TRUE,"OR_cc","default_or"
"CD013054_pub3_data","1::1","1","1","Resolution of ear discharge 2 to 4 weeks",13,0,0,TRUE,TRUE,"OR_cc","default_or"
"CD013054_pub3_data","1::2","1","2","Resolution of ear discharge 1 to 2 weeks",3,0,0,TRUE,TRUE,"OR_cc","default_or"
"CD013054_pub3_data","2::1","2","1","Resolution of ear discharge 2 to 4 weeks",10,0,1,TRUE,TRUE,"RD","sparse_events"
"CD013054_pub3_data","2::2","2","2","Resolution of ear discharge 2 to 4 weeks",3,0,0,TRUE,TRUE,"OR_cc","default_or"
"CD013054_pub3_data","3::1","3","1","Resolution of ear discharge 2 to 4 weeks",3,0,1,TRUE,TRUE,"RD","sparse_events"
"CD013054_pub3_data","7::1","7","1","Subgroup analysis: resolution of ear discharge - CSOM diagnosis",6,0,0,TRUE,TRUE,"OR_cc","default_or"
"CD013054_pub3_data","7::2","7","2","Subgroup analysis: resolution of ear discharge - CSOM diagnosis",2,0,0,TRUE,TRUE,"OR_cc","default_or"
"CD013054_pub3_data","1::overall","1","overall","Resolution of ear discharge 1 to 2 weeks",6,0,0,TRUE,TRUE,"OR_cc","default_or"
"CD013055_pub3_data","1::overall","1","overall","Resolution of ear discharge (2 to 4 weeks)",3,0,0,TRUE,TRUE,"OR_cc","default_or"
"CD013055_pub3_data","2::overall","2","overall","Resolution of ear discharge (after 4 weeks)",2,0,1,TRUE,TRUE,"RD","sparse_events"
"CD013056_pub3_data","1::1","1","1","Resolution of ear discharge (1–2 weeks)",8,0,0,TRUE,TRUE,"OR_cc","default_or"
"CD013056_pub3_data","2::1","2","1","Resolution of ear discharge (2–4 weeks)",6,0,0,TRUE,TRUE,"OR_cc","default_or"
"CD013056_pub3_data","3::1","3","1","Ear pain, discomfort, irritation",3,1,2,TRUE,TRUE,"RD","double_zero"
"CD013056_pub3_data","3::2","3","2","Ear pain, discomfort, irritation",2,0,2,TRUE,TRUE,"RD","sparse_events"
"CD013057_pub3_data","1::overall","1","overall","Resolution of ear discharge (after 4 weeks)",2,0,0,TRUE,TRUE,"OR_cc","default_or"
"CD013059_pub2_data","2::overall","2","overall","Treatment non-acceptability",37,32,35,TRUE,TRUE,"RD","double_zero"
"CD013071_pub2_data","2::overall","2","overall","Erectile function (IIEF)",18,16,17,TRUE,TRUE,"RD","double_zero"
"CD013071_pub2_data","5::overall","5","overall","Sexual quality of life (IIEF-overall satisfaction)",7,4,5,TRUE,TRUE,"RD","double_zero"
"CD013071_pub2_data","6::overall","6","overall","Cardiovascular mortality",13,6,13,TRUE,TRUE,"RD","double_zero"
"CD013071_pub2_data","7::overall","7","overall","Treatment withdrawal due to adverse events",23,7,18,TRUE,TRUE,"RD","double_zero"
"CD013071_pub2_data","8::overall","8","overall","Prostate-related events",11,4,5,TRUE,TRUE,"RD","double_zero"
"CD013071_pub2_data","11::overall","11","overall","Cardiovascular mortality (subgroup: age and testosterone level)",10,5,10,TRUE,TRUE,"RD","double_zero"
"CD013071_pub2_data","15::overall","15","overall","Cardiovascular mortality (subgroup: metabolic syndrome (MS))",10,5,10,TRUE,TRUE,"RD","double_zero"
"CD013071_pub2_data","19::overall","19","overall","Treatment withdrawal due to adverse events (sensitivity analysis)",12,1,8,TRUE,TRUE,"RD","double_zero"
"CD013071_pub2_data","20::overall","20","overall","Prostate-related events (sensitivity analysis)",10,3,4,TRUE,TRUE,"RD","double_zero"
"CD013105_pub2_data","1::overall","1","overall","Awareness of prolapse ",2,0,0,TRUE,TRUE,"OR_cc","default_or"
"CD013105_pub2_data","2::1","2","1","Repeat surgery for recurrent prolapse",7,2,3,TRUE,TRUE,"RD","double_zero"
"CD013105_pub2_data","3::overall","3","overall","Objective failure at any site ",3,1,1,TRUE,TRUE,"RD","double_zero"
"CD013105_pub2_data","4::1","4","1","POP-Q assessment ",2,1,1,FALSE,TRUE,"RD","double_zero"
"CD013105_pub2_data","4::2","4","2","POP-Q assessment ",4,3,3,FALSE,TRUE,"RD","double_zero"
"CD013105_pub2_data","4::3","4","3","POP-Q assessment ",5,4,4,FALSE,TRUE,"RD","double_zero"
"CD013105_pub2_data","1::1","1","1","Bladder function ",11,2,5,TRUE,TRUE,"RD","double_zero"
"CD013105_pub2_data","1::2","1","2","Bladder function ",4,2,2,TRUE,TRUE,"RD","double_zero"
"CD013105_pub2_data","3::1","3","1","Perioperative outcomes ",7,3,3,TRUE,TRUE,"RD","double_zero"
"CD013111_pub2_data","1::overall","1","overall","Metformin plus progestin compared to progestin. Live birth rate. RCTs",4,0,1,TRUE,TRUE,"RD","sparse_events"
"CD013111_pub2_data","2::overall","2","overall","Metformin plus progestin compared to progestin. Complete pathological response rate (12-16 weeks). RCTs",4,0,0,TRUE,TRUE,"OR_cc","default_or"
"CD013111_pub2_data","3::overall","3","overall","Metformin plus progestin compared to progestin.  Pregnancy rate. RCTs",4,0,1,TRUE,TRUE,"RD","sparse_events"
"CD013111_pub2_data","4::overall","4","overall","Metformin plus progestin compared to progestin. Surgery for persistent/progressive disease (hysterectomy). RCTs",4,0,2,TRUE,TRUE,"RD","sparse_events"
"CD013111_pub2_data","5::overall","5","overall","Metformin plus progestin compared to progestin. Severe adverse events grade 3-4.",2,0,0,TRUE,TRUE,"OR_cc","default_or"
"CD013158_pub2_data","1::overall","1","overall","Mortality prior to hospital discharge",3,1,1,TRUE,TRUE,"RD","double_zero"
"CD013158_pub2_data","2::overall","2","overall","Bronchopulmonary dysplasia",3,0,0,TRUE,TRUE,"OR_cc","default_or"
"CD013158_pub2_data","3::overall","3","overall","Surfactant utilization (number of infants receiving surfactant)",3,0,0,TRUE,TRUE,"OR_cc","default_or"
"CD013158_pub2_data","4::overall","4","overall","Any pneumothorax",2,0,1,TRUE,TRUE,"RD","sparse_events"
"CD013158_pub2_data","5::overall","5","overall","Retinopathy of prematurity (all grades)",2,0,0,TRUE,TRUE,"OR_cc","default_or"
"CD013166_pub3_data","2::overall","2","overall","Discontinuation from treatment",43,26,34,TRUE,TRUE,"RD","double_zero"
"CD013166_pub3_data","3::overall","3","overall","Treatment-related adverse events",37,33,36,TRUE,TRUE,"RD","double_zero"
"CD013197_pub2_data","1::overall","1","overall","All-cause mortality short-term",14,10,13,TRUE,TRUE,"RD","double_zero"
"CD013197_pub2_data","2::overall","2","overall","Health-related quality of life short-term",2,0,1,TRUE,TRUE,"RD","sparse_events"
"CD013197_pub2_data","4::overall","4","overall","Serious adverse events (SAEs) start of surgery until eight hours after surgery",21,7,16,TRUE,TRUE,"RD","double_zero"
"CD013197_pub2_data","5::overall","5","overall","Serious adverse events (SAEs) short-term",16,2,11,TRUE,TRUE,"RD","double_zero"
"CD013197_pub2_data","6::overall","6","overall","Non-serious adverse events (nSAEs) start of surgery until eight hours after surgery",11,3,6,TRUE,TRUE,"RD","double_zero"
"CD013197_pub2_data","7::overall","7","overall","Non-serious adverse events (nSAEs) short-term",11,2,4,TRUE,TRUE,"RD","double_zero"
"CD013197_pub2_data","8::overall","8","overall","Readmissions within three months after surgery",6,1,5,TRUE,TRUE,"RD","double_zero"
"CD013197_pub2_data","18::overall","18","overall","Serious adverse events (sensitivity analysis)",72,8,41,TRUE,TRUE,"RD","double_zero"
"CD013197_pub2_data","19::overall","19","overall","Non-serious adverse events (sensitivity analysis)",44,6,12,TRUE,TRUE,"RD","double_zero"
"CD013232_pub2_data","1::overall","1","overall","Irritability",84,80,84,TRUE,TRUE,"RD","double_zero"
"CD013232_pub2_data","2::overall","2","overall","Relapse",32,10,22,TRUE,TRUE,"RD","double_zero"
"CD013232_pub2_data","3::overall","3","overall","Improvement",168,3,88,TRUE,TRUE,"RD","double_zero"
"CD013232_pub2_data","4::overall","4","overall","Aggression",104,3,52,TRUE,TRUE,"RD","double_zero"
"CD013232_pub2_data","5::overall","5","overall","Self-injury",94,5,52,TRUE,TRUE,"RD","double_zero"
"CD013232_pub2_data","6::overall","6","overall","Adverse effects: cardiovascular",63,2,33,TRUE,TRUE,"RD","double_zero"
"CD013232_pub2_data","7::overall","7","overall","Adverse effects: gastrointestinal",222,2,107,TRUE,TRUE,"RD","double_zero"
"CD013232_pub2_data","8::overall","8","overall","Adverse effects: immune system",166,2,70,TRUE,TRUE,"RD","double_zero"
"CD013232_pub2_data","9::overall","9","overall","Adverse effects: metabolic (dichotomous)",143,0,71,TRUE,TRUE,"RD","sparse_events"
"CD013232_pub2_data","10::overall","10","overall","Adverse effects: metabolic (continuous)",46,2,19,TRUE,TRUE,"RD","double_zero"
"CD013232_pub2_data","11::overall","11","overall","Adverse effects: musculoskeletal",61,1,38,TRUE,TRUE,"RD","double_zero"
"CD013232_pub2_data","12::overall","12","overall","Adverse effects: neurological",86,0,39,TRUE,TRUE,"RD","sparse_events"
"CD013232_pub2_data","13::overall","13","overall","Adverse effects: psychological",26,1,12,TRUE,TRUE,"RD","double_zero"
"CD013232_pub2_data","14::overall","14","overall","Adverse effects: respiratory",72,8,36,TRUE,TRUE,"RD","double_zero"
"CD013232_pub2_data","15::overall","15","overall","Adverse effects: skin",48,43,47,TRUE,TRUE,"RD","double_zero"
"CD013232_pub2_data","16::overall","16","overall","Adverse effects: urinary",61,40,53,TRUE,TRUE,"RD","double_zero"
"CD013232_pub2_data","18::overall","18","overall","Tolerability/acceptability: loss to follow-up",20,5,8,TRUE,TRUE,"RD","double_zero"
"CD013255_pub2_data","1::overall","1","overall","Sinus rhythm until hospital discharge or end of study follow-up (paroxysmal AF)",49,0,0,TRUE,TRUE,"OR_cc","default_or"
"CD013255_pub2_data","2::overall","2","overall","Acute procedural success (paroxysmal AF)",41,4,4,TRUE,TRUE,"RD","double_zero"
"CD013255_pub2_data","3::overall","3","overall","Acute procedural success (paroxysmal AF)",22,12,15,TRUE,TRUE,"RD","double_zero"
"CD013255_pub2_data","4::overall","4","overall","30-day cardiovascular mortality",12,8,12,TRUE,TRUE,"RD","double_zero"
"CD013255_pub2_data","5::overall","5","overall","Stroke or systemic embolism at 30 days",10,7,10,TRUE,TRUE,"RD","double_zero"
"CD013255_pub2_data","6::overall","6","overall","Acute procedural success (paroxysmal AF)",7,0,0,TRUE,TRUE,"OR_cc","default_or"
"CD013278_pub3_data","1::1","1","1","All-cause mortality during hospital stay",7,0,0,TRUE,TRUE,"OR_cc","default_or"
"CD013278_pub3_data","1::2","1","2","All-cause mortality during hospital stay",8,1,1,TRUE,TRUE,"RD","double_zero"
"CD013278_pub3_data","2::1","2","1","Surgical PDA ligation or transcatheter occlusion",4,1,3,TRUE,TRUE,"RD","double_zero"
"CD013278_pub3_data","2::2","2","2","Surgical PDA ligation or transcatheter occlusion",7,0,1,TRUE,TRUE,"RD","sparse_events"
"CD013278_pub3_data","3::1","3","1","Receipt of any pharmacotherapy for a hs-PDA",4,0,0,TRUE,TRUE,"OR_cc","default_or"
"CD013278_pub3_data","3::2","3","2","Receipt of any pharmacotherapy for a hs-PDA",5,0,0,TRUE,TRUE,"OR_cc","default_or"
"CD013278_pub3_data","4::1","4","1","Receipt of rescue medical treatment for a hs-PDA",3,0,3,TRUE,TRUE,"RD","sparse_events"
"CD013278_pub3_data","4::2","4","2","Receipt of rescue medical treatment for a hs-PDA",4,0,1,TRUE,TRUE,"RD","sparse_events"
"CD013278_pub3_data","5::1","5","1","Chronic lung disease (CLD)",3,0,0,TRUE,TRUE,"OR_cc","default_or"
"CD013278_pub3_data","5::2","5","2","Chronic lung disease (CLD)",3,0,2,TRUE,TRUE,"RD","sparse_events"
"CD013278_pub3_data","9::1","9","1","Pneumothorax",2,0,0,TRUE,TRUE,"OR_cc","default_or"
"CD013278_pub3_data","9::2","9","2","Pneumothorax",4,0,0,TRUE,TRUE,"OR_cc","default_or"
"CD013278_pub3_data","10::1","10","1","Intraventricular hemorrhage (IVH; grades I to IV)",4,1,1,TRUE,TRUE,"RD","double_zero"
"CD013278_pub3_data","10::2","10","2","Intraventricular hemorrhage (IVH; grades I to IV)",2,1,1,FALSE,TRUE,"RD","double_zero"
"CD013278_pub3_data","11::overall","11","overall","Severe IVH (grades III and IV)",2,0,1,TRUE,TRUE,"RD","sparse_events"
"CD013278_pub3_data","12::1","12","1","Periventricular leukomalacia (PVL; any grade)",3,0,0,TRUE,TRUE,"OR_cc","default_or"
"CD013278_pub3_data","12::2","12","2","Periventricular leukomalacia (PVL; any grade)",2,0,0,TRUE,TRUE,"OR_cc","default_or"
"CD013278_pub3_data","13::1","13","1","Necrotizing enterocolitis (NEC; stage 2 or greater)",4,0,1,TRUE,TRUE,"RD","sparse_events"
"CD013278_pub3_data","13::2","13","2","Necrotizing enterocolitis (NEC; stage 2 or greater)",6,0,1,TRUE,TRUE,"RD","sparse_events"
"CD013278_pub3_data","14::1","14","1","Spontaneous intestinal perforation",2,0,2,TRUE,TRUE,"RD","sparse_events"
"CD013278_pub3_data","14::2","14","2","Spontaneous intestinal perforation",7,1,3,TRUE,TRUE,"RD","double_zero"
"CD013278_pub3_data","17::1","17","1","Severe retinopathy of prematurity (ROP)",2,1,2,FALSE,TRUE,"RD","double_zero"
"CD013278_pub3_data","17::2","17","2","Severe retinopathy of prematurity (ROP)",2,1,1,FALSE,TRUE,"RD","double_zero"
"CD013278_pub3_data","18::1","18","1","Definite sepsis",4,2,2,TRUE,TRUE,"RD","double_zero"
"CD013278_pub3_data","18::2","18","2","Definite sepsis",6,0,1,TRUE,TRUE,"RD","sparse_events"
"CD013278_pub3_data","19::1","19","1","Oliguria",3,2,2,FALSE,TRUE,"RD","double_zero"
"CD013278_pub3_data","19::2","19","2","Oliguria",2,1,1,FALSE,TRUE,"RD","double_zero"
"CD013278_pub3_data","5::3","5","3","Receipt of rescue medical treatment for a hs-PDA",2,0,0,TRUE,TRUE,"OR_cc","default_or"
"CD013278_pub3_data","6::1","6","1","Chronic lung disease (CLD)",4,0,2,TRUE,TRUE,"RD","sparse_events"
"CD013278_pub3_data","6::2","6","2","Chronic lung disease (CLD)",5,0,0,TRUE,TRUE,"OR_cc","default_or"
"CD013278_pub3_data","11::1","11","1","Pulmonary hemorrhage",2,0,1,TRUE,TRUE,"RD","sparse_events"
"CD013278_pub3_data","11::2","11","2","Pulmonary hemorrhage",5,0,1,TRUE,TRUE,"RD","sparse_events"
"CD013278_pub3_data","15::1","15","1","PVL (any grade)",2,1,1,FALSE,TRUE,"RD","double_zero"
"CD013278_pub3_data","15::2","15","2","PVL (any grade)",5,0,1,TRUE,TRUE,"RD","sparse_events"
"CD013278_pub3_data","16::1","16","1","NEC (stage 2 or greater)",2,0,2,TRUE,TRUE,"RD","sparse_events"
"CD013278_pub3_data","16::2","16","2","NEC (stage 2 or greater)",5,0,0,TRUE,TRUE,"OR_cc","default_or"
"CD013278_pub3_data","17::3","17","3","Gastrointestinal bleeding within seven days of the first dose of pharmacotherapy",2,0,0,TRUE,TRUE,"OR_cc","default_or"
"CD013278_pub3_data","20::1","20","1","Severe ROP",2,1,2,FALSE,TRUE,"RD","double_zero"
"CD013278_pub3_data","20::2","20","2","Severe ROP",4,0,0,TRUE,TRUE,"OR_cc","default_or"
"CD013278_pub3_data","21::1","21","1","Definite sepsis",2,0,0,TRUE,TRUE,"OR_cc","default_or"
"CD013278_pub3_data","21::2","21","2","Definite sepsis",5,0,1,TRUE,TRUE,"RD","sparse_events"
"CD013278_pub3_data","24::overall","24","overall","Moderate/severe neurodevelopmental impairment at 18 to 24 months",2,0,0,TRUE,TRUE,"OR_cc","default_or"
"CD013284_pub2_data","12::overall","12","overall","Proportion of participants with one or more serious adverse event of any cause",5,0,1,TRUE,TRUE,"RD","sparse_events"
"CD013284_pub2_data","13::overall","13","overall","Mortality (all-cause)",6,2,3,TRUE,TRUE,"RD","double_zero"
"CD013284_pub2_data","14::overall","14","overall","Mortality (all-cause), risk difference",6,2,3,TRUE,TRUE,"RD","double_zero"
"CD013284_pub2_data","15::overall","15","overall","Mortality (respiratory)",5,4,4,FALSE,TRUE,"RD","double_zero"
"CD013284_pub2_data","16::overall","16","overall","Mortality (respiratory), risk difference",5,4,4,FALSE,TRUE,"RD","double_zero"
"CD013294_pub2_data","2::overall","2","overall","Severe retinopathy of prematurity",3,2,2,FALSE,TRUE,"RD","double_zero"
"CD013294_pub2_data","3::overall","3","overall","Chronic lung disease or bronchopulmonary dysplasia",3,2,2,FALSE,TRUE,"RD","double_zero"
"CD013295_pub2_data","1::overall","1","overall","Need for allogeneic blood transfusion (only trials included in the NMA)",219,53,110,TRUE,TRUE,"RD","double_zero"
"CD013295_pub2_data","2::overall","2","overall","Units of red blood cells transfused (only trials included in the NMA)",83,74,83,TRUE,TRUE,"RD","double_zero"
"CD013295_pub2_data","3::overall","3","overall","Risk of experiencing DVT (only trials included in the NMA)",108,74,89,TRUE,TRUE,"RD","double_zero"
"CD013295_pub2_data","4::overall","4","overall","Length of hospital stay (only trials included in the NMA)",120,100,117,TRUE,TRUE,"RD","double_zero"
"CD013295_pub2_data","5::overall","5","overall","Length of hospital stay",100,89,94,TRUE,TRUE,"RD","double_zero"
"CD013295_pub2_data","6::overall","6","overall","Risk of experiencing DVT",124,93,119,TRUE,TRUE,"RD","double_zero"
"CD013295_pub2_data","7::overall","7","overall","Risk of experiencing PE",87,75,87,TRUE,TRUE,"RD","double_zero"
"CD013295_pub2_data","8::overall","8","overall","Risk of experiencing MI",41,31,41,TRUE,TRUE,"RD","double_zero"
"CD013295_pub2_data","9::overall","9","overall","Risk of experiencing CVA",26,24,26,TRUE,TRUE,"RD","double_zero"
"CD013295_pub2_data","10::overall","10","overall","Risk of having suspected serious drug reactions",8,7,7,FALSE,TRUE,"RD","double_zero"
"CD013303_pub2_data","2::overall","2","overall","HIV health literacy: recognition of HIV terms (short-term: immediately post-intervention)",9,8,8,FALSE,TRUE,"RD","double_zero"
"CD013303_pub2_data","3::overall","3","overall","Health-related knowledge: HIV global disease/treatment knowledge, 0 to 100 (short-term: immediately post-intervention)",13,12,12,FALSE,TRUE,"RD","double_zero"
"CD013303_pub2_data","4::overall","4","overall","Health-related knowledge: HIV knowledge, risk of getting sicker (short-term: immediately post-intervention)",12,10,10,TRUE,TRUE,"RD","double_zero"
"CD013303_pub2_data","5::overall","5","overall","Health outcomes: subjective health status (short-term: immediately post-intervention)",8,6,6,TRUE,TRUE,"RD","double_zero"
"CD013303_pub2_data","6::overall","6","overall","Health behaviour: blood glucose self-monitoring 2 times per day (capped at 2), self-report (short-term: immediately post-intervention)",11,7,7,TRUE,TRUE,"RD","double_zero"
"CD013303_pub2_data","11::overall","11","overall","Any health-related knowledge, 0 to 100 (short-term: immediately post-intervention) - by subgroup length of programme",8,6,6,TRUE,TRUE,"RD","double_zero"
"CD013303_pub2_data","12::overall","12","overall","Any health-related knowledge, 0 to 100 (short-term: immediately post-intervention) - studies without high risk of bias",4,3,3,FALSE,TRUE,"RD","double_zero"
"CD013303_pub2_data","15::overall","15","overall","Health outcome: any depression (short-term: immediately post-intervention)",5,4,4,FALSE,TRUE,"RD","double_zero"
"CD013331_pub2_data","2::overall","2","overall","Adverse effects: high-frequency TENS versus placebo or no treatment",6,5,6,FALSE,TRUE,"RD","double_zero"
"CD013331_pub2_data","4::overall","4","overall","Requirements for additional analgesics - number of women: high-frequency TENS versus placebo or no treatment",5,1,1,TRUE,TRUE,"RD","double_zero"
"CD013331_pub2_data","5::overall","5","overall","Limitation of daily activities: high-frequency TENS versus placebo or no treatment",2,0,0,TRUE,TRUE,"OR_cc","default_or"
"CD013331_pub2_data","6::overall","6","overall","Absence from work or school: high-frequency TENS versus placebo or no treatment",2,1,1,FALSE,TRUE,"RD","double_zero"
"CD013332_pub2_data","1::overall","1","overall","SSI",35,0,8,TRUE,TRUE,"RD","sparse_events"
"CD013332_pub2_data","2::overall","2","overall","All-cause mortality",22,0,6,TRUE,TRUE,"RD","sparse_events"
"CD013332_pub2_data","4::overall","4","overall","Adverse effects: Hypoglycaemia",4,0,2,TRUE,TRUE,"RD","sparse_events"
"CD013342_pub2_data","3::1","3","1","Mean function (0 to 100, 0 is best function)",10,9,9,FALSE,TRUE,"RD","double_zero"
"CD013342_pub2_data","4::1","4","1","Mean function by cell origin (0 to 100, 0 is best function)",5,4,4,FALSE,TRUE,"RD","double_zero"
"CD013342_pub2_data","6::overall","6","overall","Participant-reported global assessment of success",16,6,10,TRUE,TRUE,"RD","double_zero"
"CD013342_pub2_data","8::overall","8","overall","Withdrawals due to adverse events",8,5,7,TRUE,TRUE,"RD","double_zero"
"CD013342_pub2_data","9::overall","9","overall","Serious adverse events",8,5,8,TRUE,TRUE,"RD","double_zero"
"CD013342_pub2_data","10::overall","10","overall","Total adverse events",8,0,3,TRUE,TRUE,"RD","sparse_events"
"CD013342_pub2_data","3::overall","3","overall","Participant-reported global assessment of success",5,3,4,TRUE,TRUE,"RD","double_zero"
"CD013342_pub2_data","4::overall","4","overall","Withdrawals due to adverse events",6,2,3,TRUE,TRUE,"RD","double_zero"
"CD013342_pub2_data","5::overall","5","overall","Serious adverse events",13,4,9,TRUE,TRUE,"RD","double_zero"
"CD013342_pub2_data","7::overall","7","overall","MRI joint progression (bone marrow lesions)",9,1,3,TRUE,TRUE,"RD","double_zero"
"CD013344_pub2_data","1::overall","1","overall","Graft loss",14,0,10,TRUE,TRUE,"RD","sparse_events"
"CD013344_pub2_data","2::overall","2","overall","Persistence of decoy cells/viraemia at 12 months",13,1,3,TRUE,TRUE,"RD","double_zero"
"CD013344_pub2_data","3::overall","3","overall","Serum creatinine [µmol/L]",11,4,4,TRUE,TRUE,"RD","double_zero"
"CD013344_pub2_data","4::overall","4","overall","BK viraemia at end of study (8 to 12 months)",10,2,3,TRUE,TRUE,"RD","double_zero"
"CD013344_pub2_data","5::overall","5","overall","Sustained BK viraemia",9,2,4,TRUE,TRUE,"RD","double_zero"
"CD013344_pub2_data","6::overall","6","overall","BK viruria",6,1,3,TRUE,TRUE,"RD","double_zero"
"CD013344_pub2_data","7::overall","7","overall","Viral load reduction at 6 months",4,0,1,TRUE,TRUE,"RD","sparse_events"
"CD013344_pub2_data","8::overall","8","overall","Viral load > 10,000 copies/mL",4,1,1,TRUE,TRUE,"RD","double_zero"
"CD013344_pub2_data","9::overall","9","overall","Initial BK titre copies/L",3,1,2,TRUE,TRUE,"RD","double_zero"
"CD013344_pub2_data","10::overall","10","overall","BK virus-associated nephropathy (BKVAN)",6,1,2,TRUE,TRUE,"RD","double_zero"
"CD013344_pub2_data","11::overall","11","overall","Donor-specific antibodies",7,0,1,TRUE,TRUE,"RD","sparse_events"
"CD013344_pub2_data","12::overall","12","overall","Death",3,1,3,TRUE,TRUE,"RD","double_zero"
"CD013344_pub2_data","14::overall","14","overall","Infection",4,1,2,TRUE,TRUE,"RD","double_zero"
"CD013344_pub2_data","15::overall","15","overall","Therapy-related adverse events: tendonitis",2,0,1,TRUE,TRUE,"RD","sparse_events"
"CD013355_pub2_data","2::overall","2","overall","Pulmonary outcome: chronic lung disease",2,0,0,TRUE,TRUE,"OR_cc","default_or"
"CD013355_pub2_data","3::overall","3","overall","Haemodynamic outcome: arterial hypotension",2,0,0,TRUE,TRUE,"OR_cc","default_or"
"CD013355_pub2_data","4::overall","4","overall","Neurological outcome: periventricular leukomalacia",3,0,2,TRUE,TRUE,"RD","sparse_events"
"CD013355_pub2_data","5::overall","5","overall","Neurological outcome: overall intraventricular haemorrhage",2,0,0,TRUE,TRUE,"OR_cc","default_or"
"CD013355_pub2_data","6::overall","6","overall","Neurological outcome: severe intraventricular haemorrhage",4,0,2,TRUE,TRUE,"RD","sparse_events"
"CD013355_pub2_data","7::overall","7","overall","28-day mortality",4,0,1,TRUE,TRUE,"RD","sparse_events"
"CD013358_pub2_data","1::overall","1","overall","Systolic blood pressure (mmHg), change from baseline",28,26,26,TRUE,TRUE,"RD","double_zero"
"CD013358_pub2_data","8::overall","8","overall","LDL cholesterol (mmol/L), change from baseline",7,6,7,FALSE,TRUE,"RD","double_zero"
"CD013358_pub2_data","15::overall","15","overall","Smoking cessation",10,4,4,TRUE,TRUE,"RD","double_zero"
"CD013358_pub2_data","17::overall","17","overall","Self-efficacy, change from baseline",6,4,4,TRUE,TRUE,"RD","double_zero"
"CD013366_pub2_data","1::overall","1","overall","Venous thromboembolism",13,0,6,TRUE,TRUE,"RD","sparse_events"
"CD013366_pub2_data","2::overall","2","overall","Venous thromboembolism (subgroup analysis - age)",22,0,8,TRUE,TRUE,"RD","sparse_events"
"CD013366_pub2_data","3::overall","3","overall","Venous thromboembolism (sensitivity analysis)",14,1,6,TRUE,TRUE,"RD","double_zero"
"CD013366_pub2_data","4::overall","4","overall","PICC-associated BSI",14,1,7,TRUE,TRUE,"RD","double_zero"
"CD013366_pub2_data","5::overall","5","overall","Occlusion",16,2,8,TRUE,TRUE,"RD","double_zero"
"CD013366_pub2_data","6::overall","6","overall","Occlusion (subgroup analyses - age)",16,3,4,TRUE,TRUE,"RD","double_zero"
"CD013366_pub2_data","7::overall","7","overall","Occlusion (sensitivity analyses)",13,3,5,TRUE,TRUE,"RD","double_zero"
"CD013366_pub2_data","8::overall","8","overall","All-cause mortality",6,3,5,TRUE,TRUE,"RD","double_zero"
"CD013366_pub2_data","9::overall","9","overall","Catheter failure",5,0,2,TRUE,TRUE,"RD","sparse_events"
"CD013366_pub2_data","10::overall","10","overall","Catheter failure (sensitivity analyses)",6,0,2,TRUE,TRUE,"RD","sparse_events"
"CD013366_pub2_data","11::overall","11","overall","Incidence of PICC-related BSI",2,1,1,FALSE,TRUE,"RD","double_zero"
"CD013366_pub2_data","12::overall","12","overall","Catheter breakage",4,1,3,TRUE,TRUE,"RD","double_zero"
"CD013366_pub2_data","13::overall","13","overall","Catheter breakage (sensitivity analyses)",6,2,5,TRUE,TRUE,"RD","double_zero"
"CD013377_pub2_data","1::overall","1","overall","Overall survival",9,7,7,TRUE,TRUE,"RD","double_zero"
"CD013377_pub2_data","2::overall","2","overall","Progression-free survival ",8,5,6,TRUE,TRUE,"RD","double_zero"
"CD013377_pub2_data","3::overall","3","overall","Adverse events grades 3 to 5 (Participants with at least one serious adverse event)",6,1,2,TRUE,TRUE,"RD","double_zero"
"CD013377_pub2_data","4::overall","4","overall","Survival rates at 3 years",3,0,0,TRUE,TRUE,"OR_cc","default_or"
"CD013377_pub2_data","5::overall","5","overall","Health-related quality of life",2,1,1,FALSE,TRUE,"RD","double_zero"
"CD013396_pub2_data","1::overall","1","overall","Asthma",14,0,2,TRUE,TRUE,"RD","sparse_events"
"CD013396_pub2_data","2::overall","2","overall","Wheeze",15,0,1,TRUE,TRUE,"RD","sparse_events"
"CD013396_pub2_data","3::overall","3","overall","Atopic dermatitis",8,0,1,TRUE,TRUE,"RD","sparse_events"
"CD013396_pub2_data","4::1","4","1","Adverse events",7,2,5,TRUE,TRUE,"RD","double_zero"
"CD013396_pub2_data","4::2","4","2","Adverse events",7,4,5,TRUE,TRUE,"RD","double_zero"
"CD013396_pub2_data","4::3","4","3","Adverse events",6,3,3,TRUE,TRUE,"RD","double_zero"
"CD013396_pub2_data","4::4","4","4","Adverse events",2,0,1,TRUE,TRUE,"RD","sparse_events"
"CD013396_pub2_data","4::5","4","5","Adverse events",4,0,3,TRUE,TRUE,"RD","sparse_events"
"CD013396_pub2_data","4::6","4","6","Adverse events",2,0,0,TRUE,TRUE,"OR_cc","default_or"
"CD013396_pub2_data","4::7","4","7","Adverse events",2,0,1,TRUE,TRUE,"RD","sparse_events"
"CD013396_pub2_data","4::8","4","8","Adverse events",2,0,0,TRUE,TRUE,"OR_cc","default_or"
"CD013396_pub2_data","5::overall","5","overall","Any airway infection",11,0,0,TRUE,TRUE,"OR_cc","default_or"
"CD013396_pub2_data","6::overall","6","overall","Lower respiratory tract infection",9,0,0,TRUE,TRUE,"OR_cc","default_or"
"CD013396_pub2_data","7::overall","7","overall","Upper respiratory tract infection",9,0,0,TRUE,TRUE,"OR_cc","default_or"
"CD013396_pub2_data","8::overall","8","overall","Allergic sensitisation – total IgE (continuous)",4,2,2,TRUE,TRUE,"RD","double_zero"
"CD013396_pub2_data","9::overall","9","overall","Allergic sensitisation – skin prick against common allergens",4,0,0,TRUE,TRUE,"OR_cc","default_or"
"CD013396_pub2_data","10::overall","10","overall","Airway inflammation – eosinophil counts (continuous)",3,1,1,TRUE,TRUE,"RD","double_zero"
"CD013396_pub2_data","4::overall","4","overall","Atopic dermatitis",3,0,1,TRUE,TRUE,"RD","sparse_events"
"CD013396_pub2_data","5::1","5","1","Adverse events",2,1,2,FALSE,TRUE,"RD","double_zero"
"CD013396_pub2_data","5::4","5","4","Adverse events",2,0,1,TRUE,TRUE,"RD","sparse_events"
"CD013396_pub2_data","5::5","5","5","Adverse events",2,0,0,TRUE,TRUE,"OR_cc","default_or"
"CD013396_pub2_data","5::6","5","6","Adverse events",2,0,1,TRUE,TRUE,"RD","sparse_events"
"CD013396_pub2_data","5::7","5","7","Adverse events",2,0,0,TRUE,TRUE,"OR_cc","default_or"
"CD013396_pub2_data","5::8","5","8","Adverse events",2,0,0,TRUE,TRUE,"OR_cc","default_or"
"CD013408_pub2_data","1::overall","1","overall","All-cause mortality",5,0,0,TRUE,TRUE,"OR_cc","default_or"
"CD013408_pub2_data","2::overall","2","overall","All-cause mortality - sensitivity analysis",3,0,0,TRUE,TRUE,"OR_cc","default_or"
"CD013408_pub2_data","3::overall","3","overall","All-cause hospitalisation",2,0,0,TRUE,TRUE,"OR_cc","default_or"
"CD013408_pub2_data","5::overall","5","overall","Cardiovascular mortality",5,0,1,TRUE,TRUE,"RD","sparse_events"
"CD013408_pub2_data","6::overall","6","overall","Cardiovascular mortality - sensitivity analysis",3,0,1,TRUE,TRUE,"RD","sparse_events"
"CD013408_pub2_data","7::overall","7","overall","Cardiovascular hospitalisation",5,0,0,TRUE,TRUE,"OR_cc","default_or"
"CD013408_pub2_data","8::overall","8","overall","Cardiovascular hospitalisation - sensitivity analysis",4,0,0,TRUE,TRUE,"OR_cc","default_or"
"CD013408_pub2_data","9::overall","9","overall","AF-related emergency department visits",2,0,0,TRUE,TRUE,"OR_cc","default_or"
"CD013408_pub2_data","11::overall","11","overall","Thromboembolic complications",5,0,0,TRUE,TRUE,"OR_cc","default_or"
"CD013408_pub2_data","12::overall","12","overall","Thromboembolic complications - sensitivity analysis",3,0,0,TRUE,TRUE,"OR_cc","default_or"
"CD013408_pub2_data","13::overall","13","overall","Major cerebrovascular bleeding events",3,0,1,TRUE,TRUE,"RD","sparse_events"
"CD013408_pub2_data","15::overall","15","overall","All bleeding events",4,0,0,TRUE,TRUE,"OR_cc","default_or"
"CD013408_pub2_data","16::overall","16","overall","All bleeding events - sensitivity analysis",2,0,0,TRUE,TRUE,"OR_cc","default_or"
"CD013408_pub2_data","17::overall","17","overall","AF symptom burden",5,0,0,TRUE,TRUE,"OR_cc","default_or"
"CD013414_pub2_data","1::overall","1","overall","eGFR: change",10,4,6,TRUE,TRUE,"RD","double_zero"
"CD013414_pub2_data","4::overall","4","overall","All-cause death",13,3,4,TRUE,TRUE,"RD","double_zero"
"CD013414_pub2_data","5::overall","5","overall","Kidney failure",7,1,3,TRUE,TRUE,"RD","double_zero"
"CD013414_pub2_data","6::overall","6","overall","Adverse events",15,0,4,TRUE,TRUE,"RD","sparse_events"
"CD013414_pub2_data","8::overall","8","overall","Withdrawal due to intolerance",5,1,2,TRUE,TRUE,"RD","double_zero"
"CD013414_pub2_data","12::overall","12","overall","Vitamin B12 deficiency",2,0,1,TRUE,TRUE,"RD","sparse_events"
"CD013414_pub2_data","3::overall","3","overall","All-cause death",6,0,2,TRUE,TRUE,"RD","sparse_events"
"CD013421_pub2_data","1::overall","1","overall","Mean time to hemostasis",52,28,34,TRUE,TRUE,"RD","double_zero"
"CD013421_pub2_data","2::overall","2","overall","Proportion achieving hemostasis at time points",16,0,0,TRUE,TRUE,"OR_cc","default_or"
"CD013421_pub2_data","3::overall","3","overall","Failure of hemostatic intervention - studies combining multiple surgery indications",13,2,2,TRUE,TRUE,"RD","double_zero"
"CD013421_pub2_data","6::overall","6","overall","Postoperative bleeding up to 30 days - studies combining multiple surgery indications",8,3,5,TRUE,TRUE,"RD","double_zero"
"CD013421_pub2_data","7::overall","7","overall","Unplanned return to operating room for bleeding complications up to 30 days - studies combining multiple surgery indications",7,5,7,TRUE,TRUE,"RD","double_zero"
"CD013425_pub2_data","1::overall","1","overall","Global state: clinically important change",11,0,0,TRUE,TRUE,"OR_cc","default_or"
"CD013425_pub2_data","2::overall","2","overall","Global state: relapse",13,0,1,TRUE,TRUE,"RD","sparse_events"
"CD013425_pub2_data","3::overall","3","overall","Mental state: overall - clinically important change in overall mental state (≥ 50% reduction in PANSS endpoint score)",18,0,0,TRUE,TRUE,"OR_cc","default_or"
"CD013425_pub2_data","4::overall","4","overall","Mental state: overall - average endpoint score (PANSS, BPRS total scores, SMD, high = poor)",49,42,43,TRUE,TRUE,"RD","double_zero"
"CD013425_pub2_data","5::overall","5","overall","Adverse effects/events: specific - extrapyramidal - any effect",23,0,1,TRUE,TRUE,"RD","sparse_events"
"CD013425_pub2_data","6::overall","6","overall","Adverse effects/events: specific - metabolic - weight increase",31,0,1,TRUE,TRUE,"RD","sparse_events"
"CD013425_pub2_data","7::overall","7","overall","Quality of life: clinically important change in quality of life (≥ 20% increase in QLS endpoint score)",10,0,1,TRUE,TRUE,"RD","sparse_events"
"CD013425_pub2_data","8::overall","8","overall","Quality of life: overall - average endpoint total score (various scales, SMD, high = good)",25,11,12,TRUE,TRUE,"RD","double_zero"
"CD013425_pub2_data","9::overall","9","overall","Leaving the study early: adverse effects",35,0,8,TRUE,TRUE,"RD","sparse_events"
"CD013425_pub2_data","10::overall","10","overall","Adverse effects/events: specific - metabolic - weight increase: sensitivity analysis (high attrition rate data excluded)",15,0,1,TRUE,TRUE,"RD","sparse_events"
"CD013425_pub2_data","11::overall","11","overall","Adverse effects/events: specific - metabolic - weight increase: sensitivity analysis (fixed-effect model applied)",18,0,1,TRUE,TRUE,"RD","sparse_events"
"CD013425_pub2_data","12::overall","12","overall","Leaving the study early: adverse effects: sensitivity analysis (inadequate randomised trials excluded)",16,0,4,TRUE,TRUE,"RD","sparse_events"
"CD013425_pub2_data","13::overall","13","overall","Leaving the study early: adverse effects: sensitivity analysis (fixed-effect model applied)",21,0,7,TRUE,TRUE,"RD","sparse_events"
"CD013429_pub2_data","1::overall","1","overall","Primary: Obstructive Eustachian tube dysfunction symptoms - severity (patient-reported): change in ETDQ-7: 0 to 3 months",23,19,19,TRUE,TRUE,"RD","double_zero"
"CD013429_pub2_data","2::overall","2","overall","Primary: Obstructive Eustachian tube dysfunction symptoms - severity (patient-reported): change in ETDQ-7: > 3 months",26,19,19,TRUE,TRUE,"RD","double_zero"
"CD013429_pub2_data","3::overall","3","overall","Primary: Eustachian tube function measured by an objective or semi-objective test: improvement of tympanometry (by ear)",19,14,14,TRUE,TRUE,"RD","double_zero"
"CD013429_pub2_data","4::overall","4","overall","Primary: Eustachian tube function measured by an objective or semi-objective test: ability to perform positive Valsalva/Toynbee (by ear)",19,14,15,TRUE,TRUE,"RD","double_zero"
"CD013429_pub2_data","8::overall","8","overall","Secondary: Tympanic membrane abnormalities: normalisation of TM position",3,0,2,TRUE,TRUE,"RD","sparse_events"
"CD013445_pub2_data","1::overall","1","overall","Stone-free rate",39,0,0,TRUE,TRUE,"OR_cc","default_or"
"CD013445_pub2_data","2::overall","2","overall","Major complications",34,22,28,TRUE,TRUE,"RD","double_zero"
"CD013445_pub2_data","3::overall","3","overall","Secondary interventions",21,0,6,TRUE,TRUE,"RD","sparse_events"
"CD013445_pub2_data","5::overall","5","overall","Minor complications",35,0,7,TRUE,TRUE,"RD","sparse_events"
"CD013445_pub2_data","6::overall","6","overall","Blood transfusions",20,11,16,TRUE,TRUE,"RD","double_zero"
"CD013445_pub2_data","8::overall","8","overall","Postprocedure drainage tube or stent",18,0,1,TRUE,TRUE,"RD","sparse_events"
"CD013445_pub2_data","10::overall","10","overall","Ureteral stricture or injury",13,5,12,TRUE,TRUE,"RD","double_zero"
"CD013445_pub2_data","16::overall","16","overall","Subgroup analysis by access size: stone-free rate",25,0,0,TRUE,TRUE,"OR_cc","default_or"
"CD013445_pub2_data","17::overall","17","overall","Subgroup analysis by stone burden: stone-free rate",24,0,0,TRUE,TRUE,"OR_cc","default_or"
"CD013445_pub2_data","18::overall","18","overall","Subgroup analysis by stone location: stone-free rate",11,0,0,TRUE,TRUE,"OR_cc","default_or"
"CD013445_pub2_data","19::overall","19","overall","Subgroup analysis by stone size: stone-free rate",30,0,0,TRUE,TRUE,"OR_cc","default_or"
"CD013445_pub2_data","20::overall","20","overall","Subgroup analysis by access size: major complications",23,16,20,TRUE,TRUE,"RD","double_zero"
"CD013445_pub2_data","21::overall","21","overall","Subgroup analysis by stone burden: major complications",20,14,16,TRUE,TRUE,"RD","double_zero"
"CD013445_pub2_data","22::overall","22","overall","Subgroup analysis by stone location: major complications",9,6,7,TRUE,TRUE,"RD","double_zero"
"CD013445_pub2_data","23::overall","23","overall","Subgroup analysis by stone size: major complications",25,18,21,TRUE,TRUE,"RD","double_zero"
"CD013445_pub2_data","24::overall","24","overall","Subgroup analysis by access size: secondary interventions",15,0,5,TRUE,TRUE,"RD","sparse_events"
"CD013445_pub2_data","25::overall","25","overall","Subgroup analysis by stone burden: secondary interventions",19,6,11,TRUE,TRUE,"RD","double_zero"
"CD013445_pub2_data","26::overall","26","overall","Subgroup analysis by stone location: secondary intervention",7,2,4,TRUE,TRUE,"RD","double_zero"
"CD013445_pub2_data","27::overall","27","overall","Subgroup analysis by stone size: secondary intervention",17,1,5,TRUE,TRUE,"RD","double_zero"
"CD013445_pub2_data","28::overall","28","overall","Sensitivity analysis for stone-free rate by definition of stone freedom (≤ 4 mm by any imaging modality)",18,0,0,TRUE,TRUE,"OR_cc","default_or"
"CD013445_pub2_data","29::overall","29","overall","Sensitivity analysis for stone-free rate by definition of stone freedom (≤ 2 mm by any imaging modality)",7,0,0,TRUE,TRUE,"OR_cc","default_or"
"CD013445_pub2_data","30::overall","30","overall","Sensitivity analysis for stone-free rate by definition of stone freedom (totally stone-free by CT scan)",5,0,0,TRUE,TRUE,"OR_cc","default_or"
"CD013445_pub2_data","31::overall","31","overall","Sensitivity analysis for major complications by definition of stone freedom (≤ 4 mm by any imaging modality)",16,8,13,TRUE,TRUE,"RD","double_zero"
"CD013445_pub2_data","32::overall","32","overall","Sensitivity analysis for major complications by definition of stone freedom (≤ 2 mm by any imaging modality)",7,5,7,TRUE,TRUE,"RD","double_zero"
"CD013445_pub2_data","33::overall","33","overall","Sensitivity analysis for major complications by definition of stone freedom (totally stone-free by CT scan)",4,3,3,FALSE,TRUE,"RD","double_zero"
"CD013445_pub2_data","34::overall","34","overall","Sensitivity analysis for secondary interventions by definition of stone freedom (≤ 4 mm by any imaging modality)",9,0,3,TRUE,TRUE,"RD","sparse_events"
"CD013445_pub2_data","35::overall","35","overall","Sensitivity analysis for secondary interventions by definition of stone freedom (≤  2 mm by any imaging modality)",3,0,1,TRUE,TRUE,"RD","sparse_events"
"CD013445_pub2_data","36::overall","36","overall","Sensitivity analysis for secondary interventions by definition of stone freedom (totally stone-free by CT scan)",4,0,0,TRUE,TRUE,"OR_cc","default_or"
"CD013456_pub2_data","5::overall","5","overall","Psychosocial interventions versus inactive control; outcome 3: Dropout from treatment",13,8,9,TRUE,TRUE,"RD","double_zero"
"CD013456_pub2_data","6::overall","6","overall","Psychosocial interventions versus inactive control; outcome 4: Adverse events",11,8,11,TRUE,TRUE,"RD","double_zero"
"CD013456_pub2_data","7::overall","7","overall","Psychosocial interventions versus inactive control; outcome 5: Anxiety symptoms, post-treatment",25,13,14,TRUE,TRUE,"RD","double_zero"
"CD013456_pub2_data","8::overall","8","overall","Psychosocial interventions versus inactive control; outcome 5: Anxiety symptoms, 3 months",9,4,7,TRUE,TRUE,"RD","double_zero"
"CD013462_pub3_data","1::overall","1","overall","Rate of postoperative pancreatic fistula (grade B or C defined according to the 2005 ISGPF definition)",11,0,1,TRUE,TRUE,"RD","sparse_events"
"CD013462_pub3_data","2::overall","2","overall","Postoperative mortality",14,3,9,TRUE,TRUE,"RD","double_zero"
"CD013462_pub3_data","3::overall","3","overall","Rate of surgical reintervention",12,0,7,TRUE,TRUE,"RD","sparse_events"
"CD013462_pub3_data","4::overall","4","overall","Rate of postoperative bleeding",13,0,4,TRUE,TRUE,"RD","sparse_events"
"CD013462_pub3_data","5::overall","5","overall","Overall rate of surgical complications",10,0,1,TRUE,TRUE,"RD","sparse_events"
"CD013462_pub3_data","1::1","1","1","Rate of postoperative pancreatic fistula (grade B or C defined according to the 2005 ISGPF definition)",20,0,1,TRUE,TRUE,"RD","sparse_events"
"CD013462_pub3_data","1::2","1","2","Rate of postoperative pancreatic fistula (grade B or C defined according to the 2005 ISGPF definition)",21,2,8,TRUE,TRUE,"RD","double_zero"
"CD013462_pub3_data","2::1","2","1","Postoperative mortality",7,2,6,TRUE,TRUE,"RD","double_zero"
"CD013462_pub3_data","2::2","2","2","Postoperative mortality",8,2,7,TRUE,TRUE,"RD","double_zero"
"CD013468_pub2_data","1::overall","1","overall","Change in burn‐related pruritus",24,23,23,FALSE,TRUE,"RD","double_zero"
"CD013468_pub2_data","2::overall","2","overall","Adverse events",15,10,11,TRUE,TRUE,"RD","double_zero"
"CD013474_pub2_data","2::overall","2","overall","Overall survival (time to event): type of drug",6,5,5,FALSE,TRUE,"RD","double_zero"
"CD013474_pub2_data","3::overall","3","overall","Health-related quality of life",5,4,4,FALSE,TRUE,"RD","double_zero"
"CD013474_pub2_data","4::overall","4","overall","Grade 3 and 4 adverse events",8,5,7,TRUE,TRUE,"RD","double_zero"
"CD013474_pub2_data","5::overall","5","overall","Grade 3 and 4 adverse events: type of drug",7,5,5,TRUE,TRUE,"RD","double_zero"
"CD013474_pub2_data","8::overall","8","overall","Treatment-related mortality",4,0,1,TRUE,TRUE,"RD","sparse_events"
"CD013474_pub2_data","9::overall","9","overall","Treatment-related mortality: type of drug",4,0,1,TRUE,TRUE,"RD","sparse_events"
"CD013474_pub2_data","10::overall","10","overall","Treatment discontinuation",6,0,1,TRUE,TRUE,"RD","sparse_events"
"CD013474_pub2_data","11::overall","11","overall","Treatment discontinuation: type of drug",6,0,1,TRUE,TRUE,"RD","sparse_events"
"CD013474_pub2_data","14::overall","14","overall","Complete response rate",2,0,0,TRUE,TRUE,"OR_cc","default_or"
"CD013474_pub2_data","15::overall","15","overall","Overall response rate",2,0,0,TRUE,TRUE,"OR_cc","default_or"
"CD013476_pub2_data","6::overall","6","overall","Significant adverse events during maintenance therapy up to 6 months follow-up",4,1,4,TRUE,TRUE,"RD","double_zero"
"CD013476_pub2_data","13::overall","13","overall","Asthma exacerbations after 6 months follow-up",2,0,0,TRUE,TRUE,"OR_cc","default_or"
"CD013508_pub3_data","14::overall","14","overall","Mortality (all-cause)",3,0,2,TRUE,TRUE,"RD","sparse_events"
"CD013508_pub3_data","15::overall","15","overall","MACE",4,0,1,TRUE,TRUE,"RD","sparse_events"
"CD013539_pub2_data","4::overall","4","overall","Serious adverse events",45,0,0,TRUE,TRUE,"OR_cc","default_or"
"CD013539_pub2_data","5::overall","5","overall","Objective response rate",52,1,1,TRUE,TRUE,"RD","double_zero"
"CD013539_pub2_data","6::overall","6","overall","Mortality",40,0,4,TRUE,TRUE,"RD","sparse_events"
"CD013539_pub2_data","7::overall","7","overall","Neutralising antibodies",27,6,15,TRUE,TRUE,"RD","double_zero"
"CD013539_pub2_data","8::overall","8","overall","Antidrug antibodies",57,5,25,TRUE,TRUE,"RD","double_zero"
"CD013539_pub2_data","9::overall","9","overall","Any adverse events",43,5,17,TRUE,TRUE,"RD","double_zero"
"CD013539_pub2_data","10::overall","10","overall","Any adverse events",25,5,9,TRUE,TRUE,"RD","double_zero"
"CD013539_pub2_data","11::overall","11","overall","Any adverse events",15,0,0,TRUE,TRUE,"OR_cc","default_or"
"CD013541_pub2_data","1::overall","1","overall","Relapse (≤ 1 month postintervention)",61,43,49,TRUE,TRUE,"RD","double_zero"
"CD013541_pub2_data","2::overall","2","overall","Relapse (≤ 1 month postintervention, completer)",30,17,18,TRUE,TRUE,"RD","double_zero"
"CD013541_pub2_data","3::overall","3","overall","Relapse (> 6 months postintervention)",28,15,17,TRUE,TRUE,"RD","double_zero"
"CD013541_pub2_data","4::overall","4","overall","Relapse (> 6 months postintervention, completer)",32,19,22,TRUE,TRUE,"RD","double_zero"
"CD013561_pub2_data","1::overall","1","overall","Adverse events",2,0,1,TRUE,TRUE,"RD","sparse_events"
"CD013561_pub2_data","2::overall","2","overall","Biochemical remission according to normalisation of IGF-1 and GH",8,0,0,TRUE,TRUE,"OR_cc","default_or"
"CD013561_pub2_data","3::overall","3","overall","Biochemical remission according to IGF-1 normalisation and GH < 1 ug/L",5,0,0,TRUE,TRUE,"OR_cc","default_or"
"CD013561_pub2_data","4::overall","4","overall","Biochemical remission according to normalisation of IGF-1",4,0,0,TRUE,TRUE,"OR_cc","default_or"
"CD013561_pub2_data","5::overall","5","overall","Biochemical remission according to normalisation of GH < 1 ug/L",2,0,0,TRUE,TRUE,"OR_cc","default_or"
"CD013561_pub2_data","7::overall","7","overall","Non-surgical therapy for recurrent or persistent disease",2,0,0,TRUE,TRUE,"OR_cc","default_or"
"CD013571_pub2_data","1::overall","1","overall","Participant-reported cure or improvement: immediately after treatment",9,2,2,TRUE,TRUE,"RD","double_zero"
"CD013571_pub2_data","2::overall","2","overall","Participant-reported cure or improvement: long-term effect (> 2 months after treatment)",6,3,3,TRUE,TRUE,"RD","double_zero"
"CD013571_pub2_data","4::overall","4","overall","Symptom-related QoL: long-term effect (> 2 months after treatment)",5,3,3,TRUE,TRUE,"RD","double_zero"
"CD013571_pub2_data","5::overall","5","overall","Adverse events: immediately after treatment",5,1,1,TRUE,TRUE,"RD","double_zero"
"CD013571_pub2_data","6::overall","6","overall","Adverse events: long-term effect (> 2 months after treatment)",3,2,2,FALSE,TRUE,"RD","double_zero"
"CD013590_pub2_data","1::overall","1","overall","Frequency of crisis (mean number of pain crises)",25,19,20,TRUE,TRUE,"RD","double_zero"
"CD013590_pub2_data","2::overall","2","overall","Frequency of hospitalisation",33,28,29,TRUE,TRUE,"RD","double_zero"
"CD013590_pub2_data","3::overall","3","overall","SCD-related complications (number of participants)",18,7,10,TRUE,TRUE,"RD","double_zero"
"CD013590_pub2_data","4::overall","4","overall","SCD-related complications (number of participants)",16,11,14,TRUE,TRUE,"RD","double_zero"
"CD013590_pub2_data","5::overall","5","overall","SCD-related complications (sq mm per day)",19,16,16,TRUE,TRUE,"RD","double_zero"
"CD013590_pub2_data","6::overall","6","overall","Frequency of SCD-related complications (number of participants with infections) at 6 months",2,1,1,FALSE,TRUE,"RD","double_zero"
"CD013590_pub2_data","7::overall","7","overall","SCD-related complications (other)",6,3,6,TRUE,TRUE,"RD","double_zero"
"CD013595_pub2_data","1::overall","1","overall","Overall survival",23,8,8,TRUE,TRUE,"RD","double_zero"
"CD013595_pub2_data","2::overall","2","overall","Overall survival - cytogenetic profile at study entry",8,5,5,TRUE,TRUE,"RD","double_zero"
"CD013595_pub2_data","3::overall","3","overall","Overall survival - International Staging System disease stage",9,6,6,TRUE,TRUE,"RD","double_zero"
"CD013595_pub2_data","4::overall","4","overall","EQ-5D 3 month",5,2,2,TRUE,TRUE,"RD","double_zero"
"CD013595_pub2_data","5::overall","5","overall","EQ-5D 9 month",5,2,2,TRUE,TRUE,"RD","double_zero"
"CD013595_pub2_data","6::overall","6","overall","EQ-5D 12 month",5,2,2,TRUE,TRUE,"RD","double_zero"
"CD013595_pub2_data","7::overall","7","overall","Lymphopenia",3,0,0,TRUE,TRUE,"OR_cc","default_or"
"CD013595_pub2_data","8::overall","8","overall","Diarrhoea",3,0,0,TRUE,TRUE,"OR_cc","default_or"
"CD013595_pub2_data","9::overall","9","overall","Pneumonia",3,0,0,TRUE,TRUE,"OR_cc","default_or"
"CD013595_pub2_data","10::overall","10","overall","Nausea",2,0,0,TRUE,TRUE,"OR_cc","default_or"
"CD013613_pub2_data","3::overall","3","overall","Dropouts due to adverse events at three months",5,3,4,TRUE,TRUE,"RD","double_zero"
"CD013613_pub2_data","4::overall","4","overall","Dropouts due to adverse events at study endpoint",5,3,4,TRUE,TRUE,"RD","double_zero"
"CD013613_pub2_data","5::overall","5","overall","PTSD rate at three months",6,2,5,TRUE,TRUE,"RD","double_zero"
"CD013613_pub2_data","6::overall","6","overall","Sensitivity analysis: PTSD rate at three months (cases out of randomised)",5,1,4,TRUE,TRUE,"RD","double_zero"
"CD013613_pub2_data","7::overall","7","overall","PTSD rate at study endpoint",6,1,3,TRUE,TRUE,"RD","double_zero"
"CD013613_pub2_data","8::overall","8","overall","Sensitivity analysis: PTSD rate at study endpoint (cases out of randomised)",6,1,3,TRUE,TRUE,"RD","double_zero"
"CD013613_pub2_data","14::overall","14","overall","Dropout for any reason at three months",4,0,0,TRUE,TRUE,"OR_cc","default_or"
"CD013613_pub2_data","15::overall","15","overall","Dropout for any reason at study endpoint",6,0,0,TRUE,TRUE,"OR_cc","default_or"
"CD013614_pub2_data","1::1","1","1","Clinical improvement as measured by the ACR50 response criteria or by the EULAR good response criteria at 12 weeks",14,1,1,TRUE,TRUE,"RD","double_zero"
"CD013614_pub2_data","1::2","1","2","Clinical improvement as measured by the ACR50 response criteria or by the EULAR good response criteria at 12 weeks",6,0,0,TRUE,TRUE,"OR_cc","default_or"
"CD013614_pub2_data","1::3","1","3","Clinical improvement as measured by the ACR50 response criteria or by the EULAR good response criteria at 12 weeks",5,0,0,TRUE,TRUE,"OR_cc","default_or"
"CD013614_pub2_data","1::4","1","4","Clinical improvement as measured by the ACR50 response criteria or by the EULAR good response criteria at 12 weeks",3,0,0,TRUE,TRUE,"OR_cc","default_or"
"CD013614_pub2_data","1::5","1","5","Clinical improvement as measured by the ACR50 response criteria or by the EULAR good response criteria at 12 weeks",2,0,0,TRUE,TRUE,"OR_cc","default_or"
"CD013614_pub2_data","2::1","2","1","Clinical improvement as measured by the ACR50 response criteria or by the EULAR good response criteria at 24 weeks",10,1,1,TRUE,TRUE,"RD","double_zero"
"CD013614_pub2_data","2::2","2","2","Clinical improvement as measured by the ACR50 response criteria or by the EULAR good response criteria at 24 weeks",6,0,0,TRUE,TRUE,"OR_cc","default_or"
"CD013614_pub2_data","2::3","2","3","Clinical improvement as measured by the ACR50 response criteria or by the EULAR good response criteria at 24 weeks",4,0,0,TRUE,TRUE,"OR_cc","default_or"
"CD013614_pub2_data","2::4","2","4","Clinical improvement as measured by the ACR50 response criteria or by the EULAR good response criteria at 24 weeks",2,0,0,TRUE,TRUE,"OR_cc","default_or"
"CD013614_pub2_data","3::1","3","1","Disease activity as measured by MDA-PsA criteria or by DAS 28 or by DAS at 12 weeks",10,0,1,TRUE,TRUE,"RD","sparse_events"
"CD013614_pub2_data","3::2","3","2","Disease activity as measured by MDA-PsA criteria or by DAS 28 or by DAS at 12 weeks",7,0,0,TRUE,TRUE,"OR_cc","default_or"
"CD013614_pub2_data","4::1","4","1","Disease activity as measured by MDA-PsA criteria or by DAS 28 or by DAS at 24 weeks",5,0,0,TRUE,TRUE,"OR_cc","default_or"
"CD013614_pub2_data","4::2","4","2","Disease activity as measured by MDA-PsA criteria or by DAS 28 or by DAS at 24 weeks",4,0,0,TRUE,TRUE,"OR_cc","default_or"
"CD013614_pub2_data","4::3","4","3","Disease activity as measured by MDA-PsA criteria or by DAS 28 or by DAS at 24 weeks",4,0,0,TRUE,TRUE,"OR_cc","default_or"
"CD013614_pub2_data","5::1","5","1","Physical function as measured by the HAQ or by the proportion of patients achieving the MCID of the HAQ which is defined as 0.35 or by the MHAQ at 12 weeks",10,6,6,TRUE,TRUE,"RD","double_zero"
"CD013614_pub2_data","5::2","5","2","Physical function as measured by the HAQ or by the proportion of patients achieving the MCID of the HAQ which is defined as 0.35 or by the MHAQ at 12 weeks",4,1,1,TRUE,TRUE,"RD","double_zero"
"CD013614_pub2_data","5::3","5","3","Physical function as measured by the HAQ or by the proportion of patients achieving the MCID of the HAQ which is defined as 0.35 or by the MHAQ at 12 weeks",5,2,2,TRUE,TRUE,"RD","double_zero"
"CD013614_pub2_data","6::1","6","1","MCID in HAQ proportion of patients at 12 weeks",7,0,0,TRUE,TRUE,"OR_cc","default_or"
"CD013614_pub2_data","8::1","8","1","MCID in HAQ proportion of patients at 24 weeks",5,1,1,TRUE,TRUE,"RD","double_zero"
"CD013614_pub2_data","8::2","8","2","MCID in HAQ proportion of patients at 24 weeks",4,1,1,TRUE,TRUE,"RD","double_zero"
"CD013614_pub2_data","9::1","9","1","Health-related quality of life as measured by the SF-36 or by the PSAQOL at 12 weeks. (SF-36 MCS). ",9,8,8,FALSE,TRUE,"RD","double_zero"
"CD013614_pub2_data","9::2","9","2","Health-related quality of life as measured by the SF-36 or by the PSAQOL at 12 weeks. (SF-36 MCS). ",4,3,3,FALSE,TRUE,"RD","double_zero"
"CD013614_pub2_data","10::1","10","1","Health-related quality of life as measured by the SF-36 or by the PSAQOL at 12 weeks. (SF-36 PCS).",10,7,7,TRUE,TRUE,"RD","double_zero"
"CD013614_pub2_data","10::2","10","2","Health-related quality of life as measured by the SF-36 or by the PSAQOL at 12 weeks. (SF-36 PCS).",3,2,2,FALSE,TRUE,"RD","double_zero"
"CD013614_pub2_data","12::1","12","1","Health-related quality of life as measured by the SF-36 or by the PSAQOL at 24 weeks. (SF-36 PCS). ",6,4,4,TRUE,TRUE,"RD","double_zero"
"CD013614_pub2_data","12::2","12","2","Health-related quality of life as measured by the SF-36 or by the PSAQOL at 24 weeks. (SF-36 PCS). ",3,2,2,FALSE,TRUE,"RD","double_zero"
"CD013614_pub2_data","12::3","12","3","Health-related quality of life as measured by the SF-36 or by the PSAQOL at 24 weeks. (SF-36 PCS). ",2,1,1,FALSE,TRUE,"RD","double_zero"
"CD013614_pub2_data","14::1","14","1","Number of patients with serious adverse events at any time ",10,2,5,TRUE,TRUE,"RD","double_zero"
"CD013614_pub2_data","14::2","14","2","Number of patients with serious adverse events at any time ",4,2,2,TRUE,TRUE,"RD","double_zero"
"CD013614_pub2_data","14::3","14","3","Number of patients with serious adverse events at any time ",4,0,3,TRUE,TRUE,"RD","sparse_events"
"CD013614_pub2_data","14::4","14","4","Number of patients with serious adverse events at any time ",3,0,1,TRUE,TRUE,"RD","sparse_events"
"CD013614_pub2_data","15::1","15","1","(OR) Number of patients with serious adverse events at any time ",11,3,6,TRUE,TRUE,"RD","double_zero"
"CD013614_pub2_data","15::2","15","2","(OR) Number of patients with serious adverse events at any time ",3,1,1,TRUE,TRUE,"RD","double_zero"
"CD013614_pub2_data","15::3","15","3","(OR) Number of patients with serious adverse events at any time ",4,0,3,TRUE,TRUE,"RD","sparse_events"
"CD013614_pub2_data","15::4","15","4","(OR) Number of patients with serious adverse events at any time ",3,0,1,TRUE,TRUE,"RD","sparse_events"
"CD013614_pub2_data","16::1","16","1","Withdrawal due to adverse events",11,4,7,TRUE,TRUE,"RD","double_zero"
"CD013614_pub2_data","16::2","16","2","Withdrawal due to adverse events",4,2,2,TRUE,TRUE,"RD","double_zero"
"CD013614_pub2_data","16::3","16","3","Withdrawal due to adverse events",4,1,4,TRUE,TRUE,"RD","double_zero"
"CD013614_pub2_data","16::4","16","4","Withdrawal due to adverse events",3,0,0,TRUE,TRUE,"OR_cc","default_or"
"CD013614_pub2_data","16::5","16","5","Withdrawal due to adverse events",2,0,1,TRUE,TRUE,"RD","sparse_events"
"CD013614_pub2_data","17::1","17","1","Clinical improvement as measured by ACR20 response criteria or by the EULAR moderate response criteria or by PsARC criteria at 12 weeks",10,2,2,TRUE,TRUE,"RD","double_zero"
"CD013614_pub2_data","17::2","17","2","Clinical improvement as measured by ACR20 response criteria or by the EULAR moderate response criteria or by PsARC criteria at 12 weeks",3,1,1,TRUE,TRUE,"RD","double_zero"
"CD013614_pub2_data","17::3","17","3","Clinical improvement as measured by ACR20 response criteria or by the EULAR moderate response criteria or by PsARC criteria at 12 weeks",4,0,0,TRUE,TRUE,"OR_cc","default_or"
"CD013614_pub2_data","17::4","17","4","Clinical improvement as measured by ACR20 response criteria or by the EULAR moderate response criteria or by PsARC criteria at 12 weeks",3,0,0,TRUE,TRUE,"OR_cc","default_or"
"CD013614_pub2_data","17::5","17","5","Clinical improvement as measured by ACR20 response criteria or by the EULAR moderate response criteria or by PsARC criteria at 12 weeks",3,0,1,TRUE,TRUE,"RD","sparse_events"
"CD013614_pub2_data","18::1","18","1","Clinical improvement as measured by ACR20 response criteria or by the EULAR moderate response criteria or by PsARC criteria at 24 weeks.",6,2,2,TRUE,TRUE,"RD","double_zero"
"CD013614_pub2_data","18::2","18","2","Clinical improvement as measured by ACR20 response criteria or by the EULAR moderate response criteria or by PsARC criteria at 24 weeks.",4,2,2,TRUE,TRUE,"RD","double_zero"
"CD013614_pub2_data","18::3","18","3","Clinical improvement as measured by ACR20 response criteria or by the EULAR moderate response criteria or by PsARC criteria at 24 weeks.",3,0,0,TRUE,TRUE,"OR_cc","default_or"
"CD013614_pub2_data","18::4","18","4","Clinical improvement as measured by ACR20 response criteria or by the EULAR moderate response criteria or by PsARC criteria at 24 weeks.",2,0,0,TRUE,TRUE,"OR_cc","default_or"
"CD013614_pub2_data","19::1","19","1","Enthesitis: resolution as LEI=0 at 12 weeks",7,2,2,TRUE,TRUE,"RD","double_zero"
"CD013614_pub2_data","20::1","20","1","Improvement in enthesitis in patients with enthesitis at baseline as measured by the LEI or by the MASES at 12 weeks",6,4,5,TRUE,TRUE,"RD","double_zero"
"CD013614_pub2_data","21::1","21","1","Enthesitis: resolution as LEI=0 at 24 weeks",7,0,0,TRUE,TRUE,"OR_cc","default_or"
"CD013614_pub2_data","22::1","22","1","Improvement in enthesitis in patients with enthesitis at baseline as measured by the LEI or by the MASES at 24 weeks.",6,1,2,TRUE,TRUE,"RD","double_zero"
"CD013614_pub2_data","22::2","22","2","Improvement in enthesitis in patients with enthesitis at baseline as measured by the LEI or by the MASES at 24 weeks.",3,1,1,TRUE,TRUE,"RD","double_zero"
"CD013614_pub2_data","22::3","22","3","Improvement in enthesitis in patients with enthesitis at baseline as measured by the LEI or by the MASES at 24 weeks.",2,1,2,FALSE,TRUE,"RD","double_zero"
"CD013614_pub2_data","23::1","23","1","Resolution of dactylitis as no dactylitis at 12 weeks",8,0,0,TRUE,TRUE,"OR_cc","default_or"
"CD013614_pub2_data","24::1","24","1","Improvement in dactylitis in patients with dactylitis at baseline as measured by a simple quantitative scoring of dactylitis or by LDI or by LDI basic at 12 weeks.",7,4,4,TRUE,TRUE,"RD","double_zero"
"CD013614_pub2_data","24::2","24","2","Improvement in dactylitis in patients with dactylitis at baseline as measured by a simple quantitative scoring of dactylitis or by LDI or by LDI basic at 12 weeks.",4,2,2,TRUE,TRUE,"RD","double_zero"
"CD013614_pub2_data","24::3","24","3","Improvement in dactylitis in patients with dactylitis at baseline as measured by a simple quantitative scoring of dactylitis or by LDI or by LDI basic at 12 weeks.",2,1,1,FALSE,TRUE,"RD","double_zero"
"CD013614_pub2_data","25::1","25","1","Resolution of dactylitis as no dactylitis at 24 weeks",5,0,0,TRUE,TRUE,"OR_cc","default_or"
"CD013614_pub2_data","26::1","26","1","Improvement in dactylitis in patients with dactylitis at baseline as measured by a simple quantitative scoring of dactylitis or by LDI or by LDI basic at 24 weeks.",4,2,2,TRUE,TRUE,"RD","double_zero"
"CD013614_pub2_data","26::2","26","2","Improvement in dactylitis in patients with dactylitis at baseline as measured by a simple quantitative scoring of dactylitis or by LDI or by LDI basic at 24 weeks.",4,2,2,TRUE,TRUE,"RD","double_zero"
"CD013614_pub2_data","28::1","28","1","Improvement in pain as measured by VAS or NRS at week 24.",7,4,4,TRUE,TRUE,"RD","double_zero"
"CD013614_pub2_data","28::2","28","2","Improvement in pain as measured by VAS or NRS at week 24.",3,2,2,FALSE,TRUE,"RD","double_zero"
"CD013614_pub2_data","28::3","28","3","Improvement in pain as measured by VAS or NRS at week 24.",2,1,1,FALSE,TRUE,"RD","double_zero"
"CD013614_pub2_data","29::1","29","1","Improvement in psoriasis in patients with psoriasis at baseline as measured by the PASI75 response at 12 weeks.",9,3,3,TRUE,TRUE,"RD","double_zero"
"CD013614_pub2_data","29::2","29","2","Improvement in psoriasis in patients with psoriasis at baseline as measured by the PASI75 response at 12 weeks.",3,2,2,FALSE,TRUE,"RD","double_zero"
"CD013614_pub2_data","29::4","29","4","Improvement in psoriasis in patients with psoriasis at baseline as measured by the PASI75 response at 12 weeks.",2,0,0,TRUE,TRUE,"OR_cc","default_or"
"CD013614_pub2_data","29::5","29","5","Improvement in psoriasis in patients with psoriasis at baseline as measured by the PASI75 response at 12 weeks.",2,0,0,TRUE,TRUE,"OR_cc","default_or"
"CD013614_pub2_data","30::1","30","1","Improvement in psoriasis in patients with psoriasis at baseline as measured by the PASI75 response at 24 weeks.",6,0,0,TRUE,TRUE,"OR_cc","default_or"
"CD013614_pub2_data","30::2","30","2","Improvement in psoriasis in patients with psoriasis at baseline as measured by the PASI75 response at 24 weeks.",3,0,0,TRUE,TRUE,"OR_cc","default_or"
"CD013614_pub2_data","30::3","30","3","Improvement in psoriasis in patients with psoriasis at baseline as measured by the PASI75 response at 24 weeks.",2,0,0,TRUE,TRUE,"OR_cc","default_or"
"CD013614_pub2_data","30::4","30","4","Improvement in psoriasis in patients with psoriasis at baseline as measured by the PASI75 response at 24 weeks.",2,0,0,TRUE,TRUE,"OR_cc","default_or"
"CD013614_pub2_data","32::1","32","1","Improvement in fatigue as measured by FACIT-F scale or by the FATIGUE VAS at 24 weeks.",4,2,2,TRUE,TRUE,"RD","double_zero"
"CD013614_pub2_data","32::2","32","2","Improvement in fatigue as measured by FACIT-F scale or by the FATIGUE VAS at 24 weeks.",3,1,1,TRUE,TRUE,"RD","double_zero"
"CD013614_pub2_data","6::2","6","2","Disease activity as measured by MDA-PsA criteria or by DAS 28 or by DAS at 52 Weeks",3,0,0,TRUE,TRUE,"OR_cc","default_or"
"CD013614_pub2_data","23::2","23","2","Resolution of dactylitis as no dactylitis at 24 weeks",3,0,0,TRUE,TRUE,"OR_cc","default_or"
"CD013614_pub2_data","23::3","23","3","Resolution of dactylitis as no dactylitis at 24 weeks",3,0,0,TRUE,TRUE,"OR_cc","default_or"
"CD013614_pub2_data","25::2","25","2","Resolution of dactylitis as no dactylitis at 52 weeks",3,0,0,TRUE,TRUE,"OR_cc","default_or"
"CD013614_pub2_data","21::2","21","2","Number of patients with serious adverse events at any time",2,0,0,TRUE,TRUE,"OR_cc","default_or"
"CD013614_pub2_data","34::1","34","1","Resolution of dactylitis as no dactylitis at 24 weeks",3,0,0,TRUE,TRUE,"OR_cc","default_or"
"CD013614_pub2_data","36::1","36","1","Resolution of dactylitis as no dactylitis at 52 weeks",2,0,0,TRUE,TRUE,"OR_cc","default_or"
"CD013614_pub2_data","36::2","36","2","Resolution of dactylitis as no dactylitis at 52 weeks",2,0,0,TRUE,TRUE,"OR_cc","default_or"
"CD013614_pub2_data","41::1","41","1","Improvement in psoriasis in patients with psoriasis at baseline as measured by the PASI75 response at 12 weeks.",3,0,0,TRUE,TRUE,"OR_cc","default_or"
"CD013614_pub2_data","41::2","41","2","Improvement in psoriasis in patients with psoriasis at baseline as measured by the PASI75 response at 12 weeks.",2,0,0,TRUE,TRUE,"OR_cc","default_or"
"CD013614_pub2_data","42::1","42","1","Improvement in psoriasis in patients with psoriasis at baseline as measured by the PASI75 response at 24 weeks.",3,0,0,TRUE,TRUE,"OR_cc","default_or"
"CD013614_pub2_data","42::2","42","2","Improvement in psoriasis in patients with psoriasis at baseline as measured by the PASI75 response at 24 weeks.",2,0,0,TRUE,TRUE,"OR_cc","default_or"
"CD013614_pub2_data","43::1","43","1","Improvement in psoriasis in patients with psoriasis at baseline as measured by the PASI75 response at 52 weeks.",2,0,0,TRUE,TRUE,"OR_cc","default_or"
"CD013614_pub2_data","43::2","43","2","Improvement in psoriasis in patients with psoriasis at baseline as measured by the PASI75 response at 52 weeks.",2,0,0,TRUE,TRUE,"OR_cc","default_or"
"CD013614_pub2_data","1::overall","1","overall","Clinical improvement as measured by ACR20 response criteria or by the EULAR moderate response criteria or by PsARC criteria at 52 weeks",3,0,0,TRUE,TRUE,"OR_cc","default_or"
"CD013631_pub2_data","6::overall","6","overall","GI function: change in any GI upset or intolerance (prevalence of borborygmi) at 4 weeks",6,5,5,FALSE,TRUE,"RD","double_zero"
"CD013631_pub2_data","9::overall","9","overall","GI function: faecal characteristics (Bristol Stool Chart) at 4 weeks",4,3,4,FALSE,TRUE,"RD","double_zero"
"CD013631_pub2_data","10::overall","10","overall","GI function: faecal characteristics (Bristol Stool Chart) at 12 months",4,2,3,TRUE,TRUE,"RD","double_zero"
"CD013631_pub2_data","11::overall","11","overall","Patient-reported outcomes: HRQoL at 24 weeks",5,4,5,FALSE,TRUE,"RD","double_zero"
"CD013631_pub2_data","12::overall","12","overall","Adverse events: any adverse event",10,3,5,TRUE,TRUE,"RD","double_zero"
"CD013631_pub2_data","13::overall","13","overall","Withdrawals due to adverse events",9,5,7,TRUE,TRUE,"RD","double_zero"
"CD013631_pub2_data","26::overall","26","overall","Adverse events: number participants reporting an event",2,0,0,TRUE,TRUE,"OR_cc","default_or"
"CD013643_pub2_data","1::overall","1","overall","Number of continent women (objective measure as reported by the trialists), short term (< 1 year)",4,1,1,TRUE,TRUE,"RD","double_zero"
"CD013643_pub2_data","2::overall","2","overall","Number of continent women (objective measure as reported by the trialists), medium term (1 to 5 years)",2,1,1,FALSE,TRUE,"RD","double_zero"
"CD013643_pub2_data","6::1","6","1","Number of continent women by patient-reported measures, short term (< 1 year)",2,0,2,TRUE,TRUE,"RD","sparse_events"
"CD013643_pub2_data","6::2","6","2","Number of continent women by patient-reported measures, short term (< 1 year)",2,0,1,TRUE,TRUE,"RD","sparse_events"
"CD013643_pub2_data","14::1","14","1","Number of minor adverse events (Clavien-Dindo I, II), short term (< 1 year) ",3,0,0,TRUE,TRUE,"OR_cc","default_or"
"CD013643_pub2_data","14::2","14","2","Number of minor adverse events (Clavien-Dindo I, II), short term (< 1 year) ",4,1,2,TRUE,TRUE,"RD","double_zero"
"CD013672_pub2_data","1::overall","1","overall","Treatment retention",14,1,1,TRUE,TRUE,"RD","double_zero"
"CD013672_pub2_data","2::1","2","1","Treatment retention, subgroup analysis: buprenorphine versus methadone",4,0,0,TRUE,TRUE,"OR_cc","default_or"
"CD013672_pub2_data","2::2","2","2","Treatment retention, subgroup analysis: buprenorphine versus methadone",8,0,0,TRUE,TRUE,"OR_cc","default_or"
"CD013672_pub2_data","3::1","3","1","Treatment retention, subgroup analysis: single provider primary care setting versus availability of a primary care team",3,0,0,TRUE,TRUE,"OR_cc","default_or"
"CD013672_pub2_data","3::2","3","2","Treatment retention, subgroup analysis: single provider primary care setting versus availability of a primary care team",8,0,0,TRUE,TRUE,"OR_cc","default_or"
"CD013672_pub2_data","4::1","4","1","Treatment retention, subgroup analysis: maintenance of existing OAT versus initiation of OAT in primary care",5,0,0,TRUE,TRUE,"OR_cc","default_or"
"CD013672_pub2_data","4::2","4","2","Treatment retention, subgroup analysis: maintenance of existing OAT versus initiation of OAT in primary care",7,0,0,TRUE,TRUE,"OR_cc","default_or"
"CD013672_pub2_data","5::1","5","1","Treatment retention, subgroup analysis: DSM diagnostic criteria used versus DSM diagnostic criteria not used",5,0,0,TRUE,TRUE,"OR_cc","default_or"
"CD013672_pub2_data","5::2","5","2","Treatment retention, subgroup analysis: DSM diagnostic criteria used versus DSM diagnostic criteria not used",7,0,0,TRUE,TRUE,"OR_cc","default_or"
"CD013707_pub2_data","1::overall","1","overall","All-cause mortality within 30 days",8,2,5,TRUE,TRUE,"RD","double_zero"
"CD013707_pub2_data","2::overall","2","overall","Low cardiac output syndrome",7,3,3,TRUE,TRUE,"RD","double_zero"
"CD013707_pub2_data","3::overall","3","overall","Length of intensive care stay",8,6,6,TRUE,TRUE,"RD","double_zero"
"CD013707_pub2_data","7::overall","7","overall","Number of patients requiring mechanical circulatory support",3,1,3,TRUE,TRUE,"RD","double_zero"
"CD013707_pub2_data","8::overall","8","overall","Arrhythmia",4,2,3,TRUE,TRUE,"RD","double_zero"
"CD013707_pub2_data","9::overall","9","overall","Hypokalaemia",2,1,1,FALSE,TRUE,"RD","double_zero"
"CD013707_pub2_data","10::overall","10","overall","Reduced left ventricular ejection fraction (< 50%) or shortening fraction (< 28%)",2,0,0,TRUE,TRUE,"OR_cc","default_or"
"CD013707_pub2_data","11::overall","11","overall","Renal failure requiring replacement therapy",2,0,2,TRUE,TRUE,"RD","sparse_events"
"CD013715_pub2_data","1::overall","1","overall","PedACR70 at up to 16 weeks ",6,0,0,TRUE,TRUE,"OR_cc","default_or"
"CD013715_pub2_data","2::overall","2","overall","PedACR70 at 17 to 26 weeks",2,0,0,TRUE,TRUE,"OR_cc","default_or"
"CD013715_pub2_data","3::overall","3","overall","PedACR70 at 27 to 52 weeks ",3,0,0,TRUE,TRUE,"OR_cc","default_or"
"CD013715_pub2_data","4::overall","4","overall","Pain at up to 16 weeks ",3,2,3,FALSE,TRUE,"RD","double_zero"
"CD013715_pub2_data","5::overall","5","overall","Pain at 17 to 26 weeks ",2,1,1,FALSE,TRUE,"RD","double_zero"
"CD013715_pub2_data","6::overall","6","overall","Mean CHAQ at up to 16 weeks ",5,3,3,TRUE,TRUE,"RD","double_zero"
"CD013715_pub2_data","7::overall","7","overall","Participant global assessment of disease activity at up to 16 weeks ",4,3,4,FALSE,TRUE,"RD","double_zero"
"CD013715_pub2_data","8::overall","8","overall","Participant global assessment of disease activity at 27 to 52 weeks ",2,1,2,FALSE,TRUE,"RD","double_zero"
"CD013715_pub2_data","9::overall","9","overall","Disease remission at 17 to 26 weeks ",3,0,2,TRUE,TRUE,"RD","sparse_events"
"CD013715_pub2_data","10::overall","10","overall","Disease remission at 27 to 52 weeks ",2,0,1,TRUE,TRUE,"RD","sparse_events"
"CD013715_pub2_data","11::overall","11","overall","Withdrawals due to adverse events at up to 16 weeks",4,3,4,FALSE,TRUE,"RD","double_zero"
"CD013715_pub2_data","12::overall","12","overall","Withdrawals due to adverse events at 17 to 26 weeks",3,1,3,TRUE,TRUE,"RD","double_zero"
"CD013715_pub2_data","13::overall","13","overall","Withdrawals due to adverse events at 27 to 52 weeks",4,1,1,TRUE,TRUE,"RD","double_zero"
"CD013715_pub2_data","14::overall","14","overall","Withdrawals due to adverse events at end of study",7,5,5,TRUE,TRUE,"RD","double_zero"
"CD013715_pub2_data","15::overall","15","overall","Serious adverse events at up to 16 weeks",4,1,3,TRUE,TRUE,"RD","double_zero"
"CD013715_pub2_data","16::overall","16","overall","Serious adverse events at 17 to 26 weeks",9,8,9,FALSE,TRUE,"RD","double_zero"
"CD013715_pub2_data","17::overall","17","overall","Serious adverse events at 27 to 52 weeks",3,0,0,TRUE,TRUE,"OR_cc","default_or"
"CD013715_pub2_data","18::overall","18","overall","Serious adverse events at the end of study",6,1,4,TRUE,TRUE,"RD","double_zero"
"CD013715_pub2_data","19::overall","19","overall","PedACR50 at up to 16 weeks ",4,0,0,TRUE,TRUE,"OR_cc","default_or"
"CD013715_pub2_data","21::overall","21","overall","PedACR50 at 27 to 52 weeks ",2,0,0,TRUE,TRUE,"OR_cc","default_or"
"CD013715_pub2_data","22::overall","22","overall","Total adverse events",5,0,0,TRUE,TRUE,"OR_cc","default_or"
"CD013715_pub2_data","23::overall","23","overall","Sensitivity analysis: pedACR70 at the latest time point",7,0,0,TRUE,TRUE,"OR_cc","default_or"
"CD013719_pub2_data","1::overall","1","overall","Short-term hair regrowth ≥ 75%",18,0,5,TRUE,TRUE,"RD","sparse_events"
"CD013719_pub2_data","2::overall","2","overall","Incidence of serious adverse events",24,18,20,TRUE,TRUE,"RD","double_zero"
"CD013719_pub2_data","3::overall","3","overall","Health-related quality of life",4,1,1,TRUE,TRUE,"RD","double_zero"
"CD013719_pub2_data","5::overall","5","overall","Sensitivity analysis. Oral small molecule inhibitors: baricitinib vs placebo",4,0,0,TRUE,TRUE,"OR_cc","default_or"
"CD013719_pub2_data","11::overall","11","overall","Sensitivity analysis. Topical hair growth stimulants vs placebo: short-term hair-regrowth",2,0,0,TRUE,TRUE,"OR_cc","default_or"
"CD013726_pub2_data","4::overall","4","overall","Participant global assessment of treatment success",10,2,5,TRUE,TRUE,"RD","double_zero"
"CD013726_pub2_data","5::overall","5","overall","Reoperation (treatment failure)",9,2,6,TRUE,TRUE,"RD","double_zero"
"CD013726_pub2_data","6::overall","6","overall","Adverse events",14,0,4,TRUE,TRUE,"RD","sparse_events"
"CD013729_pub2_data","1::overall","1","overall","Change in systolic blood pressure (medium-term follow-up)",5,3,5,TRUE,TRUE,"RD","double_zero"
"CD013729_pub2_data","3::overall","3","overall","Change in diastolic blood pressure (medium-term follow-up)",3,2,3,FALSE,TRUE,"RD","double_zero"
"CD013731_pub2_data","1::overall","1","overall","Overall survival at censored observation (measured at end of treatment, i.e. 20 months)",6,1,1,TRUE,TRUE,"RD","double_zero"
"CD013731_pub2_data","2::overall","2","overall","Serious adverse events (Intention-to-treat) (measured at end of treatment, i.e. 20 months)",5,0,1,TRUE,TRUE,"RD","sparse_events"
"CD013731_pub2_data","3::overall","3","overall","Disease progression (measured at end of treatment, i.e. 20 months)",5,0,0,TRUE,TRUE,"OR_cc","default_or"
"CD013745_pub2_data","1::overall","1","overall","Rivaroxaban versus antiplatelet therapy",9,0,0,TRUE,TRUE,"OR_cc","default_or"
"CD013745_pub2_data","2::overall","2","overall","Apixaban versus antiplatelet therapy",7,0,2,TRUE,TRUE,"RD","sparse_events"
"CD013745_pub2_data","3::overall","3","overall","Edoxaban versus antiplatelet therapy",8,0,3,TRUE,TRUE,"RD","sparse_events"
"CD013745_pub2_data","4::overall","4","overall","NOACs versus antiplatelet therapy",12,1,2,TRUE,TRUE,"RD","double_zero"
"CD013745_pub2_data","5::overall","5","overall","Apixaban versus VKA",4,0,0,TRUE,TRUE,"OR_cc","default_or"
"CD013745_pub2_data","6::overall","6","overall","Edoxaban versus VKA",5,0,0,TRUE,TRUE,"OR_cc","default_or"
"CD013745_pub2_data","7::overall","7","overall","NOACs versus VKA",6,0,0,TRUE,TRUE,"OR_cc","default_or"
"CD013748_pub2_data","1::overall","1","overall","Poor functional outcome",16,0,2,TRUE,TRUE,"RD","sparse_events"
"CD013748_pub2_data","2::overall","2","overall","Case fatality",16,0,5,TRUE,TRUE,"RD","sparse_events"
"CD013748_pub2_data","3::overall","3","overall","Haemorrhagic complications",12,3,8,TRUE,TRUE,"RD","double_zero"
"CD013748_pub2_data","4::overall","4","overall","Cerebral artery vasospasm",10,0,2,TRUE,TRUE,"RD","sparse_events"
"CD013748_pub2_data","5::overall","5","overall","Delayed cerebral ischaemia",10,0,0,TRUE,TRUE,"OR_cc","default_or"
"CD013748_pub2_data","6::overall","6","overall","Cerebral infarction",6,0,2,TRUE,TRUE,"RD","sparse_events"
"CD013748_pub2_data","7::overall","7","overall","Hydrocephalus",12,2,4,TRUE,TRUE,"RD","double_zero"
"CD013757_pub3_data","1::1","1","1","Hospitalisation due to RSV infection",5,0,1,TRUE,TRUE,"RD","sparse_events"
"CD013757_pub3_data","2::overall","2","overall","Mortality",5,2,3,TRUE,TRUE,"RD","double_zero"
"CD013757_pub3_data","3::overall","3","overall","Adverse events",4,0,0,TRUE,TRUE,"OR_cc","default_or"
"CD013757_pub3_data","4::overall","4","overall","Hospitalisation due to respiratory‐related illness",6,0,0,TRUE,TRUE,"OR_cc","default_or"
"CD013757_pub3_data","5::1","5","1","Subgroup analysis: hospitalisation due to respiratory‐related illness",5,0,0,TRUE,TRUE,"OR_cc","default_or"
"CD013757_pub3_data","7::1","7","1","RSV infection",3,0,0,TRUE,TRUE,"OR_cc","default_or"
"CD013758_pub2_data","7::overall","7","overall","Overweight",3,0,1,TRUE,TRUE,"RD","sparse_events"
"CD013758_pub2_data","8::overall","8","overall","Overweight (formula with complementary foods): subgroup analysis by duration of treatment",7,0,1,TRUE,TRUE,"RD","sparse_events"
"CD013758_pub2_data","9::overall","9","overall","Obesity",5,4,4,FALSE,TRUE,"RD","double_zero"
"CD013758_pub2_data","10::overall","10","overall","Obesity (formula with complementary foods): subgroup analysis by duration of treatment",11,8,8,TRUE,TRUE,"RD","double_zero"
"CD013758_pub2_data","11::overall","11","overall","Any adverse event",8,4,5,TRUE,TRUE,"RD","double_zero"
"CD013758_pub2_data","12::overall","12","overall","Adverse events (sole feeding method)",10,8,9,TRUE,TRUE,"RD","double_zero"
"CD013758_pub2_data","13::overall","13","overall","Adverse events (formula with complementary foods)",6,4,6,TRUE,TRUE,"RD","double_zero"
"CD013763_pub3_data","2::overall","2","overall","Rates of block-related adverse events",64,57,62,TRUE,TRUE,"RD","double_zero"
"CD013763_pub3_data","4::overall","4","overall","Mean difference in postoperative pain intensity at rest - 2 hours (VAS)",51,49,49,TRUE,TRUE,"RD","double_zero"
"CD013763_pub3_data","5::overall","5","overall","Mean difference in postoperative pain intensity at rest - 48 hours (VAS)",39,34,34,TRUE,TRUE,"RD","double_zero"
"CD013763_pub3_data","8::overall","8","overall","Rate of chronic post-surgical pain after 3 months",15,1,3,TRUE,TRUE,"RD","double_zero"
"CD013763_pub3_data","9::overall","9","overall","Rate of chronic post-surgical pain after 6 months",11,8,8,TRUE,TRUE,"RD","double_zero"
"CD013763_pub3_data","11::overall","11","overall","Cumulative mean oral morphine requirement in mg - 24 hours",33,24,26,TRUE,TRUE,"RD","double_zero"
"CD013763_pub3_data","13::overall","13","overall","Rates of opioid-related adverse events (PONV)",21,0,4,TRUE,TRUE,"RD","sparse_events"
"CD013763_pub3_data","14::overall","14","overall","Rates of opioid-related adverse events (pruritus)",7,0,0,TRUE,TRUE,"OR_cc","default_or"
"CD013764_pub2_data","1::overall","1","overall","Successful abortion",6,0,0,TRUE,TRUE,"OR_cc","default_or"
"CD013764_pub2_data","2::overall","2","overall","Continued pregnancy",6,1,2,TRUE,TRUE,"RD","double_zero"
"CD013764_pub2_data","3::overall","3","overall","Blood transfusion",3,1,3,TRUE,TRUE,"RD","double_zero"
"CD013764_pub2_data","4::overall","4","overall","Hospitalisation",3,1,2,TRUE,TRUE,"RD","double_zero"
"CD013764_pub2_data","5::overall","5","overall","Emergency visit",6,1,1,TRUE,TRUE,"RD","double_zero"
"CD013764_pub2_data","6::overall","6","overall","Adherence",2,0,0,TRUE,TRUE,"OR_cc","default_or"
"CD013764_pub2_data","7::overall","7","overall","Satisfaction",2,0,0,TRUE,TRUE,"OR_cc","default_or"
"CD013773_pub2_data","2::overall","2","overall","Incidence of myopia",7,0,0,TRUE,TRUE,"OR_cc","default_or"
"CD013774_pub2_data","3::overall","3","overall","Adverse events grade 3 to 5",5,0,0,TRUE,TRUE,"OR_cc","default_or"
"CD013774_pub2_data","5::overall","5","overall","Discontinuation due to adverse events",5,0,0,TRUE,TRUE,"OR_cc","default_or"
"CD013774_pub2_data","7::overall","7","overall","Adverse events grade 3 to 5 – subgroup analysis: atezolizumab vs pembrolizumab vs durvalumab",5,2,2,TRUE,TRUE,"RD","double_zero"
"CD013774_pub2_data","9::overall","9","overall","Time to death from any cause – subgroup analysis: cisplatin-eligible vs cisplatin-ineligible participants",8,6,6,TRUE,TRUE,"RD","double_zero"
"CD013781_pub2_data","1::overall","1","overall","Secondary outcome: cardiac index (postoperative nadir)",73,17,40,TRUE,TRUE,"RD","double_zero"
"CD013781_pub2_data","2::overall","2","overall","Primary outcome: adverse events - atrial fibrillation",28,3,7,TRUE,TRUE,"RD","double_zero"
"CD013781_pub2_data","3::overall","3","overall","Primary outcome: adverse events - perioperative myocardial infarction",36,7,7,TRUE,TRUE,"RD","double_zero"
"CD013781_pub2_data","4::overall","4","overall","Secondary outcome: length of hospital stay (days)",39,13,19,TRUE,TRUE,"RD","double_zero"
"CD013781_pub2_data","5::overall","5","overall","Secondary outcome: mean arterial pressure (24 hours after surgery)",41,18,26,TRUE,TRUE,"RD","double_zero"
"CD013781_pub2_data","6::overall","6","overall","Secondary outcome: duration of mechanical ventilation (hours)",18,10,12,TRUE,TRUE,"RD","double_zero"
"CD013781_pub2_data","7::overall","7","overall","Secondary outcome: number of participants requiring additional inotropic drugs - dopamine",17,14,16,TRUE,TRUE,"RD","double_zero"
"CD013781_pub2_data","8::overall","8","overall","Secondary outcome: proportion of renal failure",17,14,16,TRUE,TRUE,"RD","double_zero"
"CD013781_pub2_data","9::overall","9","overall","Secondary outcome: PCWP",32,30,30,TRUE,TRUE,"RD","double_zero"
"CD013781_pub2_data","10::overall","10","overall","Secondary outcome: duration of mechanical ventilation (hours)",30,28,28,TRUE,TRUE,"RD","double_zero"
"CD013781_pub2_data","11::overall","11","overall","Secondary outcome: proportion of weaning failure within 48 hours of extubation",27,23,24,TRUE,TRUE,"RD","double_zero"
"CD013781_pub2_data","12::overall","12","overall","Secondary outcome: number of participants requiring mechanical circulatory support",10,8,9,TRUE,TRUE,"RD","double_zero"
"CD013781_pub2_data","13::overall","13","overall","Secondary outcome: number of participants requiring additional inotropic drugs",8,0,2,TRUE,TRUE,"RD","sparse_events"
"CD013781_pub2_data","14::overall","14","overall","Secondary outcome: number of participants requiring additional inotropic drugs - epinephrine",14,2,5,TRUE,TRUE,"RD","double_zero"
"CD013781_pub2_data","15::overall","15","overall","Secondary outcome: number of participants requiring additional inotropic drugs - norepinephrine",9,0,1,TRUE,TRUE,"RD","sparse_events"
"CD013781_pub2_data","16::overall","16","overall","Secondary outcome: number of participants requiring additional inotropic drugs - dobutamine",7,1,2,TRUE,TRUE,"RD","double_zero"
"CD013781_pub2_data","17::overall","17","overall","Secondary outcome: number of participants requiring additional inotropic drugs - phenylephrine",9,0,1,TRUE,TRUE,"RD","sparse_events"
"CD013781_pub2_data","18::overall","18","overall","Secondary outcome: proportion of renal failure",4,0,2,TRUE,TRUE,"RD","sparse_events"
"CD013781_pub2_data","19::overall","19","overall","Secondary outcome: number of participants requiring additional inotropic drugs - dobutamine",5,0,2,TRUE,TRUE,"RD","sparse_events"
"CD013781_pub2_data","20::overall","20","overall","Secondary outcome: number of participants requiring cardiac transplantation",2,1,1,FALSE,TRUE,"RD","double_zero"
"CD013781_pub2_data","21::overall","21","overall","Secondary outcome: number of participants requiring cardiopulmonary resuscitation",3,0,0,TRUE,TRUE,"OR_cc","default_or"
"CD013781_pub2_data","22::overall","22","overall","Secondary outcome: proportion of renal failure",4,1,1,TRUE,TRUE,"RD","double_zero"
"CD013781_pub2_data","25::overall","25","overall","Secondary outcome: number of participants requiring cardiac transplantation",4,1,4,TRUE,TRUE,"RD","double_zero"
"CD013781_pub2_data","27::overall","27","overall","Secondary outcome: proportion of renal failure ",9,1,2,TRUE,TRUE,"RD","double_zero"
"CD013800_pub2_data","5::overall","5","overall","Loss of residual kidney function (number who became anuric) at approximately 12-month follow-up",3,0,0,TRUE,TRUE,"OR_cc","default_or"
"CD013800_pub2_data","6::overall","6","overall","All-cause death",48,0,0,TRUE,TRUE,"OR_cc","default_or"
"CD013800_pub2_data","7::overall","7","overall","Cardiovascular death",24,0,4,TRUE,TRUE,"RD","sparse_events"
"CD013800_pub2_data","8::overall","8","overall","Infection-related death",21,0,2,TRUE,TRUE,"RD","sparse_events"
"CD013800_pub2_data","9::overall","9","overall","Bacteraemia/bloodstream infection ",2,0,0,TRUE,TRUE,"OR_cc","default_or"
"CD013800_pub2_data","10::overall","10","overall","Infection episodes (all types)",3,0,0,TRUE,TRUE,"OR_cc","default_or"
"CD013800_pub2_data","11::overall","11","overall","Bacteraemia/bloodstream infection episodes",2,0,0,TRUE,TRUE,"OR_cc","default_or"
"CD013800_pub2_data","12::overall","12","overall","Acute myocardial infarction",4,0,0,TRUE,TRUE,"OR_cc","default_or"
"CD013800_pub2_data","13::overall","13","overall","Coronary artery disease",3,0,0,TRUE,TRUE,"OR_cc","default_or"
"CD013800_pub2_data","14::overall","14","overall","Ischaemic heart disease",2,0,0,TRUE,TRUE,"OR_cc","default_or"
"CD013800_pub2_data","15::overall","15","overall","Congestive heart failure",3,0,0,TRUE,TRUE,"OR_cc","default_or"
"CD013800_pub2_data","16::overall","16","overall","Stroke",4,0,1,TRUE,TRUE,"RD","sparse_events"
"CD013800_pub2_data","17::overall","17","overall","Hospitalisation",4,0,0,TRUE,TRUE,"OR_cc","default_or"
"CD013800_pub2_data","18::overall","18","overall","All-cause hospitalisation events",4,0,0,TRUE,TRUE,"OR_cc","default_or"
"CD013800_pub2_data","19::overall","19","overall","Employed patients 1 year after dialysis initiation",2,0,0,TRUE,TRUE,"OR_cc","default_or"
"CD013801_pub2_data","21::1","21","1","Incidence of headache",3,0,1,TRUE,TRUE,"RD","sparse_events"
"CD013801_pub2_data","28::1","28","1","Incidence of all-cause mortality",3,2,3,FALSE,TRUE,"RD","double_zero"
"CD013801_pub2_data","17::overall","17","overall","Incidence of hypotension requiring vascular expansion",2,0,2,TRUE,TRUE,"RD","sparse_events"
"CD013816_pub2_data","1::overall","1","overall","Thromboembolic events (composite)",8,3,8,TRUE,TRUE,"RD","double_zero"
"CD013816_pub2_data","2::overall","2","overall","Device-pocket hematoma",9,0,1,TRUE,TRUE,"RD","sparse_events"
"CD013816_pub2_data","3::overall","3","overall","Transient ischemic attack",6,4,6,TRUE,TRUE,"RD","double_zero"
"CD013816_pub2_data","4::overall","4","overall","Ischemic stroke",7,3,7,TRUE,TRUE,"RD","double_zero"
"CD013816_pub2_data","7::overall","7","overall","Peripheral embolism",6,2,2,TRUE,TRUE,"RD","double_zero"
"CD013816_pub2_data","9::overall","9","overall","Bleeding events (composite)",7,1,3,TRUE,TRUE,"RD","double_zero"
"CD013816_pub2_data","10::overall","10","overall","Hemothorax",4,3,4,FALSE,TRUE,"RD","double_zero"
"CD013816_pub2_data","11::overall","11","overall","Cardiac tamponade",4,2,4,TRUE,TRUE,"RD","double_zero"
"CD013816_pub2_data","12::overall","12","overall","Non-tamponade pericardial effusion",4,1,3,TRUE,TRUE,"RD","double_zero"
"CD013816_pub2_data","13::overall","13","overall","All-cause mortality",4,1,3,TRUE,TRUE,"RD","double_zero"
"CD013816_pub2_data","14::overall","14","overall","Adverse events",5,0,3,TRUE,TRUE,"RD","sparse_events"
"CD013816_pub2_data","15::overall","15","overall","Adverse events - Bleeding (clinically significant bleeding that does not qualify as device-pocket hematoma, hemothorax, cardiac tamponade, or non-tamponade pericardial effusion)",4,0,3,TRUE,TRUE,"RD","sparse_events"
"CD013816_pub2_data","16::overall","16","overall","Adverse events - Pneumothorax",4,1,4,TRUE,TRUE,"RD","double_zero"
"CD013816_pub2_data","17::overall","17","overall","Adverse events - Infection",3,0,2,TRUE,TRUE,"RD","sparse_events"
"CD013821_pub2_data","6::overall","6","overall","Short-term complications",22,0,0,TRUE,TRUE,"OR_cc","default_or"
"CD013821_pub2_data","7::overall","7","overall","Long-term complications",17,0,0,TRUE,TRUE,"OR_cc","default_or"
"CD013821_pub2_data","8::overall","8","overall","Locoregional recurrence",2,0,0,TRUE,TRUE,"OR_cc","default_or"
"CD013821_pub2_data","9::overall","9","overall","Reintervention",15,0,0,TRUE,TRUE,"OR_cc","default_or"
"CD013822_pub2_data","1::overall","1","overall","Knowledge",14,12,12,TRUE,TRUE,"RD","double_zero"
"CD013822_pub2_data","2::overall","2","overall","Confidence - decisional conflict - dichotomous",4,3,3,FALSE,TRUE,"RD","double_zero"
"CD013822_pub2_data","5::overall","5","overall","Knowledge - informed choice (composite of knowledge, attitudes and intentions)",9,0,0,TRUE,TRUE,"OR_cc","default_or"
"CD013822_pub2_data","6::overall","6","overall","Knowledge - dichotomous (correct answers)",28,0,0,TRUE,TRUE,"OR_cc","default_or"
"CD013822_pub2_data","8::overall","8","overall","Anxiety - dichotomous",3,2,2,FALSE,TRUE,"RD","double_zero"
"CD013823_pub2_data","1::overall","1","overall","Maternal anaemia",2,0,0,TRUE,TRUE,"OR_cc","default_or"
"CD013823_pub2_data","2::overall","2","overall","Maternal vitamin B12 deficiency or insufficiency",2,0,0,TRUE,TRUE,"OR_cc","default_or"
"CD013823_pub2_data","3::overall","3","overall","Low birthweight (< 2500 g)",2,0,1,TRUE,TRUE,"RD","sparse_events"
"CD013823_pub2_data","4::overall","4","overall","Preterm birth (< 37 weeks)",2,0,0,TRUE,TRUE,"OR_cc","default_or"
"CD013823_pub2_data","8::overall","8","overall","Maternal hyperhomocysteinaemia",2,0,0,TRUE,TRUE,"OR_cc","default_or"
"CD013823_pub2_data","12::overall","12","overall","Infant anaemia",2,0,0,TRUE,TRUE,"OR_cc","default_or"
"CD013827_pub2_data","1::overall","1","overall","Live birth or ongoing pregnancy",7,1,1,TRUE,TRUE,"RD","double_zero"
"CD013827_pub2_data","2::overall","2","overall","Oocyte pick-up cancellation",12,1,1,TRUE,TRUE,"RD","double_zero"
"CD013827_pub2_data","3::overall","3","overall","Clinical pregnancy",7,0,0,TRUE,TRUE,"OR_cc","default_or"
"CD013827_pub2_data","4::overall","4","overall","Cumulative pregnancy rate",5,0,0,TRUE,TRUE,"OR_cc","default_or"
"CD013827_pub2_data","5::overall","5","overall","Miscarriage",18,0,2,TRUE,TRUE,"RD","sparse_events"
"CD013827_pub2_data","6::overall","6","overall","Multiple pregnancy",15,1,1,TRUE,TRUE,"RD","double_zero"
"CD013827_pub2_data","7::overall","7","overall","Premature LH surge",12,11,11,FALSE,TRUE,"RD","double_zero"
"CD013827_pub2_data","11::overall","11","overall","Total dose of gonadotropins (IU)",12,11,12,FALSE,TRUE,"RD","double_zero"
"CD013827_pub2_data","13::overall","13","overall","Live birth or ongoing pregnancy sensitivity analysis",2,0,0,TRUE,TRUE,"OR_cc","default_or"
"CD013827_pub2_data","14::overall","14","overall","Oocyte pick-up cancellation sensitivity analysis",4,0,1,TRUE,TRUE,"RD","sparse_events"
"CD013830_pub2_data","1::2","1","2","Death or major neurodevelopmental disability",4,0,0,TRUE,TRUE,"OR_cc","default_or"
"CD013830_pub2_data","2::1","2","1","Death at hospital discharge",4,0,2,TRUE,TRUE,"RD","sparse_events"
"CD013830_pub2_data","2::2","2","2","Death at hospital discharge",6,0,4,TRUE,TRUE,"RD","sparse_events"
"CD013830_pub2_data","2::3","2","3","Death at hospital discharge",4,0,4,TRUE,TRUE,"RD","sparse_events"
"CD013830_pub2_data","3::2","3","2","Major neurodevelopmental disability",4,0,0,TRUE,TRUE,"OR_cc","default_or"
"CD013830_pub2_data","4::2","4","2","Cerebral palsy or gross motor disability",4,0,0,TRUE,TRUE,"OR_cc","default_or"
"CD013830_pub2_data","5::2","5","2","Cognitive delay",2,0,0,TRUE,TRUE,"OR_cc","default_or"
"CD013830_pub2_data","6::1","6","1","Any apneic episodes",3,0,1,TRUE,TRUE,"RD","sparse_events"
"CD013830_pub2_data","6::2","6","2","Any apneic episodes",6,1,3,TRUE,TRUE,"RD","double_zero"
"CD013830_pub2_data","6::3","6","3","Any apneic episodes",4,0,0,TRUE,TRUE,"OR_cc","default_or"
"CD013830_pub2_data","7::2","7","2","Failed apnea reduction",5,3,4,TRUE,TRUE,"RD","double_zero"
"CD013830_pub2_data","7::3","7","3","Failed apnea reduction",6,1,2,TRUE,TRUE,"RD","double_zero"
"CD013830_pub2_data","8::1","8","1","Positive-pressure ventilation after institution of treatment",2,0,1,TRUE,TRUE,"RD","sparse_events"
"CD013830_pub2_data","8::2","8","2","Positive-pressure ventilation after institution of treatment",6,3,5,TRUE,TRUE,"RD","double_zero"
"CD013830_pub2_data","8::3","8","3","Positive-pressure ventilation after institution of treatment",4,1,2,TRUE,TRUE,"RD","double_zero"
"CD013830_pub2_data","10::2","10","2","Duration of oxygen therapy (days)",3,1,1,TRUE,TRUE,"RD","double_zero"
"CD013830_pub2_data","11::2","11","2","Patent ductus arteriosus (PDA) requiring any treatment",4,0,0,TRUE,TRUE,"OR_cc","default_or"
"CD013830_pub2_data","11::3","11","3","Patent ductus arteriosus (PDA) requiring any treatment",2,0,0,TRUE,TRUE,"OR_cc","default_or"
"CD013830_pub2_data","12::2","12","2","Patent ductus arteriosus (PDA) requiring ligation",4,0,0,TRUE,TRUE,"OR_cc","default_or"
"CD013830_pub2_data","13::1","13","1","Any intraventricular hemorrhage (IVH)",3,0,1,TRUE,TRUE,"RD","sparse_events"
"CD013830_pub2_data","13::2","13","2","Any intraventricular hemorrhage (IVH)",3,0,0,TRUE,TRUE,"OR_cc","default_or"
"CD013830_pub2_data","13::3","13","3","Any intraventricular hemorrhage (IVH)",3,0,0,TRUE,TRUE,"OR_cc","default_or"
"CD013830_pub2_data","14::1","14","1","Severe intraventricular hemorrhage (grades 3 and 4)",2,0,0,TRUE,TRUE,"OR_cc","default_or"
"CD013830_pub2_data","15::2","15","2","Periventricular leukomalacia (PVL)",2,0,0,TRUE,TRUE,"OR_cc","default_or"
"CD013830_pub2_data","16::1","16","1","Necrotizing enterocolitis (NEC) (Bell's stage II or greater OR any grade; requiring surgery)",2,0,1,TRUE,TRUE,"RD","sparse_events"
"CD013830_pub2_data","16::2","16","2","Necrotizing enterocolitis (NEC) (Bell's stage II or greater OR any grade; requiring surgery)",4,0,1,TRUE,TRUE,"RD","sparse_events"
"CD013830_pub2_data","17::2","17","2","Retinopathy of prematurity (ROP) in infants examined (any stage)",4,1,2,TRUE,TRUE,"RD","double_zero"
"CD013830_pub2_data","17::3","17","3","Retinopathy of prematurity (ROP) in infants examined (any stage)",2,0,1,TRUE,TRUE,"RD","sparse_events"
"CD013830_pub2_data","19::1","19","1","Oxygen therapy at 28 to 30 days",2,0,0,TRUE,TRUE,"OR_cc","default_or"
"CD013830_pub2_data","21::2","21","2","Tachycardia leading to cessation of treatment",3,1,2,TRUE,TRUE,"RD","double_zero"
"CD013830_pub2_data","21::3","21","3","Tachycardia leading to cessation of treatment",2,0,2,TRUE,TRUE,"RD","sparse_events"
"CD013830_pub2_data","5::1","5","1","Any apneic episodes",2,1,1,FALSE,TRUE,"RD","double_zero"
"CD013830_pub2_data","9::2","9","2","Corrected gestational age at last use of oxygen therapy",3,2,2,FALSE,TRUE,"RD","double_zero"
"CD013830_pub2_data","12::1","12","1","Any intraventricular hemorrhage (IVH)",2,0,1,TRUE,TRUE,"RD","sparse_events"
"CD013830_pub2_data","4::3","4","3","Failed extubation",3,0,0,TRUE,TRUE,"OR_cc","default_or"
"CD013830_pub2_data","10::3","10","3","Any intraventricular hemorrhage (IVH)",2,0,0,TRUE,TRUE,"OR_cc","default_or"
"CD013830_pub2_data","1::1","1","1","Failed extubation",2,0,1,TRUE,TRUE,"RD","sparse_events"
"CD013844_pub2_data","1::overall","1","overall","Acceptability (dropouts)",12,0,4,TRUE,TRUE,"RD","sparse_events"
"CD013844_pub2_data","2::overall","2","overall","Self-harm at short term (1-3 months) follow-up",4,0,0,TRUE,TRUE,"OR_cc","default_or"
"CD013844_pub2_data","3::overall","3","overall","Self-harm at medium-term (4-12 months) follow-up",14,2,4,TRUE,TRUE,"RD","double_zero"
"CD013844_pub2_data","4::overall","4","overall","Self-harm at long-term (> 12 months) follow-up",8,1,4,TRUE,TRUE,"RD","double_zero"
"CD013844_pub2_data","5::overall","5","overall","Suicidal ideation at postintervention follow-up",12,5,5,TRUE,TRUE,"RD","double_zero"
"CD013844_pub2_data","6::overall","6","overall","Suicidal ideation postintervention: sensitivity analysis (ICC 0.01)",18,15,15,TRUE,TRUE,"RD","double_zero"
"CD013844_pub2_data","7::overall","7","overall","Suicidal ideation postintervention: sensitivity analysis (ICC 0.05)",9,7,7,TRUE,TRUE,"RD","double_zero"
"CD013853_pub2_data","1::overall","1","overall","Exergaming vs control at the end of treatment: change in global physical functioning (composite)",12,9,10,TRUE,TRUE,"RD","double_zero"
"CD013853_pub2_data","2::overall","2","overall","Exergaming vs control at the end of treatment: change in global cognitive functioning (composite)",10,8,8,TRUE,TRUE,"RD","double_zero"
"CD013853_pub2_data","3::overall","3","overall","Exergaming vs control at the end of treatment: change in activities for daily living (ADL)",9,8,9,FALSE,TRUE,"RD","double_zero"
"CD013853_pub2_data","4::overall","4","overall","Exergaming vs alternative treatment at the end of treatment: change in lower limb functioning",8,6,7,TRUE,TRUE,"RD","double_zero"
"CD013853_pub2_data","5::overall","5","overall","Exergaming vs control at the end of treatment: change in general cognition",4,2,2,TRUE,TRUE,"RD","double_zero"
"CD013853_pub2_data","6::overall","6","overall","Exergaming vs control at the end of treatment: change in attention, processing speed, working memory",4,2,4,TRUE,TRUE,"RD","double_zero"
"CD013874_pub3_data","1::overall","1","overall","Disability worsening over 24 months",19,14,14,TRUE,TRUE,"RD","double_zero"
"CD013874_pub3_data","2::overall","2","overall","Time to relapse over 24 months",19,12,15,TRUE,TRUE,"RD","double_zero"
"CD013874_pub3_data","3::overall","3","overall","Relapse over 24 months",15,10,14,TRUE,TRUE,"RD","double_zero"
"CD013874_pub3_data","4::overall","4","overall","Total serious adverse events (SAEs)",17,9,11,TRUE,TRUE,"RD","double_zero"
"CD013874_pub3_data","5::overall","5","overall","Upper respiratory tract infection ",6,2,3,TRUE,TRUE,"RD","double_zero"
"CD013874_pub3_data","6::overall","6","overall","Urinary tract infections ",8,6,8,TRUE,TRUE,"RD","double_zero"
"CD013874_pub3_data","7::overall","7","overall","Skin infections   ",5,4,4,FALSE,TRUE,"RD","double_zero"
"CD013874_pub3_data","8::overall","8","overall","Viral infections     ",5,1,2,TRUE,TRUE,"RD","double_zero"
"CD013874_pub3_data","9::overall","9","overall","Annualised relapse rate",3,1,2,TRUE,TRUE,"RD","double_zero"
"CD013874_pub3_data","10::overall","10","overall","T2 or gadolinium MRI lesions over 24 months",5,3,3,TRUE,TRUE,"RD","double_zero"
"CD013874_pub3_data","11::overall","11","overall","Treatment discontinuation due to adverse events",5,3,3,TRUE,TRUE,"RD","double_zero"
"CD013874_pub3_data","12::overall","12","overall","Any adverse event",3,0,1,TRUE,TRUE,"RD","sparse_events"
"CD013874_pub3_data","13::overall","13","overall","Cardiovascular events over 18 to 24 months' follow-up – by type of DMT",3,1,2,TRUE,TRUE,"RD","double_zero"
"CD013875_pub2_data","1::overall","1","overall","Live birth (or ongoing pregnancy) – low risk of bias",3,0,0,TRUE,TRUE,"OR_cc","default_or"
"CD013875_pub2_data","2::overall","2","overall","Live birth (or ongoing pregnancy) – all studies",8,0,0,TRUE,TRUE,"OR_cc","default_or"
"CD013875_pub2_data","3::overall","3","overall","Live birth (or ongoing pregnancy) – sensitivity analysis (risk ratio)",8,0,0,TRUE,TRUE,"OR_cc","default_or"
"CD013875_pub2_data","4::overall","4","overall","Live birth (or ongoing pregnancy) – sensitivity analysis (live birth only)",5,0,0,TRUE,TRUE,"OR_cc","default_or"
"CD013875_pub2_data","5::overall","5","overall","Miscarriage – low risk of bias",2,0,1,TRUE,TRUE,"RD","sparse_events"
"CD013875_pub2_data","6::overall","6","overall","Miscarriage – all studies",7,0,3,TRUE,TRUE,"RD","sparse_events"
"CD013875_pub2_data","7::overall","7","overall","Miscarriage – sensitivity analysis (risk ratio)",7,0,3,TRUE,TRUE,"RD","sparse_events"
"CD013875_pub2_data","8::overall","8","overall","Miscarriage – sensitivity analysis (per clinical pregnancy)",6,0,3,TRUE,TRUE,"RD","sparse_events"
"CD013875_pub2_data","10::overall","10","overall","Clinical pregnancy – all studies",9,0,0,TRUE,TRUE,"OR_cc","default_or"
"CD013875_pub2_data","11::overall","11","overall","Clinical pregnancy – sensitivity analysis (risk ratio)",9,0,0,TRUE,TRUE,"OR_cc","default_or"
"CD013875_pub2_data","12::overall","12","overall","Clinical pregnancy – sensitivity analysis (full text only)",7,0,0,TRUE,TRUE,"OR_cc","default_or"
"CD013875_pub2_data","13::overall","13","overall","Multiple pregnancy – all studies",2,0,1,TRUE,TRUE,"RD","sparse_events"
"CD013875_pub2_data","14::overall","14","overall","Multiple pregnancy – sensitivity analysis (risk ratio)",2,0,1,TRUE,TRUE,"RD","sparse_events"
"CD014040_pub2_data","1::overall","1","overall","Live birth per participant randomized (low risk of bias studies)",16,0,0,TRUE,TRUE,"OR_cc","default_or"
"CD014040_pub2_data","2::overall","2","overall","Live birth per participant randomized (all studies)",8,0,0,TRUE,TRUE,"OR_cc","default_or"
"CD014040_pub2_data","3::overall","3","overall","Miscarriage rate per participant (low risk of bias studies)",7,0,0,TRUE,TRUE,"OR_cc","default_or"
"CD014040_pub2_data","4::overall","4","overall","Miscarriage per participant randomized (all studies)",3,0,0,TRUE,TRUE,"OR_cc","default_or"
"CD014040_pub2_data","5::overall","5","overall","Clinical pregnancy rate per participant (low risk of bias studies)",2,0,0,TRUE,TRUE,"OR_cc","default_or"
"CD014040_pub2_data","6::overall","6","overall","Clinical pregnancy per participant randomized (all studies)",3,0,0,TRUE,TRUE,"OR_cc","default_or"
"CD014040_pub2_data","7::overall","7","overall","Multiple pregnancy per participant randomized (low risk of bias studies)",2,0,0,TRUE,TRUE,"OR_cc","default_or"
"CD014040_pub2_data","8::overall","8","overall","Total fertilization failure rate per participant randomized (low risk of bias studies)",2,0,1,TRUE,TRUE,"RD","sparse_events"
"CD014040_pub2_data","9::overall","9","overall","Total fertilization failure per participant (all studies)",3,0,1,TRUE,TRUE,"RD","sparse_events"
"CD014040_pub2_data","10::overall","10","overall","Still birth rate per participant randomized (low risk of bias studies)",2,1,2,FALSE,TRUE,"RD","double_zero"
"CD014089_data","9::overall","9","overall","Number of people with healed digital ulcers",2,0,1,TRUE,TRUE,"RD","sparse_events"
"CD014089_data","11::overall","11","overall","Adverse effects",6,0,0,TRUE,TRUE,"OR_cc","default_or"
"CD014145_pub2_data","1::overall","1","overall","Failed apnea reduction after 2 to 7 days",7,0,4,TRUE,TRUE,"RD","sparse_events"
"CD014145_pub2_data","2::overall","2","overall","Need for positive pressure ventilation after initiation of treatment",5,1,3,TRUE,TRUE,"RD","double_zero"
"CD014145_pub2_data","8::overall","8","overall","Death (at any time during initial hospitalization)",2,0,1,TRUE,TRUE,"RD","sparse_events"
"CD014145_pub2_data","9::overall","9","overall","Side effects causing cessation of therapy",2,0,2,TRUE,TRUE,"RD","sparse_events"
"CD014300_pub2_data","13::overall","13","overall","Acceptability at study endpoint: children",10,1,2,TRUE,TRUE,"RD","double_zero"
"CD014300_pub2_data","14::overall","14","overall","Acceptability at study endpoint: adults",2,0,0,TRUE,TRUE,"OR_cc","default_or"
"CD014541_pub2_data","1::overall","1","overall","Symptomatic VTE: short-term (45 days or fewer)",4,0,0,TRUE,TRUE,"OR_cc","default_or"
"CD014541_pub2_data","2::overall","2","overall","Symptomatic VTE: short-term (45 days or fewer); random-effects sensitivity anaysis",4,0,0,TRUE,TRUE,"OR_cc","default_or"
"CD014541_pub2_data","3::overall","3","overall","Symptomatic VTE: short-term (45 days or fewer); COVID-19 sensitivity analysis",3,0,0,TRUE,TRUE,"OR_cc","default_or"
"CD014541_pub2_data","4::overall","4","overall","Symptomatic VTE: short-term (45 days or fewer); same extended agent sensitivity analysis",2,0,0,TRUE,TRUE,"OR_cc","default_or"
"CD014541_pub2_data","6::overall","6","overall","Symptomatic VTE: short-term (45 days or fewer); men versus women subgroup analysis",2,0,0,TRUE,TRUE,"OR_cc","default_or"
"CD014541_pub2_data","7::overall","7","overall","Symptomatic VTE: short-term (45 days or fewer); ≥ 75 years versus < 75 years of age subgroup analysis",2,0,0,TRUE,TRUE,"OR_cc","default_or"
"CD014541_pub2_data","8::overall","8","overall","Symptomatic VTE: short-term (45 days or fewer); history of cancer versus no history of cancer subgroup analysis",4,0,0,TRUE,TRUE,"OR_cc","default_or"
"CD014541_pub2_data","9::overall","9","overall","Symptomatic VTE: short-term (45 days or fewer); positive D-dimer test versus no positive D-dimer test subgroup analysis",2,0,0,TRUE,TRUE,"OR_cc","default_or"
"CD014541_pub2_data","10::overall","10","overall","Symptomatic VTE: short-term (45 days or fewer); admitting diagnosis of acute infection versus no acute infection subgroup analysis",2,0,0,TRUE,TRUE,"OR_cc","default_or"
"CD014541_pub2_data","11::overall","11","overall","Major bleeding: short-term (45 days or fewer)",7,2,2,TRUE,TRUE,"RD","double_zero"
"CD014541_pub2_data","12::overall","12","overall","Major bleeding: short-term (45 days or fewer); COVID-19 sensitivty analysis",6,1,1,TRUE,TRUE,"RD","double_zero"
"CD014541_pub2_data","13::overall","13","overall","Major bleeding: short-term (45 days or fewer); same extended agent sensitivity analysis",3,1,1,TRUE,TRUE,"RD","double_zero"
"CD014541_pub2_data","14::overall","14","overall","Major bleeding: short-term (45 days or fewer); men versus women subgroup analysis",6,0,0,TRUE,TRUE,"OR_cc","default_or"
"CD014541_pub2_data","15::overall","15","overall","Major bleeding: short-term (45 days or less); ≥ 75 years versus < 75 years of age subgroup analysis",6,0,0,TRUE,TRUE,"OR_cc","default_or"
"CD014541_pub2_data","16::overall","16","overall","Major bleeding: short-term (45 days or fewer); history of cancer versus no history of cancer subgroup analysis",4,0,1,TRUE,TRUE,"RD","sparse_events"
"CD014541_pub2_data","17::overall","17","overall","Major bleeding: short-term (45 days or fewer); positive D-dimer test versus no positive D-dimer test subgroup analysis",2,0,0,TRUE,TRUE,"OR_cc","default_or"
"CD014541_pub2_data","18::overall","18","overall","Major bleeding: short-term (45 days or fewer); admitting diagnosis of acute infection versus no acute infection subgroup analysis",4,0,0,TRUE,TRUE,"OR_cc","default_or"
"CD014541_pub2_data","19::overall","19","overall","All-cause mortality: short-term (45 days or fewer)",5,0,0,TRUE,TRUE,"OR_cc","default_or"
"CD014541_pub2_data","20::overall","20","overall","All-cause mortality: short-term (45 days or fewer); same extended agent sensitivity analysis",2,0,0,TRUE,TRUE,"OR_cc","default_or"
"CD014541_pub2_data","22::overall","22","overall","Total VTE: short-term (45 days or fewer)",5,0,0,TRUE,TRUE,"OR_cc","default_or"
"CD014541_pub2_data","26::overall","26","overall","Fatal bleeding: short-term (45 days or fewer)",7,2,6,TRUE,TRUE,"RD","double_zero"
"CD014541_pub2_data","27::overall","27","overall","VTE-related mortality: short-term (45 days or fewer)",6,0,2,TRUE,TRUE,"RD","sparse_events"
"CD014544_pub2_data","2::overall","2","overall","Proportion with zero bleeds (risk ratio)",7,0,0,TRUE,TRUE,"OR_cc","default_or"
"CD014544_pub2_data","4::overall","4","overall","HRQoL—EQ-5D-5L VAS",27,4,10,TRUE,TRUE,"RD","double_zero"
"CD014544_pub2_data","6::overall","6","overall","Adverse events",24,0,6,TRUE,TRUE,"RD","sparse_events"
"CD014574_pub2_data","3::overall","3","overall","Steroid sparing effect: long term (> 9 months)",2,0,0,TRUE,TRUE,"OR_cc","default_or"
"CD014574_pub2_data","4::overall","4","overall","Relapse requiring rescue therapy: long term (> 9 months)",2,0,0,TRUE,TRUE,"OR_cc","default_or"
"CD014574_pub2_data","5::overall","5","overall","Serious adverse events: long term ",4,0,0,TRUE,TRUE,"OR_cc","default_or"
"CD014574_pub2_data","6::overall","6","overall","Clinically significant improvement in QMG: medium term  (2-9 months)",2,0,0,TRUE,TRUE,"OR_cc","default_or"
"CD014574_pub2_data","8::overall","8","overall","Clinically significant improvement in MG-ADL: long term (> 9 months)",2,0,0,TRUE,TRUE,"OR_cc","default_or"
"CD014574_pub2_data","9::overall","9","overall","Clinially significant improvement in MG-ADL: medium term (2-9 months)",2,0,0,TRUE,TRUE,"OR_cc","default_or"
"CD014574_pub2_data","17::overall","17","overall","Steroid sparing effect: medium term (2-9 months)",2,0,0,TRUE,TRUE,"OR_cc","default_or"
"CD014574_pub2_data","23::overall","23","overall","Hospital admissions: long term (> 9 months)",2,0,1,TRUE,TRUE,"RD","sparse_events"
"CD014574_pub2_data","26::overall","26","overall","Any adverse event: long term",2,0,0,TRUE,TRUE,"OR_cc","default_or"
"CD014580_pub2_data","1::overall","1","overall","Treatment success",7,1,1,TRUE,TRUE,"RD","double_zero"
"CD014580_pub2_data","2::overall","2","overall","Stool consistency",6,2,2,TRUE,TRUE,"RD","double_zero"
"CD014580_pub2_data","3::overall","3","overall","Painful defecation",6,1,2,TRUE,TRUE,"RD","double_zero"
"CD014580_pub2_data","4::overall","4","overall","Faecal incontinence",6,2,2,TRUE,TRUE,"RD","double_zero"
"CD014580_pub2_data","5::overall","5","overall","Abdominal pain",3,2,2,FALSE,TRUE,"RD","double_zero"
"CD014585_pub2_data","1::overall","1","overall","Global symptoms of dyspepsia (dichotomous)",10,0,1,TRUE,TRUE,"RD","sparse_events"
"CD014585_pub2_data","2::overall","2","overall","Global symptoms of dyspepsia (continuous)",3,2,2,FALSE,TRUE,"RD","double_zero"
"CD014585_pub2_data","3::overall","3","overall","Incident ulcer",11,0,0,TRUE,TRUE,"OR_cc","default_or"
"CD014585_pub2_data","4::overall","4","overall","Adverse events",12,0,0,TRUE,TRUE,"OR_cc","default_or"
"CD014585_pub2_data","5::overall","5","overall","Ulcer complications ",5,1,2,TRUE,TRUE,"RD","double_zero"
"CD014585_pub2_data","1::1","1","1","Global symptoms of dyspepsia (continuous)",6,2,2,TRUE,TRUE,"RD","double_zero"
"CD014585_pub2_data","1::2","1","2","Global symptoms of dyspepsia (continuous)",5,2,2,TRUE,TRUE,"RD","double_zero"
"CD014585_pub2_data","2::1","2","1","Incident ulcer",6,0,0,TRUE,TRUE,"OR_cc","default_or"
"CD014585_pub2_data","2::2","2","2","Incident ulcer",10,0,0,TRUE,TRUE,"OR_cc","default_or"
"CD014585_pub2_data","3::1","3","1","Adverse events",5,0,0,TRUE,TRUE,"OR_cc","default_or"
"CD014585_pub2_data","3::2","3","2","Adverse events",13,0,0,TRUE,TRUE,"OR_cc","default_or"
"CD014585_pub2_data","2::3","2","3","Incident ulcer",2,0,0,TRUE,TRUE,"OR_cc","default_or"
"CD014585_pub2_data","2::4","2","4","Incident ulcer",4,0,0,TRUE,TRUE,"OR_cc","default_or"
"CD014585_pub2_data","3::3","3","3","Adverse events",2,0,0,TRUE,TRUE,"OR_cc","default_or"
"CD014585_pub2_data","3::4","3","4","Adverse events",4,0,0,TRUE,TRUE,"OR_cc","default_or"
"CD014594_pub2_data","1::overall","1","overall","First-pass success",64,27,39,TRUE,TRUE,"RD","double_zero"
"CD014594_pub2_data","2::overall","2","overall","Sensitivity analysis: first-pass success excluding rescue U/S",31,13,21,TRUE,TRUE,"RD","double_zero"
"CD014594_pub2_data","3::overall","3","overall","Time to successful CFA access: sensitivity analysis from fluoroscopy table movement or US probe application",4,2,3,TRUE,TRUE,"RD","double_zero"
"CD014594_pub2_data","4::overall","4","overall","Time to successful CFA access: sensitivity analysis from skin penetration",4,1,2,TRUE,TRUE,"RD","double_zero"
"CD014617_pub3_data","3::overall","3","overall","Proportion of eyes healed within 48 hours - Chung 1996",3,0,1,TRUE,TRUE,"RD","sparse_events"
"CD014617_pub3_data","1::2","1","2","Risk of ocular infection within one month of corneal abrasion",2,0,0,TRUE,TRUE,"OR_cc","default_or"
"CD014617_pub3_data","2::2","2","2","Proportion of eyes healed within 48 hours",2,0,0,TRUE,TRUE,"OR_cc","default_or"
"CD014623_pub2_data","6::overall","6","overall","Any adverse events",2,0,0,TRUE,TRUE,"OR_cc","default_or"
"CD014623_pub2_data","7::overall","7","overall","Serious adverse events",2,0,1,TRUE,TRUE,"RD","sparse_events"
"CD014624_pub2_data","1::1","1","1","Depression response (early phase)",8,0,4,TRUE,TRUE,"RD","sparse_events"
"CD014624_pub2_data","1::2","1","2","Depression response (early phase)",8,0,2,TRUE,TRUE,"RD","sparse_events"
"CD014624_pub2_data","1::3","1","3","Depression response (early phase)",8,0,2,TRUE,TRUE,"RD","sparse_events"
"CD014624_pub2_data","1::4","1","4","Depression response (early phase)",9,0,1,TRUE,TRUE,"RD","sparse_events"
"CD014624_pub2_data","1::5","1","5","Depression response (early phase)",8,0,0,TRUE,TRUE,"OR_cc","default_or"
"CD014624_pub2_data","1::6","1","6","Depression response (early phase)",6,0,0,TRUE,TRUE,"OR_cc","default_or"
"CD014624_pub2_data","1::7","1","7","Depression response (early phase)",7,0,0,TRUE,TRUE,"OR_cc","default_or"
"CD014624_pub2_data","1::8","1","8","Depression response (early phase)",7,0,0,TRUE,TRUE,"OR_cc","default_or"
"CD014624_pub2_data","1::9","1","9","Depression response (early phase)",7,0,0,TRUE,TRUE,"OR_cc","default_or"
"CD014624_pub2_data","1::10","1","10","Depression response (early phase)",6,0,0,TRUE,TRUE,"OR_cc","default_or"
"CD014624_pub2_data","1::11","1","11","Depression response (early phase)",6,0,0,TRUE,TRUE,"OR_cc","default_or"
"CD014624_pub2_data","2::1","2","1","Depression remission (early phase)",4,2,4,TRUE,TRUE,"RD","double_zero"
"CD014624_pub2_data","2::2","2","2","Depression remission (early phase)",4,0,2,TRUE,TRUE,"RD","sparse_events"
"CD014624_pub2_data","2::3","2","3","Depression remission (early phase)",6,0,4,TRUE,TRUE,"RD","sparse_events"
"CD014624_pub2_data","2::4","2","4","Depression remission (early phase)",7,1,5,TRUE,TRUE,"RD","double_zero"
"CD014624_pub2_data","2::5","2","5","Depression remission (early phase)",7,0,1,TRUE,TRUE,"RD","sparse_events"
"CD014624_pub2_data","2::6","2","6","Depression remission (early phase)",6,0,0,TRUE,TRUE,"OR_cc","default_or"
"CD014624_pub2_data","2::7","2","7","Depression remission (early phase)",7,0,0,TRUE,TRUE,"OR_cc","default_or"
"CD014624_pub2_data","2::8","2","8","Depression remission (early phase)",7,0,0,TRUE,TRUE,"OR_cc","default_or"
"CD014624_pub2_data","2::9","2","9","Depression remission (early phase)",7,0,0,TRUE,TRUE,"OR_cc","default_or"
"CD014624_pub2_data","2::10","2","10","Depression remission (early phase)",6,0,0,TRUE,TRUE,"OR_cc","default_or"
"CD014624_pub2_data","2::11","2","11","Depression remission (early phase)",6,0,0,TRUE,TRUE,"OR_cc","default_or"
"CD014624_pub2_data","3::1","3","1","Adverse events (mother)",9,0,0,TRUE,TRUE,"OR_cc","default_or"
"CD014624_pub2_data","3::2","3","2","Adverse events (mother)",8,0,6,TRUE,TRUE,"RD","sparse_events"
"CD014624_pub2_data","3::3","3","3","Adverse events (mother)",9,3,7,TRUE,TRUE,"RD","double_zero"
"CD014624_pub2_data","5::overall","5","overall","Treatment acceptability (measured by dropouts)",6,0,2,TRUE,TRUE,"RD","sparse_events"
"CD014624_pub2_data","2::overall","2","overall","Depression response (acute phase)",2,0,0,TRUE,TRUE,"OR_cc","default_or"
"CD014624_pub2_data","3::4","3","4","Depression remission (early phase)",2,0,0,TRUE,TRUE,"OR_cc","default_or"
"CD014624_pub2_data","4::overall","4","overall","Depression remission (acute phase)",2,0,0,TRUE,TRUE,"OR_cc","default_or"
"CD014624_pub2_data","5::1","5","1","Adverse events (mother)",2,0,0,TRUE,TRUE,"OR_cc","default_or"
"CD014624_pub2_data","5::2","5","2","Adverse events (mother)",2,0,1,TRUE,TRUE,"RD","sparse_events"
"CD014624_pub2_data","5::3","5","3","Adverse events (mother)",2,0,2,TRUE,TRUE,"RD","sparse_events"
"CD014624_pub2_data","8::overall","8","overall","Treatment acceptability",2,0,0,TRUE,TRUE,"OR_cc","default_or"
"CD014666_pub2_data","2::overall","2","overall","Fear of falling: subgrouped according to mean age",31,25,25,TRUE,TRUE,"RD","double_zero"
"CD014678_pub2_data","1::overall","1","overall","All-cause mortality (apixaban versus placebo)",40,0,0,TRUE,TRUE,"OR_cc","default_or"
"CD014678_pub2_data","2::overall","2","overall","All-cause mortality (rivaroxaban versus placebo)",43,0,0,TRUE,TRUE,"OR_cc","default_or"
"CD014678_pub2_data","3::overall","3","overall","All-cause mortality (dabigatran versus placebo)",37,0,9,TRUE,TRUE,"RD","sparse_events"
"CD014678_pub2_data","4::overall","4","overall","Myocardial infarction",34,0,0,TRUE,TRUE,"OR_cc","default_or"
"CD014678_pub2_data","5::overall","5","overall","Stroke",34,3,19,TRUE,TRUE,"RD","double_zero"
"CD014678_pub2_data","6::overall","6","overall","Stent thrombosis",13,0,0,TRUE,TRUE,"OR_cc","default_or"
"CD014678_pub2_data","7::overall","7","overall","Non-major bleeding",17,0,1,TRUE,TRUE,"RD","sparse_events"
"CD014678_pub2_data","8::overall","8","overall","Systemic embolism",5,0,5,TRUE,TRUE,"RD","sparse_events"
"CD014687_pub2_data","1::overall","1","overall","Pain: VAS (0-100) (final values): short term (up to 1 month)",17,9,11,TRUE,TRUE,"RD","double_zero"
"CD014687_pub2_data","2::overall","2","overall","Function: AOFAS (0-100) (final values): short term (up to 1 month)",12,10,10,TRUE,TRUE,"RD","double_zero"
"CD014687_pub2_data","3::overall","3","overall","Satisfaction (short term)",9,7,7,TRUE,TRUE,"RD","double_zero"
"CD014713_pub2_data","1::overall","1","overall","Unplanned hospital presentation rates - unplanned hospital admissions within one month (30 days)",7,0,0,TRUE,TRUE,"OR_cc","default_or"
"CD014713_pub2_data","2::overall","2","overall","Unplanned hospital presentation rates - unplanned hospital admissions within 12 months (365 days)",3,0,0,TRUE,TRUE,"OR_cc","default_or"
"CD014713_pub2_data","3::overall","3","overall","Unplanned hospital presentation rates - emergency department presentations within one month (30 days)",3,0,0,TRUE,TRUE,"OR_cc","default_or"
"CD014713_pub2_data","4::overall","4","overall","Unplanned hospital presentation rates - emergency department presentations within 12 months (365 days)",2,0,0,TRUE,TRUE,"OR_cc","default_or"
"CD014722_pub2_data","1::overall","1","overall","Diagnosis of mental disorders at 1-6 months ",49,41,42,TRUE,TRUE,"RD","double_zero"
"CD014722_pub2_data","2::overall","2","overall","Diagnosis of mental disorders at 7-24 months",39,31,31,TRUE,TRUE,"RD","double_zero"
"CD014722_pub2_data","3::overall","3","overall","Quality of life at 0-1 months",60,58,59,TRUE,TRUE,"RD","double_zero"
"CD014736_pub2_data","2::overall","2","overall","Six-minute walk test (metres)",8,4,7,TRUE,TRUE,"RD","double_zero"
"CD014736_pub2_data","6::overall","6","overall","Reintervention by end of follow-up",5,1,2,TRUE,TRUE,"RD","double_zero"
"CD014741_pub2_data","1::overall","1","overall","All-cause mortality",22,0,13,TRUE,TRUE,"RD","sparse_events"
"CD014741_pub2_data","2::overall","2","overall","Myocardial infarction (fatal or non-fatal)",17,0,12,TRUE,TRUE,"RD","sparse_events"
"CD014741_pub2_data","3::overall","3","overall","Unstable angina",30,6,14,TRUE,TRUE,"RD","double_zero"
"CD014741_pub2_data","4::overall","4","overall","Adverse events",42,33,35,TRUE,TRUE,"RD","double_zero"
"CD014741_pub2_data","6::overall","6","overall","Adverse events (any infections)",28,20,25,TRUE,TRUE,"RD","double_zero"
"CD014741_pub2_data","7::overall","7","overall","Stroke (fatal or non-fatal)",7,0,5,TRUE,TRUE,"RD","sparse_events"
"CD014741_pub2_data","8::overall","8","overall","Heart failure",12,0,9,TRUE,TRUE,"RD","sparse_events"
"CD014741_pub2_data","9::overall","9","overall","Heart failure",7,0,3,TRUE,TRUE,"RD","sparse_events"
"CD014755_pub2_data","1::overall","1","overall","Number of chemotherapy cycles to remission",2,1,1,FALSE,TRUE,"RD","double_zero"
"CD014762_pub2_data","1::overall","1","overall","Short-term resolution of symptoms (days 1 to 4 after randomisation)",6,2,2,TRUE,TRUE,"RD","double_zero"
"CD014762_pub2_data","2::overall","2","overall","Medium-term resolution of symptoms (days 5 to 10 after randomisation)",6,2,2,TRUE,TRUE,"RD","double_zero"
"CD014762_pub2_data","3::overall","3","overall","Adverse events (to day 30 after randomisation)",9,0,3,TRUE,TRUE,"RD","sparse_events"
"CD014762_pub2_data","4::overall","4","overall","Use of rescue antibiotic treatment (by day 30 after randomisation)",6,0,0,TRUE,TRUE,"OR_cc","default_or"
"CD014762_pub2_data","5::overall","5","overall","Emergence of antibiotic resistant bacteria",3,0,0,TRUE,TRUE,"OR_cc","default_or"
"CD014763_pub2_data","1::overall","1","overall","Surgical site infection",15,0,0,TRUE,TRUE,"OR_cc","default_or"
"CD014763_pub2_data","2::overall","2","overall","Participant satisfaction (very satisfied or satisfied)",9,0,0,TRUE,TRUE,"OR_cc","default_or"
"CD014763_pub2_data","3::overall","3","overall","Participant satisfaction (unsatisfied or very unsatisfied)",9,6,7,TRUE,TRUE,"RD","double_zero"
"CD014763_pub2_data","4::overall","4","overall","Incisional hernia",6,0,4,TRUE,TRUE,"RD","sparse_events"
"CD014763_pub2_data","5::overall","5","overall","Anastomotic leak",4,2,4,TRUE,TRUE,"RD","double_zero"
"CD014763_pub2_data","6::overall","6","overall","Intestinal obstruction",3,0,0,TRUE,TRUE,"OR_cc","default_or"
"CD014769_pub2_data","1::overall","1","overall","Any VTE",27,0,7,TRUE,TRUE,"RD","sparse_events"
"CD014769_pub2_data","2::overall","2","overall","Subgroup analysis for any VTE stratified by provoked status",27,0,7,TRUE,TRUE,"RD","sparse_events"
"CD014769_pub2_data","3::overall","3","overall","Subgroup analysis for any VTE stratified by age",6,0,2,TRUE,TRUE,"RD","sparse_events"
"CD014769_pub2_data","4::overall","4","overall","Subgroup analysis for any VTE stratified by sex",2,0,0,TRUE,TRUE,"OR_cc","default_or"
"CD014769_pub2_data","5::overall","5","overall","Subgroup analysis for any VTE stratified by disease",27,0,7,TRUE,TRUE,"RD","sparse_events"
"CD014769_pub2_data","6::overall","6","overall","Subgroup analysis for any VTE stratified by type of statin",27,0,7,TRUE,TRUE,"RD","sparse_events"
"CD014769_pub2_data","7::overall","7","overall","Subgroup analysis for any VTE statified by different doses of rosuvstatin",9,0,3,TRUE,TRUE,"RD","sparse_events"
"CD014769_pub2_data","8::overall","8","overall","Subgroup analysis for any VTE stratified by different doses of atorvastatin",11,0,3,TRUE,TRUE,"RD","sparse_events"
"CD014769_pub2_data","9::overall","9","overall","Subgroup analysis for any VTE stratified by treatment duration",27,0,7,TRUE,TRUE,"RD","sparse_events"
"CD014769_pub2_data","10::overall","10","overall","Sensitivity analysis for any VTE excluding unpublished data",9,0,1,TRUE,TRUE,"RD","sparse_events"
"CD014769_pub2_data","11::overall","11","overall","Sensitivity analysis for any VTE excluding studies with high risk of bias",8,0,1,TRUE,TRUE,"RD","sparse_events"
"CD014769_pub2_data","12::overall","12","overall","Sensitivity analysis for any VTE excluding data from  > 15% missing outcome data",11,0,1,TRUE,TRUE,"RD","sparse_events"
"CD014769_pub2_data","13::overall","13","overall","Subgroup analysis for DVT stratified by type of statin",6,0,1,TRUE,TRUE,"RD","sparse_events"
"CD014769_pub2_data","14::overall","14","overall","DVT: sensitivity analysis",5,0,1,TRUE,TRUE,"RD","sparse_events"
"CD014769_pub2_data","15::overall","15","overall","PE",5,0,1,TRUE,TRUE,"RD","sparse_events"
"CD014769_pub2_data","16::overall","16","overall","Subgroup analysis for any serious adverse event stratified by type of statin",13,0,0,TRUE,TRUE,"OR_cc","default_or"
"CD014769_pub2_data","17::overall","17","overall","Subgroup analysis for myopathy stratified by type of statin",10,0,4,TRUE,TRUE,"RD","sparse_events"
"CD014769_pub2_data","18::overall","18","overall","Subgroup analysis for rhabdomyolysis stratified by type of statin",7,0,5,TRUE,TRUE,"RD","sparse_events"
"CD014769_pub2_data","19::overall","19","overall","Bleeding",2,0,0,TRUE,TRUE,"OR_cc","default_or"
"CD014769_pub2_data","20::overall","20","overall","Subgroup analysis for muscular weakness, stiffness, or pain, stratified by type of statin",11,0,0,TRUE,TRUE,"OR_cc","default_or"
"CD014769_pub2_data","21::overall","21","overall","Subgroup analysis for gastrointestinal disorders stratified by type of statin",10,0,1,TRUE,TRUE,"RD","sparse_events"
"CD014769_pub2_data","22::overall","22","overall","Sensitivity analysis for gastrointestinal disorders",9,0,1,TRUE,TRUE,"RD","sparse_events"
"CD014769_pub2_data","23::overall","23","overall","Subgroup analysis for hepatic disorders stratified by type of statin",20,0,1,TRUE,TRUE,"RD","sparse_events"
"CD014769_pub2_data","24::overall","24","overall","Sensitivity analysis for hepatic disorders",19,0,1,TRUE,TRUE,"RD","sparse_events"
"CD014769_pub2_data","25::overall","25","overall","Subgroup analysis for renal disorders stratified by types of statins",8,0,1,TRUE,TRUE,"RD","sparse_events"
"CD014769_pub2_data","26::overall","26","overall","Subgroup analysis for mortality stratified by types of statins",24,0,1,TRUE,TRUE,"RD","sparse_events"
"CD014769_pub2_data","27::overall","27","overall","Mortality after PE",3,0,1,TRUE,TRUE,"RD","sparse_events"
"CD014769_pub2_data","28::overall","28","overall","Sensitivity analysis for mortality after PE",2,0,1,TRUE,TRUE,"RD","sparse_events"
"CD014785_pub2_data","1::overall","1","overall","Proportion of children with normal nutrition status",3,2,2,FALSE,TRUE,"RD","double_zero"
"CD014785_pub2_data","2::overall","2","overall","Proportion of children who had eaten beta-carotene rich foods (paw-paw) the day before interview",2,1,1,FALSE,TRUE,"RD","double_zero"
"CD014785_pub2_data","3::overall","3","overall","Proportion of children experiencing vomiting in the past 2 weeks",2,1,1,FALSE,TRUE,"RD","double_zero"
"CD014792_pub2_data","1::overall","1","overall","Mortality (Grade V Clavien-Dindo)",6,3,3,TRUE,TRUE,"RD","double_zero"
"CD014792_pub2_data","2::overall","2","overall","Length of hospital stay",5,3,3,TRUE,TRUE,"RD","double_zero"
"CD014792_pub2_data","3::overall","3","overall","Major complications",15,1,11,TRUE,TRUE,"RD","double_zero"
"CD014792_pub2_data","4::overall","4","overall","Minor complications",7,4,5,TRUE,TRUE,"RD","double_zero"
"CD014792_pub2_data","5::overall","5","overall","Complications related to nutritional support",12,0,7,TRUE,TRUE,"RD","sparse_events"
"CD014792_pub2_data","6::overall","6","overall","Postoperative pancreatic fistula",7,0,2,TRUE,TRUE,"RD","sparse_events"
"CD014792_pub2_data","7::overall","7","overall","Delayed gastric emptying",6,1,3,TRUE,TRUE,"RD","double_zero"
"CD014792_pub2_data","8::overall","8","overall","Post pancreatectomy haemorrhage",5,0,1,TRUE,TRUE,"RD","sparse_events"
"CD014792_pub2_data","9::overall","9","overall","Delayed gastric emptying",3,0,1,TRUE,TRUE,"RD","sparse_events"
"CD014792_pub2_data","10::overall","10","overall","Post pancreatectomy haemorrhage",2,0,1,TRUE,TRUE,"RD","sparse_events"
"CD014802_pub2_data","1::overall","1","overall","Functional outcome, measured by mRS (0 to 4), at 90 days",2,0,0,TRUE,TRUE,"OR_cc","default_or"
"CD014802_pub2_data","4::overall","4","overall","Death at more than 90 days (90 days, or up to 4 years + 11 months)",2,0,0,TRUE,TRUE,"OR_cc","default_or"
"CD014802_pub2_data","8::overall","8","overall","Serious adverse events (up to 4 years + 11 months)",2,0,0,TRUE,TRUE,"OR_cc","default_or"
"CD014802_pub2_data","9::overall","9","overall","Adverse events: hypoglycaemia (88 hours after drug bolus, or up to 4 years + 11 months)",2,0,0,TRUE,TRUE,"OR_cc","default_or"
"CD014802_pub2_data","10::overall","10","overall","Adverse events: cardiac events (7 days, or discharge, or up to 4 years + 11 months)",2,0,0,TRUE,TRUE,"OR_cc","default_or"
"CD014802_pub2_data","12::overall","12","overall","Complications: nervous system hemorrhage and infarction (7 days, or up to 4 years + 11 months)",2,0,0,TRUE,TRUE,"OR_cc","default_or"
"CD014803_pub2_data","1::overall","1","overall","Self-reported depression symptoms (continuous measure)",10,5,6,TRUE,TRUE,"RD","double_zero"
"CD014803_pub2_data","2::overall","2","overall","Depression remission (dichotomous measure)",4,0,1,TRUE,TRUE,"RD","sparse_events"
"CD014811_pub2_data","2::overall","2","overall","All-cause mortality",8,1,5,TRUE,TRUE,"RD","double_zero"
"CD014811_pub2_data","4::overall","4","overall","Readmission to hospital following discharge for the longest available follow-up stated in the trials ",5,0,0,TRUE,TRUE,"OR_cc","default_or"
"CD014811_pub2_data","5::overall","5","overall","Acute kidney injury (adverse event)",5,0,0,TRUE,TRUE,"OR_cc","default_or"
"CD014820_pub2_data","1::overall","1","overall","Acute kidney injury",138,12,25,TRUE,TRUE,"RD","double_zero"
"CD014820_pub2_data","2::overall","2","overall","Death (any cause)",128,17,51,TRUE,TRUE,"RD","double_zero"
"CD014820_pub2_data","3::overall","3","overall","Dialysis",96,30,49,TRUE,TRUE,"RD","double_zero"
"CD014820_pub2_data","4::overall","4","overall","Change in serum creatinine [mg/dL]",61,48,55,TRUE,TRUE,"RD","double_zero"
"CD014820_pub2_data","5::overall","5","overall","Change in serum cystatin C [mg/L]",44,27,36,TRUE,TRUE,"RD","double_zero"
"CD014820_pub2_data","6::overall","6","overall","Length of hospital stay [days]",59,46,53,TRUE,TRUE,"RD","double_zero"
"CD014820_pub2_data","7::overall","7","overall","Adverse events: myocardial infarction",58,9,44,TRUE,TRUE,"RD","double_zero"
"CD014820_pub2_data","8::overall","8","overall","Adverse events: stroke",45,9,41,TRUE,TRUE,"RD","double_zero"
"CD014820_pub2_data","9::overall","9","overall","Adverse events: thrombosis",37,6,19,TRUE,TRUE,"RD","double_zero"
"CD014820_pub2_data","10::overall","10","overall","Adverse events: hypertension",21,9,15,TRUE,TRUE,"RD","double_zero"
"CD014833_pub2_data","1::overall","1","overall","Incidence of depression immediately post-intervention",2,0,0,TRUE,TRUE,"OR_cc","default_or"
"CD014833_pub2_data","2::overall","2","overall","Incidence of depression short-term 1 to 3 months post-intervention",2,1,1,FALSE,TRUE,"RD","double_zero"
"CD014833_pub2_data","3::overall","3","overall","Incidence of depression medium-term 4 to 6 months post-intervention",3,1,1,TRUE,TRUE,"RD","double_zero"
"CD014833_pub2_data","7::overall","7","overall","Breastfeeding exclusivity immediately post-intervention",3,0,0,TRUE,TRUE,"OR_cc","default_or"
"CD014833_pub2_data","8::overall","8","overall","Breastfeeding exclusivity short-term 1 to 3 months post-intervention",5,0,0,TRUE,TRUE,"OR_cc","default_or"
"CD014833_pub2_data","9::overall","9","overall","Breastfeeding exclusivity medium-term 4 to 6 months post-intervention",4,0,0,TRUE,TRUE,"OR_cc","default_or"
"CD014844_pub2_data","1::overall","1","overall","Uterine infection",6,0,1,TRUE,TRUE,"RD","sparse_events"
"CD014844_pub2_data","6::overall","6","overall","Antibiotics to treat infection after uterine evacuation procedure for miscarriage",3,0,1,TRUE,TRUE,"RD","sparse_events"
"CD014844_pub2_data","7::overall","7","overall","Hospitalisation for treatment of infection",3,1,2,TRUE,TRUE,"RD","double_zero"
"CD014844_pub2_data","8::overall","8","overall","Sensitivity analysis: uterine infection – studies at low risk of bias",3,0,1,TRUE,TRUE,"RD","sparse_events"
"CD014844_pub2_data","9::1","9","1","Subgroup: uterine infection by gestation",2,0,1,TRUE,TRUE,"RD","sparse_events"
"CD014844_pub2_data","10::1","10","1","Subgroup: uterine infection by antibiotic class",5,0,0,TRUE,TRUE,"OR_cc","default_or"
"CD014844_pub2_data","11::2","11","2","Subgroup: uterine infection by length of treatment course",5,0,1,TRUE,TRUE,"RD","sparse_events"
"CD014844_pub2_data","12::1","12","1","Subgroup: uterine infection by administration route",4,0,0,TRUE,TRUE,"OR_cc","default_or"
"CD014844_pub2_data","12::2","12","2","Subgroup: uterine infection by administration route",2,0,1,TRUE,TRUE,"RD","sparse_events"
"CD014852_pub2_data","1::overall","1","overall","Disability (modified Rankin Scale 0 to 2, good status) at follow‐up ",18,8,10,TRUE,TRUE,"RD","double_zero"
"CD014852_pub2_data","2::overall","2","overall","Activities of daily living (Functional Independence Measure, Motor score) at end of intervention phase",19,17,17,TRUE,TRUE,"RD","double_zero"
"CD014852_pub2_data","3::overall","3","overall","Subgroup analysis – type of stroke: activities of daily living ",14,12,12,TRUE,TRUE,"RD","double_zero"
"CD014852_pub2_data","4::overall","4","overall","Neurological impairment (change in NIHSS score) during intervention phase",12,8,8,TRUE,TRUE,"RD","double_zero"
"CD014852_pub2_data","5::overall","5","overall","Walking capacity (2-minute walk test) at end of intervention phase",10,8,9,TRUE,TRUE,"RD","double_zero"
"CD014852_pub2_data","6::overall","6","overall","Walking capacity (6-minute walk test) at end of intervention phase",9,7,8,TRUE,TRUE,"RD","double_zero"
"CD014852_pub2_data","7::overall","7","overall","Muscle strength (grip strength) at end of intervention phase",7,6,6,FALSE,TRUE,"RD","double_zero"
"CD014852_pub2_data","11::overall","11","overall","Nutritional status (triceps skinfold thickness) at end of intervention phase",8,7,8,FALSE,TRUE,"RD","double_zero"
"CD014852_pub2_data","12::overall","12","overall","All-cause mortality at follow-up",7,4,4,TRUE,TRUE,"RD","double_zero"
"CD014852_pub2_data","13::overall","13","overall","Subgroup analysis – type of stroke: all-cause mortality ",9,3,3,TRUE,TRUE,"RD","double_zero"
"CD014852_pub2_data","14::overall","14","overall","Subgroup analysis – nutritional status at baseline: all-cause mortality ",8,1,1,TRUE,TRUE,"RD","double_zero"
"CD014852_pub2_data","15::overall","15","overall","Stroke recurrence at end of intervention phase",5,1,1,TRUE,TRUE,"RD","double_zero"
"CD014852_pub2_data","16::overall","16","overall","Change in cognitive function score (Mini-Mental State Examination) during intervention phase",7,2,2,TRUE,TRUE,"RD","double_zero"
"CD014852_pub2_data","17::overall","17","overall","Complication (pressure sores) during intervention phase",7,1,1,TRUE,TRUE,"RD","double_zero"
"CD014852_pub2_data","18::overall","18","overall","Complications (infections: pneumonia, urinary tract, and septicaemias) during intervention phase",5,0,0,TRUE,TRUE,"OR_cc","default_or"
"CD014852_pub2_data","19::overall","19","overall","Complication (pneumonia) during intervention phase",5,1,1,TRUE,TRUE,"RD","double_zero"
"CD014852_pub2_data","20::overall","20","overall","Complication (urinary tract infection) during intervention phase",4,0,0,TRUE,TRUE,"OR_cc","default_or"
"CD014852_pub2_data","21::overall","21","overall","Complication (hyper/hypoglycaemia) during intervention phase",3,0,0,TRUE,TRUE,"OR_cc","default_or"
"CD014852_pub2_data","22::overall","22","overall","Complication (gastrointestinal haemorrhage) during intervention phase",2,0,0,TRUE,TRUE,"OR_cc","default_or"
"CD014852_pub2_data","23::overall","23","overall","Complication (diarrhoea) during intervention phase",3,0,1,TRUE,TRUE,"RD","sparse_events"
"CD014852_pub2_data","25::overall","25","overall","Complication (diarrhoea) during intervention phase",2,0,0,TRUE,TRUE,"OR_cc","default_or"
"CD014852_pub2_data","26::overall","26","overall","Complication (gastrointestinal haemorrhage) during intervention phase",3,0,0,TRUE,TRUE,"OR_cc","default_or"
"CD014852_pub2_data","27::overall","27","overall","Subgroup analysis – type of stroke: gastrointestinal haemorrhage",3,0,0,TRUE,TRUE,"OR_cc","default_or"
"CD014855_pub2_data","1::overall","1","overall","Intraperitoneal abscess",7,0,1,TRUE,TRUE,"RD","sparse_events"
"CD014855_pub2_data","2::overall","2","overall","Wound infection",7,0,1,TRUE,TRUE,"RD","sparse_events"
"CD014855_pub2_data","3::overall","3","overall","Morbidity",2,0,0,TRUE,TRUE,"OR_cc","default_or"
"CD014855_pub2_data","4::overall","4","overall","Mortality",6,3,5,TRUE,TRUE,"RD","double_zero"
"CD014855_pub2_data","1::1","1","1","Intraperitoneal abscess",9,0,1,TRUE,TRUE,"RD","sparse_events"
"CD014855_pub2_data","1::2","1","2","Intraperitoneal abscess",2,0,0,TRUE,TRUE,"OR_cc","default_or"
"CD014855_pub2_data","2::1","2","1","Wound infection",8,0,1,TRUE,TRUE,"RD","sparse_events"
"CD014855_pub2_data","2::2","2","2","Wound infection",3,0,1,TRUE,TRUE,"RD","sparse_events"
"CD014855_pub2_data","3::1","3","1","Morbidity",2,0,0,TRUE,TRUE,"OR_cc","default_or"
"CD014855_pub2_data","4::1","4","1","Mortality",8,4,7,TRUE,TRUE,"RD","double_zero"
"CD014861_pub2_data","1::overall","1","overall","Adverse events (proportion of participants with at least one AE)",3,1,3,TRUE,TRUE,"RD","double_zero"
"CD014861_pub2_data","2::overall","2","overall","Hospital inpatient admission within 48 hours of administration of anti-cancer therapy (mean number of visits)",2,1,2,FALSE,TRUE,"RD","double_zero"
"CD014861_pub2_data","3::overall","3","overall","Hospital attendance within 48 hours of administration of anti-cancer therapy (mean number of visits)",4,3,3,FALSE,TRUE,"RD","double_zero"
"CD014861_pub2_data","4::overall","4","overall","Hospital attendance within 48 hours of treatment administration (proportion of participants with a visit)",3,1,3,TRUE,TRUE,"RD","double_zero"
"CD014861_pub2_data","5::overall","5","overall","Participant preference for future treatment location",2,1,1,FALSE,TRUE,"RD","double_zero"
"CD014861_pub2_data","7::overall","7","overall","Cost-effectiveness (quality-adjusted life years, Corrie 2013)",2,1,1,FALSE,TRUE,"RD","double_zero"
"CD014861_pub2_data","11::overall","11","overall","Proportion of participants completing treatment regimen as planned",4,0,0,TRUE,TRUE,"OR_cc","default_or"
"CD014869_pub2_data","1::overall","1","overall"," All-cause mortality (between  1 and 5 years)",8,0,0,TRUE,TRUE,"OR_cc","default_or"
"CD014869_pub2_data","4::overall","4","overall","Disease progression (between 1 and 5 years)",4,0,0,TRUE,TRUE,"OR_cc","default_or"
"CD014869_pub2_data","5::overall","5","overall","Adverse events considered non-serious (number of participants) (between 1 and 3 years)",4,0,3,TRUE,TRUE,"RD","sparse_events"
"CD014869_pub2_data","6::overall","6","overall","Sensitivity analysis: all-cause mortality between 1 and 5 years (best-worst case scenario)",8,0,0,TRUE,TRUE,"OR_cc","default_or"
"CD014869_pub2_data","7::overall","7","overall","Sensitivity analysis: all-cause mortality between 1 and 5 years (worst-best case scenario)",8,0,0,TRUE,TRUE,"OR_cc","default_or"
"CD014872_pub2_data","3::overall","3","overall","Progression-free survival (standard-of-care chemotherapy vs hormonal therapy)",32,30,31,TRUE,TRUE,"RD","double_zero"
"CD014872_pub2_data","4::overall","4","overall","Progression-free survival (FDA/EMA approved vs not approved)",27,22,23,TRUE,TRUE,"RD","double_zero"
"CD014872_pub2_data","5::overall","5","overall","Overall survival",30,25,26,TRUE,TRUE,"RD","double_zero"
"CD014872_pub2_data","6::overall","6","overall","Overall survival (solid cancer vs haematological cancer)",29,28,28,FALSE,TRUE,"RD","double_zero"
"CD014872_pub2_data","7::overall","7","overall","Overall survival (standard-of-care chemotherapy vs hormonal therapy)",28,26,26,TRUE,TRUE,"RD","double_zero"
"CD014872_pub2_data","9::overall","9","overall","Overall response rate",20,0,0,TRUE,TRUE,"OR_cc","default_or"
"CD014872_pub2_data","10::overall","10","overall","Overall response rate (solid cancer vs haematological cancer)",20,0,0,TRUE,TRUE,"OR_cc","default_or"
"CD014872_pub2_data","11::overall","11","overall","Overall response rate (standard-of-care chemotherapy vs hormonal therapy)",19,0,0,TRUE,TRUE,"OR_cc","default_or"
"CD014872_pub2_data","12::overall","12","overall","Overall response rate (FDA/EMA-approved vs not approved)",18,0,0,TRUE,TRUE,"OR_cc","default_or"
"CD014872_pub2_data","13::overall","13","overall","Severe adverse events",11,0,0,TRUE,TRUE,"OR_cc","default_or"
"CD014872_pub2_data","14::overall","14","overall","Severe adverse events (haematological vs non-haematological events)",9,3,3,TRUE,TRUE,"RD","double_zero"
"CD014889_pub2_data","1::overall","1","overall","All-cause mortality",6,1,2,TRUE,TRUE,"RD","double_zero"
"CD014889_pub2_data","2::overall","2","overall","Serious adverse events",6,1,1,TRUE,TRUE,"RD","double_zero"
"CD014889_pub2_data","3::overall","3","overall","Anastomosis leakage",6,1,1,TRUE,TRUE,"RD","double_zero"
"CD014889_pub2_data","4::overall","4","overall","Sepsis or mediastinitis",6,1,1,TRUE,TRUE,"RD","double_zero"
"CD014889_pub2_data","5::overall","5","overall","Esophageal stricture",2,0,0,TRUE,TRUE,"OR_cc","default_or"
"CD014891_pub2_data","1::overall","1","overall","Uncorrected distance visual acuity worse than 6/6",2,0,0,TRUE,TRUE,"OR_cc","default_or"
"CD014891_pub2_data","2::overall","2","overall","Corrected distance visual acuity worse than 6/6 ",2,0,0,TRUE,TRUE,"OR_cc","default_or"
"CD014891_pub2_data","16::overall","16","overall","Any adverse outcome: posterior capsular opacification (PCO)",2,1,2,FALSE,TRUE,"RD","double_zero"
"CD014914_pub2_data","1::overall","1","overall","Proportion of participants developing colds/URTI: primary analysis",41,1,6,TRUE,TRUE,"RD","double_zero"
"CD014914_pub2_data","2::overall","2","overall","Serious adverse events (prevention): primary analysis",20,1,3,TRUE,TRUE,"RD","double_zero"
"CD014914_pub2_data","3::overall","3","overall","Severity of nasal symptoms (prevention)",16,0,1,TRUE,TRUE,"RD","sparse_events"
"CD014914_pub2_data","4::overall","4","overall","Headache (continuous) (prevention)",18,0,2,TRUE,TRUE,"RD","sparse_events"
"CD014914_pub2_data","5::overall","5","overall","Hoarseness (continuous) (prevention)",17,0,2,TRUE,TRUE,"RD","sparse_events"
"CD014914_pub2_data","6::overall","6","overall","Muscle aches (continuous) (prevention)",2,0,0,TRUE,TRUE,"OR_cc","default_or"
"CD014914_pub2_data","7::overall","7","overall","Nasal congestion (continuous) (prevention)",2,0,0,TRUE,TRUE,"OR_cc","default_or"
"CD014914_pub2_data","8::overall","8","overall","Sneezing (continuous) (prevention)",2,0,1,TRUE,TRUE,"RD","sparse_events"
"CD014914_pub2_data","9::overall","9","overall","Sore throat (continuous) (prevention)",2,0,1,TRUE,TRUE,"RD","sparse_events"
"CD014914_pub2_data","10::overall","10","overall","Severity of sore throat (treatment)",2,0,0,TRUE,TRUE,"OR_cc","default_or"
"CD014920_pub2_data","1::overall","1","overall","Acute myocardial infarction (short term < 30 days)",2,0,0,TRUE,TRUE,"OR_cc","default_or"
"CD014920_pub2_data","3::overall","3","overall","All-cause mortality (perioperative)",2,0,1,TRUE,TRUE,"RD","sparse_events"
"CD014920_pub2_data","4::overall","4","overall","All-cause mortality (long term)",2,0,0,TRUE,TRUE,"OR_cc","default_or"
"CD014923_pub2_data","1::overall","1","overall","Gait speed - unpaired, parallel assessment < 12 months",10,6,6,TRUE,TRUE,"RD","double_zero"
"CD014923_pub2_data","2::overall","2","overall","Gait speed -  paired assessment < 12 months",9,6,8,TRUE,TRUE,"RD","double_zero"
"CD014923_pub2_data","3::overall","3","overall","Patient disability - number of participants who improved  (paired assessment < 12 months)",4,2,3,TRUE,TRUE,"RD","double_zero"
"CD014923_pub2_data","4::overall","4","overall","Patient disability - functionally independent (paired assessment < 12 months)",4,2,4,TRUE,TRUE,"RD","double_zero"
"CD014935_pub2_data","1::overall","1","overall","All-cause mortality",3,0,1,TRUE,TRUE,"RD","sparse_events"
"CD014935_pub2_data","2::overall","2","overall","All-cause mortality - Sensitivity analysis (best-case scenario)",3,0,1,TRUE,TRUE,"RD","sparse_events"
"CD014935_pub2_data","3::overall","3","overall","All-cause mortality - Sensitivity analysis (worst-case scenario)",3,0,1,TRUE,TRUE,"RD","sparse_events"
"CD014935_pub2_data","4::overall","4","overall","Serious adverse events",3,0,0,TRUE,TRUE,"OR_cc","default_or"
"CD014935_pub2_data","5::overall","5","overall","Serious adverse events - Sensitivity Analysis (fixed-effect model)",3,0,0,TRUE,TRUE,"OR_cc","default_or"
"CD014935_pub2_data","6::overall","6","overall","Serious adverse events - Sensitivity Analysis (best-case scenario)",3,0,0,TRUE,TRUE,"OR_cc","default_or"
"CD014935_pub2_data","7::overall","7","overall","Serious adverse events - Sensitivity Analysis (worst-case scenario)",3,0,0,TRUE,TRUE,"OR_cc","default_or"
"CD014937_pub2_data","1::overall","1","overall","Acute kidney injury",46,3,6,TRUE,TRUE,"RD","double_zero"
"CD014937_pub2_data","2::overall","2","overall","Any use of kidney replacement therapy",46,13,24,TRUE,TRUE,"RD","double_zero"
"CD014937_pub2_data","3::overall","3","overall","Death",44,4,18,TRUE,TRUE,"RD","double_zero"
"CD014937_pub2_data","4::overall","4","overall","Permanent dialysis",5,3,5,TRUE,TRUE,"RD","double_zero"
"CD014937_pub2_data","5::overall","5","overall","Adverse events",33,4,11,TRUE,TRUE,"RD","double_zero"
"CD014937_pub2_data","6::overall","6","overall","Changes in serum creatinine within 30 days (mg/dL]",15,8,10,TRUE,TRUE,"RD","double_zero"
"CD014937_pub2_data","7::overall","7","overall","Urinary output",16,8,10,TRUE,TRUE,"RD","double_zero"
"CD014937_pub2_data","8::overall","8","overall","Sensitivity analysis: acute kidney injury (low overall risk of bias)",9,0,2,TRUE,TRUE,"RD","sparse_events"
"CD014937_pub2_data","9::overall","9","overall","Sensitivity analysis: acute kidney injury (overall risk of bias 'some concerns' or 'low')",26,1,1,TRUE,TRUE,"RD","double_zero"
"CD014937_pub2_data","10::overall","10","overall","Sensitivity analysis: acute kidney injury (placebo-controlled studies)",21,3,3,TRUE,TRUE,"RD","double_zero"
"CD014937_pub2_data","11::overall","11","overall","Sensitivity analysis: acute kidney injury (excluding kidney transplantation)",36,3,4,TRUE,TRUE,"RD","double_zero"
"CD014937_pub2_data","12::overall","12","overall","Subgroup analysis: acute kidney injury by population",72,6,8,TRUE,TRUE,"RD","double_zero"
"CD014937_pub2_data","13::overall","13","overall","Subgroup analysis: acute kidney injury by type of diuretic",51,3,4,TRUE,TRUE,"RD","double_zero"
"CD014937_pub2_data","14::overall","14","overall","Subgroup analysis: acute kidney injury by definition",14,0,0,TRUE,TRUE,"OR_cc","default_or"
"CD014937_pub2_data","15::overall","15","overall","Subgroup analysis: acute kidney injury by age",38,3,4,TRUE,TRUE,"RD","double_zero"
"CD014937_pub2_data","17::overall","17","overall","Sensitivity analysis: any use of KRT (only studies with ""some concerns""  or a ""low"" overall risk of bias)",23,10,16,TRUE,TRUE,"RD","double_zero"
"CD014937_pub2_data","18::overall","18","overall","Sensitivity analysis: any use of KRT (placebo-controlled studies)",15,7,10,TRUE,TRUE,"RD","double_zero"
"CD014937_pub2_data","19::overall","19","overall","Sensitivity analysis: any use of KRT (excluding kidney transplantation)",32,12,23,TRUE,TRUE,"RD","double_zero"
"CD014937_pub2_data","20::overall","20","overall","Subgroup analysis: any use of KRT by population",33,13,24,TRUE,TRUE,"RD","double_zero"
"CD014937_pub2_data","21::overall","21","overall","Subgroup analysis: any use of KRT by type of diuretic",44,17,31,TRUE,TRUE,"RD","double_zero"
"CD014937_pub2_data","22::overall","22","overall","Subgroup analysis: any use of KRT by age",32,12,23,TRUE,TRUE,"RD","double_zero"
"CD014941_pub2_data","1::overall","1","overall","50% responder rate",2,0,0,TRUE,TRUE,"OR_cc","default_or"
"CD014941_pub2_data","2::overall","2","overall","Seizure freedom",2,0,0,TRUE,TRUE,"OR_cc","default_or"
"CD014941_pub2_data","3::overall","3","overall","Any adverse event",2,0,0,TRUE,TRUE,"OR_cc","default_or"
"CD014941_pub2_data","4::overall","4","overall"," ≥ 75% seizure reduction/month during the maintenance treatment period compared to baseline",2,0,0,TRUE,TRUE,"OR_cc","default_or"
"CD014941_pub2_data","5::overall","5","overall","≥ 90% seizure reduction/month during the maintenance treatment period compared to baseline",2,0,0,TRUE,TRUE,"OR_cc","default_or"
"CD014941_pub2_data","6::overall","6","overall","Withdrawal from the study due to adverse events",2,0,0,TRUE,TRUE,"OR_cc","default_or"
"CD014941_pub2_data","7::overall","7","overall","Withdrawal rate",2,0,0,TRUE,TRUE,"OR_cc","default_or"
"CD014941_pub2_data","8::overall","8","overall","Any treatment-related adverse events",2,0,0,TRUE,TRUE,"OR_cc","default_or"
"CD014941_pub2_data","9::overall","9","overall","Any serious adverse event",2,0,0,TRUE,TRUE,"OR_cc","default_or"
"CD014941_pub2_data","10::overall","10","overall","Cenobamate versus placebo - subgroup analysis, 50% responder rate",4,0,0,TRUE,TRUE,"OR_cc","default_or"
"CD014941_pub2_data","11::overall","11","overall","Cenobamate versus placebo - subgroup analysis, seizure freedom",4,0,0,TRUE,TRUE,"OR_cc","default_or"
"CD014941_pub2_data","12::overall","12","overall","Cenobamate versus placebo - subgroup analysis, any adverse event",4,0,0,TRUE,TRUE,"OR_cc","default_or"
"CD014941_pub2_data","13::overall","13","overall","Cenobamate versus placebo - subgroup analysis, ≥ 75% seizure reduction/month during the maintenance treatment period compared to baseline",4,0,0,TRUE,TRUE,"OR_cc","default_or"
"CD014941_pub2_data","14::overall","14","overall","Cenobamate versus placebo - subgroup analysis, ≥ 90% seizure reduction/month during the maintenance treatment period compared to baseline",4,0,0,TRUE,TRUE,"OR_cc","default_or"
"CD014941_pub2_data","15::overall","15","overall","Cenobamate versus placebo - subgroup analysis, withdrawal from the study due to adverse events",4,0,0,TRUE,TRUE,"OR_cc","default_or"
"CD014941_pub2_data","16::overall","16","overall","Cenobamate versus placebo - subgroup analysis, withdrawal rate",4,0,0,TRUE,TRUE,"OR_cc","default_or"
"CD014941_pub2_data","17::overall","17","overall","Cenobamate versus placebo - subgroup analysis, any treatment-related adverse events",4,0,0,TRUE,TRUE,"OR_cc","default_or"
"CD014941_pub2_data","18::overall","18","overall","Cenobamate versus placebo - subgroup analysis, any serious adverse event",4,0,0,TRUE,TRUE,"OR_cc","default_or"
"CD014941_pub2_data","19::overall","19","overall","Cenobamate versus placebo - sensitivity analysis, 50% responder rate (random-effects model)",2,0,0,TRUE,TRUE,"OR_cc","default_or"
"CD014941_pub2_data","20::overall","20","overall","Cenobamate versus placebo - sensitivity analysis, seizure freedom (random-effects model)",2,0,0,TRUE,TRUE,"OR_cc","default_or"
"CD014941_pub2_data","21::overall","21","overall","Cenobamate versus placebo - sensitivity analysis, any adverse event (random-effects model) ",2,0,0,TRUE,TRUE,"OR_cc","default_or"
"CD014944_pub2_data","1::overall","1","overall","Proportion of participants without treatment success at the longest follow-up (1–4 years)",11,0,1,TRUE,TRUE,"RD","sparse_events"
"CD014944_pub2_data","2::overall","2","overall","Proportion of participants with serious adverse events (pancreatitis, at 1 year)",4,0,0,TRUE,TRUE,"OR_cc","default_or"
"CD014959_pub2_data","1::overall","1","overall","All-cause mortality",2,0,1,TRUE,TRUE,"RD","sparse_events"
"CD014959_pub2_data","2::overall","2","overall","Proportion of people with laboratory-confirmed leptospirosis regardless of the presence of an identified clinical syndrome (inclusive of asymptomatic cases) ",6,0,1,TRUE,TRUE,"RD","sparse_events"
"CD014959_pub2_data","3::overall","3","overall","Sensitivity analysis: laboratory-confirmed leptospirosis (best-case scenario)",6,0,1,TRUE,TRUE,"RD","sparse_events"
"CD014959_pub2_data","4::overall","4","overall","Sensitivity analysis: laboratory-confirmed leptospirosis (worst-case scenario)",6,0,1,TRUE,TRUE,"RD","sparse_events"
"CD014959_pub2_data","5::overall","5","overall","Sensitivity analysis: laboratory-confirmed leptospirosis (only pre-exposure prophylaxis)",3,0,0,TRUE,TRUE,"OR_cc","default_or"
"CD014959_pub2_data","6::overall","6","overall","Sensitivity analysis: laboratory-confirmed leptospirosis (only postexposure prophylaxis)",2,0,1,TRUE,TRUE,"RD","sparse_events"
"CD014959_pub2_data","7::overall","7","overall","Sensitivity analysis: laboratory-confirmed leptospirosis (including only endemic community)",4,0,1,TRUE,TRUE,"RD","sparse_events"
"CD014959_pub2_data","8::overall","8","overall","Proportion of people with clinical diagnosis of leptospirosis regardless of the presence of laboratory confirmation ",4,0,0,TRUE,TRUE,"OR_cc","default_or"
"CD014959_pub2_data","9::overall","9","overall","Sensitivity analysis: clinical diagnosis of leptospirosis regardless of the presence of laboratory confirmation (best-case scenario)",4,0,0,TRUE,TRUE,"OR_cc","default_or"
"CD014959_pub2_data","10::overall","10","overall","Sensitivity analysis: clinical diagnosis of leptospirosis regardless of the presence of laboratory confirmation (worst-case scenario)",4,0,0,TRUE,TRUE,"OR_cc","default_or"
"CD014959_pub2_data","11::overall","11","overall","Proportion of people with clinical diagnosis of leptospirosis confirmed by laboratory diagnosis (exclusive of asymptomatic cases)",4,0,1,TRUE,TRUE,"RD","sparse_events"
"CD014959_pub2_data","12::overall","12","overall","Sensitivity analysis: clinical diagnosis confirmed by laboratory diagnosis (best-case scenario)",4,0,1,TRUE,TRUE,"RD","sparse_events"
"CD014959_pub2_data","13::overall","13","overall","Sensitivity analysis: clinical diagnosis confirmed by laboratory diagnosis (worst-case scenario)",4,0,1,TRUE,TRUE,"RD","sparse_events"
"CD014959_pub2_data","14::overall","14","overall","Proportion of people with non-serious adverse events",3,0,1,TRUE,TRUE,"RD","sparse_events"
"CD014959_pub2_data","15::overall","15","overall","Sensitivity analysis: non-serious adverse events (best-case scenario)",3,0,0,TRUE,TRUE,"OR_cc","default_or"
"CD014959_pub2_data","16::overall","16","overall","Sensitivity analysis: non-serious adverse events (worst-case scenario)",3,0,0,TRUE,TRUE,"OR_cc","default_or"
"CD014960_pub2_data","1::overall","1","overall","All-cause mortality",5,0,3,TRUE,TRUE,"RD","sparse_events"
"CD014960_pub2_data","2::overall","2","overall","Proportion of people with adverse events considered non-serious",3,0,2,TRUE,TRUE,"RD","sparse_events"
"CD014960_pub2_data","3::overall","3","overall","Days of hospitalisation ",3,2,3,FALSE,TRUE,"RD","double_zero"
"CD014964_pub2_data","3::overall","3","overall","Participant satisfaction during the procedure",3,0,1,TRUE,TRUE,"RD","sparse_events"
"CD014964_pub2_data","4::overall","4","overall","First‐attempt success",68,4,11,TRUE,TRUE,"RD","double_zero"
"CD014964_pub2_data","5::overall","5","overall","Technical failure of neuraxial anaesthesia",43,11,29,TRUE,TRUE,"RD","double_zero"
"CD014964_pub2_data","6::overall","6","overall","Pain during the procedure",6,0,0,TRUE,TRUE,"OR_cc","default_or"
"CD014964_pub2_data","7::overall","7","overall","Any adverse events",15,6,9,TRUE,TRUE,"RD","double_zero"
"CD014964_pub2_data","1::1","1","1","Number of attempts (Difficulty of palpating landmarks)",39,8,15,TRUE,TRUE,"RD","double_zero"
"CD014964_pub2_data","1::2","1","2","Number of attempts (Difficulty of palpating landmarks)",38,4,13,TRUE,TRUE,"RD","double_zero"
"CD014964_pub2_data","2::1","2","1","Number of attempts (Experience of operators)",75,12,30,TRUE,TRUE,"RD","double_zero"
"CD014964_pub2_data","2::2","2","2","Number of attempts (Experience of operators)",14,2,2,TRUE,TRUE,"RD","double_zero"
"CD014964_pub2_data","3::1","3","1","Number of attempts (Types of ultrasound guidance: preprocedural versus real‐time)",82,10,19,TRUE,TRUE,"RD","double_zero"
"CD014964_pub2_data","3::2","3","2","Number of attempts (Types of ultrasound guidance: preprocedural versus real‐time)",22,4,14,TRUE,TRUE,"RD","double_zero"
"CD014964_pub2_data","4::1","4","1","Number of attempts (Types of neuraxial anaesthesia)",34,4,6,TRUE,TRUE,"RD","double_zero"
"CD014964_pub2_data","4::2","4","2","Number of attempts (Types of neuraxial anaesthesia)",25,2,2,TRUE,TRUE,"RD","double_zero"
"CD014964_pub2_data","4::3","4","3","Number of attempts (Types of neuraxial anaesthesia)",5,0,1,TRUE,TRUE,"RD","sparse_events"
"CD014964_pub2_data","5::1","5","1","Number of attempts (Definition of outcome: used 'number of insertions through the skin')",15,0,0,TRUE,TRUE,"OR_cc","default_or"
"CD014964_pub2_data","5::2","5","2","Number of attempts (Definition of outcome: used 'number of insertions through the skin')",35,0,0,TRUE,TRUE,"OR_cc","default_or"
"CD014964_pub2_data","3::3","3","3","Technical failure (Types of neuraxial anaesthesia)",3,1,2,TRUE,TRUE,"RD","double_zero"
"CD014965_pub2_data","2::1","2","1","Aggression",8,0,4,TRUE,TRUE,"RD","sparse_events"
"CD014965_pub2_data","3::1","3","1","Weight gain above clinically relevant thresholds",3,0,2,TRUE,TRUE,"RD","sparse_events"
"CD014965_pub2_data","3::2","3","2","Weight gain above clinically relevant thresholds",3,0,2,TRUE,TRUE,"RD","sparse_events"
"CD014965_pub2_data","4::1","4","1","Weight gain as a continuous measure (in kilograms)",3,2,3,FALSE,TRUE,"RD","double_zero"
"CD014965_pub2_data","5::1","5","1","Extrapyramidal side effects: any extrapyramidal symptom",5,0,2,TRUE,TRUE,"RD","sparse_events"
"CD014965_pub2_data","5::2","5","2","Extrapyramidal side effects: any extrapyramidal symptom",3,1,2,TRUE,TRUE,"RD","double_zero"
"CD014965_pub2_data","6::1","6","1","Obsessive-compulsive behaviours",5,4,5,FALSE,TRUE,"RD","double_zero"
"CD014965_pub2_data","7::1","7","1","Inappropriate speech",6,5,6,FALSE,TRUE,"RD","double_zero"
"CD014965_pub2_data","9::1","9","1","Metabolic side effects: triglyceride levels above clinically relevant thresholds",2,1,1,FALSE,TRUE,"RD","double_zero"
"CD014965_pub2_data","11::1","11","1","Metabolic side effects: total cholesterol levels above clinically relevant thresholds",2,1,1,FALSE,TRUE,"RD","double_zero"
"CD014965_pub2_data","13::2","13","2","Other side effects: somnolence",3,0,0,TRUE,TRUE,"OR_cc","default_or"
"CD014965_pub2_data","13::3","13","3","Other side effects: somnolence",2,0,0,TRUE,TRUE,"OR_cc","default_or"
"CD014965_pub2_data","14::2","14","2","Other side effects: sedation",5,0,2,TRUE,TRUE,"RD","sparse_events"
"CD014965_pub2_data","14::3","14","3","Other side effects: sedation",2,0,0,TRUE,TRUE,"OR_cc","default_or"
"CD014965_pub2_data","15::1","15","1","Other side effects: headache",2,0,0,TRUE,TRUE,"OR_cc","default_or"
"CD014965_pub2_data","15::2","15","2","Other side effects: headache",4,0,0,TRUE,TRUE,"OR_cc","default_or"
"CD014965_pub2_data","16::2","16","2","Other side effects: constipation",2,0,1,TRUE,TRUE,"RD","sparse_events"
"CD014965_pub2_data","18::1","18","1","Other side effects: hypersalivation",4,0,2,TRUE,TRUE,"RD","sparse_events"
"CD014965_pub2_data","19::1","19","1","Other side effects: tremor",4,0,3,TRUE,TRUE,"RD","sparse_events"
"CD014965_pub2_data","20::1","20","1","Other side effects: akathisia",2,0,2,TRUE,TRUE,"RD","sparse_events"
"CD014965_pub2_data","22::2","22","2","Other side effects: rigidity",2,0,2,TRUE,TRUE,"RD","sparse_events"
"CD014965_pub2_data","23::2","23","2","Other side effects: insomnia",2,0,0,TRUE,TRUE,"OR_cc","default_or"
"CD014965_pub2_data","2::overall","2","overall","Aggression",3,2,2,FALSE,TRUE,"RD","double_zero"
"CD014965_pub2_data","3::overall","3","overall","Weight gain above clinically relevant thresholds",3,0,2,TRUE,TRUE,"RD","sparse_events"
"CD014965_pub2_data","4::overall","4","overall","Obsessive-compulsive behaviours",3,1,2,TRUE,TRUE,"RD","double_zero"
"CD014965_pub2_data","8::overall","8","overall","Social-communication adaptive functioning",3,1,3,TRUE,TRUE,"RD","double_zero"
"CD014965_pub2_data","1::overall","1","overall","Irritability",3,2,2,FALSE,TRUE,"RD","double_zero"
"CD014965_pub2_data","5::overall","5","overall","Other side effects: hypersalivation",2,0,1,TRUE,TRUE,"RD","sparse_events"
"CD014965_pub2_data","6::overall","6","overall","Other side effects: tremor",2,0,0,TRUE,TRUE,"OR_cc","default_or"
"CD014965_pub2_data","7::overall","7","overall","Other side effects: dyskinesia",2,0,2,TRUE,TRUE,"RD","sparse_events"
"CD014966_pub2_data","1::overall","1","overall","Kidney graft loss",79,0,4,TRUE,TRUE,"RD","sparse_events"
"CD014966_pub2_data","3::overall","3","overall","Kidney graft loss: female donor",10,0,1,TRUE,TRUE,"RD","sparse_events"
"CD014966_pub2_data","4::overall","4","overall","Kidney graft loss: male donor",10,0,1,TRUE,TRUE,"RD","sparse_events"
"CD014967_pub2_data","1::overall","1","overall","Proportion of infants who achieve seizure control after the first loading dose of ASM",15,2,3,TRUE,TRUE,"RD","double_zero"
"CD014967_pub2_data","2::overall","2","overall","Proportion of infants who achieve seizure control after the the maximal loading dose of ASM",15,1,2,TRUE,TRUE,"RD","double_zero"
"CD014967_pub2_data","3::overall","3","overall","Mortality before hospital discharge",15,2,7,TRUE,TRUE,"RD","double_zero"
"CD014967_pub2_data","4::overall","4","overall","Requirement for mechanical ventilation",13,4,9,TRUE,TRUE,"RD","double_zero"
"CD014967_pub2_data","5::overall","5","overall","Proportion of infants who develop sedation or drowsiness",6,1,2,TRUE,TRUE,"RD","double_zero"
"CD014967_pub2_data","6::overall","6","overall","Bradycardia",9,3,5,TRUE,TRUE,"RD","double_zero"
"CD014967_pub2_data","7::overall","7","overall","Hypotension requiring volume or inotropes",5,2,2,TRUE,TRUE,"RD","double_zero"
"CD014967_pub2_data","8::overall","8","overall","Shock requiring volume or inotropes",7,4,4,TRUE,TRUE,"RD","double_zero"
"CD014967_pub2_data","9::overall","9","overall","Recurrence of seizure before hospital discharge",3,0,0,TRUE,TRUE,"OR_cc","default_or"
"CD014967_pub2_data","10::overall","10","overall","Proportion of infants with epilepsy post-discharge",4,0,0,TRUE,TRUE,"OR_cc","default_or"
"CD014967_pub2_data","11::overall","11","overall","Duration of hospital stay",3,2,2,FALSE,TRUE,"RD","double_zero"
"CD014967_pub2_data","12::overall","12","overall","Recurrence of seizure before hospital discharge",2,1,1,FALSE,TRUE,"RD","double_zero"
"CD014967_pub2_data","15::overall","15","overall","Proportion of infants with an abnormal neurological examination at discharge",4,0,0,TRUE,TRUE,"OR_cc","default_or"
"CD014999_pub2_data","1::overall","1","overall","Rebleeding",4,0,0,TRUE,TRUE,"OR_cc","default_or"
"CD014999_pub2_data","2::overall","2","overall","Reintervention (events)",4,0,0,TRUE,TRUE,"OR_cc","default_or"
"CD014999_pub2_data","3::overall","3","overall","Reintervention (patients)",4,0,0,TRUE,TRUE,"OR_cc","default_or"
"CD014999_pub2_data","4::overall","4","overall","30-day bleeding-related mortality",3,0,1,TRUE,TRUE,"RD","sparse_events"
"CD014999_pub2_data","5::overall","5","overall","30-day all-cause mortality",4,2,2,TRUE,TRUE,"RD","double_zero"
"CD015003_pub2_data","1::overall","1","overall","All-cause mortality",9,0,1,TRUE,TRUE,"RD","sparse_events"
"CD015003_pub2_data","2::overall","2","overall","Non-fatal myocardial infarction",3,0,1,TRUE,TRUE,"RD","sparse_events"
"CD015003_pub2_data","4::overall","4","overall","Adverse events",10,0,4,TRUE,TRUE,"RD","sparse_events"
"CD015003_pub2_data","5::overall","5","overall","Cardiovascular mortality",2,0,2,TRUE,TRUE,"RD","sparse_events"
"CD015014_pub2_data","1::overall","1","overall","ED visits (proportion of residents with at least one ED visit)",7,0,0,TRUE,TRUE,"OR_cc","default_or"
"CD015014_pub2_data","2::overall","2","overall","ED visits (proportion of residents with at least one ED visit): sensitivity analysis by risk of bias",7,0,0,TRUE,TRUE,"OR_cc","default_or"
"CD015014_pub2_data","5::overall","5","overall","Unplanned hospital admissions (proportion of residents with at least one unplanned hospital admission)",8,0,1,TRUE,TRUE,"RD","sparse_events"
"CD015014_pub2_data","6::overall","6","overall","Unplanned hospital admissions (proportion of residents with at least one unplanned hospital admission): subgroup analysis by EPOC category",8,0,1,TRUE,TRUE,"RD","sparse_events"
"CD015014_pub2_data","7::overall","7","overall","Unplanned hospital admissions (proportion of residents with at least one unplanned hospital admission): subgroup analysis by type of care provided",8,0,1,TRUE,TRUE,"RD","sparse_events"
"CD015014_pub2_data","8::overall","8","overall","Unplanned hospital admissions (proportion of residents with at least one unplanned hospital admission): subgroup analysis by resident's condition",8,0,1,TRUE,TRUE,"RD","sparse_events"
"CD015014_pub2_data","9::overall","9","overall","Unplanned hospital admissions (proportion of residents with at least one unplanned hospital admission): sensitivity analysis by risk of bias",8,0,1,TRUE,TRUE,"RD","sparse_events"
"CD015014_pub2_data","10::overall","10","overall","Unplanned hospital admissions (proportion of residents with at least one unplanned hospital admission): sensitivity analysis by timing of effect",8,0,1,TRUE,TRUE,"RD","sparse_events"
"CD015014_pub2_data","13::overall","13","overall","Adverse events/falls (proportion of residents with a fall)",3,0,0,TRUE,TRUE,"OR_cc","default_or"
"CD015014_pub2_data","14::overall","14","overall","Adverse events/falls (proportion of residents with a fall): subgroup analysis by type of care provided",3,0,0,TRUE,TRUE,"OR_cc","default_or"
"CD015014_pub2_data","15::overall","15","overall","Adverse events/falls (proportion of residents with a fall): sensitivity analysis by risk of bias",3,0,0,TRUE,TRUE,"OR_cc","default_or"
"CD015014_pub2_data","16::overall","16","overall","Adverse events/falls (proportion of residents with a fall): sensitivity analysis by timing of effects",3,0,0,TRUE,TRUE,"OR_cc","default_or"
"CD015014_pub2_data","22::overall","22","overall","Adherence to clinical guideline-recommended care (proportion of residents with adequate antidepressant therapy)",2,0,0,TRUE,TRUE,"OR_cc","default_or"
"CD015014_pub2_data","23::overall","23","overall","Adherence to clinical guideline-recommended care (proportion of residents with adequate antidepressant therapy, two intervention arms combined)",2,0,0,TRUE,TRUE,"OR_cc","default_or"
"CD015014_pub2_data","24::overall","24","overall","Adherence to clinical guideline-recommended care (proportion of residents with adequate antipsychotic therapy)",2,0,2,TRUE,TRUE,"RD","sparse_events"
"CD015014_pub2_data","25::overall","25","overall","Adherence to clinical guideline-recommended care (proportion of residents with adequate antipsychotic therapy, two arms combined)",2,0,2,TRUE,TRUE,"RD","sparse_events"
"CD015014_pub2_data","32::overall","32","overall","Mortality (proportion of residents who died)",24,0,4,TRUE,TRUE,"RD","sparse_events"
"CD015014_pub2_data","33::overall","33","overall","Mortality (proportion of residents who died): sensitivity analyses by risk of bias",24,0,4,TRUE,TRUE,"RD","sparse_events"
"CD015014_pub2_data","34::overall","34","overall","Mortality (proportion of residents who died): sensitivity analysis by timing of effect",24,0,4,TRUE,TRUE,"RD","sparse_events"
"CD015014_pub2_data","35::overall","35","overall","Any hospital admission (proportion of residents with at least one hospital admission)",13,0,2,TRUE,TRUE,"RD","sparse_events"
"CD015014_pub2_data","36::overall","36","overall","Any hospital admission (proportion of residents with at least one hospital admission): sensitivity analysis by risk of bias",13,0,2,TRUE,TRUE,"RD","sparse_events"
"CD015014_pub2_data","37::overall","37","overall","Any hospital admission (proportion of residents with at least one hospital admission): sensitivity by timing of effect",13,0,2,TRUE,TRUE,"RD","sparse_events"
"CD015033_pub2_data","1::overall","1","overall","All-cause mortality (range from18 months to 24 months)",14,11,14,TRUE,TRUE,"RD","double_zero"
"CD015033_pub2_data","2::overall","2","overall","All-cause mortality. Best-worst case scenario sensitivity analysis",14,11,11,TRUE,TRUE,"RD","double_zero"
"CD015033_pub2_data","3::overall","3","overall","All-cause mortality. Worst-best case scenario sensitivity analysis",13,10,10,TRUE,TRUE,"RD","double_zero"
"CD015033_pub2_data","5::overall","5","overall","Serious adverse events (24 months)",13,11,13,TRUE,TRUE,"RD","double_zero"
"CD015033_pub2_data","6::overall","6","overall","Serious adverse events. Best-worst case scenario sensitivity analysis",13,11,11,TRUE,TRUE,"RD","double_zero"
"CD015033_pub2_data","7::overall","7","overall","Serious adverse events. Worst-best case scenario sensitivity analysis",4,2,2,TRUE,TRUE,"RD","double_zero"
"CD015033_pub2_data","10::overall","10","overall","Health-related quality of life (psychosocial health, 24 months)",3,2,2,FALSE,TRUE,"RD","double_zero"
"CD015033_pub2_data","11::overall","11","overall","Non-serious adverse events (number of events, 24 months)",3,0,0,TRUE,TRUE,"OR_cc","default_or"
"CD015033_pub2_data","12::overall","12","overall","Non-serious averse events. Best-worst case scenario sensitivity analysis",3,0,0,TRUE,TRUE,"OR_cc","default_or"
"CD015033_pub2_data","13::overall","13","overall","Non-serious averse events. Worst-best case scenario sensitivity analysis",3,0,0,TRUE,TRUE,"OR_cc","default_or"
"CD015033_pub2_data","14::overall","14","overall","Liver enzyme levels. Serum ALT levels (range from 2 months to 24 months)",12,11,11,FALSE,TRUE,"RD","double_zero"
"CD015033_pub2_data","15::overall","15","overall","Liver enzyme levels. Serum AST levels (range from 2 months to 24 months)",12,11,11,FALSE,TRUE,"RD","double_zero"
"CD015033_pub2_data","18::overall","18","overall","Imaging response. No-improvement in steatosis on ultrasound (range from 5 months to 12 months)",4,0,0,TRUE,TRUE,"OR_cc","default_or"
"CD015033_pub2_data","19::overall","19","overall","Imaging response. No-improvement in steatosis on ultrasound. Best-worst case scenario sensitivity analysis",4,0,0,TRUE,TRUE,"OR_cc","default_or"
"CD015033_pub2_data","20::overall","20","overall","Imaging response. No-improvement in steatosis on ultrasound. Worst-best case scenario sensitivity analysis",4,0,0,TRUE,TRUE,"OR_cc","default_or"
"CD015033_pub2_data","21::overall","21","overall","Imaging response. Proportion of participants without a normal ultrasound (range from 5 months to 12 months)",4,0,0,TRUE,TRUE,"OR_cc","default_or"
"CD015033_pub2_data","22::overall","22","overall","Imaging response. Proportion of participants without a normal ultrasound. Best-worst case scenario sensitivity analysis",4,0,0,TRUE,TRUE,"OR_cc","default_or"
"CD015033_pub2_data","23::overall","23","overall","Imaging response. Proportion of participants without a normal ultrasound. Worst-best case scenario sensitivity analysis",4,0,0,TRUE,TRUE,"OR_cc","default_or"
"CD015038_pub2_data","1::overall","1","overall","Mortality",12,4,5,TRUE,TRUE,"RD","double_zero"
"CD015038_pub2_data","2::overall","2","overall","Success of treatment",7,0,0,TRUE,TRUE,"OR_cc","default_or"
"CD015038_pub2_data","3::overall","3","overall","Clostridium difficile diarrhoea",3,2,2,FALSE,TRUE,"RD","double_zero"
"CD015038_pub2_data","4::overall","4","overall","Wound infection",9,0,7,TRUE,TRUE,"RD","sparse_events"
"CD015038_pub2_data","7::overall","7","overall","Intra-abdominal abscess or collection",6,0,5,TRUE,TRUE,"RD","sparse_events"
"CD015038_pub2_data","10::overall","10","overall","Complicated appendicitis at surgery",8,0,3,TRUE,TRUE,"RD","sparse_events"
"CD015038_pub2_data","15::overall","15","overall","Negative appendectomy rate (normal histology)",5,0,2,TRUE,TRUE,"RD","sparse_events"
"CD015042_pub2_data","1::overall","1","overall","Number of continuously abstinent women",3,0,0,TRUE,TRUE,"OR_cc","default_or"
"CD015042_pub2_data","3::overall","3","overall","Number of women who completed treatment",7,0,0,TRUE,TRUE,"OR_cc","default_or"
"CD015046_pub2_data","1::overall","1","overall","Adverse events&nbsp;",3,0,1,TRUE,TRUE,"RD","sparse_events"
"CD015060_pub2_data","1::overall","1","overall","Proteinuria: > 50% increase from baseline",13,6,8,TRUE,TRUE,"RD","double_zero"
"CD015060_pub2_data","2::overall","2","overall","eGFR: ≥ 60% decline from baseline at 3 years",9,6,6,TRUE,TRUE,"RD","double_zero"
"CD015060_pub2_data","3::overall","3","overall","Haematuria resolution",4,0,1,TRUE,TRUE,"RD","sparse_events"
"CD015064_pub2_data","1::overall","1","overall","Pimecrolimus 1% versus vehicle",14,2,5,TRUE,TRUE,"RD","double_zero"
"CD015066_pub2_data","2::overall","2","overall","Earplugs, PAR pass rate (%) (immediate)",2,0,0,TRUE,TRUE,"OR_cc","default_or"
"CD015084_pub2_data","1::overall","1","overall","Clinical remission",6,3,3,TRUE,TRUE,"RD","double_zero"
"CD015084_pub2_data","2::overall","2","overall","Disease improvement: clinical activity scale (Rachmilewitz index)",6,5,5,FALSE,TRUE,"RD","double_zero"
"CD015084_pub2_data","3::overall","3","overall","Disease improvement: biochemical markers of inflammation (faecal calprotectin)",5,4,4,FALSE,TRUE,"RD","double_zero"
"CD015084_pub2_data","4::overall","4","overall","Disease improvement: biochemical markers of inflammation (IL-8 in rectal dialysis fluid)",5,4,4,FALSE,TRUE,"RD","double_zero"
"CD015084_pub2_data","5::overall","5","overall","Disease improvement: biochemical markers of inflammation (PGE-2 in rectal dialysis fluid)",4,3,3,FALSE,TRUE,"RD","double_zero"
"CD015084_pub2_data","6::overall","6","overall","Withdrawals due to adverse events",6,0,2,TRUE,TRUE,"RD","sparse_events"
"CD015087_pub2_data","1::overall","1","overall","Adverse events",13,4,9,TRUE,TRUE,"RD","double_zero"
"CD015087_pub2_data","2::overall","2","overall","Pain intensity as reported by a third party (0 to 2 hours)",5,1,2,TRUE,TRUE,"RD","double_zero"
"CD015087_pub2_data","3::overall","3","overall","Pain intensity as reported by a third party (2 to 24 hours)",12,3,4,TRUE,TRUE,"RD","double_zero"
"CD015087_pub2_data","5::overall","5","overall","Opioid consumption (2 to 24 hours)",8,0,3,TRUE,TRUE,"RD","sparse_events"
"CD015087_pub2_data","6::overall","6","overall","Opioid consumption (1 to 7 days)",11,0,3,TRUE,TRUE,"RD","sparse_events"
"CD015087_pub2_data","7::overall","7","overall","Nausea and/or vomiting",4,0,1,TRUE,TRUE,"RD","sparse_events"
"CD015087_pub2_data","8::overall","8","overall","Any bleeding",5,1,3,TRUE,TRUE,"RD","double_zero"
"CD015087_pub2_data","9::overall","9","overall","Requiring rescue medication (2 to 24 hours)",7,0,1,TRUE,TRUE,"RD","sparse_events"
"CD015087_pub2_data","10::overall","10","overall","Requiring rescue medication (1 to 7 days)",2,0,1,TRUE,TRUE,"RD","sparse_events"
"CD015087_pub2_data","15::overall","15","overall","Nausea and/or vomiting",5,2,2,TRUE,TRUE,"RD","double_zero"
"CD015087_pub2_data","16::overall","16","overall","Any bleeding",5,3,4,TRUE,TRUE,"RD","double_zero"
"CD015101_data","1::overall","1","overall","All symptoms",23,21,23,TRUE,TRUE,"RD","double_zero"
"CD015122_pub2_data","1::overall","1","overall","Blood transfusion",10,0,1,TRUE,TRUE,"RD","sparse_events"
"CD015122_pub2_data","2::overall","2","overall","Stone-free rate",5,0,0,TRUE,TRUE,"OR_cc","default_or"
"CD015122_pub2_data","3::overall","3","overall","Thromboembolic events",7,6,7,FALSE,TRUE,"RD","double_zero"
"CD015122_pub2_data","4::overall","4","overall","Adverse events",5,1,2,TRUE,TRUE,"RD","double_zero"
"CD015122_pub2_data","5::overall","5","overall","Secondary interventions",3,0,0,TRUE,TRUE,"OR_cc","default_or"
"CD015122_pub2_data","6::overall","6","overall","Major Surgical complications",6,0,1,TRUE,TRUE,"RD","sparse_events"
"CD015122_pub2_data","7::overall","7","overall","Minor surgical complications",6,1,1,TRUE,TRUE,"RD","double_zero"
"CD015122_pub2_data","18::overall","18","overall","Blood transfusion (Sensitivity analysis & definition of stone freedom)",3,0,0,TRUE,TRUE,"OR_cc","default_or"
"CD015122_pub2_data","19::overall","19","overall","Stone-free rate (Sensitivity analysis & definition of stone freedom)",3,0,0,TRUE,TRUE,"OR_cc","default_or"
"CD015122_pub2_data","20::overall","20","overall","Thromboembolic events (Sensitivity analysis & definition of stone freedom)",3,2,3,FALSE,TRUE,"RD","double_zero"
"CD015122_pub2_data","21::overall","21","overall","Adverse Eeents (Sensitivity analysis & definition of stone freedom)",2,0,1,TRUE,TRUE,"RD","sparse_events"
"CD015122_pub2_data","23::overall","23","overall","Major surgical complications (Sensitivity analysis & definition of stone freedom)",3,0,0,TRUE,TRUE,"OR_cc","default_or"
"CD015122_pub2_data","24::overall","24","overall","Minor surgical complications (Sensitivity analysis & definition of stone freedom)",3,0,0,TRUE,TRUE,"OR_cc","default_or"
"CD015123_pub2_data","1::overall","1","overall","Number of participants with at least one SAE",3,0,1,TRUE,TRUE,"RD","sparse_events"
"CD015123_pub2_data","2::overall","2","overall","Number of participants with new or enlarging T2-weighted MRI lesions",3,0,1,TRUE,TRUE,"RD","sparse_events"
"CD015123_pub2_data","3::overall","3","overall","Number of participants with new Gd+ T1-weighted MRI lesions",3,0,0,TRUE,TRUE,"OR_cc","default_or"
"CD015123_pub2_data","4::overall","4","overall","Number of participants experiencing treatment discontinuation caused by AE",2,0,0,TRUE,TRUE,"OR_cc","default_or"
"CD015123_pub2_data","5::overall","5","overall","Number of participants with at least one AE",2,1,1,FALSE,TRUE,"RD","double_zero"
"CD015134_pub2_data","1::overall","1","overall","Infant hospitalisation with laboratory-confirmed RSV disease",4,1,2,TRUE,TRUE,"RD","double_zero"
"CD015134_pub2_data","2::overall","2","overall","Intrauterine growth restriction",4,1,2,TRUE,TRUE,"RD","double_zero"
"CD015134_pub2_data","3::overall","3","overall","Stillbirth",5,1,3,TRUE,TRUE,"RD","double_zero"
"CD015134_pub2_data","4::overall","4","overall","Maternal death",3,2,3,FALSE,TRUE,"RD","double_zero"
"CD015134_pub2_data","5::overall","5","overall","Preterm birth",6,0,1,TRUE,TRUE,"RD","sparse_events"
"CD015134_pub2_data","6::overall","6","overall","Congenital abnormalities",4,0,0,TRUE,TRUE,"OR_cc","default_or"
"CD015134_pub2_data","7::overall","7","overall","Infant death",6,3,3,TRUE,TRUE,"RD","double_zero"
"CD015140_pub2_data","6::overall","6","overall","Adverse events ≥ grade 3",8,4,5,TRUE,TRUE,"RD","double_zero"
"CD015140_pub2_data","7::overall","7","overall","Adverse events grades 1 and 2",4,0,0,TRUE,TRUE,"OR_cc","default_or"
"CD015140_pub2_data","10::overall","10","overall","Risk of relapse in drug-off time - fixed-effect model",5,0,1,TRUE,TRUE,"RD","sparse_events"
"CD015140_pub2_data","11::overall","11","overall","Risk of relapse in drug-off time - random-effects model",5,0,1,TRUE,TRUE,"RD","sparse_events"
"CD015140_pub2_data","12::overall","12","overall","Risk of relapse in drug-on time - fixed-effect model",9,0,1,TRUE,TRUE,"RD","sparse_events"
"CD015140_pub2_data","13::overall","13","overall","Risk of relapse in drug-on time - random-effects model",9,0,1,TRUE,TRUE,"RD","sparse_events"
"CD015140_pub2_data","14::overall","14","overall","Risk of brain relapse",3,0,0,TRUE,TRUE,"OR_cc","default_or"
"CD015140_pub2_data","16::overall","16","overall","Risk of relapse in drug-off time",4,0,0,TRUE,TRUE,"OR_cc","default_or"
"CD015140_pub2_data","17::overall","17","overall","Risk of relapse in drug-on time",4,0,0,TRUE,TRUE,"OR_cc","default_or"
"CD015140_pub2_data","18::overall","18","overall","Risk of brain relapse",3,0,0,TRUE,TRUE,"OR_cc","default_or"
"CD015145_pub2_data","3::overall","3","overall","Opioid use (MME) 0 to 24 hours after surgery",3,0,0,TRUE,TRUE,"OR_cc","default_or"
"CD015145_pub2_data","4::overall","4","overall","Opioid use (MME) 0 to 48 hours after surgery",2,0,0,TRUE,TRUE,"OR_cc","default_or"
"CD015160_pub2_data","1::overall","1","overall","Surgical site infections (as defined by the included studies) within 30 days of repair",20,10,12,TRUE,TRUE,"RD","double_zero"
"CD015160_pub2_data","2::overall","2","overall","Mortality (defined as all‐cause mortality) within 30 days of repair",11,8,8,TRUE,TRUE,"RD","double_zero"
"CD015160_pub2_data","3::overall","3","overall","Surgical site infections (as defined by the included studies) within 90 days of repair",6,4,5,TRUE,TRUE,"RD","double_zero"
"CD015160_pub2_data","5::overall","5","overall","Clinical recurrence or reoperation for recurrence within one year of repair",3,1,2,TRUE,TRUE,"RD","double_zero"
"CD015160_pub2_data","6::overall","6","overall","Mesh removal within 30 days of repair",5,4,4,FALSE,TRUE,"RD","double_zero"
"CD015192_pub2_data","1::1","1","1","Graft infection rate",5,3,4,TRUE,TRUE,"RD","double_zero"
"CD015192_pub2_data","1::2","1","2","Graft infection rate",5,4,5,FALSE,TRUE,"RD","double_zero"
"CD015192_pub2_data","2::overall","2","overall","All-cause mortality",8,1,3,TRUE,TRUE,"RD","double_zero"
"CD015192_pub2_data","3::overall","3","overall","Re-intervention rate",7,3,4,TRUE,TRUE,"RD","double_zero"
"CD015192_pub2_data","1::3","1","3","Graft infection rate",3,1,3,TRUE,TRUE,"RD","double_zero"
"CD015192_pub2_data","2::1","2","1","Surgical site infection rate",7,1,3,TRUE,TRUE,"RD","double_zero"
"CD015192_pub2_data","2::2","2","2","Surgical site infection rate",5,1,4,TRUE,TRUE,"RD","double_zero"
"CD015192_pub2_data","2::3","2","3","Surgical site infection rate",4,1,1,TRUE,TRUE,"RD","double_zero"
"CD015192_pub2_data","4::overall","4","overall","Re-intervention rate",3,0,0,TRUE,TRUE,"OR_cc","default_or"
"CD015192_pub2_data","6::overall","6","overall","Adverse events resulting from the interventions for prevention of infection",2,1,1,FALSE,TRUE,"RD","double_zero"
"CD015192_pub2_data","3::1","3","1","Adverse events resulting from the interventions for prevention of infection",2,1,1,FALSE,TRUE,"RD","double_zero"
"CD015192_pub2_data","1::overall","1","overall","Graft infection rate",10,1,3,TRUE,TRUE,"RD","double_zero"
"CD015213_pub2_data","1::overall","1","overall","Time to wound healing",17,12,15,TRUE,TRUE,"RD","double_zero"
"CD015213_pub2_data","2::overall","2","overall","Proportion of wounds healed",15,5,6,TRUE,TRUE,"RD","double_zero"
"CD015213_pub2_data","3::overall","3","overall","Recurrence rate",27,3,9,TRUE,TRUE,"RD","double_zero"
"CD015213_pub2_data","4::overall","4","overall","Recurrence rate (Subgroup analysis according to follow-up duration)",33,6,15,TRUE,TRUE,"RD","double_zero"
"CD015213_pub2_data","5::overall","5","overall","Wound infection",30,7,12,TRUE,TRUE,"RD","double_zero"
"CD015213_pub2_data","6::overall","6","overall","Wound infection (Sensitivity analysis according to risk of bias)",25,3,9,TRUE,TRUE,"RD","double_zero"
"CD015213_pub2_data","7::overall","7","overall","Wound dehiscence",27,3,15,TRUE,TRUE,"RD","double_zero"
"CD015213_pub2_data","8::overall","8","overall","Time to return to work",18,6,15,TRUE,TRUE,"RD","double_zero"
"CD015213_pub2_data","9::overall","9","overall","Operative time",14,6,12,TRUE,TRUE,"RD","double_zero"
"CD015213_pub2_data","10::overall","10","overall","Length of hospital stay",19,16,19,TRUE,TRUE,"RD","double_zero"
"CD015215_pub2_data","1::overall","1","overall","Return to normal hearing, randomised by ear (medium-term)",7,2,2,TRUE,TRUE,"RD","double_zero"
"CD015215_pub2_data","2::overall","2","overall","Mean final hearing threshold, randomised by ear (medium-term)",6,4,4,TRUE,TRUE,"RD","double_zero"
"CD015215_pub2_data","3::overall","3","overall","Change in hearing threshold from baseline, randomised by ear (medium-term)",7,6,6,FALSE,TRUE,"RD","double_zero"
"CD015215_pub2_data","5::overall","5","overall","Persistence of OME: randomised by child (very short-term)",8,5,7,TRUE,TRUE,"RD","double_zero"
"CD015215_pub2_data","6::overall","6","overall","Persistence of OME: randomised by child (medium-term)",8,4,5,TRUE,TRUE,"RD","double_zero"
"CD015215_pub2_data","7::overall","7","overall","Persistence of OME: randomised by ear (medium-term)",4,1,2,TRUE,TRUE,"RD","double_zero"
"CD015215_pub2_data","8::overall","8","overall","Mean improvement in comprehensive language, randomised by child (medium-term)",4,1,2,TRUE,TRUE,"RD","double_zero"
"CD015215_pub2_data","9::overall","9","overall","Mean improvement in expressive language, randomised by child (medium-term)",5,2,2,TRUE,TRUE,"RD","double_zero"
"CD015215_pub2_data","10::overall","10","overall","Adverse event: tympanosclerosis, randomised by ear (medium-term)",7,0,0,TRUE,TRUE,"OR_cc","default_or"
"CD015215_pub2_data","11::overall","11","overall","Presence/persistence of OME, randomised by child, measured by otoscopy (medium-term)",4,0,1,TRUE,TRUE,"RD","sparse_events"
"CD015215_pub2_data","12::overall","12","overall","Presence/persistence of OME, randomised by child, measured by tympanometry (medium-term)",5,2,2,TRUE,TRUE,"RD","double_zero"
"CD015215_pub2_data","13::overall","13","overall","Presence/persistence of OME, mean percentage of days, randomised by child (medium-term)",4,1,1,TRUE,TRUE,"RD","double_zero"
"CD015215_pub2_data","14::overall","14","overall","Presence/persistence of OME, randomised by child (long-term)",6,0,1,TRUE,TRUE,"RD","sparse_events"
"CD015215_pub2_data","15::overall","15","overall","Presence/persistence of OME, adjusted OR, randomised by child (long-term)",5,0,1,TRUE,TRUE,"RD","sparse_events"
"CD015215_pub2_data","16::overall","16","overall","Adverse event: tympanosclerosis (long-term)",5,0,3,TRUE,TRUE,"RD","sparse_events"
"CD015215_pub2_data","17::overall","17","overall","Adverse event: fibrosis (long-term)",4,1,2,TRUE,TRUE,"RD","double_zero"
"CD015215_pub2_data","18::overall","18","overall","Adverse event: segmental atrophy (long-term)",4,1,2,TRUE,TRUE,"RD","double_zero"
"CD015215_pub2_data","19::overall","19","overall","Adverse event: retraction pocket with other abnormality (long-term)",3,1,2,TRUE,TRUE,"RD","double_zero"
"CD015219_pub2_data","1::overall","1","overall","All-cause mortality – at 28 to 30 days, or in‐hospital",45,0,21,TRUE,TRUE,"RD","sparse_events"
"CD015219_pub2_data","2::overall","2","overall","Progression to invasive mechanical ventilation",50,0,10,TRUE,TRUE,"RD","sparse_events"
"CD015219_pub2_data","3::overall","3","overall","Need for admission to hospital (if ambulatory)",28,0,13,TRUE,TRUE,"RD","sparse_events"
"CD015219_pub2_data","4::overall","4","overall","Time to clinical improvement (defined as time to a 2-point reduction in participants’ admission status on WHO’s ordinal scale)",33,0,6,TRUE,TRUE,"RD","sparse_events"
"CD015219_pub2_data","5::overall","5","overall","Progression to oxygen therapy",15,0,5,TRUE,TRUE,"RD","sparse_events"
"CD015219_pub2_data","6::overall","6","overall","Need for critical or intensive care (any reason)",6,1,2,TRUE,TRUE,"RD","double_zero"
"CD015219_pub2_data","8::overall","8","overall","Duration of hospitalization",16,3,3,TRUE,TRUE,"RD","double_zero"
"CD015219_pub2_data","9::overall","9","overall","Time to negative PCR for SARS‐CoV‐2",8,0,5,TRUE,TRUE,"RD","sparse_events"
"CD015219_pub2_data","10::overall","10","overall","All adverse events",25,0,2,TRUE,TRUE,"RD","sparse_events"
"CD015219_pub2_data","11::overall","11","overall","Serious adverse events attributable to the drug",12,0,6,TRUE,TRUE,"RD","sparse_events"
"CD015219_pub2_data","12::overall","12","overall","Hyperuricaemia",10,0,4,TRUE,TRUE,"RD","sparse_events"
"CD015219_pub2_data","13::overall","13","overall","Need for admission to hospital (if ambulatory) – fixed-effect model",4,0,1,TRUE,TRUE,"RD","sparse_events"
"CD015219_pub2_data","15::overall","15","overall","All adverse events – fixed-effect model",18,0,0,TRUE,TRUE,"OR_cc","default_or"
"CD015252_pub2_data","1::overall","1","overall","Proportion of children whose hearing has returned to normal",8,3,3,TRUE,TRUE,"RD","double_zero"
"CD015252_pub2_data","2::overall","2","overall","Serious adverse event: haemorrhage",9,7,8,TRUE,TRUE,"RD","double_zero"
"CD015252_pub2_data","3::overall","3","overall","Presence or persistence of OME",16,1,3,TRUE,TRUE,"RD","double_zero"
"CD015252_pub2_data","4::overall","4","overall","Sensitivity analysis: presence or persistence of OME (complete correlation between ears)",12,0,0,TRUE,TRUE,"OR_cc","default_or"
"CD015252_pub2_data","5::overall","5","overall","Sensitivity analysis: presence or persistence of OME (no correlation between ears)",9,1,1,TRUE,TRUE,"RD","double_zero"
"CD015252_pub2_data","6::overall","6","overall","Time with effusion",2,1,1,FALSE,TRUE,"RD","double_zero"
"CD015252_pub2_data","7::overall","7","overall","Number of doctor-diagnosed acute otitis media episodes",2,1,1,FALSE,TRUE,"RD","double_zero"
"CD015252_pub2_data","8::overall","8","overall","Sensitivity analysis: presence/persistence of OME ICC 0",4,0,0,TRUE,TRUE,"OR_cc","default_or"
"CD015252_pub2_data","9::overall","9","overall","Sensitivity analysis: presence/persistence of OME ICC 1",4,0,0,TRUE,TRUE,"OR_cc","default_or"
"CD015254_pub2_data","1::overall","1","overall","Normal hearing (as complete improvement in air-bone gap in worst ear): short-term",2,0,0,TRUE,TRUE,"OR_cc","default_or"
"CD015254_pub2_data","3::overall","3","overall","Sensitivity analysis: speech reception threshold: assuming correlation coefficient of 0.3",8,2,2,TRUE,TRUE,"RD","double_zero"
"CD015254_pub2_data","4::overall","4","overall","Sensitivity analysis: speech reception threshold: assuming correlation coefficient of 0.7",8,2,2,TRUE,TRUE,"RD","double_zero"
"CD015254_pub2_data","5::overall","5","overall","Hearing threshold: speech awareness threshold (short-term)",7,1,1,TRUE,TRUE,"RD","double_zero"
"CD015254_pub2_data","6::overall","6","overall","Persistence of OME (short-term)",10,0,0,TRUE,TRUE,"OR_cc","default_or"
"CD015254_pub2_data","7::overall","7","overall","Sensitivity analysis: persistence (short-term) including cases of acute otitis (Mandel 1987)",10,0,0,TRUE,TRUE,"OR_cc","default_or"
"CD015254_pub2_data","8::overall","8","overall","Sensitivity analysis: persistence (short-term) assuming ICC of 1.0 (complete correlation between ears) (Puhakka 1985)",10,0,0,TRUE,TRUE,"OR_cc","default_or"
"CD015254_pub2_data","9::overall","9","overall","Sensitivity analysis: persistence (short-term) assuming ICC of zero (no correlation between ears) (Puhakka 1985)",10,0,0,TRUE,TRUE,"OR_cc","default_or"
"CD015254_pub2_data","10::overall","10","overall","Persistence of OME (medium-term)",2,0,0,TRUE,TRUE,"OR_cc","default_or"
"CD015254_pub2_data","11::overall","11","overall","Sensitivity analysis: persistence of OME (medium-term); defined as 'OME' or 'AOM without perforation' (Leach 2008)",2,0,0,TRUE,TRUE,"OR_cc","default_or"
"CD015254_pub2_data","14::overall","14","overall","Episodes of acute otitis media",2,0,0,TRUE,TRUE,"OR_cc","default_or"
"CD015255_pub2_data","1::overall","1","overall","Normal hearing (very short-term - up to 6 weeks)",4,2,2,TRUE,TRUE,"RD","double_zero"
"CD015255_pub2_data","2::overall","2","overall","Normal hearing (very short-term - up to 6 weeks, adjusted OR)",7,1,1,TRUE,TRUE,"RD","double_zero"
"CD015255_pub2_data","3::overall","3","overall","Normal hearing defined as complete improvement in air-bone gap (short-term - up to 3 months)",9,1,1,TRUE,TRUE,"RD","double_zero"
"CD015255_pub2_data","4::overall","4","overall","Normal hearing (medium-term - up to 1 year)",7,1,1,TRUE,TRUE,"RD","double_zero"
"CD015255_pub2_data","5::overall","5","overall","Hearing threshold (very short-term - up to 6 weeks)",4,2,2,TRUE,TRUE,"RD","double_zero"
"CD015255_pub2_data","6::overall","6","overall","Hearing threshold (difference in adjusted mean, very short-term - up to 6 weeks)",3,1,1,TRUE,TRUE,"RD","double_zero"
"CD015255_pub2_data","7::overall","7","overall","Disease-specific quality of life (very short-term - up to 6 weeks)",4,1,1,TRUE,TRUE,"RD","double_zero"
"CD015255_pub2_data","8::overall","8","overall","Disease-specific quality of life (medium-term - up to 1 year)",2,1,1,FALSE,TRUE,"RD","double_zero"
"CD015255_pub2_data","9::overall","9","overall","Persistence of OME (very short-term - up to 6 weeks)",8,0,0,TRUE,TRUE,"OR_cc","default_or"
"CD015255_pub2_data","10::overall","10","overall","Sensitivity analysis: persistence of OME (very short-term); persistence in all affected ears (Berman 1990)",10,0,0,TRUE,TRUE,"OR_cc","default_or"
"CD015255_pub2_data","11::overall","11","overall","Sensitivity analysis: persistence of OME (very short-term); effusion in both ears (Niederman 1984)",10,0,0,TRUE,TRUE,"OR_cc","default_or"
"CD015255_pub2_data","12::overall","12","overall","Persistence of OME (short-term - up to 3 months); ICC = 0.5",6,0,0,TRUE,TRUE,"OR_cc","default_or"
"CD015255_pub2_data","13::overall","13","overall","Sensitivity analysis: persistence of OME (short-term); ICC = 1.0",5,0,0,TRUE,TRUE,"OR_cc","default_or"
"CD015255_pub2_data","14::overall","14","overall","Sensitivity analysis: persistence of OME (short-term); ICC = zero",4,0,0,TRUE,TRUE,"OR_cc","default_or"
"CD015255_pub2_data","15::overall","15","overall","Sensitivity analysis: persistence of OME (short-term); persistence in all affected ears (Macknin 1985)",4,1,1,TRUE,TRUE,"RD","double_zero"
"CD015255_pub2_data","16::overall","16","overall","Persistence of OME (medium-term - up to 1 year)",2,0,0,TRUE,TRUE,"OR_cc","default_or"
"CD015255_pub2_data","17::overall","17","overall","Acute otitis media (very short-term - up to 6 weeks)",3,0,2,TRUE,TRUE,"RD","sparse_events"
"CD015255_pub2_data","22::overall","22","overall","Subgroup analysis: normal hearing: allergy versus none (very short-term - up to 6 weeks)",2,0,0,TRUE,TRUE,"OR_cc","default_or"
"CD015255_pub2_data","23::overall","23","overall","Subgroup analysis: persistence of OME: allergy versus none (very short-term - up to 6 weeks)",2,0,0,TRUE,TRUE,"OR_cc","default_or"
"CD015255_pub2_data","24::overall","24","overall","Subgroup analysis: persistence of OME: age < 4 versus ≥ 4 (very short-term - up to 6 weeks)",2,0,0,TRUE,TRUE,"OR_cc","default_or"
"CD015284_pub2_data","1::1","1","1","Seizure frequency per month",14,9,9,TRUE,TRUE,"RD","double_zero"
"CD015284_pub2_data","2::1","2","1","Quality of Life in Epilepsy Inventory Total score (QOLIE-10)",10,5,5,TRUE,TRUE,"RD","double_zero"
"CD015284_pub2_data","2::2","2","2","Quality of Life in Epilepsy Inventory Total score (QOLIE-10)",5,1,1,TRUE,TRUE,"RD","double_zero"
"CD015284_pub2_data","2::3","2","3","Quality of Life in Epilepsy Inventory Total score (QOLIE-10)",2,1,1,FALSE,TRUE,"RD","double_zero"
"CD015284_pub2_data","3::1","3","1","World Health Organization Quality of Life instrument, short version (WHOQOL- BREF) scale",7,3,3,TRUE,TRUE,"RD","double_zero"
"CD015284_pub2_data","3::2","3","2","World Health Organization Quality of Life instrument, short version (WHOQOL- BREF) scale",4,2,2,TRUE,TRUE,"RD","double_zero"
"CD015284_pub2_data","5::1","5","1","Geriatric Depression Scale (GDS)",6,5,5,FALSE,TRUE,"RD","double_zero"
"CD015284_pub2_data","6::1","6","1","Composite International Diagnostic Interview (CIDI): Depression",6,5,5,FALSE,TRUE,"RD","double_zero"
"CD015284_pub2_data","7::1","7","1","Composite International Diagnostic Interview (CIDI): Dysthymia",4,3,3,FALSE,TRUE,"RD","double_zero"
"CD015314_pub2_data","1::1","1","1","Tobacco cessation at longest follow-up",7,0,0,TRUE,TRUE,"OR_cc","default_or"
"CD015314_pub2_data","1::2","1","2","Tobacco cessation at longest follow-up",5,0,0,TRUE,TRUE,"OR_cc","default_or"
"CD015314_pub2_data","1::3","1","3","Tobacco cessation at longest follow-up",7,1,1,TRUE,TRUE,"RD","double_zero"
"CD015314_pub2_data","1::4","1","4","Tobacco cessation at longest follow-up",3,0,0,TRUE,TRUE,"OR_cc","default_or"
"CD015314_pub2_data","2::1","2","1","Subgrouped by modality of support",6,0,1,TRUE,TRUE,"RD","sparse_events"
"CD015314_pub2_data","2::2","2","2","Subgrouped by modality of support",7,1,2,TRUE,TRUE,"RD","double_zero"
"CD015314_pub2_data","2::3","2","3","Subgrouped by modality of support",8,0,0,TRUE,TRUE,"OR_cc","default_or"
"CD015314_pub2_data","1::overall","1","overall","Tobacco cessation at longest follow up",28,0,0,TRUE,TRUE,"OR_cc","default_or"
"CD015331_pub2_data","7::overall","7","overall","Mental state - general: number of participants with clinically important change in general mental state (combined time points)",5,0,0,TRUE,TRUE,"OR_cc","default_or"
"CD015331_pub2_data","8::overall","8","overall","Mental state - general: number of participants with clinically important change in general mental state (separated time points)",9,0,0,TRUE,TRUE,"OR_cc","default_or"
"CD015331_pub2_data","9::overall","9","overall","Mental state - specific: number of participants with clinically important change in positive symptoms (combined time points)",2,0,0,TRUE,TRUE,"OR_cc","default_or"
"CD015331_pub2_data","10::overall","10","overall","Mental state - specific: number of participants with clinically important change in positive symptoms (separated time points)",4,0,0,TRUE,TRUE,"OR_cc","default_or"
"CD015331_pub2_data","34::overall","34","overall","Global state - number of participants with relapse/exacerbations of psychosis (combined time points)",8,1,2,TRUE,TRUE,"RD","double_zero"
"CD015331_pub2_data","35::overall","35","overall","Global state - number of participants with relapse/exacerbations of psychosis (separated time points)",14,2,4,TRUE,TRUE,"RD","double_zero"
"CD015331_pub2_data","36::overall","36","overall","Global state - number of participants with remission (combined time points)",2,0,0,TRUE,TRUE,"OR_cc","default_or"
"CD015331_pub2_data","37::overall","37","overall","Global state - number of participants with remission (separated time points)",3,0,0,TRUE,TRUE,"OR_cc","default_or"
"CD015331_pub2_data","38::overall","38","overall","Global state - number of participants with clinically important change in global state",2,0,0,TRUE,TRUE,"OR_cc","default_or"
"CD015331_pub2_data","44::overall","44","overall","Service use - admission to hospital (combined time points)",11,0,3,TRUE,TRUE,"RD","sparse_events"
"CD015331_pub2_data","45::overall","45","overall","Service use - admission to hospital (separated time points)",15,0,4,TRUE,TRUE,"RD","sparse_events"
"CD015331_pub2_data","48::overall","48","overall","Leaving the study early - for any reason - overall acceptability (combined time points)",27,1,6,TRUE,TRUE,"RD","double_zero"
"CD015331_pub2_data","49::overall","49","overall","Leaving the study early - for any reason - overall acceptability (separated time points)",51,3,11,TRUE,TRUE,"RD","double_zero"
"CD015331_pub2_data","66::overall","66","overall","Behaviour - occurence of violent incidents",2,0,2,TRUE,TRUE,"RD","sparse_events"
"CD015331_pub2_data","67::overall","67","overall","Behaviour - participants with self-injury",2,0,1,TRUE,TRUE,"RD","sparse_events"
"CD015331_pub2_data","68::overall","68","overall","Behaviour - participants with suicide attempts",3,0,3,TRUE,TRUE,"RD","sparse_events"
"CD015331_pub2_data","70::overall","70","overall","Adverse events - specific: Non Compliance",4,0,3,TRUE,TRUE,"RD","sparse_events"
"CD015331_pub2_data","71::overall","71","overall","Adverse events - specific: Deterioration of symptoms",7,0,6,TRUE,TRUE,"RD","sparse_events"
"CD015331_pub2_data","72::overall","72","overall","Mortality - overall mortality (combined time points)",5,0,4,TRUE,TRUE,"RD","sparse_events"
"CD015331_pub2_data","73::overall","73","overall","Mortality - overall mortality (separated time points)",5,0,4,TRUE,TRUE,"RD","sparse_events"
"CD015331_pub2_data","74::overall","74","overall","Mortality - due to natural causes",3,0,3,TRUE,TRUE,"RD","sparse_events"
"CD015331_pub2_data","75::overall","75","overall","Mortality - due to suicide",2,0,2,TRUE,TRUE,"RD","sparse_events"
"CD015332_pub2_data","2::overall","2","overall","Number of participants with clinically important change in general mental state (separated time points)",9,3,3,TRUE,TRUE,"RD","double_zero"
"CD015332_pub2_data","4::overall","4","overall","Mental state – specific: mean endpoint PANSS negative (high = poor)",11,7,7,TRUE,TRUE,"RD","double_zero"
"CD015332_pub2_data","7::overall","7","overall","Global state – number of participants with relapse/exacerbations of psychosis (separated time points)",12,7,12,TRUE,TRUE,"RD","double_zero"
"CD015332_pub2_data","8::overall","8","overall","Service use – readmission to hospital ",7,6,6,FALSE,TRUE,"RD","double_zero"
"CD015332_pub2_data","10::overall","10","overall","Leaving the study early – for any reason – overall acceptability (separated time points)",11,7,8,TRUE,TRUE,"RD","double_zero"
"CD015332_pub2_data","12::overall","12","overall","Behaviour – participants with suicide attempts ",8,3,8,TRUE,TRUE,"RD","double_zero"
"CD015332_pub2_data","13::overall","13","overall","Adverse events – deterioration of symptoms ",10,8,9,TRUE,TRUE,"RD","double_zero"
"CD015332_pub2_data","14::overall","14","overall","Adverse events – participants with serious adverse events",7,6,6,FALSE,TRUE,"RD","double_zero"
"CD015332_pub2_data","15::overall","15","overall","Mortality – overall mortality ",10,8,10,TRUE,TRUE,"RD","double_zero"
"CD015332_pub2_data","16::overall","16","overall","Mortality – mortality due to natural causes ",12,10,12,TRUE,TRUE,"RD","double_zero"
"CD015332_pub2_data","17::overall","17","overall","Quality of life – mean endpoint EQ-5D-5L (high = good)",6,3,6,TRUE,TRUE,"RD","double_zero"
"CD015332_pub2_data","19::overall","19","overall","Behaviour – violent incidents (separated time points)",4,3,4,FALSE,TRUE,"RD","double_zero"
"CD015332_pub2_data","20::overall","20","overall","Behaviour – self-injury (separated time points)",4,1,2,TRUE,TRUE,"RD","double_zero"
"CD015332_pub2_data","21::overall","21","overall","Behaviour – suicide attempts (separated time points)",2,1,2,FALSE,TRUE,"RD","double_zero"
"CD015332_pub2_data","22::overall","22","overall","Adverse events – participants with at least 1 adverse event",6,0,4,TRUE,TRUE,"RD","sparse_events"
"CD015332_pub2_data","23::overall","23","overall","Adverse events – participants with serious adverse events ",3,0,1,TRUE,TRUE,"RD","sparse_events"
"CD015332_pub2_data","24::overall","24","overall","Adverse events – deterioration of symptoms ",6,3,6,TRUE,TRUE,"RD","double_zero"
"CD015332_pub2_data","32::overall","32","overall","Behaviour – violent incidents (separated time points)",2,0,2,TRUE,TRUE,"RD","sparse_events"
"CD015332_pub2_data","33::overall","33","overall","Behaviour – self-injury (separated time points)",3,0,1,TRUE,TRUE,"RD","sparse_events"
"CD015332_pub2_data","35::overall","35","overall","Adverse events – participants with at least 1 adverse event (pooled time points)",2,0,0,TRUE,TRUE,"OR_cc","default_or"
"CD015332_pub2_data","36::overall","36","overall","Adverse events – participants with at least 1 adverse event (separated time points)",2,0,0,TRUE,TRUE,"OR_cc","default_or"
"CD015332_pub2_data","37::overall","37","overall","Adverse events – participants with serious adverse events (separated time points)",3,0,0,TRUE,TRUE,"OR_cc","default_or"
"CD015332_pub2_data","38::overall","38","overall","Adverse events – deterioration of symptoms (separated time points)",5,0,4,TRUE,TRUE,"RD","sparse_events"
"CD015350_pub2_data","2::overall","2","overall","Size of infiltrate",4,2,2,TRUE,TRUE,"RD","double_zero"
"CD015350_pub2_data","5::1","5","1","Proportion cured or with complete corneal healing",4,0,0,TRUE,TRUE,"OR_cc","default_or"
"CD015350_pub2_data","5::2","5","2","Proportion cured or with complete corneal healing",7,0,2,TRUE,TRUE,"RD","sparse_events"
"CD015350_pub2_data","6::1","6","1","Proportion with non-serious or non-severe harms/adverse events",6,1,3,TRUE,TRUE,"RD","double_zero"
"CD015350_pub2_data","6::2","6","2","Proportion with non-serious or non-severe harms/adverse events",7,1,3,TRUE,TRUE,"RD","double_zero"
"CD015350_pub2_data","7::overall","7","overall","Proportion with serious/severe harms/adverse events",5,3,4,TRUE,TRUE,"RD","double_zero"
"CD015350_pub2_data","4::1","4","1","Proportion cured or with complete ulcer healing",3,0,0,TRUE,TRUE,"OR_cc","default_or"
"CD015350_pub2_data","1::overall","1","overall","Days to healing",5,3,3,TRUE,TRUE,"RD","double_zero"
"CD015373_pub2_data","1::overall","1","overall","Pain intensity (continuous), immediate-term follow-up",4,2,2,TRUE,TRUE,"RD","double_zero"
"CD015373_pub2_data","3::overall","3","overall","Pain intensity (≥ 50% reduction), immediate-term follow-up",9,1,6,TRUE,TRUE,"RD","double_zero"
"CD015373_pub2_data","4::overall","4","overall","Pain intensity (continuous), short-term follow-up",7,0,4,TRUE,TRUE,"RD","sparse_events"
"CD015373_pub2_data","7::overall","7","overall","Pain intensity (≥ 50% reduction), short-term follow-up",7,0,5,TRUE,TRUE,"RD","sparse_events"
"CD015373_pub2_data","8::overall","8","overall","Pain intensity (continuous), medium-term follow-up",2,0,1,TRUE,TRUE,"RD","sparse_events"
"CD015373_pub2_data","9::overall","9","overall","Adverse events (total)",6,0,1,TRUE,TRUE,"RD","sparse_events"
"CD015373_pub2_data","10::1","10","1","Adverse events (total): clinical condition subgroup analysis",2,0,1,TRUE,TRUE,"RD","sparse_events"
"CD015373_pub2_data","11::2","11","2","Adverse events (total): duration of administration subgroup analysis",2,0,0,TRUE,TRUE,"OR_cc","default_or"
"CD015373_pub2_data","11::3","11","3","Adverse events (total): duration of administration subgroup analysis",3,0,1,TRUE,TRUE,"RD","sparse_events"
"CD015373_pub2_data","12::overall","12","overall","Psychotomimetic effects",3,1,2,TRUE,TRUE,"RD","double_zero"
"CD015373_pub2_data","13::overall","13","overall","Hallucinations",4,0,3,TRUE,TRUE,"RD","sparse_events"
"CD015373_pub2_data","14::overall","14","overall","Sedation",4,0,3,TRUE,TRUE,"RD","sparse_events"
"CD015373_pub2_data","15::overall","15","overall","Nausea",6,0,2,TRUE,TRUE,"RD","sparse_events"
"CD015373_pub2_data","16::overall","16","overall","Vomiting",4,0,1,TRUE,TRUE,"RD","sparse_events"
"CD015373_pub2_data","17::overall","17","overall","Dizziness",2,0,1,TRUE,TRUE,"RD","sparse_events"
"CD015373_pub2_data","18::overall","18","overall","Headache",2,0,1,TRUE,TRUE,"RD","sparse_events"
"CD015373_pub2_data","23::overall","23","overall","Tolerability",8,1,8,TRUE,TRUE,"RD","double_zero"
"CD015373_pub2_data","2::overall","2","overall","Ketamine versus ketorolac: serious adverse events",5,2,4,TRUE,TRUE,"RD","double_zero"
"CD015373_pub2_data","5::overall","5","overall","Nausea",4,0,2,TRUE,TRUE,"RD","sparse_events"
"CD015373_pub2_data","6::overall","6","overall","Dizziness",5,1,3,TRUE,TRUE,"RD","double_zero"
"CD015373_pub2_data","10::overall","10","overall","Adverse events (total)",3,0,0,TRUE,TRUE,"OR_cc","default_or"
"CD015373_pub2_data","11::4","11","4","Adverse events (total): duration of administration subgroup analysis",2,0,0,TRUE,TRUE,"OR_cc","default_or"
"CD015373_pub2_data","12::2","12","2","Adverse events (total): medicine dose subgroup analysis",2,0,0,TRUE,TRUE,"OR_cc","default_or"
"CD015387_pub2_data","1::overall","1","overall","Good functional outcome at the end of scheduled follow-up",35,2,4,TRUE,TRUE,"RD","double_zero"
"CD015387_pub2_data","2::overall","2","overall","Good functional outcome at the end of scheduled follow-up: sensitivity analysis of low risk of bias trials only",8,0,0,TRUE,TRUE,"OR_cc","default_or"
"CD015387_pub2_data","3::overall","3","overall","All-cause mortality at the end of scheduled follow-up",28,1,4,TRUE,TRUE,"RD","double_zero"
"CD015387_pub2_data","4::overall","4","overall","All-cause mortality at the end of scheduled follow-up: sensitivity analysis of low risk of bias trials only",20,1,4,TRUE,TRUE,"RD","double_zero"
"CD015387_pub2_data","5::overall","5","overall","Thirty-day case fatality",17,1,3,TRUE,TRUE,"RD","double_zero"
"CD015387_pub2_data","3::1","3","1","Good functional outcome at the end of scheduled follow-up: stratified by surgical approach",2,1,1,FALSE,TRUE,"RD","double_zero"
"CD015387_pub2_data","3::3","3","3","Good functional outcome at the end of scheduled follow-up: stratified by surgical approach",6,0,0,TRUE,TRUE,"OR_cc","default_or"
"CD015387_pub2_data","6::1","6","1","All-cause mortality at the end of scheduled follow-up: stratified by surgical approach",3,0,2,TRUE,TRUE,"RD","sparse_events"
"CD015387_pub2_data","6::2","6","2","All-cause mortality at the end of scheduled follow-up: stratified by surgical approach",10,1,2,TRUE,TRUE,"RD","double_zero"
"CD015387_pub2_data","7::overall","7","overall","Thirty-day case fatality",7,1,3,TRUE,TRUE,"RD","double_zero"
"CD015387_pub2_data","8::2","8","2","Thirty-day case fatality: stratified by surgical approach",5,1,2,TRUE,TRUE,"RD","double_zero"
"CD015395_pub3_data","1::overall","1","overall","All-cause mortality at day 28",2,0,0,TRUE,TRUE,"OR_cc","default_or"
"CD015395_pub3_data","2::overall","2","overall","Worsening of clinical status at day 28: admission to hospital or death",3,0,1,TRUE,TRUE,"RD","sparse_events"
"CD015395_pub3_data","3::overall","3","overall","Worsening of clinical status at day 28: admission to hospital or death (subgroup analysis based on age)",3,0,0,TRUE,TRUE,"OR_cc","default_or"
"CD015395_pub3_data","4::overall","4","overall","Worsening of clinical status at day 28: admission to hospital or death (subgroup analysis based on ethnicity)",5,0,1,TRUE,TRUE,"RD","sparse_events"
"CD015432_pub2_data","1::overall","1","overall","Pain intensity – as reported by the child, less than 2 hours postintervention",10,7,7,TRUE,TRUE,"RD","double_zero"
"CD015432_pub2_data","2::overall","2","overall","Pain intensity – as reported by the child, 2 hours to less than 24 hours postintervention",17,14,14,TRUE,TRUE,"RD","double_zero"
"CD015432_pub2_data","3::overall","3","overall","Pain intensity – as reported by the child, from 24 hours up to 7 days postintervention",14,12,12,TRUE,TRUE,"RD","double_zero"
"CD015432_pub2_data","4::overall","4","overall","Adverse events",7,4,4,TRUE,TRUE,"RD","double_zero"
"CD015432_pub2_data","6::overall","6","overall","Number of children who required rescue medication less than 2 hours postintervention",13,4,4,TRUE,TRUE,"RD","double_zero"
"CD015432_pub2_data","7::overall","7","overall","Number of children who required rescue medication 2 hours to less than 24 hours postintervention",14,6,6,TRUE,TRUE,"RD","double_zero"
"CD015432_pub2_data","8::overall","8","overall","Number of children who required rescue medication, from 24 hours up to 7 days",10,4,5,TRUE,TRUE,"RD","double_zero"
"CD015432_pub2_data","9::overall","9","overall","Opioid consumption, less than 2 hours postintervention",17,10,11,TRUE,TRUE,"RD","double_zero"
"CD015432_pub2_data","10::overall","10","overall","Opioid consumption, 2 hours to less than 24 hours postintervention",7,6,6,FALSE,TRUE,"RD","double_zero"
"CD015432_pub2_data","13::overall","13","overall","Nausea or vomiting ",13,2,4,TRUE,TRUE,"RD","double_zero"
"CD015432_pub2_data","14::overall","14","overall","Any bleeding, including gastrointestinal bleeding and oral bleeding",14,3,7,TRUE,TRUE,"RD","double_zero"
"CD015443_pub2_data","1::overall","1","overall","Relapse (12 months)",17,1,2,TRUE,TRUE,"RD","double_zero"
"CD015443_pub2_data","2::overall","2","overall","Relapse (24 months)",27,0,3,TRUE,TRUE,"RD","sparse_events"
"CD015443_pub2_data","3::overall","3","overall","Relapse (36 months)",5,0,0,TRUE,TRUE,"OR_cc","default_or"
"CD015443_pub2_data","4::overall","4","overall","Disability worsening (24 months)",12,0,0,TRUE,TRUE,"OR_cc","default_or"
"CD015443_pub2_data","5::overall","5","overall","Disability worsening (36 months)",7,0,0,TRUE,TRUE,"OR_cc","default_or"
"CD015443_pub2_data","10::overall","10","overall","Mortality",15,0,10,TRUE,TRUE,"RD","sparse_events"
"CD015462_pub2_data","1::overall","1","overall","All-cause mortality prior to hospital discharge",2,0,0,TRUE,TRUE,"OR_cc","default_or"
"CD015462_pub2_data","5::overall","5","overall","Bronchopulmonary dysplasia/chronic lung disease: defined as 28 days of oxygen exposure at 36 weeks' postmenstrual age",3,0,2,TRUE,TRUE,"RD","sparse_events"
"CD015462_pub2_data","7::overall","7","overall","Failure to extubate within one week of commencing treatment",2,1,2,FALSE,TRUE,"RD","double_zero"
"CD015462_pub2_data","8::overall","8","overall","Failed apnea reduction after two to seven days (less than 50% reduction in apnea), for infants treated for apnea",4,3,3,FALSE,TRUE,"RD","double_zero"
"CD015462_pub2_data","16::overall","16","overall","Necrotizing enterocolitis (proven = Bell stage 2 or greater)",2,0,1,TRUE,TRUE,"RD","sparse_events"
"CD015462_pub2_data","17::overall","17","overall","Patent ductus arteriosus (PDA) requiring treatment (cyclo-oxygenase inhibitors or surgical ligation)",2,0,0,TRUE,TRUE,"OR_cc","default_or"
"CD015462_pub2_data","18::overall","18","overall","Retinopathy of prematurity (ROP) (any ROP; and severe ROP [stage 3 or greater])",2,0,1,TRUE,TRUE,"RD","sparse_events"
"CD015476_pub2_data","1::overall","1","overall","Adenoma detection rate",27,0,0,TRUE,TRUE,"OR_cc","default_or"
"CD015476_pub2_data","2::overall","2","overall","Sessile serrated lesion detection rate",7,0,1,TRUE,TRUE,"RD","sparse_events"
"CD015476_pub2_data","1::1","1","1","Adenoma detection rate between LASEREO and ELUXEO",6,0,0,TRUE,TRUE,"OR_cc","default_or"
"CD015476_pub2_data","1::2","1","2","Adenoma detection rate between LASEREO and ELUXEO",3,0,0,TRUE,TRUE,"OR_cc","default_or"
"CD015476_pub2_data","2::1","2","1","Adenoma detection rate between pre-2020 and post-2020",5,0,0,TRUE,TRUE,"OR_cc","default_or"
"CD015476_pub2_data","2::2","2","2","Adenoma detection rate between pre-2020 and post-2020",10,0,0,TRUE,TRUE,"OR_cc","default_or"
"CD015476_pub2_data","3::1","3","1","Adenoma detection rate between lesions <10 mm and ≥10 mm",3,0,0,TRUE,TRUE,"OR_cc","default_or"
"CD015476_pub2_data","3::2","3","2","Adenoma detection rate between lesions <10 mm and ≥10 mm",3,0,0,TRUE,TRUE,"OR_cc","default_or"
"CD015476_pub2_data","4::1","4","1","Adenoma detection rate between Western countries and Asia",3,0,0,TRUE,TRUE,"OR_cc","default_or"
"CD015476_pub2_data","4::2","4","2","Adenoma detection rate between Western countries and Asia",10,0,0,TRUE,TRUE,"OR_cc","default_or"
"CD015476_pub2_data","5::1","5","1","Adenoma detection rate between experienced colonoscopists and trainees",6,0,0,TRUE,TRUE,"OR_cc","default_or"
"CD015476_pub2_data","6::overall","6","overall","Adenoma detection rate excluding studies with a high overall risk of bias",12,0,0,TRUE,TRUE,"OR_cc","default_or"
"CD015476_pub2_data","7::overall","7","overall","Polyp detection rate excluding studies with a high overall risk of bias",9,0,0,TRUE,TRUE,"OR_cc","default_or"
"CD015476_pub2_data","10::overall","10","overall","Adenoma detection rate excluding studies that included patients with Lynch syndrome",14,0,0,TRUE,TRUE,"OR_cc","default_or"
"CD015476_pub2_data","11::overall","11","overall","Polyp detection rate excluding studies that included patients with Lynch syndrome",11,0,0,TRUE,TRUE,"OR_cc","default_or"
"CD015476_pub2_data","12::overall","12","overall","Serrated adenoma detection rate excluding studies that included patients with Lynch syndrome",6,0,1,TRUE,TRUE,"RD","sparse_events"
"CD015495_data","1::overall","1","overall","Overall survival (hazard ratio) in people aged 65 years and older, at any time point",18,15,15,TRUE,TRUE,"RD","double_zero"
"CD015495_data","2::overall","2","overall","Overall survival (hazard ratio) in people aged 65 to 75 years, inclusive, at any time point",16,14,14,TRUE,TRUE,"RD","double_zero"
"CD015514_pub2_data","2::overall","2","overall","Proportion of eyes with retinal displacement within 3 months",2,0,0,TRUE,TRUE,"OR_cc","default_or"
"CD015514_pub2_data","7::overall","7","overall","Adverse events - outer retinal folds",3,0,0,TRUE,TRUE,"OR_cc","default_or"
"CD015514_pub2_data","8::overall","8","overall","Adverse events - binocular diplopia and elevated intraocular pressure at 6 months",2,0,0,TRUE,TRUE,"OR_cc","default_or"
"CD015517_data","5::overall","5","overall","QoL at greater than 12 weeks to less than 6 months after the intervention",14,13,13,FALSE,TRUE,"RD","double_zero"
"CD015519_pub2_data","9::overall","9","overall","Adverse events  ≥ 6 months",2,1,2,FALSE,TRUE,"RD","double_zero"
"CD015524_pub2_data","1::overall","1","overall","Analysis 1.1. Outcome 1: Proportion of participants with serious adverse events",10,9,9,FALSE,TRUE,"RD","double_zero"
"CD015524_pub2_data","2::overall","2","overall","Analysis 1.2. Outcome 1: Proportion of participants with serious adverse events: sensitivity analysis ‘best-worst’ case scenario",11,8,8,TRUE,TRUE,"RD","double_zero"
"CD015524_pub2_data","3::overall","3","overall","Analysis 1.3. Outcome 1: Proportion of participants with serious adverse events: sensitivity analysis ‘worst-best’ case scenario",11,8,9,TRUE,TRUE,"RD","double_zero"
"CD015524_pub2_data","5::overall","5","overall","Analysis 1.5. Outcome 2: ALT (U/L): sensitivity analysis fixed-effect model",17,15,15,TRUE,TRUE,"RD","double_zero"
"CD015524_pub2_data","7::overall","7","overall","Analysis 1.7. Outcome 4: GGT (U/L)",9,8,9,FALSE,TRUE,"RD","double_zero"
"CD015524_pub2_data","8::overall","8","overall","Analysis 1.8. Outcome 5: Proportion of participants with non-serious adverse events",14,10,10,TRUE,TRUE,"RD","double_zero"
"CD015524_pub2_data","9::overall","9","overall","Analysis 1.9. Outcome 5: Proportion of participants with non-serious adverse events: sensitivity analysis on trials at ‘low’ risk of bias",12,9,9,TRUE,TRUE,"RD","double_zero"
"CD015524_pub2_data","10::overall","10","overall","Analysis 1.10. Outcome 5: Proportion of participants with non-serious adverse events: sensitivity analysis fixed-effect model",12,7,7,TRUE,TRUE,"RD","double_zero"
"CD015524_pub2_data","11::overall","11","overall","Analysis 1.11. Outcome 5: Proportion of participants with non-serious adverse events: sensitivity analysis ‘best-worst’ case scenario",11,5,5,TRUE,TRUE,"RD","double_zero"
"CD015524_pub2_data","12::overall","12","overall","Analysis 1.12. Outcome 5: Proportion of participants with non-serious adverse events: sensitivity analysis ‘worst-best’ case scenario",9,3,4,TRUE,TRUE,"RD","double_zero"
"CD015524_pub2_data","13::overall","13","overall","Analysis 1.13. Outcome 6: Proportion of participants without improvement of steatosis",6,2,2,TRUE,TRUE,"RD","double_zero"
"CD015524_pub2_data","14::overall","14","overall","Analysis 1.14. Outcome 6: Proportion of participants without improvement of steatosis: sensitivity analysis fixed-effect model",8,5,5,TRUE,TRUE,"RD","double_zero"
"CD015524_pub2_data","15::overall","15","overall","Analysis 1.15. Outcome 7: Proportion of participants without improvement of lobular inflammation",8,5,5,TRUE,TRUE,"RD","double_zero"
"CD015524_pub2_data","16::overall","16","overall","Analysis 1.16. Outcome 7: Proportion of participants without improvement of lobular inflammation: sensitivity analysis fixed-effect model",9,6,6,TRUE,TRUE,"RD","double_zero"
"CD015524_pub2_data","17::overall","17","overall","Analysis 1.17. Outcome 8: Proportion of participants without improvement of hepatocyte ballooning",9,6,6,TRUE,TRUE,"RD","double_zero"
"CD015524_pub2_data","18::overall","18","overall","Analysis 1.18. Outcome 8: Proportion of participants without improvement of hepatocyte ballooning: sensitivity analysis fixed-effect model",8,5,5,TRUE,TRUE,"RD","double_zero"
"CD015524_pub2_data","19::overall","19","overall","Analysis 1.19. Outcome 9: Proportion of participants without improvement of NAS",5,2,2,TRUE,TRUE,"RD","double_zero"
"CD015524_pub2_data","20::overall","20","overall","Analysis 1.20. Outcome 9: Proportion of participants without improvement of NAS: sensitivity analysis fixed-effect model",5,2,2,TRUE,TRUE,"RD","double_zero"
"CD015524_pub2_data","21::overall","21","overall","Analysis 1.21. Outcome 10: Proportion of participants without improvement of fibrosis",5,2,2,TRUE,TRUE,"RD","double_zero"
"CD015524_pub2_data","22::overall","22","overall","Analysis 1.22. Outcome 10: Proportion of participants without improvement of fibrosis: sensitivity analysis fixed-effect model",8,5,5,TRUE,TRUE,"RD","double_zero"
"CD015524_pub2_data","23::overall","23","overall","Analysis 1.23. Outcome 11: Proportion of participants without normalisation of ALT",7,5,5,TRUE,TRUE,"RD","double_zero"
"CD015524_pub2_data","24::overall","24","overall","Analysis 1.24. Outcome 12: Proportion of participants without normalisation of AST",6,4,4,TRUE,TRUE,"RD","double_zero"
"CD015524_pub2_data","25::overall","25","overall","Analysis 1.25. Outcome 13: Proportion of participants without improvement of LSM",5,4,4,FALSE,TRUE,"RD","double_zero"
"CD015526_pub2_data","1::overall","1","overall","Dialysis dysequilibrium syndrome",2,1,1,FALSE,TRUE,"RD","double_zero"
"CD015526_pub2_data","2::overall","2","overall","Severe dialysis dysequilibrium syndrome",2,1,2,FALSE,TRUE,"RD","double_zero"
"CD015526_pub2_data","4::overall","4","overall","Adverse events",2,0,1,TRUE,TRUE,"RD","sparse_events"
"CD015530_pub2_data","1::overall","1","overall","Incidence of herpes zoster (up to 21 months after final dose)",5,0,1,TRUE,TRUE,"RD","sparse_events"
"CD015530_pub2_data","2::overall","2","overall","All-cause mortality (up to 28 days after final dose)",2,0,0,TRUE,TRUE,"OR_cc","default_or"
"CD015530_pub2_data","3::overall","3","overall","Adverse events of any grade (up to 30 days after final dose)",3,0,0,TRUE,TRUE,"OR_cc","default_or"
"CD015530_pub2_data","5::overall","5","overall","Serious adverse events (up to 30 days after final dose)",2,0,0,TRUE,TRUE,"OR_cc","default_or"
"CD015532_data","1::overall","1","overall","Overall mortality",22,0,0,TRUE,TRUE,"OR_cc","default_or"
"CD015532_data","2::overall","2","overall","Duration to liberation from invasive mechanical ventilation",14,3,3,TRUE,TRUE,"RD","double_zero"
"CD015532_data","3::overall","3","overall","Adverse events",11,0,0,TRUE,TRUE,"OR_cc","default_or"
"CD015532_data","4::overall","4","overall","Ventilator-associated pneumonia",13,2,3,TRUE,TRUE,"RD","double_zero"
"CD015532_data","5::overall","5","overall","Postoperative bleeding",10,7,7,TRUE,TRUE,"RD","double_zero"
"CD015532_data","6::overall","6","overall","Airway obstruction",11,8,8,TRUE,TRUE,"RD","double_zero"
"CD015532_data","7::overall","7","overall","ICU length of stay",13,3,3,TRUE,TRUE,"RD","double_zero"
"CD015532_data","8::overall","8","overall","Tracheal stenosis",6,5,6,FALSE,TRUE,"RD","double_zero"
"CD015532_data","9::overall","9","overall","Ventilatory problems",5,0,0,TRUE,TRUE,"OR_cc","default_or"
"CD015532_data","10::overall","10","overall","Need for renal replacement therapy",6,0,2,TRUE,TRUE,"RD","sparse_events"
"CD015532_data","11::overall","11","overall","Postoperative bleeding",3,0,0,TRUE,TRUE,"OR_cc","default_or"
"CD015532_data","12::overall","12","overall","Need for ECMO",8,0,1,TRUE,TRUE,"RD","sparse_events"
"CD015532_data","13::overall","13","overall","Ventilatory problems",2,0,0,TRUE,TRUE,"OR_cc","default_or"
"CD015532_data","14::overall","14","overall","ICU length of stay",3,1,3,TRUE,TRUE,"RD","double_zero"
"CD015532_data","15::overall","15","overall","Hospital length of stay",4,1,3,TRUE,TRUE,"RD","double_zero"
"CD015532_data","16::overall","16","overall","Ventilatory problems",2,0,0,TRUE,TRUE,"OR_cc","default_or"
"CD015536_pub2_data","1::overall","1","overall","All-cause mortality",20,19,20,FALSE,TRUE,"RD","double_zero"
"CD015536_pub2_data","2::overall","2","overall","Proportion of people with serious adverse events",25,14,17,TRUE,TRUE,"RD","double_zero"
"CD015536_pub2_data","3::overall","3","overall","Mortality due to hepatitis B-related liver disease",11,10,10,FALSE,TRUE,"RD","double_zero"
"CD015536_pub2_data","4::overall","4","overall","Proportion of people with non-serious adverse events",13,1,1,TRUE,TRUE,"RD","double_zero"
"CD015536_pub2_data","5::overall","5","overall","Proportion of people without histological improvement",4,2,2,TRUE,TRUE,"RD","double_zero"
"CD015536_pub2_data","6::overall","6","overall","Proportion of people with detectable HBsAg",23,5,7,TRUE,TRUE,"RD","double_zero"
"CD015536_pub2_data","7::overall","7","overall","Proportion of people with detectable HBV-DNA",30,5,8,TRUE,TRUE,"RD","double_zero"
"CD015536_pub2_data","8::overall","8","overall","Proportion of people with detectable HBeAg",21,4,6,TRUE,TRUE,"RD","double_zero"
"CD015536_pub2_data","9::overall","9","overall","Proportion of people without HBeAg seroconversion",24,4,6,TRUE,TRUE,"RD","double_zero"
"CD015536_pub2_data","10::overall","10","overall","Proportion of people without normalisation of transaminases",25,4,6,TRUE,TRUE,"RD","double_zero"
"CD015536_pub2_data","1::2","1","2","Proportion of people with serious adverse events (risk of bias)",2,0,2,TRUE,TRUE,"RD","sparse_events"
"CD015536_pub2_data","1::3","1","3","Proportion of people with serious adverse events (risk of bias)",12,5,5,TRUE,TRUE,"RD","double_zero"
"CD015536_pub2_data","2::2","2","2","Proportion of people with serious adverse events (age of participants)",13,4,6,TRUE,TRUE,"RD","double_zero"
"CD015536_pub2_data","3::1","3","1","Proportion of people with serious adverse events (history of treatment with other antivirals)",3,1,1,TRUE,TRUE,"RD","double_zero"
"CD015536_pub2_data","3::2","3","2","Proportion of people with serious adverse events (history of treatment with other antivirals)",4,1,2,TRUE,TRUE,"RD","double_zero"
"CD015536_pub2_data","4::1","4","1","Proportion of people with serious adverse events (co-interventions)",10,3,4,TRUE,TRUE,"RD","double_zero"
"CD015536_pub2_data","4::2","4","2","Proportion of people with serious adverse events (co-interventions)",5,2,3,TRUE,TRUE,"RD","double_zero"
"CD015551_pub2_data","1::overall","1","overall","Incidence of herpes zoster (up to 29.4 months after final dose)",5,0,1,TRUE,TRUE,"RD","sparse_events"
"CD015551_pub2_data","2::overall","2","overall","All-cause mortality (up to 28 days after final dose)",5,0,1,TRUE,TRUE,"RD","sparse_events"
"CD015551_pub2_data","3::overall","3","overall","Any-grade adverse events (up to 30 days after final dose)",6,0,0,TRUE,TRUE,"OR_cc","default_or"
"CD015551_pub2_data","4::overall","4","overall","Serious adverse events (up to 30 days after final dose)",4,0,0,TRUE,TRUE,"OR_cc","default_or"
"CD015551_pub2_data","5::overall","5","overall","Localised events at the injection site (up to 30 days after final dose)",3,0,0,TRUE,TRUE,"OR_cc","default_or"
"CD015551_pub2_data","6::overall","6","overall","Systemic events (up to 30 days after final dose)",3,0,1,TRUE,TRUE,"RD","sparse_events"
"CD015573_data","1::overall","1","overall","Recurrence",2,0,2,TRUE,TRUE,"RD","sparse_events"
"CD015573_data","2::overall","2","overall","Minor complications of treatment",5,0,2,TRUE,TRUE,"RD","sparse_events"
"CD015584_pub2_data","1::overall","1","overall","Pain: during tenaculum placement",9,4,6,TRUE,TRUE,"RD","double_zero"
"CD015584_pub2_data","2::overall","2","overall","Pain: during intrauterine device placement",15,8,11,TRUE,TRUE,"RD","double_zero"
"CD015584_pub2_data","4::overall","4","overall","Providers' ease of placement",16,8,8,TRUE,TRUE,"RD","double_zero"
"CD015584_pub2_data","5::1","5","1","Need for adjunctive placement measures: cervical dilation",6,1,4,TRUE,TRUE,"RD","double_zero"
"CD015584_pub2_data","6::1","6","1","Placement success",12,0,0,TRUE,TRUE,"OR_cc","default_or"
"CD015584_pub2_data","8::overall","8","overall","Misoprostol side effects occurring before clinic discharge: preplacement abdominal pain or cramping",7,0,1,TRUE,TRUE,"RD","sparse_events"
"CD015584_pub2_data","9::overall","9","overall","Misoprostol side effects occurring before clinic discharge: diarrhea",9,1,5,TRUE,TRUE,"RD","double_zero"
"CD015584_pub2_data","10::overall","10","overall","Adverse events occurring before clinic discharge: vasovagal reaction",6,3,4,TRUE,TRUE,"RD","double_zero"
"CD015584_pub2_data","5::overall","5","overall","Misoprostol side effects occurring before clinic discharge: vomiting",6,1,5,TRUE,TRUE,"RD","double_zero"
"CD015584_pub2_data","1::1","1","1","Placement success (restricted to studies with low overall risk of bias)",11,0,0,TRUE,TRUE,"OR_cc","default_or"
"CD015588_pub2_data","1::overall","1","overall","All-cause death",30,13,17,TRUE,TRUE,"RD","double_zero"
"CD015588_pub2_data","2::overall","2","overall","All-cause death (Hazard Ratio)",20,19,20,FALSE,TRUE,"RD","double_zero"
"CD015588_pub2_data","3::overall","3","overall","Cardiovascular death",25,9,12,TRUE,TRUE,"RD","double_zero"
"CD015588_pub2_data","4::overall","4","overall","Cardiovascular death (Hazard Ratio)",17,15,16,TRUE,TRUE,"RD","double_zero"
"CD015588_pub2_data","5::overall","5","overall","Myocardial infarction",5,2,3,TRUE,TRUE,"RD","double_zero"
"CD015588_pub2_data","6::overall","6","overall","Myocardial infarction (Hazard Ratio)",9,7,7,TRUE,TRUE,"RD","double_zero"
"CD015588_pub2_data","7::overall","7","overall","Nonfatal myocardial infarction",5,1,3,TRUE,TRUE,"RD","double_zero"
"CD015588_pub2_data","10::overall","10","overall","Fatal or nonfatal myocardial infarction",3,0,0,TRUE,TRUE,"OR_cc","default_or"
"CD015588_pub2_data","12::overall","12","overall","Stroke",2,0,0,TRUE,TRUE,"OR_cc","default_or"
"CD015588_pub2_data","14::overall","14","overall","Nonfatal stroke",2,0,1,TRUE,TRUE,"RD","sparse_events"
"CD015588_pub2_data","16::overall","16","overall","Fatal or nonfatal stroke",3,0,0,TRUE,TRUE,"OR_cc","default_or"
"CD015588_pub2_data","18::overall","18","overall","Kidney failure",6,1,3,TRUE,TRUE,"RD","double_zero"
"CD015588_pub2_data","20::overall","20","overall","3P-MACE",10,0,1,TRUE,TRUE,"RD","sparse_events"
"CD015588_pub2_data","22::overall","22","overall","4P-MACE",4,0,0,TRUE,TRUE,"OR_cc","default_or"
"CD015588_pub2_data","26::overall","26","overall","Hospital admission for heart failure",9,0,0,TRUE,TRUE,"OR_cc","default_or"
"CD015588_pub2_data","31::overall","31","overall","Doubling of serum creatinine",2,0,0,TRUE,TRUE,"OR_cc","default_or"
"CD015588_pub2_data","33::overall","33","overall","Kidney composite outcome",8,0,0,TRUE,TRUE,"OR_cc","default_or"
"CD015588_pub2_data","42::overall","42","overall","Hypoglycaemia",18,3,5,TRUE,TRUE,"RD","double_zero"
"CD015588_pub2_data","44::overall","44","overall","Hypoglycaemia requiring third-party assistance",17,7,10,TRUE,TRUE,"RD","double_zero"
"CD015588_pub2_data","47::overall","47","overall","Withdrawn due to adverse events",17,1,3,TRUE,TRUE,"RD","double_zero"
"CD015588_pub2_data","49::overall","49","overall","Amputation",8,1,4,TRUE,TRUE,"RD","double_zero"
"CD015588_pub2_data","51::overall","51","overall","Fracture",16,1,2,TRUE,TRUE,"RD","double_zero"
"CD015588_pub2_data","53::overall","53","overall","Genital infection",16,0,4,TRUE,TRUE,"RD","sparse_events"
"CD015588_pub2_data","55::overall","55","overall","Diabetic ketoacidosis",14,4,8,TRUE,TRUE,"RD","double_zero"
"CD015592_pub3_data","1::overall","1","overall","Successful lumbar puncture procedure at the first attempt",3,0,0,TRUE,TRUE,"OR_cc","default_or"
"CD015592_pub3_data","2::overall","2","overall","Episodes of bradycardia",3,2,2,FALSE,TRUE,"RD","double_zero"
"CD015592_pub3_data","4::overall","4","overall","Episodes of desaturation (decrease of SpO2 to less than 80%)",2,1,1,FALSE,TRUE,"RD","double_zero"
"CD015594_pub2_data","3::overall","3","overall","Adverse events",2,1,1,FALSE,TRUE,"RD","double_zero"
"CD015673_pub2_data","1::overall","1","overall","Number of participants with continuous abstinence",8,0,0,TRUE,TRUE,"OR_cc","default_or"
"CD015673_pub2_data","2::overall","2","overall","Number of heavy-drinking participants",10,1,1,TRUE,TRUE,"RD","double_zero"
"CD015673_pub2_data","3::overall","3","overall","% Abstinent days",14,12,12,TRUE,TRUE,"RD","double_zero"
"CD015673_pub2_data","4::overall","4","overall","% Heavy-drinking days",6,5,5,FALSE,TRUE,"RD","double_zero"
"CD015673_pub2_data","5::overall","5","overall","Number of drinks per drinking day",10,7,7,TRUE,TRUE,"RD","double_zero"
"CD015673_pub2_data","6::overall","6","overall","Adverse events",6,0,0,TRUE,TRUE,"OR_cc","default_or"
"CD015673_pub2_data","7::overall","7","overall","Serious adverse events",4,2,3,TRUE,TRUE,"RD","double_zero"
"CD015673_pub2_data","8::overall","8","overall","Dropouts",15,1,2,TRUE,TRUE,"RD","double_zero"
"CD015673_pub2_data","9::overall","9","overall","Dropouts due to adverse events",8,2,6,TRUE,TRUE,"RD","double_zero"
"CD015698_pub2_data","5::1","5","1","Anastomotic leakage (Subgroup analysis: IPC Types)",3,1,2,TRUE,TRUE,"RD","double_zero"
"CD015698_pub2_data","6::overall","6","overall","Intra-abdominal abscess",2,0,2,TRUE,TRUE,"RD","sparse_events"
"CD015698_pub2_data","5::overall","5","overall","Anastomotic leakage",2,0,2,TRUE,TRUE,"RD","sparse_events"
"CD015701_pub2_data","2::overall","2","overall","Pregnancy",4,0,1,TRUE,TRUE,"RD","sparse_events"
"CD015701_pub2_data","3::overall","3","overall","Discontinuation of method",3,0,0,TRUE,TRUE,"OR_cc","default_or"
"CD015701_pub2_data","5::overall","5","overall","Adverse events",3,0,0,TRUE,TRUE,"OR_cc","default_or"
"CD015701_pub2_data","1::overall","1","overall","HIV acquisition",3,0,0,TRUE,TRUE,"OR_cc","default_or"
"CD015711_pub2_data","1::overall","1","overall","Spectacle independence for near vision",3,1,1,TRUE,TRUE,"RD","double_zero"
"CD015711_pub2_data","2::overall","2","overall","Spectacle independence for intermediate vision",2,0,0,TRUE,TRUE,"OR_cc","default_or"
"CD015711_pub2_data","3::overall","3","overall","Proportion of overall patient satisfaction with the procedure and its results",2,0,0,TRUE,TRUE,"OR_cc","default_or"
"CD015711_pub2_data","4::overall","4","overall","Frequency of any ocular AE",2,0,0,TRUE,TRUE,"OR_cc","default_or"
"CD015711_pub2_data","5::overall","5","overall","Proportion of participants who required further procedures",2,0,1,TRUE,TRUE,"RD","sparse_events"
"CD015721_pub2_data","1::overall","1","overall","Functional independence: mRS score < 3 within 90 days",6,0,0,TRUE,TRUE,"OR_cc","default_or"
"CD015721_pub2_data","2::overall","2","overall","Excellent functional outcome: mRS score < 2 within 90 days",6,0,0,TRUE,TRUE,"OR_cc","default_or"
"CD015721_pub2_data","3::overall","3","overall","Mortality within 90 days",6,0,0,TRUE,TRUE,"OR_cc","default_or"
"CD015721_pub2_data","4::overall","4","overall","Asymptomatic intracranial haemorrhage within 90 days",6,0,0,TRUE,TRUE,"OR_cc","default_or"
"CD015721_pub2_data","5::overall","5","overall","Symptomatic intracranial haemorrhage within 90 days",6,0,1,TRUE,TRUE,"RD","sparse_events"
"CD015721_pub2_data","6::overall","6","overall","Successful revascularisation: TICI grades 2b to 3",6,0,0,TRUE,TRUE,"OR_cc","default_or"
"CD015721_pub2_data","7::overall","7","overall","Complete revascularisation: TICI grade 3",5,0,0,TRUE,TRUE,"OR_cc","default_or"
"CD015746_pub2_data","1::1","1","1","Acute typhoid fever",7,0,2,TRUE,TRUE,"RD","sparse_events"
"CD015746_pub2_data","1::2","1","2","Acute typhoid fever",5,0,1,TRUE,TRUE,"RD","sparse_events"
"CD015746_pub2_data","1::3","1","3","Acute typhoid fever",5,0,0,TRUE,TRUE,"OR_cc","default_or"
"CD015746_pub2_data","1::4","1","4","Acute typhoid fever",2,0,0,TRUE,TRUE,"OR_cc","default_or"
"CD015746_pub2_data","2::1","2","1","All-cause mortality",8,0,0,TRUE,TRUE,"OR_cc","default_or"
"CD015746_pub2_data","2::2","2","2","All-cause mortality",9,0,0,TRUE,TRUE,"OR_cc","default_or"
"CD015746_pub2_data","2::3","2","3","All-cause mortality",3,0,0,TRUE,TRUE,"OR_cc","default_or"
"CD015746_pub2_data","3::1","3","1","Adverse events",6,0,2,TRUE,TRUE,"RD","sparse_events"
"CD015746_pub2_data","3::2","3","2","Adverse events",4,0,3,TRUE,TRUE,"RD","sparse_events"
"CD015746_pub2_data","4::1","4","1","Serious adverse events",2,0,0,TRUE,TRUE,"OR_cc","default_or"
"CD015746_pub2_data","4::2","4","2","Serious adverse events",2,0,2,TRUE,TRUE,"RD","sparse_events"
"CD015746_pub2_data","4::3","4","3","Serious adverse events",5,0,1,TRUE,TRUE,"RD","sparse_events"
"CD015746_pub2_data","4::4","4","4","Serious adverse events",2,0,0,TRUE,TRUE,"OR_cc","default_or"
"CD015749_pub2_data","2::overall","2","overall","Occurrence of adverse events",6,0,1,TRUE,TRUE,"RD","sparse_events"
"CD015751_pub2_data","2::overall","2","overall","Corneal fluorescein staining",12,9,11,TRUE,TRUE,"RD","double_zero"
"CD015751_pub2_data","4::overall","4","overall","Participant discontinuation",2,0,2,TRUE,TRUE,"RD","sparse_events"
"CD015779_data","1::overall","1","overall","Recurrence of rheumatic fever",8,0,5,TRUE,TRUE,"RD","sparse_events"
"CD015779_data","3::overall","3","overall","Progression of rheumatic heart disease (late-stage RHD)",2,0,0,TRUE,TRUE,"OR_cc","default_or"
"CD015779_data","4::overall","4","overall","Cardiac complications",2,0,1,TRUE,TRUE,"RD","sparse_events"
"CD015779_data","5::overall","5","overall","All-cause mortality (latent RHD)",3,0,1,TRUE,TRUE,"RD","sparse_events"
"CD015779_data","9::overall","9","overall","Adverse events: delayed hypersensitivity or allergic reaction",2,1,1,FALSE,TRUE,"RD","double_zero"
"CD015786_pub2_data","1::1","1","1","Overall survival",3,2,2,FALSE,TRUE,"RD","double_zero"
"CD015786_pub2_data","1::2","1","2","Overall survival",3,2,3,FALSE,TRUE,"RD","double_zero"
"CD015786_pub2_data","2::1","2","1","Progression (disease)-free survival",3,2,2,FALSE,TRUE,"RD","double_zero"
"CD015786_pub2_data","3::1","3","1","Early adverse effects",3,0,0,TRUE,TRUE,"OR_cc","default_or"
"CD015786_pub2_data","3::2","3","2","Early adverse effects",3,0,1,TRUE,TRUE,"RD","sparse_events"
"CD015786_pub2_data","3::3","3","3","Early adverse effects",2,0,0,TRUE,TRUE,"OR_cc","default_or"
"CD015786_pub2_data","4::1","4","1","Late adverse effects",3,0,1,TRUE,TRUE,"RD","sparse_events"
"CD015786_pub2_data","5::overall","5","overall","Surgically related mortality ",2,1,1,FALSE,TRUE,"RD","double_zero"
"CD015788_pub2_data","3::2","3","2","Proportion of participants who were adherent",2,0,0,TRUE,TRUE,"OR_cc","default_or"
"CD015788_pub2_data","3::5","3","5","Proportion of participants who were adherent",2,0,0,TRUE,TRUE,"OR_cc","default_or"
"CD015790_pub2_data","5::overall","5","overall","Proportion of participants who experienced any adverse events",2,0,0,TRUE,TRUE,"OR_cc","default_or"
"CD015802_pub2_data","1::overall","1","overall","Intermittent hypoxemia (IH): number of episodes in the 7 days after treatment discontinued",3,1,1,TRUE,TRUE,"RD","double_zero"
"CD015802_pub2_data","2::overall","2","overall","All-cause mortality prior to hospital discharge",2,1,1,FALSE,TRUE,"RD","double_zero"
"CD015802_pub2_data","3::overall","3","overall","All-cause mortality prior to hospital discharge",2,0,2,TRUE,TRUE,"RD","sparse_events"
"CD015804_pub2_data","2::overall","2","overall","Proportion of participants who lost fewer than 15 letters in BCVA from baseline at 24 to 48 weeks",7,0,0,TRUE,TRUE,"OR_cc","default_or"
"CD015804_pub2_data","3::overall","3","overall","Proportion of participants who experienced at least one serious ocular adverse event (AE) during the study period",7,1,3,TRUE,TRUE,"RD","double_zero"
"CD015804_pub2_data","7::overall","7","overall","Proportion of participants who experienced at least one serious non-ocular AE during the study period",7,0,1,TRUE,TRUE,"RD","sparse_events"
"CD015804_pub2_data","8::overall","8","overall","Proportion of participants who experienced TEAEs during the study period",8,0,0,TRUE,TRUE,"OR_cc","default_or"
"CD015804_pub2_data","9::overall","9","overall","Proportion of participants who experienced TEAEs leading to investigational product discontinuation or death",8,1,3,TRUE,TRUE,"RD","double_zero"
"CD015804_pub2_data","10::overall","10","overall","The cumulative incidence of antidrug antibodies (ADAs) during the study period",8,1,3,TRUE,TRUE,"RD","double_zero"
"CD015820_pub2_data","3::overall","3","overall","Subjective adherence (3 to 6 months) - 8‐Item Medication Adherence Scale self-reported questionnaire",7,6,6,FALSE,TRUE,"RD","double_zero"
"CD015820_pub2_data","4::overall","4","overall","Total hours of adherence (Baseline to 3 months)",3,2,2,FALSE,TRUE,"RD","double_zero"
"CD015820_pub2_data","6::overall","6","overall","Visual acuity > 4 months - Proportion of participants with significant change",5,0,1,TRUE,TRUE,"RD","sparse_events"
"CD015824_pub2_data","1::1","1","1","Clinical worsening",3,0,0,TRUE,TRUE,"OR_cc","default_or"
"CD015824_pub2_data","1::2","1","2","Clinical worsening",4,0,0,TRUE,TRUE,"OR_cc","default_or"
"CD015824_pub2_data","1::3","1","3","Clinical worsening",2,0,0,TRUE,TRUE,"OR_cc","default_or"
"CD015824_pub2_data","2::1","2","1","Mortality",3,0,1,TRUE,TRUE,"RD","sparse_events"
"CD015824_pub2_data","2::2","2","2","Mortality",4,0,3,TRUE,TRUE,"RD","sparse_events"
"CD015824_pub2_data","3::1","3","1","Hospitalisation",2,0,1,TRUE,TRUE,"RD","sparse_events"
"CD015824_pub2_data","6::1","6","1","Worsening in World Health Organization functional class ",3,0,0,TRUE,TRUE,"OR_cc","default_or"
"CD015824_pub2_data","6::2","6","2","Worsening in World Health Organization functional class ",5,0,1,TRUE,TRUE,"RD","sparse_events"
"CD015824_pub2_data","8::1","8","1","Serious adverse events",2,0,0,TRUE,TRUE,"OR_cc","default_or"
"CD015824_pub2_data","8::2","8","2","Serious adverse events",3,0,0,TRUE,TRUE,"OR_cc","default_or"
"CD015824_pub2_data","9::1","9","1","Withdrawal from the trial",3,0,0,TRUE,TRUE,"OR_cc","default_or"
"CD015824_pub2_data","9::2","9","2","Withdrawal from the trial",3,0,0,TRUE,TRUE,"OR_cc","default_or"
"CD015824_pub2_data","3::overall","3","overall","Hospitalisation",3,0,1,TRUE,TRUE,"RD","sparse_events"
"CD015824_pub2_data","1::overall","1","overall","Clinical worsening",3,0,0,TRUE,TRUE,"OR_cc","default_or"
"CD015824_pub2_data","2::overall","2","overall","Mortality",3,1,2,TRUE,TRUE,"RD","double_zero"
"CD015824_pub2_data","6::overall","6","overall","Worsening in World Health Organization functional class",3,0,1,TRUE,TRUE,"RD","sparse_events"
"CD015824_pub2_data","8::overall","8","overall","Serious adverse events",2,0,0,TRUE,TRUE,"OR_cc","default_or"
"CD015824_pub2_data","9::overall","9","overall","Withdrawal from the trial",3,0,2,TRUE,TRUE,"RD","sparse_events"
"CD015830_pub2_data","2::overall","2","overall","Mortality in the ICU",2,0,2,TRUE,TRUE,"RD","sparse_events"
"CD015849_pub2_data","1::overall","1","overall","All-cause death",41,15,29,TRUE,TRUE,"RD","double_zero"
"CD015849_pub2_data","2::overall","2","overall","All-cause death (Hazard ratio) ",22,13,19,TRUE,TRUE,"RD","double_zero"
"CD015849_pub2_data","3::overall","3","overall","Cardiovascular death",28,13,22,TRUE,TRUE,"RD","double_zero"
"CD015849_pub2_data","4::overall","4","overall","Cardiovascular death (Hazard ratio) ",12,11,12,FALSE,TRUE,"RD","double_zero"
"CD015849_pub2_data","5::overall","5","overall","3-point MACE",16,6,6,TRUE,TRUE,"RD","double_zero"
"CD015849_pub2_data","6::overall","6","overall","3-point MACE (Hazard ratio)",18,15,16,TRUE,TRUE,"RD","double_zero"
"CD015849_pub2_data","7::overall","7","overall","4-point MACE",6,0,2,TRUE,TRUE,"RD","sparse_events"
"CD015849_pub2_data","8::overall","8","overall","4-point MACE (Hazard ratio)",8,4,7,TRUE,TRUE,"RD","double_zero"
"CD015849_pub2_data","9::overall","9","overall","Kidney failure",10,5,8,TRUE,TRUE,"RD","double_zero"
"CD015849_pub2_data","10::overall","10","overall","Kidney failure (Hazard ratio)",5,2,5,TRUE,TRUE,"RD","double_zero"
"CD015849_pub2_data","11::overall","11","overall","Composite kidney outcome",8,2,4,TRUE,TRUE,"RD","double_zero"
"CD015849_pub2_data","12::overall","12","overall","Composite kidney outcome (Hazard ratio)",9,3,5,TRUE,TRUE,"RD","double_zero"
"CD015849_pub2_data","13::overall","13","overall","Severe hypoglycaemia",7,3,5,TRUE,TRUE,"RD","double_zero"
"CD015849_pub2_data","14::overall","14","overall","Severe hypoglycaemia (Hazard ratio)",8,3,4,TRUE,TRUE,"RD","double_zero"
"CD015849_pub2_data","15::overall","15","overall","Nonfatal myocardial infarction",3,2,2,FALSE,TRUE,"RD","double_zero"
"CD015849_pub2_data","17::overall","17","overall","Fatal myocardial infarction",3,2,3,FALSE,TRUE,"RD","double_zero"
"CD015849_pub2_data","18::overall","18","overall","Myocardial infarction (undefined)",3,1,2,TRUE,TRUE,"RD","double_zero"
"CD015849_pub2_data","19::overall","19","overall","Fatal or nonfatal myocardial infarction",4,0,0,TRUE,TRUE,"OR_cc","default_or"
"CD015849_pub2_data","20::overall","20","overall","All myocardial infarction (Hazard ratio)",2,0,0,TRUE,TRUE,"OR_cc","default_or"
"CD015849_pub2_data","21::overall","21","overall","Nonfatal stroke",2,0,0,TRUE,TRUE,"OR_cc","default_or"
"CD015849_pub2_data","22::overall","22","overall","Nonfatal stroke (Hazard ratio)",2,0,0,TRUE,TRUE,"OR_cc","default_or"
"CD015849_pub2_data","23::overall","23","overall","Fatal or nonfatal stroke",6,1,2,TRUE,TRUE,"RD","double_zero"
"CD015849_pub2_data","25::overall","25","overall","Ischaemic stroke",5,4,5,FALSE,TRUE,"RD","double_zero"
"CD015849_pub2_data","26::overall","26","overall","Haemorrhagic stroke",2,1,2,FALSE,TRUE,"RD","double_zero"
"CD015849_pub2_data","27::overall","27","overall","Heart failure",2,0,2,TRUE,TRUE,"RD","sparse_events"
"CD015849_pub2_data","28::overall","28","overall","Hospitalisation due to heart failure",4,0,1,TRUE,TRUE,"RD","sparse_events"
"CD015849_pub2_data","38::overall","38","overall","Serious adverse events",2,0,0,TRUE,TRUE,"OR_cc","default_or"
"CD015849_pub2_data","39::overall","39","overall","Withdrawal due to adverse events",8,1,2,TRUE,TRUE,"RD","double_zero"
"CD015849_pub2_data","41::overall","41","overall","Hypoglycaemia",3,0,1,TRUE,TRUE,"RD","sparse_events"
"CD015849_pub2_data","43::overall","43","overall","Acute kidney injury",3,1,3,TRUE,TRUE,"RD","double_zero"
"CD015854_data","1::overall","1","overall","Achievement of definitions of improvement (assessed with IMACS DOI, measured at 8 weeks) ",6,2,3,TRUE,TRUE,"RD","double_zero"
"CD015854_data","2::overall","2","overall","Withdrawals for either lack of benefit or adverse events",5,2,4,TRUE,TRUE,"RD","double_zero"
"CD015854_data","1::1","1","1","Improvement in function or disability (assessed with change in Health Assessment Questionnaire) ",5,4,4,FALSE,TRUE,"RD","double_zero"
"CD015854_data","1::2","1","2","Improvement in function or disability (assessed with change in Health Assessment Questionnaire) ",4,3,4,FALSE,TRUE,"RD","double_zero"
"CD015854_data","2::1","2","1","Improvement of muscle strength (assessed with change in MMT8)",4,3,3,FALSE,TRUE,"RD","double_zero"
"CD015854_data","2::2","2","2","Improvement of muscle strength (assessed with change in MMT8)",4,2,3,TRUE,TRUE,"RD","double_zero"
"CD015854_data","3::1","3","1","Improvement in muscle strength (assessed with change in MMT8) (GIV analysis)",4,2,2,TRUE,TRUE,"RD","double_zero"
"CD015854_data","3::2","3","2","Improvement in muscle strength (assessed with change in MMT8) (GIV analysis)",4,2,3,TRUE,TRUE,"RD","double_zero"
"CD015854_data","4::1","4","1","Achievement of definitions of improvement (assessed with IMACS DOI) ",5,3,3,TRUE,TRUE,"RD","double_zero"
"CD015854_data","4::2","4","2","Achievement of definitions of improvement (assessed with IMACS DOI) ",3,2,2,FALSE,TRUE,"RD","double_zero"
"CD015854_data","5::overall","5","overall","Achievement of definitions of improvement (assessed with moderate or major improvement on Total Improvement Score (TIS))",3,1,1,TRUE,TRUE,"RD","double_zero"
"CD015854_data","6::overall","6","overall","Serious adverse event",2,1,1,FALSE,TRUE,"RD","double_zero"
"CD015854_data","7::overall","7","overall","Withdrawals for either lack of benefit or adverse events",2,0,1,TRUE,TRUE,"RD","sparse_events"
"CD015854_data","3::overall","3","overall","Improvement in muscle strength (assessed with change in muscle strength score) ",4,1,3,TRUE,TRUE,"RD","double_zero"
"CD015854_data","4::overall","4","overall","Achievement of definitions of improvement (assessed with minimal improvement on Total Improvement Score (TIS), measured at 8 weeks)",2,1,1,FALSE,TRUE,"RD","double_zero"
"CD015854_data","5::1","5","1","Serious adverse event",3,1,2,TRUE,TRUE,"RD","double_zero"
"CD015854_data","5::2","5","2","Serious adverse event",2,1,1,FALSE,TRUE,"RD","double_zero"
"CD015854_data","6::1","6","1","Withdrawals for either lack of benefit or adverse events",4,2,3,TRUE,TRUE,"RD","double_zero"
"CD015854_data","6::2","6","2","Withdrawals for either lack of benefit or adverse events",4,1,3,TRUE,TRUE,"RD","double_zero"
"CD015854_data","6::3","6","3","Serious adverse event",3,1,3,TRUE,TRUE,"RD","double_zero"
"CD015854_data","7::1","7","1","Withdrawals for either lack of benefit or adverse events",2,0,1,TRUE,TRUE,"RD","sparse_events"
"CD015854_data","7::2","7","2","Withdrawals for either lack of benefit or adverse events",2,0,1,TRUE,TRUE,"RD","sparse_events"
"CD015854_data","7::3","7","3","Withdrawals for either lack of benefit or adverse events",2,0,2,TRUE,TRUE,"RD","sparse_events"
"CD015855_data","3::overall","3","overall","Improvement of muscle strength (assessed with achievement of meaningful improvement in muscle strength defined using the modified BMRC index) ",9,8,8,FALSE,TRUE,"RD","double_zero"
"CD015855_data","4::1","4","1","Improvement of muscle strength (assessed with change in MMT or other validated muscle score)",5,2,2,TRUE,TRUE,"RD","double_zero"
"CD015855_data","4::2","4","2","Improvement of muscle strength (assessed with change in MMT or other validated muscle score)",4,1,1,TRUE,TRUE,"RD","double_zero"
"CD015855_data","5::overall","5","overall","Achievement of definitions of improvement (assessed with minimal improvement on Total Improvement Score (TIS)) ",6,0,2,TRUE,TRUE,"RD","sparse_events"
"CD015855_data","6::1","6","1","Change in skin disease activity (assessed with change in the CDASI) ",2,1,1,FALSE,TRUE,"RD","double_zero"
"CD015855_data","6::2","6","2","Change in skin disease activity (assessed with change in the CDASI) ",2,1,2,FALSE,TRUE,"RD","double_zero"
"CD015855_data","7::overall","7","overall","Serious adverse event",2,0,1,TRUE,TRUE,"RD","sparse_events"
"CD015855_data","8::overall","8","overall","Withdrawals for either lack of benefit or adverse events",3,1,2,TRUE,TRUE,"RD","double_zero"
"CD015855_data","1::overall","1","overall","Improvement of muscle strength (assessed with achievement of  ≥ 15% improvement in muscle strength)",11,7,7,TRUE,TRUE,"RD","double_zero"
"CD015855_data","2::overall","2","overall","Improvement in muscle strength (assessed with change in muscle strength)",10,7,8,TRUE,TRUE,"RD","double_zero"
"CD015855_data","6::overall","6","overall","Withdrawals for either lack of benefit or adverse events ",5,0,1,TRUE,TRUE,"RD","sparse_events"
"CD015855_data","4::overall","4","overall","Cumulative corticosteroid dose ",4,1,3,TRUE,TRUE,"RD","double_zero"
"CD015875_data","3::overall","3","overall","Waist circumference (cm) (10 to 19 years)",2,1,2,FALSE,TRUE,"RD","double_zero"
"CD015875_data","7::overall","7","overall","Adverse events (10 to 19 years) ",5,4,5,FALSE,TRUE,"RD","double_zero"
"CD015875_data","8::overall","8","overall","BMI Z-scores (10 to 19 years)",3,0,1,TRUE,TRUE,"RD","sparse_events"
"CD015875_data","9::overall","9","overall","BMI percentile (10 to 19 years)",2,0,1,TRUE,TRUE,"RD","sparse_events"
"CD015875_data","10::overall","10","overall","Hip circumference (cm) (10 to 19 years)",2,0,1,TRUE,TRUE,"RD","sparse_events"
"CD015894_pub2_data","4::overall","4","overall","Any harms",2,1,2,FALSE,TRUE,"RD","double_zero"
"CD015932_pub2_data","2::overall","2","overall","ICU length of stay",2,1,1,FALSE,TRUE,"RD","double_zero"
"CD015932_pub2_data","4::overall","4","overall","In-hospital mortality",2,0,1,TRUE,TRUE,"RD","sparse_events"
"CD015932_pub2_data","11::overall","11","overall","Rate of pulmonary complications (pneumonia)",2,0,0,TRUE,TRUE,"OR_cc","default_or"
"CD015932_pub2_data","1::1","1","1","All-cause mortality",3,0,0,TRUE,TRUE,"OR_cc","default_or"
"CD015932_pub2_data","1::2","1","2","All-cause mortality",3,0,0,TRUE,TRUE,"OR_cc","default_or"
"CD015932_pub2_data","2::1","2","1","ICU length of stay",3,0,0,TRUE,TRUE,"OR_cc","default_or"
"CD015932_pub2_data","2::2","2","2","ICU length of stay",3,0,0,TRUE,TRUE,"OR_cc","default_or"
"CD015932_pub2_data","3::2","3","2","Rate of pulmonary complications (pneumonia)",2,0,0,TRUE,TRUE,"OR_cc","default_or"
"CD015932_pub2_data","1::4","1","4","All-cause mortality",4,0,0,TRUE,TRUE,"OR_cc","default_or"
"CD015932_pub2_data","2::4","2","4","All-cause mortality (with RCT)",4,0,0,TRUE,TRUE,"OR_cc","default_or"
"CD015932_pub2_data","12::2","12","2","Rate of pulmonary complications – pneumonia",2,0,0,TRUE,TRUE,"OR_cc","default_or"
"CD015932_pub2_data","12::4","12","4","Rate of pulmonary complications – pneumonia",3,0,0,TRUE,TRUE,"OR_cc","default_or"
"CD015932_pub2_data","12::5","12","5","Rate of pulmonary complications – pneumonia",3,0,0,TRUE,TRUE,"OR_cc","default_or"
"CD015932_pub2_data","13::2","13","2","Rate of pulmonary complications – pneumonia (with RCT)",2,0,0,TRUE,TRUE,"OR_cc","default_or"
"CD015932_pub2_data","13::4","13","4","Rate of pulmonary complications – pneumonia (with RCT)",3,0,0,TRUE,TRUE,"OR_cc","default_or"
"CD015932_pub2_data","13::5","13","5","Rate of pulmonary complications – pneumonia (with RCT)",3,0,0,TRUE,TRUE,"OR_cc","default_or"
"CD015932_pub2_data","15::4","15","4","Rate of pulmonary complications – ventilator-associated pneumonia",2,0,0,TRUE,TRUE,"OR_cc","default_or"
"CD016001_data","1::2","1","2","Death",8,6,8,TRUE,TRUE,"RD","double_zero"
"CD016002_data","1::1","1","1","Death",18,16,18,TRUE,TRUE,"RD","double_zero"
"CD016002_data","1::2","1","2","Death",16,11,14,TRUE,TRUE,"RD","double_zero"
"CD016002_data","3::1","3","1","Secondary events",3,1,3,TRUE,TRUE,"RD","double_zero"
"CD016002_data","3::2","3","2","Secondary events",9,3,8,TRUE,TRUE,"RD","double_zero"
"CD016002_data","4::2","4","2","Falls",5,0,3,TRUE,TRUE,"RD","sparse_events"
"CD016031_data","6::overall","6","overall","Comparison 1: Anterior vs posterior, Outcome 6: Functional status, early (≤ 4 months, categorical data)",5,0,0,TRUE,TRUE,"OR_cc","default_or"
"CD016031_data","7::overall","7","overall","Comparison 1: Anterior vs posterior, Outcome 7: Functional status, intermediate (4-24 months, categorical data)",3,1,1,TRUE,TRUE,"RD","double_zero"
"CD016031_data","8::overall","8","overall","Comparison 1: Anterior vs posterior, Outcome 8: Functional status, intermediate (4-24 months, continuous data)",6,0,0,TRUE,TRUE,"OR_cc","default_or"
"CD016031_data","9::overall","9","overall","Comparison 1: Anterior vs posterior, Outcome 9: Mortality, early (≤ 4 months, categorical data)",8,0,2,TRUE,TRUE,"RD","sparse_events"
"CD016031_data","10::overall","10","overall","Comparison 1: Anterior vs posterior, Outcome 10: Mortality, intermediate (4-24 months, categorical data)",6,1,2,TRUE,TRUE,"RD","double_zero"
"CD016031_data","11::overall","11","overall","Comparison 1: Anterior vs posterior, Outcome 11: Mortality, late (≥ 24 months, categorical data)",3,0,2,TRUE,TRUE,"RD","sparse_events"
"CD016031_data","13::overall","13","overall","Comparison 1: Anterior vs posterior, Outcome 13: Pain, intermediate (4-24 months, categorical data)",5,0,2,TRUE,TRUE,"RD","sparse_events"
"CD016031_data","14::overall","14","overall","Comparison 1: Anterior vs posterior, Outcome 14: Pain, intermediate (4-24 months, continuous data)",4,0,2,TRUE,TRUE,"RD","sparse_events"
"CD016031_data","17::1","17","1","Comparison 1: Anterior vs posterior, Outcome 17: Adverse events, implant related (categorical data)",16,13,15,TRUE,TRUE,"RD","double_zero"
"CD016031_data","17::2","17","2","Comparison 1: Anterior vs posterior, Outcome 17: Adverse events, implant related (categorical data)",11,8,11,TRUE,TRUE,"RD","double_zero"
"CD016031_data","17::3","17","3","Comparison 1: Anterior vs posterior, Outcome 17: Adverse events, implant related (categorical data)",4,2,4,TRUE,TRUE,"RD","double_zero"
"CD016031_data","17::4","17","4","Comparison 1: Anterior vs posterior, Outcome 17: Adverse events, implant related (categorical data)",4,2,4,TRUE,TRUE,"RD","double_zero"
"CD016031_data","17::5","17","5","Comparison 1: Anterior vs posterior, Outcome 17: Adverse events, implant related (categorical data)",4,3,4,FALSE,TRUE,"RD","double_zero"
"CD016031_data","18::1","18","1","Comparison 1: Anterior vs posterior, Outcome 18: Adverse events, not implant related (categorical data)",10,2,4,TRUE,TRUE,"RD","double_zero"
"CD016031_data","20::1","20","1","Comparison 1: Anterior vs posterior, Outcome 20: Operative details (Categorical data)",5,0,0,TRUE,TRUE,"OR_cc","default_or"
"CD016031_data","13::1","13","1","Comparison 2: Anterior vs lateral, Outcome 13: Adverse events, implant related (categorical data)",3,2,3,FALSE,TRUE,"RD","double_zero"
"CD016031_data","13::2","13","2","Comparison 2: Anterior vs lateral, Outcome 13: Adverse events, implant related (categorical data)",4,3,4,FALSE,TRUE,"RD","double_zero"
"CD016031_data","13::3","13","3","Comparison 2: Anterior vs lateral, Outcome 13: Adverse events, implant related (categorical data)",2,1,2,FALSE,TRUE,"RD","double_zero"
"CD016031_data","13::5","13","5","Comparison 2: Anterior vs lateral, Outcome 13: Adverse events, implant related (categorical data)",2,0,1,TRUE,TRUE,"RD","sparse_events"
"CD016031_data","14::1","14","1","Comparison 2 Anterior vs lateral, Outcome 14: Adverse events, not implant related (categorical data)",2,0,2,TRUE,TRUE,"RD","sparse_events"
"CD016031_data","14::2","14","2","Comparison 2 Anterior vs lateral, Outcome 14: Adverse events, not implant related (categorical data)",2,1,2,FALSE,TRUE,"RD","double_zero"
"CD016031_data","14::3","14","3","Comparison 2 Anterior vs lateral, Outcome 14: Adverse events, not implant related (categorical data)",2,1,2,FALSE,TRUE,"RD","double_zero"
"CD016031_data","15::1","15","1","Comparison 2: Anterior vs lateral, Outcome 15: Operative details (Continuous data)",14,5,13,TRUE,TRUE,"RD","double_zero"
"CD016031_data","15::2","15","2","Comparison 2: Anterior vs lateral, Outcome 15: Operative details (Continuous data)",6,2,5,TRUE,TRUE,"RD","double_zero"
"CD016031_data","15::3","15","3","Comparison 2: Anterior vs lateral, Outcome 15: Operative details (Continuous data)",6,2,5,TRUE,TRUE,"RD","double_zero"
"CD016031_data","16::1","16","1","Comparison 2: Anterior vs lateral, Outcome 16: Operative details (Categorical data)",4,0,1,TRUE,TRUE,"RD","sparse_events"
"CD016031_data","15::4","15","4","Comparison 3: Lateral vs posterior, Outcome 15: Adverse events, implant related (categorical data)",6,0,4,TRUE,TRUE,"RD","sparse_events"
"CD016031_data","15::5","15","5","Comparison 3: Lateral vs posterior, Outcome 15: Adverse events, implant related (categorical data)",6,1,5,TRUE,TRUE,"RD","double_zero"
"CD016031_data","16::2","16","2","Comparison 3: Lateral vs posterior, Outcome 16: Adverse events, not implant related (categorical data)",2,0,1,TRUE,TRUE,"RD","sparse_events"
"CD016031_data","16::3","16","3","Comparison 3: Lateral vs posterior, Outcome 16: Adverse events, not implant related (categorical data)",6,2,6,TRUE,TRUE,"RD","double_zero"
"CD016031_data","16::4","16","4","Comparison 3: Lateral vs posterior, Outcome 16: Adverse events, not implant related (categorical data)",3,0,0,TRUE,TRUE,"OR_cc","default_or"
"CD016031_data","16::5","16","5","Comparison 3: Lateral vs posterior, Outcome 16: Adverse events, not implant related (categorical data)",2,0,0,TRUE,TRUE,"OR_cc","default_or"
"CD016058_pub2_data","1::overall","1","overall","Vaping cessation at 6 months or longer",10,4,6,TRUE,TRUE,"RD","double_zero"
"CD016058_pub2_data","2::overall","2","overall","Number of participants reporting SAEs",10,4,5,TRUE,TRUE,"RD","double_zero"
"CD016058_pub2_data","3::overall","3","overall","Vaping cessation at between 3 & 6 months",9,0,1,TRUE,TRUE,"RD","sparse_events"
"CD016058_pub2_data","4::overall","4","overall","Number of participants reporting AEs",6,0,1,TRUE,TRUE,"RD","sparse_events"
"CD016064_data","5::1","5","1","Multifactorial interventions (grouped by alignment with QCA theory): Risk of falling sensitivity analyses: excluding trials at high risk of bias",13,9,11,TRUE,TRUE,"RD","double_zero"
"CD016064_data","5::2","5","2","Multifactorial interventions (grouped by alignment with QCA theory): Risk of falling sensitivity analyses: excluding trials at high risk of bias",11,9,10,TRUE,TRUE,"RD","double_zero"
"CD016064_data","5::3","5","3","Adverse events",4,3,3,FALSE,TRUE,"RD","double_zero"
"CD016119_data","1::overall","1","overall","Requirement for blood transfusion",18,2,3,TRUE,TRUE,"RD","double_zero"
"CD016119_data","2::overall","2","overall","Incidence of haemorrhage",9,0,0,TRUE,TRUE,"OR_cc","default_or"
"CD016119_data","3::overall","3","overall","Size of fibroid on incidence of haemorrhage",6,0,1,TRUE,TRUE,"RD","sparse_events"
"CD016119_data","8::overall","8","overall","Major surgery at time of procedure",5,0,3,TRUE,TRUE,"RD","sparse_events"
"CD016119_data","9::overall","9","overall","Postpartum fever",13,1,2,TRUE,TRUE,"RD","double_zero"
"CD016119_data","11::overall","11","overall","Additional uterotonics or tranexamic acid",3,0,0,TRUE,TRUE,"OR_cc","default_or"
"CD016119_data","19::overall","19","overall","Ileus",2,0,1,TRUE,TRUE,"RD","sparse_events"
"CD016119_data","20::overall","20","overall","Complications (unspecified)",3,0,1,TRUE,TRUE,"RD","sparse_events"
"CD016120_data","1::overall","1","overall","Allogenic (donor) blood transfusion",3,0,1,TRUE,TRUE,"RD","sparse_events"
"CD016120_data","2::overall","2","overall","Transfusion related adverse reactions",4,0,2,TRUE,TRUE,"RD","sparse_events"
"CD016120_data","3::overall","3","overall","Haemorrhage",2,0,1,TRUE,TRUE,"RD","sparse_events"
"CD016120_data","12::overall","12","overall","Side effects",5,1,2,TRUE,TRUE,"RD","double_zero"
"CD016131_data","1::1","1","1","RSV-associated lower respiratory tract illness",5,0,0,TRUE,TRUE,"OR_cc","default_or"
"CD016131_data","1::2","1","2","RSV-associated lower respiratory tract illness",2,0,0,TRUE,TRUE,"OR_cc","default_or"
"CD016131_data","2::overall","2","overall","RSV-associated acute respiratory illness",10,1,3,TRUE,TRUE,"RD","double_zero"
"CD016131_data","3::overall","3","overall","Mortality from illness caused by RSV",9,5,9,TRUE,TRUE,"RD","double_zero"
"CD016131_data","4::overall","4","overall","All-cause mortality&nbsp;",9,6,6,TRUE,TRUE,"RD","double_zero"
"CD016131_data","5::1","5","1","Serious adverse events (SAEs) related to vaccination",4,0,1,TRUE,TRUE,"RD","sparse_events"
"CD016131_data","5::2","5","2","Serious adverse events (SAEs) related to vaccination",2,1,1,FALSE,TRUE,"RD","double_zero"
"CD016131_data","6::1","6","1","Any unsolicited adverse events (spontaneously reported/ other adverse events)",4,1,1,TRUE,TRUE,"RD","double_zero"
"CD016131_data","6::2","6","2","Any unsolicited adverse events (spontaneously reported/ other adverse events)",2,0,0,TRUE,TRUE,"OR_cc","default_or"
"CD016131_data","7::1","7","1","Any solicited adverse events (Local reactions- redness, swelling, pain/tenderness and systemic reactions - fever, fatigue, etc.)",2,0,0,TRUE,TRUE,"OR_cc","default_or"
"CD016131_data","1::overall","1","overall","RSV-associated lower respiratory tract infection",7,0,0,TRUE,TRUE,"OR_cc","default_or"
"CD016131_data","5::overall","5","overall","Serious adverse events (SAEs) related to vaccination&nbsp;",6,1,1,TRUE,TRUE,"RD","double_zero"
"CD016131_data","2::1","2","1","Medically attended RSV-associated severe lower respiratory tract illness in infants",2,0,1,TRUE,TRUE,"RD","sparse_events"
"CD016147_data","1::overall","1","overall","Manual removal of the placenta (end of treatment)",7,0,0,TRUE,TRUE,"OR_cc","default_or"
"CD016147_data","2::overall","2","overall","PPH ≥ 1000 mL (end of treatment)",5,0,0,TRUE,TRUE,"OR_cc","default_or"
"CD016147_data","3::overall","3","overall","Adverse effects (shivering)",4,0,0,TRUE,TRUE,"OR_cc","default_or"
"CD016147_data","4::overall","4","overall","Adverse effects (nausea)",2,0,1,TRUE,TRUE,"RD","sparse_events"
"CD016147_data","6::overall","6","overall","Adverse effects (abdominal pain)",2,0,0,TRUE,TRUE,"OR_cc","default_or"
"CD016147_data","8::overall","8","overall","Adverse effects (dizziness)",2,0,1,TRUE,TRUE,"RD","sparse_events"
"CD016147_data","11::overall","11","overall","Blood transfusion",3,0,0,TRUE,TRUE,"OR_cc","default_or"
"CD016148_data","1::overall","1","overall","2nd degree tears",17,0,1,TRUE,TRUE,"RD","sparse_events"
"CD016148_data","2::overall","2","overall","3rd or 4th degree tears",15,1,6,TRUE,TRUE,"RD","double_zero"
"CD016148_data","3::overall","3","overall","3rd degree tears",12,4,8,TRUE,TRUE,"RD","double_zero"
"CD016148_data","4::overall","4","overall","4th degree tears",6,2,4,TRUE,TRUE,"RD","double_zero"
"CD016148_data","5::overall","5","overall","PPH ≥ 500mL",3,1,1,TRUE,TRUE,"RD","double_zero"
"CD016168_data","1::overall","1","overall","Severe maternal morbidity – composite excluding ICU admission",4,3,3,FALSE,TRUE,"RD","double_zero"
"CD016168_data","2::overall","2","overall","Severe maternal morbidity – ICU admission",4,1,2,TRUE,TRUE,"RD","double_zero"
"CD016168_data","3::overall","3","overall","Breastfeeding",3,0,0,TRUE,TRUE,"OR_cc","default_or"
"CD016168_data","4::overall","4","overall","Severe maternal morbidity – hysterectomy (randomised studies)",2,0,2,TRUE,TRUE,"RD","sparse_events"
"CD016168_data","5::overall","5","overall","Severe maternal morbidity – hysterectomy (non-randomised studies)",2,0,0,TRUE,TRUE,"OR_cc","default_or"
"CD016168_data","6::overall","6","overall","Adverse effects – thromboembolic events",3,1,3,TRUE,TRUE,"RD","double_zero"
"CD016168_data","7::overall","7","overall","Adverse effects – dizziness up to 24 hours",2,0,0,TRUE,TRUE,"OR_cc","default_or"
"CD016168_data","8::overall","8","overall","Adverse effects – shivering up to 24 hours",2,0,1,TRUE,TRUE,"RD","sparse_events"
"CD016168_data","9::overall","9","overall","Adverse effects – fever up to 24 hours",2,0,1,TRUE,TRUE,"RD","sparse_events"
"CD016168_data","10::overall","10","overall","Adverse effects – abdominal pain up to 24 hours",2,0,1,TRUE,TRUE,"RD","sparse_events"
"CD016168_data","11::overall","11","overall","Adverse effects – headache up to 24 hours",2,0,1,TRUE,TRUE,"RD","sparse_events"
"CD016168_data","12::overall","12","overall","Adverse effects – nausea or vomiting up to 24 hours",2,0,1,TRUE,TRUE,"RD","sparse_events"
"CD016168_data","13::overall","13","overall","Adverse effects – fainting up to 24 hours",2,0,0,TRUE,TRUE,"OR_cc","default_or"
"CD016168_data","14::overall","14","overall","Adverse effects – palpitations up to 24 hours",2,1,1,FALSE,TRUE,"RD","double_zero"
"CD016168_data","15::overall","15","overall","Adverse effects – allergic reaction up to 24 hours",2,1,2,FALSE,TRUE,"RD","double_zero"
"CD016168_data","16::overall","16","overall","Adverse effects – urticaria up to 24 hours",2,1,2,FALSE,TRUE,"RD","double_zero"
"CD016168_data","17::overall","17","overall","Adverse effects – itching up to 24 hours",2,1,2,FALSE,TRUE,"RD","double_zero"
"CD016168_data","18::overall","18","overall","Adverse effects – shortness of breath up to 24 hours",2,1,2,FALSE,TRUE,"RD","double_zero"
"CD016211_data","1::overall","1","overall","Maternal sepsis",4,0,0,TRUE,TRUE,"OR_cc","default_or"
"CD016211_data","2::2","2","2","Maternal sepsis: subgroup analysis (polypharmacy vs monopharmacy)",4,0,0,TRUE,TRUE,"OR_cc","default_or"
"CD016211_data","3::overall","3","overall","Maternal mortality",4,1,2,TRUE,TRUE,"RD","double_zero"
"CD016211_data","4::2","4","2","Maternal mortality: subgroup analysis (polypharmacy vs monopharmacy)",4,1,2,TRUE,TRUE,"RD","double_zero"
"CD016211_data","11::overall","11","overall","Adverse effects of antibiotics: vomiting",3,0,0,TRUE,TRUE,"OR_cc","default_or"
"CD016211_data","12::overall","12","overall","Adverse effects of antibiotics: diarrhea",2,0,1,TRUE,TRUE,"RD","sparse_events"
"CD016211_data","15::overall","15","overall","Other maternal infections: chorioamnionitis",2,0,0,TRUE,TRUE,"OR_cc","default_or"
"CD016211_data","16::overall","16","overall","Other maternal infections: endometritis",2,0,0,TRUE,TRUE,"OR_cc","default_or"
"CD016211_data","17::overall","17","overall","Other maternal infections: mastitis or breast abscess",4,0,1,TRUE,TRUE,"RD","sparse_events"
"CD016211_data","18::overall","18","overall","Other maternal infections: pyelonephritis",2,0,0,TRUE,TRUE,"OR_cc","default_or"
"CD016211_data","19::overall","19","overall","Other neonatal infections",2,0,0,TRUE,TRUE,"OR_cc","default_or"
"CD016278_data","1::overall","1","overall","Estimated blood loss ≥ 1000ml",4,0,0,TRUE,TRUE,"OR_cc","default_or"
"CD016278_data","2::overall","2","overall","Calculated blood loss ≥ 1000ml",2,0,0,TRUE,TRUE,"OR_cc","default_or"
"CD016278_data","3::overall","3","overall","Maternal death",6,5,6,FALSE,TRUE,"RD","double_zero"
"CD016278_data","5::overall","5","overall","Blood transfusion",5,1,2,TRUE,TRUE,"RD","double_zero"
"CD016278_data","6::overall","6","overall","Receipt of surgical interventions to control PPH",4,1,2,TRUE,TRUE,"RD","double_zero"
"CD016278_data","7::overall","7","overall","Thromboembolic events",4,2,2,TRUE,TRUE,"RD","double_zero"
"CD016278_data","8::overall","8","overall","Receipt of additional uterotonics",4,0,0,TRUE,TRUE,"OR_cc","default_or"
"CD016278_data","9::overall","9","overall","Hysterectomy",2,0,1,TRUE,TRUE,"RD","sparse_events"
"CD016278_data","12::overall","12","overall","Clinical diagnosis of PPH",3,0,1,TRUE,TRUE,"RD","sparse_events"
"CD016278_data","15::overall","15","overall","Myocardial infarction",4,3,4,FALSE,TRUE,"RD","double_zero"
"CD016278_data","16::overall","16","overall","Stroke",4,3,4,FALSE,TRUE,"RD","double_zero"
"CD016278_data","17::overall","17","overall","Seizures",4,2,4,TRUE,TRUE,"RD","double_zero"
"CD016278_data","19::overall","19","overall","ICU admission",3,1,1,TRUE,TRUE,"RD","double_zero"
"CD016278_data","20::overall","20","overall","Nausea",3,0,0,TRUE,TRUE,"OR_cc","default_or"
"CD016278_data","21::overall","21","overall","Vomiting",2,0,1,TRUE,TRUE,"RD","sparse_events"
"CD000547_pub3_data","1::overall","1","overall","Uterine volume (mL) (preoperative)",28,28,28,FALSE,TRUE,"RD","double_zero"
"CD000547_pub3_data","3::overall","3","overall","Fibroid volume (mL) (preoperative)",24,24,24,FALSE,TRUE,"RD","double_zero"
"CD000547_pub3_data","11::overall","11","overall","Duration of hospital stay (days)",4,4,4,FALSE,TRUE,"RD","double_zero"
"CD000547_pub3_data","13::overall","13","overall","Postoperative haemoglobin",4,4,4,FALSE,TRUE,"RD","double_zero"
"CD000547_pub3_data","2::overall","2","overall","Postoperative morbidity (complications)",4,4,4,FALSE,TRUE,"RD","double_zero"
"CD001155_pub3_data","9::overall","9","overall","Atypical femoral fracture",10,10,10,FALSE,TRUE,"RD","double_zero"
"CD001396_pub4_data","15::overall","15","overall","Psychological symptoms",8,8,8,FALSE,TRUE,"RD","double_zero"
"CD001396_pub4_data","16::overall","16","overall","Physical symptoms",7,7,7,FALSE,TRUE,"RD","double_zero"
"CD001396_pub4_data","17::overall","17","overall","Functional symptoms",3,3,3,FALSE,TRUE,"RD","double_zero"
"CD001396_pub4_data","18::overall","18","overall","Irritability",7,7,7,FALSE,TRUE,"RD","double_zero"
"CD001552_pub3_data","4::overall","4","overall","Symptoms at long-term follow-up: over 3 months",8,8,8,FALSE,TRUE,"RD","double_zero"
"CD001552_pub3_data","5::overall","5","overall","Function at short-term follow-up: 3 months or less",8,8,8,FALSE,TRUE,"RD","double_zero"
"CD001703_pub4_data","1::overall","1","overall","Non-specific low back pain: pain intensity (0 to 100) at immediate-term follow-up (≤ 4 weeks)",8,8,8,FALSE,TRUE,"RD","double_zero"
"CD001703_pub4_data","2::overall","2","overall","Non-specific low back pain: pain intensity (0 to 100) at short-term follow-up (> 4 to 16 weeks)",16,16,16,FALSE,TRUE,"RD","double_zero"
"CD001703_pub4_data","4::overall","4","overall","Non-specific low back pain: disability (RMDQ, 0 to 24) at short-term follow-up (> 4 to 16 weeks): SNRI",6,6,6,FALSE,TRUE,"RD","double_zero"
"CD001703_pub4_data","6::overall","6","overall","Non-specific low back pain: disability (RMDQ, 0 to 24) at short-term follow-up (> 4 to 16 weeks): TCA",4,4,4,FALSE,TRUE,"RD","double_zero"
"CD001703_pub4_data","8::overall","8","overall","Non-specific low back pain: depressive symptoms (BDI, 0 to 63) at short-term follow-up (> 4 to 16 weeks): SNRI",4,4,4,FALSE,TRUE,"RD","double_zero"
"CD001703_pub4_data","10::overall","10","overall","Non-specific low back pain: depressive symptoms (BDI, 0 to 63) at short-term follow-up (> 4 to 16 weeks): TCA",2,2,2,FALSE,TRUE,"RD","double_zero"
"CD001703_pub4_data","13::overall","13","overall","Non-specific low back pain: HRQoL (EQ-5D, 0 to 1) at short-term follow-up (> 4 to 16 weeks): SNRI",6,6,6,FALSE,TRUE,"RD","double_zero"
"CD001703_pub4_data","14::overall","14","overall","Non-specific low back pain: HRQoL (SMD) at short-term follow-up (> 4 to 16 weeks): TCA",2,2,2,FALSE,TRUE,"RD","double_zero"
"CD001703_pub4_data","16::overall","16","overall","Spine-related leg pain: pain intensity (0 to 100) at immediate-term follow-up (≤ 4 weeks)",3,3,3,FALSE,TRUE,"RD","double_zero"
"CD001703_pub4_data","17::overall","17","overall","Spine-related leg pain: pain intensity (0 to 100) at short-term follow-up (> 4 to 16 weeks)",2,2,2,FALSE,TRUE,"RD","double_zero"
"CD001703_pub4_data","19::overall","19","overall","Spine-related leg pain: disability (SMD) at immediate-term follow-up (≤ 4 weeks)",2,2,2,FALSE,TRUE,"RD","double_zero"
"CD001703_pub4_data","20::overall","20","overall","Spine-related leg pain: disability (ODI, 0 to 100) at short-term follow-up (> 4 to 16 weeks)",2,2,2,FALSE,TRUE,"RD","double_zero"
"CD001797_pub4_data","4::overall","4","overall","Change in mean disability score within 6 weeks",7,7,7,FALSE,TRUE,"RD","double_zero"
"CD001797_pub4_data","5::overall","5","overall","Change in mean disability score within 6 weeks; generic inverse variance approach",2,2,2,FALSE,TRUE,"RD","double_zero"
"CD001920_pub4_data","1::overall","1","overall","Independence in ADL scales",219,219,219,FALSE,TRUE,"RD","double_zero"
"CD001920_pub4_data","2::overall","2","overall","Motor function scales",279,279,279,FALSE,TRUE,"RD","double_zero"
"CD001920_pub4_data","3::overall","3","overall","Balance (Berg Balance Scale)",207,207,207,FALSE,TRUE,"RD","double_zero"
"CD001920_pub4_data","4::overall","4","overall","Gait velocity",244,244,244,FALSE,TRUE,"RD","double_zero"
"CD001920_pub4_data","7::overall","7","overall","Neurophysiological approaches compared to other: Independence in ADL scales",124,124,124,FALSE,TRUE,"RD","double_zero"
"CD001920_pub4_data","8::overall","8","overall","Neurophysiological approaches compared to other: Motor function scales",15,15,15,FALSE,TRUE,"RD","double_zero"
"CD001920_pub4_data","9::overall","9","overall","Neurophysiological approaches compared to other: Balance (Berg Balance Scale)",12,12,12,FALSE,TRUE,"RD","double_zero"
"CD001920_pub4_data","10::overall","10","overall","Neurophysiological approaches compared to other approaches: Gait velocity",16,16,16,FALSE,TRUE,"RD","double_zero"
"CD002042_pub6_data","5::4","5","4","30-day mortality: subgroup by clinical specialties",2,2,2,FALSE,TRUE,"RD","double_zero"
"CD002052_pub4_data","4::overall","4","overall","Days on mechanical ventilation",4,4,4,FALSE,TRUE,"RD","double_zero"
"CD002052_pub4_data","5::overall","5","overall","Days of supplemental oxygen use",3,3,3,FALSE,TRUE,"RD","double_zero"
"CD002052_pub4_data","8::overall","8","overall","Length of NICU stay (days)",3,3,3,FALSE,TRUE,"RD","double_zero"
"CD002112_pub2_data","1::1","1","1","Mean number of wet nights at the end of treatment",16,16,16,FALSE,TRUE,"RD","double_zero"
"CD002112_pub2_data","1::2","1","2","Mean number of wet nights at the end of treatment",20,20,20,FALSE,TRUE,"RD","double_zero"
"CD002112_pub2_data","1::3","1","3","Mean number of wet nights at the end of treatment",12,12,12,FALSE,TRUE,"RD","double_zero"
"CD002112_pub2_data","1::4","1","4","Mean number of wet nights at the end of treatment",6,6,6,FALSE,TRUE,"RD","double_zero"
"CD002112_pub2_data","1::5","1","5","Mean number of wet nights at the end of treatment",4,4,4,FALSE,TRUE,"RD","double_zero"
"CD002112_pub2_data","1::overall","1","overall","Mean number of wet nights at the end of treatment",4,4,4,FALSE,TRUE,"RD","double_zero"
"CD002112_pub2_data","3::3","3","3","Mean number of wet nights at follow-up",2,2,2,FALSE,TRUE,"RD","double_zero"
"CD002115_pub6_data","1::overall","1","overall","Self-reported improvement in faecal incontinence (continuous data)",5,5,5,FALSE,TRUE,"RD","double_zero"
"CD002115_pub6_data","3::overall","3","overall","Number of participants with self-reported improvement in constipation (continuous)",7,7,7,FALSE,TRUE,"RD","double_zero"
"CD002115_pub6_data","6::overall","6","overall","Mean number of bowel movements per week (continuous)",7,7,7,FALSE,TRUE,"RD","double_zero"
"CD002115_pub6_data","8::overall","8","overall","Mean time spent on bowel care per week (continuous; time taken for defecation in minutes)",2,2,2,FALSE,TRUE,"RD","double_zero"
"CD002115_pub6_data","4::overall","4","overall","Mean number of FI episodes (continuous)",2,2,2,FALSE,TRUE,"RD","double_zero"
"CD002115_pub6_data","5::overall","5","overall","Mean number of bowel movements per week (continuous)",2,2,2,FALSE,TRUE,"RD","double_zero"
"CD002115_pub6_data","7::overall","7","overall","Mean time spent per week on bowel care (continuous)",3,3,3,FALSE,TRUE,"RD","double_zero"
"CD002203_pub5_data","1::overall","1","overall","FEV1 % predicted (mean change from baseline)",23,23,23,FALSE,TRUE,"RD","double_zero"
"CD002203_pub5_data","2::overall","2","overall","FVC % predicted (percentage change from baseline)",13,13,13,FALSE,TRUE,"RD","double_zero"
"CD002203_pub5_data","28::overall","28","overall","Change in physical domain of CFQ-R QoL score",2,2,2,FALSE,TRUE,"RD","double_zero"
"CD002203_pub5_data","30::overall","30","overall","Change in psychosocial domain of CFQ-R QoL score",2,2,2,FALSE,TRUE,"RD","double_zero"
"CD002203_pub5_data","31::overall","31","overall","Change in body image domain of CFQ-R QoL score",2,2,2,FALSE,TRUE,"RD","double_zero"
"CD002243_pub5_data","14::overall","14","overall","Length of intensive care unit stay for all participants",25,25,25,FALSE,TRUE,"RD","double_zero"
"CD002243_pub5_data","15::overall","15","overall","Length of intensive care unit stay for survivors",10,10,10,FALSE,TRUE,"RD","double_zero"
"CD002243_pub5_data","16::overall","16","overall","Length of hospital stay for all participants",31,31,31,FALSE,TRUE,"RD","double_zero"
"CD002243_pub5_data","17::overall","17","overall","Length of hospital stay for survivors",9,9,9,FALSE,TRUE,"RD","double_zero"
"CD002243_pub5_data","20::overall","20","overall","SOFA score at day 7",17,17,17,FALSE,TRUE,"RD","double_zero"
"CD002243_pub5_data","6::overall","6","overall","Length of intensive care unit stay for all participants",4,4,4,FALSE,TRUE,"RD","double_zero"
"CD002243_pub5_data","7::overall","7","overall","Length of hospital stay for all participants",4,4,4,FALSE,TRUE,"RD","double_zero"
"CD002971_pub6_data","4::overall","4","overall","In-hospital rate of weight gain (g/kg/day) until term equivalent",9,9,9,FALSE,TRUE,"RD","double_zero"
"CD002971_pub6_data","5::overall","5","overall","In-hospital rate of head circumference growth (mm/week) until term equivalent",9,9,9,FALSE,TRUE,"RD","double_zero"
"CD002971_pub6_data","6::overall","6","overall","Weight (kg) at 18 months post-term",2,2,2,FALSE,TRUE,"RD","double_zero"
"CD002971_pub6_data","7::overall","7","overall","Head circumference (cm) at 18 months post-term",2,2,2,FALSE,TRUE,"RD","double_zero"
"CD002971_pub6_data","8::overall","8","overall","Bayley Mental Development Index at 18 months",2,2,2,FALSE,TRUE,"RD","double_zero"
"CD002971_pub6_data","9::overall","9","overall","Bayley Psychomotor Development Index at 18 months",2,2,2,FALSE,TRUE,"RD","double_zero"
"CD002971_pub6_data","10::overall","10","overall","Bayley-III",6,6,6,FALSE,TRUE,"RD","double_zero"
"CD003216_pub3_data","5::overall","5","overall","DESIGN-R score",2,2,2,FALSE,TRUE,"RD","double_zero"
"CD003218_pub3_data","1::overall","1","overall","Mean improvement in the Maintenance of Wakefulness Test",3,3,3,FALSE,TRUE,"RD","double_zero"
"CD003218_pub3_data","2::overall","2","overall","Mean improvement in the Epworth Sleepiness Scale",5,5,5,FALSE,TRUE,"RD","double_zero"
"CD003218_pub3_data","3::overall","3","overall","Mean improvement in the Multiple Sleep Latency Test",2,2,2,FALSE,TRUE,"RD","double_zero"
"CD003218_pub3_data","4::overall","4","overall","Quality of life",2,2,2,FALSE,TRUE,"RD","double_zero"
"CD003218_pub3_data","5::overall","5","overall","Proportion of participants with at least 1 adverse event",6,6,6,FALSE,TRUE,"RD","double_zero"
"CD003331_pub6_data","7::overall","7","overall","Health-related quality of life (MLWHF) up to 12 months' follow-up",22,22,22,FALSE,TRUE,"RD","double_zero"
"CD003331_pub6_data","8::overall","8","overall","Health-related quality of life (all scales) up to 12 months' follow-up",38,38,38,FALSE,TRUE,"RD","double_zero"
"CD003331_pub6_data","9::overall","9","overall","Health-related quality of life (MLWHF) more than 12 months' follow-up",3,3,3,FALSE,TRUE,"RD","double_zero"
"CD003376_pub4_data","9::overall","9","overall","Atypical femoral fractures",3,3,3,FALSE,TRUE,"RD","double_zero"
"CD003414_pub4_data","7::1","7","1","Endometrial thickness",9,9,9,FALSE,TRUE,"RD","double_zero"
"CD003414_pub4_data","7::2","7","2","Endometrial thickness",5,5,5,FALSE,TRUE,"RD","double_zero"
"CD003414_pub4_data","7::3","7","3","Endometrial thickness",3,3,3,FALSE,TRUE,"RD","double_zero"
"CD003429_pub5_data","1::overall","1","overall","Annualized joint bleeding rates",3,3,3,FALSE,TRUE,"RD","double_zero"
"CD003429_pub5_data","4::1","4","1","Quality of life",2,2,2,FALSE,TRUE,"RD","double_zero"
"CD003429_pub5_data","5::overall","5","overall","Annualized overall bleeding rates",3,3,3,FALSE,TRUE,"RD","double_zero"
"CD003429_pub5_data","6::overall","6","overall","Radiologic joint score (Pettersson score)",2,2,2,FALSE,TRUE,"RD","double_zero"
"CD003429_pub5_data","7::1","7","1","Clotting factor concentrate usage ",3,3,3,FALSE,TRUE,"RD","double_zero"
"CD003429_pub5_data","7::2","7","2","Clotting factor concentrate usage ",2,2,2,FALSE,TRUE,"RD","double_zero"
"CD003429_pub5_data","8::1","8","1","Sensitivity analysis (fixed-effect model): clotting factor concentrate usage ",3,3,3,FALSE,TRUE,"RD","double_zero"
"CD003429_pub5_data","8::2","8","2","Sensitivity analysis (fixed-effect model): clotting factor concentrate usage ",2,2,2,FALSE,TRUE,"RD","double_zero"
"CD003429_pub5_data","9::overall","9","overall","Number of clotting factor infusions (per participant per month)",2,2,2,FALSE,TRUE,"RD","double_zero"
"CD003451_pub3_data","1::overall","1","overall","Overjet",25,25,25,FALSE,TRUE,"RD","double_zero"
"CD003451_pub3_data","2::overall","2","overall","ANB",37,37,37,FALSE,TRUE,"RD","double_zero"
"CD003451_pub3_data","3::overall","3","overall","Wits",17,17,17,FALSE,TRUE,"RD","double_zero"
"CD003451_pub3_data","4::overall","4","overall","Piers-Harris self-concept scale",3,3,3,FALSE,TRUE,"RD","double_zero"
"CD003477_pub5_data","1::overall","1","overall","Emotional well-being including quality of life",32,32,32,FALSE,TRUE,"RD","double_zero"
"CD003477_pub5_data","2::overall","2","overall","Mood disturbance or negative affect: depression",28,28,28,FALSE,TRUE,"RD","double_zero"
"CD003477_pub5_data","3::overall","3","overall","Mood disturbance or negative affect: anxiety",24,24,24,FALSE,TRUE,"RD","double_zero"
"CD003477_pub5_data","4::overall","4","overall","Behaviour problems: agitation or aggression",23,23,23,FALSE,TRUE,"RD","double_zero"
"CD003477_pub5_data","5::overall","5","overall","Behaviour problems: overall",28,28,28,FALSE,TRUE,"RD","double_zero"
"CD003477_pub5_data","6::overall","6","overall","Social behaviour",10,10,10,FALSE,TRUE,"RD","double_zero"
"CD003477_pub5_data","7::overall","7","overall","Cognition",13,13,13,FALSE,TRUE,"RD","double_zero"
"CD003594_pub7_data","6::overall","6","overall","Time to remission [days]",2,2,2,FALSE,TRUE,"RD","double_zero"
"CD003598_pub3_data","4::overall","4","overall","eGFR [mL/min/1.73 m²]",30,30,30,FALSE,TRUE,"RD","double_zero"
"CD003833_pub5_data","1::overall","1","overall","Walking distance",6,6,6,FALSE,TRUE,"RD","double_zero"
"CD003833_pub5_data","2::overall","2","overall","Ankle brachial index",3,3,3,FALSE,TRUE,"RD","double_zero"
"CD003833_pub5_data","3::overall","3","overall","Cholesterol",15,15,15,FALSE,TRUE,"RD","double_zero"
"CD003833_pub5_data","4::overall","4","overall","Triglycerides",4,4,4,FALSE,TRUE,"RD","double_zero"
"CD003833_pub5_data","5::overall","5","overall","Blood pressure",4,4,4,FALSE,TRUE,"RD","double_zero"
"CD003962_pub3_data","11::overall","11","overall","Change in serum creatinine",5,5,5,FALSE,TRUE,"RD","double_zero"
"CD003962_pub3_data","12::overall","12","overall","Creatinine clearance",26,26,26,FALSE,TRUE,"RD","double_zero"
"CD004184_pub3_data","5::overall","5","overall","24-hour mean systolic blood pressure (SBP) change by ambulatory blood pressure monitoring (ABPM) (mmHg)",52,52,52,FALSE,TRUE,"RD","double_zero"
"CD004184_pub3_data","6::overall","6","overall","24-hour mean diastolic blood pressure (DBP) change by ABPM (mmHg)",52,52,52,FALSE,TRUE,"RD","double_zero"
"CD004184_pub3_data","7::overall","7","overall","Mean SBP change by ABPM (mmHg)",14,14,14,FALSE,TRUE,"RD","double_zero"
"CD004184_pub3_data","8::overall","8","overall","Mean DBP change by ABPM (mmHg)",14,14,14,FALSE,TRUE,"RD","double_zero"
"CD004184_pub3_data","9::overall","9","overall","Surge of SBP (mmHg)",10,10,10,FALSE,TRUE,"RD","double_zero"
"CD004184_pub3_data","10::overall","10","overall","Surge of DBP (mmHg)",10,10,10,FALSE,TRUE,"RD","double_zero"
"CD004372_pub3_data","1::overall","1","overall","Mean difference in HADS-D scores at 3-month follow-up",2,2,2,FALSE,TRUE,"RD","double_zero"
"CD004372_pub3_data","2::overall","2","overall","Mean difference in HADS-D scores at 12-month follow-up",2,2,2,FALSE,TRUE,"RD","double_zero"
"CD004508_pub5_data","7::overall","7","overall","Time to the presence of bowel sounds (random-effects model)",3,3,3,FALSE,TRUE,"RD","double_zero"
"CD004508_pub5_data","8::overall","8","overall","Time to the first passage of flatus",5,5,5,FALSE,TRUE,"RD","double_zero"
"CD004508_pub5_data","9::overall","9","overall","Time to the first passage of stool",4,4,4,FALSE,TRUE,"RD","double_zero"
"CD004508_pub5_data","10::overall","10","overall","Time to the first solid diet (random-effects model)",3,3,3,FALSE,TRUE,"RD","double_zero"
"CD004508_pub5_data","11::overall","11","overall","Hospital stay (random-effects model)",5,5,5,FALSE,TRUE,"RD","double_zero"
"CD004667_pub6_data","9::overall","9","overall","Maternal death",3,3,3,FALSE,TRUE,"RD","double_zero"
"CD004703_pub3_data","4::overall","4","overall","Early postoperative pain (30th postoperative day)",3,3,3,FALSE,TRUE,"RD","double_zero"
"CD004736_pub6_data","77::overall","77","overall","Infant Hb concentration within the first 6 months (in g/L counting the last reported measure after birth within this period) (ALL)",3,3,3,FALSE,TRUE,"RD","double_zero"
"CD004762_pub3_data","1::overall","1","overall","Improvement of myotonia: visual analogue scale ",7,7,7,FALSE,TRUE,"RD","double_zero"
"CD004762_pub3_data","2::overall","2","overall","Relaxation time (seconds, 90% to 5%)",9,9,9,FALSE,TRUE,"RD","double_zero"
"CD004762_pub3_data","3::overall","3","overall","Quality of life: 36-item Short Form",5,5,5,FALSE,TRUE,"RD","double_zero"
"CD004762_pub3_data","4::overall","4","overall","Quality of life: Individualized Neuromuscular Quality of Life",6,6,6,FALSE,TRUE,"RD","double_zero"
"CD004762_pub3_data","5::overall","5","overall","Quality of life: Individualized Neuromuscular Quality of Life",2,2,2,FALSE,TRUE,"RD","double_zero"
"CD004871_pub5_data","1::overall","1","overall","Pain (short-term)",26,26,26,FALSE,TRUE,"RD","double_zero"
"CD004871_pub5_data","4::overall","4","overall","Participant-reported treatment success (short-term)",9,9,9,FALSE,TRUE,"RD","double_zero"
"CD004871_pub5_data","8::overall","8","overall","Pain (short-term): subgroup analysis by disorder classification",9,9,9,FALSE,TRUE,"RD","double_zero"
"CD004871_pub5_data","9::overall","9","overall","Pain (short-term): subgroup analysis by dose",12,12,12,FALSE,TRUE,"RD","double_zero"
"CD004871_pub5_data","10::overall","10","overall","Pain (short-term): subgroup analysis by disorder classification",11,11,11,FALSE,TRUE,"RD","double_zero"
"CD004871_pub5_data","11::overall","11","overall","Pain (short-term): subgroup analysis by symptom duration",8,8,8,FALSE,TRUE,"RD","double_zero"
"CD004871_pub5_data","12::overall","12","overall","Function-disability (short-term): subgroup analysis by dose",7,7,7,FALSE,TRUE,"RD","double_zero"
"CD004871_pub5_data","13::overall","13","overall","Function-disability (short-term): subgroup analysis by disorder classification",6,6,6,FALSE,TRUE,"RD","double_zero"
"CD004871_pub5_data","14::overall","14","overall","Function-disability (short-term): subgroup analysis by disorder duration",4,4,4,FALSE,TRUE,"RD","double_zero"
"CD004953_pub5_data","10::overall","10","overall","Duration of mechanical ventilation",7,7,7,FALSE,TRUE,"RD","double_zero"
"CD004953_pub5_data","11::overall","11","overall","Sensitivity analysis - Duration of mechanical ventilation",6,6,6,FALSE,TRUE,"RD","double_zero"
"CD004992_pub4_data","5::overall","5","overall","Serum anti-Müllerian hormone levels (ng/mL) three months after surgery (short term)",3,3,3,FALSE,TRUE,"RD","double_zero"
"CD004992_pub4_data","6::overall","6","overall","Serum anti-Müllerian hormone levels (ng/mL) six months after surgery",2,2,2,FALSE,TRUE,"RD","double_zero"
"CD004992_pub4_data","7::overall","7","overall","Antral follicle count (number of follicles) six months after surgery",3,3,3,FALSE,TRUE,"RD","double_zero"
"CD004992_pub4_data","8::overall","8","overall","Ovarian volume (cm3) six months after surgery",3,3,3,FALSE,TRUE,"RD","double_zero"
"CD005343_pub7_data","1::overall","1","overall","Overall survival",4,4,4,FALSE,TRUE,"RD","double_zero"
"CD005343_pub7_data","2::overall","2","overall","Overall survival by age",10,10,10,FALSE,TRUE,"RD","double_zero"
"CD005343_pub7_data","3::overall","3","overall","Overall survival by stage",6,6,6,FALSE,TRUE,"RD","double_zero"
"CD005343_pub7_data","4::overall","4","overall","Overall survival by residual disease",9,9,9,FALSE,TRUE,"RD","double_zero"
"CD005343_pub7_data","5::overall","5","overall","Progression-free survival",4,4,4,FALSE,TRUE,"RD","double_zero"
"CD005343_pub7_data","9::overall","9","overall","EORTC QLQ-C30 QoL at 6 months: functional status",15,15,15,FALSE,TRUE,"RD","double_zero"
"CD005343_pub7_data","10::overall","10","overall","EORTC QLQ-C30 QoL at 6 months; symptoms",16,16,16,FALSE,TRUE,"RD","double_zero"
"CD005343_pub7_data","11::overall","11","overall","EORTC QLQ-C30 QoL at 12 months; functional status",15,15,15,FALSE,TRUE,"RD","double_zero"
"CD005343_pub7_data","12::overall","12","overall","EORTC QLQ-C30 QoL at 12 months; symptoms",16,16,16,FALSE,TRUE,"RD","double_zero"
"CD005343_pub7_data","13::overall","13","overall","EORTC QLQ OV-28 score at 6 months",8,8,8,FALSE,TRUE,"RD","double_zero"
"CD005343_pub7_data","14::overall","14","overall","EORTC QLQ OV-28 score 12 months",8,8,8,FALSE,TRUE,"RD","double_zero"
"CD005495_pub5_data","1::overall","1","overall","Cognitive outcome in infancy - Developmental Quotient",110,110,110,FALSE,TRUE,"RD","double_zero"
"CD005495_pub5_data","3::overall","3","overall","Cognitive outcome at school age - Intelligence Quotient ",24,24,24,FALSE,TRUE,"RD","double_zero"
"CD005495_pub5_data","4::overall","4","overall","Motor outcome in infancy - Developmental Quotient",92,92,92,FALSE,TRUE,"RD","double_zero"
"CD005495_pub5_data","5::overall","5","overall","Motor outcome at preschool age ",12,12,12,FALSE,TRUE,"RD","double_zero"
"CD005495_pub5_data","6::overall","6","overall","Motor outcome at school age ",12,12,12,FALSE,TRUE,"RD","double_zero"
"CD005566_pub4_data","8::overall","8","overall","Postoperative bleeding (mL)",80,80,80,FALSE,TRUE,"RD","double_zero"
"CD005566_pub4_data","9::overall","9","overall","Mechanical ventilation time (minutes)",32,32,32,FALSE,TRUE,"RD","double_zero"
"CD005566_pub4_data","10::overall","10","overall","ICU stay (hours)",30,30,30,FALSE,TRUE,"RD","double_zero"
"CD005566_pub4_data","11::overall","11","overall","Hospital stay (days)",25,25,25,FALSE,TRUE,"RD","double_zero"
"CD005595_pub4_data","1::overall","1","overall","Activity limitation (using OMAS; at the end of treatment)",24,24,24,FALSE,TRUE,"RD","double_zero"
"CD005595_pub4_data","3::overall","3","overall","Activity limitation (using different measurement tools; long-term follow-up, > 6 months)",17,17,17,FALSE,TRUE,"RD","double_zero"
"CD005595_pub4_data","5::overall","5","overall","HRQoL (using different measurement tools; short-term follow-up, ≤ 6 months)",15,15,15,FALSE,TRUE,"RD","double_zero"
"CD005595_pub4_data","6::overall","6","overall","HRQoL (using different measurement tools; long-term follow-up, > 6 months)",11,11,11,FALSE,TRUE,"RD","double_zero"
"CD005595_pub4_data","7::overall","7","overall","Participant satisfaction (VAS, /10; end of treatment, and short-term follow-up of ≤ 6 months)",7,7,7,FALSE,TRUE,"RD","double_zero"
"CD005595_pub4_data","9::overall","9","overall","Pain (VAS; short-term follow-up, ≤ 6 months)",10,10,10,FALSE,TRUE,"RD","double_zero"
"CD005951_pub5_data","7::overall","7","overall","Quality of life (EuroQoL health utility score)",2,2,2,FALSE,TRUE,"RD","double_zero"
"CD005951_pub5_data","8::overall","8","overall","Mood (Zung Depression Scale)",2,2,2,FALSE,TRUE,"RD","double_zero"
"CD005951_pub5_data","11::overall","11","overall","Barthel Index",2,2,2,FALSE,TRUE,"RD","double_zero"
"CD006124_pub3_data","7::overall","7","overall","Hospital stay",9,9,9,FALSE,TRUE,"RD","double_zero"
"CD006185_pub6_data","3::overall","3","overall","Walking velocity (metres per second) at end of intervention phase",73,73,73,FALSE,TRUE,"RD","double_zero"
"CD006185_pub6_data","4::overall","4","overall","Walking velocity (metres per second) at follow-up",17,17,17,FALSE,TRUE,"RD","double_zero"
"CD006185_pub6_data","5::overall","5","overall","Walking capacity (metres walked in 6 minutes) at end of intervention phase",42,42,42,FALSE,TRUE,"RD","double_zero"
"CD006185_pub6_data","6::overall","6","overall","Walking capacity (metres walked in 6 minutes) at follow-up",15,15,15,FALSE,TRUE,"RD","double_zero"
"CD006185_pub6_data","2::1","2","1","Walking velocity: ambulatory status at start of study",58,58,58,FALSE,TRUE,"RD","double_zero"
"CD006185_pub6_data","2::2","2","2","Walking velocity: ambulatory status at start of study",46,46,46,FALSE,TRUE,"RD","double_zero"
"CD006185_pub6_data","2::3","2","3","Walking velocity: ambulatory status at start of study",38,38,38,FALSE,TRUE,"RD","double_zero"
"CD006185_pub6_data","3::1","3","1","Walking capacity: ambulatory status at start of study",34,34,34,FALSE,TRUE,"RD","double_zero"
"CD006185_pub6_data","3::2","3","2","Walking capacity: ambulatory status at start of study",27,27,27,FALSE,TRUE,"RD","double_zero"
"CD006185_pub6_data","3::3","3","3","Walking capacity: ambulatory status at start of study",20,20,20,FALSE,TRUE,"RD","double_zero"
"CD006185_pub6_data","2::4","2","4","Different devices for regaining walking speed",3,3,3,FALSE,TRUE,"RD","double_zero"
"CD006185_pub6_data","3::4","3","4","Different devices for regaining walking capacity",2,2,2,FALSE,TRUE,"RD","double_zero"
"CD006515_pub2_data","5::overall","5","overall","Residual kidney function (end of study CrCl) [mL/min]",2,2,2,FALSE,TRUE,"RD","double_zero"
"CD006515_pub2_data","8::overall","8","overall","Blood pressure [mm Hg]",2,2,2,FALSE,TRUE,"RD","double_zero"
"CD006515_pub2_data","12::overall","12","overall","Dialysis adequacy measures",4,4,4,FALSE,TRUE,"RD","double_zero"
"CD006536_pub5_data","9::overall","9","overall","Quality of life measures",6,6,6,FALSE,TRUE,"RD","double_zero"
"CD006536_pub5_data","10::overall","10","overall","NYHA classification",11,11,11,FALSE,TRUE,"RD","double_zero"
"CD006536_pub5_data","11::overall","11","overall","Exercise tolerance",7,7,7,FALSE,TRUE,"RD","double_zero"
"CD006536_pub5_data","12::overall","12","overall","Maximum VO2 (mL/kg/min)",4,4,4,FALSE,TRUE,"RD","double_zero"
"CD006536_pub5_data","13::overall","13","overall","VE/VCO2 slope",4,4,4,FALSE,TRUE,"RD","double_zero"
"CD006536_pub5_data","14::overall","14","overall","Peak heart rate (bpm)",4,4,4,FALSE,TRUE,"RD","double_zero"
"CD006536_pub5_data","15::overall","15","overall","LVEF measured by MRI (< 12 months)",51,51,51,FALSE,TRUE,"RD","double_zero"
"CD006536_pub5_data","16::overall","16","overall","LVEF measured by MRI (≥ 12 months)",34,34,34,FALSE,TRUE,"RD","double_zero"
"CD006536_pub5_data","17::overall","17","overall","LVEF measured by echocardiography (< 12 months)",49,49,49,FALSE,TRUE,"RD","double_zero"
"CD006536_pub5_data","18::overall","18","overall","LVEF measured by echocardiography (≥ 12 months)",32,32,32,FALSE,TRUE,"RD","double_zero"
"CD006536_pub5_data","19::overall","19","overall","LVEF measured by SPECT (< 12 months)",21,21,21,FALSE,TRUE,"RD","double_zero"
"CD006536_pub5_data","20::overall","20","overall","LVEF measured by SPECT (≥ 12 months)",11,11,11,FALSE,TRUE,"RD","double_zero"
"CD006536_pub5_data","21::overall","21","overall","LVEF measured by left ventricular angiography (< 12 months)",24,24,24,FALSE,TRUE,"RD","double_zero"
"CD006536_pub5_data","22::overall","22","overall","LVEF measured by left ventricular angiography (≥ 12 months)",5,5,5,FALSE,TRUE,"RD","double_zero"
"CD006536_pub5_data","23::overall","23","overall","LVEF measured by radionuclide ventriculography (RNV) (< 12 months)",10,10,10,FALSE,TRUE,"RD","double_zero"
"CD006632_pub3_data","1::1","1","1","Inhospital mortality",7,7,7,FALSE,TRUE,"RD","double_zero"
"CD006632_pub3_data","2::overall","2","overall","Mortality (up to 6 months)",6,6,6,FALSE,TRUE,"RD","double_zero"
"CD006632_pub3_data","3::1","3","1","Inhospital complications",11,11,11,FALSE,TRUE,"RD","double_zero"
"CD006632_pub3_data","4::1","4","1","Hospital readmission (up to 6 months)",9,9,9,FALSE,TRUE,"RD","double_zero"
"CD006632_pub3_data","5::1","5","1","Length of hospital stay (days)",25,25,25,FALSE,TRUE,"RD","double_zero"
"CD006632_pub3_data","5::2","5","2","Length of hospital stay (days)",3,3,3,FALSE,TRUE,"RD","double_zero"
"CD006632_pub3_data","6::1","6","1","Hospital cost and charges",10,10,10,FALSE,TRUE,"RD","double_zero"
"CD006632_pub3_data","7::1","7","1","Adherence to recommended practice",3,3,3,FALSE,TRUE,"RD","double_zero"
"CD006632_pub3_data","8::overall","8","overall","Sensitivity analysis: Risk of bias inhospital mortality (studies at high RoB excluded)",5,5,5,FALSE,TRUE,"RD","double_zero"
"CD006632_pub3_data","9::overall","9","overall","Sensitivity analysis: Risk of bias 6 months mortality (studies at high RoB excluded)",2,2,2,FALSE,TRUE,"RD","double_zero"
"CD006632_pub3_data","10::overall","10","overall","Sensitivity analysis: Risk of bias inhospital complications (studies at high RoB excluded)",5,5,5,FALSE,TRUE,"RD","double_zero"
"CD006632_pub3_data","11::overall","11","overall","Sensitivity analysis: Risk of bias hospital readmission (up to 6 months; studies at high RoB excluded)",5,5,5,FALSE,TRUE,"RD","double_zero"
"CD006632_pub3_data","12::overall","12","overall","Sensitivity analysis: Risk of bias length of hospital stay in days (studies at high RoB excluded)",12,12,12,FALSE,TRUE,"RD","double_zero"
"CD006632_pub3_data","1::overall","1","overall","Inhospital mortality",2,2,2,FALSE,TRUE,"RD","double_zero"
"CD006632_pub3_data","3::overall","3","overall","Hospital readmission (up to 6 months)",2,2,2,FALSE,TRUE,"RD","double_zero"
"CD006632_pub3_data","4::overall","4","overall","Length of hospital stay (days)",4,4,4,FALSE,TRUE,"RD","double_zero"
"CD006632_pub3_data","5::3","5","3","Hospital cost and charges",3,3,3,FALSE,TRUE,"RD","double_zero"
"CD006632_pub3_data","6::overall","6","overall","Sensitivity analysis: Risk of bias 6-month mortality (studies at high risk of bias excluded)",2,2,2,FALSE,TRUE,"RD","double_zero"
"CD006712_pub3_data","1::overall","1","overall","Pain with dilation",13,13,13,FALSE,TRUE,"RD","double_zero"
"CD006712_pub3_data","2::overall","2","overall","Pain with aspiration",10,10,10,FALSE,TRUE,"RD","double_zero"
"CD006712_pub3_data","3::overall","3","overall","Pain with aspiration (lidocaine)",2,2,2,FALSE,TRUE,"RD","double_zero"
"CD006913_pub3_data","1::1","1","1","Quality of life (short-term) -  psychotherapy vs care-as-usual, with Xiao",20,20,20,FALSE,TRUE,"RD","double_zero"
"CD006913_pub3_data","1::2","1","2","Quality of life (short-term) -  psychotherapy vs care-as-usual, with Xiao",16,16,16,FALSE,TRUE,"RD","double_zero"
"CD006913_pub3_data","1::3","1","3","Quality of life (short-term) -  psychotherapy vs care-as-usual, with Xiao",61,61,61,FALSE,TRUE,"RD","double_zero"
"CD006913_pub3_data","2::1","2","1","Quality of life (short-term) -  psychotherapy vs care-as-usual, revised",21,21,21,FALSE,TRUE,"RD","double_zero"
"CD006913_pub3_data","2::2","2","2","Quality of life (short-term) -  psychotherapy vs care-as-usual, revised",15,15,15,FALSE,TRUE,"RD","double_zero"
"CD006913_pub3_data","2::3","2","3","Quality of life (short-term) -  psychotherapy vs care-as-usual, revised",36,36,36,FALSE,TRUE,"RD","double_zero"
"CD006913_pub3_data","3::1","3","1","IBDQ (short-term) -  psychotherapy vs care-as-usual",15,15,15,FALSE,TRUE,"RD","double_zero"
"CD006913_pub3_data","3::2","3","2","IBDQ (short-term) -  psychotherapy vs care-as-usual",13,13,13,FALSE,TRUE,"RD","double_zero"
"CD006913_pub3_data","3::3","3","3","IBDQ (short-term) -  psychotherapy vs care-as-usual",43,43,43,FALSE,TRUE,"RD","double_zero"
"CD006913_pub3_data","4::1","4","1","Quality of life (long-term) - psychotherapy vs care-as usual",19,19,19,FALSE,TRUE,"RD","double_zero"
"CD006913_pub3_data","4::2","4","2","Quality of life (long-term) - psychotherapy vs care-as usual",13,13,13,FALSE,TRUE,"RD","double_zero"
"CD006913_pub3_data","4::3","4","3","Quality of life (long-term) - psychotherapy vs care-as usual",12,12,12,FALSE,TRUE,"RD","double_zero"
"CD006913_pub3_data","5::3","5","3","IBDQ (long-term) - psychotherapy vs care-as-usual ",8,8,8,FALSE,TRUE,"RD","double_zero"
"CD006913_pub3_data","9::1","9","1","Quality of life (long-term), by comorbidity - psychotherapy vs care-as-usual",27,27,27,FALSE,TRUE,"RD","double_zero"
"CD006913_pub3_data","9::2","9","2","Quality of life (long-term), by comorbidity - psychotherapy vs care-as-usual",34,34,34,FALSE,TRUE,"RD","double_zero"
"CD006913_pub3_data","10::1","10","1","Quality of life (short-term), by type of therapy - psychotherapy vs care-as-usual",21,21,21,FALSE,TRUE,"RD","double_zero"
"CD006913_pub3_data","10::2","10","2","Quality of life (short-term), by type of therapy - psychotherapy vs care-as-usual",15,15,15,FALSE,TRUE,"RD","double_zero"
"CD006913_pub3_data","10::3","10","3","Quality of life (short-term), by type of therapy - psychotherapy vs care-as-usual",12,12,12,FALSE,TRUE,"RD","double_zero"
"CD006913_pub3_data","10::4","10","4","Quality of life (short-term), by type of therapy - psychotherapy vs care-as-usual",6,6,6,FALSE,TRUE,"RD","double_zero"
"CD006913_pub3_data","11::3","11","3","Quality of life (long-term), by type of therapy - psychotherapy vs care-as-usual",6,6,6,FALSE,TRUE,"RD","double_zero"
"CD006913_pub3_data","14::2","14","2","Quality of life (short-term), by mode of application - psychotherapy vs care-as-usual",9,9,9,FALSE,TRUE,"RD","double_zero"
"CD006913_pub3_data","14::3","14","3","Quality of life (short-term), by mode of application - psychotherapy vs care-as-usual",4,4,4,FALSE,TRUE,"RD","double_zero"
"CD006913_pub3_data","15::2","15","2","Quality of life (short-term), by training of provider - psychotherapy vs care-as-usual",9,9,9,FALSE,TRUE,"RD","double_zero"
"CD006913_pub3_data","15::3","15","3","Quality of life (short-term), by training of provider - psychotherapy vs care-as-usual",2,2,2,FALSE,TRUE,"RD","double_zero"
"CD006913_pub3_data","9::3","9","3","Quality of life (short-term), by type of therapy - educational intervention vs care-as-usual",9,9,9,FALSE,TRUE,"RD","double_zero"
"CD006913_pub3_data","5::4","5","4","Quality of life (short-term) - educational intervention vs active control",3,3,3,FALSE,TRUE,"RD","double_zero"
"CD006913_pub3_data","11::4","11","4","Anxiety (short-term) - educational intervention vs active control",2,2,2,FALSE,TRUE,"RD","double_zero"
"CD006913_pub3_data","17::1","17","1","Disease activity (short-term) - educational intervention vs active control",2,2,2,FALSE,TRUE,"RD","double_zero"
"CD006913_pub3_data","17::3","17","3","Disease activity (short-term) - educational intervention vs active control",3,3,3,FALSE,TRUE,"RD","double_zero"
"CD006913_pub3_data","18::3","18","3","Disease activity (long-term) - educational intervention vs active control",2,2,2,FALSE,TRUE,"RD","double_zero"
"CD006913_pub3_data","19::2","19","2","Quality of life (short-term) - relaxation technique vs active control",3,3,3,FALSE,TRUE,"RD","double_zero"
"CD006913_pub3_data","20::2","20","2","IBDQ (short-term) - relaxation techniques vs active control",3,3,3,FALSE,TRUE,"RD","double_zero"
"CD006913_pub3_data","21::1","21","1","Quality of life (long-term) - relaxation techniques vs active control",2,2,2,FALSE,TRUE,"RD","double_zero"
"CD006913_pub3_data","22::1","22","1","IBDQ (long-term) - relaxation techniques vs active control",2,2,2,FALSE,TRUE,"RD","double_zero"
"CD006913_pub3_data","23::1","23","1","Depressive symptoms (shortterm) - relaxation techniques vs active control",2,2,2,FALSE,TRUE,"RD","double_zero"
"CD006913_pub3_data","24::1","24","1","Depressive symptoms (long-term) - relaxation techniques vs active control",2,2,2,FALSE,TRUE,"RD","double_zero"
"CD006913_pub3_data","25::1","25","1","Anxiety (short-term) - relaxation techniques vs active control",2,2,2,FALSE,TRUE,"RD","double_zero"
"CD006913_pub3_data","26::1","26","1","Anxiety (long-term) - relaxation techniques vs active control",2,2,2,FALSE,TRUE,"RD","double_zero"
"CD006913_pub3_data","29::2","29","2","Disease activity (short-term) - relaxation techniques vs active control",3,3,3,FALSE,TRUE,"RD","double_zero"
"CD006913_pub3_data","30::1","30","1","Disease activity (long-term) - relaxation techniques vs active control",2,2,2,FALSE,TRUE,"RD","double_zero"
"CD006919_pub5_data","8::overall","8","overall","Number of oocytes 100 µg vs 25 µg",2,2,2,FALSE,TRUE,"RD","double_zero"
"CD006919_pub5_data","10::overall","10","overall","Amount of gonadotropins administered",2,2,2,FALSE,TRUE,"RD","double_zero"
"CD006982_pub5_data","1::overall","1","overall","Growth (g) at 3 and 6 months",8,8,8,FALSE,TRUE,"RD","double_zero"
"CD006982_pub5_data","2::overall","2","overall","Growth (daily weight gain, grams/d) during neonatal care",3,3,3,FALSE,TRUE,"RD","double_zero"
"CD006982_pub5_data","5::overall","5","overall","Duration of initial hospitalisation (days) ",5,5,5,FALSE,TRUE,"RD","double_zero"
"CD006982_pub5_data","6::overall","6","overall","Duration of oxygen treatment (days)",2,2,2,FALSE,TRUE,"RD","double_zero"
"CD007024_pub3_data","1::overall","1","overall","Frequency of cocaine use",27,27,27,FALSE,TRUE,"RD","double_zero"
"CD007024_pub3_data","2::overall","2","overall","Amount of cocaine use",20,20,20,FALSE,TRUE,"RD","double_zero"
"CD007079_pub4_data","7::overall","7","overall","Maternal bone mineral density (g/cm2) – first phalanx (calcium 300 mg)",20,20,20,FALSE,TRUE,"RD","double_zero"
"CD007079_pub4_data","8::overall","8","overall","Maternal bone mineral density (g/cm2) – second metacarpal (calcium 300 mg)",7,7,7,FALSE,TRUE,"RD","double_zero"
"CD007079_pub4_data","9::overall","9","overall","Maternal bone mineral density (g/cm2) – fourth metacarpal (calcium 300 mg)",4,4,4,FALSE,TRUE,"RD","double_zero"
"CD007079_pub4_data","11::overall","11","overall","Maternal bone mineral density (g/cm2) – second metacarpal (calcium 600 mg)",5,5,5,FALSE,TRUE,"RD","double_zero"
"CD007110_pub4_data","4::overall","4","overall","Subgroup analysis – CVPP chemotherapy vs eBEACOPP and ABVD chemotherapy",2,2,2,FALSE,TRUE,"RD","double_zero"
"CD007130_pub5_data","2::overall","2","overall","Exercise capacity ≤ 12 months",28,28,28,FALSE,TRUE,"RD","double_zero"
"CD007130_pub5_data","3::overall","3","overall","Exercise capacity 12 to 24 months",3,3,3,FALSE,TRUE,"RD","double_zero"
"CD007130_pub5_data","5::overall","5","overall","Total cholesterol 3 to 12 months (mmol/L)",11,11,11,FALSE,TRUE,"RD","double_zero"
"CD007130_pub5_data","6::overall","6","overall","HDL cholesterol 3 to 12 months (mmol/L)",9,9,9,FALSE,TRUE,"RD","double_zero"
"CD007130_pub5_data","7::overall","7","overall","LDL cholesterol 3 to 12 months (mmol/L)",6,6,6,FALSE,TRUE,"RD","double_zero"
"CD007130_pub5_data","8::overall","8","overall","Triglycerides 3 to 12 months (mmol/L)",7,7,7,FALSE,TRUE,"RD","double_zero"
"CD007130_pub5_data","9::overall","9","overall","Systolic blood pressure 3 to 12 months (mmHg)",14,14,14,FALSE,TRUE,"RD","double_zero"
"CD007130_pub5_data","10::overall","10","overall","Diastolic blood pressure 3 to 12 months (mmHg)",13,13,13,FALSE,TRUE,"RD","double_zero"
"CD007156_pub3_data","1::overall","1","overall","Interincisal distance (mm)",46,46,46,FALSE,TRUE,"RD","double_zero"
"CD007156_pub3_data","2::overall","2","overall","Burning sensation (VAS)",22,22,22,FALSE,TRUE,"RD","double_zero"
"CD007310_pub3_data","2::overall","2","overall","Dilation achieved (mm)",9,9,9,FALSE,TRUE,"RD","double_zero"
"CD007310_pub3_data","1::overall","1","overall","Procedure time (minutes)",14,14,14,FALSE,TRUE,"RD","double_zero"
"CD007374_pub3_data","6::overall","6","overall","Patient-oriented measures: beliefs at the end of follow-up (attitude scales)",5,5,5,FALSE,TRUE,"RD","double_zero"
"CD007374_pub3_data","7::overall","7","overall","Patient-oriented measures: knowledge of diabetes at the end of treatment",11,11,11,FALSE,TRUE,"RD","double_zero"
"CD007374_pub3_data","8::overall","8","overall","Patient-oriented measures: general knowledge of diabetes",2,2,2,FALSE,TRUE,"RD","double_zero"
"CD007374_pub3_data","9::overall","9","overall","Patient-oriented measures: self-efficacy at the end of treatment",4,4,4,FALSE,TRUE,"RD","double_zero"
"CD007374_pub3_data","10::overall","10","overall","Patient-oriented measures: self-efficacy at the end of follow-up",5,5,5,FALSE,TRUE,"RD","double_zero"
"CD007374_pub3_data","12::overall","12","overall","Patient-oriented measures: behavioural changes at the end of treatment",5,5,5,FALSE,TRUE,"RD","double_zero"
"CD007374_pub3_data","13::overall","13","overall","Patient-oriented measures: behavioural changes at the end of follow-up",10,10,10,FALSE,TRUE,"RD","double_zero"
"CD007374_pub3_data","16::overall","16","overall","Blood pressure [mm Hg]",2,2,2,FALSE,TRUE,"RD","double_zero"
"CD007374_pub3_data","19::overall","19","overall","Quality of life",5,5,5,FALSE,TRUE,"RD","double_zero"
"CD007374_pub3_data","20::overall","20","overall","Lipids [mmol/L]",4,4,4,FALSE,TRUE,"RD","double_zero"
"CD007491_pub3_data","1::overall","1","overall","Mortality at 3 months using IPD",3,3,3,FALSE,TRUE,"RD","double_zero"
"CD007491_pub3_data","2::overall","2","overall","Mortality at 6 months' follow-up (using published data, and IPD from Wilson and Shepperd)",5,5,5,FALSE,TRUE,"RD","double_zero"
"CD007491_pub3_data","3::overall","3","overall","Readmission to hospital after discharge from hospital at home or inpatient care (3 to 12 months' follow-up)",8,8,8,FALSE,TRUE,"RD","double_zero"
"CD007491_pub3_data","5::overall","5","overall","Living in residential care at follow-up",4,4,4,FALSE,TRUE,"RD","double_zero"
"CD007569_pub4_data","2::overall","2","overall","Quality of life",7,7,7,FALSE,TRUE,"RD","double_zero"
"CD007572_pub4_data","5::3","5","3","Disease activity (change in CDAI)",2,2,2,FALSE,TRUE,"RD","double_zero"
"CD007572_pub4_data","8::1","8","1","Quality of life (IBDQ score)",2,2,2,FALSE,TRUE,"RD","double_zero"
"CD007572_pub4_data","8::2","8","2","Quality of life (IBDQ score)",2,2,2,FALSE,TRUE,"RD","double_zero"
"CD007639_pub3_data","7::overall","7","overall","Deposition (sputum AUC)",11,11,11,FALSE,TRUE,"RD","double_zero"
"CD007639_pub3_data","8::overall","8","overall","Deposition (lung)",2,2,2,FALSE,TRUE,"RD","double_zero"
"CD007639_pub3_data","9::overall","9","overall","Deposition (lung - central to peripheral ratio)",2,2,2,FALSE,TRUE,"RD","double_zero"
"CD007639_pub3_data","10::overall","10","overall","Adherence",3,3,3,FALSE,TRUE,"RD","double_zero"
"CD007639_pub3_data","14::overall","14","overall","Change in FEV1 ",2,2,2,FALSE,TRUE,"RD","double_zero"
"CD007674_pub3_data","1::overall","1","overall","Reduction in anxiety severity",55,55,55,FALSE,TRUE,"RD","double_zero"
"CD007674_pub3_data","7::overall","7","overall","Quality of life",39,39,39,FALSE,TRUE,"RD","double_zero"
"CD007784_pub3_data","11::overall","11","overall","End of treatment kidney function",18,18,18,FALSE,TRUE,"RD","double_zero"
"CD007784_pub3_data","12::overall","12","overall","End of treatment proteinuria",7,7,7,FALSE,TRUE,"RD","double_zero"
"CD007784_pub3_data","18::overall","18","overall","Total cholesterol",27,27,27,FALSE,TRUE,"RD","double_zero"
"CD007784_pub3_data","19::overall","19","overall","LDL cholesterol",24,24,24,FALSE,TRUE,"RD","double_zero"
"CD007784_pub3_data","20::overall","20","overall","Triglycerides",20,20,20,FALSE,TRUE,"RD","double_zero"
"CD007784_pub3_data","21::overall","21","overall","HDL cholesterol",22,22,22,FALSE,TRUE,"RD","double_zero"
"CD007784_pub3_data","27::overall","27","overall","Subgroup analysis (statin dose): total cholesterol",27,27,27,FALSE,TRUE,"RD","double_zero"
"CD007784_pub3_data","28::overall","28","overall","Subgroup analysis (statin dose): LDL cholesterol",24,24,24,FALSE,TRUE,"RD","double_zero"
"CD007784_pub3_data","29::overall","29","overall","Subgroup analysis (statin dose): HDL cholesterol",22,22,22,FALSE,TRUE,"RD","double_zero"
"CD007784_pub3_data","30::overall","30","overall","Subgroup analysis (statin dose): triglycerides",20,20,20,FALSE,TRUE,"RD","double_zero"
"CD007784_pub3_data","31::overall","31","overall","Subgroup analysis (age): total cholesterol",27,27,27,FALSE,TRUE,"RD","double_zero"
"CD007784_pub3_data","33::overall","33","overall","Subgroup analysis (age): LDL cholesterol",24,24,24,FALSE,TRUE,"RD","double_zero"
"CD007784_pub3_data","34::overall","34","overall","Subgroup analysis (age): HDL cholesterol",22,22,22,FALSE,TRUE,"RD","double_zero"
"CD007784_pub3_data","35::overall","35","overall","Subgroup analysis (age): triglycerides",20,20,20,FALSE,TRUE,"RD","double_zero"
"CD007784_pub3_data","39::overall","39","overall","Subgroup analysis (diabetes mellitus): total cholesterol",27,27,27,FALSE,TRUE,"RD","double_zero"
"CD007784_pub3_data","40::overall","40","overall","Subgroup analysis (diabetes mellitus): LDL cholesterol",24,24,24,FALSE,TRUE,"RD","double_zero"
"CD007784_pub3_data","41::overall","41","overall","Subgroup analysis (diabetes mellitus): HDL cholesterol",22,22,22,FALSE,TRUE,"RD","double_zero"
"CD007784_pub3_data","42::overall","42","overall","Subgroup analysis (diabetes mellitus): triglycerides",20,20,20,FALSE,TRUE,"RD","double_zero"
"CD007784_pub3_data","43::overall","43","overall","Subgroup analysis (baseline cholesterol): total cholesterol",27,27,27,FALSE,TRUE,"RD","double_zero"
"CD007784_pub3_data","44::overall","44","overall","Subgroup analysis (baseline cholesterol): LDL cholesterol",24,24,24,FALSE,TRUE,"RD","double_zero"
"CD007784_pub3_data","46::overall","46","overall","Subgroup analysis (baseline cholesterol): HDL cholesterol",22,22,22,FALSE,TRUE,"RD","double_zero"
"CD007784_pub3_data","47::overall","47","overall","Subgroup analysis (baseline cholesterol): triglycerides",20,20,20,FALSE,TRUE,"RD","double_zero"
"CD007784_pub3_data","49::overall","49","overall","Subgroup analysis (allocation concealment): total cholesterol",27,27,27,FALSE,TRUE,"RD","double_zero"
"CD007784_pub3_data","51::overall","51","overall","Subgroup analysis (allocation concealment): triglycerides",20,20,20,FALSE,TRUE,"RD","double_zero"
"CD007784_pub3_data","52::overall","52","overall","Subgroup analysis (kidney function): end of treatment kidney function",17,17,17,FALSE,TRUE,"RD","double_zero"
"CD007784_pub3_data","58::overall","58","overall","Sensitvitiy analysis (funding): total cholesterol",22,22,22,FALSE,TRUE,"RD","double_zero"
"CD007784_pub3_data","59::overall","59","overall","Sensitivity analysis (funding): LDL cholesterol",19,19,19,FALSE,TRUE,"RD","double_zero"
"CD007784_pub3_data","60::overall","60","overall","Sensitivy analysis (funding): HDL cholesterol",19,19,19,FALSE,TRUE,"RD","double_zero"
"CD007784_pub3_data","61::overall","61","overall","Sensitivity analysis (funding): triglycerides",17,17,17,FALSE,TRUE,"RD","double_zero"
"CD007809_pub3_data","1::overall","1","overall","Pain (0-10 numerical rating scale) at 12 weeks",11,11,11,FALSE,TRUE,"RD","double_zero"
"CD007809_pub3_data","2::overall","2","overall","Function (FHSQ) at 12 weeks",11,11,11,FALSE,TRUE,"RD","double_zero"
"CD007809_pub3_data","3::overall","3","overall","Quality of life (Assessment of Quality of Life instrument) at 12 weeks",10,10,10,FALSE,TRUE,"RD","double_zero"
"CD007809_pub3_data","7::overall","7","overall","Quality of life (SF-36 - Vitality)",4,4,4,FALSE,TRUE,"RD","double_zero"
"CD007809_pub3_data","8::overall","8","overall","Quality of life (SF-36 - Social Functioning)",4,4,4,FALSE,TRUE,"RD","double_zero"
"CD007809_pub3_data","9::overall","9","overall","Quality of life (SF-36 - Role-Emotional)",4,4,4,FALSE,TRUE,"RD","double_zero"
"CD007809_pub3_data","10::overall","10","overall","Quality of life (SF-36 - Mental Health)",4,4,4,FALSE,TRUE,"RD","double_zero"
"CD007809_pub3_data","12::overall","12","overall","Number of participants withdrawing due to an adverse event",4,4,4,FALSE,TRUE,"RD","double_zero"
"CD007809_pub3_data","13::overall","13","overall","Passive, non-weightbearing peak dorsiflexion of the big toe",4,4,4,FALSE,TRUE,"RD","double_zero"
"CD007809_pub3_data","21::overall","21","overall","Passive, non-weightbearing peak dorsiflexion of the big toe",2,2,2,FALSE,TRUE,"RD","double_zero"
"CD007837_pub3_data","1::overall","1","overall","Cobb angle (°)",11,11,11,FALSE,TRUE,"RD","double_zero"
"CD007837_pub3_data","2::overall","2","overall","Angle of trunk rotation (ATR) (°)",5,5,5,FALSE,TRUE,"RD","double_zero"
"CD007837_pub3_data","4::overall","4","overall","Subjective evaluation (Spinal Appearance Questionnaire – General) (points)",6,6,6,FALSE,TRUE,"RD","double_zero"
"CD007837_pub3_data","5::overall","5","overall","Subjective evaluation (SRS-22 Self-Image) (points)",6,6,6,FALSE,TRUE,"RD","double_zero"
"CD007837_pub3_data","6::overall","6","overall","Quality of life (SRS-22 Total score) (points)",5,5,5,FALSE,TRUE,"RD","double_zero"
"CD007837_pub3_data","7::overall","7","overall","Back pain (SRS-22 Pain, SF-36 Pain)",5,5,5,FALSE,TRUE,"RD","double_zero"
"CD007837_pub3_data","8::overall","8","overall","Mental health (SRS-22 Mental Health, SF-36 Mental Health) (points)",3,3,3,FALSE,TRUE,"RD","double_zero"
"CD007859_pub5_data","1::overall","1","overall","Alignment rate (LII reduction; mm): multistrand StSt versus conventional StSt",51,51,51,FALSE,TRUE,"RD","double_zero"
"CD007859_pub5_data","2::overall","2","overall","Alignment rate (LII reduction; mm): multistrand StSt versus superelastic nickel-titanium (NiTi)",33,33,33,FALSE,TRUE,"RD","double_zero"
"CD007859_pub5_data","3::overall","3","overall","Alignment rate (LII reduction; mm): multistrand StSt versus thermoelastic nickel-titanium (NiTi)",36,36,36,FALSE,TRUE,"RD","double_zero"
"CD007859_pub5_data","6::overall","6","overall","Pain (100-mm VAS)",18,18,18,FALSE,TRUE,"RD","double_zero"
"CD007872_pub4_data","15::overall","15","overall","Estimated mean blood loss",2,2,2,FALSE,TRUE,"RD","double_zero"
"CD007872_pub4_data","17::overall","17","overall","Myocardial infarction",2,2,2,FALSE,TRUE,"RD","double_zero"
"CD007872_pub4_data","18::overall","18","overall","Stroke",2,2,2,FALSE,TRUE,"RD","double_zero"
"CD007872_pub4_data","20::overall","20","overall","Organ failure/dysfunction                     ",2,2,2,FALSE,TRUE,"RD","double_zero"
"CD007895_pub3_data","1::overall","1","overall","Systolic blood pressure, measured as change-from-baseline",4,4,4,FALSE,TRUE,"RD","double_zero"
"CD007895_pub3_data","2::overall","2","overall","Diastolic blood pressure, measured as change-from-baseline",5,5,5,FALSE,TRUE,"RD","double_zero"
"CD007895_pub3_data","3::overall","3","overall","Heart rate, measured as change-from-baseline",2,2,2,FALSE,TRUE,"RD","double_zero"
"CD007896_pub4_data","1::overall","1","overall","Systolic blood pressure",425,425,425,FALSE,TRUE,"RD","double_zero"
"CD007896_pub4_data","2::overall","2","overall","Diastolic blood pressure",425,425,425,FALSE,TRUE,"RD","double_zero"
"CD007896_pub4_data","3::overall","3","overall","Heart rate (beats per minute)",358,358,358,FALSE,TRUE,"RD","double_zero"
"CD008063_pub3_data","1::overall","1","overall","Extent of substance use",148,148,148,FALSE,TRUE,"RD","double_zero"
"CD008063_pub3_data","2::overall","2","overall","Readiness to change",12,12,12,FALSE,TRUE,"RD","double_zero"
"CD008063_pub3_data","3::overall","3","overall","Retention in treatment",19,19,19,FALSE,TRUE,"RD","double_zero"
"CD008145_pub4_data","1::overall","1","overall","Reception of DTP3 by 1 year of age",28,28,28,FALSE,TRUE,"RD","double_zero"
"CD008145_pub4_data","2::overall","2","overall","Uptake of BCG vaccine",13,13,13,FALSE,TRUE,"RD","double_zero"
"CD008145_pub4_data","3::overall","3","overall","Uptake of OPV3 vaccine",14,14,14,FALSE,TRUE,"RD","double_zero"
"CD008145_pub4_data","4::overall","4","overall","Uptake of HBV3 vaccine",7,7,7,FALSE,TRUE,"RD","double_zero"
"CD008145_pub4_data","5::overall","5","overall","Uptake of BCG + DTP3 + OPV vaccines",7,7,7,FALSE,TRUE,"RD","double_zero"
"CD008145_pub4_data","6::overall","6","overall","Uptake of measles vaccine",8,8,8,FALSE,TRUE,"RD","double_zero"
"CD008145_pub4_data","7::overall","7","overall","Uptake of at least 1 vaccine",5,5,5,FALSE,TRUE,"RD","double_zero"
"CD008145_pub4_data","8::overall","8","overall","Reception of all recommended vaccines by 2 years of age",3,3,3,FALSE,TRUE,"RD","double_zero"
"CD008165_pub5_data","1::overall","1","overall","Medication appropriateness (as measured by an implicit tool)",8,8,8,FALSE,TRUE,"RD","double_zero"
"CD008165_pub5_data","2::overall","2","overall","Medication appropriateness (as measured by an implicit tool) (excluding Crotty 2004a)",7,7,7,FALSE,TRUE,"RD","double_zero"
"CD008165_pub5_data","3::overall","3","overall","Number of potentially inappropriate medications",9,9,9,FALSE,TRUE,"RD","double_zero"
"CD008165_pub5_data","5::overall","5","overall","Number of potential prescribing omissions",3,3,3,FALSE,TRUE,"RD","double_zero"
"CD008176_pub3_data","9::overall","9","overall","eGFR at end of study",95,95,95,FALSE,TRUE,"RD","double_zero"
"CD008176_pub3_data","10::overall","10","overall","Change in eGFR",83,83,83,FALSE,TRUE,"RD","double_zero"
"CD008176_pub3_data","11::overall","11","overall","Serum creatinine at end of study",59,59,59,FALSE,TRUE,"RD","double_zero"
"CD008176_pub3_data","12::overall","12","overall","Change in serum creatinine",45,45,45,FALSE,TRUE,"RD","double_zero"
"CD008176_pub3_data","13::overall","13","overall","Urinary albumin/creatinine ratio at end of study",15,15,15,FALSE,TRUE,"RD","double_zero"
"CD008176_pub3_data","14::overall","14","overall","Change in urinary albumin/creatinine ratio",20,20,20,FALSE,TRUE,"RD","double_zero"
"CD008176_pub3_data","15::overall","15","overall","Proteinuria at end of study",27,27,27,FALSE,TRUE,"RD","double_zero"
"CD008176_pub3_data","16::overall","16","overall","Change in proteinuria",24,24,24,FALSE,TRUE,"RD","double_zero"
"CD008176_pub3_data","26::overall","26","overall","Sensitivity analysis: change in eGFR without imputed SD",9,9,9,FALSE,TRUE,"RD","double_zero"
"CD008176_pub3_data","27::overall","27","overall","Sensitivity analysis: change in serum creatinine without imputed SD",3,3,3,FALSE,TRUE,"RD","double_zero"
"CD008176_pub3_data","28::overall","28","overall","Sensitivity analysis: change in urinary albumin/creatinine ratio without imputed SD",2,2,2,FALSE,TRUE,"RD","double_zero"
"CD008237_pub4_data","4::overall","4","overall","Performance time",3,3,3,FALSE,TRUE,"RD","double_zero"
"CD008309_pub3_data","13::overall","13","overall","Duration of any respiratory support (mechanical ventilation, continuous positive airway pressure, high flow) (days; in survivors)",3,3,3,FALSE,TRUE,"RD","double_zero"
"CD008309_pub3_data","14::overall","14","overall","Postnatal systemic corticosteroid therapy for BPD prevention",2,2,2,FALSE,TRUE,"RD","double_zero"
"CD008309_pub3_data","17::overall","17","overall","Intraventricular haemorrhage grade III and IV",2,2,2,FALSE,TRUE,"RD","double_zero"
"CD008309_pub3_data","24::overall","24","overall","Duration of hospitalisation (days)",4,4,4,FALSE,TRUE,"RD","double_zero"
"CD008309_pub3_data","28::overall","28","overall","Number of hospital readmissions with respiratory illness in the first two years",2,2,2,FALSE,TRUE,"RD","double_zero"
"CD008349_pub5_data","1::overall","1","overall","Upper limb function post intervention (composite measure)",90,90,90,FALSE,TRUE,"RD","double_zero"
"CD008349_pub5_data","2::overall","2","overall","Hand function post intervention (grip strength)",20,20,20,FALSE,TRUE,"RD","double_zero"
"CD008349_pub5_data","3::overall","3","overall","Upper limb function post intervention: amount of use (subjective)",11,11,11,FALSE,TRUE,"RD","double_zero"
"CD008349_pub5_data","4::overall","4","overall","Upper limb function at short term follow-up (up to 3 months)",17,17,17,FALSE,TRUE,"RD","double_zero"
"CD008349_pub5_data","5::1","5","1","Upper limb function: subgroup analysis based on amount of therapy ",45,45,45,FALSE,TRUE,"RD","double_zero"
"CD008349_pub5_data","5::2","5","2","Upper limb function: subgroup analysis based on amount of therapy ",43,43,43,FALSE,TRUE,"RD","double_zero"
"CD008349_pub5_data","6::1","6","1","Upper limb function: subgroup analysis based on time since onset of stroke",28,28,28,FALSE,TRUE,"RD","double_zero"
"CD008349_pub5_data","6::2","6","2","Upper limb function: subgroup analysis based on time since onset of stroke",35,35,35,FALSE,TRUE,"RD","double_zero"
"CD008349_pub5_data","7::1","7","1","Upper limb function: subgroup analysis based on virtual reality application being customised or non-customised for rehabilitation settings ",46,46,46,FALSE,TRUE,"RD","double_zero"
"CD008349_pub5_data","7::2","7","2","Upper limb function: subgroup analysis based on virtual reality application being customised or non-customised for rehabilitation settings ",21,21,21,FALSE,TRUE,"RD","double_zero"
"CD008349_pub5_data","8::1","8","1","Upper limb function: subgroup analysis based on level of immersion of customised virtual reality application ",4,4,4,FALSE,TRUE,"RD","double_zero"
"CD008349_pub5_data","8::2","8","2","Upper limb function: subgroup analysis based on level of immersion of customised virtual reality application ",39,39,39,FALSE,TRUE,"RD","double_zero"
"CD008349_pub5_data","9::overall","9","overall","Gait speed post intervention ",13,13,13,FALSE,TRUE,"RD","double_zero"
"CD008349_pub5_data","10::overall","10","overall","Timed Up and Go Test post intervention ",25,25,25,FALSE,TRUE,"RD","double_zero"
"CD008349_pub5_data","11::overall","11","overall","Balance post intervention ",26,26,26,FALSE,TRUE,"RD","double_zero"
"CD008349_pub5_data","12::overall","12","overall","Cognitive function post intervention",9,9,9,FALSE,TRUE,"RD","double_zero"
"CD008349_pub5_data","13::overall","13","overall","Activity limitation post intervention ",34,34,34,FALSE,TRUE,"RD","double_zero"
"CD008349_pub5_data","14::overall","14","overall","Participation restriction and quality of life post intervention ",16,16,16,FALSE,TRUE,"RD","double_zero"
"CD008349_pub5_data","3::1","3","1","Upper limb function: subgroup analysis based on amount of therapy",17,17,17,FALSE,TRUE,"RD","double_zero"
"CD008349_pub5_data","3::2","3","2","Upper limb function: subgroup analysis based on amount of therapy",5,5,5,FALSE,TRUE,"RD","double_zero"
"CD008349_pub5_data","4::1","4","1","Upper limb function: subgroup analysis based on time since onset of stroke",11,11,11,FALSE,TRUE,"RD","double_zero"
"CD008349_pub5_data","4::2","4","2","Upper limb function: subgroup analysis based on time since onset of stroke",10,10,10,FALSE,TRUE,"RD","double_zero"
"CD008349_pub5_data","6::overall","6","overall","Gait speed post intervention",3,3,3,FALSE,TRUE,"RD","double_zero"
"CD008349_pub5_data","7::overall","7","overall","Mobility: Timed Up and Go Test post intervention",8,8,8,FALSE,TRUE,"RD","double_zero"
"CD008349_pub5_data","8::overall","8","overall","Balance post intervention",12,12,12,FALSE,TRUE,"RD","double_zero"
"CD008469_pub3_data","2::overall","2","overall","Exacerbations requiring a course of oral corticosteroids: subgrouped by time frame of follow-up",8,8,8,FALSE,TRUE,"RD","double_zero"
"CD008469_pub3_data","3::overall","3","overall","Quality of life",6,6,6,FALSE,TRUE,"RD","double_zero"
"CD008469_pub3_data","5::overall","5","overall","Days missed from school",2,2,2,FALSE,TRUE,"RD","double_zero"
"CD008493_pub5_data","7::overall","7","overall","Length of stay in the intensive care unit (hours)",14,14,14,FALSE,TRUE,"RD","double_zero"
"CD008493_pub5_data","8::overall","8","overall","Length of stay in the hospital (days)",5,5,5,FALSE,TRUE,"RD","double_zero"
"CD008552_pub8_data","1::overall","1","overall","Vegetable intake",45,45,45,FALSE,TRUE,"RD","double_zero"
"CD008552_pub8_data","2::overall","2","overall","Vegetable intake - sensitivity analysis - risk of bias",18,18,18,FALSE,TRUE,"RD","double_zero"
"CD008552_pub8_data","3::overall","3","overall","Vegetable intake - sensitivity analysis - primary outcome",32,32,32,FALSE,TRUE,"RD","double_zero"
"CD008552_pub8_data","4::overall","4","overall","Vegetable intake - sensitivity analysis - missing data",30,30,30,FALSE,TRUE,"RD","double_zero"
"CD008552_pub8_data","5::overall","5","overall","Vegetable intake - subgroup analysis - setting",43,43,43,FALSE,TRUE,"RD","double_zero"
"CD008552_pub8_data","6::overall","6","overall","Vegetable intake - subgroup analysis - modality",43,43,43,FALSE,TRUE,"RD","double_zero"
"CD008552_pub8_data","7::overall","7","overall","Vegetable intake - subgroup analysis - age",15,15,15,FALSE,TRUE,"RD","double_zero"
"CD008564_pub3_data","8::overall","8","overall","Systolic blood pressure change from baseline at one year",6,6,6,FALSE,TRUE,"RD","double_zero"
"CD008564_pub3_data","9::overall","9","overall","Diastolic blood pressure change from baseline at one year",6,6,6,FALSE,TRUE,"RD","double_zero"
"CD008564_pub3_data","11::overall","11","overall","Number of antihypertensive drugs that each participant needed at end of study",4,4,4,FALSE,TRUE,"RD","double_zero"
"CD008628_pub3_data","1::overall","1","overall","Function in the long term; measured using AOFAS",11,11,11,FALSE,TRUE,"RD","double_zero"
"CD008628_pub3_data","2::overall","2","overall","Function in the long term; using measurement tools other than AOFAS score ",5,5,5,FALSE,TRUE,"RD","double_zero"
"CD008628_pub3_data","6::overall","6","overall","HRQoL in the long term; measured using SF-36 (PCS)",2,2,2,FALSE,TRUE,"RD","double_zero"
"CD008628_pub3_data","11::overall","11","overall","Radiological measurements: Böhler angle",2,2,2,FALSE,TRUE,"RD","double_zero"
"CD008688_pub3_data","8::overall","8","overall","Operation time",3,3,3,FALSE,TRUE,"RD","double_zero"
"CD008709_pub4_data","19::overall","19","overall","Quality of life: at 12 months",12,12,12,FALSE,TRUE,"RD","double_zero"
"CD008771_pub3_data","2::overall","2","overall","Head circumference",2,2,2,FALSE,TRUE,"RD","double_zero"
"CD008771_pub3_data","4::overall","4","overall","Nitrogen balance",4,4,4,FALSE,TRUE,"RD","double_zero"
"CD008771_pub3_data","5::overall","5","overall","Metabolic acidosis, pH within first 24 hours of birth",2,2,2,FALSE,TRUE,"RD","double_zero"
"CD008771_pub3_data","7::overall","7","overall","Metabolic acidosis, bicarbonate level within first 24 hours of birth",3,3,3,FALSE,TRUE,"RD","double_zero"
"CD008771_pub3_data","8::overall","8","overall","Metabolic acidosis, bicarbonate level at 2 days after birth",2,2,2,FALSE,TRUE,"RD","double_zero"
"CD008771_pub3_data","9::overall","9","overall","Metabolic acidosis, bicarbonate level at days 3 to 4",2,2,2,FALSE,TRUE,"RD","double_zero"
"CD008771_pub3_data","11::overall","11","overall","Plasma ammonia level at days 3 to 4 after birth",3,3,3,FALSE,TRUE,"RD","double_zero"
"CD008771_pub3_data","12::overall","12","overall","BUN level in first 2 days after birth",4,4,4,FALSE,TRUE,"RD","double_zero"
"CD008771_pub3_data","13::overall","13","overall","BUN level at days 3 to 4 after birth",4,4,4,FALSE,TRUE,"RD","double_zero"
"CD008771_pub3_data","14::overall","14","overall","BUN level at days 6 to 7 after birth",3,3,3,FALSE,TRUE,"RD","double_zero"
"CD008771_pub3_data","20::overall","20","overall","Time to regain birthweight in days",2,2,2,FALSE,TRUE,"RD","double_zero"
"CD008873_pub5_data","8::overall","8","overall","Maternal death (death while pregnant or within 42 days of termination of pregnancy) (ALL)",2,2,2,FALSE,TRUE,"RD","double_zero"
"CD008873_pub5_data","9::overall","9","overall","Maternal vitamin D concentration at term (25-hydroxyvitamin D) (nmol/L) (ALL)",7,7,7,FALSE,TRUE,"RD","double_zero"
"CD008873_pub5_data","10::overall","10","overall","Birth length (cm)",3,3,3,FALSE,TRUE,"RD","double_zero"
"CD008873_pub5_data","11::overall","11","overall","Head circumference at birth (cm)",4,4,4,FALSE,TRUE,"RD","double_zero"
"CD008879_pub3_data","3::overall","3","overall","Length of hospital stay (days)",11,11,11,FALSE,TRUE,"RD","double_zero"
"CD008940_pub4_data","6::1","6","1","Cannabis use at end of treatment",15,15,15,FALSE,TRUE,"RD","double_zero"
"CD008940_pub4_data","6::2","6","2","Cannabis use at end of treatment",13,13,13,FALSE,TRUE,"RD","double_zero"
"CD008940_pub4_data","6::3","6","3","Cannabis use at end of treatment",4,4,4,FALSE,TRUE,"RD","double_zero"
"CD008940_pub4_data","4::3","4","3","Cannabis use at end of treatment",2,2,2,FALSE,TRUE,"RD","double_zero"
"CD008973_pub3_data","3::overall","3","overall","Change in retractability score",2,2,2,FALSE,TRUE,"RD","double_zero"
"CD009022_pub4_data","1::overall","1","overall","Postoperative pain at 12 hours",6,6,6,FALSE,TRUE,"RD","double_zero"
"CD009022_pub4_data","2::overall","2","overall","Postoperative pain at 24 hours: VAS pain score",4,4,4,FALSE,TRUE,"RD","double_zero"
"CD009022_pub4_data","3::overall","3","overall","Wound cosmesis: Body Image Questionnaire (BIQ score)",3,3,3,FALSE,TRUE,"RD","double_zero"
"CD009022_pub4_data","4::overall","4","overall","Wound cosmesis: VAS scale",3,3,3,FALSE,TRUE,"RD","double_zero"
"CD009022_pub4_data","5::overall","5","overall","Operating time (minutes)",11,11,11,FALSE,TRUE,"RD","double_zero"
"CD009022_pub4_data","12::overall","12","overall","Length of hospital stay (days)",10,10,10,FALSE,TRUE,"RD","double_zero"
"CD009022_pub4_data","13::overall","13","overall","Return to normal activities (days)",4,4,4,FALSE,TRUE,"RD","double_zero"
"CD009102_pub2_data","5::overall","5","overall","Apgar scores at 5 minutes",3,3,3,FALSE,TRUE,"RD","double_zero"
"CD009102_pub2_data","9::overall","9","overall","Duration of respiratory support, i.e. nasal continuous airway pressure and ventilation via an endotracheal tube, considered separately and in total (days)",2,2,2,FALSE,TRUE,"RD","double_zero"
"CD009235_pub4_data","1::overall","1","overall","Duration of mechanical ventilation",143,143,143,FALSE,TRUE,"RD","double_zero"
"CD009235_pub4_data","3::overall","3","overall","ICU length of stay",66,66,66,FALSE,TRUE,"RD","double_zero"
"CD009235_pub4_data","4::overall","4","overall","Hospital length of stay",26,26,26,FALSE,TRUE,"RD","double_zero"
"CD009235_pub4_data","5::overall","5","overall","Time from randomization to first extubation",12,12,12,FALSE,TRUE,"RD","double_zero"
"CD009235_pub4_data","6::overall","6","overall","Time from intubation (or ICU admission if admitted ventilated) to successful extubation",31,31,31,FALSE,TRUE,"RD","double_zero"
"CD009235_pub4_data","7::overall","7","overall","Time from intubation to randomization",20,20,20,FALSE,TRUE,"RD","double_zero"
"CD009235_pub4_data","8::overall","8","overall","Duration of weaning",8,8,8,FALSE,TRUE,"RD","double_zero"
"CD009235_pub4_data","14::1","14","1","Duration of mechanical ventilation by study population",13,13,13,FALSE,TRUE,"RD","double_zero"
"CD009235_pub4_data","14::2","14","2","Duration of mechanical ventilation by study population",18,18,18,FALSE,TRUE,"RD","double_zero"
"CD009235_pub4_data","14::3","14","3","Duration of mechanical ventilation by study population",20,20,20,FALSE,TRUE,"RD","double_zero"
"CD009235_pub4_data","15::1","15","1","ICU length of stay by study population",9,9,9,FALSE,TRUE,"RD","double_zero"
"CD009235_pub4_data","15::2","15","2","ICU length of stay by study population",12,12,12,FALSE,TRUE,"RD","double_zero"
"CD009235_pub4_data","15::3","15","3","ICU length of stay by study population",19,19,19,FALSE,TRUE,"RD","double_zero"
"CD009235_pub4_data","17::1","17","1","Duration of mechanical ventilation by automated system",18,18,18,FALSE,TRUE,"RD","double_zero"
"CD009235_pub4_data","17::2","17","2","Duration of mechanical ventilation by automated system",9,9,9,FALSE,TRUE,"RD","double_zero"
"CD009235_pub4_data","17::3","17","3","Duration of mechanical ventilation by automated system",7,7,7,FALSE,TRUE,"RD","double_zero"
"CD009235_pub4_data","17::4","17","4","Duration of mechanical ventilation by automated system",5,5,5,FALSE,TRUE,"RD","double_zero"
"CD009235_pub4_data","17::5","17","5","Duration of mechanical ventilation by automated system",4,4,4,FALSE,TRUE,"RD","double_zero"
"CD009235_pub4_data","17::6","17","6","Duration of mechanical ventilation by automated system",3,3,3,FALSE,TRUE,"RD","double_zero"
"CD009235_pub4_data","17::7","17","7","Duration of mechanical ventilation by automated system",5,5,5,FALSE,TRUE,"RD","double_zero"
"CD009235_pub4_data","18::1","18","1","ICU length of stay by automated system",15,15,15,FALSE,TRUE,"RD","double_zero"
"CD009235_pub4_data","18::2","18","2","ICU length of stay by automated system",6,6,6,FALSE,TRUE,"RD","double_zero"
"CD009235_pub4_data","18::3","18","3","ICU length of stay by automated system",8,8,8,FALSE,TRUE,"RD","double_zero"
"CD009235_pub4_data","18::4","18","4","ICU length of stay by automated system",4,4,4,FALSE,TRUE,"RD","double_zero"
"CD009235_pub4_data","18::5","18","5","ICU length of stay by automated system",4,4,4,FALSE,TRUE,"RD","double_zero"
"CD009235_pub4_data","18::6","18","6","ICU length of stay by automated system",3,3,3,FALSE,TRUE,"RD","double_zero"
"CD009235_pub4_data","20::1","20","1","Duration of mechanical ventilation by non-automated strategy (control arm)",14,14,14,FALSE,TRUE,"RD","double_zero"
"CD009235_pub4_data","20::2","20","2","Duration of mechanical ventilation by non-automated strategy (control arm)",37,37,37,FALSE,TRUE,"RD","double_zero"
"CD009235_pub4_data","21::1","21","1","ICU length of stay by non-automated strategy (control arm)",8,8,8,FALSE,TRUE,"RD","double_zero"
"CD009235_pub4_data","21::2","21","2","ICU length of stay by non-automated strategy (control arm)",32,32,32,FALSE,TRUE,"RD","double_zero"
"CD009235_pub4_data","2::overall","2","overall","ICU length of stay (days)",39,39,39,FALSE,TRUE,"RD","double_zero"
"CD009252_pub2_data","1::overall","1","overall","Lower urinary tract symptom-specific quality of life",26,26,26,FALSE,TRUE,"RD","double_zero"
"CD009298_pub3_data","5::overall","5","overall","Maternal mortality",6,6,6,FALSE,TRUE,"RD","double_zero"
"CD009298_pub3_data","6::1","6","1","Maternal mortality (Subgroup analysis: occiput posterior versus occiput transverse position)",5,5,5,FALSE,TRUE,"RD","double_zero"
"CD009298_pub3_data","6::2","6","2","Maternal mortality (Subgroup analysis: occiput posterior versus occiput transverse position)",2,2,2,FALSE,TRUE,"RD","double_zero"
"CD009298_pub3_data","7::1","7","1","Maternal mortality (Subgroup analysis: nulliparous versus multiparous)",6,6,6,FALSE,TRUE,"RD","double_zero"
"CD009298_pub3_data","7::2","7","2","Maternal mortality (Subgroup analysis: nulliparous versus multiparous)",5,5,5,FALSE,TRUE,"RD","double_zero"
"CD009298_pub3_data","8::1","8","1","Maternal mortality (Subgroup analysis: digital (fingers) versus whole-hand rotation)",3,3,3,FALSE,TRUE,"RD","double_zero"
"CD009298_pub3_data","8::2","8","2","Maternal mortality (Subgroup analysis: digital (fingers) versus whole-hand rotation)",5,5,5,FALSE,TRUE,"RD","double_zero"
"CD009298_pub3_data","8::3","8","3","Maternal mortality (Subgroup analysis: digital (fingers) versus whole-hand rotation)",2,2,2,FALSE,TRUE,"RD","double_zero"
"CD009298_pub3_data","9::overall","9","overall","Perinatal mortality",6,6,6,FALSE,TRUE,"RD","double_zero"
"CD009298_pub3_data","10::1","10","1","Perinatal mortality (Subgroup analysis: occiput posterior versus occiput transverse position)",5,5,5,FALSE,TRUE,"RD","double_zero"
"CD009298_pub3_data","10::2","10","2","Perinatal mortality (Subgroup analysis: occiput posterior versus occiput transverse position)",2,2,2,FALSE,TRUE,"RD","double_zero"
"CD009298_pub3_data","11::1","11","1","Perinatal mortality (Subgroup analysis: nulliparous versus multiparous)",6,6,6,FALSE,TRUE,"RD","double_zero"
"CD009298_pub3_data","11::2","11","2","Perinatal mortality (Subgroup analysis: nulliparous versus multiparous)",5,5,5,FALSE,TRUE,"RD","double_zero"
"CD009298_pub3_data","12::1","12","1","Perinatal mortality (Subgroup analysis: digital (fingers) versus whole-hand rotation)",3,3,3,FALSE,TRUE,"RD","double_zero"
"CD009298_pub3_data","12::2","12","2","Perinatal mortality (Subgroup analysis: digital (fingers) versus whole-hand rotation)",5,5,5,FALSE,TRUE,"RD","double_zero"
"CD009298_pub3_data","12::3","12","3","Perinatal mortality (Subgroup analysis: digital (fingers) versus whole-hand rotation)",2,2,2,FALSE,TRUE,"RD","double_zero"
"CD009298_pub3_data","48::overall","48","overall","Neonatal exchange transfusion",4,4,4,FALSE,TRUE,"RD","double_zero"
"CD009298_pub3_data","49::overall","49","overall","Polycythaemia treated with partial volume exchange transfusion",4,4,4,FALSE,TRUE,"RD","double_zero"
"CD009298_pub3_data","50::overall","50","overall","Neonatal stroke",4,4,4,FALSE,TRUE,"RD","double_zero"
"CD009298_pub3_data","54::overall","54","overall","Neonatal encephalopathy",4,4,4,FALSE,TRUE,"RD","double_zero"
"CD009417_pub3_data","2::overall","2","overall","Length of hospitalisation (days)",6,6,6,FALSE,TRUE,"RD","double_zero"
"CD009417_pub3_data","6::overall","6","overall","Duration of mechanical ventilation",3,3,3,FALSE,TRUE,"RD","double_zero"
"CD009417_pub3_data","8::overall","8","overall","Duration of supplemental oxygen",3,3,3,FALSE,TRUE,"RD","double_zero"
"CD009417_pub3_data","10::overall","10","overall","Duration of stay in the ICU",2,2,2,FALSE,TRUE,"RD","double_zero"
"CD009508_pub2_data","1::overall","1","overall","Incontinence quality of life",35,35,35,FALSE,TRUE,"RD","double_zero"
"CD009508_pub2_data","2::overall","2","overall","Incontinence episodes",21,21,21,FALSE,TRUE,"RD","double_zero"
"CD009531_pub3_data","6::overall","6","overall","Physical health status",34,34,34,FALSE,TRUE,"RD","double_zero"
"CD009531_pub3_data","11::overall","11","overall","Social functioning/disability",8,8,8,FALSE,TRUE,"RD","double_zero"
"CD009535_pub3_data","3::overall","3","overall","All-cause annual hospital admission rate (number of admissions/patient-year)",2,2,2,FALSE,TRUE,"RD","double_zero"
"CD009535_pub3_data","4::overall","4","overall","All-cause hospitalisation days/patient-year",2,2,2,FALSE,TRUE,"RD","double_zero"
"CD009535_pub3_data","6::overall","6","overall","Physical functioning (SF-12; SF-36)",2,2,2,FALSE,TRUE,"RD","double_zero"
"CD009535_pub3_data","7::overall","7","overall","Role: Physical (SF-12; SF-36)",2,2,2,FALSE,TRUE,"RD","double_zero"
"CD009535_pub3_data","8::overall","8","overall","Bodily pain (SF-12; SF-36)",2,2,2,FALSE,TRUE,"RD","double_zero"
"CD009535_pub3_data","9::overall","9","overall","General health (SF-12; SF-36)",2,2,2,FALSE,TRUE,"RD","double_zero"
"CD009535_pub3_data","10::overall","10","overall","Vitality (SF-12; SF-36)",2,2,2,FALSE,TRUE,"RD","double_zero"
"CD009535_pub3_data","11::overall","11","overall","Social functioning (SF-12; SF-36)",2,2,2,FALSE,TRUE,"RD","double_zero"
"CD009535_pub3_data","12::overall","12","overall","Role: Emotional (SF-12; SF-36)",2,2,2,FALSE,TRUE,"RD","double_zero"
"CD009535_pub3_data","13::overall","13","overall","Mental health (SF-12; SF-36)",2,2,2,FALSE,TRUE,"RD","double_zero"
"CD009535_pub3_data","14::overall","14","overall","Physical Component Summary (SF-12; SF-36)",5,5,5,FALSE,TRUE,"RD","double_zero"
"CD009535_pub3_data","15::overall","15","overall","Mental Component Summary (SF-12; SF-36)",5,5,5,FALSE,TRUE,"RD","double_zero"
"CD009535_pub3_data","16::overall","16","overall","Symptoms and problems (KDQOL-SF)",2,2,2,FALSE,TRUE,"RD","double_zero"
"CD009535_pub3_data","17::overall","17","overall","Effects of kidney disease (KDQOL-SF)",2,2,2,FALSE,TRUE,"RD","double_zero"
"CD009535_pub3_data","18::overall","18","overall","Burden of kidney disease (KDQOL-SF)",2,2,2,FALSE,TRUE,"RD","double_zero"
"CD009535_pub3_data","19::overall","19","overall","Work status (KDQOL-SF)",2,2,2,FALSE,TRUE,"RD","double_zero"
"CD009535_pub3_data","20::overall","20","overall","Cognitive function (KDQOL-SF)",2,2,2,FALSE,TRUE,"RD","double_zero"
"CD009535_pub3_data","21::overall","21","overall","Quality of social interaction (KDQOL-SF)",2,2,2,FALSE,TRUE,"RD","double_zero"
"CD009535_pub3_data","22::overall","22","overall","Sexual function (KDQOL-SF)",2,2,2,FALSE,TRUE,"RD","double_zero"
"CD009535_pub3_data","23::overall","23","overall","Sleep (KDQOL-SF)",2,2,2,FALSE,TRUE,"RD","double_zero"
"CD009535_pub3_data","24::overall","24","overall","Recovery time",2,2,2,FALSE,TRUE,"RD","double_zero"
"CD009535_pub3_data","25::overall","25","overall","Annual direct healthcare costs in first year of dialysis (currency as reported)",4,4,4,FALSE,TRUE,"RD","double_zero"
"CD009535_pub3_data","26::overall","26","overall","Annual direct healthcare costs in second year of dialysis (currency as reported)",4,4,4,FALSE,TRUE,"RD","double_zero"
"CD009535_pub3_data","27::overall","27","overall","Systolic blood pressure (NRSIs)",4,4,4,FALSE,TRUE,"RD","double_zero"
"CD009535_pub3_data","28::overall","28","overall","Diastolic blood pressure (NSRIs)",3,3,3,FALSE,TRUE,"RD","double_zero"
"CD009535_pub3_data","29::overall","29","overall","Mean arterial pressure",2,2,2,FALSE,TRUE,"RD","double_zero"
"CD009535_pub3_data","30::overall","30","overall","Left ventricular mass index [g/m2]",2,2,2,FALSE,TRUE,"RD","double_zero"
"CD009679_pub3_data","1::overall","1","overall","Generic quality of life (SF-36 scores) at 24 months",20,20,20,FALSE,TRUE,"RD","double_zero"
"CD009679_pub3_data","5::overall","5","overall","WOMAC Function score",11,11,11,FALSE,TRUE,"RD","double_zero"
"CD009679_pub3_data","9::overall","9","overall","Knee range of motion (degrees) at 24 months",5,5,5,FALSE,TRUE,"RD","double_zero"
"CD009679_pub3_data","10::overall","10","overall","Intraoperative measures (length of surgery, blood loss)",2,2,2,FALSE,TRUE,"RD","double_zero"
"CD009730_pub3_data","6::overall","6","overall","Weight (absolute change (kg))",8,8,8,FALSE,TRUE,"RD","double_zero"
"CD009730_pub3_data","9::overall","9","overall","Adverse effects – serum",4,4,4,FALSE,TRUE,"RD","double_zero"
"CD009730_pub3_data","14::overall","14","overall","Renal toxicity",2,2,2,FALSE,TRUE,"RD","double_zero"
"CD009752_pub3_data","10::overall","10","overall","Haemoglobin (g/dL) levels postoperatively ",6,6,6,FALSE,TRUE,"RD","double_zero"
"CD009752_pub3_data","14::overall","14","overall","Postoperative drain output mg/kg/hr",4,4,4,FALSE,TRUE,"RD","double_zero"
"CD009752_pub3_data","15::overall","15","overall","Postoperative chest drain output mL per participant",2,2,2,FALSE,TRUE,"RD","double_zero"
"CD009752_pub3_data","16::overall","16","overall","Duration of mechanical ventilation (hours)",3,3,3,FALSE,TRUE,"RD","double_zero"
"CD009752_pub3_data","17::overall","17","overall","Duration of ICU stay (days)",4,4,4,FALSE,TRUE,"RD","double_zero"
"CD009752_pub3_data","18::overall","18","overall","Cerebral oxygen content post surgery (rSO2)",2,2,2,FALSE,TRUE,"RD","double_zero"
"CD009752_pub3_data","19::overall","19","overall","'Peak' lactate levels (mmol/L)",3,3,3,FALSE,TRUE,"RD","double_zero"
"CD009752_pub3_data","22::overall","22","overall","Blood glucose (mg/dL) in prime prior to CPB ",2,2,2,FALSE,TRUE,"RD","double_zero"
"CD009788_pub3_data","2::overall","2","overall","Functioning – general",4,4,4,FALSE,TRUE,"RD","double_zero"
"CD009788_pub3_data","8::overall","8","overall","Functioning – specific: social skills",2,2,2,FALSE,TRUE,"RD","double_zero"
"CD009788_pub3_data","9::overall","9","overall","Mental state",7,7,7,FALSE,TRUE,"RD","double_zero"
"CD009788_pub3_data","10::overall","10","overall","Quality of life",4,4,4,FALSE,TRUE,"RD","double_zero"
"CD010136_pub4_data","3::overall","3","overall","Pain at 72 hours",2,2,2,FALSE,TRUE,"RD","double_zero"
"CD010136_pub4_data","5::overall","5","overall","Swelling at 24 hours",2,2,2,FALSE,TRUE,"RD","double_zero"
"CD010136_pub4_data","6::overall","6","overall","Swelling at 48 hours",2,2,2,FALSE,TRUE,"RD","double_zero"
"CD010136_pub4_data","7::overall","7","overall","Swelling at 72 hours",2,2,2,FALSE,TRUE,"RD","double_zero"
"CD010189_pub3_data","1::overall","1","overall","Overall survival",6,6,6,FALSE,TRUE,"RD","double_zero"
"CD010189_pub3_data","2::overall","2","overall","Disease free survival",6,6,6,FALSE,TRUE,"RD","double_zero"
"CD010189_pub3_data","3::overall","3","overall","Incidence of non-relapse or transplant-related mortality",3,3,3,FALSE,TRUE,"RD","double_zero"
"CD010189_pub3_data","4::overall","4","overall","Incidence of extensive chronic GvHD",4,4,4,FALSE,TRUE,"RD","double_zero"
"CD010189_pub3_data","5::overall","5","overall","Incidence of acute GvHD grade III-IV",3,3,3,FALSE,TRUE,"RD","double_zero"
"CD010189_pub3_data","6::overall","6","overall","Incidence of overall chronic GvHD",4,4,4,FALSE,TRUE,"RD","double_zero"
"CD010189_pub3_data","7::overall","7","overall","Incidence of relapse",3,3,3,FALSE,TRUE,"RD","double_zero"
"CD010189_pub3_data","8::overall","8","overall","Time to platelet engraftment",4,4,4,FALSE,TRUE,"RD","double_zero"
"CD010189_pub3_data","9::overall","9","overall","Time to neutrophil engraftment",5,5,5,FALSE,TRUE,"RD","double_zero"
"CD010189_pub3_data","10::overall","10","overall","Incidence of acute GvHD grade II-IV",6,6,6,FALSE,TRUE,"RD","double_zero"
"CD010216_pub9_data","5::overall","5","overall","Heart rate (bpm)",6,6,6,FALSE,TRUE,"RD","double_zero"
"CD010216_pub9_data","6::overall","6","overall","Systolic blood pressure",8,8,8,FALSE,TRUE,"RD","double_zero"
"CD010216_pub9_data","7::overall","7","overall","Blood oxygen saturation",6,6,6,FALSE,TRUE,"RD","double_zero"
"CD010216_pub9_data","9::overall","9","overall","NNAL (pmol/mg creatinine))",8,8,8,FALSE,TRUE,"RD","double_zero"
"CD010216_pub9_data","10::overall","10","overall","2-HPMA (pmol/mg creatinine)",5,5,5,FALSE,TRUE,"RD","double_zero"
"CD010216_pub9_data","13::overall","13","overall","CEMA (pmol/mg creatinine)",2,2,2,FALSE,TRUE,"RD","double_zero"
"CD010216_pub9_data","14::overall","14","overall","AAMA (pmol/mg creatinine)",2,2,2,FALSE,TRUE,"RD","double_zero"
"CD010216_pub9_data","15::overall","15","overall","FEV1",3,3,3,FALSE,TRUE,"RD","double_zero"
"CD010216_pub9_data","16::overall","16","overall","FEV1/FVC (%)",4,4,4,FALSE,TRUE,"RD","double_zero"
"CD010216_pub9_data","17::overall","17","overall","PEF (L/min)",3,3,3,FALSE,TRUE,"RD","double_zero"
"CD010533_pub3_data","2::overall","2","overall","Progression-free survival (PFS)",21,21,21,FALSE,TRUE,"RD","double_zero"
"CD010779_pub2_data","1::overall","1","overall","Passive range of motion without standardised force",4,4,4,FALSE,TRUE,"RD","double_zero"
"CD010779_pub2_data","2::overall","2","overall","Passive range of motion with standardised force ",9,9,9,FALSE,TRUE,"RD","double_zero"
"CD010779_pub2_data","4::overall","4","overall","Pain",3,3,3,FALSE,TRUE,"RD","double_zero"
"CD010779_pub2_data","5::overall","5","overall","Function",3,3,3,FALSE,TRUE,"RD","double_zero"
"CD010856_pub3_data","1::overall","1","overall","Change in the number of decayed, missing or filled primary teeth (dmft)",7,7,7,FALSE,TRUE,"RD","double_zero"
"CD010856_pub3_data","2::overall","2","overall","Change in the number of decayed, missing or filled permanent teeth (DMFT)",7,7,7,FALSE,TRUE,"RD","double_zero"
"CD010856_pub3_data","4::overall","4","overall","Change in the proportion of caries-free participants (primary teeth)",7,7,7,FALSE,TRUE,"RD","double_zero"
"CD010856_pub3_data","5::overall","5","overall","Change in the proportion of caries-free participants (permanent teeth)",6,6,6,FALSE,TRUE,"RD","double_zero"
"CD010856_pub3_data","6::overall","6","overall","Sensitivity analysis - all included studies: change in the number of decayed, missing or filled primary teeth (dmft)",11,11,11,FALSE,TRUE,"RD","double_zero"
"CD010856_pub3_data","7::overall","7","overall","Sensitivity analysis - all included studies: change in the number of decayed, missing or filled permanent teeth (DMFT)",12,12,12,FALSE,TRUE,"RD","double_zero"
"CD010856_pub3_data","8::overall","8","overall","Sensitivity analysis - all included studies: change in the proportion of caries-free participants (primary teeth)",12,12,12,FALSE,TRUE,"RD","double_zero"
"CD010856_pub3_data","9::overall","9","overall","Sensitivity analysis - all included studies: change in the proportion of caries-free participants (permanent teeth)",9,9,9,FALSE,TRUE,"RD","double_zero"
"CD010856_pub3_data","10::overall","10","overall","Sensitivity analysis - change in analytical approach: change in the number of decayed, missing or filled primary teeth (dmft)",2,2,2,FALSE,TRUE,"RD","double_zero"
"CD010856_pub3_data","11::overall","11","overall","Sensitivity analysis - excluding studies with imputed standard deviations: change in the number of decayed, missing or filled primary teeth (dmft)",4,4,4,FALSE,TRUE,"RD","double_zero"
"CD010856_pub3_data","12::overall","12","overall","Sensitivity analysis - excluding studies with imputed standard deviations: change in the number of decayed, missing or filled permanent teeth (DMFT)",3,3,3,FALSE,TRUE,"RD","double_zero"
"CD010966_pub4_data","9::overall","9","overall","Weight (kg) (absolute change from baseline)",10,10,10,FALSE,TRUE,"RD","double_zero"
"CD010966_pub4_data","10::overall","10","overall","BMI (absolute change from baseline)",13,13,13,FALSE,TRUE,"RD","double_zero"
"CD010966_pub4_data","11::overall","11","overall","BMI (relative change from baseline)",4,4,4,FALSE,TRUE,"RD","double_zero"
"CD010966_pub4_data","13::overall","13","overall","FEV1 % predicted (relative change from baseline) ",6,6,6,FALSE,TRUE,"RD","double_zero"
"CD010966_pub4_data","14::overall","14","overall","FEV1 % predicted (absolute change from baseline) ",8,8,8,FALSE,TRUE,"RD","double_zero"
"CD010966_pub4_data","20::overall","20","overall","Sweat chloride (change from baseline) ",7,7,7,FALSE,TRUE,"RD","double_zero"
"CD010966_pub4_data","23::overall","23","overall","Absolute change from baseline in body weight",2,2,2,FALSE,TRUE,"RD","double_zero"
"CD010966_pub4_data","24::overall","24","overall","BMI (change from baseline) ",4,4,4,FALSE,TRUE,"RD","double_zero"
"CD011039_pub2_data","8::overall","8","overall","Improvement in kidney function (parameters)",2,2,2,FALSE,TRUE,"RD","double_zero"
"CD011039_pub2_data","9::overall","9","overall","Improvement in liver function (parameters)",6,6,6,FALSE,TRUE,"RD","double_zero"
"CD011044_pub3_data","1::overall","1","overall","Overall survival",52,52,52,FALSE,TRUE,"RD","double_zero"
"CD011044_pub3_data","2::overall","2","overall","Progression-free survival",35,35,35,FALSE,TRUE,"RD","double_zero"
"CD011197_pub3_data","4::overall","4","overall","AFSS symptom severity",5,5,5,FALSE,TRUE,"RD","double_zero"
"CD011197_pub3_data","5::overall","5","overall","AFSS symptom burden",3,3,3,FALSE,TRUE,"RD","double_zero"
"CD011197_pub3_data","6::overall","6","overall","AFSS episode frequency",4,4,4,FALSE,TRUE,"RD","double_zero"
"CD011197_pub3_data","7::overall","7","overall","AFSS episode duration",3,3,3,FALSE,TRUE,"RD","double_zero"
"CD011197_pub3_data","8::overall","8","overall","Quality of life, SF-36 mental component score",6,6,6,FALSE,TRUE,"RD","double_zero"
"CD011197_pub3_data","9::overall","9","overall","Quality of life, SF-36 physical component score",6,6,6,FALSE,TRUE,"RD","double_zero"
"CD011197_pub3_data","10::overall","10","overall","Quality of life, SF-36 physical function",9,9,9,FALSE,TRUE,"RD","double_zero"
"CD011197_pub3_data","11::overall","11","overall","Quality of life, SF-36 physical role functioning",6,6,6,FALSE,TRUE,"RD","double_zero"
"CD011197_pub3_data","12::overall","12","overall","Quality of life, SF-36 bodily pain",8,8,8,FALSE,TRUE,"RD","double_zero"
"CD011197_pub3_data","13::overall","13","overall","Quality of life, SF-36 general health",8,8,8,FALSE,TRUE,"RD","double_zero"
"CD011197_pub3_data","14::overall","14","overall","Quality of life, SF-36 vitality",8,8,8,FALSE,TRUE,"RD","double_zero"
"CD011197_pub3_data","15::overall","15","overall","Quality of life, SF-36 social functioning",8,8,8,FALSE,TRUE,"RD","double_zero"
"CD011197_pub3_data","16::overall","16","overall","Quality of life, SF-36 role emotional",9,9,9,FALSE,TRUE,"RD","double_zero"
"CD011197_pub3_data","17::overall","17","overall","Quality of life, SF-36 mental health",7,7,7,FALSE,TRUE,"RD","double_zero"
"CD011197_pub3_data","18::overall","18","overall","Exercise capacity (VO2peak)",7,7,7,FALSE,TRUE,"RD","double_zero"
"CD011197_pub3_data","19::overall","19","overall","Exercise capacity (6MWT)",8,8,8,FALSE,TRUE,"RD","double_zero"
"CD011197_pub3_data","20::overall","20","overall","Exercise capacity (SMD)",12,12,12,FALSE,TRUE,"RD","double_zero"
"CD011305_pub3_data","1::overall","1","overall","All-cause mortality at 0 to 7 days",4,4,4,FALSE,TRUE,"RD","double_zero"
"CD011305_pub3_data","5::overall","5","overall","Death due to bleeding  (0 to 3 months)",4,4,4,FALSE,TRUE,"RD","double_zero"
"CD011305_pub3_data","15::overall","15","overall","Mean number of RBC transfusions (units) per participant (0 to 3 months)",5,5,5,FALSE,TRUE,"RD","double_zero"
"CD011305_pub3_data","16::overall","16","overall","Interval between RBC transfusions (days) (0 to 3 months)",2,2,2,FALSE,TRUE,"RD","double_zero"
"CD011305_pub3_data","19::overall","19","overall","Number of PLT transfusions (doses) per participant (0 to 3 months)",3,3,3,FALSE,TRUE,"RD","double_zero"
"CD011330_pub2_data","1::1","1","1","Global symptoms score",7,7,7,FALSE,TRUE,"RD","double_zero"
"CD011330_pub2_data","1::2","1","2","Global symptoms score",4,4,4,FALSE,TRUE,"RD","double_zero"
"CD011330_pub2_data","1::3","1","3","Global symptoms score",5,5,5,FALSE,TRUE,"RD","double_zero"
"CD011330_pub2_data","3::2","3","2","Withdrawal due to adverse events",2,2,2,FALSE,TRUE,"RD","double_zero"
"CD011330_pub2_data","4::1","4","1","Psychological symptoms",4,4,4,FALSE,TRUE,"RD","double_zero"
"CD011330_pub2_data","4::2","4","2","Psychological symptoms",2,2,2,FALSE,TRUE,"RD","double_zero"
"CD011330_pub2_data","4::3","4","3","Psychological symptoms",3,3,3,FALSE,TRUE,"RD","double_zero"
"CD011330_pub2_data","5::1","5","1","Physical symptoms",3,3,3,FALSE,TRUE,"RD","double_zero"
"CD011330_pub2_data","5::3","5","3","Physical symptoms",3,3,3,FALSE,TRUE,"RD","double_zero"
"CD011381_pub3_data","8::overall","8","overall","Comparisons for quality of life - physical (MS related: MSQOL-54 PH; MSQoL-54; MSIS29 Psychological)",5,5,5,FALSE,TRUE,"RD","double_zero"
"CD011381_pub3_data","10::overall","10","overall","Comparisons for quality of life - mental (MS related: MSQOL-54 PH; MSQoL-54; MSIS29 Psychological)",5,5,5,FALSE,TRUE,"RD","double_zero"
"CD011468_pub2_data","3::overall","3","overall","Quality of life",2,2,2,FALSE,TRUE,"RD","double_zero"
"CD011575_pub3_data","12::overall","12","overall","Mean systolic BP achieved",4,4,4,FALSE,TRUE,"RD","double_zero"
"CD011575_pub3_data","13::overall","13","overall","Mean diastolic BP achieved",4,4,4,FALSE,TRUE,"RD","double_zero"
"CD011600_pub3_data","1::overall","1","overall","Moderate-to-severe exacerbations (Rate)",9,9,9,FALSE,TRUE,"RD","double_zero"
"CD011600_pub3_data","2::overall","2","overall","Moderate-to-severe exacerbations (Time-to-first)",9,9,9,FALSE,TRUE,"RD","double_zero"
"CD011600_pub3_data","4::overall","4","overall","Moderate-to-severe exacerbations (Rate, stratified by eosinophil count)",8,8,8,FALSE,TRUE,"RD","double_zero"
"CD011600_pub3_data","6::overall","6","overall","Severe exacerbations (Rate)",7,7,7,FALSE,TRUE,"RD","double_zero"
"CD011600_pub3_data","7::overall","7","overall","Severe exacerbations (Time-to-first)",3,3,3,FALSE,TRUE,"RD","double_zero"
"CD011600_pub3_data","8::overall","8","overall","All exacerbations (Rate)",2,2,2,FALSE,TRUE,"RD","double_zero"
"CD011600_pub3_data","9::overall","9","overall","Change in SGRQ",9,9,9,FALSE,TRUE,"RD","double_zero"
"CD011600_pub3_data","11::overall","11","overall","SGRQ, end of study",2,2,2,FALSE,TRUE,"RD","double_zero"
"CD011600_pub3_data","13::overall","13","overall","Pneumonia (Time-to-first)",6,6,6,FALSE,TRUE,"RD","double_zero"
"CD011600_pub3_data","16::overall","16","overall","Change in E-RS",3,3,3,FALSE,TRUE,"RD","double_zero"
"CD011600_pub3_data","17::overall","17","overall","TDI, ≥ 1-unit increase",2,2,2,FALSE,TRUE,"RD","double_zero"
"CD011600_pub3_data","18::overall","18","overall","TDI (Focal score), over 24 weeks",6,6,6,FALSE,TRUE,"RD","double_zero"
"CD011600_pub3_data","19::overall","19","overall","Change in trough FEV1 (mL)",9,9,9,FALSE,TRUE,"RD","double_zero"
"CD011600_pub3_data","20::overall","20","overall","Trough FEV1, end of study (mL)",2,2,2,FALSE,TRUE,"RD","double_zero"
"CD011600_pub3_data","21::overall","21","overall","FEV1 AUC 0 to 4 (mL), end of study",2,2,2,FALSE,TRUE,"RD","double_zero"
"CD011600_pub3_data","22::overall","22","overall","Change in trough FVC (mL)",2,2,2,FALSE,TRUE,"RD","double_zero"
"CD011600_pub3_data","24::overall","24","overall","Death, all causes (Time-to-event)",6,6,6,FALSE,TRUE,"RD","double_zero"
"CD011624_pub3_data","1::overall","1","overall","Hypertensive disorders of pregnancy (including pre-eclampsia, pregnancy-induced hypertension, eclampsia)",2,2,2,FALSE,TRUE,"RD","double_zero"
"CD011624_pub3_data","2::overall","2","overall","Perinatal (foetal and neonatal) mortality",2,2,2,FALSE,TRUE,"RD","double_zero"
"CD011624_pub3_data","3::overall","3","overall","Large-for-gestational-age",3,3,3,FALSE,TRUE,"RD","double_zero"
"CD011624_pub3_data","4::overall","4","overall","Composite of mortality or serious morbidity (as defined by trial)",3,3,3,FALSE,TRUE,"RD","double_zero"
"CD011624_pub3_data","5::overall","5","overall","Caesarean section",3,3,3,FALSE,TRUE,"RD","double_zero"
"CD011624_pub3_data","12::overall","12","overall","Use of pharmacological therapy",4,4,4,FALSE,TRUE,"RD","double_zero"
"CD011624_pub3_data","22::overall","22","overall","Neonatal death",2,2,2,FALSE,TRUE,"RD","double_zero"
"CD011624_pub3_data","23::overall","23","overall","Macrosomia",3,3,3,FALSE,TRUE,"RD","double_zero"
"CD011624_pub3_data","24::overall","24","overall","Small-for-gestational-age",4,4,4,FALSE,TRUE,"RD","double_zero"
"CD011624_pub3_data","26::overall","26","overall","Gestational age at birth (weeks)",4,4,4,FALSE,TRUE,"RD","double_zero"
"CD011624_pub3_data","27::overall","27","overall","Birthweight",4,4,4,FALSE,TRUE,"RD","double_zero"
"CD011624_pub3_data","33::overall","33","overall","Infant hypoglycaemia",3,3,3,FALSE,TRUE,"RD","double_zero"
"CD011624_pub3_data","34::overall","34","overall","Neonatal jaundice (hyperbilirubinaemia)",2,2,2,FALSE,TRUE,"RD","double_zero"
"CD011624_pub3_data","41::overall","41","overall","Admission to neonatal intensive care unit/nursery",2,2,2,FALSE,TRUE,"RD","double_zero"
"CD011626_pub3_data","1::overall","1","overall","Cardiac T2* value (ms)",15,15,15,FALSE,TRUE,"RD","double_zero"
"CD011626_pub3_data","2::overall","2","overall","Myocardial iron concentration (mg/g)",14,14,14,FALSE,TRUE,"RD","double_zero"
"CD011626_pub3_data","3::overall","3","overall","Left ventricular ejection fraction (%)",6,6,6,FALSE,TRUE,"RD","double_zero"
"CD011626_pub3_data","4::overall","4","overall","Serum ferritin (μg/mL)",9,9,9,FALSE,TRUE,"RD","double_zero"
"CD011626_pub3_data","5::overall","5","overall","Liver T2* value (ms)",6,6,6,FALSE,TRUE,"RD","double_zero"
"CD011626_pub3_data","6::overall","6","overall","Liver iron concentration (mg/g)",4,4,4,FALSE,TRUE,"RD","double_zero"
"CD011670_pub3_data","7::overall","7","overall","Total length of hospital stay (days)",5,5,5,FALSE,TRUE,"RD","double_zero"
"CD011671_pub3_data","8::overall","8","overall","Duration of delayed graft function",4,4,4,FALSE,TRUE,"RD","double_zero"
"CD011689_pub4_data","8::overall","8","overall","Blood loss",110,110,110,FALSE,TRUE,"RD","double_zero"
"CD011689_pub4_data","9::overall","9","overall","Change in haemoglobin",83,83,83,FALSE,TRUE,"RD","double_zero"
"CD011689_pub4_data","8::1","8","1","Blood loss",190,190,190,FALSE,TRUE,"RD","double_zero"
"CD011689_pub4_data","8::2","8","2","Blood loss",26,26,26,FALSE,TRUE,"RD","double_zero"
"CD011689_pub4_data","9::1","9","1","Change in haemoglobin",142,142,142,FALSE,TRUE,"RD","double_zero"
"CD011689_pub4_data","9::2","9","2","Change in haemoglobin",23,23,23,FALSE,TRUE,"RD","double_zero"
"CD011689_pub4_data","8::3","8","3","Blood loss",2,2,2,FALSE,TRUE,"RD","double_zero"
"CD011762_pub2_data","14::overall","14","overall","Volume of blood loss",49,49,49,FALSE,TRUE,"RD","double_zero"
"CD011778_pub2_data","1::overall","1","overall","PPD (change from baseline (mm)); 3 months",45,45,45,FALSE,TRUE,"RD","double_zero"
"CD011778_pub2_data","2::overall","2","overall","PPD (change from baseline (mm)); 6 months",21,21,21,FALSE,TRUE,"RD","double_zero"
"CD011778_pub2_data","3::overall","3","overall","BOP (change from baseline (%)); 3 months",18,18,18,FALSE,TRUE,"RD","double_zero"
"CD011778_pub2_data","4::overall","4","overall","BOP (change from baseline (%)); 6 months",10,10,10,FALSE,TRUE,"RD","double_zero"
"CD011778_pub2_data","5::overall","5","overall","CAL (change from baseline (mm)); 3 months",42,42,42,FALSE,TRUE,"RD","double_zero"
"CD011778_pub2_data","6::overall","6","overall","CAL (change from baseline (mm)); 6 months",17,17,17,FALSE,TRUE,"RD","double_zero"
"CD011778_pub2_data","7::overall","7","overall","REC (change from baseline (mm)); 3 months",15,15,15,FALSE,TRUE,"RD","double_zero"
"CD011778_pub2_data","8::overall","8","overall","REC (change from baseline (mm)); 6 months",5,5,5,FALSE,TRUE,"RD","double_zero"
"CD011778_pub2_data","9::overall","9","overall","PPD at 6 months. Subgroup analysis according to type of control (placebo or negative control)",17,17,17,FALSE,TRUE,"RD","double_zero"
"CD011778_pub2_data","10::overall","10","overall","CAL at 6 months. Subgroup analysis according to type of control (placebo or negative control)",15,15,15,FALSE,TRUE,"RD","double_zero"
"CD011793_pub3_data","2::overall","2","overall","Cardiopulmonary bypass time (minutes)",10,10,10,FALSE,TRUE,"RD","double_zero"
"CD011793_pub3_data","3::overall","3","overall","Aortic cross-clamp time (minutes)",12,12,12,FALSE,TRUE,"RD","double_zero"
"CD011793_pub3_data","4::overall","4","overall","Length of hospital stay (days)",11,11,11,FALSE,TRUE,"RD","double_zero"
"CD011793_pub3_data","5::overall","5","overall","Postoperative blood loss (mL)",8,8,8,FALSE,TRUE,"RD","double_zero"
"CD011793_pub3_data","7::overall","7","overall","Pain scores",5,5,5,FALSE,TRUE,"RD","double_zero"
"CD011793_pub3_data","8::overall","8","overall","Quality of life",4,4,4,FALSE,TRUE,"RD","double_zero"
"CD011793_pub3_data","9::overall","9","overall","Index admission costs",2,2,2,FALSE,TRUE,"RD","double_zero"
"CD011793_pub3_data","10::overall","10","overall","Intensive care unit stay (days)",9,9,9,FALSE,TRUE,"RD","double_zero"
"CD011793_pub3_data","11::overall","11","overall","Postoperative pulmonary function tests (% FEV1)",5,5,5,FALSE,TRUE,"RD","double_zero"
"CD011793_pub3_data","14::overall","14","overall","Postoperative ventilation time (hours)",9,9,9,FALSE,TRUE,"RD","double_zero"
"CD011800_pub2_data","2::overall","2","overall","Secondary hyperparathyroidism (achieved parathyroid hormone level)",3,3,3,FALSE,TRUE,"RD","double_zero"
"CD011800_pub2_data","7::overall","7","overall","Secondary hyperparathyroidism (change in parathyroid hormone level from baseline)",2,2,2,FALSE,TRUE,"RD","double_zero"
"CD011806_pub2_data","4::overall","4","overall","Quality of life (QoL) (end of follow-up/change in score)",4,4,4,FALSE,TRUE,"RD","double_zero"
"CD011806_pub2_data","5::overall","5","overall","QoL (end of follow-up/change in score) – sensitivity analysis (fixed-effect)",2,2,2,FALSE,TRUE,"RD","double_zero"
"CD011806_pub2_data","8::overall","8","overall","Withdrawals due to adverse events – sensitivity analysis (removal of studies at risk of bias)",4,4,4,FALSE,TRUE,"RD","double_zero"
"CD011806_pub2_data","9::overall","9","overall","Disease activity at end of follow-up (Crohn's disease)",3,3,3,FALSE,TRUE,"RD","double_zero"
"CD011806_pub2_data","10::overall","10","overall","Disease activity at end of follow-up (Crohn's disease) – sensitivity analysis (fixed-effect)",3,3,3,FALSE,TRUE,"RD","double_zero"
"CD011806_pub2_data","12::overall","12","overall","Disease activity at end of follow-up (ulcerative colitis)",3,3,3,FALSE,TRUE,"RD","double_zero"
"CD011806_pub2_data","13::overall","13","overall","Disease activity at end of follow-up (ulcerative colitis) – sensitivity analysis (fixed-effect)",3,3,3,FALSE,TRUE,"RD","double_zero"
"CD011806_pub2_data","14::overall","14","overall","Normalisation of vitamin D levels – vitamin D levels at end of study period (continuous outcomes)",4,4,4,FALSE,TRUE,"RD","double_zero"
"CD011806_pub2_data","15::overall","15","overall","Normalisation of vitamin D levels – vitamin D levels at end of study period (continuous outcomes) – sensitivity analysis (fixed effect)",5,5,5,FALSE,TRUE,"RD","double_zero"
"CD011851_pub3_data","3::overall","3","overall","Low-density lipoprotein cholesterol",8,8,8,FALSE,TRUE,"RD","double_zero"
"CD011851_pub3_data","4::overall","4","overall","Low-density lipoprotein cholesterol: sensitivity analysis using fixed-effect model",8,8,8,FALSE,TRUE,"RD","double_zero"
"CD011851_pub3_data","5::overall","5","overall","Low-density lipoprotein cholesterol: sensitivity analysis excluding studies with high risk of bias",3,3,3,FALSE,TRUE,"RD","double_zero"
"CD011851_pub3_data","6::overall","6","overall","Systolic blood pressure",8,8,8,FALSE,TRUE,"RD","double_zero"
"CD011851_pub3_data","7::overall","7","overall","Systolic blood pressure: sensitivity analysis using fixed-effect model",8,8,8,FALSE,TRUE,"RD","double_zero"
"CD011851_pub3_data","8::overall","8","overall","Systolic blood pressure: sensitivity of analysis excluding studies with high risk of bias",3,3,3,FALSE,TRUE,"RD","double_zero"
"CD011851_pub3_data","9::overall","9","overall"," Systolic blood pressure: sensitivity analysis excluding outlier",7,7,7,FALSE,TRUE,"RD","double_zero"
"CD011851_pub3_data","10::overall","10","overall","Diastolic blood pressure",5,5,5,FALSE,TRUE,"RD","double_zero"
"CD011851_pub3_data","11::overall","11","overall","Diastolic blood pressure: sensitivity analysis using fixed-effect model",5,5,5,FALSE,TRUE,"RD","double_zero"
"CD011851_pub3_data","12::overall","12","overall","Diastolic blood pressure: sensitivity analysis excluding studies with high risk of bias",2,2,2,FALSE,TRUE,"RD","double_zero"
"CD011851_pub3_data","13::overall","13","overall","Heart rate",4,4,4,FALSE,TRUE,"RD","double_zero"
"CD011851_pub3_data","14::overall","14","overall","Heart rate: sensitivity analysis using fixed-effect model",4,4,4,FALSE,TRUE,"RD","double_zero"
"CD011866_pub3_data","6::overall","6","overall","Frequency of drug intake, end of treatment",11,11,11,FALSE,TRUE,"RD","double_zero"
"CD011866_pub3_data","7::overall","7","overall","Longest period of abstinence",19,19,19,FALSE,TRUE,"RD","double_zero"
"CD011866_pub3_data","8::overall","8","overall","Craving",10,10,10,FALSE,TRUE,"RD","double_zero"
"CD011866_pub3_data","9::overall","9","overall","Severity of dependence",6,6,6,FALSE,TRUE,"RD","double_zero"
"CD011866_pub3_data","10::overall","10","overall","Depression",2,2,2,FALSE,TRUE,"RD","double_zero"
"CD011885_pub2_data","9::overall","9","overall","General mental state: average endpoint BPRS total score (lower is better)",2,2,2,FALSE,TRUE,"RD","double_zero"
"CD011885_pub2_data","11::overall","11","overall","Global state: CGI-Severity endpoint or change score (lower is better)",3,3,3,FALSE,TRUE,"RD","double_zero"
"CD011885_pub2_data","14::overall","14","overall","Positive symptoms: average endpoint or change PANSS positive subscore (lower is better)",4,4,4,FALSE,TRUE,"RD","double_zero"
"CD011885_pub2_data","16::overall","16","overall","Negative symptoms: average endpoint or change in PANSS negative subscore (lower is better)",4,4,4,FALSE,TRUE,"RD","double_zero"
"CD011885_pub2_data","19::overall","19","overall","Depressive symptoms: average endpoint PANSS G6 item (depression) score (lower is better)",2,2,2,FALSE,TRUE,"RD","double_zero"
"CD011885_pub2_data","23::overall","23","overall","Aggressive behaviour: average endpoint PANSS-Excited Component subscore (lower is better)",2,2,2,FALSE,TRUE,"RD","double_zero"
"CD011885_pub2_data","24::overall","24","overall","Duration of hospitalisation in days (lower is better)",2,2,2,FALSE,TRUE,"RD","double_zero"
"CD011885_pub2_data","27::overall","27","overall","Adverse effects: extrapyramidal – akathisia measured by mean score change in BAS (lower is better)",2,2,2,FALSE,TRUE,"RD","double_zero"
"CD011885_pub2_data","35::overall","35","overall","Adverse effects: extrapyramidal – parkinsonism measured by mean score change in SAS (lower is better)",2,2,2,FALSE,TRUE,"RD","double_zero"
"CD011885_pub2_data","54::overall","54","overall","Adverse effects: weight – average change in kg (lower is better)",3,3,3,FALSE,TRUE,"RD","double_zero"
"CD012067_pub3_data","11::overall","11","overall","Health-related quality of life",2,2,2,FALSE,TRUE,"RD","double_zero"
"CD012079_pub2_data","8::overall","8","overall","POP-Q assessment ",40,40,40,FALSE,TRUE,"RD","double_zero"
"CD012079_pub2_data","9::overall","9","overall","POP-Q assessment Total Vaginal Length (TVL)",9,9,9,FALSE,TRUE,"RD","double_zero"
"CD012079_pub2_data","13::overall","13","overall","Pelvic Organ Prolapse/Urinary Incontinence Sexual Function Questionnaire 12 (PISQ-12) (0-48)",8,8,8,FALSE,TRUE,"RD","double_zero"
"CD012079_pub2_data","14::overall","14","overall","Quality of life",14,14,14,FALSE,TRUE,"RD","double_zero"
"CD012079_pub2_data","15::overall","15","overall","Quality of life (combined) ",9,9,9,FALSE,TRUE,"RD","double_zero"
"CD012079_pub2_data","17::overall","17","overall","Operating time (minutes)",19,19,19,FALSE,TRUE,"RD","double_zero"
"CD012152_pub4_data","15::overall","15","overall","Receipt of any medications for hypoglycaemia such as glucagon or corticosteroids",2,2,2,FALSE,TRUE,"RD","double_zero"
"CD012152_pub4_data","18::overall","18","overall","Duration of initial hospital stay (days)",2,2,2,FALSE,TRUE,"RD","double_zero"
"CD012170_pub2_data","1::overall","1","overall","Amount of physical activity",36,36,36,FALSE,TRUE,"RD","double_zero"
"CD012170_pub2_data","2::overall","2","overall","Minutes of sedentary behaviour",20,20,20,FALSE,TRUE,"RD","double_zero"
"CD012170_pub2_data","3::overall","3","overall","Physical health quality of life",3,3,3,FALSE,TRUE,"RD","double_zero"
"CD012178_pub2_data","6::overall","6","overall","Any reported adverse effects",3,3,3,FALSE,TRUE,"RD","double_zero"
"CD012214_pub3_data","2::overall","2","overall","Progression of endometrial hyperplasia to endometrial cancer",4,4,4,FALSE,TRUE,"RD","double_zero"
"CD012268_pub2_data","1::overall","1","overall","Body weight",21,21,21,FALSE,TRUE,"RD","double_zero"
"CD012268_pub2_data","2::overall","2","overall","BMI",9,9,9,FALSE,TRUE,"RD","double_zero"
"CD012268_pub2_data","3::overall","3","overall","Waist circumference",6,6,6,FALSE,TRUE,"RD","double_zero"
"CD012268_pub2_data","4::overall","4","overall","Fat mass",14,14,14,FALSE,TRUE,"RD","double_zero"
"CD012268_pub2_data","5::overall","5","overall","Subgroup analysis: body weight by menopausal status",10,10,10,FALSE,TRUE,"RD","double_zero"
"CD012268_pub2_data","6::overall","6","overall","Subgroup analysis: body weight by sex",21,21,21,FALSE,TRUE,"RD","double_zero"
"CD012268_pub2_data","7::overall","7","overall","Subgroup analysis: body weight by baseline BMI",21,21,21,FALSE,TRUE,"RD","double_zero"
"CD012268_pub2_data","8::overall","8","overall","Subgroup analysis: body weight by dose",21,21,21,FALSE,TRUE,"RD","double_zero"
"CD012268_pub2_data","9::overall","9","overall","Subgroup analysis: body weight by co-intervention",21,21,21,FALSE,TRUE,"RD","double_zero"
"CD012268_pub2_data","10::overall","10","overall","Subgroup analysis: body weight by trial duration",21,21,21,FALSE,TRUE,"RD","double_zero"
"CD012268_pub2_data","11::overall","11","overall","Subgroup analysis: body weight by trial size",21,21,21,FALSE,TRUE,"RD","double_zero"
"CD012268_pub2_data","12::overall","12","overall","Subgroup analysis: intention-to-treat",21,21,21,FALSE,TRUE,"RD","double_zero"
"CD012397_pub2_data","9::overall","9","overall","Specific behaviours: average endpoint in aggression score",2,2,2,FALSE,TRUE,"RD","double_zero"
"CD012429_pub2_data","15::overall","15","overall","Change in movement disorders (BARS)",3,3,3,FALSE,TRUE,"RD","double_zero"
"CD012429_pub2_data","16::overall","16","overall","Change in movement disorders (AIMS)",3,3,3,FALSE,TRUE,"RD","double_zero"
"CD012429_pub2_data","17::overall","17","overall","Change in movement disorders (SAS)",3,3,3,FALSE,TRUE,"RD","double_zero"
"CD012445_pub2_data","1::overall","1","overall","Child emotional and behavioural adjustment – postintervention",8,8,8,FALSE,TRUE,"RD","double_zero"
"CD012445_pub2_data","2::overall","2","overall","Child emotional and behavioural adjustment – latest follow-up",4,4,4,FALSE,TRUE,"RD","double_zero"
"CD012445_pub2_data","3::overall","3","overall","Parenting skills – postintervention",6,6,6,FALSE,TRUE,"RD","double_zero"
"CD012445_pub2_data","4::overall","4","overall","Parenting skills – latest follow-up",4,4,4,FALSE,TRUE,"RD","double_zero"
"CD012445_pub2_data","5::overall","5","overall","Parental depression/anxiety – postintervention",2,2,2,FALSE,TRUE,"RD","double_zero"
"CD012445_pub2_data","6::overall","6","overall","Parental depression or anxiety – latest follow-up",2,2,2,FALSE,TRUE,"RD","double_zero"
"CD012445_pub2_data","7::overall","7","overall","Parenting stress – postintervention",5,5,5,FALSE,TRUE,"RD","double_zero"
"CD012445_pub2_data","8::overall","8","overall","Parenting stress – latest follow-up",4,4,4,FALSE,TRUE,"RD","double_zero"
"CD012445_pub2_data","9::overall","9","overall","Parent mindfulness – postintervention",7,7,7,FALSE,TRUE,"RD","double_zero"
"CD012445_pub2_data","10::overall","10","overall","Parent mindfulness – latest follow-up",4,4,4,FALSE,TRUE,"RD","double_zero"
"CD012532_pub2_data","1::overall","1","overall","Overall Survival",7,7,7,FALSE,TRUE,"RD","double_zero"
"CD012532_pub2_data","2::overall","2","overall","Progression-free survival",7,7,7,FALSE,TRUE,"RD","double_zero"
"CD012570_pub2_data","5::overall","5","overall","Systolic blood pressure",10,10,10,FALSE,TRUE,"RD","double_zero"
"CD012570_pub2_data","6::overall","6","overall","Diastolic blood pressure",10,10,10,FALSE,TRUE,"RD","double_zero"
"CD012572_pub3_data","6::overall","6","overall","Systolic blood pressure",5,5,5,FALSE,TRUE,"RD","double_zero"
"CD012572_pub3_data","7::overall","7","overall","Systolic blood pressure subgrouped on duration",5,5,5,FALSE,TRUE,"RD","double_zero"
"CD012572_pub3_data","8::overall","8","overall","Systolic blood pressure subgrouped on drug type",5,5,5,FALSE,TRUE,"RD","double_zero"
"CD012572_pub3_data","9::overall","9","overall","Diastolic blood pressure",5,5,5,FALSE,TRUE,"RD","double_zero"
"CD012572_pub3_data","10::overall","10","overall","Diastolic blood pressure subgrouped on duration",5,5,5,FALSE,TRUE,"RD","double_zero"
"CD012572_pub3_data","11::overall","11","overall","Diastolic blood pressure subgrouped on drug type",5,5,5,FALSE,TRUE,"RD","double_zero"
"CD012586_pub2_data","8::1","8","1","Oocyte number",35,35,35,FALSE,TRUE,"RD","double_zero"
"CD012586_pub2_data","8::2","8","2","Oocyte number",10,10,10,FALSE,TRUE,"RD","double_zero"
"CD012586_pub2_data","8::3","8","3","Oocyte number",5,5,5,FALSE,TRUE,"RD","double_zero"
"CD012586_pub2_data","9::1","9","1","Blastocyst number",8,8,8,FALSE,TRUE,"RD","double_zero"
"CD012586_pub2_data","10::1","10","1","Frozen embryo number",9,9,9,FALSE,TRUE,"RD","double_zero"
"CD012586_pub2_data","10::2","10","2","Frozen embryo number",4,4,4,FALSE,TRUE,"RD","double_zero"
"CD012623_pub2_data","2::overall","2","overall","Visual outcome gained following intervention in ETDRS letters",6,6,6,FALSE,TRUE,"RD","double_zero"
"CD012642_pub2_data","8::overall","8","overall","Periventricular leukomalacia",2,2,2,FALSE,TRUE,"RD","double_zero"
"CD012642_pub2_data","9::overall","9","overall","Maximal weight loss %",3,3,3,FALSE,TRUE,"RD","double_zero"
"CD012693_pub3_data","7::overall","7","overall","Log(N oocytes retrieved); data presented on the log scale - cannot interpret pooled estimates as N of oocytes",12,12,12,FALSE,TRUE,"RD","double_zero"
"CD012693_pub3_data","15::overall","15","overall","Total dose of FSH",23,23,23,FALSE,TRUE,"RD","double_zero"
"CD012693_pub3_data","16::overall","16","overall","Duration of FSH administration",22,22,22,FALSE,TRUE,"RD","double_zero"
"CD012693_pub3_data","34::overall","34","overall","Dose-response: total dose of FSH",4,4,4,FALSE,TRUE,"RD","double_zero"
"CD012693_pub3_data","35::overall","35","overall","Dose-response: duration of FSH administration",6,6,6,FALSE,TRUE,"RD","double_zero"
"CD012850_pub2_data","9::overall","9","overall","Muscle pain at rest (continuous data)",4,4,4,FALSE,TRUE,"RD","double_zero"
"CD012850_pub2_data","10::overall","10","overall","Muscle pain at rest (continuous data)",4,4,4,FALSE,TRUE,"RD","double_zero"
"CD012850_pub2_data","21::overall","21","overall","Range of mandibular motion (maximum unassisted (mandibular) opening",3,3,3,FALSE,TRUE,"RD","double_zero"
"CD012850_pub2_data","22::overall","22","overall","Range of mandibular motion (unassisted (mandibular) opening without pain)",4,4,4,FALSE,TRUE,"RD","double_zero"
"CD012850_pub2_data","23::overall","23","overall","Range of mandibular motion (unassisted (mandibular) opening without pain)",4,4,4,FALSE,TRUE,"RD","double_zero"
"CD012850_pub2_data","24::overall","24","overall","Range of mandibular motion (unassisted (mandibular) opening without pain)",2,2,2,FALSE,TRUE,"RD","double_zero"
"CD012850_pub2_data","25::overall","25","overall","Range of mandibular motion (unassisted (mandibular) opening without pain)",2,2,2,FALSE,TRUE,"RD","double_zero"
"CD012850_pub2_data","26::overall","26","overall","Range of mandibular motion (unassisted (mandibular) opening without pain)",2,2,2,FALSE,TRUE,"RD","double_zero"
"CD012850_pub2_data","27::overall","27","overall","Range of mandibular motion (maximum assisted (mandibular opening)",2,2,2,FALSE,TRUE,"RD","double_zero"
"CD012850_pub2_data","28::overall","28","overall","Depression",2,2,2,FALSE,TRUE,"RD","double_zero"
"CD012891_pub2_data","2::overall","2","overall","Standard controlled ovarian hyperstimulation with gonadotropins versus controlled ovarian hyperstimulation with gonadotropins + tamoxifen: number of oocytes retrieved after ovarian stimulation",2,2,2,FALSE,TRUE,"RD","double_zero"
"CD012905_pub2_data","4::overall","4","overall","Change in serum creatinine from baseline",17,17,17,FALSE,TRUE,"RD","double_zero"
"CD012905_pub2_data","5::overall","5","overall","Change in urine output from baseline",5,5,5,FALSE,TRUE,"RD","double_zero"
"CD012925_pub2_data","1::overall","1","overall","Provider adherence to recommended practice (dichotomous outcomes)",19,19,19,FALSE,TRUE,"RD","double_zero"
"CD012925_pub2_data","3::overall","3","overall","Client's health behaviour",15,15,15,FALSE,TRUE,"RD","double_zero"
"CD012925_pub2_data","7::overall","7","overall","Client utilisation of primary healthcare and/or services (risk difference)",8,8,8,FALSE,TRUE,"RD","double_zero"
"CD012967_pub2_data","4::overall","4","overall","Change in impairment score at 24 months",2,2,2,FALSE,TRUE,"RD","double_zero"
"CD012993_pub2_data","2::overall","2","overall","Change in FVC from baseline",7,7,7,FALSE,TRUE,"RD","double_zero"
"CD012993_pub2_data","6::overall","6","overall","Quality of life - PROMIS - fatigue score",3,3,3,FALSE,TRUE,"RD","double_zero"
"CD013038_pub3_data","1::overall","1","overall","Time to reach full sucking feeds (days)",3,3,3,FALSE,TRUE,"RD","double_zero"
"CD013038_pub3_data","2::overall","2","overall","Time to reach full sucking feeds (days) – by type of exposure",3,3,3,FALSE,TRUE,"RD","double_zero"
"CD013038_pub3_data","3::overall","3","overall","Duration of parenteral nutrition (days)",3,3,3,FALSE,TRUE,"RD","double_zero"
"CD013038_pub3_data","4::overall","4","overall","Time to reach full enteral feeds (days)",4,4,4,FALSE,TRUE,"RD","double_zero"
"CD013038_pub3_data","5::overall","5","overall","Time to reach full enteral feeds (days) – by type of exposure",4,4,4,FALSE,TRUE,"RD","double_zero"
"CD013038_pub3_data","8::overall","8","overall","Time to first discharge home (days)",5,5,5,FALSE,TRUE,"RD","double_zero"
"CD013038_pub3_data","9::overall","9","overall","Time to first discharge home (postmenstrual age in weeks)",4,4,4,FALSE,TRUE,"RD","double_zero"
"CD013038_pub3_data","10::overall","10","overall","Time to first discharge home (days) – by type of exposure",5,5,5,FALSE,TRUE,"RD","double_zero"
"CD013038_pub3_data","11::overall","11","overall","Time to first discharge home (postmenstrual age in weeks) – by type of exposure",4,4,4,FALSE,TRUE,"RD","double_zero"
"CD013042_pub2_data","1::overall","1","overall","Mean pain (0 to 10, 0 is no pain)",87,87,87,FALSE,TRUE,"RD","double_zero"
"CD013042_pub2_data","2::overall","2","overall","Mean disability (0 to 100, 0 is no disability)",75,75,75,FALSE,TRUE,"RD","double_zero"
"CD013042_pub2_data","7::overall","7","overall","Pain-free grip strength (SMD)",30,30,30,FALSE,TRUE,"RD","double_zero"
"CD013059_pub2_data","1::overall","1","overall","Depressive symptomatology",299,299,299,FALSE,TRUE,"RD","double_zero"
"CD013059_pub2_data","3::overall","3","overall","Quality of life and psychological well-being",25,25,25,FALSE,TRUE,"RD","double_zero"
"CD013059_pub2_data","4::overall","4","overall","Anxious symptomatology",2,2,2,FALSE,TRUE,"RD","double_zero"
"CD013071_pub2_data","1::overall","1","overall","Erectile function (AMS sexual)",9,9,9,FALSE,TRUE,"RD","double_zero"
"CD013071_pub2_data","3::overall","3","overall","Erectile function (conversion to IIEF-EF)",13,13,13,FALSE,TRUE,"RD","double_zero"
"CD013071_pub2_data","4::overall","4","overall","Sexual quality of life (AMS total)",7,7,7,FALSE,TRUE,"RD","double_zero"
"CD013071_pub2_data","9::overall","9","overall","Lower urinary tract symptoms",9,9,9,FALSE,TRUE,"RD","double_zero"
"CD013071_pub2_data","10::overall","10","overall","Erectile function (subgroup: age and testosterone level, conversion to IIEF-EF)",10,10,10,FALSE,TRUE,"RD","double_zero"
"CD013071_pub2_data","12::overall","12","overall","Erectile function (subgroup: metabolic syndrome (MS), conversion to IIEF-EF)",10,10,10,FALSE,TRUE,"RD","double_zero"
"CD013071_pub2_data","13::overall","13","overall","Sexual quality of life (subgroup: metabolic syndrome (MS), AMS total)",6,6,6,FALSE,TRUE,"RD","double_zero"
"CD013071_pub2_data","14::overall","14","overall","Sexual quality of life (subgroup: metabolic syndrome (MS), IIEF - overall satisfaction)",4,4,4,FALSE,TRUE,"RD","double_zero"
"CD013071_pub2_data","16::overall","16","overall","Erectile function (conversion to IIEF-EF; sensitivity analysis)",6,6,6,FALSE,TRUE,"RD","double_zero"
"CD013071_pub2_data","17::overall","17","overall","Sexual quality of life (AMS total; sensitivity analysis)",5,5,5,FALSE,TRUE,"RD","double_zero"
"CD013071_pub2_data","18::overall","18","overall","Sexual quality of life (IIEF-overall satisfaction; sensitivity analysis)",2,2,2,FALSE,TRUE,"RD","double_zero"
"CD013071_pub2_data","21::overall","21","overall","Lower urinary tract symptoms (sensitivity analysis)",6,6,6,FALSE,TRUE,"RD","double_zero"
"CD013078_pub2_data","1::overall","1","overall","Pain intensity at the end of the treatment (6 months)",6,6,6,FALSE,TRUE,"RD","double_zero"
"CD013078_pub2_data","2::overall","2","overall","Function at the end of treatment",7,7,7,FALSE,TRUE,"RD","double_zero"
"CD013078_pub2_data","3::overall","3","overall","Function at 6 months' follow-up",4,4,4,FALSE,TRUE,"RD","double_zero"
"CD013078_pub2_data","4::overall","4","overall","Function at 6 months' follow-up",3,3,3,FALSE,TRUE,"RD","double_zero"
"CD013105_pub2_data","5::1","5","1","Adverse events ",2,2,2,FALSE,TRUE,"RD","double_zero"
"CD013105_pub2_data","6::2","6","2","Patient-reported outcome measures ",3,3,3,FALSE,TRUE,"RD","double_zero"
"CD013105_pub2_data","6::3","6","3","Patient-reported outcome measures ",3,3,3,FALSE,TRUE,"RD","double_zero"
"CD013105_pub2_data","6::4","6","4","Patient-reported outcome measures ",2,2,2,FALSE,TRUE,"RD","double_zero"
"CD013105_pub2_data","6::5","6","5","Patient-reported outcome measures ",3,3,3,FALSE,TRUE,"RD","double_zero"
"CD013105_pub2_data","2::6","2","6","Patient-reported outcome measures ",2,2,2,FALSE,TRUE,"RD","double_zero"
"CD013105_pub2_data","3::3","3","3","Perioperative outcomes ",5,5,5,FALSE,TRUE,"RD","double_zero"
"CD013105_pub2_data","3::5","3","5","Perioperative outcomes ",2,2,2,FALSE,TRUE,"RD","double_zero"
"CD013105_pub2_data","2::2","2","2","Adverse events ",3,3,3,FALSE,TRUE,"RD","double_zero"
"CD013105_pub2_data","1::10","1","10","Patient-reported outcome measures ",2,2,2,FALSE,TRUE,"RD","double_zero"
"CD013166_pub3_data","1::overall","1","overall","Erectile function ",32,32,32,FALSE,TRUE,"RD","double_zero"
"CD013166_pub3_data","4::overall","4","overall","Penile rigidity",4,4,4,FALSE,TRUE,"RD","double_zero"
"CD013166_pub3_data","1::1","1","1","Subgroup analysis by PDE-5i response status: erectile function",3,3,3,FALSE,TRUE,"RD","double_zero"
"CD013166_pub3_data","3::1","3","1","Subgroup analysis by PDE-5i response status: treatment-related adverse events",2,2,2,FALSE,TRUE,"RD","double_zero"
"CD013232_pub2_data","17::overall","17","overall","Quality of life",16,16,16,FALSE,TRUE,"RD","double_zero"
"CD013232_pub2_data","19::overall","19","overall","Subgroup analysis: age - irritability",14,14,14,FALSE,TRUE,"RD","double_zero"
"CD013232_pub2_data","21::overall","21","overall","Subgroup analysis: cognitive ability - irritability",13,13,13,FALSE,TRUE,"RD","double_zero"
"CD013278_pub3_data","7::1","7","1","Duration of ventilator support (days)",3,3,3,FALSE,TRUE,"RD","double_zero"
"CD013278_pub3_data","7::2","7","2","Duration of ventilator support (days)",5,5,5,FALSE,TRUE,"RD","double_zero"
"CD013278_pub3_data","8::1","8","1","Duration of need for supplementary oxygen (days)",2,2,2,FALSE,TRUE,"RD","double_zero"
"CD013278_pub3_data","8::2","8","2","Duration of need for supplementary oxygen (days)",4,4,4,FALSE,TRUE,"RD","double_zero"
"CD013278_pub3_data","23::2","23","2","Duration of hospitalization",4,4,4,FALSE,TRUE,"RD","double_zero"
"CD013284_pub2_data","1::overall","1","overall","Rate of moderate or severe exacerbations",11,11,11,FALSE,TRUE,"RD","double_zero"
"CD013284_pub2_data","2::overall","2","overall","Rate of moderate or severe exacerbations (stratified by baseline 25(OH)D)",20,20,20,FALSE,TRUE,"RD","double_zero"
"CD013284_pub2_data","3::overall","3","overall","Rate of moderate or severe exacerbations (stratified by baseline FEV1, % predicted)",10,10,10,FALSE,TRUE,"RD","double_zero"
"CD013284_pub2_data","4::overall","4","overall","Rate of moderate or severe exacerbations (stratified by baseline corticosteroid use)",10,10,10,FALSE,TRUE,"RD","double_zero"
"CD013284_pub2_data","5::overall","5","overall","Proportion of participants experiencing one or more exacerbations (moderate or severe)",5,5,5,FALSE,TRUE,"RD","double_zero"
"CD013284_pub2_data","6::overall","6","overall","Time to first exacerbation",4,4,4,FALSE,TRUE,"RD","double_zero"
"CD013284_pub2_data","7::overall","7","overall","Rate of severe exacerbation, requiring ED attendance or hospitalisation",4,4,4,FALSE,TRUE,"RD","double_zero"
"CD013284_pub2_data","8::overall","8","overall","Rate of moderate exacerbation",3,3,3,FALSE,TRUE,"RD","double_zero"
"CD013284_pub2_data","9::overall","9","overall","Incidence of study defined exacerbation",5,5,5,FALSE,TRUE,"RD","double_zero"
"CD013284_pub2_data","10::overall","10","overall","Inter-arm difference in mean change in FEV1 (% predicted)",7,7,7,FALSE,TRUE,"RD","double_zero"
"CD013284_pub2_data","11::overall","11","overall","Inter-arm difference in mean change in FVC (% predicted)",5,5,5,FALSE,TRUE,"RD","double_zero"
"CD013294_pub2_data","1::overall","1","overall","Time (%) in target oxygen saturation range",15,15,15,FALSE,TRUE,"RD","double_zero"
"CD013294_pub2_data","4::overall","4","overall","Time (%) above alarm limit or desired oxygen saturation range, regardless of fraction of inspired oxygen received",10,10,10,FALSE,TRUE,"RD","double_zero"
"CD013294_pub2_data","5::overall","5","overall","Time (%) above alarm limit or desired oxygen saturation range, excluding time in room air",5,5,5,FALSE,TRUE,"RD","double_zero"
"CD013294_pub2_data","6::overall","6","overall","Time (%) below alarm limit or desired oxygen saturation range",11,11,11,FALSE,TRUE,"RD","double_zero"
"CD013294_pub2_data","7::overall","7","overall","Hypoxic episodes during study period",4,4,4,FALSE,TRUE,"RD","double_zero"
"CD013294_pub2_data","8::overall","8","overall","Time (%) with oxygen saturation below 80%",3,3,3,FALSE,TRUE,"RD","double_zero"
"CD013294_pub2_data","9::overall","9","overall","Time with oxygen saturation between 97% and 100%, excluding time in room air",2,2,2,FALSE,TRUE,"RD","double_zero"
"CD013294_pub2_data","11::overall","11","overall","Average oxygen saturation (%)",8,8,8,FALSE,TRUE,"RD","double_zero"
"CD013294_pub2_data","12::overall","12","overall","Average fraction of inspired oxygen",8,8,8,FALSE,TRUE,"RD","double_zero"
"CD013294_pub2_data","13::overall","13","overall","Number of manual adjustments during study",4,4,4,FALSE,TRUE,"RD","double_zero"
"CD013303_pub2_data","1::overall","1","overall","HIV health literacy: understanding HIV terms (short-term: immediately post-intervention)",11,11,11,FALSE,TRUE,"RD","double_zero"
"CD013303_pub2_data","7::overall","7","overall","Health behaviour: physical activity, average daily steps (short-term: immediately post-intervention)",6,6,6,FALSE,TRUE,"RD","double_zero"
"CD013303_pub2_data","8::overall","8","overall","Health behaviour: physical activity, average daily steps (short-term: three months post-intervention)",5,5,5,FALSE,TRUE,"RD","double_zero"
"CD013303_pub2_data","9::overall","9","overall","Self-efficacy to manage one's disease (short-term: immediately post-intervention)",7,7,7,FALSE,TRUE,"RD","double_zero"
"CD013303_pub2_data","10::overall","10","overall","Any health-related knowledge, 0 to 100 (short-term: immediately post-intervention) - all studies",7,7,7,FALSE,TRUE,"RD","double_zero"
"CD013303_pub2_data","13::overall","13","overall","Any health-related knowledge, 0 to 100 (short-term: immediately post-intervention) - without Kaur 2019",6,6,6,FALSE,TRUE,"RD","double_zero"
"CD013303_pub2_data","14::overall","14","overall","Any health-related knowledge, 0 to 100 (medium-term: up to 6 months post-intervention)",4,4,4,FALSE,TRUE,"RD","double_zero"
"CD013303_pub2_data","16::overall","16","overall","Health outcome: any depression (medium-term: up to 6 months post-intervention)",3,3,3,FALSE,TRUE,"RD","double_zero"
"CD013303_pub2_data","23::overall","23","overall","Self-efficacy to manage one's disease (short-term: immediately post-intervention) - all studies",4,4,4,FALSE,TRUE,"RD","double_zero"
"CD013303_pub2_data","24::overall","24","overall","Self-efficacy to manage one's disease (short-term: immediately post-intervention) - studies without high risk of bias",2,2,2,FALSE,TRUE,"RD","double_zero"
"CD013331_pub2_data","1::overall","1","overall","Pain relief: high-frequency TENS versus placebo or no treatment",18,18,18,FALSE,TRUE,"RD","double_zero"
"CD013331_pub2_data","3::overall","3","overall","Requirements for additional analgesics - number of tablets: high-frequency TENS versus placebo or no treatment",7,7,7,FALSE,TRUE,"RD","double_zero"
"CD013332_pub2_data","3::overall","3","overall","Hospital length of stay",6,6,6,FALSE,TRUE,"RD","double_zero"
"CD013342_pub2_data","1::1","1","1","Mean overall pain (0 to 10, 0 is no pain)",20,20,20,FALSE,TRUE,"RD","double_zero"
"CD013342_pub2_data","1::2","1","2","Mean overall pain (0 to 10, 0 is no pain)",21,21,21,FALSE,TRUE,"RD","double_zero"
"CD013342_pub2_data","1::3","1","3","Mean overall pain (0 to 10, 0 is no pain)",16,16,16,FALSE,TRUE,"RD","double_zero"
"CD013342_pub2_data","2::1","2","1","Mean overall pain by cell origin (0 to 10, 0 is no pain)",15,15,15,FALSE,TRUE,"RD","double_zero"
"CD013342_pub2_data","2::2","2","2","Mean overall pain by cell origin (0 to 10, 0 is no pain)",15,15,15,FALSE,TRUE,"RD","double_zero"
"CD013342_pub2_data","3::2","3","2","Mean function (0 to 100, 0 is best function)",10,10,10,FALSE,TRUE,"RD","double_zero"
"CD013342_pub2_data","3::3","3","3","Mean function (0 to 100, 0 is best function)",6,6,6,FALSE,TRUE,"RD","double_zero"
"CD013342_pub2_data","4::2","4","2","Mean function by cell origin (0 to 100, 0 is best function)",3,3,3,FALSE,TRUE,"RD","double_zero"
"CD013342_pub2_data","5::1","5","1","Mean quality of life (SF-36 mental health)",2,2,2,FALSE,TRUE,"RD","double_zero"
"CD013342_pub2_data","5::2","5","2","Mean quality of life (SF-36 mental health)",2,2,2,FALSE,TRUE,"RD","double_zero"
"CD013342_pub2_data","12::overall","12","overall","Mean overall pain (0 to 10 points, 0 is no pain)",7,7,7,FALSE,TRUE,"RD","double_zero"
"CD013342_pub2_data","2::3","2","3","Mean function (0 to 100, 0 is best function)",12,12,12,FALSE,TRUE,"RD","double_zero"
"CD013353_pub2_data","1::overall","1","overall","PIPP during endotracheal suctioning",12,12,12,FALSE,TRUE,"RD","double_zero"
"CD013353_pub2_data","2::overall","2","overall","ALPS-Neo Scale during endotracheal suctioning",4,4,4,FALSE,TRUE,"RD","double_zero"
"CD013353_pub2_data","3::overall","3","overall","Heart rate during endotracheal suctioning (bpm)",7,7,7,FALSE,TRUE,"RD","double_zero"
"CD013353_pub2_data","4::overall","4","overall","Oxygen saturation during endotracheal suctioning (%)",4,4,4,FALSE,TRUE,"RD","double_zero"
"CD013355_pub2_data","1::overall","1","overall","PIPP during endotracheal suctioning",4,4,4,FALSE,TRUE,"RD","double_zero"
"CD013358_pub2_data","2::overall","2","overall","Diastolic blood pressure (mmHg), change from baseline",44,44,44,FALSE,TRUE,"RD","double_zero"
"CD013358_pub2_data","3::overall","3","overall","Anxiety, change from baseline",40,40,40,FALSE,TRUE,"RD","double_zero"
"CD013358_pub2_data","4::overall","4","overall","Depression, change from baseline",44,44,44,FALSE,TRUE,"RD","double_zero"
"CD013358_pub2_data","5::overall","5","overall","Perceived stress, change from baseline",40,40,40,FALSE,TRUE,"RD","double_zero"
"CD013358_pub2_data","6::overall","6","overall","Well-being",15,15,15,FALSE,TRUE,"RD","double_zero"
"CD013358_pub2_data","7::overall","7","overall","Total cholesterol (mmol/L), change from baseline",6,6,6,FALSE,TRUE,"RD","double_zero"
"CD013358_pub2_data","9::overall","9","overall","HDL cholesterol (mmol/L), change from baseline",7,7,7,FALSE,TRUE,"RD","double_zero"
"CD013358_pub2_data","10::overall","10","overall","Triglycerides (mmol/L), change from baseline",5,5,5,FALSE,TRUE,"RD","double_zero"
"CD013358_pub2_data","11::overall","11","overall","Fasting blood glucose (mmol/L), change from baseline",5,5,5,FALSE,TRUE,"RD","double_zero"
"CD013358_pub2_data","12::overall","12","overall","HbA1c (%), change from baseline",10,10,10,FALSE,TRUE,"RD","double_zero"
"CD013358_pub2_data","13::overall","13","overall","Weight (kg), change from baseline",16,16,16,FALSE,TRUE,"RD","double_zero"
"CD013358_pub2_data","14::overall","14","overall","BMI (kg/m2), change from baseline",19,19,19,FALSE,TRUE,"RD","double_zero"
"CD013358_pub2_data","16::overall","16","overall","Quality of life, change from baseline",10,10,10,FALSE,TRUE,"RD","double_zero"
"CD013358_pub2_data","18::overall","18","overall","Quality of life, change from baseline",15,15,15,FALSE,TRUE,"RD","double_zero"
"CD013358_pub2_data","19::overall","19","overall","Self-efficacy, change from baseline",6,6,6,FALSE,TRUE,"RD","double_zero"
"CD013366_pub2_data","14::overall","14","overall","PICC dwell time",2,2,2,FALSE,TRUE,"RD","double_zero"
"CD013396_pub2_data","5::2","5","2","Adverse events",2,2,2,FALSE,TRUE,"RD","double_zero"
"CD013396_pub2_data","5::3","5","3","Adverse events",2,2,2,FALSE,TRUE,"RD","double_zero"
"CD013414_pub2_data","2::overall","2","overall","eGFR: final measure",8,8,8,FALSE,TRUE,"RD","double_zero"
"CD013414_pub2_data","10::overall","10","overall","Quality of life",2,2,2,FALSE,TRUE,"RD","double_zero"
"CD013414_pub2_data","7::overall","7","overall","UACR: % change",2,2,2,FALSE,TRUE,"RD","double_zero"
"CD013421_pub2_data","4::overall","4","overall","Intraoperative blood loss - studies combining multiple surgery indications",3,3,3,FALSE,TRUE,"RD","double_zero"
"CD013421_pub2_data","5::overall","5","overall","Operating time - studies combining multiple surgery indications",3,3,3,FALSE,TRUE,"RD","double_zero"
"CD013429_pub2_data","5::overall","5","overall","Primary: Eustachian tube function measured by an objective or semi-objective test: Eustachian Tube Score",4,4,4,FALSE,TRUE,"RD","double_zero"
"CD013429_pub2_data","6::overall","6","overall","Secondary: Hearing: air-bone gap 0-3 months",2,2,2,FALSE,TRUE,"RD","double_zero"
"CD013429_pub2_data","7::overall","7","overall","Secondary: Hearing: air-bone gap over 3 months",3,3,3,FALSE,TRUE,"RD","double_zero"
"CD013429_pub2_data","9::overall","9","overall","Secondary: Quality of life: ear stuffiness VAS",4,4,4,FALSE,TRUE,"RD","double_zero"
"CD013429_pub2_data","10::overall","10","overall","Secondary: Quality of life: COMOT-15",4,4,4,FALSE,TRUE,"RD","double_zero"
"CD013445_pub2_data","4::overall","4","overall","Length of hospital stay",26,26,26,FALSE,TRUE,"RD","double_zero"
"CD013445_pub2_data","7::overall","7","overall","Procedure time",29,29,29,FALSE,TRUE,"RD","double_zero"
"CD013445_pub2_data","11::overall","11","overall","Pain on postoperative day 0",7,7,7,FALSE,TRUE,"RD","double_zero"
"CD013445_pub2_data","12::overall","12","overall","Pain on postoperative day 1",8,8,8,FALSE,TRUE,"RD","double_zero"
"CD013445_pub2_data","13::overall","13","overall","Pain on postoperative days 2 to 7",2,2,2,FALSE,TRUE,"RD","double_zero"
"CD013456_pub2_data","1::overall","1","overall","Psychosocial interventions versus inactive control; outcome 1: PTSD symptoms, post-treatment",33,33,33,FALSE,TRUE,"RD","double_zero"
"CD013456_pub2_data","2::overall","2","overall","Psychosocial interventions versus inactive control; outcome 1: PTSD symptoms, 3 months",17,17,17,FALSE,TRUE,"RD","double_zero"
"CD013456_pub2_data","3::overall","3","overall","Psychosocial interventions versus inactive control; outcome 2: Depressive symptoms, post-treatment",22,22,22,FALSE,TRUE,"RD","double_zero"
"CD013456_pub2_data","4::overall","4","overall","Psychosocial interventions versus inactive control; outcome 2: Depressive symptoms, 3 months",14,14,14,FALSE,TRUE,"RD","double_zero"
"CD013456_pub2_data","9::overall","9","overall","Psychosocial interventions versus inactive control; outcome 6: Global mental health/distress, post-treatment",12,12,12,FALSE,TRUE,"RD","double_zero"
"CD013456_pub2_data","10::overall","10","overall","Trauma-focused versus non trauma-focused interventions; outcome 5: Anxiety symptoms, 3 months",6,6,6,FALSE,TRUE,"RD","double_zero"
"CD013456_pub2_data","11::overall","11","overall","Trauma-focused versus non trauma-focused interventions; outcome 5: Anxiety symptoms, 6 months",3,3,3,FALSE,TRUE,"RD","double_zero"
"CD013456_pub2_data","12::overall","12","overall","Trauma-focused versus non-trauma focused interventions; outcome 7: Trauma-related beliefs, post-treatment",5,5,5,FALSE,TRUE,"RD","double_zero"
"CD013456_pub2_data","13::overall","13","overall","Trauma-focused versus non trauma-focused interventions; outcome 7: Global mental health/distress, post-treatment",4,4,4,FALSE,TRUE,"RD","double_zero"
"CD013456_pub2_data","14::overall","14","overall","Trauma-focused versus non trauma-focused interventions; outcome 7: Global mental health/distress, 3 months",3,3,3,FALSE,TRUE,"RD","double_zero"
"CD013468_pub2_data","3::overall","3","overall","Participant health-related quality of life",2,2,2,FALSE,TRUE,"RD","double_zero"
"CD013474_pub2_data","1::overall","1","overall","Overall survival (time to event)",7,7,7,FALSE,TRUE,"RD","double_zero"
"CD013474_pub2_data","6::overall","6","overall","Progression-free survival (time to event)",8,8,8,FALSE,TRUE,"RD","double_zero"
"CD013474_pub2_data","7::overall","7","overall","Progression-free survival (time to event): type of drug",5,5,5,FALSE,TRUE,"RD","double_zero"
"CD013474_pub2_data","12::overall","12","overall","All adverse events",6,6,6,FALSE,TRUE,"RD","double_zero"
"CD013474_pub2_data","13::overall","13","overall","All adverse events: type of drug",6,6,6,FALSE,TRUE,"RD","double_zero"
"CD013476_pub2_data","1::overall","1","overall","Disease-specific health-related quality of life scores at 6 months follow-up (SNOT-score)",3,3,3,FALSE,TRUE,"RD","double_zero"
"CD013476_pub2_data","11::overall","11","overall","Change in medication score at 6 months follow-up (dosage of inhaled/intranasal corticosteroid) ",2,2,2,FALSE,TRUE,"RD","double_zero"
"CD013476_pub2_data","12::overall","12","overall","Symptom score after 6 months follow-up",3,3,3,FALSE,TRUE,"RD","double_zero"
"CD013508_pub3_data","1::overall","1","overall","Depression",21,21,21,FALSE,TRUE,"RD","double_zero"
"CD013508_pub3_data","2::overall","2","overall","HADS-D ",8,8,8,FALSE,TRUE,"RD","double_zero"
"CD013508_pub3_data","3::overall","3","overall","BDI-II",3,3,3,FALSE,TRUE,"RD","double_zero"
"CD013508_pub3_data","4::overall","4","overall","PHQ-9",4,4,4,FALSE,TRUE,"RD","double_zero"
"CD013508_pub3_data","5::overall","5","overall","Anxiety",19,19,19,FALSE,TRUE,"RD","double_zero"
"CD013508_pub3_data","6::overall","6","overall","HADS-A",9,9,9,FALSE,TRUE,"RD","double_zero"
"CD013508_pub3_data","7::overall","7","overall","GAD-7",3,3,3,FALSE,TRUE,"RD","double_zero"
"CD013508_pub3_data","8::overall","8","overall","BAI",3,3,3,FALSE,TRUE,"RD","double_zero"
"CD013508_pub3_data","9::overall","9","overall","HRQoL (PCS)",13,13,13,FALSE,TRUE,"RD","double_zero"
"CD013508_pub3_data","10::overall","10","overall","SF12/36 (PCS)",8,8,8,FALSE,TRUE,"RD","double_zero"
"CD013508_pub3_data","11::overall","11","overall","HRQoL (MCS)",13,13,13,FALSE,TRUE,"RD","double_zero"
"CD013508_pub3_data","12::overall","12","overall","SF12/36 (MCS)",8,8,8,FALSE,TRUE,"RD","double_zero"
"CD013508_pub3_data","13::overall","13","overall","Self-efficacy",3,3,3,FALSE,TRUE,"RD","double_zero"
"CD013539_pub2_data","1::overall","1","overall","Progression-free survival",9,9,9,FALSE,TRUE,"RD","double_zero"
"CD013539_pub2_data","2::overall","2","overall","Duration of response",3,3,3,FALSE,TRUE,"RD","double_zero"
"CD013539_pub2_data","3::overall","3","overall","Overall survival",5,5,5,FALSE,TRUE,"RD","double_zero"
"CD013541_pub2_data","5::overall","5","overall","Service use: average number of hospital admissions (1-6 months postintervention)",8,8,8,FALSE,TRUE,"RD","double_zero"
"CD013541_pub2_data","6::overall","6","overall","Service use: average number of hospital admissions (> 6 months postintervention)",6,6,6,FALSE,TRUE,"RD","double_zero"
"CD013541_pub2_data","7::overall","7","overall","Service use: days in hospital (≤ 1 month postintervention)",11,11,11,FALSE,TRUE,"RD","double_zero"
"CD013541_pub2_data","8::overall","8","overall","Service use: days in hospital (1-6 months postintervention)",5,5,5,FALSE,TRUE,"RD","double_zero"
"CD013541_pub2_data","9::overall","9","overall","Service use: days in hospital (> 6 months postintervention)",7,7,7,FALSE,TRUE,"RD","double_zero"
"CD013541_pub2_data","10::overall","10","overall","Mental state: insight (≤ 1 month postintervention, positive outcome)",3,3,3,FALSE,TRUE,"RD","double_zero"
"CD013571_pub2_data","3::overall","3","overall","Number of incontinence episodes per 24 hours: immediately after treatment",6,6,6,FALSE,TRUE,"RD","double_zero"
"CD013571_pub2_data","7::overall","7","overall","Number of incontinence episodes per 24 hours: immediately after treatment",4,4,4,FALSE,TRUE,"RD","double_zero"
"CD013571_pub2_data","8::overall","8","overall","Number of incontinence episodes per 24 hours: long-term effect (> 2 months after treatment)",5,5,5,FALSE,TRUE,"RD","double_zero"
"CD013571_pub2_data","9::overall","9","overall","Number of urgency episodes per 24 hours: immediately after treatment",4,4,4,FALSE,TRUE,"RD","double_zero"
"CD013571_pub2_data","10::overall","10","overall","Number of urgency episodes per 24 hours: long-term effect (> 2 months after treatment)",5,5,5,FALSE,TRUE,"RD","double_zero"
"CD013571_pub2_data","11::overall","11","overall","Number of micturition episodes per 24 hours: immediately after treatment",5,5,5,FALSE,TRUE,"RD","double_zero"
"CD013571_pub2_data","12::overall","12","overall","Number of micturition episodes per 24 hours: long-term effect (> 2 months after treatment)",6,6,6,FALSE,TRUE,"RD","double_zero"
"CD013571_pub2_data","13::overall","13","overall","Number of micturition episodes per 24 hours: long-term effect (> 2 months after treatment)",2,2,2,FALSE,TRUE,"RD","double_zero"
"CD013590_pub2_data","8::overall","8","overall","Haemoglobin status (g/dL) (at up to 6 months)",2,2,2,FALSE,TRUE,"RD","double_zero"
"CD013590_pub2_data","9::overall","9","overall","Haemoglobin % (at over 12 months)",6,6,6,FALSE,TRUE,"RD","double_zero"
"CD013590_pub2_data","10::overall","10","overall","Laboratory markers of haemolysis and inflammation",3,3,3,FALSE,TRUE,"RD","double_zero"
"CD013590_pub2_data","11::overall","11","overall","Laboratory markers of haemolysis and inflammation",2,2,2,FALSE,TRUE,"RD","double_zero"
"CD013591_pub2_data","1::overall","1","overall","Physical activity (moderate to vigorous physical activity)",9,9,9,FALSE,TRUE,"RD","double_zero"
"CD013591_pub2_data","2::overall","2","overall","Physical activity (other measures)",14,14,14,FALSE,TRUE,"RD","double_zero"
"CD013591_pub2_data","3::overall","3","overall","Anthropometric measures (BMI)",13,13,13,FALSE,TRUE,"RD","double_zero"
"CD013591_pub2_data","4::overall","4","overall","Anthropometric measures (body weight)",14,14,14,FALSE,TRUE,"RD","double_zero"
"CD013591_pub2_data","5::overall","5","overall","Self-efficacy (scores)",3,3,3,FALSE,TRUE,"RD","double_zero"
"CD013591_pub2_data","6::overall","6","overall","Dietary behaviour (fruit/vegetable intake)",2,2,2,FALSE,TRUE,"RD","double_zero"
"CD013591_pub2_data","7::overall","7","overall","Dietary behaviour (energy intake)",4,4,4,FALSE,TRUE,"RD","double_zero"
"CD013591_pub2_data","8::overall","8","overall","Dietary behaviour (other measures - unhealthy)",5,5,5,FALSE,TRUE,"RD","double_zero"
"CD013591_pub2_data","9::overall","9","overall","Dietary behaviour (other measures - healthy)",6,6,6,FALSE,TRUE,"RD","double_zero"
"CD013613_pub2_data","1::overall","1","overall","PTSD severity at three months",6,6,6,FALSE,TRUE,"RD","double_zero"
"CD013613_pub2_data","2::overall","2","overall","PTSD severity at study endpoint",8,8,8,FALSE,TRUE,"RD","double_zero"
"CD013613_pub2_data","9::overall","9","overall","Depression severity at three months",4,4,4,FALSE,TRUE,"RD","double_zero"
"CD013613_pub2_data","10::overall","10","overall","Depression severity at study endpoint",5,5,5,FALSE,TRUE,"RD","double_zero"
"CD013613_pub2_data","11::overall","11","overall","Anxiety severity at three months",3,3,3,FALSE,TRUE,"RD","double_zero"
"CD013613_pub2_data","12::overall","12","overall","Anxiety severity at study endpoint",3,3,3,FALSE,TRUE,"RD","double_zero"
"CD013613_pub2_data","13::overall","13","overall","Functional disability at study endpoint",2,2,2,FALSE,TRUE,"RD","double_zero"
"CD013614_pub2_data","5::4","5","4","Physical function as measured by the HAQ or by the proportion of patients achieving the MCID of the HAQ which is defined as 0.35 or by the MHAQ at 12 weeks",2,2,2,FALSE,TRUE,"RD","double_zero"
"CD013614_pub2_data","7::1","7","1","Physical function as measured by the HAQ or by the proportion of patients achieving the MCID of the HAQ which is defined as 0.35 or by the MHAQ at 24 weeks",6,6,6,FALSE,TRUE,"RD","double_zero"
"CD013614_pub2_data","7::2","7","2","Physical function as measured by the HAQ or by the proportion of patients achieving the MCID of the HAQ which is defined as 0.35 or by the MHAQ at 24 weeks",4,4,4,FALSE,TRUE,"RD","double_zero"
"CD013614_pub2_data","7::3","7","3","Physical function as measured by the HAQ or by the proportion of patients achieving the MCID of the HAQ which is defined as 0.35 or by the MHAQ at 24 weeks",2,2,2,FALSE,TRUE,"RD","double_zero"
"CD013614_pub2_data","7::4","7","4","Physical function as measured by the HAQ or by the proportion of patients achieving the MCID of the HAQ which is defined as 0.35 or by the MHAQ at 24 weeks",2,2,2,FALSE,TRUE,"RD","double_zero"
"CD013614_pub2_data","9::3","9","3","Health-related quality of life as measured by the SF-36 or by the PSAQOL at 12 weeks. (SF-36 MCS). ",2,2,2,FALSE,TRUE,"RD","double_zero"
"CD013614_pub2_data","10::4","10","4","Health-related quality of life as measured by the SF-36 or by the PSAQOL at 12 weeks. (SF-36 PCS).",2,2,2,FALSE,TRUE,"RD","double_zero"
"CD013614_pub2_data","11::1","11","1","Health-related quality of life as measured by the SF-36 or by the PSAQOL at 24 weeks. (SF-36 MCS). ",6,6,6,FALSE,TRUE,"RD","double_zero"
"CD013614_pub2_data","11::2","11","2","Health-related quality of life as measured by the SF-36 or by the PSAQOL at 24 weeks. (SF-36 MCS). ",4,4,4,FALSE,TRUE,"RD","double_zero"
"CD013614_pub2_data","11::3","11","3","Health-related quality of life as measured by the SF-36 or by the PSAQOL at 24 weeks. (SF-36 MCS). ",2,2,2,FALSE,TRUE,"RD","double_zero"
"CD013614_pub2_data","11::4","11","4","Health-related quality of life as measured by the SF-36 or by the PSAQOL at 24 weeks. (SF-36 MCS). ",2,2,2,FALSE,TRUE,"RD","double_zero"
"CD013614_pub2_data","12::4","12","4","Health-related quality of life as measured by the SF-36 or by the PSAQOL at 24 weeks. (SF-36 PCS). ",2,2,2,FALSE,TRUE,"RD","double_zero"
"CD013614_pub2_data","13::1","13","1","Radiographic progression (change from baseline) at 24 weeks",6,6,6,FALSE,TRUE,"RD","double_zero"
"CD013614_pub2_data","13::2","13","2","Radiographic progression (change from baseline) at 24 weeks",3,3,3,FALSE,TRUE,"RD","double_zero"
"CD013614_pub2_data","13::4","13","4","Radiographic progression (change from baseline) at 24 weeks",2,2,2,FALSE,TRUE,"RD","double_zero"
"CD013614_pub2_data","20::2","20","2","Improvement in enthesitis in patients with enthesitis at baseline as measured by the LEI or by the MASES at 12 weeks",2,2,2,FALSE,TRUE,"RD","double_zero"
"CD013614_pub2_data","27::1","27","1","Improvement in pain as measured by VAS or NRS at week 12.",9,9,9,FALSE,TRUE,"RD","double_zero"
"CD013614_pub2_data","27::2","27","2","Improvement in pain as measured by VAS or NRS at week 12.",2,2,2,FALSE,TRUE,"RD","double_zero"
"CD013614_pub2_data","27::3","27","3","Improvement in pain as measured by VAS or NRS at week 12.",3,3,3,FALSE,TRUE,"RD","double_zero"
"CD013614_pub2_data","31::1","31","1","Improvement in fatigue as measured by FACIT-F scale or by the FATIGUE VAS at 12 weeks.",8,8,8,FALSE,TRUE,"RD","double_zero"
"CD013614_pub2_data","31::2","31","2","Improvement in fatigue as measured by FACIT-F scale or by the FATIGUE VAS at 12 weeks.",2,2,2,FALSE,TRUE,"RD","double_zero"
"CD013614_pub2_data","33::1","33","1","Health-related quality of life as measured by the SF-36 or by the PSAQOL at 24 weeks. (SF-36 MCS). ",5,5,5,FALSE,TRUE,"RD","double_zero"
"CD013614_pub2_data","33::4","33","4","Health-related quality of life as measured by the SF-36 or by the PSAQOL at 24 weeks. (SF-36 MCS). ",2,2,2,FALSE,TRUE,"RD","double_zero"
"CD013614_pub2_data","35::1","35","1","Improvement in dactylitis in patients with dactylitis at baseline as measured by a simple quantitative scoring of dactylitis or by LDI or by LDI basic at 24 weeks.",2,2,2,FALSE,TRUE,"RD","double_zero"
"CD013614_pub2_data","37::1","37","1","Improvement in dactylitis in patients with dactylitis at baseline as measured by a simple quantitative scoring of dactylitis or by LDI or by LDI basic at 52 weeks.",2,2,2,FALSE,TRUE,"RD","double_zero"
"CD013614_pub2_data","38::1","38","1","Improvement in pain as measured by VAS or NRS at week 12.",2,2,2,FALSE,TRUE,"RD","double_zero"
"CD013614_pub2_data","38::2","38","2","Improvement in pain as measured by VAS or NRS at week 12.",2,2,2,FALSE,TRUE,"RD","double_zero"
"CD013614_pub2_data","39::1","39","1","Improvement in pain as measured by VAS or NRS at week 24.",3,3,3,FALSE,TRUE,"RD","double_zero"
"CD013614_pub2_data","40::1","40","1","Improvement in pain as measured by VAS or NRS at week 52.",2,2,2,FALSE,TRUE,"RD","double_zero"
"CD013614_pub2_data","44::1","44","1","Improvement in fatigue as measured by FACIT-F scale or by the FATIGUE VAS at 12 weeks.",2,2,2,FALSE,TRUE,"RD","double_zero"
"CD013614_pub2_data","45::1","45","1","Improvement in fatigue as measured by FACIT-F scale or by the FATIGUE VAS at 24 weeks.",2,2,2,FALSE,TRUE,"RD","double_zero"
"CD013614_pub2_data","46::1","46","1","Improvement in fatigue as measured by FACIT-F scale or by the FATIGUE VAS at 52 weeks.",2,2,2,FALSE,TRUE,"RD","double_zero"
"CD013631_pub2_data","1::overall","1","overall","Patient-reported outcomes: HRQoL at 12 weeks",13,13,13,FALSE,TRUE,"RD","double_zero"
"CD013631_pub2_data","2::overall","2","overall","Kidney function: serum creatinine at 8 weeks",13,13,13,FALSE,TRUE,"RD","double_zero"
"CD013631_pub2_data","3::overall","3","overall","Uraemic toxins: urea at 4 weeks",12,12,12,FALSE,TRUE,"RD","double_zero"
"CD013631_pub2_data","4::overall","4","overall","Uraemic toxins: indoxyl sulfate at 4 weeks",5,5,5,FALSE,TRUE,"RD","double_zero"
"CD013631_pub2_data","5::overall","5","overall","Uraemic toxins: p-cresol sulfate at 4 weeks",9,9,9,FALSE,TRUE,"RD","double_zero"
"CD013631_pub2_data","7::overall","7","overall","GI function: change in any GI upset or intolerance (GSRS Total Index at 12 months)",7,7,7,FALSE,TRUE,"RD","double_zero"
"CD013631_pub2_data","8::overall","8","overall","GI function: faecal pH at 7 weeks",4,4,4,FALSE,TRUE,"RD","double_zero"
"CD013643_pub2_data","3::1","3","1","Improvement in patient-reported incontinence, short term (< 1 year)",3,3,3,FALSE,TRUE,"RD","double_zero"
"CD013643_pub2_data","3::2","3","2","Improvement in patient-reported incontinence, short term (< 1 year)",5,5,5,FALSE,TRUE,"RD","double_zero"
"CD013643_pub2_data","5::overall","5","overall","Number of major adverse events (Clavien-Dindo III-V), short term (< 1 year)",9,9,9,FALSE,TRUE,"RD","double_zero"
"CD013643_pub2_data","8::2","8","2","Improvement in incontinence-specific quality of life, short term (< 1 year)",2,2,2,FALSE,TRUE,"RD","double_zero"
"CD013643_pub2_data","10::overall","10","overall","Improvement in clinical measures of urinary incontinence (mean number of voids on 3-day voiding diary), short term (< 1 year)",2,2,2,FALSE,TRUE,"RD","double_zero"
"CD013643_pub2_data","12::1","12","1","Improvement in patient-reported sexual function, short term (< 1 year)",2,2,2,FALSE,TRUE,"RD","double_zero"
"CD013643_pub2_data","12::2","12","2","Improvement in patient-reported sexual function, short term (< 1 year)",2,2,2,FALSE,TRUE,"RD","double_zero"
"CD013707_pub2_data","4::overall","4","overall","Length of hospital stay",6,6,6,FALSE,TRUE,"RD","double_zero"
"CD013707_pub2_data","5::overall","5","overall","Duration of mechanical ventilation",4,4,4,FALSE,TRUE,"RD","double_zero"
"CD013707_pub2_data","6::overall","6","overall","Inotrope score",3,3,3,FALSE,TRUE,"RD","double_zero"
"CD013726_pub2_data","1::overall","1","overall","Pain",9,9,9,FALSE,TRUE,"RD","double_zero"
"CD013726_pub2_data","2::overall","2","overall","Function",12,12,12,FALSE,TRUE,"RD","double_zero"
"CD013726_pub2_data","3::overall","3","overall","Quality of life",2,2,2,FALSE,TRUE,"RD","double_zero"
"CD013726_pub2_data","7::overall","7","overall","Serious adverse events",14,14,14,FALSE,TRUE,"RD","double_zero"
"CD013726_pub2_data","8::overall","8","overall","Radiological measurement of the hallux valgus angle",12,12,12,FALSE,TRUE,"RD","double_zero"
"CD013729_pub2_data","2::overall","2","overall","Change in systolic blood pressure: sensitivity analysis (low risk of bias for random sequence generation, allocation concealment, and incomplete outcome data)",4,4,4,FALSE,TRUE,"RD","double_zero"
"CD013729_pub2_data","4::overall","4","overall","Change in total cholesterol (medium-term follow-up)",3,3,3,FALSE,TRUE,"RD","double_zero"
"CD013729_pub2_data","5::overall","5","overall","Change in low-density lipoprotein (LDL) cholesterol (medium-term follow-up)",2,2,2,FALSE,TRUE,"RD","double_zero"
"CD013729_pub2_data","6::overall","6","overall","Change in high-density lipoprotein (HDL) cholesterol (medium-term follow-up)",2,2,2,FALSE,TRUE,"RD","double_zero"
"CD013729_pub2_data","7::overall","7","overall","Change in triglycerides (medium-term follow-up)",2,2,2,FALSE,TRUE,"RD","double_zero"
"CD013757_pub3_data","6::overall","6","overall","Length of hospital stay",2,2,2,FALSE,TRUE,"RD","double_zero"
"CD013757_pub3_data","8::overall","8","overall","Days of supplemental oxygen",2,2,2,FALSE,TRUE,"RD","double_zero"
"CD013757_pub3_data","9::overall","9","overall","Intensive care unit length of stay",2,2,2,FALSE,TRUE,"RD","double_zero"
"CD013757_pub3_data","10::overall","10","overall","Mechanical ventilation days",2,2,2,FALSE,TRUE,"RD","double_zero"
"CD013758_pub2_data","1::overall","1","overall","Underweight (weight-for-age z-score)",11,11,11,FALSE,TRUE,"RD","double_zero"
"CD013758_pub2_data","2::overall","2","overall","Underweight (weight-for-age z-score): subgroup analysis by duration of treatment",31,31,31,FALSE,TRUE,"RD","double_zero"
"CD013758_pub2_data","3::overall","3","overall","Stunting (height-for-age z-score)",11,11,11,FALSE,TRUE,"RD","double_zero"
"CD013758_pub2_data","4::overall","4","overall","Stunting (height-for-age z-score): subgroup analysis by duration of treatment",31,31,31,FALSE,TRUE,"RD","double_zero"
"CD013758_pub2_data","5::overall","5","overall","Wasting (weight-for-height z-score)",11,11,11,FALSE,TRUE,"RD","double_zero"
"CD013758_pub2_data","6::overall","6","overall","Wasting (weight-for-height z-score): subgroup analysis by duration of treatment",30,30,30,FALSE,TRUE,"RD","double_zero"
"CD013758_pub2_data","14::overall","14","overall","Weight (kg)",18,18,18,FALSE,TRUE,"RD","double_zero"
"CD013758_pub2_data","15::overall","15","overall","Weight (kg): subgroup analysis by duration of treatment",22,22,22,FALSE,TRUE,"RD","double_zero"
"CD013758_pub2_data","16::overall","16","overall","Height (cm)",15,15,15,FALSE,TRUE,"RD","double_zero"
"CD013758_pub2_data","17::overall","17","overall","Height (cm): subgroup analysis by duration of treatment",21,21,21,FALSE,TRUE,"RD","double_zero"
"CD013758_pub2_data","18::overall","18","overall","BMI (z-score)",16,16,16,FALSE,TRUE,"RD","double_zero"
"CD013758_pub2_data","19::overall","19","overall","BMI (z-score): subgroup analysis by duration of treatment",23,23,23,FALSE,TRUE,"RD","double_zero"
"CD013758_pub2_data","20::overall","20","overall","BMI (kg/m2)",13,13,13,FALSE,TRUE,"RD","double_zero"
"CD013758_pub2_data","21::overall","21","overall","BMI (kg/m2): subgroup analysis by duration of treatment",18,18,18,FALSE,TRUE,"RD","double_zero"
"CD013758_pub2_data","22::overall","22","overall","Head circumference (z-score)",3,3,3,FALSE,TRUE,"RD","double_zero"
"CD013758_pub2_data","23::overall","23","overall","Head circumference (z-score): subgroup analysis by duration of treatment",9,9,9,FALSE,TRUE,"RD","double_zero"
"CD013758_pub2_data","24::overall","24","overall","Head circumference (cm)",3,3,3,FALSE,TRUE,"RD","double_zero"
"CD013758_pub2_data","25::overall","25","overall","Head circumference (cm): subgroup analysis by duration of treatment",9,9,9,FALSE,TRUE,"RD","double_zero"
"CD013763_pub3_data","1::overall","1","overall","Mean difference in postoperative pain intensity at rest (24 hours postoperatively) (VAS)",62,62,62,FALSE,TRUE,"RD","double_zero"
"CD013763_pub3_data","3::overall","3","overall","Mean difference in postoperative pain intensity during activity (24 hours postoperatively) (VAS)",48,48,48,FALSE,TRUE,"RD","double_zero"
"CD013763_pub3_data","6::overall","6","overall","Mean difference in postoperative pain intensity during activity - 2 hours (VAS)",20,20,20,FALSE,TRUE,"RD","double_zero"
"CD013763_pub3_data","7::overall","7","overall","Mean difference in postoperative pain intensity during activity - 48 hours (VAS)",15,15,15,FALSE,TRUE,"RD","double_zero"
"CD013763_pub3_data","10::overall","10","overall","Cumulative mean oral morphine requirement in mg - 2 hours",6,6,6,FALSE,TRUE,"RD","double_zero"
"CD013763_pub3_data","12::overall","12","overall","Cumulative mean oral morphine requirement in mg - 48 hours",4,4,4,FALSE,TRUE,"RD","double_zero"
"CD013773_pub2_data","1::overall","1","overall","Refractive error (D)",9,9,9,FALSE,TRUE,"RD","double_zero"
"CD013773_pub2_data","3::overall","3","overall","Axial length (mm)",7,7,7,FALSE,TRUE,"RD","double_zero"
"CD013774_pub2_data","1::overall","1","overall","Time to death from any cause",5,5,5,FALSE,TRUE,"RD","double_zero"
"CD013774_pub2_data","2::overall","2","overall","Health-related quality of life",3,3,3,FALSE,TRUE,"RD","double_zero"
"CD013774_pub2_data","4::overall","4","overall","Time to disease progression",2,2,2,FALSE,TRUE,"RD","double_zero"
"CD013774_pub2_data","6::overall","6","overall","Time to death from any cause – subgroup analysis: atezolizumab vs pembrolizumab vs durvalumab",3,3,3,FALSE,TRUE,"RD","double_zero"
"CD013774_pub2_data","8::overall","8","overall","Time to death from any cause – subgroup analysis: ECOG PS of 0 versus 1 versus ≧ 2",5,5,5,FALSE,TRUE,"RD","double_zero"
"CD013774_pub2_data","10::overall","10","overall","Time to death from any cause – subgroup analysis: ECOG PS of 0 versus 1",2,2,2,FALSE,TRUE,"RD","double_zero"
"CD013789_pub2_data","1::overall","1","overall","Scar improvement (VSS) (PGT vs other scar management therapy)",16,16,16,FALSE,TRUE,"RD","double_zero"
"CD013789_pub2_data","2::overall","2","overall","Scar improvement (POSAS) (participant/caregiver, PGT vs other scar management therapy)",13,13,13,FALSE,TRUE,"RD","double_zero"
"CD013789_pub2_data","3::overall","3","overall","Scar improvement (POSAS) (observer, PGT vs other scar management therapy)",13,13,13,FALSE,TRUE,"RD","double_zero"
"CD013789_pub2_data","4::overall","4","overall","Pain (POSAS participant/caregiver, PGT vs other scar management therapy)",13,13,13,FALSE,TRUE,"RD","double_zero"
"CD013789_pub2_data","5::overall","5","overall","Pruritus (POSAS participant/caregiver, PGT vs other scar management therapy)",13,13,13,FALSE,TRUE,"RD","double_zero"
"CD013789_pub2_data","6::overall","6","overall","Scar thickness (ultrasound, PGT vs other scar management therapy)",38,38,38,FALSE,TRUE,"RD","double_zero"
"CD013789_pub2_data","7::overall","7","overall","Scar thickness (POSAS, PGT vs other scar management therapy)",26,26,26,FALSE,TRUE,"RD","double_zero"
"CD013789_pub2_data","8::overall","8","overall","Scar thickness (ultrasound, high vs low pressure)",10,10,10,FALSE,TRUE,"RD","double_zero"
"CD013789_pub2_data","9::overall","9","overall","Scar pigmentation (VSS, PGT vs other scar management therapy)",6,6,6,FALSE,TRUE,"RD","double_zero"
"CD013789_pub2_data","10::overall","10","overall","Scar pigmentation (POSAS observer, PGT vs other scar management therapy)",13,13,13,FALSE,TRUE,"RD","double_zero"
"CD013789_pub2_data","11::overall","11","overall","Scar colour (POSAS participant/caregiver, PGT vs other scar management therapy)",13,13,13,FALSE,TRUE,"RD","double_zero"
"CD013789_pub2_data","12::overall","12","overall","Scar colour – lightness (PGT vs other scar management therapy)",38,38,38,FALSE,TRUE,"RD","double_zero"
"CD013789_pub2_data","13::overall","13","overall","Scar colour – redness (PGT vs other scar management therapy)",38,38,38,FALSE,TRUE,"RD","double_zero"
"CD013789_pub2_data","14::overall","14","overall","Scar colour – redness (high vs low pressure)",8,8,8,FALSE,TRUE,"RD","double_zero"
"CD013789_pub2_data","15::overall","15","overall","Scar colour – yellowness (PGT vs other scar management therapy)",30,30,30,FALSE,TRUE,"RD","double_zero"
"CD013789_pub2_data","16::overall","16","overall","Scar pliability (VSS, PGT vs other scar management therapy)",26,26,26,FALSE,TRUE,"RD","double_zero"
"CD013789_pub2_data","17::overall","17","overall","Scar pliability (POSAS participant/caregiver, PGT vs other scar management therapy)",13,13,13,FALSE,TRUE,"RD","double_zero"
"CD013789_pub2_data","18::overall","18","overall","Scar pliability (POSAS observer, PGT vs other scar management therapy)",13,13,13,FALSE,TRUE,"RD","double_zero"
"CD013789_pub2_data","19::overall","19","overall","Scar texture (POSAS participant/caregiver, PGT vs other scar management therapy)",13,13,13,FALSE,TRUE,"RD","double_zero"
"CD013789_pub2_data","20::overall","20","overall","Scar relief (POSAS observer, PGT vs other scar management therapy)",13,13,13,FALSE,TRUE,"RD","double_zero"
"CD013789_pub2_data","21::overall","21","overall","Scar height (VSS, PGT vs other scar management therapy)",6,6,6,FALSE,TRUE,"RD","double_zero"
"CD013789_pub2_data","22::overall","22","overall","Vascularity (POSAS observer, PGT vs other scar management therapy)",13,13,13,FALSE,TRUE,"RD","double_zero"
"CD013800_pub2_data","1::overall","1","overall","Residual kidney function at 6 months [mL/min/1.73 m2]",2,2,2,FALSE,TRUE,"RD","double_zero"
"CD013800_pub2_data","2::overall","2","overall","Residual kidney function at 12 months [mL/min/1.73 m2]",3,3,3,FALSE,TRUE,"RD","double_zero"
"CD013800_pub2_data","3::overall","3","overall","Residual kidney function at 24 months [mL/min/1.73 m2]",3,3,3,FALSE,TRUE,"RD","double_zero"
"CD013800_pub2_data","4::overall","4","overall","Residual urine volume at 12 months [mL/day]",3,3,3,FALSE,TRUE,"RD","double_zero"
"CD013801_pub2_data","27::1","27","1","Incidence of all-cause mortality",4,4,4,FALSE,TRUE,"RD","double_zero"
"CD013810_pub2_data","1::overall","1","overall","Sleepiness (Epworth Sleepiness Scale)",4,4,4,FALSE,TRUE,"RD","double_zero"
"CD013810_pub2_data","2::overall","2","overall","Quality of life (Functional Outcomes of Sleep Questionnaire)",4,4,4,FALSE,TRUE,"RD","double_zero"
"CD013810_pub2_data","3::overall","3","overall","Quality of life (Assessment of Quality of Life – 8 Dimensions – Psychosocial Superdimension)",2,2,2,FALSE,TRUE,"RD","double_zero"
"CD013810_pub2_data","4::overall","4","overall","Quality of life (Assessment of Quality of Life – 8 Dimensions – Physical Superdimension)",2,2,2,FALSE,TRUE,"RD","double_zero"
"CD013810_pub2_data","5::overall","5","overall","Quality of life (Assessment of Quality of Life – 8 Dimensions – Global Utility)",2,2,2,FALSE,TRUE,"RD","double_zero"
"CD013810_pub2_data","6::overall","6","overall","Quality of life (EuroQol 5-Dimensions)",2,2,2,FALSE,TRUE,"RD","double_zero"
"CD013810_pub2_data","7::overall","7","overall","Quality of life (EuroQol Thermometer)",2,2,2,FALSE,TRUE,"RD","double_zero"
"CD013810_pub2_data","8::overall","8","overall","Quality of life (36-Item Short Form – Physical Component Summary)",2,2,2,FALSE,TRUE,"RD","double_zero"
"CD013810_pub2_data","9::overall","9","overall","Quality of life (36-Item Short Form – Mental Component Summary)",2,2,2,FALSE,TRUE,"RD","double_zero"
"CD013810_pub2_data","10::overall","10","overall","Quality of life (Visual Analogical Well-being Scale)",2,2,2,FALSE,TRUE,"RD","double_zero"
"CD013810_pub2_data","11::overall","11","overall","Cardiovascular event incident rate per 100 participants per year",2,2,2,FALSE,TRUE,"RD","double_zero"
"CD013810_pub2_data","12::overall","12","overall","Cardiovascular risk factor (body mass index)",3,3,3,FALSE,TRUE,"RD","double_zero"
"CD013810_pub2_data","16::overall","16","overall","Continuous positive airway pressure adherence",2,2,2,FALSE,TRUE,"RD","double_zero"
"CD013816_pub2_data","5::overall","5","overall","Deep vein thrombosis",4,4,4,FALSE,TRUE,"RD","double_zero"
"CD013816_pub2_data","6::overall","6","overall","Pulmonary embolism",4,4,4,FALSE,TRUE,"RD","double_zero"
"CD013816_pub2_data","8::overall","8","overall","Valve thrombosis",3,3,3,FALSE,TRUE,"RD","double_zero"
"CD013816_pub2_data","19::overall","19","overall","Economic costs - Days of hospitalization",3,3,3,FALSE,TRUE,"RD","double_zero"
"CD013821_pub2_data","1::overall","1","overall","Postoperative psychosocial well-being",6,6,6,FALSE,TRUE,"RD","double_zero"
"CD013821_pub2_data","2::overall","2","overall","Postoperative physical well-being",6,6,6,FALSE,TRUE,"RD","double_zero"
"CD013821_pub2_data","3::overall","3","overall","Postoperative sexual well-being",6,6,6,FALSE,TRUE,"RD","double_zero"
"CD013821_pub2_data","4::overall","4","overall","Satisfaction with breast",6,6,6,FALSE,TRUE,"RD","double_zero"
"CD013821_pub2_data","5::overall","5","overall","Satisfaction with reconstruction",4,4,4,FALSE,TRUE,"RD","double_zero"
"CD013821_pub2_data","10::overall","10","overall","Duration of surgery (minutes)",2,2,2,FALSE,TRUE,"RD","double_zero"
"CD013821_pub2_data","11::overall","11","overall","Length of postoperative stay (days)",4,4,4,FALSE,TRUE,"RD","double_zero"
"CD013822_pub2_data","3::overall","3","overall","Confidence - regret/anticipated regret",12,12,12,FALSE,TRUE,"RD","double_zero"
"CD013822_pub2_data","4::overall","4","overall","Knowledge - continuous",7,7,7,FALSE,TRUE,"RD","double_zero"
"CD013822_pub2_data","7::overall","7","overall","Anxiety - continuous",8,8,8,FALSE,TRUE,"RD","double_zero"
"CD013822_pub2_data","9::overall","9","overall","Cancer worry",3,3,3,FALSE,TRUE,"RD","double_zero"
"CD013822_pub2_data","10::overall","10","overall","Cancer worry - long term",2,2,2,FALSE,TRUE,"RD","double_zero"
"CD013823_pub2_data","5::overall","5","overall","Maternal total vitamin B12 concentrations",3,3,3,FALSE,TRUE,"RD","double_zero"
"CD013823_pub2_data","6::overall","6","overall","Maternal total vitamin B12 concentrations",2,2,2,FALSE,TRUE,"RD","double_zero"
"CD013823_pub2_data","7::overall","7","overall","Maternal haemoglobin concentrations",3,3,3,FALSE,TRUE,"RD","double_zero"
"CD013823_pub2_data","9::overall","9","overall","Infant total vitamin B12 concentrations",2,2,2,FALSE,TRUE,"RD","double_zero"
"CD013823_pub2_data","10::overall","10","overall","Infant homocysteine concentrations",2,2,2,FALSE,TRUE,"RD","double_zero"
"CD013823_pub2_data","11::overall","11","overall","Infant haemoglobin concentrations",2,2,2,FALSE,TRUE,"RD","double_zero"
"CD013827_pub2_data","8::overall","8","overall","Total oocytes",14,14,14,FALSE,TRUE,"RD","double_zero"
"CD013827_pub2_data","9::overall","9","overall","MII oocytes",13,13,13,FALSE,TRUE,"RD","double_zero"
"CD013827_pub2_data","10::overall","10","overall","Duration of stimulation (days)",14,14,14,FALSE,TRUE,"RD","double_zero"
"CD013827_pub2_data","12::overall","12","overall","Moderate or severe OHSS",10,10,10,FALSE,TRUE,"RD","double_zero"
"CD013834_pub2_data","1::overall","1","overall","TUG",41,41,41,FALSE,TRUE,"RD","double_zero"
"CD013834_pub2_data","2::overall","2","overall","MS Walking Scale - 12",17,17,17,FALSE,TRUE,"RD","double_zero"
"CD013834_pub2_data","3::overall","3","overall","Walking endurance",15,15,15,FALSE,TRUE,"RD","double_zero"
"CD013834_pub2_data","4::overall","4","overall","Gait speed",13,13,13,FALSE,TRUE,"RD","double_zero"
"CD013844_pub2_data","8::overall","8","overall","Suicidal ideation postintervention: sensitivity analysis (ICC 0.1)",7,7,7,FALSE,TRUE,"RD","double_zero"
"CD013844_pub2_data","9::overall","9","overall","Suicidal ideation at short-term (1-3 months) follow-up",5,5,5,FALSE,TRUE,"RD","double_zero"
"CD013844_pub2_data","10::overall","10","overall","Hopelessness at postintervention follow-up",8,8,8,FALSE,TRUE,"RD","double_zero"
"CD013844_pub2_data","11::overall","11","overall","Hopelessness at short-term (1-3 months) follow-up",3,3,3,FALSE,TRUE,"RD","double_zero"
"CD013874_pub3_data","14::overall","14","overall","Time to cardiovascular events over 24 months' follow-up",3,3,3,FALSE,TRUE,"RD","double_zero"
"CD014145_pub2_data","3::overall","3","overall","Side effects causing cessation of therapy",4,4,4,FALSE,TRUE,"RD","double_zero"
"CD014160_pub2_data","2::overall","2","overall","Adverse events (e.g. local irritation, vital sign instability)",2,2,2,FALSE,TRUE,"RD","double_zero"
"CD014300_pub2_data","1::overall","1","overall","Mental well-being at study endpoint: children",3,3,3,FALSE,TRUE,"RD","double_zero"
"CD014300_pub2_data","3::overall","3","overall","Mental well-being at study endpoint: adults",3,3,3,FALSE,TRUE,"RD","double_zero"
"CD014300_pub2_data","7::overall","7","overall","Resilience at study endpoint: children",2,2,2,FALSE,TRUE,"RD","double_zero"
"CD014300_pub2_data","11::overall","11","overall","Prosocial behaviour at study endpoint: children",5,5,5,FALSE,TRUE,"RD","double_zero"
"CD014300_pub2_data","12::overall","12","overall","Prosocial behaviour at follow-up: children",2,2,2,FALSE,TRUE,"RD","double_zero"
"CD014428_pub2_data","1::1","1","1","Pain intensity",10,10,10,FALSE,TRUE,"RD","double_zero"
"CD014428_pub2_data","1::2","1","2","Pain intensity",5,5,5,FALSE,TRUE,"RD","double_zero"
"CD014428_pub2_data","1::3","1","3","Pain intensity",2,2,2,FALSE,TRUE,"RD","double_zero"
"CD014428_pub2_data","2::1","2","1","Function",9,9,9,FALSE,TRUE,"RD","double_zero"
"CD014428_pub2_data","3::1","3","1","Anxiety (Anxiety Component Summary)",3,3,3,FALSE,TRUE,"RD","double_zero"
"CD014428_pub2_data","4::1","4","1","Depression (Depression Component Summary)",4,4,4,FALSE,TRUE,"RD","double_zero"
"CD014428_pub2_data","5::1","5","1","Health-related quality of life (Mental Component Summary)",3,3,3,FALSE,TRUE,"RD","double_zero"
"CD014544_pub2_data","1::overall","1","overall","Annualized Bleeding Rates (ABR)",37,37,37,FALSE,TRUE,"RD","double_zero"
"CD014544_pub2_data","3::overall","3","overall","HRQoL—Haem-A-QoL",14,14,14,FALSE,TRUE,"RD","double_zero"
"CD014544_pub2_data","5::overall","5","overall","HRQoL—EQ-5D-5L Utility Index Score",12,12,12,FALSE,TRUE,"RD","double_zero"
"CD014573_data","1::overall","1","overall","Cases of cholera (2 doses + booster dose; 2-year follow-up; per-protocol analysis)",3,3,3,FALSE,TRUE,"RD","double_zero"
"CD014573_data","2::overall","2","overall","Cases of cholera (2 doses ± booster dose; 5-month and 2-year follow-up; per-protocol analysis)",4,4,4,FALSE,TRUE,"RD","double_zero"
"CD014580_pub2_data","6::overall","6","overall","Quality of life",2,2,2,FALSE,TRUE,"RD","double_zero"
"CD014580_pub2_data","7::overall","7","overall","Faecal incontinence",2,2,2,FALSE,TRUE,"RD","double_zero"
"CD014585_pub2_data","6::overall","6","overall","Quality of life",2,2,2,FALSE,TRUE,"RD","double_zero"
"CD014594_pub2_data","5::overall","5","overall","Time to successful CFA access: sensitivity analysis excluding rescue U/S",2,2,2,FALSE,TRUE,"RD","double_zero"
"CD014624_pub2_data","5::4","5","4","Adverse events (mother)",2,2,2,FALSE,TRUE,"RD","double_zero"
"CD014666_pub2_data","1::overall","1","overall","Fear of falling: subgrouped according to intervention approach",28,28,28,FALSE,TRUE,"RD","double_zero"
"CD014666_pub2_data","3::overall","3","overall","Fear of falling: subgrouped according to control",29,29,29,FALSE,TRUE,"RD","double_zero"
"CD014666_pub2_data","4::overall","4","overall","Fear of falling: subgrouped according to ""A Matter of Balance"" (AMB) versus non-AMB based interventions",23,23,23,FALSE,TRUE,"RD","double_zero"
"CD014666_pub2_data","5::overall","5","overall","Fear of falling: subgrouped according to group versus individual interventions",19,19,19,FALSE,TRUE,"RD","double_zero"
"CD014688_pub2_data","1::overall","1","overall","Child/adolescent quality of life between baseline and 12 months (self-reported) ",11,11,11,FALSE,TRUE,"RD","double_zero"
"CD014688_pub2_data","2::overall","2","overall","Child/adolescent quality of life between baseline and 12 months (parent proxy-reported)",2,2,2,FALSE,TRUE,"RD","double_zero"
"CD014722_pub2_data","4::overall","4","overall","Quality of life at 7-24 months ",19,19,19,FALSE,TRUE,"RD","double_zero"
"CD014722_pub2_data","5::overall","5","overall","Depressive symptoms at 0-1 months",15,15,15,FALSE,TRUE,"RD","double_zero"
"CD014722_pub2_data","6::overall","6","overall","Depressive symptoms at 1-6 months",9,9,9,FALSE,TRUE,"RD","double_zero"
"CD014722_pub2_data","7::overall","7","overall","Depressive symptoms at 7-24 months",20,20,20,FALSE,TRUE,"RD","double_zero"
"CD014722_pub2_data","8::overall","8","overall","Anxiety symptoms at 0-1 months",13,13,13,FALSE,TRUE,"RD","double_zero"
"CD014722_pub2_data","9::overall","9","overall","Distress/PTSD symptoms at 0-1 months",12,12,12,FALSE,TRUE,"RD","double_zero"
"CD014722_pub2_data","10::overall","10","overall","Social outcomes at 0-1 months",12,12,12,FALSE,TRUE,"RD","double_zero"
"CD014722_pub2_data","11::overall","11","overall","Social outcomes at 1-6 months",24,24,24,FALSE,TRUE,"RD","double_zero"
"CD014722_pub2_data","12::overall","12","overall","Social outcomes at 7-24 months",15,15,15,FALSE,TRUE,"RD","double_zero"
"CD014722_pub2_data","13::overall","13","overall","Depressive symptoms at 7-24 months",13,13,13,FALSE,TRUE,"RD","double_zero"
"CD014722_pub2_data","14::overall","14","overall","Anxiety symptoms at 0-1 months",9,9,9,FALSE,TRUE,"RD","double_zero"
"CD014722_pub2_data","15::overall","15","overall","Anxiety symptoms at 1-6 months ",5,5,5,FALSE,TRUE,"RD","double_zero"
"CD014722_pub2_data","16::overall","16","overall","Anxiety symptoms at 7-24 months",2,2,2,FALSE,TRUE,"RD","double_zero"
"CD014722_pub2_data","17::overall","17","overall","Distress/PTSD symptoms at 0-1 months",19,19,19,FALSE,TRUE,"RD","double_zero"
"CD014722_pub2_data","18::overall","18","overall","Distress/PTSD symptoms at 1-6 months ",9,9,9,FALSE,TRUE,"RD","double_zero"
"CD014722_pub2_data","19::overall","19","overall","Distress/PTSD symptoms at 7-24 months",5,5,5,FALSE,TRUE,"RD","double_zero"
"CD014722_pub2_data","20::overall","20","overall","Social outcomes at 0-1 months",5,5,5,FALSE,TRUE,"RD","double_zero"
"CD014736_pub2_data","1::overall","1","overall","Maximum Walking Distance (metres)",8,8,8,FALSE,TRUE,"RD","double_zero"
"CD014736_pub2_data","3::overall","3","overall","Pain-free walking distance at end of follow-up (change from baseline, metres)",4,4,4,FALSE,TRUE,"RD","double_zero"
"CD014736_pub2_data","4::overall","4","overall","Health-related quality of life: SF-36 Mental component - Absolute values at end of follow-up",2,2,2,FALSE,TRUE,"RD","double_zero"
"CD014741_pub2_data","5::overall","5","overall","Adverse events (by patients)",47,47,47,FALSE,TRUE,"RD","double_zero"
"CD014758_pub3_data","1::overall","1","overall","Change in refractive error from baseline",124,124,124,FALSE,TRUE,"RD","double_zero"
"CD014758_pub3_data","2::overall","2","overall","Change in axial length from baseline",87,87,87,FALSE,TRUE,"RD","double_zero"
"CD014758_pub3_data","3::overall","3","overall","Change in refractive error following cessation of treatment ",24,24,24,FALSE,TRUE,"RD","double_zero"
"CD014758_pub3_data","4::overall","4","overall","Change in axial length following cessation of treatment ",24,24,24,FALSE,TRUE,"RD","double_zero"
"CD014758_pub3_data","5::overall","5","overall","Change in refractive error from baseline (3 years)",2,2,2,FALSE,TRUE,"RD","double_zero"
"CD014758_pub3_data","6::overall","6","overall","Change in axial length from baseline (3 years)",2,2,2,FALSE,TRUE,"RD","double_zero"
"CD014758_pub3_data","7::overall","7","overall","Change in refractive error  from baseline (5 years)",2,2,2,FALSE,TRUE,"RD","double_zero"
"CD014758_pub3_data","8::overall","8","overall","Change in axial length from baseline (5 years)",2,2,2,FALSE,TRUE,"RD","double_zero"
"CD014758_pub3_data","9::overall","9","overall","Change in refractive error following cessation of treatment ",4,4,4,FALSE,TRUE,"RD","double_zero"
"CD014758_pub3_data","10::overall","10","overall","Change in axial length following cessation of treatment ",3,3,3,FALSE,TRUE,"RD","double_zero"
"CD014763_pub2_data","7::overall","7","overall","Operative time (minutes)",11,11,11,FALSE,TRUE,"RD","double_zero"
"CD014763_pub2_data","8::overall","8","overall","Length of hospital stay (days)",11,11,11,FALSE,TRUE,"RD","double_zero"
"CD014811_pub2_data","1::overall","1","overall","Net weight loss (kg)",8,8,8,FALSE,TRUE,"RD","double_zero"
"CD014811_pub2_data","3::overall","3","overall","Length of hospital stay (days)",7,7,7,FALSE,TRUE,"RD","double_zero"
"CD014833_pub2_data","4::overall","4","overall","Depressive symptoms immediately post-intervention",4,4,4,FALSE,TRUE,"RD","double_zero"
"CD014833_pub2_data","5::overall","5","overall","Depressive symptoms short-term 1 to 3 months post-intervention",2,2,2,FALSE,TRUE,"RD","double_zero"
"CD014845_pub2_data","1::overall","1","overall","Food selection/purchasing (kcal)",21,21,21,FALSE,TRUE,"RD","double_zero"
"CD014845_pub2_data","2::overall","2","overall","Subgroup analysis: food selection/purchasing by setting (kcal)",20,20,20,FALSE,TRUE,"RD","double_zero"
"CD014845_pub2_data","3::overall","3","overall","Subgroup analysis: food selection/purchasing by label type (kcal)",20,20,20,FALSE,TRUE,"RD","double_zero"
"CD014845_pub2_data","4::overall","4","overall","Subgroup analysis: food selection/purchasing by socioeconomic status (kcal)",19,19,19,FALSE,TRUE,"RD","double_zero"
"CD014845_pub2_data","5::overall","5","overall","Additional exploratory subgroup analysis: food selection/purchasing by placement of labels",19,19,19,FALSE,TRUE,"RD","double_zero"
"CD014845_pub2_data","6::overall","6","overall","Sensitivity analysis: food selection/purchasing by low risk of bias (kcal)",19,19,19,FALSE,TRUE,"RD","double_zero"
"CD014845_pub2_data","7::overall","7","overall","Sensitivity analysis: food selection/purchasing excluding Reynolds 2022, Vasiljevic 2018, Vasiljevic 2019",16,16,16,FALSE,TRUE,"RD","double_zero"
"CD014845_pub2_data","8::overall","8","overall","Food consumption (kcal)",10,10,10,FALSE,TRUE,"RD","double_zero"
"CD014845_pub2_data","9::overall","9","overall","Subgroup analysis: food consumption by setting (kcal)",10,10,10,FALSE,TRUE,"RD","double_zero"
"CD014845_pub2_data","10::overall","10","overall","Subgroup analysis: food consumption by label type (kcal)",10,10,10,FALSE,TRUE,"RD","double_zero"
"CD014845_pub2_data","11::overall","11","overall","Subgroup analysis: food consumption by socioeconomic status (kcal)",10,10,10,FALSE,TRUE,"RD","double_zero"
"CD014845_pub2_data","12::overall","12","overall","Sensitivity analysis: food consumption by low risk of bias (kcal)",10,10,10,FALSE,TRUE,"RD","double_zero"
"CD014852_pub2_data","8::overall","8","overall","Nutritional status change (body weight ) during intervention phase",10,10,10,FALSE,TRUE,"RD","double_zero"
"CD014852_pub2_data","9::overall","9","overall","Subgroup analysis – type of stroke: nutritional status (body weight ) ",10,10,10,FALSE,TRUE,"RD","double_zero"
"CD014852_pub2_data","10::overall","10","overall","Subgroup analysis – nutritional status at baseline: nutritional status (body weight ) ",10,10,10,FALSE,TRUE,"RD","double_zero"
"CD014855_pub2_data","5::overall","5","overall","Hospital stay",5,5,5,FALSE,TRUE,"RD","double_zero"
"CD014855_pub2_data","4::2","4","2","Mortality",2,2,2,FALSE,TRUE,"RD","double_zero"
"CD014855_pub2_data","5::1","5","1","Hospital stay",6,6,6,FALSE,TRUE,"RD","double_zero"
"CD014855_pub2_data","5::2","5","2","Hospital stay",3,3,3,FALSE,TRUE,"RD","double_zero"
"CD014861_pub2_data","6::overall","6","overall","Cost (healthcare system perspective: 2022 AUD values)",8,8,8,FALSE,TRUE,"RD","double_zero"
"CD014861_pub2_data","8::overall","8","overall","Health-related quality of life (EORTC QLQC30 all domains)",5,5,5,FALSE,TRUE,"RD","double_zero"
"CD014861_pub2_data","9::overall","9","overall","Health-related quality of life (EORTC QOL-C30)",2,2,2,FALSE,TRUE,"RD","double_zero"
"CD014861_pub2_data","10::overall","10","overall","Participant satisfaction (Borras 2001)",7,7,7,FALSE,TRUE,"RD","double_zero"
"CD014871_pub2_data","1::overall","1","overall","Walking energy cost",2,2,2,FALSE,TRUE,"RD","double_zero"
"CD014871_pub2_data","2::overall","2","overall","Perceived intensity of exertion on different terrains (range 6 to 20)",2,2,2,FALSE,TRUE,"RD","double_zero"
"CD014871_pub2_data","3::overall","3","overall","Self-selected comfortable walking speed",8,8,8,FALSE,TRUE,"RD","double_zero"
"CD014871_pub2_data","4::overall","4","overall","Self-selected comfortable walking speed on uneven terrain",2,2,2,FALSE,TRUE,"RD","double_zero"
"CD014871_pub2_data","5::overall","5","overall","Sit-to-stand five times test",2,2,2,FALSE,TRUE,"RD","double_zero"
"CD014871_pub2_data","6::overall","6","overall","Four-square step test",2,2,2,FALSE,TRUE,"RD","double_zero"
"CD014871_pub2_data","7::overall","7","overall","Timed stair ascent",2,2,2,FALSE,TRUE,"RD","double_zero"
"CD014871_pub2_data","8::overall","8","overall","Forty-yard dash",2,2,2,FALSE,TRUE,"RD","double_zero"
"CD014871_pub2_data","9::overall","9","overall","Cadence",3,3,3,FALSE,TRUE,"RD","double_zero"
"CD014871_pub2_data","11::overall","11","overall","Stride length",2,2,2,FALSE,TRUE,"RD","double_zero"
"CD014871_pub2_data","12::overall","12","overall","Step length",4,4,4,FALSE,TRUE,"RD","double_zero"
"CD014871_pub2_data","14::overall","14","overall","Double support time",2,2,2,FALSE,TRUE,"RD","double_zero"
"CD014871_pub2_data","21::overall","21","overall","Peak ankle dorsiflexion angle in terminal stance",2,2,2,FALSE,TRUE,"RD","double_zero"
"CD014871_pub2_data","22::overall","22","overall","Peak ankle dorsiflexion angle in swing",2,2,2,FALSE,TRUE,"RD","double_zero"
"CD014871_pub2_data","25::overall","25","overall","Peak knee flexion angle in midstance",2,2,2,FALSE,TRUE,"RD","double_zero"
"CD014871_pub2_data","29::overall","29","overall","Peak hip flexion angle in the swing phase",2,2,2,FALSE,TRUE,"RD","double_zero"
"CD014871_pub2_data","32::overall","32","overall","Peak pelvis elevation in the swing phase",2,2,2,FALSE,TRUE,"RD","double_zero"
"CD014871_pub2_data","34::overall","34","overall","Peak ankle dorsiflexion moment in terminal stance",3,3,3,FALSE,TRUE,"RD","double_zero"
"CD014871_pub2_data","43::overall","43","overall","Peak hip flexion moment in pre-swing",2,2,2,FALSE,TRUE,"RD","double_zero"
"CD014871_pub2_data","45::overall","45","overall","Peak ankle power in terminal stance",4,4,4,FALSE,TRUE,"RD","double_zero"
"CD014871_pub2_data","48::overall","48","overall","Peak hip power in pre-swing",2,2,2,FALSE,TRUE,"RD","double_zero"
"CD014872_pub2_data","1::overall","1","overall","Progression-free survival",35,35,35,FALSE,TRUE,"RD","double_zero"
"CD014872_pub2_data","2::overall","2","overall","Progression-free survival (solid cancer vs haematological cancer)",34,34,34,FALSE,TRUE,"RD","double_zero"
"CD014872_pub2_data","8::overall","8","overall","Overall survival (FDA/EMA-approved vs not approved)",20,20,20,FALSE,TRUE,"RD","double_zero"
"CD014872_pub2_data","15::overall","15","overall","Quality of life ",3,3,3,FALSE,TRUE,"RD","double_zero"
"CD014891_pub2_data","3::overall","3","overall","Uncorrected distance visual acuity (logMAR)",2,2,2,FALSE,TRUE,"RD","double_zero"
"CD014891_pub2_data","6::overall","6","overall","Uncorrected near visual acuity (logMAR)",2,2,2,FALSE,TRUE,"RD","double_zero"
"CD014891_pub2_data","9::overall","9","overall","Uncorrected intermediate visual acuity (logMAR)",2,2,2,FALSE,TRUE,"RD","double_zero"
"CD014891_pub2_data","12::overall","12","overall","Contrast sensitivity under photopic and mesopic conditions",2,2,2,FALSE,TRUE,"RD","double_zero"
"CD014932_pub2_data","1::overall","1","overall","Reduction in disease severity, as measured by clinical signs (SCORAD)",11,11,11,FALSE,TRUE,"RD","double_zero"
"CD014932_pub2_data","2::overall","2","overall","Short-term reduction in disease severity, as measured by clinical signs (SCORAD)",13,13,13,FALSE,TRUE,"RD","double_zero"
"CD014932_pub2_data","3::overall","3","overall","Reduction in disease severity, as measured by patient-reported symptoms",9,9,9,FALSE,TRUE,"RD","double_zero"
"CD014932_pub2_data","4::overall","4","overall","Improvement in quality-of-life measures (DLQI): all scales, infants, children, and family",9,9,9,FALSE,TRUE,"RD","double_zero"
"CD014932_pub2_data","5::overall","5","overall","Improvement in quality-of-life measures: family impact",8,8,8,FALSE,TRUE,"RD","double_zero"
"CD014932_pub2_data","6::overall","6","overall","Improvement in psychological well-being measures",2,2,2,FALSE,TRUE,"RD","double_zero"
"CD014935_pub2_data","9::overall","9","overall","Days of hospitalisation",3,3,3,FALSE,TRUE,"RD","double_zero"
"CD014935_pub2_data","10::overall","10","overall","Days of hospitalisation - Sensitivity analysis (fixed-effect model)",3,3,3,FALSE,TRUE,"RD","double_zero"
"CD014965_pub2_data","1::1","1","1","Irritability",13,13,13,FALSE,TRUE,"RD","double_zero"
"CD014965_pub2_data","1::2","1","2","Irritability",11,11,11,FALSE,TRUE,"RD","double_zero"
"CD014965_pub2_data","7::2","7","2","Inappropriate speech",2,2,2,FALSE,TRUE,"RD","double_zero"
"CD014965_pub2_data","24::2","24","2","Lethargy/withdrawal",2,2,2,FALSE,TRUE,"RD","double_zero"
"CD014965_pub2_data","24::3","24","3","Lethargy/withdrawal",5,5,5,FALSE,TRUE,"RD","double_zero"
"CD014965_pub2_data","25::2","25","2","Hyperactivity",2,2,2,FALSE,TRUE,"RD","double_zero"
"CD014965_pub2_data","25::3","25","3","Hyperactivity",5,5,5,FALSE,TRUE,"RD","double_zero"
"CD014965_pub2_data","26::2","26","2","Stereotypy",2,2,2,FALSE,TRUE,"RD","double_zero"
"CD014965_pub2_data","26::3","26","3","Stereotypy",5,5,5,FALSE,TRUE,"RD","double_zero"
"CD014965_pub2_data","27::2","27","2","Clinical improvement",3,3,3,FALSE,TRUE,"RD","double_zero"
"CD014965_pub2_data","9::overall","9","overall","Stereotypy",2,2,2,FALSE,TRUE,"RD","double_zero"
"CD014965_pub2_data","10::overall","10","overall","Clinical improvement",2,2,2,FALSE,TRUE,"RD","double_zero"
"CD014966_pub2_data","2::overall","2","overall","Kidney graft loss: time-to-event analysis",6,6,6,FALSE,TRUE,"RD","double_zero"
"CD014967_pub2_data","14::overall","14","overall","Proportion of infants discharged on gavage feeds",2,2,2,FALSE,TRUE,"RD","double_zero"
"CD014999_pub2_data","6::overall","6","overall","Duration of hospitalization",2,2,2,FALSE,TRUE,"RD","double_zero"
"CD015014_pub2_data","3::overall","3","overall","ED visits (mean number of ED visits per resident)",2,2,2,FALSE,TRUE,"RD","double_zero"
"CD015014_pub2_data","4::overall","4","overall","ED visits: logarithm of rate ratio per person-time",2,2,2,FALSE,TRUE,"RD","double_zero"
"CD015014_pub2_data","11::overall","11","overall","Unplanned hospital admissions (mean number of unplanned hospital admissions per resident)",3,3,3,FALSE,TRUE,"RD","double_zero"
"CD015014_pub2_data","12::overall","12","overall","Unplanned hospital admissions (logarithm of rate ratio)",4,4,4,FALSE,TRUE,"RD","double_zero"
"CD015014_pub2_data","17::overall","17","overall","Adverse events/falls (mean number of falls per resident)",2,2,2,FALSE,TRUE,"RD","double_zero"
"CD015014_pub2_data","18::overall","18","overall","Adverse events/falls (logarithm of rate ratio)",4,4,4,FALSE,TRUE,"RD","double_zero"
"CD015014_pub2_data","28::overall","28","overall","Quality of life (standardised mean difference)",12,12,12,FALSE,TRUE,"RD","double_zero"
"CD015014_pub2_data","29::overall","29","overall","Quality of life (standardised mean difference): sensitivity analysis by risk of bias",12,12,12,FALSE,TRUE,"RD","double_zero"
"CD015014_pub2_data","30::overall","30","overall","Quality of life (standardised mean difference): sensitivity analysis by timing of effect",12,12,12,FALSE,TRUE,"RD","double_zero"
"CD015014_pub2_data","31::overall","31","overall","Quality of life (no meta-analysis, calculations for individual studies)",6,6,6,FALSE,TRUE,"RD","double_zero"
"CD015014_pub2_data","38::overall","38","overall","Any hospital admission (mean number of hospital admissions per resident)",4,4,4,FALSE,TRUE,"RD","double_zero"
"CD015014_pub2_data","40::overall","40","overall","Length of hospital stay (mean number of days per resident)",5,5,5,FALSE,TRUE,"RD","double_zero"
"CD015014_pub2_data","41::overall","41","overall","Length of hospital stay (mean number of days per resident): subgroup analysis by type of care provided",5,5,5,FALSE,TRUE,"RD","double_zero"
"CD015014_pub2_data","42::overall","42","overall","Length of hospital stay (mean number of days per resident): sensitivity analysis by risk of bias",5,5,5,FALSE,TRUE,"RD","double_zero"
"CD015014_pub2_data","43::overall","43","overall","Length of hospital stay (mean number of days per resident): sensitivity analysis by timing of effect",5,5,5,FALSE,TRUE,"RD","double_zero"
"CD015014_pub2_data","44::overall","44","overall","Length of hospital stay (mean number of days per resident): no meta-analysis, calculations for individual studies ",6,6,6,FALSE,TRUE,"RD","double_zero"
"CD015014_pub2_data","45::overall","45","overall","Length of hospital stay (mean number of days per admission/admitted resident) ",2,2,2,FALSE,TRUE,"RD","double_zero"
"CD015014_pub2_data","48::overall","48","overall","'Next of kin' satisfaction with the health care received",2,2,2,FALSE,TRUE,"RD","double_zero"
"CD015033_pub2_data","9::overall","9","overall","Health-related quality of life (physical health, 24 months)",3,3,3,FALSE,TRUE,"RD","double_zero"
"CD015033_pub2_data","16::overall","16","overall","Liver enzyme levels. Serum ALP levels (range from 2 months to 24 months)",5,5,5,FALSE,TRUE,"RD","double_zero"
"CD015033_pub2_data","17::overall","17","overall","Liver enzyme levels. Serum GGT levels (range from 12 months to 24 months)",3,3,3,FALSE,TRUE,"RD","double_zero"
"CD015033_pub2_data","4::overall","4","overall","Serum AST levels (for treatment time)",11,11,11,FALSE,TRUE,"RD","double_zero"
"CD015038_pub2_data","11::overall","11","overall","Pain score (acute)",3,3,3,FALSE,TRUE,"RD","double_zero"
"CD015038_pub2_data","13::overall","13","overall","Length of hospital stay",11,11,11,FALSE,TRUE,"RD","double_zero"
"CD015038_pub2_data","14::overall","14","overall","Period of sick leave",9,9,9,FALSE,TRUE,"RD","double_zero"
"CD015038_pub2_data","16::overall","16","overall","Postoperative quality of life",3,3,3,FALSE,TRUE,"RD","double_zero"
"CD015040_pub2_data","1::overall","1","overall","PTSD symptom severity: immediately after treatment, SMD (ITT, endpoint)",16,16,16,FALSE,TRUE,"RD","double_zero"
"CD015040_pub2_data","2::overall","2","overall","PTSD symptom severity: immediately after treatment, SMD (ITT, endpoint; with data imputation)",17,17,17,FALSE,TRUE,"RD","double_zero"
"CD015040_pub2_data","3::overall","3","overall","PTSD symptom severity: change from baseline to immediately after treatment, SMD (ITT, with data imputation)",10,10,10,FALSE,TRUE,"RD","double_zero"
"CD015040_pub2_data","4::overall","4","overall","PTSD symptom severity: immediately after treatment, SMD (per-protocol, endpoint)",3,3,3,FALSE,TRUE,"RD","double_zero"
"CD015042_pub2_data","2::overall","2","overall","Number of drinks per day",2,2,2,FALSE,TRUE,"RD","double_zero"
"CD015066_pub2_data","1::overall","1","overall","Personal attenuation rating (PAR; dB) (immediate, short-term, long-term)",6,6,6,FALSE,TRUE,"RD","double_zero"
"CD015083_pub2_data","1::overall","1","overall","Referral for or receipt of any lumbar spine imaging at last follow-up within 12 months",130,130,130,FALSE,TRUE,"RD","double_zero"
"CD015083_pub2_data","2::overall","2","overall","Prescription or use of opioid medication at last follow-up within 12 months",110,110,110,FALSE,TRUE,"RD","double_zero"
"CD015083_pub2_data","3::overall","3","overall","Referral to surgeon or lumbar spine surgery at last follow-up within 12 months",73,73,73,FALSE,TRUE,"RD","double_zero"
"CD015083_pub2_data","4::overall","4","overall","Admission to hospital for non-specific LBP at last follow-up within 12 months",85,85,85,FALSE,TRUE,"RD","double_zero"
"CD015083_pub2_data","5::overall","5","overall","Pain at last follow-up within 12 months",299,299,299,FALSE,TRUE,"RD","double_zero"
"CD015083_pub2_data","6::overall","6","overall","Back-related function at last follow-up within 12 months",365,365,365,FALSE,TRUE,"RD","double_zero"
"CD015083_pub2_data","7::overall","7","overall","Adverse events at last follow-up within 12 months",75,75,75,FALSE,TRUE,"RD","double_zero"
"CD015083_pub2_data","8::overall","8","overall","Referral for or receipt of advanced lumbar spine imaging at last follow-up within 12 months",67,67,67,FALSE,TRUE,"RD","double_zero"
"CD015083_pub2_data","9::overall","9","overall","Prescription or use of anti-epileptics, benzodiazepines, or muscle relaxants at last follow-up within 12 months",54,54,54,FALSE,TRUE,"RD","double_zero"
"CD015083_pub2_data","10::overall","10","overall","Referral or use of any injection to the lumbar spine at last follow-up within 12 months",64,64,64,FALSE,TRUE,"RD","double_zero"
"CD015083_pub2_data","11::overall","11","overall","Health-related quality of life at last follow-up within 12 months",181,181,181,FALSE,TRUE,"RD","double_zero"
"CD015083_pub2_data","12::overall","12","overall","Participant satisfaction with care at last follow-up within 12 months",86,86,86,FALSE,TRUE,"RD","double_zero"
"CD015101_data","2::overall","2","overall","GSS",8,8,8,FALSE,TRUE,"RD","double_zero"
"CD015101_data","3::overall","3","overall","VAS (symptoms)",6,6,6,FALSE,TRUE,"RD","double_zero"
"CD015101_data","4::overall","4","overall","BCTQ (SSS)",4,4,4,FALSE,TRUE,"RD","double_zero"
"CD015120_pub2_data","1::overall","1","overall","Smoking cessation",61,61,61,FALSE,TRUE,"RD","double_zero"
"CD015120_pub2_data","2::overall","2","overall","Smoking cessation (patch comparator)",2,2,2,FALSE,TRUE,"RD","double_zero"
"CD015122_pub2_data","9::overall","9","overall","Hospital length of stay (days)",7,7,7,FALSE,TRUE,"RD","double_zero"
"CD015122_pub2_data","26::overall","26","overall","Hospital length of stay (days) (Sensitivity analysis & definition of Stone freedom)",3,3,3,FALSE,TRUE,"RD","double_zero"
"CD015140_pub2_data","1::overall","1","overall","Overall survival (OS) - fixed-effect model",7,7,7,FALSE,TRUE,"RD","double_zero"
"CD015140_pub2_data","2::overall","2","overall","Overall survival (OS) - random-effects model",3,3,3,FALSE,TRUE,"RD","double_zero"
"CD015140_pub2_data","3::overall","3","overall","Disease-free survival (DFS) - fixed-effect model",5,5,5,FALSE,TRUE,"RD","double_zero"
"CD015140_pub2_data","4::overall","4","overall","Disease-free survival (DFS) - random-effects model",5,5,5,FALSE,TRUE,"RD","double_zero"
"CD015140_pub2_data","5::overall","5","overall","Disease-free survival (DFS) in stage IB",2,2,2,FALSE,TRUE,"RD","double_zero"
"CD015140_pub2_data","8::1","8","1","Health-related quality of life (HRQoL) - mixed model of repeated measures (MMRM) of mean change from baseline up to Week 96 in SF-36 PCS, MCS, and health domain scores",3,3,3,FALSE,TRUE,"RD","double_zero"
"CD015140_pub2_data","8::2","8","2","Health-related quality of life (HRQoL) - mixed model of repeated measures (MMRM) of mean change from baseline up to Week 96 in SF-36 PCS, MCS, and health domain scores",3,3,3,FALSE,TRUE,"RD","double_zero"
"CD015140_pub2_data","9::1","9","1","Health-related quality of life (HRQoL) - time to deterioration (TTD) analysis from baseline up to Week 96 of the SF-36 PCS, MCS, and health domain scores",4,4,4,FALSE,TRUE,"RD","double_zero"
"CD015140_pub2_data","9::2","9","2","Health-related quality of life (HRQoL) - time to deterioration (TTD) analysis from baseline up to Week 96 of the SF-36 PCS, MCS, and health domain scores",4,4,4,FALSE,TRUE,"RD","double_zero"
"CD015140_pub2_data","2::1","2","1","Overall survival (OS) by EGFR type mutation",3,3,3,FALSE,TRUE,"RD","double_zero"
"CD015140_pub2_data","2::2","2","2","Overall survival (OS) by EGFR type mutation",3,3,3,FALSE,TRUE,"RD","double_zero"
"CD015140_pub2_data","3::1","3","1","Overall survival (OS) by age",2,2,2,FALSE,TRUE,"RD","double_zero"
"CD015140_pub2_data","3::2","3","2","Overall survival (OS) by age",2,2,2,FALSE,TRUE,"RD","double_zero"
"CD015140_pub2_data","4::1","4","1","Overall survival (OS) by smoking status",2,2,2,FALSE,TRUE,"RD","double_zero"
"CD015140_pub2_data","4::2","4","2","Overall survival (OS) by smoking status",2,2,2,FALSE,TRUE,"RD","double_zero"
"CD015140_pub2_data","5::1","5","1","Overall survival (OS) by gender",3,3,3,FALSE,TRUE,"RD","double_zero"
"CD015140_pub2_data","5::2","5","2","Overall survival (OS) by gender",3,3,3,FALSE,TRUE,"RD","double_zero"
"CD015140_pub2_data","7::1","7","1","Disease-free survival (DFS) by EGFR type mutation",4,4,4,FALSE,TRUE,"RD","double_zero"
"CD015140_pub2_data","7::2","7","2","Disease-free survival (DFS) by EGFR type mutation",4,4,4,FALSE,TRUE,"RD","double_zero"
"CD015140_pub2_data","10::1","10","1","Disease-free survival (DFS) by smoking status",4,4,4,FALSE,TRUE,"RD","double_zero"
"CD015140_pub2_data","10::2","10","2","Disease-free survival (DFS) by smoking status",4,4,4,FALSE,TRUE,"RD","double_zero"
"CD015140_pub2_data","11::1","11","1","Disease-free survival (DFS) by gender",4,4,4,FALSE,TRUE,"RD","double_zero"
"CD015140_pub2_data","11::2","11","2","Disease-free survival (DFS) by gender",4,4,4,FALSE,TRUE,"RD","double_zero"
"CD015140_pub2_data","14::1","14","1","Health-related quality of life (HRQoL) - FACT-L",2,2,2,FALSE,TRUE,"RD","double_zero"
"CD015140_pub2_data","15::overall","15","overall","Health-related quality of life (HRQoL) - LCSS",2,2,2,FALSE,TRUE,"RD","double_zero"
"CD015158_pub2_data","6::overall","6","overall","Individual CF-CT scores (at 5 years)",5,5,5,FALSE,TRUE,"RD","double_zero"
"CD015158_pub2_data","18::overall","18","overall"," Quality of life: Cystic Fibrosis Questionnaire Revised (CFQ-R) score (child self-report)",8,8,8,FALSE,TRUE,"RD","double_zero"
"CD015158_pub2_data","19::overall","19","overall","Quality of life: Cystic Fibrosis Questionnaire Revised (CFQ-R) score (parent proxy report)",11,11,11,FALSE,TRUE,"RD","double_zero"
"CD015158_pub2_data","21::overall","21","overall","Pediatric Quality of Life Inventory (PedsQL) total score",2,2,2,FALSE,TRUE,"RD","double_zero"
"CD015160_pub2_data","4::overall","4","overall","Clinical recurrence or reoperation for recurrence within 30 days of repair",3,3,3,FALSE,TRUE,"RD","double_zero"
"CD015160_pub2_data","7::overall","7","overall","Mesh removal within 90 days of repair",4,4,4,FALSE,TRUE,"RD","double_zero"
"CD015213_pub2_data","11::overall","11","overall","Postoperative or post-procedural pain",8,8,8,FALSE,TRUE,"RD","double_zero"
"CD015213_pub2_data","12::overall","12","overall","Operative time",12,12,12,FALSE,TRUE,"RD","double_zero"
"CD015213_pub2_data","13::overall","13","overall","Length of hospital stay",6,6,6,FALSE,TRUE,"RD","double_zero"
"CD015213_pub2_data","14::overall","14","overall","Postoperative or post-procedural pain",2,2,2,FALSE,TRUE,"RD","double_zero"
"CD015215_pub2_data","4::overall","4","overall","Adverse event: perforation/retraction, randomised by ear (medium-term)",8,8,8,FALSE,TRUE,"RD","double_zero"
"CD015215_pub2_data","48::overall","48","overall","Generic health-related quality of life: TAIQOL (medium-term)",9,9,9,FALSE,TRUE,"RD","double_zero"
"CD015215_pub2_data","50::overall","50","overall","Literacy (long-term)",9,9,9,FALSE,TRUE,"RD","double_zero"
"CD015215_pub2_data","51::overall","51","overall","Phonological awareness (long-term)",2,2,2,FALSE,TRUE,"RD","double_zero"
"CD015215_pub2_data","52::overall","52","overall","Attention, impulsivity and psychosocial function, long-term (1): disruptive behaviour disorders, child behaviour and impairment rating",10,10,10,FALSE,TRUE,"RD","double_zero"
"CD015215_pub2_data","53::overall","53","overall","Attention, impulsivity and psychosocial function, long-term (2): social skills",2,2,2,FALSE,TRUE,"RD","double_zero"
"CD015215_pub2_data","54::overall","54","overall","Attention, impulsivity and psychosocial function, long-term: Visual and auditory continuous performance",4,4,4,FALSE,TRUE,"RD","double_zero"
"CD015215_pub2_data","55::overall","55","overall","Intelligence and academic achievement (long-term)",2,2,2,FALSE,TRUE,"RD","double_zero"
"CD015254_pub2_data","2::overall","2","overall","Hearing threshold: speech reception threshold (short-term). Correction of variance assuming correlation coefficient of 0.5",3,3,3,FALSE,TRUE,"RD","double_zero"
"CD015284_pub2_data","1::2","1","2","Seizure frequency per month",4,4,4,FALSE,TRUE,"RD","double_zero"
"CD015284_pub2_data","3::3","3","3","World Health Organization Quality of Life instrument, short version (WHOQOL- BREF) scale",2,2,2,FALSE,TRUE,"RD","double_zero"
"CD015284_pub2_data","4::1","4","1","Satisfaction With Life Scale (SWLS) scale",9,9,9,FALSE,TRUE,"RD","double_zero"
"CD015284_pub2_data","4::2","4","2","Satisfaction With Life Scale (SWLS) scale",4,4,4,FALSE,TRUE,"RD","double_zero"
"CD015284_pub2_data","4::3","4","3","Satisfaction With Life Scale (SWLS) scale",2,2,2,FALSE,TRUE,"RD","double_zero"
"CD015284_pub2_data","8::1","8","1","Washington Psychosocial Seizure Inventory (WPSI): Total score",3,3,3,FALSE,TRUE,"RD","double_zero"
"CD015284_pub2_data","9::1","9","1","Patient Health Questionnaire – 9 items (PHQ‐9): Depression",3,3,3,FALSE,TRUE,"RD","double_zero"
"CD015284_pub2_data","9::2","9","2","Patient Health Questionnaire – 9 items (PHQ‐9): Depression",3,3,3,FALSE,TRUE,"RD","double_zero"
"CD015284_pub2_data","9::3","9","3","Patient Health Questionnaire – 9 items (PHQ‐9): Depression",3,3,3,FALSE,TRUE,"RD","double_zero"
"CD015284_pub2_data","10::1","10","1","Neurological Disorders Depression Inventory for Epilepsy (NDDIE)",3,3,3,FALSE,TRUE,"RD","double_zero"
"CD015284_pub2_data","10::2","10","2","Neurological Disorders Depression Inventory for Epilepsy (NDDIE)",2,2,2,FALSE,TRUE,"RD","double_zero"
"CD015284_pub2_data","11::1","11","1","Generalized Anxiety Disorder–7 items (GAD-7)",4,4,4,FALSE,TRUE,"RD","double_zero"
"CD015284_pub2_data","11::2","11","2","Generalized Anxiety Disorder–7 items (GAD-7)",2,2,2,FALSE,TRUE,"RD","double_zero"
"CD015284_pub2_data","12::1","12","1","Depression Anxiety Stress Scales–21 items: DASS-21 total score",4,4,4,FALSE,TRUE,"RD","double_zero"
"CD015284_pub2_data","12::2","12","2","Depression Anxiety Stress Scales–21 items: DASS-21 total score",2,2,2,FALSE,TRUE,"RD","double_zero"
"CD015284_pub2_data","13::1","13","1","Work and Social Adjustment Scale (WSAS)",3,3,3,FALSE,TRUE,"RD","double_zero"
"CD015284_pub2_data","13::2","13","2","Work and Social Adjustment Scale (WSAS)",3,3,3,FALSE,TRUE,"RD","double_zero"
"CD015284_pub2_data","5::2","5","2","Change in seizure frequency per month from baseline",2,2,2,FALSE,TRUE,"RD","double_zero"
"CD015284_pub2_data","8::2","8","2","Seizure severity",2,2,2,FALSE,TRUE,"RD","double_zero"
"CD015284_pub2_data","14::1","14","1","Epilepsy and Learning Disabilities Quality of Life Scale: side effects",2,2,2,FALSE,TRUE,"RD","double_zero"
"CD015284_pub2_data","17::2","17","2","Epilepsy Self-Management Scale",2,2,2,FALSE,TRUE,"RD","double_zero"
"CD015284_pub2_data","18::2","18","2","Stigma",2,2,2,FALSE,TRUE,"RD","double_zero"
"CD015326_pub2_data","1::1","1","1","BMI (Short-term)",14,14,14,FALSE,TRUE,"RD","double_zero"
"CD015326_pub2_data","2::1","2","1","zBMI (Short-term)",2,2,2,FALSE,TRUE,"RD","double_zero"
"CD015326_pub2_data","3::overall","3","overall","zBMI (Medium-term)",10,10,10,FALSE,TRUE,"RD","double_zero"
"CD015326_pub2_data","4::overall","4","overall","BMI percentile (Short-term)",21,21,21,FALSE,TRUE,"RD","double_zero"
"CD015326_pub2_data","5::1","5","1","zBMI (Short-term) - Subgroup analysis: Socioeconomic status",2,2,2,FALSE,TRUE,"RD","double_zero"
"CD015326_pub2_data","5::2","5","2","zBMI (Short-term) - Subgroup analysis: Socioeconomic status",3,3,3,FALSE,TRUE,"RD","double_zero"
"CD015326_pub2_data","6::overall","6","overall","zBMI (Medium-term) - Sensitivity Analysis: ICC=0.04",12,12,12,FALSE,TRUE,"RD","double_zero"
"CD015326_pub2_data","1::overall","1","overall","BMI (Short-term)",8,8,8,FALSE,TRUE,"RD","double_zero"
"CD015326_pub2_data","2::overall","2","overall","BMI (Medium-term)",12,12,12,FALSE,TRUE,"RD","double_zero"
"CD015326_pub2_data","5::overall","5","overall","BMI percentile (Short-term)",17,17,17,FALSE,TRUE,"RD","double_zero"
"CD015326_pub2_data","7::1","7","1","BMI (Short-term) - Subgroup analysis: Setting of intervention",5,5,5,FALSE,TRUE,"RD","double_zero"
"CD015326_pub2_data","8::1","8","1","zBMI (Short-term) - Subgroup analysis: Setting of intervention",2,2,2,FALSE,TRUE,"RD","double_zero"
"CD015326_pub2_data","10::1","10","1","zBMI (Medium-term) - Subgroup analysis: Socioeconomic status",2,2,2,FALSE,TRUE,"RD","double_zero"
"CD015326_pub2_data","10::2","10","2","zBMI (Medium-term) - Subgroup analysis: Socioeconomic status",7,7,7,FALSE,TRUE,"RD","double_zero"
"CD015326_pub2_data","11::overall","11","overall","BMI (Short-term) - Sensitivity Analysis: ICC=0.04 ",7,7,7,FALSE,TRUE,"RD","double_zero"
"CD015326_pub2_data","13::overall","13","overall","zBMI (Short Term) -  Sensitivity Analysis ICC=0.04 ",3,3,3,FALSE,TRUE,"RD","double_zero"
"CD015326_pub2_data","14::overall","14","overall","zBMI (Medium Term) - Sensitivity Analysis ICC=0.04 ",4,4,4,FALSE,TRUE,"RD","double_zero"
"CD015326_pub2_data","7::overall","7","overall","BMI percentile (Short Term)",2,2,2,FALSE,TRUE,"RD","double_zero"
"CD015326_pub2_data","8::overall","8","overall","BMI percentile (Medium Term)",6,6,6,FALSE,TRUE,"RD","double_zero"
"CD015326_pub2_data","9::overall","9","overall","BMI percentile (Long Term)",2,2,2,FALSE,TRUE,"RD","double_zero"
"CD015326_pub2_data","10::3","10","3","BMI (Short Term) - Subgroup Analysis - Setting of Intervention",4,4,4,FALSE,TRUE,"RD","double_zero"
"CD015326_pub2_data","10::4","10","4","BMI (Short Term) - Subgroup Analysis - Setting of Intervention",4,4,4,FALSE,TRUE,"RD","double_zero"
"CD015326_pub2_data","11::1","11","1","BMI (Short Term) - Subgroup Analysis- Socioeconomic Status",6,6,6,FALSE,TRUE,"RD","double_zero"
"CD015326_pub2_data","11::2","11","2","BMI (Short Term) - Subgroup Analysis- Socioeconomic Status",7,7,7,FALSE,TRUE,"RD","double_zero"
"CD015326_pub2_data","12::2","12","2","BMI (Medium Term) - Subgroup Analysis- Setting of Intervention",3,3,3,FALSE,TRUE,"RD","double_zero"
"CD015326_pub2_data","12::3","12","3","BMI (Medium Term) - Subgroup Analysis- Setting of Intervention",3,3,3,FALSE,TRUE,"RD","double_zero"
"CD015326_pub2_data","12::4","12","4","BMI (Medium Term) - Subgroup Analysis- Setting of Intervention",3,3,3,FALSE,TRUE,"RD","double_zero"
"CD015326_pub2_data","13::1","13","1","BMI (Medium Term) - Subgroup Analysis - Socioeconomic Status",5,5,5,FALSE,TRUE,"RD","double_zero"
"CD015326_pub2_data","13::2","13","2","BMI (Medium Term) - Subgroup Analysis - Socioeconomic Status",5,5,5,FALSE,TRUE,"RD","double_zero"
"CD015326_pub2_data","14::1","14","1","BMI (Medium Term) - Subgroup Analysis - Duration of Intervention",7,7,7,FALSE,TRUE,"RD","double_zero"
"CD015326_pub2_data","14::2","14","2","BMI (Medium Term) - Subgroup Analysis - Duration of Intervention",3,3,3,FALSE,TRUE,"RD","double_zero"
"CD015326_pub2_data","15::1","15","1","BMI (Long Term) - Subgroup Analysis - Setting of Intervention",2,2,2,FALSE,TRUE,"RD","double_zero"
"CD015326_pub2_data","15::2","15","2","BMI (Long Term) - Subgroup Analysis - Setting of Intervention",3,3,3,FALSE,TRUE,"RD","double_zero"
"CD015326_pub2_data","16::1","16","1","BMI (Long Term) - Subgroup Analysis - Socioeconomic Status",4,4,4,FALSE,TRUE,"RD","double_zero"
"CD015326_pub2_data","17::1","17","1","BMI (Long Term) - Subgroup Analysis - Duration of Intervention",4,4,4,FALSE,TRUE,"RD","double_zero"
"CD015326_pub2_data","18::1","18","1","zBMI (Short Term) - Subgroup Analysis - Setting of Intervention",4,4,4,FALSE,TRUE,"RD","double_zero"
"CD015326_pub2_data","18::2","18","2","zBMI (Short Term) - Subgroup Analysis - Setting of Intervention",5,5,5,FALSE,TRUE,"RD","double_zero"
"CD015326_pub2_data","18::3","18","3","zBMI (Short Term) - Subgroup Analysis - Setting of Intervention",4,4,4,FALSE,TRUE,"RD","double_zero"
"CD015326_pub2_data","19::1","19","1","zBMI (Short Term) - Subgroup Analysis - Socioeconomic Status",9,9,9,FALSE,TRUE,"RD","double_zero"
"CD015326_pub2_data","19::2","19","2","zBMI (Short Term) - Subgroup Analysis - Socioeconomic Status",5,5,5,FALSE,TRUE,"RD","double_zero"
"CD015326_pub2_data","20::1","20","1","zBMI (Short Term) - Subgroup Analysis - Duration of Intervention",13,13,13,FALSE,TRUE,"RD","double_zero"
"CD015326_pub2_data","21::1","21","1","zBMI (Medium Term) - Subgroup Analysis - Setting of Intervention",3,3,3,FALSE,TRUE,"RD","double_zero"
"CD015326_pub2_data","21::2","21","2","zBMI (Medium Term) - Subgroup Analysis - Setting of Intervention",8,8,8,FALSE,TRUE,"RD","double_zero"
"CD015326_pub2_data","21::3","21","3","zBMI (Medium Term) - Subgroup Analysis - Setting of Intervention",3,3,3,FALSE,TRUE,"RD","double_zero"
"CD015326_pub2_data","21::4","21","4","zBMI (Medium Term) - Subgroup Analysis - Setting of Intervention",2,2,2,FALSE,TRUE,"RD","double_zero"
"CD015326_pub2_data","22::1","22","1","zBMI (Medium Term) - Subgroup Analysis - Socioeconomic Status",7,7,7,FALSE,TRUE,"RD","double_zero"
"CD015326_pub2_data","22::2","22","2","zBMI (Medium Term) - Subgroup Analysis - Socioeconomic Status",9,9,9,FALSE,TRUE,"RD","double_zero"
"CD015326_pub2_data","23::1","23","1","zBMI (Medium Term) -  Subgroup Analysis - Duration of Intervention",10,10,10,FALSE,TRUE,"RD","double_zero"
"CD015326_pub2_data","23::2","23","2","zBMI (Medium Term) -  Subgroup Analysis - Duration of Intervention",4,4,4,FALSE,TRUE,"RD","double_zero"
"CD015326_pub2_data","23::3","23","3","zBMI (Medium Term) -  Subgroup Analysis - Duration of Intervention",2,2,2,FALSE,TRUE,"RD","double_zero"
"CD015326_pub2_data","24::2","24","2","zBMI (Long Term) - Subgroup Analysis - Setting of Intervention",3,3,3,FALSE,TRUE,"RD","double_zero"
"CD015326_pub2_data","24::3","24","3","zBMI (Long Term) - Subgroup Analysis - Setting of Intervention",5,5,5,FALSE,TRUE,"RD","double_zero"
"CD015326_pub2_data","25::1","25","1","zBMI (Long Term) - Subgroup Analysis - Socioeconomic Status",7,7,7,FALSE,TRUE,"RD","double_zero"
"CD015326_pub2_data","25::2","25","2","zBMI (Long Term) - Subgroup Analysis - Socioeconomic Status",3,3,3,FALSE,TRUE,"RD","double_zero"
"CD015326_pub2_data","26::1","26","1","zBMI (Long Term) - Subgroup Analysis - Duration of Intervention",7,7,7,FALSE,TRUE,"RD","double_zero"
"CD015326_pub2_data","26::2","26","2","zBMI (Long Term) - Subgroup Analysis - Duration of Intervention",3,3,3,FALSE,TRUE,"RD","double_zero"
"CD015326_pub2_data","28::1","28","1","BMI percentile (Medium Term) - Subgroup Analysis - Setting of Intervention",3,3,3,FALSE,TRUE,"RD","double_zero"
"CD015326_pub2_data","28::2","28","2","BMI percentile (Medium Term) - Subgroup Analysis - Setting of Intervention",3,3,3,FALSE,TRUE,"RD","double_zero"
"CD015326_pub2_data","29::1","29","1","BMI percentile (Medium Term) - Subgroup Analysis - Socioeconomic Status",3,3,3,FALSE,TRUE,"RD","double_zero"
"CD015326_pub2_data","29::2","29","2","BMI percentile (Medium Term) - Subgroup Analysis - Socioeconomic Status",3,3,3,FALSE,TRUE,"RD","double_zero"
"CD015326_pub2_data","30::1","30","1","BMI percentile (Medium Term)- Subgroup Analysis - Duration of Intervention",4,4,4,FALSE,TRUE,"RD","double_zero"
"CD015326_pub2_data","30::2","30","2","BMI percentile (Medium Term)- Subgroup Analysis - Duration of Intervention",2,2,2,FALSE,TRUE,"RD","double_zero"
"CD015326_pub2_data","32::1","32","1","BMI (Short Term) - Sensitivity Analysis ICC=0.04",13,13,13,FALSE,TRUE,"RD","double_zero"
"CD015326_pub2_data","33::overall","33","overall","BMI (Medium Term) - Sensitivity Analysis ICC=0.04 ",10,10,10,FALSE,TRUE,"RD","double_zero"
"CD015326_pub2_data","34::overall","34","overall","BMI (Long Term) - Sensitivity Analysis ICC=0.04 ",5,5,5,FALSE,TRUE,"RD","double_zero"
"CD015326_pub2_data","35::overall","35","overall","BMI-z (Short Term) - Sensitivity Analysis ICC=0.04 ",14,14,14,FALSE,TRUE,"RD","double_zero"
"CD015326_pub2_data","36::overall","36","overall","zBMI (Medium Term) - Sensitivity Analysis ICC=0.04 ",16,16,16,FALSE,TRUE,"RD","double_zero"
"CD015326_pub2_data","37::overall","37","overall","zBMI (Long Term) - Sensitivity Analysis ICC=0.04 ",10,10,10,FALSE,TRUE,"RD","double_zero"
"CD015326_pub2_data","38::overall","38","overall","BMI percentile (Medium Term) - Sensitivity Analysis ICC=0.04 ",6,6,6,FALSE,TRUE,"RD","double_zero"
"CD015331_pub2_data","1::overall","1","overall","Mental state - general: mean endpoint PANSS total (high = poor)",30,30,30,FALSE,TRUE,"RD","double_zero"
"CD015331_pub2_data","2::overall","2","overall","Mental state - general: mean change PANSS total (high = poor)",3,3,3,FALSE,TRUE,"RD","double_zero"
"CD015331_pub2_data","3::overall","3","overall","Mental state - general: mean endpoint PSYRATS (high = poor)",3,3,3,FALSE,TRUE,"RD","double_zero"
"CD015331_pub2_data","4::overall","4","overall","Mental state - general: mean endpoint BPRS total (high = poor)",10,10,10,FALSE,TRUE,"RD","double_zero"
"CD015331_pub2_data","5::overall","5","overall","Mental state - general: mean endpoint overall symptom scales (high = poor) (combined time points)",22,22,22,FALSE,TRUE,"RD","double_zero"
"CD015331_pub2_data","6::overall","6","overall","Mental state - general: mean endpoint overall symptom scales (high = poor) (separated time points)",40,40,40,FALSE,TRUE,"RD","double_zero"
"CD015331_pub2_data","11::overall","11","overall","Mental state - specific: mean endpoint PANSS positive (high = poor)",30,30,30,FALSE,TRUE,"RD","double_zero"
"CD015331_pub2_data","12::overall","12","overall","Mental state - specific: mean change PANSS positive (high = poor)",3,3,3,FALSE,TRUE,"RD","double_zero"
"CD015331_pub2_data","13::overall","13","overall","Mental state - specific: mean endpoint BPRS positive (high = poor)",10,10,10,FALSE,TRUE,"RD","double_zero"
"CD015331_pub2_data","14::overall","14","overall","Mental state - specific: mean endpoint SAPS (high = poor)",4,4,4,FALSE,TRUE,"RD","double_zero"
"CD015331_pub2_data","15::overall","15","overall","Mental state - specific: mean endpoint positive symptoms scales (high = poor) (combined time points)",24,24,24,FALSE,TRUE,"RD","double_zero"
"CD015331_pub2_data","16::overall","16","overall","Mental state - specific: mean endpoint positive symptoms scales (high = poor) (separated time points)",44,44,44,FALSE,TRUE,"RD","double_zero"
"CD015331_pub2_data","17::overall","17","overall","Mental state - specific: mean endpoint PANSS negative (high = poor)",28,28,28,FALSE,TRUE,"RD","double_zero"
"CD015331_pub2_data","18::overall","18","overall","Mental state - specific: mean change PANSS negative (high = poor)",3,3,3,FALSE,TRUE,"RD","double_zero"
"CD015331_pub2_data","19::overall","19","overall","Mental state - specific: mean endpoint BPRS negative (high = poor)",4,4,4,FALSE,TRUE,"RD","double_zero"
"CD015331_pub2_data","20::overall","20","overall","Mental state - specific: mean endpoint SANS (high = poor)",10,10,10,FALSE,TRUE,"RD","double_zero"
"CD015331_pub2_data","21::overall","21","overall","Mental state - specific: mean endpoint BNSS (high = poor)",2,2,2,FALSE,TRUE,"RD","double_zero"
"CD015331_pub2_data","22::overall","22","overall","Mental state - specific: mean endpoint negative symptoms scale (high = poor) (combined time points)",24,24,24,FALSE,TRUE,"RD","double_zero"
"CD015331_pub2_data","23::overall","23","overall","Mental state - specific: mean endpoint negative symptoms scale (high = poor) (separated time points)",42,42,42,FALSE,TRUE,"RD","double_zero"
"CD015331_pub2_data","24::overall","24","overall","Mental state - specific: mean endpoint BDI short form (high = poor)",3,3,3,FALSE,TRUE,"RD","double_zero"
"CD015331_pub2_data","25::overall","25","overall","Mental state - specific: mean endpoint BDI-II (high = poor)",4,4,4,FALSE,TRUE,"RD","double_zero"
"CD015331_pub2_data","26::overall","26","overall","Mental state - specific: mean endpoint HADS Depression (high = poor)",4,4,4,FALSE,TRUE,"RD","double_zero"
"CD015331_pub2_data","27::overall","27","overall","Mental state - specific: mean endpoint CDS (high = poor)",16,16,16,FALSE,TRUE,"RD","double_zero"
"CD015331_pub2_data","28::overall","28","overall","Mental state - specific: mean change CDS (high = poor)",3,3,3,FALSE,TRUE,"RD","double_zero"
"CD015331_pub2_data","29::overall","29","overall","Mental state - specific: mean endpoint MADRS (high = poor)",2,2,2,FALSE,TRUE,"RD","double_zero"
"CD015331_pub2_data","30::overall","30","overall","Mental state - specific: mean endpoint Hamilton Depression (high = poor)",2,2,2,FALSE,TRUE,"RD","double_zero"
"CD015331_pub2_data","32::overall","32","overall","Mental state - specific: mean endpoint depressive symptoms (high = poor) (combined time points)",18,18,18,FALSE,TRUE,"RD","double_zero"
"CD015331_pub2_data","33::overall","33","overall","Mental state - specific: mean endpoint depressive symptoms (high = poor) (separated time points)",30,30,30,FALSE,TRUE,"RD","double_zero"
"CD015331_pub2_data","39::overall","39","overall","Global state - mean endpoint CGI (high = poor) (separated time points)",3,3,3,FALSE,TRUE,"RD","double_zero"
"CD015331_pub2_data","40::overall","40","overall","Global state - mean endpoint/change CGI-S (high = poor) (separated time points)",4,4,4,FALSE,TRUE,"RD","double_zero"
"CD015331_pub2_data","41::overall","41","overall","Global state - mean endpoint CGI-I (high = poor) (separated time points)",3,3,3,FALSE,TRUE,"RD","double_zero"
"CD015331_pub2_data","42::overall","42","overall","Global state - mean endpoint/change global state scales (high = poor) (combined time points)",4,4,4,FALSE,TRUE,"RD","double_zero"
"CD015331_pub2_data","43::overall","43","overall","Global state - mean endpoint/change global state scales (high = poor) (separated time points)",7,7,7,FALSE,TRUE,"RD","double_zero"
"CD015331_pub2_data","46::overall","46","overall","Service use - number of days in hospital (combined time points)",7,7,7,FALSE,TRUE,"RD","double_zero"
"CD015331_pub2_data","47::overall","47","overall","Service use - number of days in hospital (separated time points)",11,11,11,FALSE,TRUE,"RD","double_zero"
"CD015331_pub2_data","50::overall","50","overall","Functioning - mean endpoint GAF (high = good)",19,19,19,FALSE,TRUE,"RD","double_zero"
"CD015331_pub2_data","51::overall","51","overall","Functioning - mean change GAF (high = good)",2,2,2,FALSE,TRUE,"RD","double_zero"
"CD015331_pub2_data","52::overall","52","overall","Functioning - mean endpoint SOFAS (high = good)",9,9,9,FALSE,TRUE,"RD","double_zero"
"CD015331_pub2_data","53::overall","53","overall","Functioning - mean endpoint PSP (high = good)",6,6,6,FALSE,TRUE,"RD","double_zero"
"CD015331_pub2_data","55::overall","55","overall","Functioning - mean endpoint FESFS (high = good)",2,2,2,FALSE,TRUE,"RD","double_zero"
"CD015331_pub2_data","56::overall","56","overall","Functioning - mean endpoint functioning scale (high = good) (combined time points)",18,18,18,FALSE,TRUE,"RD","double_zero"
"CD015331_pub2_data","57::overall","57","overall","Functioning - mean endpoint functioning scale (high = good) (separated time points)",35,35,35,FALSE,TRUE,"RD","double_zero"
"CD015331_pub2_data","58::overall","58","overall","Quality of life - mean endpoint WHO QoL-bref (high = good)",5,5,5,FALSE,TRUE,"RD","double_zero"
"CD015331_pub2_data","59::overall","59","overall","Quality of life - mean endpoint EQ5d (WHO) (high = good)",5,5,5,FALSE,TRUE,"RD","double_zero"
"CD015331_pub2_data","60::overall","60","overall","Quality of life - mean endpoint QLS (high = good)",2,2,2,FALSE,TRUE,"RD","double_zero"
"CD015331_pub2_data","61::overall","61","overall","Quality of life - mean endpoint MSQoL (high = good)",2,2,2,FALSE,TRUE,"RD","double_zero"
"CD015331_pub2_data","62::overall","62","overall","Quality of life - mean change MSQoL (high = good)",2,2,2,FALSE,TRUE,"RD","double_zero"
"CD015331_pub2_data","63::overall","63","overall","Quality of life - MANSA (high = good)",2,2,2,FALSE,TRUE,"RD","double_zero"
"CD015331_pub2_data","64::overall","64","overall","Quality of life - mean endpoint quality of life scale (high = good) (combined time points)",9,9,9,FALSE,TRUE,"RD","double_zero"
"CD015331_pub2_data","65::overall","65","overall","Quality of life - mean endpoint quality of life scale (high = good) (separated time points)",15,15,15,FALSE,TRUE,"RD","double_zero"
"CD015331_pub2_data","76::overall","76","overall","Sensitivity analysis - Blinding of outcome assessor",21,21,21,FALSE,TRUE,"RD","double_zero"
"CD015331_pub2_data","77::overall","77","overall","Sensitivity analysis - Assumptions for missing data",17,17,17,FALSE,TRUE,"RD","double_zero"
"CD015331_pub2_data","78::overall","78","overall","Sensitivity analysis - Risk of Bias",16,16,16,FALSE,TRUE,"RD","double_zero"
"CD015331_pub2_data","79::overall","79","overall","Sensitivity analysis - Imputed values",20,20,20,FALSE,TRUE,"RD","double_zero"
"CD015331_pub2_data","80::overall","80","overall","Sensitivity analysis - Fixed-effect",22,22,22,FALSE,TRUE,"RD","double_zero"
"CD015331_pub2_data","81::overall","81","overall","Sensitivity analysis excluding outliers",21,21,21,FALSE,TRUE,"RD","double_zero"
"CD015331_pub2_data","82::overall","82","overall","Subgroup analysis - Different types of CBT",22,22,22,FALSE,TRUE,"RD","double_zero"
"CD015331_pub2_data","83::overall","83","overall","Subgroup analysis - Modality of treatment",22,22,22,FALSE,TRUE,"RD","double_zero"
"CD015331_pub2_data","84::overall","84","overall","Subgroup analysis - Method of delivery",22,22,22,FALSE,TRUE,"RD","double_zero"
"CD015331_pub2_data","85::overall","85","overall","Subgroup analysis - Control group",22,22,22,FALSE,TRUE,"RD","double_zero"
"CD015332_pub2_data","1::overall","1","overall","Mental state – general: mean endpoint PANSS total (high = poor)",11,11,11,FALSE,TRUE,"RD","double_zero"
"CD015332_pub2_data","3::overall","3","overall","Mental state – specific: mean endpoint PANSS positive (high = poor)",14,14,14,FALSE,TRUE,"RD","double_zero"
"CD015332_pub2_data","5::overall","5","overall","Mental state – specific: mean endpoint BDI (high = poor)",11,11,11,FALSE,TRUE,"RD","double_zero"
"CD015332_pub2_data","6::overall","6","overall","Mental state – specific: mean endpoint BAI (high = poor)",10,10,10,FALSE,TRUE,"RD","double_zero"
"CD015332_pub2_data","9::overall","9","overall","Service use – mean number of days in hospital ",6,6,6,FALSE,TRUE,"RD","double_zero"
"CD015332_pub2_data","11::overall","11","overall","Functioning – mean endpoint PSP (high = good)",8,8,8,FALSE,TRUE,"RD","double_zero"
"CD015332_pub2_data","18::overall","18","overall","Quality of life – mean endpoint quality of life scales (high = good)",6,6,6,FALSE,TRUE,"RD","double_zero"
"CD015332_pub2_data","25::overall","25","overall","Adverse events – mean endpoint ANNSERS (high = poor)",6,6,6,FALSE,TRUE,"RD","double_zero"
"CD015332_pub2_data","26::overall","26","overall","Functioning – mean endpoint SOFAS (high = good)",3,3,3,FALSE,TRUE,"RD","double_zero"
"CD015332_pub2_data","27::overall","27","overall","Functioning – mean endpoint functioning scales (high = good)",7,7,7,FALSE,TRUE,"RD","double_zero"
"CD015332_pub2_data","28::overall","28","overall","Quality of life – mean endpoint WHOQOL (high = good)",2,2,2,FALSE,TRUE,"RD","double_zero"
"CD015332_pub2_data","29::overall","29","overall","Quality of life – mean endpoint EQ-5D-5L (high = good)",2,2,2,FALSE,TRUE,"RD","double_zero"
"CD015332_pub2_data","30::overall","30","overall","Quality of life – mean endpoint Quality of Life Scale (high = good)",3,3,3,FALSE,TRUE,"RD","double_zero"
"CD015332_pub2_data","31::overall","31","overall","Quality of life – mean endpoint quality of life scales (high = good)",7,7,7,FALSE,TRUE,"RD","double_zero"
"CD015332_pub2_data","40::overall","40","overall","Adverse events – mean endpoint ANNSERS (high = poor)",4,4,4,FALSE,TRUE,"RD","double_zero"
"CD015332_pub2_data","41::overall","41","overall","Adverse events – mean endpoint UKU (high = poor)",5,5,5,FALSE,TRUE,"RD","double_zero"
"CD015350_pub2_data","1::1","1","1","Days to healing",5,5,5,FALSE,TRUE,"RD","double_zero"
"CD015350_pub2_data","1::2","1","2","Days to healing",6,6,6,FALSE,TRUE,"RD","double_zero"
"CD015350_pub2_data","3::1","3","1","Distance visual acuity",2,2,2,FALSE,TRUE,"RD","double_zero"
"CD015383_pub2_data","1::overall","1","overall","Anxiety on STAI-T (scale 20 to 80)",6,6,6,FALSE,TRUE,"RD","double_zero"
"CD015383_pub2_data","2::overall","2","overall","Anxiety on STAI-S (scale 20 to 80)",6,6,6,FALSE,TRUE,"RD","double_zero"
"CD015383_pub2_data","3::overall","3","overall","Depression on BDI (scale 0 to 63)",5,5,5,FALSE,TRUE,"RD","double_zero"
"CD015383_pub2_data","4::overall","4","overall","Depression on different scales (BDI, HADS-D), SMD",5,5,5,FALSE,TRUE,"RD","double_zero"
"CD015432_pub2_data","5::overall","5","overall","Pain intensity – as reported by a third party, e.g. parents and caregivers, less than 2 hours postintervention",7,7,7,FALSE,TRUE,"RD","double_zero"
"CD015432_pub2_data","11::overall","11","overall","Opioid consumption, from 24 hours up to 7 days postintervention",3,3,3,FALSE,TRUE,"RD","double_zero"
"CD015432_pub2_data","12::overall","12","overall","Time to rescue medication, as reported by a third party, e.g. parents and caregivers",5,5,5,FALSE,TRUE,"RD","double_zero"
"CD015443_pub2_data","9::overall","9","overall","QoL physical (SF-36) ",2,2,2,FALSE,TRUE,"RD","double_zero"
"CD015448_pub2_data","1::overall","1","overall","Mean change from baseline in symptom scores at 4 weeks",16,16,16,FALSE,TRUE,"RD","double_zero"
"CD015448_pub2_data","2::overall","2","overall","Mean change from baseline in symptom scores at 6 months",5,5,5,FALSE,TRUE,"RD","double_zero"
"CD015448_pub2_data","3::overall","3","overall","Mean change from baseline in meibomian gland expression scores at 4 weeks—SMD",11,11,11,FALSE,TRUE,"RD","double_zero"
"CD015448_pub2_data","4::overall","4","overall","Mean change from baseline in meibum quality scores at 4 weeks—SMD",4,4,4,FALSE,TRUE,"RD","double_zero"
"CD015448_pub2_data","5::overall","5","overall","Mean change from baseline in meibomian gland atrophy at 3 months",2,2,2,FALSE,TRUE,"RD","double_zero"
"CD015448_pub2_data","6::overall","6","overall","Mean change from baseline in tear film breakup time at 4 weeks—SMD",5,5,5,FALSE,TRUE,"RD","double_zero"
"CD015448_pub2_data","7::overall","7","overall","Mean change from baseline in non-invasive tear film breakup time at 4 weeks",3,3,3,FALSE,TRUE,"RD","double_zero"
"CD015462_pub2_data","9::overall","9","overall","Apnea: number of episodes (defined as interruption of breathing for more than 20 seconds) after 24 hours from commencing treatment over a 24-hour period",4,4,4,FALSE,TRUE,"RD","double_zero"
"CD015462_pub2_data","10::overall","10","overall","Apnea: number of episodes (defined as interruption of breathing for more than 20 seconds) after one week",5,5,5,FALSE,TRUE,"RD","double_zero"
"CD015462_pub2_data","13::overall","13","overall","Number of days of supplemental oxygen",2,2,2,FALSE,TRUE,"RD","double_zero"
"CD015476_pub2_data","3::overall","3","overall","Number of adenomas per participant",11,11,11,FALSE,TRUE,"RD","double_zero"
"CD015476_pub2_data","4::overall","4","overall","Number of polyps per participant",7,7,7,FALSE,TRUE,"RD","double_zero"
"CD015476_pub2_data","5::overall","5","overall","Number of flat polyps per participant",4,4,4,FALSE,TRUE,"RD","double_zero"
"CD015476_pub2_data","8::overall","8","overall","Number of adenomas per participant excluding studies with a high overall risk of bias",9,9,9,FALSE,TRUE,"RD","double_zero"
"CD015476_pub2_data","9::overall","9","overall","Number of polyps per participant excluding studies with a high overall risk of bias",6,6,6,FALSE,TRUE,"RD","double_zero"
"CD015476_pub2_data","13::overall","13","overall","Number of adenomas per participant excluding studies that included patients with Lynch syndrome",10,10,10,FALSE,TRUE,"RD","double_zero"
"CD015476_pub2_data","14::overall","14","overall","Number of polyps per participant excluding studies that included patients with Lynch syndrome",6,6,6,FALSE,TRUE,"RD","double_zero"
"CD015476_pub2_data","15::overall","15","overall","Number of flat polyps per participant excluding studies that included patients with Lynch syndrome",3,3,3,FALSE,TRUE,"RD","double_zero"
"CD015495_data","3::overall","3","overall","Overall survival (hazard ratio) in people aged 75 years and older, at any time point",7,7,7,FALSE,TRUE,"RD","double_zero"
"CD015514_pub2_data","3::overall","3","overall","Mean change in visual acuity (logMAR) at 3 months",2,2,2,FALSE,TRUE,"RD","double_zero"
"CD015517_data","1::overall","1","overall","CRF at 12 weeks or less after the intervention",72,72,72,FALSE,TRUE,"RD","double_zero"
"CD015517_data","2::overall","2","overall","CRF at greater than 12 weeks to less than 6 months after the intervention",40,40,40,FALSE,TRUE,"RD","double_zero"
"CD015517_data","3::overall","3","overall","CRF at 6 months or greater after the intervention",47,47,47,FALSE,TRUE,"RD","double_zero"
"CD015517_data","4::overall","4","overall","QoL at 12 weeks or less after the intervention",25,25,25,FALSE,TRUE,"RD","double_zero"
"CD015517_data","6::overall","6","overall","QoL at 6 months or greater after the intervention",6,6,6,FALSE,TRUE,"RD","double_zero"
"CD015517_data","7::overall","7","overall","Anxiety ≤ 12 weeks after the intervention ",3,3,3,FALSE,TRUE,"RD","double_zero"
"CD015517_data","8::overall","8","overall","Anxiety ≥ 6 months after the intervention",5,5,5,FALSE,TRUE,"RD","double_zero"
"CD015517_data","9::overall","9","overall","Depression ≤ 12 weeks after the intervention",4,4,4,FALSE,TRUE,"RD","double_zero"
"CD015518_data","1::overall","1","overall","Cancer-related fatigue ≤ 12 weeks",88,88,88,FALSE,TRUE,"RD","double_zero"
"CD015518_data","2::overall","2","overall","Cancer-related fatigue > 12 weeks to < 6 months",80,80,80,FALSE,TRUE,"RD","double_zero"
"CD015518_data","3::overall","3","overall","Cancer-related fatigue ≥ 6 months",18,18,18,FALSE,TRUE,"RD","double_zero"
"CD015518_data","4::overall","4","overall","Quality of life ≤ 12 weeks",13,13,13,FALSE,TRUE,"RD","double_zero"
"CD015518_data","7::overall","7","overall","Depression ≤ 12 weeks",4,4,4,FALSE,TRUE,"RD","double_zero"
"CD015519_pub2_data","1::overall","1","overall","Cancer-related fatigue (CRF) ≤ 12 weeks",13,13,13,FALSE,TRUE,"RD","double_zero"
"CD015519_pub2_data","2::overall","2","overall","CRF  ≥ 6 months",10,10,10,FALSE,TRUE,"RD","double_zero"
"CD015519_pub2_data","3::overall","3","overall","Quality of life (QoL) ≤ 12 weeks",8,8,8,FALSE,TRUE,"RD","double_zero"
"CD015519_pub2_data","5::overall","5","overall","Depression ≤ 12 weeks",2,2,2,FALSE,TRUE,"RD","double_zero"
"CD015520_data","1::overall","1","overall","CRF ≤ 12 weeks ",8,8,8,FALSE,TRUE,"RD","double_zero"
"CD015520_data","2::overall","2","overall","CRF > 12 weeks to < 6 months",2,2,2,FALSE,TRUE,"RD","double_zero"
"CD015520_data","3::overall","3","overall","CRF ≥ 6 months",6,6,6,FALSE,TRUE,"RD","double_zero"
"CD015520_data","4::overall","4","overall","QoL ≤ 12 weeks",5,5,5,FALSE,TRUE,"RD","double_zero"
"CD015520_data","5::overall","5","overall","QoL > 12 weeks to < 6 months ",5,5,5,FALSE,TRUE,"RD","double_zero"
"CD015520_data","6::overall","6","overall","Depression ≤ 12 weeks",4,4,4,FALSE,TRUE,"RD","double_zero"
"CD015520_data","7::overall","7","overall","Depression > 12 weeks to < 6 months ",3,3,3,FALSE,TRUE,"RD","double_zero"
"CD015520_data","8::overall","8","overall","Depression ≥  6 months",2,2,2,FALSE,TRUE,"RD","double_zero"
"CD015520_data","9::overall","9","overall","Anxiety ≤ 12 weeks",2,2,2,FALSE,TRUE,"RD","double_zero"
"CD015520_data","1::1","1","1","CRF ≤ 12 weeks ",14,14,14,FALSE,TRUE,"RD","double_zero"
"CD015520_data","1::2","1","2","CRF ≤ 12 weeks ",16,16,16,FALSE,TRUE,"RD","double_zero"
"CD015520_data","2::1","2","1","QoL ≤ 12 weeks",8,8,8,FALSE,TRUE,"RD","double_zero"
"CD015520_data","2::2","2","2","QoL ≤ 12 weeks",14,14,14,FALSE,TRUE,"RD","double_zero"
"CD015520_data","3::1","3","1","Depression ≤ 12 weeks",4,4,4,FALSE,TRUE,"RD","double_zero"
"CD015520_data","3::2","3","2","Depression ≤ 12 weeks",4,4,4,FALSE,TRUE,"RD","double_zero"
"CD015524_pub2_data","4::overall","4","overall","Analysis 1.4. Outcome 2: ALT (U/L)",15,15,15,FALSE,TRUE,"RD","double_zero"
"CD015524_pub2_data","6::overall","6","overall","Analysis 1.6. Outcome 3: AST (U/L)",14,14,14,FALSE,TRUE,"RD","double_zero"
"CD015524_pub2_data","26::overall","26","overall","Analysis 1.26. Outcome 14: TC (mmol/L)",5,5,5,FALSE,TRUE,"RD","double_zero"
"CD015524_pub2_data","27::overall","27","overall","Analysis 1.27. Outcome 14: TC (mmol/L): sensitivity analysis fixed-effect model",5,5,5,FALSE,TRUE,"RD","double_zero"
"CD015524_pub2_data","28::overall","28","overall","Analysis 1.28. Outcome 15: TG (mmol/L)",4,4,4,FALSE,TRUE,"RD","double_zero"
"CD015524_pub2_data","29::overall","29","overall","Analysis 1.29. Outcome 15: TG (mmol/L): sensitivity analysis fixed-effect model",4,4,4,FALSE,TRUE,"RD","double_zero"
"CD015524_pub2_data","30::overall","30","overall","Analysis 1.30. Outcome 16: HDL cholesterol (mmol/L)",6,6,6,FALSE,TRUE,"RD","double_zero"
"CD015524_pub2_data","31::overall","31","overall","Analysis 1.31. Outcome 16: HDL cholesterol (mmol/L): sensitivity analysis fixed-effect model",6,6,6,FALSE,TRUE,"RD","double_zero"
"CD015524_pub2_data","32::overall","32","overall","Analysis 1.32. Outcome 17: LDL cholesterol (mmol/L)",4,4,4,FALSE,TRUE,"RD","double_zero"
"CD015524_pub2_data","33::overall","33","overall","Analysis 1.33. Outcome 17: LDL cholesterol (mmol/L): sensitivity analysis fixed-effect model",4,4,4,FALSE,TRUE,"RD","double_zero"
"CD015524_pub2_data","34::overall","34","overall","Analysis 1.34. Outcome 18: FBS (mmol/L)",3,3,3,FALSE,TRUE,"RD","double_zero"
"CD015524_pub2_data","35::overall","35","overall","Analysis 1.35. Outcome 19: BMI (kg/m2)",5,5,5,FALSE,TRUE,"RD","double_zero"
"CD015524_pub2_data","36::overall","36","overall","Analysis 1.36. Outcome 19: BMI (kg/m2): sensitivity analysis fixed-effect model",3,3,3,FALSE,TRUE,"RD","double_zero"
"CD015526_pub2_data","3::overall","3","overall","Death",2,2,2,FALSE,TRUE,"RD","double_zero"
"CD015532_data","17::overall","17","overall","ICU length of stay",5,5,5,FALSE,TRUE,"RD","double_zero"
"CD015573_data","3::overall","3","overall","Duration of hospital stay (days)",2,2,2,FALSE,TRUE,"RD","double_zero"
"CD015584_pub2_data","3::overall","3","overall","Pain: after intrauterine device placement before clinic discharge",6,6,6,FALSE,TRUE,"RD","double_zero"
"CD015584_pub2_data","7::overall","7","overall","Patient satisfaction with procedure",2,2,2,FALSE,TRUE,"RD","double_zero"
"CD015584_pub2_data","6::overall","6","overall","Adverse events occurring before clinic discharge: uterine perforation",7,7,7,FALSE,TRUE,"RD","double_zero"
"CD015588_pub2_data","13::overall","13","overall","Stroke (Hazard Ratio)",7,7,7,FALSE,TRUE,"RD","double_zero"
"CD015588_pub2_data","19::overall","19","overall","Kidney failure (Hazard Ratio)",3,3,3,FALSE,TRUE,"RD","double_zero"
"CD015588_pub2_data","21::overall","21","overall","3P-MACE (Hazard Ratio)",10,10,10,FALSE,TRUE,"RD","double_zero"
"CD015588_pub2_data","25::overall","25","overall","Heart failure (Hazard Ratio)",5,5,5,FALSE,TRUE,"RD","double_zero"
"CD015588_pub2_data","28::overall","28","overall","eGFR",2,2,2,FALSE,TRUE,"RD","double_zero"
"CD015588_pub2_data","29::overall","29","overall","Change eGFR",3,3,3,FALSE,TRUE,"RD","double_zero"
"CD015588_pub2_data","32::overall","32","overall","Doubling of serum creatinine (Hazard Ratio)",2,2,2,FALSE,TRUE,"RD","double_zero"
"CD015588_pub2_data","34::overall","34","overall","Kidney composite outcome (Hazard Ratio)",9,9,9,FALSE,TRUE,"RD","double_zero"
"CD015588_pub2_data","43::overall","43","overall","Hypoglycaemia (Hazard Ratio)",9,9,9,FALSE,TRUE,"RD","double_zero"
"CD015588_pub2_data","45::overall","45","overall","HbA1c [%]",15,15,15,FALSE,TRUE,"RD","double_zero"
"CD015588_pub2_data","46::overall","46","overall","Change HbA1c [%]",6,6,6,FALSE,TRUE,"RD","double_zero"
"CD015588_pub2_data","50::overall","50","overall","Amputation (Hazard Ratio)",8,8,8,FALSE,TRUE,"RD","double_zero"
"CD015588_pub2_data","52::overall","52","overall","Fracture (Hazard Ratio)",11,11,11,FALSE,TRUE,"RD","double_zero"
"CD015588_pub2_data","54::overall","54","overall","Genital infection (Hazard Ratio)",13,13,13,FALSE,TRUE,"RD","double_zero"
"CD015588_pub2_data","56::overall","56","overall","Diabetic ketoacidosis (Hazard Ratio)",6,6,6,FALSE,TRUE,"RD","double_zero"
"CD015592_pub3_data","5::overall","5","overall","Apnea: number of episodes (interruption of breathing for more than 20 seconds) during the procedure",2,2,2,FALSE,TRUE,"RD","double_zero"
"CD015594_pub2_data","1::overall","1","overall","Neonatal Facial Coding System pain score during the procedure",2,2,2,FALSE,TRUE,"RD","double_zero"
"CD015636_pub2_data","1::overall","1","overall","All serotypes",2,2,2,FALSE,TRUE,"RD","double_zero"
"CD015673_pub2_data","10::overall","10","overall","Craving",3,3,3,FALSE,TRUE,"RD","double_zero"
"CD015746_pub2_data","1::overall","1","overall","Acute typhoid fever sensitivity analysis for cRCTs (Mitra 2016)",7,7,7,FALSE,TRUE,"RD","double_zero"
"CD015746_pub2_data","2::overall","2","overall","Acute typhoid fever sensitivity analysis for cRCTs (Qadri 2021)",7,7,7,FALSE,TRUE,"RD","double_zero"
"CD015746_pub2_data","3::overall","3","overall","All-cause mortality sensitivity analysis for cRCTs (Qadri 2021)",7,7,7,FALSE,TRUE,"RD","double_zero"
"CD015746_pub2_data","4::overall","4","overall","Serious adverse events sensitivity analysis for cRCTs (Qadri 2021)",7,7,7,FALSE,TRUE,"RD","double_zero"
"CD015749_pub2_data","1::overall","1","overall","Changes in physical function and strength",8,8,8,FALSE,TRUE,"RD","double_zero"
"CD015749_pub2_data","3::overall","3","overall","Body composition and weight",19,19,19,FALSE,TRUE,"RD","double_zero"
"CD015749_pub2_data","4::overall","4","overall","Appetite",7,7,7,FALSE,TRUE,"RD","double_zero"
"CD015749_pub2_data","5::overall","5","overall","Fatigue",6,6,6,FALSE,TRUE,"RD","double_zero"
"CD015749_pub2_data","6::overall","6","overall","Biochemical markers ",3,3,3,FALSE,TRUE,"RD","double_zero"
"CD015749_pub2_data","7::overall","7","overall","Biochemical markers ",6,6,6,FALSE,TRUE,"RD","double_zero"
"CD015751_pub2_data","1::overall","1","overall","Contact lens discomfort",6,6,6,FALSE,TRUE,"RD","double_zero"
"CD015751_pub2_data","3::overall","3","overall","Conjunctival redness",6,6,6,FALSE,TRUE,"RD","double_zero"
"CD015751_pub2_data","5::overall","5","overall","Comfortable lens wear time (hours)",3,3,3,FALSE,TRUE,"RD","double_zero"
"CD015751_pub2_data","6::overall","6","overall","Other dry eye symptoms",4,4,4,FALSE,TRUE,"RD","double_zero"
"CD015786_pub2_data","2::2","2","2","Progression (disease)-free survival",2,2,2,FALSE,TRUE,"RD","double_zero"
"CD015788_pub2_data","2::3","2","3","Difference in final mean adherence",2,2,2,FALSE,TRUE,"RD","double_zero"
"CD015788_pub2_data","4::1","4","1","Change in intraocular pressure (IOP) mmHg",2,2,2,FALSE,TRUE,"RD","double_zero"
"CD015788_pub2_data","4::2","4","2","Change in intraocular pressure (IOP) mmHg",2,2,2,FALSE,TRUE,"RD","double_zero"
"CD015790_pub2_data","1::overall","1","overall","Overall health-related quality of life – change score",3,3,3,FALSE,TRUE,"RD","double_zero"
"CD015790_pub2_data","2::overall","2","overall","Overall health-related quality of life – final value",3,3,3,FALSE,TRUE,"RD","double_zero"
"CD015790_pub2_data","3::overall","3","overall","Overall vision-related quality of life – change score",6,6,6,FALSE,TRUE,"RD","double_zero"
"CD015790_pub2_data","4::overall","4","overall","Overall vision-related quality of life – final value",6,6,6,FALSE,TRUE,"RD","double_zero"
"CD015790_pub2_data","6::overall","6","overall","QOL subscore: psychological well-being, emotional distress, depression and anxiety-change score",5,5,5,FALSE,TRUE,"RD","double_zero"
"CD015790_pub2_data","7::overall","7","overall","QOL subscore: psychological well-being, emotional distress, depression and anxiety-final value",7,7,7,FALSE,TRUE,"RD","double_zero"
"CD015790_pub2_data","8::overall","8","overall","QOL subscore: physical functioning-change score",4,4,4,FALSE,TRUE,"RD","double_zero"
"CD015790_pub2_data","9::overall","9","overall","QOL subscore: physical functioning-final value",6,6,6,FALSE,TRUE,"RD","double_zero"
"CD015790_pub2_data","10::overall","10","overall","QOL subscore: self-efficacy-change score",3,3,3,FALSE,TRUE,"RD","double_zero"
"CD015790_pub2_data","11::overall","11","overall","QOL subscore: self-efficacy-final value",4,4,4,FALSE,TRUE,"RD","double_zero"
"CD015790_pub2_data","12::overall","12","overall","QOL subscore: adaptation to vision loss-final value",4,4,4,FALSE,TRUE,"RD","double_zero"
"CD015804_pub2_data","1::overall","1","overall","Change from baseline in best-corrected visual acuity (BCVA) at 8 to 12 weeks",8,8,8,FALSE,TRUE,"RD","double_zero"
"CD015804_pub2_data","6::overall","6","overall","Change from baseline in the subscale and composite scores NEI-VFQ-25 at 24 to 48 weeks",2,2,2,FALSE,TRUE,"RD","double_zero"
"CD015804_pub2_data","11::overall","11","overall","Mean maximum serum concentration after first injection (ng/mL)",3,3,3,FALSE,TRUE,"RD","double_zero"
"CD015820_pub2_data","1::overall","1","overall","Objective adherence (1 week to 3 months)",7,7,7,FALSE,TRUE,"RD","double_zero"
"CD015820_pub2_data","2::overall","2","overall","Subjective adherence (3 to 6 months) - subjective physician assessment % adherence",4,4,4,FALSE,TRUE,"RD","double_zero"
"CD015820_pub2_data","5::overall","5","overall","Visual acuity (1 week to 3 months)",2,2,2,FALSE,TRUE,"RD","double_zero"
"CD015824_pub2_data","4::1","4","1","Change from baseline in 6-minute walk distance (6MWD) (subgroups with different formulations)",3,3,3,FALSE,TRUE,"RD","double_zero"
"CD015824_pub2_data","4::2","4","2","Change from baseline in 6-minute walk distance (6MWD) (subgroups with different formulations)",5,5,5,FALSE,TRUE,"RD","double_zero"
"CD015824_pub2_data","4::3","4","3","Change from baseline in 6-minute walk distance (6MWD) (subgroups with different formulations)",2,2,2,FALSE,TRUE,"RD","double_zero"
"CD015824_pub2_data","5::1","5","1","Change from baseline in 6MWD (subgroups with different study durations)",9,9,9,FALSE,TRUE,"RD","double_zero"
"CD015824_pub2_data","5::2","5","2","Change from baseline in 6MWD (subgroups with different study durations)",4,4,4,FALSE,TRUE,"RD","double_zero"
"CD015824_pub2_data","7::1","7","1","Change from baseline in Borg Dyspnea Scale",2,2,2,FALSE,TRUE,"RD","double_zero"
"CD015824_pub2_data","7::2","7","2","Change from baseline in Borg Dyspnea Scale",2,2,2,FALSE,TRUE,"RD","double_zero"
"CD015824_pub2_data","4::overall","4","overall","Change from baseline in 6-minute walk distance (6MWD)",3,3,3,FALSE,TRUE,"RD","double_zero"
"CD015849_pub2_data","16::overall","16","overall","Nonfatal myocardial infarction (Hazard ratio)",2,2,2,FALSE,TRUE,"RD","double_zero"
"CD015849_pub2_data","24::overall","24","overall","Fatal or nonfatal stroke (Hazard ratio)",2,2,2,FALSE,TRUE,"RD","double_zero"
"CD015849_pub2_data","34::overall","34","overall","Change in body weight [kg]",3,3,3,FALSE,TRUE,"RD","double_zero"
"CD015849_pub2_data","36::overall","36","overall","Change in BMI [kg/m2]",2,2,2,FALSE,TRUE,"RD","double_zero"
"CD015849_pub2_data","44::overall","44","overall","Acute kidney injury (Hazard ratio)",2,2,2,FALSE,TRUE,"RD","double_zero"
"CD015849_pub2_data","46::overall","46","overall","HbA1c [%]",3,3,3,FALSE,TRUE,"RD","double_zero"
"CD015849_pub2_data","47::overall","47","overall","Change in HbA1c [%]",2,2,2,FALSE,TRUE,"RD","double_zero"
"CD015849_pub2_data","48::overall","48","overall","Change in HbA1c [%]",5,5,5,FALSE,TRUE,"RD","double_zero"
"CD015854_data","3::3","3","3","Improvement of muscle strength (assessed with change in MMT24, measured at 12 weeks)",2,2,2,FALSE,TRUE,"RD","double_zero"
"CD015875_data","6::overall","6","overall","Diastolic blood pressure (mmHg) (10 to 19 years) ",3,3,3,FALSE,TRUE,"RD","double_zero"
"CD015894_pub2_data","1::1","1","1","Pain assessed with a validated scale for procedural pain in newborns during the procedure",8,8,8,FALSE,TRUE,"RD","double_zero"
"CD015894_pub2_data","1::2","1","2","Pain assessed with a validated scale for procedural pain in newborns during the procedure",5,5,5,FALSE,TRUE,"RD","double_zero"
"CD015894_pub2_data","2::1","2","1","Pain assessed with a validated scale for procedural pain in newborns up to 10 minutes after the procedure",4,4,4,FALSE,TRUE,"RD","double_zero"
"CD015894_pub2_data","2::2","2","2","Pain assessed with a validated scale for procedural pain in newborns up to 10 minutes after the procedure",3,3,3,FALSE,TRUE,"RD","double_zero"
"CD015894_pub2_data","3::overall","3","overall","Pain assessed with a validated scale for procedural pain in newborns at one to two hours after the procedure",4,4,4,FALSE,TRUE,"RD","double_zero"
"CD015932_pub2_data","7::overall","7","overall","ICU length of stay (days)",2,2,2,FALSE,TRUE,"RD","double_zero"
"CD015932_pub2_data","5::2","5","2","ICU length of stay (with RCT)",2,2,2,FALSE,TRUE,"RD","double_zero"
"CD015932_pub2_data","5::4","5","4","ICU length of stay (with RCT)",4,4,4,FALSE,TRUE,"RD","double_zero"
"CD016001_data","1::1","1","1","Death",21,21,21,FALSE,TRUE,"RD","double_zero"
"CD016031_data","18::2","18","2","Comparison 1: Anterior vs posterior, Outcome 18: Adverse events, not implant related (categorical data)",2,2,2,FALSE,TRUE,"RD","double_zero"
"CD016031_data","19::1","19","1","Comparison 1: Anterior vs posterior, Outcome 19: Operative details (Continuous data)",12,12,12,FALSE,TRUE,"RD","double_zero"
"CD016031_data","19::2","19","2","Comparison 1: Anterior vs posterior, Outcome 19: Operative details (Continuous data)",8,8,8,FALSE,TRUE,"RD","double_zero"
"CD016031_data","21::1","21","1","Comparison 1: Anterior vs posterior, Outcome 21: Post-operative care outcomes (Continuous data)",3,3,3,FALSE,TRUE,"RD","double_zero"
"CD016064_data","1::overall","1","overall","Rate of falls",12,12,12,FALSE,TRUE,"RD","double_zero"
"CD016064_data","2::overall","2","overall","Risk of falling",11,11,11,FALSE,TRUE,"RD","double_zero"
"CD016064_data","3::overall","3","overall","Risk of fracture",10,10,10,FALSE,TRUE,"RD","double_zero"
"CD016064_data","4::overall","4","overall","Rate of falls sensitivity analyses: excluding trials at high risk of bias",8,8,8,FALSE,TRUE,"RD","double_zero"
"CD016064_data","5::overall","5","overall","Risk of falling sensitivity analyses: excluding trials at high risk of bias",10,10,10,FALSE,TRUE,"RD","double_zero"
"CD016064_data","6::overall","6","overall","Risk of fracture sensitivity analyses: excluding trials at high risk of bias",23,23,23,FALSE,TRUE,"RD","double_zero"
"CD016064_data","1::1","1","1","Rate of falls",109,109,109,FALSE,TRUE,"RD","double_zero"
"CD016064_data","1::2","1","2","Rate of falls",45,45,45,FALSE,TRUE,"RD","double_zero"
"CD016064_data","2::1","2","1","Risk of falling",71,71,71,FALSE,TRUE,"RD","double_zero"
"CD016064_data","2::2","2","2","Risk of falling",45,45,45,FALSE,TRUE,"RD","double_zero"
"CD016064_data","3::1","3","1","Risk of fracture",46,46,46,FALSE,TRUE,"RD","double_zero"
"CD016064_data","3::2","3","2","Risk of fracture",16,16,16,FALSE,TRUE,"RD","double_zero"
"CD016064_data","4::1","4","1","Multifactorial interventions (grouped by alignment with QCA theory): Rate of falls sensitivity analyses: excluding trials at high risk of bias",15,15,15,FALSE,TRUE,"RD","double_zero"
"CD016064_data","4::2","4","2","Multifactorial interventions (grouped by alignment with QCA theory): Rate of falls sensitivity analyses: excluding trials at high risk of bias",9,9,9,FALSE,TRUE,"RD","double_zero"
"CD016064_data","6::1","6","1","Multifactorial interventions (grouped by alignment with QCA theory): Risk of fracture sensitivity analyses: excluding trials at high risk of bias",8,8,8,FALSE,TRUE,"RD","double_zero"
"CD016064_data","6::2","6","2","Multifactorial interventions (grouped by alignment with QCA theory): Risk of fracture sensitivity analyses: excluding trials at high risk of bias",2,2,2,FALSE,TRUE,"RD","double_zero"
"CD016064_data","7::overall","7","overall","Rate of falls sensitivity analysis: active exercise excluding trials with <40 participants",19,19,19,FALSE,TRUE,"RD","double_zero"
"CD016064_data","8::overall","8","overall","Rate of falls sensitivity analysis: active exercise excluding trials at high risk of bias",11,11,11,FALSE,TRUE,"RD","double_zero"
"CD016064_data","9::overall","9","overall","Risk of falling sensitivity analysis: active exercise excluding trials at high risk of bias",10,10,10,FALSE,TRUE,"RD","double_zero"
"CD016064_data","3::3","3","3","Risk of fracture",4,4,4,FALSE,TRUE,"RD","double_zero"
"CD016064_data","1::3","1","3","Rate of falls",17,17,17,FALSE,TRUE,"RD","double_zero"
"CD016064_data","1::4","1","4","Rate of falls",6,6,6,FALSE,TRUE,"RD","double_zero"
"CD016064_data","1::5","1","5","Rate of falls",3,3,3,FALSE,TRUE,"RD","double_zero"
"CD016064_data","2::3","2","3","Risk of falling",18,18,18,FALSE,TRUE,"RD","double_zero"
"CD016064_data","2::4","2","4","Risk of falling",3,3,3,FALSE,TRUE,"RD","double_zero"
"CD016064_data","2::5","2","5","Risk of falling",3,3,3,FALSE,TRUE,"RD","double_zero"
"CD016064_data","4::3","4","3","Rate of falls (grouped by level of cognition) sensitivity analysis: excluding trials at high risk of bias",3,3,3,FALSE,TRUE,"RD","double_zero"
"CD016064_data","1::6","1","6","Rate of falls",2,2,2,FALSE,TRUE,"RD","double_zero"
"CD016119_data","4::overall","4","overall","Change in haemoglobin",16,16,16,FALSE,TRUE,"RD","double_zero"
"CD016119_data","5::overall","5","overall","Length of hospitalisation",15,15,15,FALSE,TRUE,"RD","double_zero"
"CD016119_data","6::overall","6","overall","Length of hospitalisation – sensitivity analysis",13,13,13,FALSE,TRUE,"RD","double_zero"
"CD016119_data","7::overall","7","overall","Length of operation",19,19,19,FALSE,TRUE,"RD","double_zero"
"CD016119_data","10::overall","10","overall","Estimated blood loss",6,6,6,FALSE,TRUE,"RD","double_zero"
"CD016119_data","12::overall","12","overall","Postpartum haemoglobin concentration",16,16,16,FALSE,TRUE,"RD","double_zero"
"CD016119_data","14::overall","14","overall","Fatigue",2,2,2,FALSE,TRUE,"RD","double_zero"
"CD016120_data","4::overall","4","overall","Length of hospitalisation",3,3,3,FALSE,TRUE,"RD","double_zero"
"CD016120_data","5::overall","5","overall","Length of operation",2,2,2,FALSE,TRUE,"RD","double_zero"
"CD016120_data","7::overall","7","overall","Estimated blood loss",2,2,2,FALSE,TRUE,"RD","double_zero"
"CD016120_data","8::overall","8","overall"," Postpartum haemoglobin concentration",3,3,3,FALSE,TRUE,"RD","double_zero"
"CD016120_data","11::overall","11","overall","Amniotic fluid embolism",3,3,3,FALSE,TRUE,"RD","double_zero"
"CD016120_data","13::overall","13","overall","Clotting abnormalities: Prothrombin time (PT) at day 1 postpartum",3,3,3,FALSE,TRUE,"RD","double_zero"
"CD016120_data","14::overall","14","overall","Clotting abnormalities: Activated partial thromboplastin time (APTT) at day 1 postpartum",3,3,3,FALSE,TRUE,"RD","double_zero"
"CD016120_data","16::overall","16","overall","Clotting abnormalities: Red blood cell count at day 1 postpartum",2,2,2,FALSE,TRUE,"RD","double_zero"
"CD016120_data","17::overall","17","overall","Clotting abnormalities: Platelets amount at day 1 postpartum",3,3,3,FALSE,TRUE,"RD","double_zero"
"CD016120_data","18::overall","18","overall","Clotting abnormalities: Fibrinogen count at day 1 postpartum",3,3,3,FALSE,TRUE,"RD","double_zero"
"CD016136_data","1::overall","1","overall","Implementation outcome",72,72,72,FALSE,TRUE,"RD","double_zero"
"CD016136_data","2::overall","2","overall","ICC 0.07",60,60,60,FALSE,TRUE,"RD","double_zero"
"CD016136_data","3::overall","3","overall","ICC 0.351",30,30,30,FALSE,TRUE,"RD","double_zero"
"CD016136_data","4::overall","4","overall","Adjusting for clustering where the unit of analysis was unclear ",30,30,30,FALSE,TRUE,"RD","double_zero"
"CD016136_data","5::overall","5","overall","Including trials that explicitly described a trial aim or objective to test the effectiveness of an implementation strategy on an implementation outcome",13,13,13,FALSE,TRUE,"RD","double_zero"
"CD016147_data","12::overall","12","overall","Blood loss (mL)",3,3,3,FALSE,TRUE,"RD","double_zero"
"CD016278_data","13::overall","13","overall","Estimated mean blood loss (mL)",2,2,2,FALSE,TRUE,"RD","double_zero"
"CD016278_data","14::overall","14","overall","Calculated mean blood loss (mL)",3,3,3,FALSE,TRUE,"RD","double_zero"
"CD016278_data","18::overall","18","overall","Organ failure/dysfunction",2,2,2,FALSE,TRUE,"RD","double_zero"
